Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AADACL2 MGC72001 ENSG00000197953 "Arylacetamide deacetylase like 2" Q6P093 3 151733916-151761339 "Predicted secreted proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 10 "placenta: 8.6;skin 1: 26.1;tongue: 22.2" "Cell type enriched" "Detected in some" 8 "Suprabasal keratinocytes: 26.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "hTCEpi: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Secreted in other tissues" NA NA "unprognostic (2.20e-2)" "unprognostic (3.10e-3)" "unprognostic (2.63e-2)" "unprognostic (1.37e-1)" "unprognostic (1.22e-1)" "unprognostic (3.00e-1)" "unprognostic (2.91e-4)" 1.3 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.4 0.8 0.0 0.7 0.0 0.0 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.4 0.0 0.0 0.4 0.0 0.2 26.1 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.0 22.2 1.0 0.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.1 0.0 0.0 0.0 AADACL3 ENSG00000188984 "Arylacetamide deacetylase like 3" Q5VUY0 1 12716115-12728759 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "placenta: 13.4;skin 1: 4.7" "Cell type enhanced" "Detected in single" 35 "Extravillous trophoblasts: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (3.01e-1)" "unprognostic (2.54e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC007846.2 ENSG00000285471 17 5772926-6080792 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "placenta: 3.0;testis: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "RH-30: 29.7" NA NA 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 3.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 29.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC064853.3 ENSG00000284631 2 227616998-227618655 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.9;epididymis: 4.4;placenta: 8.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 18 "U-2197: 15.8" NA NA 0.0 0.0 0.9 1.4 0.0 0.5 0.0 0.0 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 8.4 0.0 0.0 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 1.2 1.3 2.9 0.8 0.6 0.8 0.4 0.1 0.4 0.3 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.7 0.6 0.0 0.1 0.2 0.4 0.0 0.0 0.2 0.0 0.3 0.1 0.1 0.2 0.8 0.1 0.0 0.1 0.3 0.2 0.1 0.3 0.1 0.0 0.1 0.2 0.3 0.2 0.1 0.2 0.0 0.0 0.2 0.2 0.3 0.7 0.3 0.1 15.8 0.3 0.2 0.1 0.5 0.1 0.1 0.4 2.9 0.8 0.4 0.6 0.4 0.2 0.7 0.4 0.4 0.2 1.2 0.7 0.8 2.1 0.6 0.4 1.3 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC064853.5 ENSG00000284667 2 227666804-227667061 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 8 "placenta: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC064853.6 ENSG00000284704 2 227614538-227614840 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 17 "placenta: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 33 "HeLa: 3.3" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC096582.3 ENSG00000283247 7 45859994-45873082 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 4 "breast: 2.8;epididymis: 1.2;placenta: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.2" NA NA 0.1 0.0 0.1 0.1 0.1 0.0 2.8 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 3.3 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.3 0.3 0.1 0.3 0.6 0.0 0.1 0.1 0.1 0.7 0.8 0.1 0.8 0.4 0.4 0.5 0.0 0.3 0.4 0.4 0.4 0.1 0.3 0.5 0.0 0.1 0.5 0.1 0.1 0.3 1.2 0.6 0.0 0.3 0.2 0.0 0.5 0.2 0.5 0.2 0.0 0.2 0.4 0.3 0.4 0.1 0.8 1.0 0.4 0.2 1.0 0.4 0.2 0.7 0.6 0.0 2.2 0.4 0.2 0.5 0.1 0.7 0.1 0.2 0.3 0.1 1.4 1.3 0.2 0.7 1.3 0.2 1.2 0.2 0.3 0.0 0.1 0.2 0.3 0.0 0.3 0.5 0.3 0.6 0.0 0.4 0.3 0.4 0.3 0.3 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC104389.5 ENSG00000284931 11 5248270-5254783 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 26 "placenta: 321.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 1409 "HEL: 431.1;K-562: 158.9" HPA043234 Uncertain NA NA "HPA043234: AB_2678378" 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 321.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 431.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 158.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACKR2 "CCBP2, CCR10, CCR9, CMKBR9, D6" ENSG00000144648 "Atypical chemokine receptor 2" O00590 3 42804752-42887974 "G-protein coupled receptors, Predicted membrane proteins" "Inflammatory response" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "placenta: 96.2;salivary gland: 74.8" "Group enriched" "Detected in many" 10 "Cytotrophoblasts: 26.5;Extravillous trophoblasts: 87.8;Syncytiotrophoblasts: 61.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "eosinophil: 7.3;NK-cell: 2.2" "Group enriched" "Detected in many" 5 "granulocytes: 7.3;NK-cells: 2.2" "Cell line enhanced" "Detected in some" "BEWO: 32.2;HEL: 10.3;SK-BR-3: 17.2;U-937: 6.5" "Group enriched" "Detected in many" 9 "amygdala: 2.3;basal ganglia: 7.0;cerebral cortex: 5.0;hippocampal formation: 2.6" "Not detected" "Not detected" "HPA013819, HPA073493" Enhanced Supported Nucleoplasm,Vesicles,Cytosol NA NA "Vesicles, Cytosol" Nucleoplasm "HPA013819: AB_1846126, HPA073493: AB_2686610" "unprognostic (1.12e-1)" "unprognostic (2.51e-1)" "unprognostic (1.90e-2)" "unprognostic (8.15e-2)" "unprognostic (7.51e-2)" "unprognostic (1.54e-2)" "unprognostic (1.21e-3)" "unprognostic (1.74e-1)" "unprognostic (2.99e-1)" "unprognostic (6.20e-2)" "unprognostic (8.47e-2)" "unprognostic (8.45e-2)" "unprognostic (1.13e-4)" "unprognostic (5.13e-3)" "unprognostic (3.22e-1)" "unprognostic (5.58e-3)" "unprognostic (6.09e-2)" 10.4 0.9 0.4 0.7 0.5 0.4 5.3 0.2 0.4 2.9 1.8 0.1 0.6 0.7 2.0 5.2 2.5 2.4 1.2 1.0 0.5 0.4 1.1 14.5 1.5 1.0 0.5 0.2 0.9 0.7 0.3 0.6 96.2 0.2 1.1 2.0 0.3 74.8 0.4 2.1 2.5 1.0 3.2 0.7 1.1 0.9 1.5 0.1 0.4 3.8 2.3 2.0 3.2 4.1 0.8 0.4 7.3 0.6 2.2 0.4 0.3 0.1 0.0 0.1 0.2 1.5 0.1 32.2 0.0 0.0 0.0 0.0 0.3 0.1 0.7 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.1 10.3 0.2 1.8 0.0 0.1 1.2 0.3 0.3 0.0 0.0 0.0 0.0 0.3 1.3 0.2 0.2 0.2 0.0 0.1 0.0 0.4 0.1 0.1 0.0 0.0 0.4 4.5 0.1 0.1 0.8 17.2 0.0 1.9 1.7 0.1 0.0 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 6.5 0.1 0.7 0.2 7.3 0.4 0.5 0.1 0.2 0.1 0.2 0.4 0.8 0.3 0.3 1.0 2.2 0.6 0.3 0.1 0.3 0.4 0.5 0.2 0.4 0.5 0.4 0.5 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.6 0.6 2.5 1.4 0.0 0.0 2.0 26.5 1.7 0.0 1.9 1.4 2.0 0.0 0.0 87.8 1.8 0.4 2.3 5.8 4.6 1.6 1.7 3.7 0.3 1.1 0.3 0.2 0.0 0.0 0.1 2.5 0.6 0.0 1.1 0.3 0.9 0.0 0.0 4.5 3.3 0.0 61.6 0.5 0.4 0.1 ACOXL FLJ11042 ENSG00000153093 "Acyl-CoA oxidase like" Q9NUZ1 2 110732573-111118222 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 29.7;lung: 20.8;placenta: 23.8" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 2: 27.4" "Group enriched" "Detected in some" 6 "lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.1" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "A-431: 9.1;RPMI-8226: 16.5;RT4: 21.3;U-266/70: 14.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA035392, HPA035393" Supported Nucleoli,Cytosol NA NA Cytosol Nucleoli "HPA035392: AB_2674604, HPA035393: AB_2674605" "unprognostic (1.62e-1)" "unprognostic (7.30e-2)" "unprognostic (6.77e-4)" "unprognostic (2.93e-7)" "unprognostic (1.32e-2)" "unprognostic (7.84e-5)" "unprognostic (1.28e-1)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (7.31e-2)" "unprognostic (7.24e-2)" "unprognostic (3.24e-1)" "unprognostic (1.72e-1)" "unprognostic (2.11e-1)" "unprognostic (2.73e-1)" "unprognostic (1.72e-1)" "prognostic favorable (6.48e-4)" 0.3 0.3 0.2 0.5 0.4 1.6 0.3 0.2 0.4 0.4 0.4 0.2 2.3 0.0 0.3 29.7 0.2 0.5 0.4 0.3 0.2 0.2 0.6 0.2 20.8 0.6 0.2 0.2 0.2 0.4 4.9 0.7 23.8 0.4 4.1 0.1 0.2 0.5 0.2 0.3 0.4 0.3 2.6 0.2 1.3 0.4 4.6 0.2 0.6 1.5 0.2 0.9 8.5 5.2 1.0 0.6 4.1 1.1 0.7 0.6 0.3 9.1 0.0 0.2 0.3 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.6 0.6 0.2 0.2 0.1 0.2 1.0 0.0 0.0 0.0 0.2 3.2 0.2 0.4 0.2 0.0 0.1 0.2 0.1 1.0 0.0 0.1 0.3 0.0 0.4 1.4 1.4 0.1 3.3 0.7 0.4 3.1 0.1 0.4 0.1 0.2 16.5 0.0 21.3 2.0 0.4 0.1 0.4 0.1 0.7 0.2 1.0 0.3 0.2 0.4 0.2 0.1 14.4 3.7 0.5 0.1 0.2 0.2 2.2 1.1 0.5 0.4 0.7 0.2 1.0 0.4 0.6 0.2 0.8 0.5 0.4 4.1 0.7 0.4 0.6 0.4 0.3 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.2 0.0 27.4 0.0 0.2 0.2 0.6 0.4 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.1 0.0 1.2 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.0 0.3 0.9 2.2 0.3 0.0 0.0 0.0 0.7 ACSS1 "ACAS2L, AceCS2L, dJ568C11.3, MGC33843" ENSG00000154930 "Acyl-CoA synthetase short chain family member 1" Q9NUB1 20 25006230-25058980 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.4" "Cell type enhanced" "Detected in many" 14 "Cytotrophoblasts: 211.3;Syncytiotrophoblasts: 350.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 19.6;JURKAT: 20.6;OE19: 25.4;RPMI-8226: 29.2;U-937: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041014, HPA043228" Enhanced NA NA "HPA041014: AB_2677251, HPA043228: AB_2678372" "unprognostic (6.87e-2)" "prognostic favorable (9.37e-4)" "unprognostic (5.32e-2)" "unprognostic (1.54e-1)" "unprognostic (2.78e-1)" "unprognostic (3.03e-2)" "unprognostic (3.20e-3)" "prognostic favorable (8.33e-5)" "unprognostic (2.44e-1)" "unprognostic (2.17e-2)" "unprognostic (2.43e-1)" "unprognostic (7.72e-2)" "unprognostic (4.58e-3)" "unprognostic (5.85e-2)" "unprognostic (2.68e-1)" "unprognostic (3.69e-1)" "unprognostic (1.60e-1)" 6.1 4.8 22.8 8.6 26.6 16.3 9.1 17.1 19.6 9.0 14.0 21.8 9.7 28.1 8.5 12.3 7.5 10.8 12.4 32.4 26.3 9.2 19.5 5.5 10.8 13.4 15.1 20.4 12.3 28.8 9.3 5.7 66.4 21.3 14.8 12.5 9.9 21.8 10.2 19.5 9.3 25.9 8.0 11.1 16.1 26.9 21.6 22.9 11.9 14.9 4.8 12.2 8.7 7.1 7.2 4.4 8.7 6.3 12.6 5.5 2.7 0.0 4.7 1.4 0.0 4.5 1.7 0.1 0.5 2.0 2.0 1.4 4.7 0.6 8.2 0.8 1.9 8.8 2.4 6.9 1.0 0.4 0.0 0.6 14.1 0.1 19.6 4.6 3.3 0.1 2.9 3.5 0.2 0.0 0.0 4.4 20.6 0.7 15.8 0.1 0.5 19.0 5.6 0.1 25.4 7.6 14.9 0.4 29.2 3.0 3.7 3.4 0.1 0.9 1.9 13.1 0.1 9.1 7.5 0.6 0.0 0.0 0.0 0.2 11.0 0.7 0.0 0.2 20.3 5.2 6.3 3.7 8.7 5.5 6.3 4.5 5.2 3.7 4.8 4.4 7.2 3.2 4.9 0.8 12.6 4.1 2.8 3.2 2.7 22.8 26.6 17.1 19.6 26.3 9.2 15.1 20.4 21.3 22.9 11.9 13.7 25.6 6.7 4.6 2.4 60.2 45.9 9.4 9.1 10.4 0.0 211.3 64.6 3.4 72.5 7.1 29.0 23.3 6.7 6.5 11.6 9.5 5.7 5.0 43.5 0.0 0.0 9.2 7.5 14.5 31.9 8.1 6.8 2.8 28.5 14.3 3.0 14.0 30.4 14.0 0.7 19.4 14.4 0.9 1.1 3.8 350.8 23.5 21.3 3.0 ACTBL2 DKFZp686D0972 ENSG00000169067 "Actin, beta like 2" Q562R1 5 57480016-57482809 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 2.4;placenta: 4.2;skin 1: 3.4" "Cell type enhanced" "Detected in some" 15 "Ductal cells: 1.3;Early spermatids: 2.3;Pancreatic endocrine cells: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.2;hTERT-RPE1: 3.4;RPTEC TERT1: 3.9;SiHa: 6.8;U-2 OS: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041264, HPA041271" Uncertain NA NA 2600000000 "HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (7.83e-2)" "unprognostic (1.70e-1)" "unprognostic (2.96e-1)" "unprognostic (8.66e-2)" "unprognostic (2.57e-2)" "unprognostic (2.39e-1)" "unprognostic (3.63e-2)" "unprognostic (1.22e-1)" "unprognostic (1.14e-3)" "unprognostic (3.20e-1)" "unprognostic (2.48e-3)" "unprognostic (1.60e-2)" "unprognostic (2.04e-2)" "unprognostic (1.92e-2)" 0.2 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.2 0.0 0.8 0.0 0.0 1.2 0.1 0.1 3.4 0.0 0.6 0.0 0.0 0.2 1.2 0.0 0.0 1.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.3 0.0 2.2 0.0 0.8 1.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.1 0.1 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.9 0.0 0.0 0.0 6.8 0.6 0.0 0.6 0.0 0.0 0.0 0.0 4.3 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 2.3 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ADAM12 "MCMPMltna, MLTN" ENSG00000148848 "ADAM metallopeptidase domain 12" O43184 10 126012381-126388455 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 50 "placenta: 487.4" "Cell type enhanced" "Detected in many" 24 "Cone photoreceptor cells: 96.2;Extravillous trophoblasts: 348.4;Syncytiotrophoblasts: 108.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 9.8" "Lineage enriched" "Detected in single" 98 "T-cells: 9.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 47.3;hTEC/SVTERT24-B: 29.7;U-2197: 29.3;U-251 MG: 26.2;U-87 MG: 22.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA030866, HPA030867, HPA030868" Enhanced Supported "Plasma membrane" "Secreted in female reproductive system" NA NA "Plasma membrane" "HPA030866: AB_2673636, HPA030867: AB_10602428, HPA030868: AB_2673638" "unprognostic (3.35e-1)" "unprognostic (1.05e-3)" "unprognostic (3.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.34e-2)" "unprognostic (2.16e-1)" "unprognostic (2.91e-6)" "unprognostic (2.17e-2)" "unprognostic (4.85e-2)" "unprognostic (1.30e-2)" "unprognostic (2.53e-2)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.39e-14)" "unprognostic (3.11e-3)" "unprognostic (9.06e-3)" "unprognostic (4.70e-3)" "unprognostic (3.47e-3)" 6.0 0.0 0.6 2.1 2.8 0.0 5.9 0.6 0.6 8.0 0.5 0.5 0.4 0.0 2.6 0.5 0.5 0.1 4.6 0.7 0.6 0.7 1.0 0.4 1.1 1.0 0.8 0.5 8.2 0.6 0.0 1.1 487.4 0.8 0.7 0.1 0.9 1.1 0.4 0.5 0.3 0.4 1.5 0.7 0.5 0.1 0.7 0.6 0.5 0.4 0.5 1.2 4.5 0.8 0.0 0.0 0.0 0.0 0.0 9.8 0.1 5.0 0.7 2.0 0.0 6.0 12.4 0.0 13.2 1.1 4.5 11.3 0.0 0.0 0.0 0.0 47.3 9.5 0.0 0.0 0.4 4.9 0.5 0.1 0.0 8.0 0.0 0.9 0.0 10.5 15.2 0.0 29.7 0.9 8.6 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.5 1.3 0.1 13.5 0.1 9.0 1.5 0.0 0.2 0.8 0.0 0.0 0.0 16.3 5.4 29.3 26.2 0.0 0.1 0.0 22.5 0.0 10.0 0.0 0.0 0.0 0.5 0.0 9.8 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.6 2.8 0.6 0.6 0.6 0.7 0.8 0.5 0.8 0.6 0.0 3.4 0.0 0.4 1.3 0.8 1.4 0.0 1.4 0.0 0.0 96.2 12.1 0.0 7.6 6.3 1.1 0.4 0.0 1.0 348.4 2.0 0.6 49.5 0.0 14.2 6.4 0.0 2.5 0.3 1.1 15.5 0.7 1.7 15.4 0.2 5.5 1.9 0.0 0.7 0.0 31.5 0.0 1.2 5.1 5.5 0.5 108.0 3.1 0.7 0.5 ADAMTS14 ENSG00000138316 "ADAM metallopeptidase with thrombospondin type 1 motif 14" Q8WXS8 10 70672803-70762441 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.4;gallbladder: 12.3;placenta: 13.5" "Group enriched" "Detected in some" 6 "granulocytes: 4.6;Paneth cells: 11.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.1" "Lineage enriched" "Detected in single" 11 "monocytes: 1.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.8;CAPAN-2: 10.4;K-562: 11.6;RH-30: 6.3;U-138 MG: 10.5" "Region enriched" "Detected in single" 5 "hippocampal formation: 0.4" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (1.30e-1)" "unprognostic (1.04e-2)" "unprognostic (5.98e-3)" "unprognostic (3.54e-3)" "unprognostic (2.17e-3)" "unprognostic (2.40e-1)" "unprognostic (5.33e-3)" "unprognostic (2.35e-1)" "unprognostic (1.06e-1)" "unprognostic (3.28e-2)" "unprognostic (3.98e-2)" "unprognostic (6.81e-2)" "unprognostic (3.84e-13)" "unprognostic (3.90e-2)" "unprognostic (1.14e-1)" "unprognostic (1.81e-1)" "unprognostic (2.16e-2)" 1.7 0.5 4.6 5.4 10.7 1.1 0.6 1.0 4.7 1.3 3.3 13.4 1.0 4.1 1.4 1.0 1.8 1.1 12.3 2.8 7.2 3.0 0.7 0.5 2.7 2.0 8.1 5.7 0.7 0.5 0.2 0.4 13.5 4.0 1.1 3.6 2.6 1.6 0.4 0.4 2.5 5.7 3.9 4.6 0.8 2.6 0.9 5.9 0.5 0.4 2.3 2.3 6.7 0.8 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 4.8 0.0 1.2 3.7 0.3 2.0 0.0 10.4 0.0 0.8 1.9 0.5 0.8 0.0 0.0 0.1 4.0 0.0 0.4 0.0 0.3 0.0 0.0 2.7 0.4 0.1 0.9 0.2 1.2 0.0 0.0 11.6 0.0 1.5 0.0 0.0 1.0 0.4 0.1 0.0 0.0 6.3 0.2 0.0 0.0 4.0 0.7 0.0 0.1 0.3 0.2 0.0 0.0 0.0 10.5 0.1 0.9 0.5 1.0 0.0 0.0 0.5 1.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 4.6 10.7 1.0 4.7 7.2 3.0 8.1 5.7 4.0 5.9 0.0 0.0 0.0 0.0 0.8 0.0 0.8 0.0 1.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.1 1.0 0.0 4.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.2 11.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.0 0.1 0.0 ADAMTS18 ADAMTS21 ENSG00000140873 "ADAM metallopeptidase with thrombospondin type 1 motif 18" Q8TE60 16 77247813-77435114 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adipose tissue: 16.1;brain: 31.9;placenta: 27.6" "Group enriched" "Detected in some" 6 "Muller glia cells: 16.4;Rod photoreceptor cells: 8.0" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in all" 5 "cerebellum: 31.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 13.2;HUVEC TERT2: 8.9;SuSa: 12.5;U-87 MG: 5.5" "Region enriched" "Detected in single" 5 "cerebellum: 3.7" "Not detected" "Not detected" HPA044326 Uncertain Approved "Midbody,Mitotic spindle" "Secreted to extracellular matrix" Yes NA "Midbody, Mitotic spindle" "HPA044326: AB_10961006" "unprognostic (1.10e-2)" "unprognostic (2.78e-1)" "unprognostic (1.38e-1)" "unprognostic (2.50e-1)" "unprognostic (8.13e-2)" "unprognostic (2.05e-2)" "unprognostic (1.09e-1)" "unprognostic (6.27e-2)" "unprognostic (2.46e-2)" "unprognostic (2.98e-1)" "unprognostic (4.11e-2)" "unprognostic (2.20e-2)" "unprognostic (8.17e-4)" "unprognostic (1.77e-5)" "unprognostic (2.17e-1)" "unprognostic (3.41e-1)" "unprognostic (2.47e-4)" 16.1 0.6 1.1 0.8 5.1 0.4 3.2 31.9 3.3 2.2 0.4 8.2 0.0 0.5 1.6 0.4 0.5 0.7 1.1 0.4 2.0 1.3 0.5 0.3 0.5 0.5 1.8 1.4 0.5 0.8 0.4 1.4 27.6 6.4 1.0 0.4 0.2 2.1 0.5 1.0 0.4 0.4 1.2 3.7 0.3 0.3 0.7 2.4 0.0 0.4 0.0 0.3 0.8 0.4 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 12.5 0.0 0.5 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.1 5.1 31.9 3.3 2.0 1.3 1.8 1.4 6.4 2.4 0.0 0.0 0.0 0.1 0.1 0.4 0.5 0.0 0.0 0.0 1.8 2.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.0 0.0 ADAMTS20 GON-1 ENSG00000173157 "ADAM metallopeptidase with thrombospondin type 1 motif 20" P59510 12 43353866-43551921 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "brain: 5.1;placenta: 3.6;retina: 1.5;testis: 2.3" "Cell type enhanced" "Detected in single" 24 "Bipolar cells: 2.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 6.6;NB-4: 2.9;NTERA-2: 5.2;SuSa: 4.4;U-266/70: 7.4;U-266/84: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027608, HPA027609" Uncertain "Secreted to extracellular matrix" NA NA "HPA027608: AB_10600098, HPA027609: AB_10599024" "unprognostic (3.18e-2)" "unprognostic (1.19e-1)" "unprognostic (1.91e-2)" "unprognostic (2.04e-1)" "unprognostic (9.61e-2)" "unprognostic (3.29e-1)" "unprognostic (6.67e-2)" "unprognostic (2.26e-1)" "unprognostic (1.05e-4)" "unprognostic (7.42e-2)" "unprognostic (2.02e-1)" "unprognostic (9.81e-3)" "unprognostic (2.57e-1)" 0.2 0.0 0.7 0.1 1.4 0.1 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.2 0.0 3.6 5.1 0.0 0.0 1.5 0.2 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 2.3 1.1 0.0 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.6 0.2 0.0 0.0 2.9 5.2 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.7 0.0 0.0 0.1 4.4 1.4 0.0 0.0 0.0 0.7 0.0 0.0 7.4 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 1.2 0.3 0.7 0.6 0.0 5.1 1.1 0.0 0.0 0.0 0.0 0.0 2.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.0 ADAMTS5 "ADAMTS11, ADMP-2" ENSG00000154736 "ADAM metallopeptidase with thrombospondin type 1 motif 5" Q9UNA0 21 26917912-26966513 "Cancer-related genes, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 21.2;placenta: 20.9" "Cell type enhanced" "Detected in many" 16 "Fibroblasts: 51.0;Leydig cells: 58.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "classical monocyte: 1.5" "Lineage enriched" "Detected in single" 6 "monocytes: 1.5" "Cell line enhanced" "Detected in some" "ASC diff: 23.9;ASC TERT1: 10.1;fHDF/TERT166: 9.5;RH-30: 25.2;U-87 MG: 9.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in single" "HPA005661, CAB025996, HPA030906, HPA030908" Approved Supported Nucleoplasm "Secreted to extracellular matrix" NA NA 18000 Nucleoplasm "CAB025996: , HPA005661: AB_1078101, HPA030906: AB_2673654, HPA030908: AB_2673655" "unprognostic (1.97e-1)" "unprognostic (2.88e-3)" "unprognostic (2.69e-2)" "unprognostic (4.01e-2)" "unprognostic (4.67e-1)" "unprognostic (2.10e-2)" "unprognostic (4.38e-8)" "unprognostic (1.11e-3)" "unprognostic (7.66e-2)" "unprognostic (6.17e-2)" "unprognostic (8.13e-2)" "unprognostic (7.76e-2)" "prognostic unfavorable (2.46e-4)" "unprognostic (6.69e-3)" "unprognostic (3.01e-1)" "prognostic unfavorable (8.54e-4)" "unprognostic (1.15e-1)" 14.1 0.4 1.0 1.6 0.6 0.0 21.2 2.5 0.9 5.5 2.3 0.4 7.2 0.3 10.7 8.2 1.2 3.3 1.0 6.9 1.0 0.0 1.6 0.8 1.2 0.4 1.1 0.4 14.9 0.4 0.1 0.4 20.9 1.5 2.2 0.8 2.3 1.8 9.7 11.0 3.3 2.4 6.2 1.1 6.4 1.8 2.3 0.4 0.6 5.3 1.5 0.6 2.8 3.1 0.0 0.2 0.0 1.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 23.9 10.1 0.0 1.3 0.2 1.4 0.5 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 2.1 0.0 0.9 0.0 0.3 0.0 2.5 0.1 0.0 5.5 0.0 1.0 0.2 0.2 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 25.2 0.0 2.2 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 6.4 0.3 1.3 0.6 0.0 0.0 0.0 9.1 0.1 1.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.6 2.5 0.9 1.0 0.0 1.1 0.4 1.5 0.4 0.0 0.3 0.0 0.1 2.6 1.9 2.6 0.0 0.0 1.2 3.5 0.0 0.8 0.0 0.0 4.8 7.1 0.0 0.0 0.2 1.4 51.0 0.2 0.0 0.0 1.8 0.0 1.7 2.5 0.0 0.8 58.1 0.8 3.3 0.0 0.0 0.0 0.0 0.0 8.5 2.2 0.0 12.9 13.7 0.0 0.5 2.6 2.3 0.0 0.0 0.1 ADAMTS6 ADAM-TS6 ENSG00000049192 "ADAM metallopeptidase with thrombospondin type 1 motif 6" Q9UKP5 5 65148736-65481920 "Cancer-related genes, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 32.4" "Cell type enhanced" "Detected in many" 7 "B-cells: 16.4;Cytotrophoblasts: 28.3;Muller glia cells: 28.3;Peritubular cells: 17.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 4.8;naive B-cell: 3.6" "Group enriched" "Detected in many" 13 "B-cells: 4.8;T-cells: 1.4" "Cell line enhanced" "Detected in many" "BJ: 10.0;HBF TERT88: 11.0;hTEC/SVTERT24-B: 10.2;hTERT-HME1: 12.2;TIME: 11.5;U-2197: 13.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA043441 Enhanced "Secreted to extracellular matrix" NA Yes "HPA043441: AB_2678484" "unprognostic (1.53e-1)" "unprognostic (1.40e-1)" "unprognostic (2.70e-3)" "unprognostic (4.33e-2)" "unprognostic (1.03e-2)" "unprognostic (2.39e-2)" "unprognostic (8.24e-2)" "unprognostic (1.65e-2)" "unprognostic (4.77e-2)" "unprognostic (8.04e-2)" "unprognostic (1.56e-1)" "unprognostic (2.13e-1)" "unprognostic (1.13e-6)" "unprognostic (3.23e-5)" "unprognostic (2.09e-1)" "unprognostic (3.02e-4)" "unprognostic (4.18e-3)" 2.2 0.7 0.9 2.0 0.8 0.3 1.8 0.2 1.8 2.9 1.4 0.8 1.6 0.6 5.1 3.0 1.0 2.7 6.3 2.3 0.8 0.9 1.5 0.5 2.3 1.7 0.8 1.4 1.8 0.5 0.4 2.0 32.4 2.9 2.3 0.9 1.4 0.6 0.9 0.4 0.8 2.4 5.4 3.2 3.4 1.8 1.9 0.7 3.3 0.9 1.2 1.9 3.6 1.7 4.8 0.2 0.0 0.0 0.0 1.4 0.1 2.1 0.0 0.5 0.5 0.0 1.7 0.0 10.0 5.9 6.2 7.4 0.0 0.2 0.0 0.0 3.8 4.4 0.4 0.1 1.9 11.0 1.5 0.0 0.1 3.7 0.2 0.3 0.0 0.5 0.7 0.0 10.2 12.2 3.0 5.5 1.0 0.0 0.0 3.8 0.0 0.5 0.0 0.0 0.2 0.0 0.3 2.1 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 1.4 0.0 0.0 11.5 2.4 3.7 13.1 8.0 0.0 0.0 0.0 2.8 0.5 0.0 0.0 0.0 0.0 1.3 0.0 1.0 4.8 0.3 0.5 0.0 3.6 1.3 1.4 0.0 0.0 0.0 0.2 0.0 0.1 0.9 0.8 0.2 1.4 0.8 0.9 0.8 1.4 2.9 0.7 0.0 0.0 16.4 0.0 0.2 7.8 2.2 0.0 0.0 0.0 3.5 0.0 28.3 0.0 0.7 12.3 9.9 0.0 0.0 0.0 3.5 4.0 0.1 1.1 0.0 2.2 0.0 0.0 5.5 0.0 6.4 11.2 2.9 0.0 0.0 0.6 28.3 1.7 0.0 17.0 0.8 0.7 6.5 4.1 4.9 1.3 0.0 11.9 0.0 0.2 0.0 ADAMTSL4 "DKFZP434K1772, TSRC1" ENSG00000143382 "ADAMTS like 4" Q6UY14 1 150549369-150560937 "Disease related genes, Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 157.1" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 113.3;Extravillous trophoblasts: 39.4;Syncytiotrophoblasts: 83.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 1.6;intermediate monocyte: 1.8;neutrophil: 2.3;non-classical monocyte: 3.5" "Group enriched" "Detected in many" 5 "granulocytes: 2.3;monocytes: 3.5" "Cell line enhanced" "Detected in many" "ASC TERT1: 30.2;BEWO: 63.6;HSkMC: 14.2;K-562: 20.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA006279 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 47000000 "Plasma membrane, Cytosol" "HPA006279: AB_1078102" "unprognostic (2.00e-2)" "unprognostic (1.24e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (8.09e-4)" "prognostic unfavorable (2.43e-4)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (7.52e-2)" "unprognostic (3.56e-2)" "unprognostic (1.68e-2)" "unprognostic (1.28e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (4.35e-7)" "unprognostic (1.90e-1)" "unprognostic (5.23e-2)" "unprognostic (1.44e-2)" "unprognostic (7.40e-3)" 14.4 2.4 0.8 8.9 1.4 2.2 13.2 0.7 1.1 11.0 8.2 1.5 3.9 2.2 9.7 8.1 19.7 11.1 6.6 10.7 1.0 0.2 3.4 14.9 13.3 2.3 1.4 0.4 14.5 1.8 0.2 1.3 157.1 3.4 9.4 2.4 19.1 5.7 2.3 21.1 5.4 6.0 17.4 2.2 3.9 8.9 3.3 1.1 0.8 3.8 15.5 4.8 19.1 15.9 0.0 0.5 2.3 3.5 0.0 0.1 0.6 6.7 0.1 0.1 1.2 6.2 30.2 63.6 6.5 5.7 3.9 2.2 0.5 2.6 0.0 1.3 4.4 0.0 3.4 0.2 0.9 1.6 0.5 0.1 1.9 0.7 2.7 5.0 0.0 0.9 14.2 0.2 0.9 2.2 3.3 0.0 0.0 20.3 0.2 0.6 0.1 0.0 0.3 1.1 0.1 0.2 0.0 0.0 0.0 0.6 0.2 0.0 0.2 2.0 5.0 0.0 3.3 1.4 3.5 1.2 0.2 1.8 2.7 0.1 0.6 0.1 1.4 0.2 1.2 0.1 0.0 1.6 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 3.5 0.0 0.0 0.6 0.8 1.4 0.7 1.1 1.0 0.2 1.4 0.4 3.4 1.1 0.0 1.0 0.8 2.1 2.2 1.0 2.0 7.6 1.4 0.0 0.0 0.0 113.3 0.0 1.1 0.4 3.5 0.0 0.0 0.5 39.4 15.5 1.3 2.3 9.2 28.7 0.0 0.0 1.3 22.6 0.0 27.9 16.5 3.3 25.2 0.0 2.4 7.4 0.0 3.2 0.0 2.4 0.0 1.4 0.0 0.9 2.5 83.2 0.0 0.1 1.7 ADGRF4 "FLJ38076, GPR115, PGR18" ENSG00000153294 "Adhesion G protein-coupled receptor F4" Q8IZF3 6 47685864-47722021 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 15.8;placenta: 23.9;skin 1: 30.7;tongue: 17.8" "Cell type enhanced" "Detected in some" 14 "Extravillous trophoblasts: 9.6;Pancreatic endocrine cells: 12.3;Syncytiotrophoblasts: 6.1;Urothelial cells: 16.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 8.7;HBEC3-KT: 13.8;hTCEpi: 21.5;OE19: 12.0;U-87 MG: 18.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA007131, HPA007158" Enhanced Uncertain Mitochondria NA NA Mitochondria "HPA007131: AB_2667756, HPA007158: AB_1849254" "unprognostic (1.40e-2)" "unprognostic (7.06e-3)" "unprognostic (2.11e-1)" "unprognostic (4.68e-2)" "unprognostic (3.79e-2)" "unprognostic (3.77e-2)" "unprognostic (2.04e-3)" "unprognostic (2.64e-1)" "unprognostic (3.47e-1)" "prognostic unfavorable (5.52e-4)" "unprognostic (2.86e-1)" "unprognostic (1.66e-8)" "unprognostic (1.62e-3)" "unprognostic (2.01e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-1)" 0.0 0.5 0.0 0.1 0.1 0.0 1.9 0.3 0.0 7.0 1.0 0.1 0.0 0.0 1.0 0.0 15.8 0.9 0.5 0.3 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 23.9 0.2 1.9 1.2 0.0 1.8 0.0 0.4 30.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 17.8 14.0 2.3 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.8 0.0 0.0 0.0 0.0 0.6 0.0 3.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.5 8.7 0.0 13.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 21.5 0.2 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 12.0 0.8 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.2 1.2 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.3 0.0 3.3 0.2 0.0 0.0 0.0 3.0 9.6 0.1 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.1 0.0 0.0 16.0 ADGRG6 "FLJ14937, GPR126" ENSG00000112414 "Adhesion G protein-coupled receptor G6" Q86SQ4 6 142301854-142446266 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "liver: 51.9;placenta: 104.9" "Cell type enriched" "Detected in many" 5 "Hepatocytes: 118.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 13 "myeloid DC: 3.5" "Lineage enriched" "Detected in single" 13 "dendritic cells: 3.5" "Cell line enhanced" "Detected in many" "A549: 25.7;Hep G2: 24.0;hTERT-HME1: 24.4;HUVEC TERT2: 47.1;MCF7: 44.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017346 Approved NA NA 70000000 "HPA017346: AB_1849260" "unprognostic (1.04e-2)" "unprognostic (2.72e-2)" "unprognostic (7.37e-2)" "unprognostic (3.00e-2)" "unprognostic (8.64e-4)" "unprognostic (1.67e-1)" "unprognostic (2.98e-1)" "prognostic unfavorable (8.78e-4)" "unprognostic (1.80e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.78e-5)" "unprognostic (4.46e-1)" "unprognostic (6.49e-2)" "unprognostic (2.15e-1)" "unprognostic (1.36e-2)" "unprognostic (2.97e-2)" "unprognostic (4.59e-2)" 5.6 1.4 1.1 4.1 1.0 0.0 6.1 0.5 1.1 4.1 14.0 1.0 2.7 8.9 2.2 2.8 9.1 2.6 8.8 4.4 1.4 1.1 5.3 51.9 12.0 2.6 1.9 0.8 1.4 3.1 0.3 0.7 104.9 1.3 7.2 3.3 3.3 6.3 3.6 1.5 7.8 17.5 5.0 2.3 6.1 6.6 1.5 0.9 2.2 2.1 3.9 4.7 11.3 9.2 0.0 3.5 0.0 0.2 0.0 0.1 0.0 4.8 25.7 0.5 2.7 0.1 0.0 0.0 6.7 1.2 5.1 3.2 20.5 14.9 0.0 6.0 3.8 1.4 12.1 0.7 6.4 8.4 0.0 2.0 1.0 4.4 24.0 5.0 4.0 0.0 0.0 10.4 0.1 24.4 2.9 47.1 0.1 0.1 0.0 2.0 44.2 0.0 0.0 0.2 1.7 5.9 0.0 2.3 5.0 2.6 10.9 0.0 0.0 1.9 9.0 4.2 4.4 4.9 0.0 1.6 0.0 2.3 2.2 3.3 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 1.0 0.5 1.1 1.4 1.1 1.9 0.8 1.3 0.9 6.0 5.1 0.5 15.4 0.0 0.0 1.4 15.3 5.3 14.8 8.7 0.0 4.8 0.0 11.5 0.0 4.4 0.8 0.0 4.7 24.6 0.6 11.8 0.0 118.8 2.0 0.0 0.0 16.5 24.7 0.2 0.6 0.6 0.0 1.0 0.9 0.0 22.8 3.6 0.4 10.3 0.0 6.5 0.5 1.6 5.1 0.0 11.3 0.0 1.8 21.0 ADM AM ENSG00000148926 Adrenomedullin P35318 11 10304680-10307397 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 133.1" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 624.9;Extravillous trophoblasts: 468.6;Syncytiotrophoblasts: 907.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 19 "neutrophil: 62.3" "Lineage enriched" "Detected in many" 19 "granulocytes: 62.3" "Cell line enhanced" "Detected in many" "ASC diff: 110.1;fHDF/TERT166: 55.0;HSkMC: 67.3;U-138 MG: 58.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB016075, HPA068955" Approved "Secreted to blood" NA NA 31000 46000 "CAB016075: AB_628693, HPA068955: " "unprognostic (1.67e-1)" "unprognostic (2.89e-2)" "unprognostic (1.78e-1)" "unprognostic (5.22e-2)" "unprognostic (1.55e-2)" "unprognostic (5.27e-3)" "prognostic unfavorable (7.56e-4)" "unprognostic (1.78e-3)" "unprognostic (1.06e-1)" "unprognostic (2.83e-1)" "unprognostic (8.13e-3)" "unprognostic (3.12e-1)" "prognostic unfavorable (6.33e-4)" "unprognostic (9.70e-3)" "unprognostic (2.01e-1)" "unprognostic (2.02e-2)" "unprognostic (1.62e-2)" 65.2 18.3 6.8 18.3 12.4 21.1 52.1 2.5 15.0 28.3 23.3 5.9 1.6 4.8 11.6 8.0 26.5 7.9 18.7 28.3 4.7 3.5 17.3 26.1 34.3 15.2 8.0 2.0 19.0 16.0 10.8 8.4 133.1 14.2 13.8 7.0 23.5 9.6 2.1 92.3 28.7 8.0 11.8 12.7 14.6 10.7 11.6 9.9 0.3 15.9 13.3 10.1 76.1 32.4 0.1 0.6 62.3 3.2 0.0 0.0 0.4 5.4 4.3 5.2 1.4 110.1 47.3 8.2 41.6 39.0 39.4 27.2 21.9 6.7 0.0 1.9 55.0 22.5 7.8 1.5 6.4 33.1 0.1 1.7 0.1 2.1 2.6 14.0 0.2 0.1 67.3 5.2 4.5 7.2 14.6 8.9 0.0 0.0 0.0 9.8 0.1 0.0 1.2 9.8 1.2 1.7 0.1 0.1 7.7 2.4 7.4 0.1 0.4 15.8 3.4 0.0 5.9 4.8 0.0 2.5 58.0 0.8 36.2 6.0 0.4 4.4 1.5 17.3 0.0 17.2 0.0 1.7 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 62.3 0.0 3.2 0.0 0.0 0.4 6.8 12.4 2.5 15.0 4.7 3.5 8.0 2.0 14.2 9.9 8.9 20.1 28.2 624.9 170.6 2.1 75.8 28.1 13.4 39.8 3.5 7.9 112.5 13.3 103.4 0.5 81.7 87.8 0.0 27.4 468.6 90.7 189.9 9.2 14.1 64.4 3.2 64.8 117.9 65.7 0.5 122.8 65.2 38.8 8.2 96.0 4.3 56.7 31.5 18.0 50.7 14.1 0.0 70.6 5.1 1.9 109.8 907.2 6.9 24.6 220.0 ADRB1 ADRB1R ENSG00000043591 "Adrenoceptor beta 1" P08588 10 114044056-114046908 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 48.0;placenta: 41.7" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 80.0;Cytotrophoblasts: 56.3;Sertoli cells: 51.8;Syncytiotrophoblasts: 32.2" "Cancer enriched" "Detected in many" 10 "prostate cancer: 12.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 10.2;PC-3: 4.0;THP-1: 6.9;TIME: 8.9;U-937: 5.2" "Group enriched" "Detected in many" 4 "amygdala: 10.0;basal ganglia: 7.3;cerebral cortex: 17.1;hippocampal formation: 11.3;thalamus: 6.9" "Low region specificity" "Detected in many" HPA067972 Enhanced NA NA "HPA067972: AB_2685936" "unprognostic (1.45e-3)" "unprognostic (1.18e-3)" "unprognostic (1.44e-1)" "unprognostic (4.92e-2)" "unprognostic (3.22e-1)" "unprognostic (8.88e-2)" "unprognostic (9.28e-2)" "unprognostic (3.52e-2)" "unprognostic (1.51e-1)" "unprognostic (1.96e-2)" "unprognostic (2.77e-4)" "unprognostic (1.33e-1)" "unprognostic (7.80e-3)" "unprognostic (1.53e-1)" "unprognostic (1.85e-1)" "unprognostic (1.59e-2)" "unprognostic (1.44e-1)" 4.3 1.0 6.9 1.1 14.0 1.3 5.9 1.0 10.7 0.8 3.1 0.8 0.0 1.8 0.9 0.9 1.9 0.8 0.9 48.0 5.6 2.4 1.7 2.5 18.3 0.9 3.5 4.4 0.8 2.4 0.9 1.2 41.7 2.6 6.5 1.6 4.5 10.7 0.8 3.1 0.9 2.3 0.9 1.3 1.7 1.4 1.0 2.5 0.0 1.0 0.0 1.1 1.1 0.4 1.4 1.9 0.1 1.3 0.0 0.5 0.1 2.1 1.3 0.2 1.3 0.0 0.0 0.3 0.1 0.1 0.2 0.2 0.5 1.6 0.3 0.4 0.0 0.6 0.4 0.1 0.1 0.3 10.2 0.6 0.4 0.2 0.2 0.0 0.4 0.7 0.0 1.1 0.0 2.1 0.2 0.3 1.6 0.1 0.1 0.2 1.2 1.6 1.4 0.5 0.3 4.0 0.3 0.4 0.1 0.0 1.7 0.2 0.4 0.0 0.8 0.1 0.5 0.3 6.9 8.9 0.3 0.1 0.2 0.2 0.0 0.1 0.5 0.0 5.2 0.2 0.0 1.3 0.0 0.5 0.9 0.0 0.6 0.1 0.3 1.9 1.4 0.0 0.4 0.1 0.0 0.1 0.2 0.0 0.1 6.9 14.0 1.0 10.7 5.6 2.4 3.5 4.4 2.6 2.5 17.9 8.5 0.0 4.2 0.9 4.7 80.0 5.1 12.0 13.6 0.0 0.0 56.3 1.7 0.0 0.1 0.7 0.0 0.0 0.2 2.1 3.7 7.1 0.0 0.2 3.9 12.7 0.0 0.6 2.4 0.0 0.0 0.6 1.7 0.0 3.1 0.7 0.1 0.3 0.4 0.0 1.2 51.8 0.8 0.5 0.0 0.0 32.2 1.5 0.4 3.1 AFF1 "AF-4, AF4, MLLT2, PBM1" ENSG00000172493 "AF4/FMR2 family member 1" P51825 4 86935002-87141054 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 121.7" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 212.1;Rod photoreceptor cells: 150.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069947 Approved Nucleoplasm,Mitochondria No No "Nucleoplasm, Mitochondria" "HPA069947: AB_2686219" "unprognostic (1.01e-1)" "unprognostic (7.56e-2)" "unprognostic (2.57e-3)" "unprognostic (1.53e-1)" "unprognostic (1.33e-1)" "unprognostic (1.55e-2)" "unprognostic (1.79e-1)" "unprognostic (6.23e-2)" "unprognostic (6.09e-2)" "unprognostic (7.13e-2)" "unprognostic (1.24e-1)" "unprognostic (8.32e-3)" "unprognostic (5.86e-2)" "unprognostic (1.33e-2)" "unprognostic (4.41e-1)" "unprognostic (2.55e-1)" "unprognostic (2.71e-2)" 33.7 16.6 8.0 11.8 9.5 19.5 26.5 6.5 12.2 20.2 21.0 10.5 18.9 11.1 27.4 16.6 15.8 18.6 15.3 22.4 10.3 5.3 27.6 15.5 18.4 12.9 9.3 5.5 24.7 19.0 28.6 18.5 121.7 9.5 16.8 14.3 27.0 16.0 25.6 58.8 18.6 16.2 20.3 11.5 13.9 15.0 6.7 10.3 17.0 38.8 21.1 13.9 19.5 26.5 11.3 14.6 21.1 5.4 5.1 8.8 2.8 7.9 7.3 6.1 6.4 10.1 12.1 8.6 8.0 11.8 6.1 9.2 7.7 14.8 9.0 11.0 9.8 7.8 3.6 9.6 12.1 8.5 15.4 3.8 18.8 19.1 6.4 7.8 18.0 14.9 9.8 8.8 10.5 9.3 8.9 22.5 7.6 11.5 25.6 2.6 2.1 16.2 5.2 8.1 13.3 2.6 12.9 3.6 11.5 18.1 7.6 13.9 2.5 12.3 8.1 3.9 13.4 4.8 15.1 11.3 11.4 10.4 6.9 4.4 22.2 12.3 15.6 9.4 20.8 4.1 3.5 5.4 11.7 6.7 4.1 7.4 8.0 8.8 6.6 6.0 11.3 4.7 4.4 21.1 5.1 2.2 14.6 7.5 2.8 8.0 9.5 6.5 12.2 10.3 5.3 9.3 5.5 9.5 10.3 38.7 57.2 25.4 12.5 21.4 44.7 96.4 40.8 40.2 31.8 87.2 212.1 0.9 3.3 11.6 6.6 38.8 30.8 46.7 10.9 3.8 14.6 24.9 23.3 27.7 11.3 17.5 31.0 65.1 43.0 5.4 27.0 25.6 21.9 8.2 40.8 22.0 11.1 31.7 26.9 40.9 150.1 25.8 15.6 3.5 6.4 27.7 27.5 15.2 25.3 14.4 AFF2 "FMR2, FRAXE" ENSG00000155966 "AF4/FMR2 family member 2" P51816 X 148500619-149000663 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.6;brain: 13.6;epididymis: 15.1;pituitary gland: 17.4;placenta: 17.4" "Cell type enhanced" "Detected in some" 12 "Cone photoreceptor cells: 21.6;Peritubular cells: 16.6;Rod photoreceptor cells: 13.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "basophil: 1.7;eosinophil: 2.5;neutrophil: 4.5" "Lineage enriched" "Detected in single" 12 "granulocytes: 4.5" "Cell line enhanced" "Detected in some" "Daudi: 30.3;HL-60: 12.8;U-698: 44.3;U-937: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003139 Approved NA NA "HPA003139: AB_1078107" "unprognostic (5.68e-2)" "unprognostic (1.96e-1)" "unprognostic (6.60e-2)" "unprognostic (9.29e-3)" "unprognostic (1.88e-2)" "unprognostic (3.96e-1)" "unprognostic (1.54e-1)" "unprognostic (5.00e-2)" "unprognostic (5.37e-2)" "unprognostic (1.59e-1)" "unprognostic (1.08e-2)" "unprognostic (5.31e-2)" "unprognostic (6.80e-2)" "unprognostic (9.78e-5)" "unprognostic (2.54e-2)" "unprognostic (1.23e-1)" "unprognostic (9.34e-2)" 1.9 0.6 4.2 5.3 3.7 13.6 1.1 13.6 5.9 4.8 0.4 0.2 1.2 0.2 0.8 15.1 0.5 0.6 2.9 1.3 10.7 5.2 0.7 0.3 3.6 6.3 2.3 5.9 2.0 0.5 0.2 17.4 17.4 3.9 1.0 0.3 0.2 0.8 2.1 0.4 1.3 0.5 0.3 2.4 0.8 0.4 2.8 0.0 5.5 1.1 0.0 7.3 1.0 0.7 0.1 0.0 4.5 0.1 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 30.3 0.0 1.7 0.0 0.0 4.7 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 12.8 0.4 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.9 0.0 1.6 3.8 1.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.5 1.7 0.0 0.5 0.0 1.4 0.1 0.1 44.3 0.0 9.4 0.0 1.7 0.1 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 4.5 0.0 0.0 0.0 0.0 0.0 4.2 3.7 13.6 5.9 10.7 5.2 2.3 5.9 3.9 0.0 0.0 0.0 0.0 0.0 0.3 4.6 1.5 0.0 0.0 0.0 0.0 21.6 0.1 0.0 0.3 6.4 0.0 0.0 0.0 0.0 0.1 1.0 0.2 5.7 0.0 0.1 1.6 0.0 0.0 0.0 3.6 7.2 0.0 0.0 1.0 0.0 0.9 0.0 0.0 16.6 0.3 13.4 6.5 0.4 0.2 0.2 0.0 0.2 0.0 0.0 0.0 AGTR1 "AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R" ENSG00000144891 "Angiotensin II receptor type 1" P30556 3 148697784-148743008 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 29.6;placenta: 44.9" "Group enriched" "Detected in many" 5 "Leydig cells: 134.3;Sertoli cells: 142.3" "Group enriched" "Detected in many" 8 "breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 64.4;ASC TERT1: 9.0;BJ hTERT+ SV40 Large T+: 12.3;HBF TERT88: 19.4;HSkMC: 11.7" "Low region specificity" "Detected in many" HPA003596 Enhanced Uncertain Vesicles NA NA Vesicles "HPA003596: AB_1845163" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.48e-4)" "unprognostic (5.28e-3)" "unprognostic (1.55e-1)" "unprognostic (3.46e-1)" "unprognostic (1.28e-2)" "unprognostic (3.26e-2)" "unprognostic (3.08e-2)" "unprognostic (9.25e-3)" "unprognostic (4.11e-2)" "unprognostic (4.79e-2)" "unprognostic (3.21e-3)" "unprognostic (1.46e-1)" "unprognostic (2.54e-1)" "unprognostic (5.41e-3)" 18.8 11.6 0.0 0.1 0.0 0.0 10.8 0.0 0.0 0.8 5.5 0.0 0.6 0.5 0.5 2.2 1.6 3.1 0.0 0.1 5.7 29.6 2.6 0.0 0.9 0.8 0.6 0.6 0.8 44.9 1.3 1.0 1.0 1.0 2.9 4.4 0.7 1.1 0.0 2.3 1.7 0.2 4.1 0.0 4.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 64.4 9.0 0.0 0.0 1.3 12.3 7.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 1.1 0.6 0.3 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 3.1 0.0 5.7 5.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.2 0.0 0.0 6.6 0.2 13.7 1.2 0.0 26.8 0.6 0.0 22.7 29.4 0.8 0.2 134.3 0.0 1.7 0.0 0.0 4.5 0.8 0.0 7.1 0.0 0.0 142.3 15.5 0.0 0.4 1.5 0.2 0.0 0.0 0.0 AHR bHLHe76 ENSG00000106546 "Aryl hydrocarbon receptor" P35869 7 16916359-17346152 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Cell cycle, Transcription, Transcription regulation" "Activator, DNA-binding, Receptor, Repressor" "Cancer-related genes, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 69.6" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 140.0;granulocytes: 130.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 28.0;hTERT-HME1: 29.2;RT4: 24.0" "CAB005072, HPA029722, HPA029723" Enhanced Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "CAB005072: AB_633731, HPA029722: AB_10599189, HPA029723: AB_10599025" "unprognostic (1.29e-2)" "unprognostic (1.21e-2)" "unprognostic (2.13e-1)" "unprognostic (1.39e-2)" "unprognostic (7.28e-2)" "unprognostic (1.22e-1)" "unprognostic (1.44e-1)" "unprognostic (3.39e-1)" "unprognostic (4.32e-2)" "unprognostic (9.98e-2)" "unprognostic (1.24e-3)" "unprognostic (2.89e-1)" "unprognostic (7.53e-3)" "unprognostic (2.00e-1)" "unprognostic (2.82e-3)" "unprognostic (3.25e-2)" "unprognostic (9.45e-2)" 23.1 12.2 2.5 13.2 3.5 19.8 19.1 1.6 3.5 14.6 14.0 5.7 8.7 8.5 11.9 10.1 14.2 11.2 22.2 14.8 3.2 2.2 7.3 23.9 26.4 20.0 6.5 2.5 21.3 6.8 4.5 3.8 69.6 3.7 21.4 8.9 10.9 11.1 8.5 5.2 16.6 13.7 12.1 4.8 15.6 13.3 6.8 4.0 7.1 12.4 7.9 12.3 26.7 26.6 1.1 9.3 5.6 7.6 3.1 2.9 2.0 3.0 2.5 1.0 0.0 7.7 5.3 0.4 6.3 9.1 2.9 4.3 3.0 6.8 0.0 1.9 9.2 11.6 8.4 0.6 5.7 7.7 0.1 1.4 1.8 3.2 2.7 14.3 3.0 4.5 7.2 28.0 11.1 29.2 13.3 9.7 0.0 0.2 0.0 13.2 1.5 0.0 4.8 0.8 23.0 4.0 0.0 0.0 0.1 9.3 24.0 0.9 0.0 4.7 5.1 4.6 7.7 3.6 1.0 1.6 1.2 0.0 15.9 0.0 1.3 0.0 0.0 20.4 11.7 20.0 0.7 7.6 5.6 0.7 3.6 1.1 0.8 2.6 1.4 9.3 1.1 1.5 1.1 0.8 3.1 1.3 2.2 2.9 2.0 2.5 3.5 1.6 3.5 3.2 2.2 6.5 2.5 3.7 4.0 140.0 72.8 9.4 40.0 66.9 34.6 12.9 43.3 42.8 75.1 7.0 7.9 3.1 0.0 15.8 4.8 55.4 13.6 0.0 13.4 1.2 31.0 42.7 130.4 40.0 24.3 41.3 5.2 44.2 75.1 2.4 3.4 73.2 67.4 36.9 10.6 0.5 24.6 16.9 2.5 5.6 5.7 6.5 41.1 2.4 2.3 78.0 18.0 7.5 12.6 90.1 AKR1B15 ENSG00000227471 "Aldo-keto reductase family 1 member B15" C9JRZ8 7 134549136-134579875 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 61.7;placenta: 31.8" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 2.3;Late spermatids: 2.7;Syncytiotrophoblasts: 8.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Lineage enhanced" "Detected in single" "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "A549: 15.5;HDLM-2: 12.3;Hep G2: 10.8;SK-BR-3: 5.2;U-87 MG: 6.6" "HPA020280, HPA073633" Uncertain Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA020280: AB_10602228, HPA073633: AB_2686620" "unprognostic (2.35e-1)" "unprognostic (3.85e-2)" "unprognostic (9.74e-3)" "unprognostic (2.74e-2)" "unprognostic (2.08e-1)" "prognostic favorable (8.36e-4)" "prognostic unfavorable (1.80e-5)" "unprognostic (5.04e-2)" "unprognostic (2.39e-1)" "unprognostic (2.75e-1)" "unprognostic (2.14e-3)" "unprognostic (1.24e-1)" "unprognostic (1.22e-7)" "unprognostic (6.88e-2)" "unprognostic (4.29e-1)" "unprognostic (2.99e-3)" "prognostic unfavorable (1.90e-5)" 2.7 0.1 0.1 0.1 0.1 0.0 61.7 0.1 0.2 1.6 0.6 0.2 0.1 5.6 0.1 1.5 3.8 0.0 2.2 0.1 0.1 0.0 0.1 0.8 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 31.8 0.2 0.8 0.2 0.5 2.9 0.1 11.6 1.9 1.7 0.8 0.4 0.1 5.0 0.6 0.1 0.3 0.4 16.1 1.8 1.5 3.0 0.1 0.0 1.8 0.1 0.4 0.0 0.3 0.0 15.5 0.2 0.0 0.6 0.5 1.0 0.0 0.4 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.7 0.1 0.0 0.1 0.0 12.3 0.1 0.1 0.2 10.8 0.0 0.2 0.5 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.2 3.2 0.3 0.0 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.6 5.2 0.0 0.1 0.1 0.3 0.0 0.1 0.7 0.4 0.0 0.2 0.2 0.2 6.6 0.2 0.2 1.8 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.1 AL049629.2 ENSG00000284969 "CD59 glycoprotein " 11 33698261-33722467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "placenta: 65.2" "Cell type enhanced" "Detected in some" 23 "Ciliated cells: 5.3;Ductal cells: 8.2;Exocrine glandular cells: 12.5;Pancreatic endocrine cells: 27.1" "Group enriched" "Detected in some" 6 "memory CD8 T-cell: 1.6;T-reg: 2.5" "Lineage enriched" "Detected in single" 8 "T-cells: 2.5" "Cell line enhanced" "Detected in many" "HBEC3-KT: 19.4;HUVEC TERT2: 24.9;TIME: 30.6;U-2197: 26.0" HPA026494 Uncertain Uncertain "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA026494: AB_1846321" 3.2 0.4 0.3 2.8 0.5 1.2 2.2 0.4 2.6 0.7 0.5 0.1 0.9 1.5 1.3 2.3 1.5 0.3 2.6 2.4 1.6 2.0 0.6 1.9 2.0 0.9 1.0 0.4 1.3 0.1 0.2 65.2 0.9 0.4 0.4 0.5 3.1 1.3 3.9 0.0 0.1 1.4 0.7 0.4 3.6 1.0 0.5 0.2 1.0 1.4 1.4 0.8 2.9 0.0 0.3 0.0 0.0 0.0 2.5 0.2 0.5 1.5 0.1 1.0 1.6 3.8 0.0 8.4 3.8 1.1 1.0 0.0 4.3 0.0 0.9 5.7 0.5 1.0 0.1 19.4 1.8 0.8 0.1 0.1 3.3 0.4 0.4 0.2 0.5 1.4 1.3 0.5 6.9 0.9 24.9 0.1 0.2 3.3 7.1 0.4 0.7 0.3 0.2 0.6 11.4 0.2 0.7 0.5 2.2 0.9 0.0 0.1 0.9 1.5 2.8 0.1 0.4 0.0 30.6 3.2 1.2 26.0 3.2 1.7 1.5 0.1 7.4 0.0 7.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 5.3 3.4 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALAS2 ASB ENSG00000158578 "5'-aminolevulinate synthase 2" P22557 X 55009055-55031064 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Heme biosynthesis" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 130.9;placenta: 53.5" "Cell type enriched" "Detected in some" 86 "Erythroid cells: 1168.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 6 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 6 "dendritic cells: 2.0" "Group enriched" "Detected in some" 87 "HEL: 32.8;K-562: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "Intracellular and membrane" NA NA "unprognostic (7.82e-2)" "unprognostic (2.01e-1)" "unprognostic (6.41e-2)" "unprognostic (1.14e-2)" "unprognostic (2.98e-3)" "unprognostic (5.59e-2)" "unprognostic (1.37e-1)" "unprognostic (1.47e-1)" "unprognostic (8.68e-2)" "unprognostic (4.07e-2)" "unprognostic (2.72e-1)" "unprognostic (3.45e-1)" "unprognostic (2.32e-2)" "unprognostic (6.63e-3)" "unprognostic (4.39e-1)" "unprognostic (1.23e-1)" "unprognostic (1.89e-1)" 1.7 0.4 0.8 0.4 0.8 130.9 0.5 0.2 0.5 0.3 0.4 0.5 0.0 0.4 0.3 0.3 2.3 1.0 0.5 2.9 0.7 0.7 1.6 2.4 17.3 0.3 1.3 0.7 6.1 2.3 0.3 1.0 53.5 2.3 2.6 0.3 1.0 0.5 0.3 3.7 0.4 0.4 1.1 0.9 22.3 0.3 0.5 0.0 0.4 3.2 0.0 0.3 7.0 6.5 0.3 2.0 0.3 0.1 0.0 0.3 10.7 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 32.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.1 0.1 0.0 0.2 0.3 0.0 0.0 2.0 0.0 10.7 0.8 0.8 0.2 0.5 0.7 0.7 1.3 0.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.8 0.0 0.0 0.0 1168.1 0.2 0.6 0.2 0.0 0.0 0.8 1.9 0.0 1.7 0.0 1.3 0.0 0.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 ALPP ENSG00000163283 "Alkaline phosphatase, placental" P05187 2 232378534-232382889 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "placenta: 240.2" "Group enriched" "Detected in some" 19 "Alveolar cells type 1: 11.9;Club cells: 3.4;Syncytiotrophoblasts: 5.6" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HaCaT: 88.1;SiHa: 24.3" "CAB026327, HPA038764, HPA038765, HPA051699" Enhanced Approved "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "CAB026327: , HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577" "unprognostic (4.86e-2)" "unprognostic (5.19e-3)" "unprognostic (6.67e-3)" "unprognostic (2.60e-1)" "unprognostic (2.44e-3)" "unprognostic (1.26e-2)" "prognostic unfavorable (4.33e-4)" "unprognostic (1.44e-1)" "unprognostic (4.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 240.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.5 1.6 0.5 1.1 0.5 0.3 0.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 9.9 0.0 0.0 0.0 0.0 88.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 24.3 8.6 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.7 0.5 0.2 0.5 0.3 0.3 0.3 0.1 1.0 0.4 0.4 1.6 1.1 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 3.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 5.6 0.0 0.0 0.0 ANKRD33 "C12orf7, DKFZp686O1689, PANKY" ENSG00000167612 "Ankyrin repeat domain 33" Q7Z3H0 12 51887960-51891664 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "placenta: 21.9;retina: 19.5" "Group enriched" "Detected in some" 23 "Cone photoreceptor cells: 157.1;Rod photoreceptor cells: 154.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA058753 Enhanced NA NA "HPA058753: AB_2683808" "unprognostic (4.42e-2)" "unprognostic (2.13e-5)" "unprognostic (8.25e-4)" "unprognostic (2.37e-1)" "unprognostic (3.25e-5)" "unprognostic (2.42e-1)" "unprognostic (4.07e-1)" "unprognostic (6.21e-2)" "unprognostic (5.51e-10)" "unprognostic (4.41e-3)" "unprognostic (5.56e-2)" "unprognostic (2.18e-1)" 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 1.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.8 21.9 0.0 0.0 0.0 19.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.0 0.0 157.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.3 0.0 0.0 0.0 154.5 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.0 0.0 ANO2 "C12orf3, TMEM16B" ENSG00000047617 "Anoctamin 2" Q9NQ90 12 5531869-5946232 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "placenta: 46.9;retina: 30.6;testis: 13.4" "Group enriched" "Detected in many" 12 "Cone photoreceptor cells: 76.6;Early spermatids: 58.6;Late spermatids: 219.4;Rod photoreceptor cells: 168.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "basophil: 5.1" "Lineage enriched" "Detected in single" 51 "granulocytes: 5.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.6;HUVEC TERT2: 8.5;U-2 OS: 22.5" "Region enriched" "Detected in some" 4 "basal ganglia: 20.0" "HPA036276, HPA057499" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA036276: AB_10670713, HPA057499: AB_2732613" "unprognostic (6.32e-2)" "unprognostic (1.01e-1)" "unprognostic (3.77e-1)" "unprognostic (1.25e-2)" "unprognostic (1.55e-1)" "unprognostic (4.05e-3)" "unprognostic (2.86e-1)" "unprognostic (2.62e-1)" "unprognostic (1.11e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-3)" "unprognostic (3.78e-3)" "unprognostic (1.04e-2)" "unprognostic (1.10e-2)" "unprognostic (9.93e-2)" "unprognostic (2.27e-1)" "unprognostic (2.17e-1)" 5.8 0.1 1.0 1.3 2.3 0.0 4.3 1.2 1.3 3.3 1.0 1.6 0.9 0.8 1.8 2.1 0.9 1.9 1.5 3.9 1.9 0.9 1.2 0.9 4.7 0.9 1.6 2.0 0.9 0.9 1.4 0.9 46.9 1.2 1.4 0.7 30.6 0.9 1.6 2.3 0.6 0.9 2.1 1.1 1.9 1.0 13.4 0.9 0.9 1.6 1.3 0.9 1.3 2.3 0.0 0.0 5.1 0.0 0.0 0.0 0.2 2.2 0.0 4.0 0.0 0.0 0.2 1.9 0.0 8.6 0.4 0.9 0.0 0.1 0.1 0.2 0.0 0.1 0.3 0.0 0.1 0.6 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.5 0.0 0.0 1.7 0.0 0.8 0.0 0.0 4.1 2.0 0.0 1.7 0.0 0.9 0.1 0.1 0.0 0.0 2.1 1.4 0.0 3.7 1.2 0.0 0.2 0.0 22.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 1.0 2.3 1.2 1.3 1.9 0.9 1.6 2.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 7.4 1.1 0.0 0.0 0.0 0.0 76.6 1.1 0.0 0.0 58.6 3.6 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.2 9.5 0.0 1.8 0.0 219.4 0.3 0.0 0.0 0.0 0.0 10.6 0.0 0.0 1.4 0.0 168.7 0.0 0.4 1.5 1.3 0.1 2.1 0.0 0.0 0.0 AOC1 "ABP1, DAO" ENSG00000002726 "Amine oxidase, copper containing 1" P19801 7 150824627-150861504 "Enzymes, Predicted secreted proteins" "Heparin-binding, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 108.6;placenta: 240.4" "Cell type enhanced" "Detected in many" 19 "Collecting duct cells: 258.2;Enterocytes: 648.3;Paneth cells: 375.2" "Group enriched" "Detected in many" 5 "colorectal cancer: 61.3;endometrial cancer: 39.1;pancreatic cancer: 26.9;renal cancer: 69.4;stomach cancer: 43.2" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 10 "eosinophil: 20.3" "Lineage enriched" "Detected in many" 20 "granulocytes: 20.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 16.4;HaCaT: 5.0;NB-4: 5.0;RPMI-8226: 6.0;THP-1: 21.4" "Not detected" "Not detected" "HPA031032, HPA031033" Approved "Secreted in other tissues" NA NA 800000 "HPA031032: AB_10670150, HPA031033: AB_10669670" "unprognostic (1.73e-2)" "unprognostic (2.53e-1)" "unprognostic (1.58e-2)" "unprognostic (2.84e-2)" "unprognostic (6.31e-3)" "unprognostic (8.31e-3)" "unprognostic (9.07e-3)" "unprognostic (6.42e-2)" "unprognostic (1.21e-1)" "unprognostic (1.96e-1)" "unprognostic (3.11e-1)" "prognostic favorable (1.71e-4)" "unprognostic (5.32e-3)" "unprognostic (3.62e-2)" "unprognostic (1.49e-2)" "unprognostic (1.69e-1)" "unprognostic (1.64e-1)" 0.3 0.3 0.3 6.7 0.3 0.0 0.3 0.3 0.3 0.9 68.3 0.2 1.2 30.2 0.3 3.9 1.7 0.3 4.4 0.3 0.3 0.3 37.9 1.5 0.3 0.6 0.3 0.1 0.3 0.6 0.0 0.3 240.4 0.1 1.3 15.5 0.1 0.4 0.2 0.3 0.8 108.6 0.2 0.3 0.4 2.7 1.8 0.1 0.7 0.3 0.1 1.0 0.4 0.4 0.0 1.0 20.3 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.8 0.1 0.0 0.0 0.0 2.5 16.4 0.0 2.2 0.0 1.4 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.3 0.1 5.0 0.2 1.5 0.0 0.0 0.0 6.0 0.2 0.1 1.8 2.1 0.0 0.7 0.0 0.3 0.6 21.4 0.5 0.2 0.1 0.5 0.0 0.2 0.1 0.1 0.1 0.8 0.0 0.1 0.1 20.3 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.1 0.1 0.0 0.0 2.2 0.0 0.0 0.0 0.3 0.0 0.0 1.2 258.2 0.0 1.1 13.3 0.0 5.7 0.0 648.3 0.0 3.0 3.0 0.2 0.9 5.7 0.0 2.8 0.0 41.6 0.0 0.0 8.4 0.0 1.3 0.0 115.4 108.6 0.0 2.2 375.2 0.0 73.1 0.0 0.0 0.1 2.8 0.7 0.1 2.9 0.0 80.4 0.3 APELA "ELA, Ende, tdl" ENSG00000248329 "Apelin receptor early endogenous ligand" P0DMC3 4 164877004-164898965 "Predicted secreted proteins" "Angiogenesis, Differentiation, Gastrulation" "Developmental protein, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 7.8;prostate: 8.2" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 22.2;Syncytiotrophoblasts: 34.2" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "neutrophil: 2.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "NTERA-2: 27.8;SuSa: 17.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (2.97e-2)" "unprognostic (6.97e-2)" "unprognostic (9.83e-4)" "unprognostic (8.92e-3)" "unprognostic (1.43e-3)" "unprognostic (4.50e-2)" "unprognostic (2.21e-1)" "unprognostic (1.71e-1)" "unprognostic (3.38e-3)" "unprognostic (1.68e-1)" "unprognostic (2.18e-2)" "unprognostic (1.89e-1)" "unprognostic (4.34e-1)" "unprognostic (8.35e-2)" "unprognostic (1.95e-4)" 0.0 0.0 0.0 0.1 0.0 0.2 2.8 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 3.9 0.0 1.5 0.1 0.0 2.2 0.7 0.0 0.0 0.0 7.8 0.0 8.2 0.0 0.0 1.9 0.0 0.0 1.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.4 0.0 0.6 0.6 2.5 0.3 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.1 0.1 0.0 0.0 0.1 0.0 0.7 0.3 0.7 0.1 0.1 0.1 0.3 0.2 0.2 0.0 0.6 0.3 0.3 2.5 0.3 0.0 0.6 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 22.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.9 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 34.2 0.0 0.0 0.0 APLN "apelin, XNPEP2" ENSG00000171388 Apelin Q9ULZ1 X 129645259-129654937 "Predicted secreted proteins" "Angiogenesis, Gastrulation, Host-virus interaction" "Developmental protein, Hormone" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.8;placenta: 52.0" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 2.2;Cardiomyocytes: 5.5;Glandular cells: 1.5;Melanocytes: 1.7" "Group enriched" "Detected in all" 6 "glioma: 44.2;renal cancer: 21.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HUVEC TERT2: 106.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA "unprognostic (1.50e-1)" "prognostic unfavorable (2.92e-4)" "unprognostic (1.57e-1)" "unprognostic (1.27e-1)" "unprognostic (4.50e-2)" "unprognostic (5.94e-2)" "prognostic unfavorable (9.32e-4)" "prognostic unfavorable (6.09e-4)" "unprognostic (4.71e-2)" "unprognostic (2.25e-1)" "unprognostic (3.30e-1)" "unprognostic (9.12e-2)" "prognostic unfavorable (9.61e-5)" "unprognostic (1.55e-1)" "unprognostic (1.15e-1)" "unprognostic (2.26e-1)" "unprognostic (8.42e-2)" 3.8 9.7 10.0 2.8 8.0 0.7 2.3 2.0 10.9 0.9 1.2 21.8 0.0 1.5 1.4 1.0 1.3 0.9 1.1 8.3 9.7 10.3 5.2 1.0 13.6 0.8 13.9 7.6 12.5 0.9 0.9 4.3 52.0 14.5 1.5 1.0 0.0 1.3 1.2 2.9 1.2 1.0 2.5 19.3 1.1 1.1 1.6 10.7 0.0 1.6 0.2 0.9 1.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.6 0.1 0.4 0.8 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.3 2.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.3 1.7 0.0 1.5 0.0 0.0 106.9 0.3 0.0 0.4 0.5 0.0 0.0 0.1 0.3 0.0 5.7 0.0 0.1 0.1 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.1 18.1 0.4 0.0 7.8 0.4 0.1 0.0 0.0 7.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 8.0 2.0 8.1 9.7 10.3 13.9 7.6 14.5 10.7 0.0 2.2 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.8 1.2 1.5 1.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 1.0 0.0 0.0 0.0 APLNR "AGTRL1, APJ, APJR, FLJ90771" ENSG00000134817 "Apelin receptor" P35414 11 57233577-57237314 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Angiogenesis, Gastrulation, Host-virus interaction" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 63.8;lymphoid tissue: 44.1;placenta: 40.4" "Group enriched" "Detected in some" 5 "Endothelial cells: 24.9;Ito cells: 12.9" "Cancer enhanced" "Detected in all" "glioma: 50.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 18 "AF22: 10.2;HEL: 8.7;K-562: 2.6;NTERA-2: 3.0;SuSa: 4.3" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" CAB025842 Approved NA NA "CAB025842: " "unprognostic (5.06e-2)" "unprognostic (3.56e-1)" "unprognostic (2.70e-2)" "unprognostic (1.00e-1)" "unprognostic (2.79e-1)" "unprognostic (6.68e-3)" "unprognostic (1.32e-2)" "unprognostic (2.55e-1)" "unprognostic (1.11e-1)" "unprognostic (1.80e-1)" "unprognostic (1.26e-1)" "unprognostic (4.72e-1)" "unprognostic (1.77e-3)" "unprognostic (3.27e-2)" "unprognostic (8.13e-2)" "unprognostic (1.13e-1)" "unprognostic (7.13e-3)" 8.4 2.1 26.1 3.8 14.2 0.0 3.3 3.8 21.0 1.2 2.3 30.8 0.0 1.8 1.6 0.0 1.8 1.2 5.7 7.2 24.8 9.3 2.5 8.0 3.5 4.0 17.3 10.2 1.2 1.4 1.9 1.5 40.4 32.8 1.2 2.8 0.2 1.7 0.8 5.8 3.0 1.7 4.7 63.8 44.1 1.5 1.2 18.2 0.1 3.1 0.6 1.8 3.8 1.5 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.0 26.1 14.2 3.8 16.3 24.8 9.3 17.3 10.2 32.8 18.2 0.0 0.0 0.0 0.0 2.1 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 24.9 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 12.9 0.6 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.8 0.1 0.0 0.0 0.0 AREG "AREGB, SDGF" ENSG00000109321 Amphiregulin P15514 4 74445134-74455009 "Cancer-related genes, Predicted membrane proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 83.5" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 759.9;Basal keratinocytes: 994.1;Enterocytes: 632.3;granulocytes: 633.9;Urothelial cells: 1407.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 9 "basophil: 8.2;eosinophil: 11.6;NK-cell: 3.3" "Group enriched" "Detected in many" 9 "granulocytes: 11.6;NK-cells: 3.3" "Cell line enhanced" "Detected in some" "CACO-2: 42.8;HBEC3-KT: 74.1;hTCEpi: 75.5;hTERT-HME1: 161.4;MCF7: 46.5" "Region enriched" "Detected in single" 4 "olfactory region: 1.5" "Low region specificity" "Detected in all" "HPA008720, CAB023519" Approved Approved Mitochondria NA NA 1520000 Mitochondria "CAB023519: AB_2060673, HPA008720: AB_1844978" "unprognostic (1.44e-2)" "unprognostic (1.84e-3)" "unprognostic (3.36e-2)" "unprognostic (2.26e-1)" "unprognostic (3.54e-3)" "prognostic unfavorable (2.61e-5)" "unprognostic (1.02e-2)" "prognostic unfavorable (1.05e-5)" "unprognostic (2.90e-1)" "unprognostic (8.06e-2)" "prognostic unfavorable (8.32e-5)" "unprognostic (2.56e-2)" "unprognostic (2.49e-3)" "unprognostic (2.40e-2)" "unprognostic (1.69e-1)" "unprognostic (1.23e-1)" "unprognostic (6.83e-3)" 19.5 1.1 0.4 9.2 2.1 28.9 20.3 0.3 0.4 5.7 6.7 0.2 0.2 0.7 1.7 1.6 22.3 6.0 34.8 13.6 0.5 0.4 2.5 1.7 14.4 13.3 0.4 0.0 5.8 1.0 0.0 7.8 83.5 1.3 1.9 5.0 1.4 3.9 0.9 9.9 3.4 10.0 1.5 1.0 11.3 5.3 4.6 0.0 1.6 1.2 13.4 13.6 8.7 4.6 0.4 0.8 11.6 0.0 3.3 0.4 0.1 1.7 12.2 0.0 0.0 0.1 0.1 0.0 0.3 0.5 0.0 0.3 42.8 6.8 0.0 0.9 0.0 0.0 1.9 0.0 74.1 0.7 0.0 0.0 0.0 0.3 2.0 23.0 0.2 0.0 0.7 75.5 4.4 161.4 0.1 0.0 0.0 0.1 0.0 1.6 46.5 0.0 0.0 0.0 8.8 4.9 0.0 0.0 0.0 4.2 0.3 0.0 0.0 2.5 0.1 0.0 0.0 1.3 0.0 0.1 0.0 1.7 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 8.2 0.0 11.6 0.0 0.0 0.0 0.3 0.4 0.0 0.8 0.4 0.2 0.0 0.1 3.3 0.0 0.1 0.0 0.1 0.4 2.1 0.3 0.4 0.5 0.4 0.4 0.0 1.3 0.0 184.6 339.4 82.8 759.9 994.1 0.0 30.5 71.4 92.3 310.5 48.8 0.0 1.3 0.0 52.7 45.1 3.9 632.3 0.0 8.6 1.2 28.2 73.6 633.9 2.9 31.8 0.0 39.8 10.4 189.5 5.9 0.3 134.1 32.1 1.8 188.0 0.0 301.5 221.0 1.1 0.5 0.0 19.4 4.4 52.0 45.0 299.4 0.9 149.6 119.9 1407.8 ARHGAP42 "AD031, FLJ32810, GRAF3, TMEM133" ENSG00000165895 "Rho GTPase activating protein 42" "A6NI28, Q9H2Q1" 11 100687653-100993941 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 38.0" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 44.7;Early spermatids: 72.6;Rod photoreceptor cells: 60.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 23.1;RH-30: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039924, HPA060528" Uncertain Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA039924: AB_10674428, HPA060528: AB_2684308" "unprognostic (1.04e-1)" "unprognostic (9.84e-2)" "unprognostic (3.21e-3)" "unprognostic (2.74e-1)" "unprognostic (1.50e-2)" "unprognostic (4.17e-2)" "unprognostic (1.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.30e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (9.29e-4)" "unprognostic (1.32e-1)" "unprognostic (1.75e-2)" "unprognostic (1.51e-1)" "unprognostic (2.65e-1)" "unprognostic (8.45e-2)" "unprognostic (1.03e-1)" 11.1 4.9 6.8 8.9 5.8 0.9 10.4 3.0 7.0 9.8 8.3 4.1 2.3 9.9 11.4 7.7 4.3 5.6 9.5 6.5 8.8 3.8 11.9 12.7 13.7 5.1 6.3 5.3 4.8 2.6 9.1 6.0 38.0 5.9 4.8 8.4 25.5 5.1 3.8 9.0 7.2 12.1 5.8 8.7 8.2 11.7 4.1 6.7 12.7 10.9 7.4 3.8 5.5 7.9 1.5 2.5 0.0 0.0 0.7 0.4 0.3 0.5 3.6 4.6 0.1 2.6 3.5 3.2 0.6 0.9 1.1 2.1 4.4 23.1 0.7 6.5 1.7 4.1 7.8 2.3 1.7 1.1 0.0 2.0 11.2 9.1 1.5 4.6 0.1 0.0 3.3 2.2 4.3 0.7 2.6 1.7 2.8 0.4 0.0 3.5 0.6 1.2 0.0 5.6 6.4 5.7 3.4 16.0 0.4 5.4 15.0 2.5 1.6 7.7 0.3 6.1 10.0 0.8 1.4 3.0 3.0 3.7 3.6 1.7 3.3 0.0 4.5 3.5 2.7 13.1 0.0 0.0 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.7 0.0 2.5 0.0 0.3 6.8 5.8 3.0 7.0 8.8 3.8 6.3 5.3 5.9 6.7 44.7 4.0 5.1 4.8 2.2 2.6 4.2 10.2 16.0 21.6 3.5 23.6 0.6 1.7 4.1 72.6 2.9 10.0 23.3 3.3 1.8 4.5 10.0 0.0 5.9 1.3 1.6 1.7 9.2 0.3 27.0 1.1 2.2 10.1 0.0 2.8 31.8 6.5 5.7 2.5 15.8 60.0 38.8 12.3 1.9 1.6 3.0 5.4 0.0 2.4 17.3 ARID3A "BRIGHT, DRIL1" ENSG00000116017 "AT-rich interaction domain 3A" Q99856 19 925781-975934 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 38.3" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 156.8;Extravillous trophoblasts: 418.2;Syncytiotrophoblasts: 433.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 64.0;CACO-2: 21.6;K-562: 27.8;THP-1: 19.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA004793, HPA076330" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA004793: AB_1847870, HPA076330: AB_2732309" "unprognostic (1.34e-1)" "unprognostic (2.62e-3)" "unprognostic (4.08e-2)" "unprognostic (1.15e-1)" "unprognostic (1.31e-3)" "unprognostic (5.67e-2)" "unprognostic (3.40e-3)" "unprognostic (1.38e-1)" "unprognostic (5.22e-2)" "unprognostic (2.54e-1)" "prognostic favorable (1.95e-5)" "unprognostic (4.00e-1)" "prognostic unfavorable (3.22e-4)" "unprognostic (3.29e-1)" "unprognostic (2.67e-3)" "unprognostic (1.30e-1)" "unprognostic (8.95e-2)" 4.0 2.3 1.7 6.2 2.3 11.5 4.4 4.8 3.8 3.6 5.0 1.6 3.3 4.2 2.9 2.9 4.1 2.7 3.2 2.1 2.2 1.5 4.4 2.6 6.1 7.8 2.8 2.0 1.6 5.5 3.4 4.1 38.3 2.1 2.3 1.8 2.6 2.8 5.6 2.0 3.3 5.0 2.6 2.4 8.3 3.4 17.8 2.5 6.6 2.1 2.1 4.6 4.0 6.9 1.5 9.2 6.4 2.9 1.9 0.5 0.8 1.1 1.5 5.3 1.3 2.2 1.7 64.0 5.0 3.2 2.7 1.8 21.6 0.1 0.4 1.2 1.7 0.6 0.4 2.1 1.1 1.2 6.6 1.5 2.1 1.9 19.4 0.9 7.4 5.5 2.4 1.7 1.7 0.4 0.4 0.9 1.7 27.8 6.2 0.7 1.7 2.8 8.4 5.1 0.8 0.3 6.5 1.6 4.1 0.3 1.1 2.5 4.9 1.6 1.3 0.9 12.3 2.3 19.9 1.5 1.8 2.4 2.5 0.5 14.6 13.0 3.8 1.1 4.3 1.2 0.8 2.4 1.6 0.5 2.1 0.5 1.5 0.3 0.4 1.5 0.9 0.5 0.2 6.4 1.9 2.9 9.2 0.3 0.8 1.7 2.3 4.8 3.8 2.2 1.5 2.8 2.0 2.1 2.5 6.0 3.2 27.9 7.8 13.2 8.8 6.5 0.0 0.0 1.2 14.0 7.9 156.8 8.3 4.8 29.9 7.8 3.2 23.3 2.8 418.2 16.2 7.5 3.5 6.7 78.2 6.4 45.1 9.8 34.1 2.0 6.6 32.5 15.1 35.1 11.2 2.3 9.8 0.0 6.0 4.5 3.3 0.0 12.8 0.6 8.5 13.4 433.4 10.9 4.3 1.8 ARL14EPL ENSG00000268223 "ADP ribosylation factor like GTPase 14 effector protein like" P0DKL9 5 116032324-116060118 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "placenta: 5.9" "Cell type enhanced" "Detected in some" 21 "Collecting duct cells: 1.8;Early spermatids: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 7 "intermediate monocyte: 1.9;MAIT T-cell: 2.9;non-classical monocyte: 1.4" "Group enriched" "Detected in many" 8 "monocytes: 1.9;T-cells: 2.9" "Cell line enriched" "Detected in some" 30 "HDLM-2: 60.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" NA NA "unprognostic (1.41e-1)" "unprognostic (3.84e-1)" "unprognostic (2.51e-2)" "unprognostic (6.47e-3)" "unprognostic (1.60e-2)" "unprognostic (3.79e-2)" "unprognostic (4.05e-2)" "unprognostic (1.40e-1)" "unprognostic (1.50e-1)" "unprognostic (7.65e-2)" 0.8 0.2 0.1 1.3 1.0 2.5 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.5 0.0 0.1 0.2 0.6 0.1 1.4 1.6 1.1 0.0 0.6 0.0 0.0 1.1 5.9 1.4 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.5 0.0 0.5 0.8 0.1 1.8 0.8 0.0 0.1 0.0 1.5 2.3 0.0 0.0 0.0 0.3 1.9 0.0 2.9 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 60.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.9 2.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.1 0.2 1.1 0.0 1.4 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ARMS2 "ARMD8, LOC387715" ENSG00000254636 "Age-related maculopathy susceptibility 2" P0C7Q2 10 122454653-122457352 "Disease related genes, Predicted intracellular proteins" "Age-related macular degeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "placenta: 21.2;testis: 6.6" "Group enriched" "Detected in some" 4 "Early spermatids: 16.7;Late spermatids: 45.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;HeLa: 1.3;HSkMC: 1.5;SiHa: 1.1;SuSa: 2.1;TIME: 1.3;WM-115: 2.0" HPA067225 Enhanced NA NA "HPA067225: AB_2685806" "unprognostic (3.05e-1)" "unprognostic (1.50e-1)" "unprognostic (5.69e-3)" "unprognostic (2.29e-1)" "unprognostic (2.61e-2)" "unprognostic (2.84e-2)" "unprognostic (3.49e-2)" "unprognostic (1.98e-2)" "unprognostic (3.47e-3)" "unprognostic (3.60e-2)" "unprognostic (5.29e-5)" "unprognostic (2.53e-2)" "unprognostic (9.46e-3)" "unprognostic (2.68e-2)" "unprognostic (5.25e-2)" 0.5 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.0 0.7 0.2 0.2 0.2 0.4 1.7 0.3 0.2 0.2 0.4 0.2 0.2 0.2 0.2 2.3 0.2 0.0 1.0 21.2 0.2 0.2 0.0 0.2 2.7 0.2 0.2 1.9 0.2 0.2 0.2 0.2 0.2 6.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.5 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 1.1 0.0 0.0 2.1 0.0 0.0 1.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 16.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 45.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.5 0.0 7.2 0.0 0.0 0.0 ARSI "FLJ16069, SPG66" ENSG00000183876 "Arylsulfatase family member I" Q5FYB1 5 150296343-150339307 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 24.2" "Cell type enhanced" "Detected in some" 19 "Basal keratinocytes: 10.8;granulocytes: 4.6;Melanocytes: 20.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 9.5;HaCaT: 18.5;Hep G2: 11.4;hTEC/SVTERT24-B: 18.6;U-87 MG: 23.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "HPA038386, HPA038398" Uncertain Approved "Golgi apparatus" "Secreted in other tissues" NA NA "Golgi apparatus" "HPA038386: AB_10669781, HPA038398: AB_2675995" "unprognostic (6.08e-2)" "unprognostic (1.70e-2)" "unprognostic (9.41e-3)" "unprognostic (4.77e-3)" "unprognostic (1.54e-3)" "unprognostic (2.83e-3)" "unprognostic (2.76e-1)" "prognostic unfavorable (9.11e-4)" "unprognostic (1.06e-1)" "unprognostic (5.81e-3)" "unprognostic (4.85e-2)" "unprognostic (1.26e-1)" "unprognostic (3.39e-7)" "unprognostic (7.18e-2)" "unprognostic (1.29e-1)" "unprognostic (3.64e-3)" "prognostic unfavorable (1.19e-4)" 2.0 0.5 2.1 4.3 2.0 0.9 0.5 0.7 2.0 4.9 2.1 0.6 0.3 1.0 5.0 1.2 4.2 3.6 2.2 2.4 1.7 1.1 1.4 0.8 6.2 0.4 2.5 1.0 3.3 0.8 0.0 1.8 24.2 2.0 5.5 0.8 6.9 0.8 1.5 1.4 9.2 1.0 5.6 6.6 1.2 1.6 1.1 1.0 0.8 0.6 9.2 1.6 5.2 4.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 2.2 0.6 0.0 0.0 0.5 0.0 4.7 7.1 9.5 6.9 0.6 1.1 0.0 1.9 6.7 0.8 18.5 0.1 3.1 3.3 0.0 0.0 0.0 0.2 11.4 0.9 0.0 0.0 0.5 2.0 18.6 0.5 6.4 0.1 0.0 0.0 0.1 1.5 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.1 0.0 3.8 0.5 0.7 6.9 0.0 0.0 0.0 0.1 6.3 0.2 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 2.1 2.0 0.7 2.0 1.7 1.1 2.5 1.0 2.0 1.0 0.0 0.0 0.0 0.0 10.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.9 0.0 4.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 20.3 0.0 0.0 2.0 0.5 0.0 0.4 0.8 0.2 0.0 0.8 0.0 0.7 4.1 1.1 0.0 0.0 0.0 ART4 "CD297, DO, DOK1" ENSG00000111339 "ADP-ribosyltransferase 4 (Dombrock blood group)" Q93070 12 14825569-14843533 "Blood group antigen proteins, CD markers, Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 33.7;lymphoid tissue: 17.8;placenta: 17.8" "Cell type enhanced" "Detected in many" 20 "Erythroid cells: 93.5;Hepatocytes: 21.3;Ito cells: 55.3" "Cancer enhanced" "Detected in some" "liver cancer: 3.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 5.2;HEL: 10.3;Hep G2: 6.1;HUVEC TERT2: 23.4" "Region enhanced" "Detected in single" "olfactory region: 2.2" "Low region specificity" "Detected in single" HPA075664 Approved "Rods & Rings" "Secreted to blood" NA NA 11000000 "Rods & Rings" "HPA075664: " "unprognostic (2.50e-2)" "unprognostic (1.12e-1)" "unprognostic (1.57e-1)" "unprognostic (1.18e-2)" "unprognostic (1.55e-1)" "unprognostic (1.37e-2)" "unprognostic (1.92e-1)" "unprognostic (1.90e-2)" "unprognostic (1.10e-1)" "unprognostic (2.64e-1)" "unprognostic (1.37e-1)" "unprognostic (1.90e-2)" "unprognostic (2.62e-3)" "unprognostic (4.33e-3)" "unprognostic (1.25e-3)" "unprognostic (1.05e-1)" "unprognostic (1.71e-1)" 2.7 2.0 0.2 1.7 0.2 2.4 2.1 0.2 0.2 1.4 1.3 0.1 1.9 0.0 1.1 3.7 3.1 1.9 6.1 10.1 0.2 0.2 6.6 33.7 2.1 17.0 0.2 0.0 1.3 1.9 0.0 0.4 17.8 0.3 0.8 0.2 0.0 0.7 0.4 1.9 0.5 0.8 1.5 0.2 17.8 0.5 1.4 0.0 0.1 4.6 1.3 1.3 1.3 1.2 0.6 0.6 1.4 0.4 0.6 1.3 0.3 0.0 0.0 0.2 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 6.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.4 0.5 0.3 0.4 0.5 0.3 0.3 0.2 0.6 0.5 1.3 1.4 0.6 0.2 0.6 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.3 0.0 0.0 0.6 0.0 0.8 0.2 1.8 1.4 12.7 0.0 0.0 1.8 11.8 0.1 0.0 0.7 0.4 2.8 0.0 93.5 1.8 1.4 1.9 0.1 0.0 21.3 0.1 0.0 0.0 55.3 7.5 0.0 1.7 0.6 1.7 0.0 0.0 0.2 0.3 0.0 0.0 0.0 12.6 6.5 0.8 0.0 0.0 0.1 0.2 0.0 0.0 0.3 ASCL2 "ASH2, bHLHa45, HASH2" ENSG00000183734 "Achaete-scute family bHLH transcription factor 2" Q99929 11 2268495-2270952 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 21.8;placenta: 16.0" "Cell type enriched" "Detected in many" 12 "Extravillous trophoblasts: 947.6" "Group enriched" "Detected in many" 5 "colorectal cancer: 76.1;stomach cancer: 23.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 8.6" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "BEWO: 18.5;NB-4: 5.4;OE19: 10.0;SCLC-21H: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "unprognostic (2.71e-3)" "prognostic favorable (5.11e-4)" "unprognostic (2.03e-1)" "unprognostic (2.33e-2)" "unprognostic (1.72e-1)" "unprognostic (2.69e-2)" "unprognostic (2.93e-2)" "unprognostic (7.88e-2)" "unprognostic (3.79e-2)" "unprognostic (1.22e-2)" "prognostic favorable (4.73e-4)" "unprognostic (5.85e-2)" "unprognostic (1.45e-6)" "unprognostic (8.86e-3)" "unprognostic (5.48e-2)" "unprognostic (6.12e-4)" "unprognostic (1.07e-3)" 0.5 0.3 0.7 2.2 1.3 0.9 1.1 0.0 1.2 2.7 7.3 1.4 21.8 9.2 3.6 1.2 2.5 0.7 0.4 0.8 0.6 0.4 2.5 1.1 0.9 0.9 1.5 0.6 0.4 1.5 0.0 0.1 16.0 1.1 3.3 3.4 0.1 9.7 9.5 0.6 10.0 7.3 0.2 3.7 3.0 2.8 1.6 1.1 1.1 0.7 0.8 2.7 3.6 3.3 0.1 1.0 8.6 2.0 0.0 3.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 18.5 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 1.9 0.0 5.4 0.4 10.0 0.0 0.0 0.0 0.0 0.0 0.4 15.1 0.0 0.0 0.3 0.0 0.0 1.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 4.5 1.4 8.6 3.0 2.0 0.2 0.1 0.7 1.7 1.0 0.0 0.2 1.7 1.2 0.0 1.7 0.0 0.0 0.3 0.7 1.3 0.0 1.2 0.6 0.4 1.5 0.6 1.1 1.1 0.0 0.0 1.9 12.4 12.0 0.0 0.8 0.0 1.4 0.0 19.2 0.0 15.5 6.6 0.1 0.0 0.7 6.8 0.0 0.0 947.6 0.8 3.8 0.0 0.2 28.4 0.0 75.2 20.3 18.4 0.0 1.7 8.5 1.7 1.0 19.5 0.0 0.0 3.4 1.4 0.3 0.0 0.0 0.3 0.3 11.3 4.1 19.5 8.5 77.9 4.6 ATG9B "APG9L2, FLJ14885, NOS3AS, SONE" ENSG00000181652 "Autophagy related 9B" Q674R7 7 151012209-151024499 "Predicted membrane proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 67.1" "Cell type enhanced" "Detected in many" 21 "Early spermatids: 27.7;Late spermatids: 21.7;Syncytiotrophoblasts: 96.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "memory CD4 T-cell: 6.0;naive CD4 T-cell: 11.0;naive CD8 T-cell: 4.1;T-reg: 5.9" "Lineage enriched" "Detected in many" 7 "T-cells: 11.0" "Group enriched" "Detected in some" 5 "BEWO: 17.0;CAPAN-2: 5.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "unprognostic (1.59e-1)" "unprognostic (2.18e-2)" "unprognostic (1.31e-1)" "unprognostic (5.03e-2)" "unprognostic (1.53e-3)" "unprognostic (1.05e-3)" "unprognostic (2.79e-3)" "unprognostic (6.66e-2)" "unprognostic (2.38e-3)" "unprognostic (6.76e-2)" "unprognostic (2.02e-1)" "unprognostic (5.06e-2)" "unprognostic (2.08e-6)" "unprognostic (2.82e-2)" "unprognostic (2.70e-2)" "unprognostic (6.34e-2)" "unprognostic (2.63e-1)" 0.0 0.5 0.0 0.2 8.8 0.1 0.1 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.5 1.2 15.4 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 6.1 67.1 0.3 0.0 0.0 0.0 0.4 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 8.8 10.5 0.0 0.1 1.6 0.8 0.2 0.1 0.4 11.0 1.9 0.7 0.0 0.9 0.2 0.0 0.0 17.0 0.0 0.0 0.0 0.0 0.1 5.5 0.4 0.1 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.7 1.1 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.8 0.2 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 2.0 0.5 0.7 0.0 1.5 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.2 1.3 0.0 1.2 1.1 6.0 1.6 0.0 1.6 11.0 4.1 0.0 0.4 0.1 0.8 5.9 1.9 0.0 0.0 3.2 0.2 0.0 1.7 1.1 0.0 16.0 0.0 0.0 0.0 6.6 0.0 0.3 27.7 1.0 0.0 0.0 0.2 2.3 0.0 0.3 14.9 0.0 1.7 0.0 0.0 3.7 0.0 21.7 0.6 0.2 0.0 0.0 0.0 0.5 2.4 0.0 0.7 0.0 0.4 0.0 0.2 16.9 10.4 0.3 96.6 2.2 0.0 1.1 ATP10D "ATPVD, KIAA1487" ENSG00000145246 "ATPase phospholipid transporting 10D (putative)" Q9P241 4 47485288-47593486 "Enzymes, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 55.7" "Cell type enhanced" "Detected in many" 11 "Leydig cells: 57.5;Syncytiotrophoblasts: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "basophil: 31.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 31.5" "Cell line enhanced" "Detected in many" "HAP1: 24.4" HPA050808 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA050808: AB_2681242" "unprognostic (1.62e-1)" "unprognostic (2.97e-1)" "unprognostic (4.93e-2)" "unprognostic (1.47e-2)" "unprognostic (1.16e-1)" "unprognostic (4.23e-2)" "unprognostic (1.65e-2)" "unprognostic (8.05e-2)" "unprognostic (3.48e-2)" "unprognostic (3.54e-2)" "unprognostic (3.04e-1)" "unprognostic (2.43e-1)" "prognostic favorable (5.00e-8)" "unprognostic (3.97e-2)" "unprognostic (4.47e-3)" "unprognostic (1.11e-2)" "unprognostic (3.37e-2)" 8.1 9.7 7.6 6.8 8.0 1.4 6.9 3.9 7.5 10.2 7.4 5.2 10.4 4.5 12.9 10.1 15.2 6.7 8.6 7.4 7.3 4.0 14.5 5.8 9.4 6.7 7.0 4.8 10.0 6.2 16.9 18.6 55.7 8.1 8.1 4.5 7.7 7.5 11.5 2.8 14.8 6.0 11.4 8.9 12.7 7.6 3.9 7.3 3.6 10.7 5.4 9.2 9.9 13.1 3.6 1.8 31.5 2.9 1.0 0.9 0.6 1.4 1.0 2.3 1.6 6.7 7.3 0.4 10.4 12.6 5.0 9.0 5.4 9.0 4.6 3.9 16.8 8.5 2.7 24.4 8.7 7.7 1.8 1.9 3.7 1.7 0.3 6.0 1.1 2.3 6.3 6.7 9.8 6.5 16.5 8.4 2.3 0.0 2.5 13.6 0.5 2.4 0.7 0.8 0.0 1.3 2.8 5.3 0.0 9.1 1.8 1.5 2.9 4.8 1.2 3.1 5.4 2.2 1.2 12.7 12.4 2.5 1.1 4.5 1.1 0.8 0.0 6.1 6.9 3.9 31.5 1.4 0.1 0.6 2.3 0.9 1.3 0.2 0.3 1.8 3.6 0.0 0.4 0.7 1.0 2.9 1.1 0.3 0.6 7.6 8.0 3.9 7.5 7.3 4.0 7.0 4.8 8.1 7.3 8.9 6.9 15.0 7.9 17.1 10.9 3.6 0.0 2.7 2.3 15.7 29.5 27.1 1.7 4.3 1.6 14.0 1.6 0.0 4.1 7.4 11.8 5.8 2.3 4.9 11.7 12.7 9.2 17.8 16.1 0.6 57.5 9.1 6.8 7.2 4.3 28.8 2.7 2.5 23.7 9.1 8.9 25.8 9.8 0.4 2.7 23.6 147.8 11.5 3.7 6.5 ATP1A4 ATP1AL2 ENSG00000132681 "ATPase Na+/K+ transporting subunit alpha 4" Q13733 1 160151570-160186977 "Enzymes, Predicted membrane proteins" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 13.1;seminal vesicle: 19.0;testis: 35.8" "Cell type enhanced" "Detected in some" 20 "Cytotrophoblasts: 20.6;Early spermatids: 67.0;Syncytiotrophoblasts: 31.9" "Group enriched" "Detected in some" 8 "breast cancer: 0.8;urothelial cancer: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "BEWO: 10.8;HDLM-2: 26.8;RT4: 32.4" "Not detected" "Not detected" NA NA "unprognostic (1.33e-1)" "unprognostic (4.01e-3)" "unprognostic (2.20e-1)" "unprognostic (1.94e-1)" "unprognostic (2.09e-1)" "unprognostic (8.55e-2)" "unprognostic (1.22e-1)" "unprognostic (7.48e-3)" "unprognostic (2.45e-1)" "unprognostic (8.77e-3)" "unprognostic (1.98e-2)" "unprognostic (3.17e-2)" "unprognostic (2.43e-3)" "unprognostic (1.07e-1)" "unprognostic (1.30e-1)" "unprognostic (4.09e-2)" "prognostic favorable (2.20e-4)" 0.4 0.3 0.4 0.8 0.3 0.0 2.2 0.4 0.3 0.3 0.3 0.0 11.2 0.0 0.2 0.3 0.3 0.3 0.8 0.3 0.3 0.3 0.2 0.2 0.3 3.8 0.3 0.0 0.2 0.2 0.0 0.3 13.1 0.0 0.6 0.0 0.4 1.2 19.0 3.2 0.3 0.5 1.6 0.3 1.1 0.3 35.8 0.0 0.9 0.2 0.2 1.6 8.9 5.9 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.4 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 1.1 0.0 5.5 0.2 0.0 0.8 0.0 0.0 0.0 1.8 0.0 20.6 0.0 0.0 67.0 0.0 0.0 0.0 0.0 11.9 0.4 0.7 1.1 0.0 2.4 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.4 0.0 2.1 0.0 0.0 0.2 0.2 0.0 31.9 0.0 0.0 11.2 ATP6V1B1 "ATP6B1, RTA1B, VATB, Vma2, VPP3" ENSG00000116039 "ATPase H+ transporting V1 subunit B1" P15313 2 70935868-70965431 "Disease related genes, Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 37.9;placenta: 29.0;salivary gland: 106.9" "Cell type enhanced" "Detected in some" 21 "Cytotrophoblasts: 143.1;Distal tubular cells: 41.4;Extravillous trophoblasts: 41.7;Melanocytes: 28.7;Syncytiotrophoblasts: 54.2" "Group enriched" "Detected in many" 5 "ovarian cancer: 94.7;renal cancer: 23.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 1.0;non-classical monocyte: 1.4" "Group enriched" "Detected in many" 12 "monocytes: 1.4;T-cells: 1.0" "Group enriched" "Detected in some" 9 "BEWO: 13.8;HaCaT: 12.7;SK-BR-3: 31.3" "Not detected" "Not detected" "CAB009523, HPA031847" Enhanced Approved "Nucleoplasm,Nuclear membrane" No NA "Nucleoplasm, Nuclear membrane" "CAB009523: AB_677577, HPA031847: AB_2674072" "unprognostic (2.28e-2)" "unprognostic (6.02e-2)" "unprognostic (2.20e-5)" "unprognostic (1.15e-2)" "unprognostic (3.96e-1)" "unprognostic (1.31e-1)" "unprognostic (2.22e-2)" "unprognostic (2.17e-1)" "unprognostic (1.19e-2)" "unprognostic (1.48e-1)" "unprognostic (2.94e-2)" "unprognostic (1.40e-1)" "unprognostic (1.33e-3)" "unprognostic (1.03e-1)" "unprognostic (2.70e-1)" "unprognostic (3.63e-5)" "unprognostic (1.97e-2)" 0.6 0.0 0.1 0.1 0.1 0.0 4.4 0.8 0.2 12.2 0.1 0.1 6.9 0.1 0.5 0.4 0.5 5.0 0.1 0.3 0.1 0.0 37.9 0.1 2.1 0.1 0.1 0.1 2.0 1.1 0.0 1.7 29.0 0.1 0.6 0.0 7.4 106.9 1.1 0.1 11.8 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.3 0.1 1.6 1.1 0.1 0.2 0.0 0.0 0.0 1.4 0.0 1.0 0.0 0.2 0.2 0.4 0.8 1.7 2.0 13.8 0.2 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.8 0.0 12.7 0.4 0.0 0.0 0.3 0.4 0.0 0.2 0.2 0.0 0.0 0.0 1.0 0.1 0.0 0.2 2.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.1 0.3 0.9 0.4 31.3 0.0 1.8 0.3 0.0 0.3 0.4 0.1 0.6 0.3 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.1 0.1 0.8 0.2 0.1 0.0 0.1 0.1 0.1 0.1 3.0 0.0 0.0 1.8 0.1 0.8 0.4 0.0 1.4 1.2 0.0 7.9 143.1 41.4 0.0 0.6 0.6 0.0 0.0 0.5 41.7 0.7 0.7 0.0 0.0 10.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.3 0.5 0.0 1.1 0.0 3.4 0.0 0.3 0.4 1.3 0.4 54.2 0.0 0.0 0.6 ATP6V1C2 "ATP6C2, VMA5" ENSG00000143882 "ATPase H+ transporting V1 subunit C2" Q8NEY4 2 10721649-10785110 "Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 49.3;placenta: 39.0;retina: 54.4;salivary gland: 41.8" "Cell type enhanced" "Detected in some" 19 "Cytotrophoblasts: 101.4;Distal tubular cells: 38.1;Intestinal endocrine cells: 39.9;Syncytiotrophoblasts: 141.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "BEWO: 40.6;SK-BR-3: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA034734, HPA067305" Approved Uncertain Mitochondria NA NA Mitochondria "HPA034734: AB_2674305, HPA067305: AB_2732763" "unprognostic (2.29e-1)" "unprognostic (1.86e-1)" "unprognostic (1.15e-2)" "unprognostic (6.55e-3)" "unprognostic (2.69e-2)" "unprognostic (2.20e-2)" "unprognostic (7.03e-3)" "unprognostic (8.53e-2)" "unprognostic (1.29e-1)" "unprognostic (2.11e-2)" "unprognostic (6.77e-2)" "unprognostic (2.73e-2)" "prognostic unfavorable (1.12e-11)" "unprognostic (6.17e-2)" "unprognostic (3.30e-1)" "unprognostic (2.37e-1)" "unprognostic (8.27e-2)" 1.4 0.9 0.4 0.4 0.5 1.1 2.4 0.5 0.8 21.2 0.8 0.6 49.3 0.1 2.1 30.5 6.9 0.8 0.8 0.7 0.8 0.3 13.2 2.0 0.8 0.5 0.4 0.4 0.9 1.1 0.1 8.9 39.0 0.5 1.8 0.7 54.4 41.8 15.1 0.4 36.7 0.7 0.4 0.6 1.3 0.6 0.8 0.4 0.9 1.4 6.0 3.5 0.5 7.2 1.1 0.8 0.6 1.7 0.9 2.2 1.1 0.3 0.4 1.3 1.5 0.0 0.0 40.6 0.6 0.0 0.0 0.0 0.8 1.0 1.0 0.8 0.0 0.6 0.6 0.6 0.0 0.0 0.5 1.5 0.5 0.6 1.4 0.0 0.9 0.6 0.0 0.1 0.0 0.0 1.0 0.0 0.3 0.4 2.0 0.0 1.2 0.3 1.5 1.0 0.6 0.4 0.8 0.7 3.3 0.0 0.9 1.1 1.3 0.3 14.5 0.4 5.5 1.4 2.1 0.2 0.5 1.0 0.6 0.5 3.5 1.0 0.6 0.6 0.8 0.4 0.3 0.8 0.6 2.2 1.7 1.3 1.1 1.0 1.7 0.5 0.9 1.0 0.5 0.0 0.9 0.8 0.8 0.9 1.1 0.4 0.5 0.5 0.8 0.8 0.3 0.4 0.4 0.5 0.4 0.0 1.6 0.0 4.2 0.3 0.0 1.0 0.0 2.7 2.3 7.0 0.0 101.4 38.1 0.0 0.6 0.1 0.0 0.0 0.2 23.0 0.5 0.6 2.3 0.0 12.0 0.0 39.9 0.0 0.3 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.4 2.0 141.4 0.0 0.6 0.3 B3GNT3 "B3GN-T3, B3GNT-3, beta3Gn-T3, HP10328, TMEM3" ENSG00000179913 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3" Q9Y2A9 19 17794828-17813082 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 69.9;intestine: 61.6;placenta: 56.0" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 53.5;Cytotrophoblasts: 51.9;Enterocytes: 58.5;Mucus-secreting cells: 40.2;Paneth cells: 42.5;Syncytiotrophoblasts: 57.1;Urothelial cells: 43.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "memory CD4 T-cell: 2.7;memory CD8 T-cell: 1.1;naive CD4 T-cell: 3.2" "Lineage enriched" "Detected in single" 32 "T-cells: 3.2" "Cell line enhanced" "Detected in some" "A-431: 16.5;BEWO: 16.3;CAPAN-2: 44.2;OE19: 40.5;RT4: 15.8;SK-BR-3: 15.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA024298 Enhanced "Intracellular and membrane" NA NA "HPA024298: AB_1845236" "unprognostic (1.10e-1)" "unprognostic (5.19e-2)" "unprognostic (1.84e-1)" "unprognostic (4.84e-3)" "unprognostic (1.10e-1)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.25e-5)" "unprognostic (3.26e-1)" "unprognostic (4.64e-2)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.91e-1)" "unprognostic (1.44e-2)" "unprognostic (7.38e-2)" "unprognostic (1.26e-1)" "unprognostic (7.10e-2)" "unprognostic (2.57e-2)" 0.4 0.2 0.2 8.7 0.3 0.0 1.8 0.2 0.3 3.5 25.3 0.0 12.0 16.6 0.4 1.2 15.1 0.6 69.9 0.5 0.2 0.3 11.4 2.5 1.0 1.2 0.2 0.0 0.3 9.1 0.0 0.3 56.0 0.0 4.4 22.4 0.3 24.4 12.8 0.3 2.0 61.6 1.9 0.2 0.3 21.8 0.3 0.0 0.3 0.4 2.6 18.3 10.2 5.4 0.0 0.0 0.0 0.0 0.0 3.2 0.6 16.5 4.4 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.2 44.2 0.0 11.3 0.0 0.0 1.6 0.0 5.3 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.1 40.5 7.1 0.0 0.0 0.4 9.8 15.8 0.0 0.0 0.0 15.0 0.0 0.0 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 1.1 0.0 0.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.2 0.3 0.2 0.3 0.2 0.0 0.0 0.0 0.0 2.9 0.5 1.3 0.1 0.0 0.4 53.5 0.0 6.8 15.7 0.0 51.9 1.7 15.2 0.0 0.5 58.5 0.0 24.8 5.9 0.7 7.2 5.7 0.0 5.1 0.0 15.6 0.6 0.0 0.0 0.0 0.0 0.0 1.0 40.2 0.0 23.5 42.5 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 57.1 0.0 20.6 43.1 BCAR3 "AND-34, NSP2, SH2D3B" ENSG00000137936 "BCAR3, NSP family adaptor protein" O75815 1 93561786-93847150 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 59.5" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 102.8;Extravillous trophoblasts: 70.7;Sertoli cells: 71.1;Urothelial cells: 114.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.4;memory B-cell: 4.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 46.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014858 Approved Approved "Plasma membrane,Centrosome,Cytosol" NA NA "Plasma membrane, Cytosol" Centrosome "HPA014858: AB_1845302" "unprognostic (9.16e-2)" "unprognostic (2.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.60e-3)" "prognostic unfavorable (8.41e-4)" "prognostic unfavorable (5.42e-4)" "prognostic unfavorable (8.92e-7)" "unprognostic (2.44e-1)" "unprognostic (3.66e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (1.51e-2)" "prognostic favorable (3.08e-7)" "unprognostic (2.13e-1)" "unprognostic (1.14e-1)" "unprognostic (7.05e-2)" "unprognostic (1.87e-1)" 26.0 10.4 10.1 11.6 14.2 0.9 23.1 8.6 8.1 10.2 14.1 10.0 6.2 12.4 5.7 5.9 8.9 9.4 15.5 10.6 10.6 8.0 15.5 11.0 12.8 11.8 11.7 5.6 11.2 4.1 4.5 4.6 59.5 10.6 11.2 15.7 10.1 20.5 14.5 19.5 13.3 14.8 10.6 9.7 5.4 15.2 7.3 8.0 2.6 10.0 6.6 11.7 12.7 17.7 4.5 1.7 4.4 1.1 0.0 0.3 0.1 15.3 6.6 12.4 0.9 5.4 4.2 10.7 15.9 27.8 13.1 8.1 1.1 11.5 2.5 5.5 24.5 17.1 9.6 0.3 20.6 11.5 1.1 0.3 0.0 4.8 2.8 9.7 0.1 0.0 5.0 22.8 13.6 46.2 12.7 14.4 0.3 0.4 0.1 35.5 2.3 0.3 0.0 3.9 6.7 22.9 1.0 17.9 0.3 34.4 19.5 0.4 1.0 7.7 8.3 9.9 5.0 9.3 0.6 16.9 19.6 5.0 8.3 21.0 1.3 0.5 0.3 2.9 0.0 7.1 4.4 0.0 0.1 0.0 1.1 0.0 4.5 0.1 0.0 0.8 2.5 0.0 0.3 0.0 0.0 0.0 1.7 0.3 0.1 10.1 14.2 8.6 8.1 10.6 8.0 11.7 5.6 10.6 8.0 3.0 7.4 7.4 102.8 8.8 1.0 6.7 7.6 10.7 9.1 14.0 0.0 23.0 23.2 11.1 8.4 17.3 20.2 0.0 5.6 70.7 9.3 24.4 3.5 9.4 10.3 20.6 14.3 5.5 4.3 11.2 9.5 8.1 18.6 16.2 20.7 4.3 17.7 20.7 1.1 15.6 0.4 71.1 19.3 3.2 2.9 8.9 15.8 0.0 10.0 114.7 BIRC7 "KIAP, ML-IAP, mliap, RNF50" ENSG00000101197 "Baculoviral IAP repeat containing 7" Q96CA5 20 63235883-63240507 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Protease inhibitor, Thiol protease inhibitor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 14.4;placenta: 13.6;retina: 21.1" "Group enriched" "Detected in some" 5 "Hofbauer cells: 56.9;Melanocytes: 25.3;Muller glia cells: 46.0" "Cancer enriched" "Detected in many" 10 "melanoma: 73.7" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 2.0" "Lineage enriched" "Detected in single" 9 "T-cells: 2.0" "Cell line enriched" "Detected in some" 4 "SK-MEL-30: 63.7" "Not detected" "Not detected" "HPA047850, HPA061283" Enhanced Nucleoplasm,Centrosome,Cytosol NA NA Nucleoplasm "Centrosome, Cytosol" "HPA047850: AB_2680181, HPA061283: " "unprognostic (3.60e-1)" "unprognostic (7.94e-2)" "unprognostic (2.70e-2)" "unprognostic (1.78e-3)" "unprognostic (1.15e-1)" "unprognostic (8.11e-2)" "unprognostic (1.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.62e-3)" "unprognostic (1.24e-2)" "unprognostic (6.90e-2)" "unprognostic (2.27e-1)" "unprognostic (8.82e-3)" "unprognostic (1.22e-2)" "unprognostic (4.77e-2)" "unprognostic (2.55e-2)" "unprognostic (4.84e-2)" 1.6 1.3 1.0 0.7 1.0 0.3 0.7 0.1 2.2 3.0 1.3 0.5 0.1 0.4 0.8 14.4 0.3 0.3 0.5 2.8 0.9 1.1 2.6 0.8 2.3 2.2 4.9 1.0 0.2 0.1 0.1 0.6 13.6 1.5 0.4 0.3 21.1 0.8 0.1 0.1 4.9 0.3 0.2 4.3 1.6 0.3 0.4 0.3 0.3 0.3 1.0 0.5 0.4 1.8 0.0 0.0 0.0 0.2 0.0 2.0 0.1 0.1 1.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 2.2 0.4 0.0 6.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 63.7 1.6 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 1.0 0.1 2.2 0.9 1.1 4.9 1.0 1.5 0.3 0.0 0.6 0.0 0.0 1.1 0.0 0.6 0.0 0.0 0.0 1.8 0.0 1.4 0.0 0.6 0.1 0.0 0.0 0.0 0.6 8.2 0.5 0.0 2.3 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 46.0 2.3 0.0 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 BMP1 PCOLC ENSG00000168487 "Bone morphogenetic protein 1" P13497 8 22164736-22212326 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor, Hydrolase, Metalloprotease, Protease" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "lung: 72.2;placenta: 106.2" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 61.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014572 Enhanced "Secreted to extracellular matrix" NA NA 2100000 "HPA014572: AB_1845390" "unprognostic (1.24e-1)" "unprognostic (8.01e-2)" "unprognostic (3.75e-2)" "unprognostic (5.89e-2)" "unprognostic (1.34e-2)" "unprognostic (6.76e-2)" "unprognostic (9.53e-2)" "unprognostic (2.64e-3)" "unprognostic (1.66e-1)" "unprognostic (9.75e-3)" "unprognostic (7.05e-3)" "unprognostic (3.14e-2)" "prognostic unfavorable (3.37e-9)" "unprognostic (2.11e-2)" "unprognostic (6.57e-2)" "unprognostic (1.50e-3)" "unprognostic (3.34e-2)" 6.9 11.7 2.7 3.6 4.6 1.1 5.9 7.8 4.2 8.1 5.8 3.1 3.7 4.4 9.4 5.2 4.8 7.7 5.4 3.4 2.6 1.3 4.9 9.2 72.2 3.2 3.4 1.5 5.2 3.7 2.8 2.2 106.2 3.5 6.5 4.7 4.6 2.4 4.6 2.4 6.8 5.7 11.0 3.6 3.2 2.9 2.2 3.6 1.0 7.1 2.4 2.9 9.9 9.5 0.0 0.9 0.1 1.4 0.8 2.2 0.4 4.6 4.8 1.3 6.2 15.2 11.3 6.8 20.2 16.8 10.3 9.6 2.5 3.0 1.1 12.7 18.5 6.4 10.1 1.5 5.3 2.0 1.0 2.1 1.7 7.3 2.8 12.4 0.7 3.4 12.8 8.5 8.0 2.6 18.3 10.0 0.6 2.1 2.0 5.6 1.7 0.4 1.0 0.8 6.9 2.6 1.1 3.3 4.9 8.9 0.7 0.8 3.3 14.6 0.8 3.3 5.6 0.9 2.0 12.6 2.7 5.9 6.5 5.9 1.0 0.6 0.2 5.3 2.7 7.4 0.0 1.4 0.0 2.2 0.7 1.4 0.0 0.4 1.0 0.0 0.0 0.3 1.7 0.1 0.8 0.5 0.9 0.0 0.4 2.7 4.6 7.8 4.2 2.6 1.3 3.4 1.5 3.5 3.6 6.0 61.3 0.5 5.3 5.6 1.5 3.0 2.5 1.4 2.3 5.2 0.0 2.4 0.0 21.2 0.5 10.5 18.6 0.0 7.1 8.6 24.4 2.5 15.0 15.8 4.1 1.6 2.9 14.1 4.0 0.5 9.5 3.5 10.1 0.0 5.5 3.2 11.4 11.0 10.3 3.1 1.0 25.8 18.4 0.9 3.6 4.5 20.4 1.9 9.7 6.4 BMP5 ENSG00000112175 "Bone morphogenetic protein 5" P22003 6 55753645-55875564 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.7;prostate: 29.4;retina: 21.2" "Cell type enhanced" "Detected in some" 20 "Cardiomyocytes: 4.9;Erythroid cells: 23.3;Fibroblasts: 12.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "pons and medulla: 5.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "AF22: 22.6;U-2 OS: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (2.84e-4)" "unprognostic (9.07e-4)" "unprognostic (3.50e-1)" "unprognostic (1.27e-1)" "unprognostic (6.21e-2)" "unprognostic (1.58e-1)" "unprognostic (2.39e-3)" "unprognostic (1.29e-1)" "unprognostic (1.20e-1)" "unprognostic (6.76e-2)" "unprognostic (4.43e-3)" "unprognostic (3.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.30e-1)" "unprognostic (4.76e-2)" 2.1 0.6 0.2 3.3 0.2 0.1 1.5 0.7 0.7 0.2 4.3 0.0 0.0 5.0 0.1 0.2 1.9 0.2 1.5 3.4 0.3 0.2 1.6 1.9 14.3 0.2 2.0 1.4 0.2 1.2 0.1 5.0 42.7 5.2 29.4 4.7 21.2 1.7 0.0 7.0 0.2 10.2 5.5 3.6 0.1 1.9 0.2 0.0 0.0 1.5 5.0 0.1 11.8 1.3 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 22.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 1.8 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.7 0.7 0.3 0.2 2.0 1.4 5.2 0.0 0.0 4.0 0.0 0.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.4 12.4 0.0 0.0 0.0 2.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 1.6 0.0 0.0 0.0 BMP6 "VGR, VGR1" ENSG00000153162 "Bone morphogenetic protein 6" P22004 6 7726797-7881422 "Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 17.4" "Group enriched" "Detected in some" 4 "Endothelial cells: 9.0;Ito cells: 19.0" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 8 "basophil: 4.0;neutrophil: 2.3" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.0" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 59.0;Karpas-707: 30.6;SiHa: 25.7;TIME: 27.0;U-266/84: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002773, HPA062683" Approved Approved Mitochondria "Secreted to blood" No No 4970000 21000 Mitochondria "CAB002773: , HPA062683: AB_2684832" "prognostic favorable (6.45e-4)" "unprognostic (2.99e-1)" "unprognostic (4.20e-1)" "unprognostic (6.71e-2)" "unprognostic (2.44e-1)" "unprognostic (7.27e-2)" "unprognostic (4.66e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "unprognostic (6.94e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (1.26e-1)" "unprognostic (1.82e-2)" "unprognostic (8.29e-2)" "unprognostic (2.95e-1)" "unprognostic (2.29e-3)" 10.5 1.5 1.7 1.3 2.8 0.0 7.7 0.2 1.1 2.5 2.7 1.9 2.1 0.0 1.5 1.1 1.6 3.8 1.7 1.4 6.6 1.4 5.8 0.7 2.2 5.8 0.1 0.0 2.8 17.4 1.5 2.2 1.1 2.2 1.4 1.7 2.0 2.0 1.9 3.4 3.4 1.5 0.5 1.8 2.9 1.7 0.3 0.4 4.0 0.0 0.0 0.2 2.1 0.3 0.9 0.1 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.4 0.6 0.1 0.4 0.0 0.0 0.0 2.0 5.6 8.7 0.5 0.3 0.3 6.0 0.0 0.0 0.2 1.0 3.8 59.0 0.0 0.0 30.6 0.0 0.1 0.0 0.0 0.3 0.2 4.2 0.2 0.0 5.3 0.2 0.0 4.4 0.0 25.7 0.0 0.0 3.9 0.0 0.0 27.0 0.0 1.7 0.1 0.8 3.9 13.4 0.0 0.9 0.0 0.5 4.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.4 0.3 0.0 0.0 2.3 0.0 0.0 0.2 0.0 2.1 0.0 0.3 0.0 0.0 0.2 0.0 2.8 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.5 9.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.2 0.0 0.0 19.0 1.0 1.8 0.0 0.0 1.7 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 BPGM ENSG00000172331 "Bisphosphoglycerate mutase" P07738 7 134646808-134679813 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis "Hydrolase, Isomerase" "Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "placenta: 184.7" "Group enriched" "Detected in all" 5 "Distal tubular cells: 109.5;Erythroid cells: 303.7;Syncytiotrophoblasts: 308.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 38.0;RT4: 61.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016493, HPA028735" Enhanced Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA 69000000 "Nucleoli, Nucleoli rim" Nucleoplasm "HPA016493: AB_1845414, HPA028735: AB_10600791" "unprognostic (2.56e-1)" "prognostic favorable (7.95e-4)" "unprognostic (3.19e-1)" "unprognostic (3.94e-1)" "unprognostic (1.78e-1)" "unprognostic (5.22e-2)" "unprognostic (3.81e-3)" "unprognostic (1.96e-1)" "unprognostic (7.74e-2)" "unprognostic (4.67e-3)" "unprognostic (7.42e-2)" "unprognostic (5.69e-2)" "prognostic favorable (1.54e-8)" "unprognostic (2.18e-1)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (3.78e-2)" 6.1 7.3 13.6 4.5 11.1 37.7 6.9 11.7 11.6 7.1 6.9 9.1 6.1 4.3 5.4 10.2 14.6 4.7 6.9 7.3 12.5 14.2 19.1 8.1 8.0 5.2 13.9 7.8 5.7 5.4 16.5 14.4 184.7 12.4 7.5 5.4 6.7 10.6 10.3 17.7 5.5 6.0 6.6 15.9 8.6 6.8 7.4 8.8 8.5 7.5 22.2 13.3 24.9 9.5 11.6 10.2 28.2 12.8 9.8 14.5 12.8 4.5 5.5 7.4 9.9 8.5 5.0 7.4 13.7 16.6 5.3 8.0 2.2 6.1 5.5 4.1 7.6 10.6 3.7 7.8 7.5 9.4 38.0 6.8 3.2 5.1 2.5 5.8 6.0 4.2 4.9 6.9 10.0 5.5 8.2 19.3 7.0 9.2 7.0 12.6 2.2 9.8 8.4 7.6 9.3 5.3 7.5 5.3 4.0 12.1 61.1 6.3 10.7 6.3 7.7 6.8 8.2 5.1 3.9 14.7 8.5 2.0 11.4 11.1 11.5 13.2 6.9 14.7 5.8 14.5 28.2 9.8 27.6 14.5 12.8 10.4 11.6 9.5 12.7 10.2 10.5 13.2 13.4 18.0 9.8 12.5 6.7 12.0 12.8 13.6 11.1 11.7 11.6 12.5 14.2 13.9 7.8 12.4 8.8 8.9 26.7 14.4 18.4 34.7 20.3 20.5 15.3 29.4 14.8 26.2 2.0 35.3 109.5 38.4 2.2 11.9 5.1 303.7 15.9 28.0 17.1 21.1 24.3 4.3 13.3 19.1 12.6 8.0 7.3 5.1 9.5 11.3 21.9 19.8 3.8 18.6 36.1 3.5 11.3 47.1 11.6 6.5 24.7 27.9 22.5 11.5 308.5 21.5 4.5 13.7 BZW2 "HSPC028, MST017, MSTP017" ENSG00000136261 "Basic leucine zipper and W2 domains 2" Q9Y6E2 7 16646131-16706523 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 104.4;skeletal muscle: 89.7" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 786.3;Syncytiotrophoblasts: 638.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022813, HPA026709" Enhanced Approved "Plasma membrane,Actin filaments,Cytosol" NA NA "Plasma membrane, Actin filaments, Cytosol" "HPA022813: AB_1845511, HPA026709: AB_10600752" "unprognostic (2.27e-3)" "unprognostic (1.77e-3)" "unprognostic (5.91e-2)" "unprognostic (4.79e-3)" "unprognostic (2.80e-2)" "unprognostic (7.08e-3)" "prognostic unfavorable (7.86e-8)" "unprognostic (9.13e-3)" "unprognostic (8.49e-3)" "unprognostic (2.81e-2)" "unprognostic (1.83e-3)" "unprognostic (3.37e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (1.00e-1)" "unprognostic (1.66e-1)" "unprognostic (6.77e-2)" "unprognostic (1.25e-1)" 10.6 7.2 4.2 7.8 8.5 10.1 13.5 3.4 8.9 7.9 13.6 3.4 22.0 7.7 7.6 7.6 17.9 7.1 6.1 70.8 4.4 2.8 8.4 10.2 8.1 11.4 3.5 5.8 6.4 12.3 1.8 5.7 104.4 2.5 9.8 16.2 13.2 10.1 25.3 89.7 16.8 8.0 16.6 2.8 8.4 15.6 3.5 3.4 14.5 13.6 41.1 11.1 16.8 10.3 17.2 37.3 1.7 20.3 20.1 23.6 16.3 17.0 16.5 28.1 40.6 13.8 24.4 25.2 24.3 32.0 24.1 25.6 40.0 25.9 39.7 29.0 18.8 17.6 35.5 33.1 27.8 31.9 5.3 19.1 24.8 18.7 22.5 14.3 33.8 15.6 18.7 15.1 21.0 38.8 18.7 34.3 29.2 47.3 8.6 19.5 20.0 17.1 39.2 28.7 50.3 34.2 20.6 18.4 41.8 22.8 31.1 36.0 21.2 9.6 85.9 12.8 33.8 37.8 29.4 19.5 19.1 24.1 28.0 26.8 16.5 17.2 56.0 9.3 42.6 68.2 0.9 17.4 1.7 11.0 20.3 17.9 17.2 16.1 14.9 37.3 15.8 23.6 19.5 0.7 20.1 14.5 14.4 11.9 16.3 4.2 8.5 3.4 8.9 4.4 2.8 3.5 5.8 2.5 3.4 20.8 55.0 24.4 57.3 51.2 48.9 247.1 10.2 32.1 46.6 45.4 60.9 187.5 49.7 33.5 5.3 35.0 23.9 0.0 56.6 786.3 42.5 23.4 20.7 12.2 59.0 6.4 29.3 9.8 28.9 4.8 11.2 28.7 23.6 49.5 35.3 13.3 39.9 31.7 9.2 14.7 83.3 6.5 31.1 4.7 3.8 45.0 638.0 16.2 80.3 79.3 C16orf74 MGC17624 ENSG00000154102 "Chromosome 16 open reading frame 74" Q96GX8 16 85690084-85751129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 44.6" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 47.6;Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 69.6;Syncytiotrophoblasts: 62.1;Urothelial cells: 43.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 26.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 34.3;hTCEpi: 29.3;T-47d: 30.5" "Low region specificity" "Detected in all" HPA049367 Uncertain Approved "Plasma membrane,Centrosome" NA NA "Plasma membrane" Centrosome "HPA049367: AB_2680730" "unprognostic (1.16e-1)" "unprognostic (2.21e-2)" "unprognostic (6.74e-3)" "unprognostic (2.15e-3)" "unprognostic (3.65e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.08e-3)" "unprognostic (4.22e-3)" "prognostic unfavorable (4.08e-4)" "unprognostic (5.06e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (3.40e-1)" "unprognostic (1.76e-3)" "unprognostic (2.51e-1)" "unprognostic (3.55e-1)" "unprognostic (2.15e-2)" "unprognostic (9.07e-3)" 2.7 0.7 6.3 5.6 3.9 9.3 6.8 0.6 3.3 4.7 3.0 1.4 10.8 1.5 2.1 3.7 6.8 1.5 2.4 1.8 9.2 1.7 2.0 0.8 2.0 11.7 2.0 2.1 0.9 2.1 3.9 1.0 44.6 1.6 7.1 1.3 18.8 4.5 9.5 1.5 6.3 4.2 3.9 1.5 12.9 3.0 1.4 1.5 0.4 4.7 6.2 10.3 18.9 10.0 26.3 8.8 10.3 8.2 3.3 8.3 5.4 12.2 4.1 0.1 1.7 1.9 2.1 5.1 1.5 2.0 4.8 1.3 3.1 11.5 0.1 17.4 1.2 2.0 17.7 0.7 34.3 2.7 0.0 2.7 0.0 1.8 0.3 5.2 0.3 0.0 4.5 29.3 4.6 20.1 3.6 15.6 2.1 0.0 0.0 0.1 10.3 0.0 18.7 1.1 13.2 11.8 0.5 0.0 1.0 0.0 14.0 3.9 1.0 6.2 3.2 3.1 1.4 30.5 5.2 15.9 3.1 8.0 1.3 4.4 4.3 3.1 13.5 0.0 4.4 0.6 0.0 8.2 10.3 0.6 2.7 2.2 20.4 4.5 3.6 8.8 26.3 7.6 4.7 3.2 3.3 0.8 0.1 8.3 5.4 6.3 3.9 0.6 3.3 9.2 1.7 2.0 2.1 1.6 1.5 3.0 0.6 38.4 47.6 8.2 17.9 1.2 0.0 1.4 3.4 1.8 55.0 38.4 3.3 2.8 1.3 2.1 0.0 0.0 1.0 13.5 4.8 4.1 0.0 0.0 4.3 14.3 0.0 1.3 0.8 0.0 3.1 1.6 18.6 0.0 0.0 8.8 2.2 0.0 3.2 1.7 69.6 0.0 3.4 0.9 6.4 6.0 62.1 0.9 0.0 43.2 C18orf54 "LAS2, MGC33382" ENSG00000166845 "Chromosome 18 open reading frame 54" Q8IYD9 18 54357917-54385218 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 21.4;testis: 25.2" "Cell type enhanced" "Detected in many" 18 "Early spermatids: 73.3;Extravillous trophoblasts: 22.1;Late spermatids: 23.0;Spermatocytes: 34.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040704 Approved Nucleoplasm "Secreted in male reproductive system" NA NA Nucleoplasm "HPA040704: AB_10959454" "unprognostic (2.96e-1)" "unprognostic (5.58e-2)" "unprognostic (5.29e-2)" "unprognostic (8.63e-3)" "unprognostic (2.40e-1)" "unprognostic (1.05e-1)" "unprognostic (5.60e-6)" "unprognostic (1.11e-2)" "unprognostic (7.85e-3)" "unprognostic (2.55e-2)" "unprognostic (5.91e-3)" "unprognostic (1.13e-2)" "unprognostic (3.06e-5)" "unprognostic (2.29e-1)" "unprognostic (4.21e-1)" "unprognostic (1.28e-2)" "unprognostic (7.05e-2)" 2.9 1.3 2.8 4.8 7.7 2.0 2.1 4.5 4.3 4.1 2.4 3.8 1.0 1.3 3.6 1.1 2.0 1.9 2.1 2.0 3.3 2.2 1.6 0.9 2.5 4.0 10.0 3.4 2.5 1.1 1.9 1.0 21.4 5.7 1.8 2.3 0.7 1.4 1.6 1.0 1.8 2.0 2.7 5.8 4.3 1.5 25.2 6.7 9.3 1.9 1.2 4.0 2.1 3.2 1.4 0.6 1.9 4.1 0.8 2.1 0.6 5.8 3.4 14.6 6.9 3.6 6.3 4.9 9.7 4.2 9.8 12.6 2.2 3.1 4.3 2.7 3.2 4.3 6.3 10.1 5.3 12.8 14.4 3.2 4.2 3.7 3.7 0.8 4.8 4.6 2.1 1.1 13.3 6.2 4.2 11.7 5.7 4.4 9.4 14.0 1.8 5.2 3.0 7.2 1.1 6.7 4.0 10.8 3.0 4.8 4.0 8.1 4.6 4.0 1.7 2.2 8.7 2.5 4.1 10.5 18.2 8.0 3.0 5.3 5.7 6.4 6.4 4.8 8.2 12.8 1.9 0.7 0.3 1.3 0.8 1.2 0.9 1.1 0.9 0.6 1.4 1.0 1.2 0.0 0.8 4.1 0.3 2.1 0.6 2.8 7.7 4.5 4.3 3.3 2.2 10.0 3.4 5.7 6.7 0.0 1.1 0.0 0.6 0.3 1.6 1.2 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.1 73.3 2.6 0.1 0.0 0.2 22.1 1.5 0.3 0.0 0.0 2.1 0.0 0.0 4.9 2.8 23.0 1.4 1.7 1.7 1.8 0.6 2.3 0.3 0.0 0.7 0.2 0.7 0.0 1.4 34.4 16.0 0.4 1.7 0.7 0.8 0.7 C1QTNF6 "CTRP6, ZACRP6" ENSG00000133466 "C1q and TNF related 6" Q9BXI9 22 37180167-37199385 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "endometrium 1: 23.7;placenta: 79.5" "Cell type enriched" "Detected in many" 12 "Extravillous trophoblasts: 349.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 45.0;RT4: 20.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002042 Enhanced Approved Nucleoplasm "Secreted to blood" No No 354000000 Nucleoplasm "HPA002042: AB_1078342" "unprognostic (9.65e-2)" "unprognostic (1.21e-2)" "unprognostic (2.32e-1)" "unprognostic (2.23e-3)" "unprognostic (1.25e-3)" "unprognostic (3.01e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (9.60e-6)" "unprognostic (6.96e-2)" "unprognostic (5.11e-2)" "unprognostic (2.61e-2)" "unprognostic (1.72e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.61e-2)" "unprognostic (5.36e-2)" "unprognostic (1.08e-3)" "unprognostic (1.52e-2)" 3.3 4.4 1.2 4.2 1.6 0.8 2.5 1.2 1.8 7.8 2.5 1.3 1.6 1.0 23.7 7.2 1.6 5.2 6.2 3.1 1.4 0.7 3.9 7.9 9.2 3.1 1.2 1.3 5.9 2.3 1.4 1.4 79.5 1.7 4.3 2.5 4.4 2.2 3.4 1.5 3.1 3.2 5.7 1.8 4.6 1.8 3.5 1.2 1.6 2.4 1.7 1.8 5.1 2.7 2.4 1.1 1.8 0.5 4.0 3.8 1.0 6.7 8.4 4.4 1.5 0.8 8.9 13.4 1.4 2.8 1.1 0.8 1.5 9.9 0.0 5.7 2.3 0.6 14.0 0.1 3.4 0.5 1.9 1.1 1.1 3.2 1.5 3.1 0.0 0.9 12.3 1.9 0.9 0.2 3.0 10.6 0.3 0.0 3.1 0.4 45.0 0.0 0.2 2.8 1.0 0.1 0.1 0.0 1.1 10.2 20.8 0.7 5.7 0.4 8.1 1.1 2.4 2.8 0.2 3.6 0.4 2.3 0.1 0.0 6.5 0.1 0.0 0.9 0.8 1.2 1.0 0.5 1.5 0.7 0.5 0.8 0.8 1.3 1.0 0.5 2.4 2.9 2.2 1.8 4.0 0.3 1.1 3.8 1.0 1.2 1.6 1.2 1.8 1.4 0.7 1.2 1.3 1.7 1.2 0.0 0.0 3.0 1.4 1.3 0.9 1.1 2.5 4.0 2.3 1.8 0.0 4.2 1.7 1.9 1.7 1.4 2.6 0.0 1.0 349.8 8.9 0.6 1.1 5.0 8.4 0.0 0.0 11.6 1.0 6.2 0.6 0.9 5.0 1.0 2.1 4.2 2.0 3.5 0.4 1.3 0.7 0.0 3.3 7.0 4.0 0.3 28.8 2.5 3.9 1.0 C20orf202 ENSG00000215595 "Chromosome 20 open reading frame 202" A1L168 20 1203454-1208274 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "placenta: 8.2" "Cell type enhanced" "Detected in some" 24 "Collecting duct cells: 1.8;Early spermatids: 2.9;Late spermatids: 1.6;Sertoli cells: 6.5" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in single" "T-reg: 2.0" "Lineage enriched" "Detected in single" 11 "T-cells: 2.0" "Cell line enhanced" "Detected in some" "Daudi: 4.1;U-266/70: 3.1;U-266/84: 1.4" "Low region specificity" "Detected in all" HPA042786 Uncertain NA NA "HPA042786: AB_10795760" "unprognostic (8.20e-2)" "unprognostic (1.66e-1)" "unprognostic (7.27e-2)" "unprognostic (2.73e-2)" "unprognostic (3.49e-3)" "unprognostic (1.92e-3)" "unprognostic (1.15e-2)" "unprognostic (7.41e-3)" "unprognostic (1.92e-1)" "unprognostic (7.40e-2)" "unprognostic (1.29e-2)" "unprognostic (7.55e-2)" "unprognostic (5.82e-3)" "unprognostic (7.98e-2)" "unprognostic (5.70e-3)" "unprognostic (1.26e-1)" "unprognostic (7.24e-3)" 1.3 0.1 1.3 0.2 1.0 0.0 0.7 2.6 0.8 0.3 0.7 0.6 0.2 0.0 0.6 1.0 1.5 1.1 1.2 1.1 0.9 0.2 3.2 0.3 1.4 0.0 0.7 1.0 0.4 8.2 0.1 0.5 0.8 1.4 1.0 1.1 2.5 0.3 1.7 0.4 0.6 1.4 0.3 0.2 0.8 0.2 0.0 0.0 0.0 0.1 0.0 2.0 0.2 0.2 0.0 0.4 0.0 0.5 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.1 4.1 0.1 0.0 0.3 0.2 0.1 0.2 0.1 1.0 0.3 0.4 0.0 1.0 0.2 0.4 0.0 0.2 0.1 0.0 0.4 0.2 0.0 0.0 1.2 1.2 0.0 0.3 0.1 0.0 0.1 0.5 0.0 0.0 0.2 0.4 0.0 0.0 0.2 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.1 0.1 0.2 0.3 3.1 1.4 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 C2orf72 LOC257407 ENSG00000204128 "Chromosome 2 open reading frame 72" A6NCS6 2 231037490-231049719 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 22.5;placenta: 23.9" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 33.1;Hepatocytes: 111.5;Paneth cells: 62.8" "Cancer enhanced" "Detected in many" "liver cancer: 40.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 13.1;CACO-2: 3.0;EFO-21: 4.9;OE19: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044962 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA044962: AB_10960863" "unprognostic (4.90e-2)" "unprognostic (7.03e-2)" "unprognostic (2.15e-1)" "unprognostic (7.44e-3)" "unprognostic (2.88e-2)" "unprognostic (6.41e-2)" "unprognostic (3.38e-1)" "unprognostic (6.51e-2)" "unprognostic (6.25e-3)" "unprognostic (1.84e-1)" "prognostic favorable (5.27e-4)" "unprognostic (2.65e-1)" "prognostic unfavorable (4.74e-4)" "unprognostic (2.78e-1)" "unprognostic (7.23e-3)" "unprognostic (2.70e-2)" "unprognostic (5.19e-2)" 1.0 0.9 6.5 0.9 8.4 0.8 1.6 1.7 10.1 0.8 7.8 9.9 0.0 2.3 0.8 1.1 0.9 0.9 1.8 0.8 7.7 4.7 1.4 22.5 1.2 0.8 5.1 7.9 0.8 6.1 1.7 1.7 23.9 8.2 2.0 2.5 0.8 1.0 0.9 0.8 0.8 2.6 1.0 2.2 0.8 4.2 0.9 5.9 0.0 0.8 0.0 0.8 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 13.1 0.0 0.0 0.1 0.0 3.0 0.0 0.0 4.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 5.6 0.1 0.0 0.0 0.3 0.0 0.0 0.1 2.2 0.1 1.5 0.8 0.8 0.9 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.4 1.7 10.1 7.7 4.7 5.1 7.9 8.2 5.9 0.0 0.0 1.9 0.0 0.1 0.6 0.3 33.1 0.0 0.0 0.0 0.0 1.4 1.7 2.0 7.3 0.0 15.3 0.0 1.8 9.0 0.0 0.9 0.0 111.5 0.5 0.0 4.7 3.7 2.5 25.8 0.3 0.0 1.7 0.0 13.2 9.7 1.0 62.8 3.9 1.4 0.3 0.0 0.1 0.5 0.9 0.0 4.3 0.0 24.3 0.1 C2orf83 DKFZp547H025 ENSG00000042304 "Chromosome 2 open reading frame 83" Q53S99 2 227610090-227648606 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "placenta: 16.3" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 1.6;Late spermatids: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "U-2197: 12.6" HPA030319 Approved NA NA "HPA030319: AB_10602112" "unprognostic (1.12e-2)" "unprognostic (1.03e-1)" 0.1 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 C4orf19 FLJ11017 ENSG00000154274 "Chromosome 4 open reading frame 19" Q8IY42 4 37453941-37623495 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 37.7;placenta: 38.3" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 45.7;Exocrine glandular cells: 45.6;Pancreatic endocrine cells: 48.4;Paneth cells: 37.4;Syncytiotrophoblasts: 39.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 11.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 11.4" "Group enriched" "Detected in some" 5 "OE19: 25.1;RT4: 32.3;SK-BR-3: 13.0;T-47d: 46.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043458, HPA052894" Enhanced Supported "Cell Junctions" No No "Cell Junctions" "HPA043458: AB_10960696, HPA052894: AB_2681982" "unprognostic (8.83e-2)" "unprognostic (7.86e-2)" "unprognostic (3.00e-3)" "unprognostic (2.04e-2)" "unprognostic (2.23e-1)" "unprognostic (3.59e-3)" "unprognostic (5.55e-2)" "unprognostic (2.29e-1)" "unprognostic (6.66e-2)" "unprognostic (9.96e-2)" "unprognostic (1.35e-1)" "unprognostic (4.38e-2)" "prognostic favorable (1.49e-11)" "unprognostic (1.33e-1)" "unprognostic (1.60e-1)" "unprognostic (1.63e-3)" "unprognostic (8.19e-3)" 2.0 0.5 2.6 1.5 2.7 1.6 2.2 2.8 5.4 6.5 14.6 2.5 2.3 10.3 4.2 1.9 2.1 1.7 7.4 0.7 4.4 1.7 11.9 26.2 2.8 0.0 3.1 2.5 0.6 37.7 5.8 6.1 38.3 6.2 1.9 14.0 1.9 22.2 9.8 0.6 1.7 11.0 2.3 3.8 0.6 12.4 1.5 2.2 0.0 1.3 1.0 3.3 5.9 2.9 0.9 2.2 11.4 2.1 1.2 1.2 0.3 0.0 0.0 1.3 0.1 0.0 0.0 1.7 0.3 0.0 0.0 0.0 5.2 2.0 0.0 1.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.0 0.2 25.1 0.7 0.0 3.2 0.0 5.1 32.3 0.4 0.1 0.2 13.0 0.4 1.7 46.3 0.2 0.2 0.1 1.9 0.0 0.6 0.0 0.0 0.2 0.0 2.6 2.2 0.9 2.1 2.5 0.8 0.3 0.5 0.3 0.5 0.5 0.3 0.9 0.8 1.2 11.4 1.2 0.2 2.2 0.9 0.3 2.6 2.7 2.8 5.4 4.4 1.7 3.1 2.5 6.2 2.2 0.0 13.0 1.3 4.9 0.2 0.2 0.2 22.9 6.7 0.0 10.4 0.0 5.1 10.0 18.9 1.0 0.1 45.7 0.0 45.6 4.6 0.2 5.3 0.0 11.5 0.6 0.0 9.2 0.0 0.0 1.3 0.0 0.0 3.3 1.0 28.4 4.3 48.4 37.4 0.0 7.9 1.0 0.0 0.1 0.1 0.0 0.0 39.7 0.0 28.5 13.7 CADM3 "BIgR, FLJ10698, IGSF4B, Necl-1, NECL1, SynCAM3, TSLL1" ENSG00000162706 "Cell adhesion molecule 3" Q8N126 1 159171609-159203313 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 96.5;placenta: 43.1" "Cell type enhanced" "Detected in some" 18 "Bipolar cells: 103.2;Fibroblasts: 46.4;Horizontal cells: 33.4;Melanocytes: 23.6;Muller glia cells: 35.4" "Cancer enhanced" "Detected in many" "glioma: 27.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 19.8;HSkMC: 66.3;hTERT-HME1: 35.5;U-2 OS: 9.9;WM-115: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002981, CAB025746" Enhanced Supported Approved Cytosol "Intracellular and membrane" NA NA 790000 Cytosol "CAB025746: , HPA002981: AB_1078916" "unprognostic (1.74e-2)" "unprognostic (8.26e-2)" "unprognostic (1.34e-2)" "unprognostic (1.33e-2)" "unprognostic (9.32e-2)" "unprognostic (4.84e-2)" "unprognostic (1.05e-1)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (1.12e-1)" "unprognostic (1.98e-2)" "unprognostic (6.12e-3)" "prognostic unfavorable (1.03e-5)" "unprognostic (5.52e-2)" "unprognostic (2.59e-1)" "unprognostic (3.64e-1)" "prognostic unfavorable (5.75e-4)" 8.9 5.4 23.3 8.5 41.0 0.9 6.1 88.4 96.5 18.0 8.8 6.9 0.7 3.2 2.2 1.6 7.2 3.2 4.1 4.3 23.2 27.4 1.1 1.1 2.9 7.8 18.5 22.4 1.2 2.0 1.0 7.4 43.1 30.4 1.7 8.9 4.5 2.6 3.6 2.0 7.7 6.4 4.1 9.6 7.6 2.8 2.4 4.6 0.0 4.8 0.7 5.9 10.2 7.4 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.3 0.0 0.0 0.0 2.8 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.0 19.8 0.0 0.0 66.3 0.0 0.0 35.5 0.0 1.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1.1 0.0 0.0 1.5 0.0 0.0 2.6 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 41.0 88.4 55.6 23.2 27.4 18.5 22.4 30.4 4.6 0.0 0.3 0.0 0.0 6.0 103.2 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.1 4.0 0.0 0.0 0.0 0.4 46.4 0.1 0.0 0.0 1.0 33.4 0.0 4.3 0.0 4.7 0.6 0.0 23.6 0.0 0.0 35.4 0.0 0.0 0.0 0.0 7.5 0.0 3.9 0.9 1.7 3.8 0.6 0.0 0.0 0.0 CALHM4 "C6orf78, FAM26D, FLJ32239" ENSG00000164451 "Calcium homeostasis modulator family member 4" Q5JW98 6 116529013-116558868 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 14 "placenta: 29.7;skin 1: 9.1" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 45.7" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "pons and medulla: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CACO-2: 2.8;SuSa: 6.2" "Intracellular and membrane" NA NA "unprognostic (7.95e-2)" "unprognostic (3.44e-4)" "unprognostic (1.99e-1)" "unprognostic (1.44e-2)" 0.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.6 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.2 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 29.7 1.4 0.0 0.0 0.2 0.0 0.0 0.5 9.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.3 0.1 0.0 2.8 0.0 0.3 0.2 0.2 0.3 0.0 0.3 0.6 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 1.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 6.2 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.2 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.7 0.0 0.0 0.0 CAPN6 "CalpM, CANPX, CAPNX" ENSG00000077274 "Calpain 6" Q9Y6Q1 X 111245103-111270523 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "epididymis: 62.9;placenta: 173.5" "Group enriched" "Detected in some" 4 "Extravillous trophoblasts: 165.5;Syncytiotrophoblasts: 117.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 25.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "NK-cell: 1.2;plasmacytoid DC: 2.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HDLM-2: 10.1;NTERA-2: 15.8;SuSa: 14.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA040259 Approved "Nucleoplasm,Centriolar satellite,Cytosol" NA NA "Centriolar satellite" "Nucleoplasm, Cytosol" "HPA040259: " "unprognostic (1.27e-3)" "unprognostic (2.04e-1)" "unprognostic (2.69e-2)" "unprognostic (5.77e-3)" "unprognostic (2.07e-1)" "unprognostic (9.93e-2)" "unprognostic (8.39e-3)" "unprognostic (1.06e-1)" "unprognostic (2.08e-1)" "unprognostic (9.45e-3)" "unprognostic (5.12e-1)" "unprognostic (6.25e-2)" "unprognostic (7.67e-2)" "unprognostic (6.50e-2)" "unprognostic (5.02e-3)" "unprognostic (2.66e-1)" "unprognostic (6.30e-2)" 1.7 0.0 0.2 1.7 0.2 0.0 6.0 0.3 0.3 3.9 4.2 0.2 23.4 0.2 18.2 62.9 2.4 2.9 2.6 0.4 0.2 0.0 5.1 0.4 0.3 1.1 0.2 0.4 1.9 4.1 0.0 0.2 173.5 0.3 3.6 2.2 2.1 5.6 21.7 1.7 1.0 1.3 2.0 0.3 1.0 7.2 2.8 0.2 0.5 1.7 4.7 2.9 1.4 2.6 0.1 2.0 0.8 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 15.8 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.1 0.3 0.4 0.3 0.0 14.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.2 0.2 0.3 0.3 0.2 0.0 0.2 0.4 0.3 0.2 0.0 0.0 0.0 1.0 0.1 0.0 0.3 10.2 0.0 0.0 7.0 0.0 35.2 3.3 5.0 0.0 0.0 0.0 0.0 0.6 165.5 2.6 0.2 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 2.7 0.0 20.8 0.0 0.0 0.0 0.5 0.0 0.0 0.0 117.5 0.0 0.0 0.3 CCDC102B "ACY1L, AN, C18orf14, FLJ23594, HsT1731" ENSG00000150636 "Coiled-coil domain containing 102B" Q68D86 18 68715209-69055189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 33.7" "Cell type enhanced" "Detected in many" 14 "Early spermatids: 113.6;Late spermatids: 49.0;Sertoli cells: 77.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "plasmacytoid DC: 11.5" "Lineage enriched" "Detected in many" 4 "dendritic cells: 11.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 10.8;BJ hTERT+: 20.8;fHDF/TERT166: 18.7;HSkMC: 11.5;Karpas-707: 7.4" "Not detected" "Not detected" "HPA040623, HPA048194" Approved Approved Mitochondria,Cytosol NA NA Mitochondria Cytosol "HPA040623: AB_10805715, HPA048194: AB_2680309" "unprognostic (3.92e-2)" "unprognostic (1.62e-1)" "unprognostic (5.58e-2)" "unprognostic (9.50e-3)" "unprognostic (7.13e-2)" "unprognostic (3.50e-1)" "unprognostic (7.87e-3)" "unprognostic (1.36e-1)" "unprognostic (5.59e-2)" "unprognostic (8.62e-3)" "unprognostic (1.95e-1)" "unprognostic (6.04e-2)" "prognostic unfavorable (2.90e-6)" "unprognostic (2.21e-2)" "unprognostic (2.12e-2)" "unprognostic (8.00e-3)" "unprognostic (3.13e-3)" 8.7 4.2 6.4 4.7 7.1 1.3 4.4 3.2 8.0 4.2 4.8 4.9 2.9 2.3 4.0 6.4 4.7 2.9 16.9 4.7 6.0 5.4 5.9 3.3 16.4 11.5 7.0 5.0 3.3 3.1 3.2 5.0 33.7 8.7 4.0 6.1 4.0 3.2 2.2 2.1 2.9 3.9 6.4 9.3 3.3 4.7 4.3 7.0 1.7 6.8 5.0 2.9 16.9 4.0 0.9 11.5 0.4 0.3 1.3 2.6 0.3 0.0 0.0 2.9 0.2 2.7 10.8 0.2 0.6 20.8 0.2 0.3 0.1 0.3 0.1 0.4 18.7 0.3 0.2 0.1 0.2 0.3 0.9 0.3 0.6 0.0 0.9 5.3 0.1 0.3 11.5 0.4 0.3 2.6 0.4 0.1 1.4 0.0 7.4 1.7 0.0 0.4 0.2 0.6 0.1 0.3 0.9 0.2 0.3 0.1 0.0 1.3 1.1 0.1 0.0 0.0 1.2 0.2 0.9 2.9 0.4 0.2 0.1 0.2 3.2 0.2 0.5 1.5 1.2 1.8 0.0 0.1 0.4 1.4 0.3 1.3 0.6 0.8 1.1 0.3 0.9 2.6 1.6 0.0 1.3 0.2 11.5 0.3 0.3 6.4 7.1 3.2 8.0 6.0 5.4 7.0 5.0 8.7 7.0 0.0 2.1 0.5 0.6 0.6 5.6 7.4 0.0 1.4 3.4 3.5 5.9 0.7 5.0 0.6 113.6 4.5 0.0 0.0 1.5 0.5 3.6 0.5 2.3 0.6 3.0 6.4 0.0 4.3 2.2 49.0 30.0 3.1 0.0 2.8 0.2 10.8 0.3 0.3 8.5 4.5 12.2 77.6 22.5 1.6 2.7 0.5 0.2 1.0 0.4 0.5 CCDC194 ENSG00000269720 "Coiled-coil domain containing 194" A0A1B0GVG4 19 17390509-17394158 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "ovary: 2.3;placenta: 1.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.4;PC-3: 2.2;U-266/70: 2.3;U-266/84: 1.7" "Not detected" "Not detected" NA NA "unprognostic (1.50e-3)" "unprognostic (1.37e-1)" "unprognostic (1.87e-4)" "unprognostic (2.75e-3)" "unprognostic (1.41e-1)" "unprognostic (1.28e-2)" "unprognostic (3.09e-1)" "unprognostic (9.87e-2)" "unprognostic (3.07e-1)" "unprognostic (5.84e-2)" "unprognostic (1.23e-1)" "unprognostic (2.64e-2)" "unprognostic (5.22e-14)" "unprognostic (1.04e-1)" "unprognostic (6.70e-3)" "unprognostic (2.60e-1)" "unprognostic (1.86e-2)" 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.2 0.0 0.0 2.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.8 0.7 0.9 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.7 1.4 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.4 0.0 2.2 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.3 1.7 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCL8 "HC14, MCP-2, SCYA8" ENSG00000108700 "C-C motif chemokine ligand 8" P80075 17 34319036-34321402 "Cancer-related genes, Predicted secreted proteins" "Chemotaxis, Inflammatory response" "Cytokine, Heparin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 19.7" "Cell type enriched" "Detected in some" 13 "Smooth muscle cells: 106.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "classical monocyte: 5.8" "Lineage enriched" "Detected in single" 8 "monocytes: 5.8" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.9;BJ hTERT+ SV40 Large T+ RasG12V: 1.8;EFO-21: 4.1;HSkMC: 6.1" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 32000 "unprognostic (7.51e-2)" "unprognostic (3.20e-1)" "unprognostic (1.90e-2)" "unprognostic (4.03e-2)" "unprognostic (8.00e-2)" "unprognostic (1.59e-2)" "unprognostic (1.52e-1)" "unprognostic (1.65e-1)" "unprognostic (9.97e-2)" "unprognostic (1.67e-3)" "unprognostic (1.46e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (1.05e-7)" "unprognostic (1.39e-1)" "unprognostic (1.88e-2)" "unprognostic (5.65e-2)" "unprognostic (3.41e-2)" 10.6 2.8 1.0 7.2 1.2 0.2 4.4 0.6 1.6 0.8 12.0 1.4 1.1 6.9 3.4 3.8 1.2 2.9 3.7 2.4 0.8 0.7 2.8 2.1 8.4 1.3 0.8 0.9 5.3 0.8 6.0 1.6 19.7 1.1 1.5 8.0 5.0 1.1 2.9 1.5 1.3 13.1 4.1 2.4 3.1 1.9 1.6 0.2 2.1 3.0 4.0 2.7 4.4 0.8 0.7 0.2 0.0 5.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.9 0.5 0.1 0.0 1.9 0.0 1.8 0.0 0.0 0.0 4.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 1.2 0.6 1.6 0.8 0.7 0.8 0.9 1.1 0.2 0.0 0.0 0.0 0.2 3.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.7 0.5 0.0 0.0 1.6 0.0 2.8 0.1 0.0 0.0 7.7 0.0 0.0 0.0 0.6 0.8 0.0 4.6 5.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 106.5 0.0 0.0 4.6 0.1 0.0 0.0 0.1 CCNE1 CCNE ENSG00000105173 "Cyclin E1" P24864 19 29811898-29824308 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 23.3;placenta: 46.7" "Cell type enriched" "Detected in many" 14 "Extravillous trophoblasts: 1526.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 81.6" "Low region specificity" "Detected in all" "CAB000308, CAB016682, HPA018169" Approved Enhanced Nucleoplasm Yes Yes Nucleoplasm "CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384" "unprognostic (2.90e-3)" "unprognostic (1.33e-2)" "unprognostic (1.47e-3)" "prognostic unfavorable (6.35e-6)" "unprognostic (5.78e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (3.89e-5)" "unprognostic (1.26e-3)" "unprognostic (3.14e-3)" "prognostic unfavorable (2.97e-4)" "unprognostic (3.29e-2)" "unprognostic (7.07e-2)" "unprognostic (1.11e-16)" "unprognostic (5.61e-2)" "unprognostic (1.92e-1)" "unprognostic (6.63e-2)" "unprognostic (1.46e-1)" 1.6 6.8 2.4 4.5 2.9 23.3 0.6 6.3 3.3 0.8 3.0 1.7 1.1 2.3 1.2 0.6 4.7 0.7 2.2 4.4 2.3 2.8 1.2 0.7 1.1 4.6 1.9 1.9 0.9 1.4 1.7 1.0 46.7 2.8 1.1 3.8 1.5 3.2 1.2 2.2 4.4 2.5 3.0 1.7 4.6 2.0 12.3 1.6 4.1 1.6 2.1 5.9 2.7 2.5 2.7 1.6 1.6 1.9 0.0 1.4 0.5 4.1 8.6 6.6 9.4 1.4 1.6 81.6 6.6 1.4 2.9 3.6 8.7 8.4 3.5 15.7 2.9 3.8 1.3 7.8 3.4 4.2 11.1 4.8 2.9 8.4 9.1 1.1 11.5 7.9 1.7 1.9 4.0 0.5 0.9 3.5 3.5 11.8 1.6 4.4 6.2 6.3 3.3 11.0 9.4 2.0 9.5 7.7 2.6 2.2 6.6 5.6 4.7 9.5 11.7 1.0 10.1 2.6 8.6 2.0 6.9 25.9 4.1 4.4 6.6 4.6 23.9 3.9 1.4 3.7 0.0 0.1 0.0 0.6 1.9 1.1 2.7 0.5 0.4 1.6 0.2 0.1 0.9 1.6 0.0 1.9 0.0 1.4 0.5 2.4 2.9 6.3 3.3 2.3 2.8 1.9 1.9 2.8 1.6 0.0 1.1 0.8 1.0 4.2 2.4 2.8 0.0 0.0 2.3 0.0 0.0 112.5 0.0 0.4 7.1 1.1 1.7 0.0 0.6 1526.8 4.8 1.9 0.0 0.0 37.5 3.2 2.9 1.3 0.3 2.6 1.1 1.1 1.7 0.0 2.7 1.8 1.0 2.9 2.1 0.2 0.8 6.5 3.1 14.1 19.5 5.3 96.8 2.2 3.8 2.4 CCSAP "C1orf96, CSAP, FLJ41471" ENSG00000154429 "Centriole, cilia and spindle associated protein" Q6IQ19 1 229321005-229343294 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.6;placenta: 28.7" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 92.0;Syncytiotrophoblasts: 85.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BEWO: 39.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028402, HPA043443" Enhanced Supported NA NA "HPA028402: AB_10603681, HPA043443: AB_2678485" "unprognostic (4.93e-2)" "unprognostic (7.50e-2)" "unprognostic (1.80e-1)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.41e-4)" "unprognostic (2.63e-1)" "unprognostic (1.18e-1)" "unprognostic (3.26e-1)" "unprognostic (4.97e-2)" "unprognostic (1.57e-1)" "prognostic unfavorable (4.50e-13)" "unprognostic (9.67e-2)" "unprognostic (4.93e-1)" "unprognostic (4.15e-2)" "unprognostic (1.03e-1)" 3.4 3.9 19.3 4.9 20.5 13.3 6.8 29.9 39.6 3.7 3.1 9.8 1.4 3.8 3.7 3.0 4.1 2.3 3.7 3.1 14.1 8.9 2.2 3.8 4.8 4.6 9.8 20.7 6.9 3.0 4.3 5.7 28.7 8.9 4.7 3.7 4.9 4.7 3.8 3.0 13.3 3.4 3.0 10.7 5.3 3.4 2.7 11.3 8.5 2.8 0.4 4.2 3.7 2.8 1.0 1.9 5.8 3.2 0.5 2.0 0.4 6.6 3.6 4.8 8.8 3.3 3.0 39.3 4.8 2.4 5.5 5.3 4.4 4.1 4.2 3.6 4.2 4.5 5.2 10.2 3.6 5.6 7.7 9.9 4.4 3.6 3.2 2.0 7.1 8.7 1.1 2.9 4.3 5.5 4.4 3.9 9.8 5.9 6.4 4.4 2.2 20.1 7.6 4.4 5.0 5.3 5.9 12.3 2.8 2.6 4.1 9.8 13.2 9.0 5.5 4.6 4.2 4.3 10.0 2.5 4.8 7.4 6.5 7.4 5.9 9.1 3.1 5.7 7.2 5.6 5.8 1.5 3.1 0.9 3.0 2.0 0.5 1.1 1.3 1.3 1.0 1.1 0.9 2.4 0.5 3.2 1.9 1.4 0.4 19.3 20.5 29.9 22.1 14.1 8.9 9.8 20.7 8.9 11.3 8.9 1.4 0.9 5.3 7.2 92.0 3.3 0.0 1.4 2.3 1.8 39.3 12.5 5.0 1.4 30.4 1.5 0.7 23.3 0.3 30.8 4.0 6.4 0.0 2.6 9.8 17.5 2.4 1.8 13.2 17.3 0.0 17.3 5.0 1.8 2.5 11.3 0.5 0.0 2.5 0.0 42.1 0.0 3.9 0.5 0.9 14.3 85.1 4.4 1.5 5.4 CD200 "MOX1, MOX2, MRC, OX-2" ENSG00000091972 "CD200 molecule" P41217 3 112332347-112362812 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 63.5" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 82.9;Intestinal endocrine cells: 36.9;Syncytiotrophoblasts: 63.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 16 "memory B-cell: 9.9;naive B-cell: 36.4" "Lineage enriched" "Detected in many" 25 "B-cells: 36.4" "Cell line enhanced" "Detected in some" "AF22: 31.9;HHSteC: 11.7;NTERA-2: 19.9;REH: 17.0;SH-SY5Y: 9.8;SK-MEL-30: 11.7;WM-115: 34.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031149 Approved NA NA "HPA031149: AB_10600694" "unprognostic (1.84e-1)" "unprognostic (5.08e-2)" "unprognostic (1.79e-1)" "unprognostic (2.03e-3)" "unprognostic (4.97e-1)" "unprognostic (1.21e-2)" "unprognostic (9.29e-2)" "unprognostic (2.25e-2)" "unprognostic (3.06e-1)" "unprognostic (3.14e-2)" "unprognostic (1.21e-2)" "unprognostic (1.27e-1)" "unprognostic (8.97e-2)" "unprognostic (1.06e-2)" "unprognostic (2.80e-1)" "unprognostic (4.49e-2)" "unprognostic (1.22e-2)" 12.8 9.5 18.1 10.9 34.3 1.8 7.1 20.9 38.3 16.0 4.5 11.0 1.5 2.6 21.4 5.7 7.0 20.3 10.1 5.8 17.3 42.4 4.9 1.0 7.2 17.7 12.7 19.3 9.3 3.8 10.9 27.9 63.5 19.6 9.7 6.5 7.5 5.4 13.0 1.4 2.8 4.3 13.9 8.4 4.4 3.4 2.3 6.7 12.7 12.4 1.6 17.6 13.9 3.9 36.4 1.1 1.2 0.1 0.6 1.4 1.3 0.0 0.0 31.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.4 0.0 3.4 0.1 0.1 0.1 0.3 0.0 0.1 0.2 11.7 0.0 0.0 0.2 0.1 0.6 0.0 0.1 4.5 0.0 0.0 0.3 0.0 0.0 0.4 0.1 19.9 0.0 0.0 17.0 0.0 0.2 0.2 0.0 8.4 9.8 0.0 0.1 11.7 6.2 0.0 0.1 0.0 0.1 1.1 0.0 0.1 0.0 0.1 0.0 0.3 0.1 34.7 1.2 0.1 0.1 0.1 0.0 1.4 9.9 0.8 0.2 0.5 36.4 0.9 0.5 0.7 0.6 0.1 1.1 0.4 1.3 18.1 34.3 20.9 38.3 17.3 42.4 12.7 19.3 19.6 6.7 3.0 14.5 33.0 11.5 3.8 24.4 0.4 0.0 4.0 2.3 1.8 0.0 2.3 0.0 0.3 20.1 82.9 0.7 0.0 0.0 7.3 5.6 4.6 2.3 0.0 0.8 3.2 36.9 1.8 0.0 21.1 0.3 1.9 8.5 24.4 5.5 5.6 0.3 2.9 0.0 0.0 2.5 0.0 4.1 0.5 0.2 2.9 63.5 0.7 5.8 17.2 CD248 "CD164L1, TEM1" ENSG00000174807 "CD248 molecule" Q9HCU0 11 66314487-66317044 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 71.0" "Cell type enhanced" "Detected in many" 14 "Fibroblasts: 70.0;Leydig cells: 69.3;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "naive CD8 T-cell: 17.8" "Lineage enriched" "Detected in single" 122 "T-cells: 17.8" "Cell line enhanced" "Detected in some" "ASC diff: 68.1;ASC TERT1: 67.2;BJ: 29.4;BJ hTERT+: 44.3;fHDF/TERT166: 59.3;HSkMC: 71.6;U-2197: 107.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA051856 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 27000000 "Plasma membrane" Nucleoplasm "HPA051856: AB_2681640" "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.95e-2)" "unprognostic (2.77e-2)" "unprognostic (1.14e-2)" "unprognostic (2.61e-1)" "unprognostic (7.21e-3)" "unprognostic (1.36e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-2)" "unprognostic (6.31e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (2.69e-7)" "unprognostic (1.90e-2)" "unprognostic (2.92e-2)" "unprognostic (1.25e-1)" "unprognostic (1.30e-2)" 59.2 3.5 0.8 14.4 2.5 0.0 55.2 0.6 2.2 21.2 7.6 1.9 6.3 2.7 14.1 22.9 14.8 17.7 12.3 18.2 1.2 0.5 5.3 1.7 9.3 16.2 1.3 1.6 15.6 4.9 1.4 2.3 71.0 2.1 10.6 2.7 11.5 4.6 8.0 6.7 13.3 7.5 27.6 1.2 1.9 7.5 8.0 0.7 4.1 9.4 6.6 4.5 19.5 17.6 0.1 0.0 0.0 0.0 0.0 17.8 1.9 0.0 0.0 0.6 0.0 68.1 67.2 0.0 29.4 44.3 2.2 2.0 0.0 0.0 0.0 0.7 59.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 13.5 0.0 0.0 71.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.1 107.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 2.3 0.0 0.1 2.8 17.8 0.0 0.0 0.0 0.0 0.0 1.9 0.8 2.5 0.6 2.2 1.2 0.5 1.3 1.6 2.1 0.7 0.0 0.0 0.0 0.0 11.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.3 2.5 0.0 0.0 0.0 2.5 70.0 0.0 0.0 0.0 5.5 0.0 0.0 4.3 0.0 0.4 69.3 0.0 11.8 1.0 0.0 3.6 0.4 0.0 19.1 0.0 0.0 32.3 12.2 0.1 0.0 7.2 3.7 0.0 0.0 0.0 CD274 "B7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1" ENSG00000120217 "CD274 molecule" Q9NZQ7 9 5450503-5470566 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 23.9;placenta: 56.0" "Cell type enhanced" "Detected in many" 14 "granulocytes: 26.7;monocytes: 73.9;Syncytiotrophoblasts: 37.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.4" "Group enriched" "Detected in many" 6 "granulocytes: 8.4;T-cells: 2.4" "Cell line enhanced" "Detected in many" "HDLM-2: 34.2;HHSteC: 22.8;U-251 MG: 37.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003528, CAB076385" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" Nucleoplasm "CAB076385: AB_2687655, HPA003528: " "prognostic favorable (8.89e-4)" "unprognostic (4.54e-2)" "prognostic favorable (1.64e-5)" "unprognostic (1.27e-2)" "unprognostic (2.96e-2)" "unprognostic (1.08e-1)" "unprognostic (4.61e-2)" "unprognostic (1.44e-1)" "unprognostic (1.68e-2)" "unprognostic (5.67e-4)" "unprognostic (7.39e-3)" "unprognostic (1.69e-2)" "unprognostic (1.24e-2)" "unprognostic (1.35e-1)" "unprognostic (1.49e-2)" "unprognostic (2.67e-1)" "unprognostic (9.02e-2)" 3.4 2.1 1.7 10.8 3.2 1.4 2.2 2.5 3.3 2.0 2.3 2.5 2.8 2.6 1.7 2.4 3.0 1.9 4.3 9.5 1.4 3.7 3.0 3.6 23.9 6.4 2.3 0.7 1.7 2.7 3.8 7.4 56.0 3.2 2.9 2.2 3.3 1.7 1.6 4.3 1.3 2.7 2.3 2.4 12.8 1.9 1.2 1.0 11.6 3.7 2.1 5.8 3.1 1.9 0.9 0.0 8.4 0.1 0.4 2.4 0.7 5.9 0.1 0.0 0.2 0.0 0.0 0.0 11.9 10.1 3.0 4.2 0.0 1.9 0.0 0.2 0.3 1.5 0.2 0.0 5.2 9.9 34.2 0.0 3.4 0.1 0.0 22.8 0.0 0.0 0.2 0.0 6.3 9.3 3.1 5.9 0.3 0.0 1.1 9.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.7 0.3 0.6 0.1 0.0 0.1 0.1 0.9 0.7 0.9 0.0 0.1 10.9 6.5 2.0 0.2 37.9 0.2 0.1 0.1 2.1 0.1 0.0 8.4 0.1 0.3 1.2 0.1 2.1 0.9 2.4 1.8 0.0 0.2 1.3 0.7 5.7 0.4 0.0 0.0 1.1 0.7 1.7 3.2 2.5 3.3 1.4 3.7 2.3 0.7 3.2 1.0 11.9 10.7 0.5 1.2 4.0 1.4 6.5 0.0 4.0 3.4 0.0 0.0 4.9 0.0 6.4 0.2 6.3 0.8 0.0 3.7 20.2 1.9 0.9 26.7 1.0 4.9 0.0 0.0 10.4 1.9 0.0 0.3 7.7 3.3 73.9 0.1 0.6 12.0 0.0 0.4 0.4 0.1 0.0 0.9 0.5 0.7 2.3 37.2 1.3 0.2 2.2 CD59 "16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20" ENSG00000085063 "CD59 molecule (CD59 blood group)" P13987 11 33703010-33736491 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 285.5" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 1502.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 217.5;U-2197: 180.1" "CAB001448, HPA026494" Supported Uncertain "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 98000000 "Golgi apparatus, Vesicles" "CAB001448: AB_563604, HPA026494: AB_1846321" "unprognostic (2.07e-2)" "prognostic unfavorable (3.81e-5)" "unprognostic (7.40e-2)" "unprognostic (1.14e-2)" "unprognostic (2.11e-2)" "prognostic unfavorable (3.10e-5)" "unprognostic (5.65e-2)" "unprognostic (1.46e-1)" "unprognostic (4.47e-2)" "unprognostic (2.98e-1)" "prognostic unfavorable (2.92e-5)" "unprognostic (1.66e-2)" "prognostic favorable (1.39e-10)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.31e-1)" "unprognostic (1.03e-2)" "unprognostic (3.09e-1)" 96.7 41.0 36.7 26.3 44.3 23.8 76.0 25.9 32.7 44.8 36.9 24.0 57.9 16.5 45.4 132.8 68.4 53.2 67.6 90.5 35.6 38.4 100.0 61.0 86.4 39.8 39.7 25.8 39.3 52.3 60.6 48.0 285.5 68.7 47.4 37.7 51.4 114.8 62.6 70.6 43.4 25.0 52.4 32.9 26.2 54.7 28.1 23.1 16.1 85.9 57.7 40.0 51.2 63.4 13.5 20.5 42.8 4.8 17.7 60.4 11.1 16.8 15.8 4.7 13.8 109.9 86.2 2.7 96.0 107.2 24.1 28.2 7.3 50.7 1.3 17.2 103.4 28.7 19.0 8.6 95.8 33.8 26.8 13.1 1.7 56.0 11.0 30.0 10.1 5.8 40.0 24.2 20.4 98.3 66.8 146.8 5.9 11.8 39.0 151.5 15.4 4.7 4.2 2.6 31.1 82.5 1.8 14.6 13.5 72.7 28.8 3.2 4.4 33.4 15.5 17.6 13.9 11.8 1.0 217.5 55.4 13.3 180.1 33.3 17.3 33.8 1.6 47.6 0.0 96.2 30.5 4.8 42.8 11.3 1.6 14.4 13.5 24.0 12.7 20.5 10.6 15.7 9.3 28.4 17.7 0.9 10.5 60.4 11.1 36.7 44.3 25.9 32.7 35.6 38.4 39.7 25.8 68.7 23.1 253.1 215.4 44.4 795.7 254.1 47.4 262.5 430.6 580.9 208.1 230.3 31.4 513.5 139.3 1251.4 102.0 802.4 90.2 140.2 547.4 330.2 284.0 787.9 136.2 175.7 400.2 44.5 160.2 566.0 129.7 49.4 219.8 141.1 1204.5 272.3 85.9 184.1 823.9 122.8 192.3 162.3 45.0 271.7 576.8 86.8 27.6 248.5 699.7 62.8 98.2 1502.4 CDH5 "7B4, CD144" ENSG00000179776 "Cadherin 5" P33151 16 66366622-66404786 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 96.6" "Cell type enhanced" "Detected in many" 15 "Endothelial cells: 155.1;Ito cells: 190.9;Syncytiotrophoblasts: 67.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HUVEC TERT2: 113.8;TIME: 97.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB028366, HPA075875" Approved Supported "Nucleoplasm,Nuclear membrane,Plasma membrane" NA NA 1000000000 "Plasma membrane" "Nucleoplasm, Nuclear membrane" "CAB028366: AB_2276033, HPA075875: " "unprognostic (1.05e-1)" "unprognostic (8.13e-2)" "unprognostic (6.11e-2)" "unprognostic (4.89e-2)" "unprognostic (4.96e-2)" "unprognostic (5.50e-3)" "unprognostic (9.38e-2)" "unprognostic (5.28e-2)" "unprognostic (1.32e-1)" "unprognostic (1.46e-1)" "unprognostic (2.33e-2)" "unprognostic (2.32e-1)" "prognostic unfavorable (5.14e-4)" "unprognostic (9.49e-3)" "unprognostic (3.01e-2)" "unprognostic (2.22e-1)" "unprognostic (3.15e-2)" 48.7 5.6 4.0 6.2 5.8 0.6 28.1 2.6 4.8 11.1 6.6 3.4 5.5 3.7 18.7 11.2 8.4 7.2 12.6 21.7 4.5 4.3 7.8 12.7 43.7 9.7 6.5 2.8 7.7 3.6 5.0 3.5 96.6 7.6 9.0 4.8 8.5 5.2 4.4 19.0 7.0 6.8 12.1 5.4 10.8 5.7 6.7 3.3 1.2 16.6 15.7 4.5 11.7 11.3 0.0 0.6 0.4 0.8 0.1 0.1 1.1 0.0 0.0 0.7 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 113.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.3 0.0 0.0 97.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.4 0.1 0.0 0.6 0.1 1.1 4.0 5.8 2.6 4.8 4.5 4.3 6.5 2.8 7.6 3.3 0.0 10.4 0.0 0.0 3.7 0.0 14.6 7.6 0.0 1.2 1.8 0.0 3.3 0.0 0.1 33.0 155.1 0.0 0.0 0.0 40.7 3.1 0.1 3.5 1.5 2.1 0.0 0.0 190.9 29.5 47.7 5.8 2.3 11.8 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 3.1 13.4 0.2 2.6 67.5 0.0 0.0 0.0 CDKN1C "BWCR, BWS, KIP2, P57" ENSG00000129757 "Cyclin dependent kinase inhibitor 1C" P49918 11 2883213-2885773 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle" "Protein kinase inhibitor" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 60.3;placenta: 105.6" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 482.4;Extravillous trophoblasts: 1267.0;Syncytiotrophoblasts: 1874.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "intermediate monocyte: 26.1;non-classical monocyte: 60.3" "Lineage enriched" "Detected in many" 12 "monocytes: 60.3" "Cell line enhanced" "Detected in many" "EFO-21: 8.4;HeLa: 8.7;RPMI-8226: 11.4;SH-SY5Y: 23.3;SiHa: 16.3;SK-MEL-30: 8.9" HPA002924 Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Nucleoplasm, Nuclear bodies, Cytosol" "HPA002924: AB_1079548" "unprognostic (5.49e-3)" "unprognostic (2.62e-1)" "unprognostic (9.82e-3)" "unprognostic (5.79e-3)" "unprognostic (4.15e-1)" "unprognostic (2.84e-2)" "unprognostic (1.95e-2)" "unprognostic (1.85e-1)" "unprognostic (3.13e-1)" "unprognostic (3.15e-1)" "unprognostic (2.95e-1)" "unprognostic (3.39e-2)" "unprognostic (2.15e-1)" "unprognostic (3.31e-2)" "unprognostic (8.53e-2)" "unprognostic (1.93e-1)" "unprognostic (2.94e-1)" 53.6 20.7 3.3 5.4 11.9 3.4 13.0 0.9 9.2 10.6 6.9 18.4 3.9 3.3 8.3 5.2 9.9 8.5 7.7 6.9 8.5 5.4 22.7 3.0 5.1 1.8 28.7 4.9 30.9 7.9 1.5 4.0 105.6 11.5 7.2 1.9 8.3 3.1 5.9 27.6 3.0 7.9 6.3 27.9 7.1 7.4 4.3 14.5 0.3 2.0 7.6 2.1 11.2 9.8 0.0 5.0 1.4 60.3 0.0 0.3 2.5 0.1 0.0 1.1 0.0 0.3 0.3 1.2 0.2 0.4 0.2 0.0 2.2 0.2 0.0 8.4 0.1 0.1 0.3 0.2 0.2 0.1 3.8 0.8 0.1 8.7 0.0 2.3 0.0 1.0 1.7 1.1 0.0 0.1 0.1 0.2 0.0 1.8 0.6 0.3 0.0 0.0 4.0 7.5 0.3 2.7 1.5 0.0 11.4 0.5 0.0 2.5 23.3 16.3 0.2 8.9 0.6 0.1 1.9 0.3 0.0 1.6 0.0 0.0 4.9 0.0 0.0 0.0 1.3 4.6 1.4 0.2 0.2 0.1 26.1 0.3 0.0 0.1 0.1 5.0 0.0 0.2 0.0 0.3 0.0 60.3 0.0 0.1 2.5 3.3 11.9 0.9 5.6 8.5 5.4 28.7 4.9 11.5 14.5 3.0 7.2 0.8 96.5 9.5 7.1 23.0 22.9 5.3 10.3 29.6 5.9 482.4 13.3 9.2 178.7 49.1 4.0 0.0 0.5 1267.0 69.5 86.8 0.0 3.0 79.4 7.9 102.1 54.6 16.1 196.4 68.7 19.6 33.7 1.0 14.2 61.0 3.5 2.5 41.8 39.1 25.4 32.3 35.6 1.4 2.7 10.3 1874.3 3.9 5.2 72.7 CDSN D6S586E ENSG00000204539 Corneodesmosin 6 31115090-31120446 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 19.2;skin 1: 109.3;tongue: 29.7" "Group enriched" "Detected in some" 6 "granulocytes: 4.6;Suprabasal keratinocytes: 4.5" "Group enriched" "Detected in some" 8 "head and neck cancer: 2.4;melanoma: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 7 "A-431: 5.9" "Group enriched" "Detected in some" 5 "amygdala: 1.0;cerebral cortex: 1.5;hippocampal formation: 1.0" "Not detected" "Not detected" "HPA044730, HPA054184" Enhanced "Secreted in other tissues" NA NA "HPA044730: AB_10964923, HPA054184: AB_2682409" "unprognostic (1.46e-1)" "unprognostic (6.96e-2)" "unprognostic (1.20e-1)" "unprognostic (1.85e-1)" "unprognostic (3.44e-2)" "unprognostic (8.80e-2)" "unprognostic (8.13e-2)" "unprognostic (3.92e-4)" "unprognostic (3.92e-3)" "unprognostic (1.74e-4)" "unprognostic (6.34e-2)" "unprognostic (2.75e-1)" "unprognostic (2.22e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 109.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 29.7 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.1 CEACAM8 "CD66b, CGM6" ENSG00000124469 "Carcinoembryonic antigen related cell adhesion molecule 8" P31997 19 42580241-42595055 "CD markers, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 71.0;placenta: 35.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "neutrophil: 4.2;non-classical monocyte: 3.0" "Group enriched" "Detected in many" 6 "granulocytes: 4.2;monocytes: 3.0" "Low cell line specificity" "Detected in some" CAB033676 Approved "Intracellular and membrane" NA NA 15000000 "CAB033676: AB_1125678" "unprognostic (2.01e-1)" "unprognostic (4.52e-2)" "unprognostic (3.31e-1)" "unprognostic (6.30e-2)" "unprognostic (2.68e-1)" "unprognostic (1.62e-1)" "unprognostic (1.71e-2)" "unprognostic (7.77e-2)" "unprognostic (9.62e-2)" 0.2 0.0 0.1 0.0 0.1 71.0 0.1 0.1 0.4 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 6.6 0.1 0.1 0.1 0.4 4.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 35.6 0.1 0.0 0.1 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.1 10.1 0.0 0.1 0.1 1.9 0.1 0.0 0.0 0.0 0.7 0.5 0.1 4.2 3.0 0.6 0.4 4.1 0.9 0.3 1.2 2.1 0.0 0.5 0.3 1.4 0.0 0.0 0.1 0.2 0.4 1.2 0.3 0.5 0.6 0.5 0.0 0.3 0.0 0.2 0.3 0.5 0.7 0.7 0.1 0.8 0.7 0.0 0.1 0.1 0.1 0.3 0.0 0.8 0.7 1.6 0.0 0.3 0.4 0.9 0.6 0.3 0.1 0.5 0.5 1.3 0.4 0.5 0.8 0.8 0.1 0.3 1.2 0.5 1.3 0.9 0.8 1.4 0.3 1.5 0.5 1.5 1.4 0.8 0.8 1.3 0.7 0.6 0.5 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.5 0.3 0.4 4.2 0.6 3.0 0.1 0.1 4.1 0.1 0.1 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CGA "FSHA, GPHa, GPHA1, HCG, LHA, TSHA" ENSG00000135346 "Glycoprotein hormones, alpha polypeptide" P01215 6 87085498-87095406 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 62 "pituitary gland: 398.8;placenta: 489.3" "Cell type enriched" "Detected in some" 30 "Syncytiotrophoblasts: 71349.9" "Cancer enhanced" "Detected in many" "testis cancer: 13.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 28 "BEWO: 73.5;SuSa: 141.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 11 "hypothalamus: 69.2" "CAB023350, HPA029698" Enhanced "Secreted to blood" NA NA "CAB023350: AB_617281, HPA029698: AB_2673153" "unprognostic (1.66e-1)" "unprognostic (2.10e-1)" "unprognostic (3.22e-5)" "unprognostic (1.46e-2)" "unprognostic (1.51e-1)" "unprognostic (2.69e-2)" "unprognostic (3.17e-1)" "unprognostic (7.04e-3)" "unprognostic (1.51e-1)" "unprognostic (2.85e-1)" "unprognostic (4.32e-2)" "unprognostic (8.32e-2)" "unprognostic (9.15e-3)" 0.1 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 398.8 489.3 0.2 0.1 0.0 0.0 0.1 0.1 0.2 0.2 0.0 0.6 0.0 0.1 7.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 2.2 1.9 3.5 1.5 1.1 2.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 73.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 141.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.3 1.1 1.0 1.7 0.5 0.7 1.3 0.8 1.4 0.6 2.2 1.2 2.1 3.5 1.1 1.5 1.9 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 7.0 0.0 1223.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2346.5 0.1 1.5 0.0 0.0 567.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 71349.9 0.0 0.0 0.3 CGB3 CGB ENSG00000104827 "Chorionic gonadotropin beta subunit 3" P0DN86 19 49022869-49024333 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 6.7;placenta: 15.0" "Cell type enriched" "Detected in some" 38 "Syncytiotrophoblasts: 724.1" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.9;testis cancer: 4.2" "Cell type enhanced" "Detected in single" "T-reg: 1.0" "Lineage enriched" "Detected in single" 6 "T-cells: 1.0" "Cell line enriched" "Detected in some" 20 "BEWO: 39.7" "CAB000042, CAB010884, HPA038925, HPA038934" Enhanced Approved Cytosol "Secreted to blood" NA NA Cytosol "CAB000042: , CAB010884: AB_259037, HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (1.39e-1)" "unprognostic (7.88e-2)" "unprognostic (6.92e-2)" "unprognostic (1.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 6.7 15.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 39.7 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 1.3 0.5 0.0 0.0 0.1 0.2 0.0 1.9 0.7 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 724.1 0.0 0.0 0.0 CGB5 HCG ENSG00000189052 "Chorionic gonadotropin beta subunit 5" P0DN86 19 49043884-49045311 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "placenta: 105.2" "Cell type enriched" "Detected in some" 7 "Syncytiotrophoblasts: 16.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 10.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "BEWO: 46.9;U-251 MG: 21.3" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (1.38e-1)" "unprognostic (1.68e-1)" "unprognostic (1.51e-3)" "prognostic unfavorable (1.18e-5)" "unprognostic (1.07e-1)" "prognostic unfavorable (9.47e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.1 12.7 105.2 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.4 0.2 0.0 0.0 0.0 0.0 46.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.1 0.0 21.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 CGB8 ENSG00000213030 "Chorionic gonadotropin beta subunit 8" P0DN86 19 49047638-49049106 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 85 "pituitary gland: 7.0;placenta: 22.2" "Cell type enriched" "Detected in some" 15 "Syncytiotrophoblasts: 37.1" "Cancer enhanced" "Detected in some" "testis cancer: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 61.9;U-251 MG: 21.5" "HPA038925, HPA038934" Supported Approved Cytosol "Secreted to blood" NA NA Cytosol "HPA038925: AB_2676272, HPA038934: AB_2676277" "unprognostic (3.35e-2)" "unprognostic (1.72e-1)" "unprognostic (7.44e-3)" "unprognostic (4.70e-1)" "unprognostic (1.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.0 22.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.2 0.0 0.0 1.9 0.0 0.0 0.3 1.4 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.9 0.0 0.2 0.0 1.2 2.6 0.2 21.5 0.0 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 CHAT ENSG00000070748 "Choline O-acetyltransferase" P28329 10 49609095-49665104 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Neurotransmitter biosynthesis" "Acyltransferase, Transferase" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 5.4;placenta: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 8 "basal ganglia: 5.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "NB-4: 15.9" "Region enhanced" "Detected in many" "basal ganglia: 18.4" "Group enriched" "Detected in all" 4 "basal ganglia: 7.7;pons and medulla: 8.1" "CAB002313, HPA048547, CAB079053" Supported Supported NA NA "CAB002313: AB_563661, CAB079053: , HPA048547: AB_2680437" "unprognostic (2.34e-2)" "unprognostic (6.10e-2)" "unprognostic (5.28e-2)" "unprognostic (6.96e-2)" "unprognostic (2.80e-2)" "unprognostic (3.98e-1)" "unprognostic (1.09e-1)" 0.2 0.0 0.2 0.3 5.4 0.0 0.2 0.2 0.2 0.2 0.6 0.2 0.2 1.6 0.2 0.5 0.2 0.0 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.9 0.0 0.2 10.4 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 1.1 0.2 0.4 0.2 0.0 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 1.0 0.3 0.2 0.6 1.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 1.1 15.9 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.7 0.4 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.1 0.0 1.4 0.0 0.0 0.2 0.3 0.4 0.1 0.5 0.3 1.0 0.4 0.1 0.6 0.5 0.3 0.0 0.6 0.1 1.0 0.2 0.0 0.2 5.4 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHSY1 "CSS1, KIAA0990" ENSG00000131873 "Chondroitin sulfate synthase 1" Q86X52 15 101175723-101251932 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" Transferase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 72.5" "Cell type enhanced" "Detected in many" 4 "Smooth muscle cells: 68.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 69.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted - unknown location" NA NA "unprognostic (7.28e-2)" "unprognostic (6.39e-2)" "unprognostic (9.24e-2)" "unprognostic (1.55e-1)" "unprognostic (7.60e-2)" "unprognostic (9.51e-3)" "unprognostic (1.46e-1)" "unprognostic (3.02e-3)" "unprognostic (1.77e-1)" "unprognostic (1.32e-2)" "unprognostic (5.97e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (6.33e-5)" "unprognostic (3.44e-2)" "unprognostic (1.02e-1)" "unprognostic (8.91e-3)" "unprognostic (5.58e-3)" 23.2 15.6 14.4 14.6 13.7 15.7 17.7 8.5 11.1 17.7 6.5 9.6 8.6 4.9 15.6 11.6 9.1 14.1 19.0 19.0 11.4 7.5 9.0 8.1 20.6 12.4 15.3 5.5 21.9 6.0 5.9 8.7 72.5 12.9 13.6 7.0 12.1 9.8 10.1 7.3 13.7 6.8 16.4 11.9 18.4 9.3 10.8 13.5 8.3 9.7 9.2 8.7 14.3 20.0 1.9 1.5 8.7 2.4 1.2 3.2 1.0 2.8 3.5 11.9 6.0 6.2 8.4 7.9 6.9 6.1 8.4 8.6 3.0 2.3 6.8 4.1 11.5 5.5 7.9 7.9 8.8 9.3 7.6 3.9 13.5 4.0 3.5 7.7 20.5 14.0 7.7 7.4 7.2 6.6 9.6 9.9 3.1 4.9 69.8 6.3 2.4 2.8 14.1 13.7 5.5 2.5 6.4 12.0 10.1 5.8 5.6 2.1 11.3 7.3 3.6 12.5 10.2 4.1 25.5 8.3 13.8 7.9 6.5 14.5 12.4 28.6 4.0 10.7 19.5 10.2 0.0 2.4 5.1 2.9 1.5 3.1 1.7 1.8 3.1 1.5 1.9 1.0 1.9 8.7 1.2 1.6 0.9 3.2 1.0 14.4 13.7 8.5 11.1 11.4 7.5 15.3 5.5 12.9 13.5 0.0 17.8 6.2 17.2 51.4 9.0 7.1 2.5 10.7 11.4 15.7 5.9 5.6 1.7 4.4 0.7 37.9 0.9 23.3 1.9 19.4 44.1 15.0 24.4 4.9 14.0 36.5 2.9 57.7 14.0 1.3 50.9 17.6 25.3 1.0 3.4 9.1 4.6 3.4 44.2 1.9 7.3 45.3 68.0 3.9 7.2 54.6 11.6 8.7 3.1 8.5 CLDN19 ENSG00000164007 "Claudin 19" Q8N6F1 1 42733093-42740254 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "Disease mutation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "brain: 13.8;kidney: 22.5;placenta: 20.9;retina: 37.0" "Cell type enriched" "Detected in some" 7 "Extravillous trophoblasts: 192.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.6" "Group enriched" "Detected in some" 54 "midbrain: 13.8;pons and medulla: 9.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CACO-2: 5.1;Hep G2: 10.6;SuSa: 6.4" "Region enhanced" "Detected in some" "olfactory region: 6.7" "Low region specificity" "Detected in all" NA NA "unprognostic (6.23e-4)" "unprognostic (1.80e-1)" "unprognostic (1.85e-6)" "unprognostic (5.30e-2)" "unprognostic (1.73e-1)" "unprognostic (3.21e-2)" "unprognostic (3.22e-1)" "unprognostic (9.45e-2)" "unprognostic (1.95e-1)" "unprognostic (2.68e-1)" "unprognostic (7.22e-2)" "unprognostic (8.76e-3)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (3.29e-3)" 1.0 0.2 0.1 0.1 0.2 0.2 1.6 0.2 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.9 0.6 0.3 0.1 0.4 0.2 0.1 22.5 0.2 0.2 0.1 13.8 0.0 0.2 0.2 0.1 0.2 20.9 9.5 0.4 0.1 37.0 1.2 2.7 0.4 0.8 0.3 1.0 6.2 0.1 0.5 0.2 0.0 1.3 0.1 2.6 0.1 0.8 1.0 0.5 0.4 1.4 0.3 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.3 0.2 0.2 0.2 0.5 0.2 0.2 0.2 0.5 0.5 0.5 1.4 0.2 0.2 0.4 0.3 0.1 0.1 0.2 0.2 0.1 0.2 0.1 13.8 0.0 9.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.0 0.0 1.2 12.2 0.0 9.1 28.2 0.0 0.0 0.0 0.0 0.0 0.0 192.3 0.2 0.1 0.0 0.0 4.4 0.0 0.0 0.6 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.0 0.0 0.1 0.0 10.4 0.0 0.0 0.0 CLDN6 ENSG00000184697 "Claudin 6" P56747 16 3014712-3020071 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 9.5;testis: 4.8" "Cell type enhanced" "Detected in some" 28 "Cytotrophoblasts: 21.7;Ductal cells: 18.1;Extravillous trophoblasts: 119.4;Syncytiotrophoblasts: 36.8" "Group enriched" "Detected in many" 8 "endometrial cancer: 25.8;ovarian cancer: 73.6;testis cancer: 112.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "neutrophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Group enriched" "Detected in some" 6 "BEWO: 85.2;CACO-2: 23.1;NTERA-2: 78.4;SuSa: 61.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (2.59e-1)" "unprognostic (1.44e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (2.42e-6)" "unprognostic (1.16e-1)" "unprognostic (1.58e-1)" "unprognostic (6.08e-2)" "unprognostic (1.92e-1)" "unprognostic (5.50e-4)" "unprognostic (1.02e-2)" "unprognostic (5.88e-1)" "unprognostic (1.98e-2)" "unprognostic (7.66e-4)" "unprognostic (1.79e-3)" "unprognostic (1.02e-1)" "unprognostic (4.99e-2)" "prognostic unfavorable (1.78e-4)" 0.1 0.9 0.5 0.1 3.7 0.5 0.1 2.5 1.0 0.1 0.6 0.1 0.1 0.5 0.4 0.1 0.1 0.4 0.7 0.2 0.7 0.8 0.2 0.1 0.9 0.1 0.7 0.1 0.1 3.3 0.0 1.2 9.5 1.5 0.1 0.4 0.1 0.1 0.1 0.6 0.0 0.4 0.1 0.3 0.2 0.4 4.8 0.1 1.3 0.2 0.1 0.1 0.3 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 85.2 0.0 0.0 0.0 0.0 23.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 78.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 61.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.5 3.7 2.5 1.0 0.7 0.8 0.7 0.1 1.5 0.1 3.0 0.0 0.0 1.2 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 21.7 0.0 18.1 0.1 0.0 0.0 0.0 0.0 119.4 0.2 0.5 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.4 0.4 36.8 0.0 0.0 0.1 CLDN9 ENSG00000213937 "Claudin 9" O95484 16 3012456-3014505 "Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.5;pancreas: 9.6;pituitary gland: 15.9;placenta: 10.2" "Cell type enhanced" "Detected in some" 12 "Cholangiocytes: 10.2;Ductal cells: 8.3;Pancreatic endocrine cells: 5.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "CAPAN-2: 5.7;MCF7: 19.5;SCLC-21H: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA076613 Supported "Vesicles,Cell Junctions" NA NA "Cell Junctions" Vesicles "HPA076613: AB_2686808" "unprognostic (7.93e-2)" "unprognostic (1.40e-1)" "unprognostic (1.43e-2)" "prognostic unfavorable (2.24e-6)" "unprognostic (4.91e-2)" "unprognostic (6.04e-2)" "unprognostic (1.13e-1)" "unprognostic (2.75e-1)" "unprognostic (1.64e-2)" "unprognostic (5.06e-2)" "unprognostic (8.97e-3)" "unprognostic (4.51e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (1.29e-1)" "unprognostic (7.71e-3)" "unprognostic (5.55e-2)" 0.3 0.4 0.4 0.5 2.1 5.2 0.3 16.5 1.4 0.6 1.0 0.3 0.3 1.8 0.3 0.9 0.3 2.3 1.1 0.4 0.8 0.8 0.6 2.6 1.5 0.3 1.4 0.3 0.3 9.6 4.8 15.9 10.2 0.5 0.3 0.1 0.3 1.7 0.3 1.5 0.4 1.2 0.3 2.2 1.0 0.3 0.3 0.3 1.2 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.3 0.1 0.0 2.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 5.7 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 19.5 0.0 1.6 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.1 15.3 0.1 0.8 0.8 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 2.1 16.5 1.4 0.8 0.8 1.4 0.3 0.5 0.3 0.0 0.0 0.0 1.8 0.1 1.4 0.3 10.2 2.7 0.0 0.0 0.0 0.2 0.0 8.3 0.0 0.0 0.0 0.0 1.6 0.7 0.0 0.7 0.0 0.0 0.1 0.0 1.7 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 5.9 1.1 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.4 0.9 0.0 0.2 1.7 CLEC1A "CLEC1, MGC34328" ENSG00000150048 "C-type lectin domain family 1 member A" Q8NC01 12 10069554-10111627 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 40.8" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 45.1;Endothelial cells: 22.2;Extravillous trophoblasts: 51.1;Ito cells: 14.7;Syncytiotrophoblasts: 43.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 2.2;intermediate monocyte: 1.3;myeloid DC: 5.2;neutrophil: 2.8" "Group enriched" "Detected in many" 14 "dendritic cells: 5.2;granulocytes: 2.8;monocytes: 2.2" "Cell line enhanced" "Detected in some" "BEWO: 18.8;HUVEC TERT2: 15.9;SuSa: 5.1;U-266/70: 4.3;U-266/84: 9.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "unprognostic (7.63e-2)" "unprognostic (2.51e-2)" "unprognostic (5.96e-2)" "unprognostic (2.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.16e-2)" "unprognostic (1.37e-1)" "unprognostic (1.03e-1)" "unprognostic (7.15e-2)" "unprognostic (2.73e-2)" "unprognostic (3.26e-2)" "unprognostic (1.81e-1)" "unprognostic (3.35e-3)" "unprognostic (3.94e-2)" "unprognostic (1.28e-1)" "unprognostic (1.20e-1)" "unprognostic (2.02e-2)" 27.4 2.1 1.6 4.9 3.0 0.5 14.0 1.2 1.9 9.7 3.1 1.2 2.4 1.4 16.1 6.0 4.3 4.2 4.9 4.8 2.0 1.8 3.6 2.5 19.9 4.5 3.1 0.6 4.9 4.1 1.0 2.6 40.8 3.4 5.2 2.0 2.3 2.0 2.3 4.8 2.9 3.0 7.6 3.5 5.8 2.6 3.3 1.7 20.4 5.6 3.6 3.0 6.4 12.3 0.2 5.2 2.8 2.2 0.2 0.1 0.5 0.0 0.0 0.3 0.2 0.2 0.1 18.8 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.3 1.1 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.2 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 15.9 0.0 0.0 1.6 0.0 0.0 0.0 0.4 2.6 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.2 0.2 0.0 5.1 0.0 0.0 1.2 0.0 0.2 0.2 0.0 4.3 9.5 0.0 0.2 0.0 0.0 0.2 2.2 0.1 0.0 1.3 0.1 0.1 0.0 0.0 5.2 0.2 0.1 0.0 2.8 0.2 0.5 0.2 0.0 0.5 1.6 3.0 1.2 1.9 2.0 1.8 3.1 0.6 3.4 1.7 0.0 0.3 0.0 0.1 1.9 0.0 0.9 0.0 0.0 0.0 0.0 0.0 45.1 0.0 0.0 0.3 22.2 0.0 0.0 0.0 51.1 1.7 0.2 0.0 0.0 4.4 0.0 0.0 14.7 6.5 0.0 6.9 1.8 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.7 2.4 1.4 43.6 0.0 0.0 0.4 CLIC3 ENSG00000169583 "Chloride intracellular channel 3" O95833 9 136994635-136996803 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 163.5;esophagus: 74.1;placenta: 103.5" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 778.7;Extravillous trophoblasts: 921.9;Syncytiotrophoblasts: 1705.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 130.8" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 10 "plasmacytoid DC: 163.5" "Lineage enriched" "Detected in many" 10 "dendritic cells: 163.5" "Cell line enhanced" "Detected in some" "BEWO: 68.1;MCF7: 31.0;SK-BR-3: 13.0;T-47d: 29.6;TIME: 23.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA005963 Enhanced Supported "Nuclear bodies" NA NA "Nuclear bodies" "HPA005963: AB_1078536" "unprognostic (4.30e-2)" "unprognostic (2.53e-1)" "unprognostic (3.54e-1)" "unprognostic (1.55e-2)" "unprognostic (5.42e-3)" "unprognostic (1.85e-1)" "unprognostic (6.79e-2)" "unprognostic (5.82e-3)" "unprognostic (1.39e-1)" "unprognostic (3.26e-3)" "unprognostic (7.73e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (1.95e-2)" "unprognostic (1.65e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (7.74e-4)" 1.9 0.2 0.1 1.6 0.2 1.2 1.1 0.0 0.5 17.6 0.5 0.1 0.0 0.2 1.3 6.8 74.1 0.6 0.8 1.8 0.2 0.1 0.4 0.2 27.3 1.4 0.2 0.2 0.4 0.2 0.1 0.5 103.5 0.8 1.0 0.1 1.3 8.2 0.6 0.2 25.0 0.8 0.3 0.6 2.2 2.9 0.6 0.0 15.7 55.5 53.4 43.1 0.8 28.1 0.2 163.5 0.6 0.1 17.1 15.8 10.2 5.5 0.0 0.0 0.0 0.1 0.3 68.1 0.5 0.2 0.1 0.0 0.3 2.7 0.0 4.5 4.8 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.7 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.0 0.0 11.7 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 9.3 13.0 0.0 0.0 29.6 0.0 23.5 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 15.8 0.1 6.9 0.1 2.2 9.6 0.6 0.2 0.5 8.6 0.6 17.1 0.1 163.5 0.7 10.2 0.1 0.2 0.0 0.5 0.2 0.1 0.2 0.2 0.8 0.0 199.5 37.7 10.4 3.5 3.4 0.0 1.6 0.0 1.4 30.7 1.8 0.0 778.7 8.3 2.3 0.7 5.8 6.5 0.0 5.8 921.9 16.8 2.3 1.1 0.8 81.9 0.0 4.7 4.3 1.0 5.3 116.2 0.2 10.1 3.6 3.8 0.0 49.2 9.9 39.3 0.3 0.0 0.0 1.7 0.0 0.2 16.9 1705.4 70.8 2.9 18.2 COBLL1 KIAA0977 ENSG00000082438 "Cordon-bleu WH2 repeat protein like 1" Q53SF7 2 164653624-164843679 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 154.2" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 207.6;Cone photoreceptor cells: 235.6;Rod photoreceptor cells: 204.2;Syncytiotrophoblasts: 277.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 17 "memory B-cell: 15.5;naive B-cell: 9.2;plasmacytoid DC: 5.5" "Group enriched" "Detected in many" 18 "B-cells: 15.5;dendritic cells: 5.5" "Cell line enhanced" "Detected in many" "Karpas-707: 29.3;RPTEC TERT1: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044933, HPA053344" Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "HPA044933: AB_2679148, HPA053344: AB_2682123" "unprognostic (1.20e-1)" "unprognostic (3.13e-1)" "unprognostic (6.82e-2)" "unprognostic (2.38e-2)" "unprognostic (3.65e-2)" "unprognostic (1.03e-1)" "unprognostic (4.49e-3)" "unprognostic (1.10e-3)" "unprognostic (1.70e-1)" "unprognostic (2.76e-2)" "unprognostic (3.65e-2)" "unprognostic (1.77e-1)" "prognostic favorable (5.27e-13)" "unprognostic (1.56e-1)" "unprognostic (1.52e-1)" "unprognostic (2.47e-1)" "unprognostic (1.42e-1)" 14.3 35.7 3.3 4.1 4.0 1.1 9.3 1.4 4.0 8.1 7.0 3.3 17.7 4.3 5.3 11.2 16.3 2.9 9.7 3.7 4.1 3.2 35.6 43.4 10.8 4.7 4.5 2.9 7.1 23.4 4.9 8.9 154.2 5.2 11.9 3.1 8.8 8.0 22.6 2.6 8.2 5.8 9.7 3.9 4.6 12.6 3.0 2.6 1.2 7.6 9.6 6.9 13.0 11.1 15.5 5.5 0.0 0.0 0.5 0.0 0.3 4.7 1.1 3.0 0.0 3.4 0.6 5.4 16.1 6.5 2.8 2.6 3.9 2.0 0.4 3.1 1.5 2.4 17.3 12.0 10.0 2.9 1.3 4.6 4.5 4.7 16.2 4.9 0.0 0.0 0.8 9.4 0.4 13.2 2.8 10.0 0.6 0.0 29.3 3.5 5.3 0.1 0.0 1.4 11.7 5.4 0.6 11.6 4.8 29.5 16.3 6.6 2.5 7.0 6.8 2.2 5.7 5.1 0.0 4.3 5.2 4.4 2.0 3.7 11.0 4.1 1.5 2.1 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.5 0.0 5.5 0.0 0.3 3.3 4.0 1.4 4.0 4.1 3.2 4.5 2.9 5.2 2.6 65.5 51.4 43.3 40.0 86.4 11.5 10.1 22.9 12.0 29.6 207.6 235.6 40.1 53.0 22.3 0.0 41.7 10.7 0.0 28.9 56.5 18.0 52.9 32.4 126.9 7.6 3.2 21.4 6.2 3.7 0.4 13.6 3.0 18.6 0.0 10.3 171.4 30.8 3.5 7.4 27.0 204.2 45.3 41.9 0.5 0.9 61.5 277.1 1.9 9.2 67.1 COL11A1 "CO11A1, COLL6, STL2" ENSG00000060718 "Collagen type XI alpha 1 chain" P12107 1 102876467-103108872 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness, Stickler syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 33.3" "Group enriched" "Detected in some" 7 "Early spermatids: 12.1;Melanocytes: 10.1;Muller glia cells: 27.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 38.5;BJ: 13.5;BJ hTERT+ SV40 Large T+ RasG12V: 28.8;HBF TERT88: 16.3;HSkMC: 48.5;SuSa: 21.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA058335 Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" No No 270000 "Endoplasmic reticulum" "HPA058335: AB_2683682" "unprognostic (2.60e-3)" "unprognostic (6.61e-4)" "unprognostic (9.58e-2)" "unprognostic (5.06e-5)" "unprognostic (2.83e-1)" "unprognostic (2.85e-2)" "unprognostic (6.03e-3)" "unprognostic (2.23e-3)" "unprognostic (9.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.12e-2)" "unprognostic (1.94e-2)" "unprognostic (3.01e-12)" "unprognostic (1.27e-2)" "unprognostic (3.53e-1)" "unprognostic (3.54e-2)" "unprognostic (2.32e-2)" 1.2 1.8 8.6 1.3 9.1 0.8 1.5 2.0 7.9 2.3 1.1 4.1 0.0 1.0 1.8 1.0 0.8 0.8 5.9 0.8 8.3 8.6 1.0 0.8 1.2 0.9 8.1 5.9 1.2 1.9 1.0 5.5 33.3 11.1 1.1 1.4 5.9 3.3 2.2 0.9 2.4 0.9 1.3 9.0 2.2 0.9 4.7 5.8 0.0 0.9 0.6 0.8 1.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 38.5 0.0 1.5 2.1 0.0 13.5 5.2 7.8 28.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 48.5 0.0 0.3 0.0 5.9 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 2.7 0.0 0.0 0.0 2.4 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.2 9.0 0.0 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.6 9.1 2.0 7.9 8.3 8.6 8.1 5.9 11.1 5.8 0.0 2.1 0.0 0.0 1.5 0.6 0.4 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.5 2.1 0.0 2.3 0.0 0.2 0.0 0.0 0.0 0.0 0.9 1.1 0.6 10.1 0.0 0.0 27.8 0.1 0.0 0.0 0.0 1.7 0.0 1.9 0.5 0.4 1.0 0.2 0.0 0.0 0.0 COL17A1 "BP180, BPAG2" ENSG00000065618 "Collagen type XVII alpha 1 chain" Q9UMD9 10 104031286-104086002 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 85.8;skin 1: 123.2;tongue: 64.0" "Cell type enriched" "Detected in many" 4 "Basal keratinocytes: 520.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 227.4" "Region enriched" "Detected in single" 4 "basal ganglia: 1.2" "Cell type enriched" "Detected in single" 15 "neutrophil: 3.7" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 24.8;HaCaT: 56.6;HBEC3-KT: 90.6;hTCEpi: 117.8;hTERT-HME1: 100.3" "Region enriched" "Detected in single" 4 "cerebellum: 1.1" "Not detected" "Not detected" "HPA043673, HPA052963" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted to extracellular matrix" NA NA "Plasma membrane" "Golgi apparatus" "HPA043673: AB_10960893, HPA052963: AB_2681999" "prognostic favorable (1.38e-4)" "unprognostic (1.33e-1)" "unprognostic (4.01e-1)" "unprognostic (1.01e-1)" "unprognostic (9.65e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (6.82e-3)" "unprognostic (1.63e-1)" "unprognostic (7.85e-3)" "prognostic unfavorable (1.86e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (3.75e-2)" "unprognostic (8.35e-2)" 0.2 0.0 0.2 4.4 1.2 7.5 8.1 0.2 0.2 15.2 9.3 0.2 0.9 2.0 0.6 2.6 31.5 0.1 1.2 0.2 0.2 0.1 0.4 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.0 0.6 85.8 0.2 5.0 5.4 0.2 15.5 7.3 0.5 123.2 23.2 0.8 0.2 0.3 3.9 4.0 0.2 18.1 2.0 64.0 24.7 3.0 17.3 0.0 0.0 3.7 0.2 0.0 0.0 0.8 3.1 0.0 0.1 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.7 0.0 0.5 56.6 0.1 90.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.8 0.0 100.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.0 5.1 3.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.2 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 0.0 0.0 0.8 0.2 1.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.6 0.0 12.4 520.3 0.6 0.8 0.0 2.7 20.5 0.0 0.0 3.5 0.0 0.7 8.5 1.0 105.8 0.0 0.8 8.3 2.1 0.6 0.0 0.0 1.2 0.0 2.4 0.0 0.0 2.6 0.3 1.0 32.1 0.0 5.9 0.4 45.8 16.1 0.7 0.0 0.4 0.0 1.7 8.3 1.1 121.8 4.7 0.0 14.5 8.0 COL4A1 ENSG00000187498 "Collagen type IV alpha 1 chain" P02462 13 110148963-110307149 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 163.4" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 577.1;Ito cells: 181.7;Sertoli cells: 498.0;Smooth muscle cells: 250.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "eosinophil: 1.1" "Lineage enhanced" "Detected in single" "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "ASC diff: 74.0;EFO-21: 126.5;TIME: 45.0" "Low region specificity" "Detected in many" CAB001695 Approved "Secreted to extracellular matrix" NA NA 55000 "CAB001695: " "unprognostic (3.82e-2)" "prognostic unfavorable (4.67e-4)" "unprognostic (2.27e-1)" "unprognostic (1.02e-1)" "unprognostic (3.28e-1)" "unprognostic (2.40e-1)" "unprognostic (1.10e-1)" "unprognostic (6.51e-3)" "unprognostic (1.06e-2)" "unprognostic (9.79e-2)" "unprognostic (1.73e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.30e-7)" "unprognostic (1.47e-3)" "unprognostic (1.72e-2)" "unprognostic (1.58e-1)" "unprognostic (1.16e-2)" 86.0 10.0 1.6 23.5 3.0 0.2 65.2 1.5 2.0 20.5 27.7 1.6 14.3 4.4 52.3 21.8 20.6 18.8 38.8 29.2 2.5 1.5 21.1 5.7 37.3 28.9 2.6 1.0 20.0 8.5 9.1 3.9 163.4 5.0 24.6 5.9 7.6 5.9 17.3 24.6 6.9 11.6 58.1 4.1 60.5 16.0 8.7 1.1 3.1 16.5 9.0 3.8 47.0 24.5 0.0 0.4 1.1 0.1 0.0 0.0 0.0 5.1 2.0 26.7 0.0 74.0 19.9 37.6 33.7 8.0 18.6 9.2 0.5 0.0 0.0 126.5 6.2 8.1 3.5 0.0 7.6 4.2 0.1 3.9 0.0 4.0 0.0 20.8 0.0 0.0 7.2 1.1 18.4 8.4 29.2 28.5 0.0 0.0 0.0 4.1 0.0 0.0 0.0 3.7 0.0 0.4 0.0 7.9 0.0 39.8 0.0 0.1 3.6 0.0 0.0 7.4 28.5 0.0 1.7 45.0 5.5 16.6 0.1 12.8 0.0 0.1 0.2 0.0 0.0 40.1 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 3.0 1.5 2.0 2.5 1.5 2.6 1.0 5.0 1.1 38.7 12.8 3.4 7.1 12.5 0.7 31.3 7.6 4.0 1.2 22.7 0.0 40.0 1.7 11.1 0.5 125.5 0.0 0.0 0.2 577.1 125.0 3.3 1.1 0.8 24.5 0.0 0.0 181.7 6.3 0.7 35.6 3.9 28.7 1.0 0.3 2.8 0.5 0.0 102.9 11.3 0.3 498.0 250.4 1.2 5.1 13.2 37.6 0.0 0.2 0.9 COL4A2 "DKFZp686I14213, FLJ22259" ENSG00000134871 "Collagen type IV alpha 2 chain" P08572 13 110305812-110513027 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 125.7" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 463.3;Peritubular cells: 165.5;Sertoli cells: 368.7;Smooth muscle cells: 174.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 145.1;WM-115: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB010751, HPA029118, HPA069337" Enhanced Supported Vesicles "Secreted to extracellular matrix" NA NA 1900000 Vesicles "CAB010751: AB_476828, HPA029118: , HPA069337: " "unprognostic (2.43e-1)" "unprognostic (4.13e-3)" "unprognostic (8.04e-2)" "unprognostic (6.03e-3)" "unprognostic (2.20e-1)" "unprognostic (2.64e-2)" "unprognostic (3.45e-2)" "unprognostic (1.15e-2)" "unprognostic (3.50e-2)" "unprognostic (1.78e-1)" "unprognostic (1.49e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (3.49e-5)" "unprognostic (1.33e-2)" "unprognostic (1.57e-2)" "unprognostic (6.95e-2)" "prognostic unfavorable (9.25e-4)" 87.2 9.5 4.6 26.1 3.3 0.1 50.1 2.0 3.0 37.2 53.1 1.9 30.3 7.6 48.4 25.5 23.0 26.3 52.4 26.6 3.6 1.4 18.4 5.7 35.9 17.5 3.8 1.7 25.7 8.3 7.3 3.8 125.7 5.0 26.9 5.5 12.2 7.6 29.3 26.3 9.2 16.9 84.1 2.8 58.5 23.4 11.0 1.9 4.2 16.0 8.0 5.7 65.3 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.6 6.6 30.1 0.0 39.2 16.3 47.4 40.8 14.8 24.3 11.4 0.7 0.0 0.0 145.1 9.5 10.7 11.4 0.0 12.2 4.7 1.5 6.3 0.0 11.2 0.3 28.9 0.0 0.1 7.3 0.7 17.0 11.7 31.1 25.4 0.0 0.0 0.1 4.0 0.2 0.0 1.0 4.7 0.2 2.3 0.0 12.4 0.0 26.8 0.2 0.9 4.9 0.0 0.1 12.8 13.5 0.0 0.5 43.7 13.4 34.1 0.3 22.1 0.0 0.2 0.6 0.3 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.6 3.3 2.0 3.0 3.6 1.4 3.8 1.7 5.0 1.9 77.4 8.0 1.4 6.5 8.5 2.0 27.9 25.5 2.7 2.3 50.6 0.0 67.8 1.7 25.5 1.6 98.7 13.4 0.0 3.7 463.3 94.4 2.1 1.1 1.6 26.8 0.0 0.0 139.3 5.4 1.5 56.1 5.8 37.1 3.6 5.1 9.5 2.8 0.0 165.5 16.1 0.2 368.7 174.9 0.2 8.1 6.0 56.2 0.0 3.7 1.2 COX4I2 "COX4-2, COX4B, COX4L2, COXIV-2, dJ857M17.2" ENSG00000131055 "Cytochrome c oxidase subunit 4I2" Q96KJ9 20 31637888-31645006 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 60.7" "Group enriched" "Detected in some" 34 "Sertoli cells: 407.4;Smooth muscle cells: 177.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 11 "naive B-cell: 2.6" "Lineage enriched" "Detected in single" 11 "B-cells: 2.6" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (2.64e-1)" "unprognostic (2.09e-2)" "unprognostic (2.76e-3)" "unprognostic (2.18e-2)" "unprognostic (4.51e-2)" "prognostic favorable (6.04e-5)" "unprognostic (5.60e-2)" "unprognostic (1.13e-1)" "unprognostic (2.51e-1)" "unprognostic (7.45e-2)" "unprognostic (1.04e-2)" "unprognostic (5.35e-2)" "prognostic unfavorable (9.78e-4)" "unprognostic (1.11e-1)" "unprognostic (3.30e-3)" "unprognostic (1.43e-1)" "unprognostic (5.59e-2)" 9.9 0.7 1.6 1.7 1.9 0.1 7.9 0.7 2.5 4.7 2.2 1.5 0.9 1.1 5.9 3.5 7.1 2.6 5.4 15.5 1.7 1.4 2.0 0.5 24.6 4.9 2.4 1.0 1.9 1.9 2.1 1.1 60.7 2.7 5.2 1.6 4.1 2.4 2.8 12.8 2.5 2.7 3.9 1.2 0.8 2.0 1.5 2.1 0.5 8.0 7.5 2.3 3.7 3.7 2.6 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 6.3 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 1.9 0.7 2.5 1.7 1.4 2.4 1.0 2.7 2.1 0.0 0.0 0.0 0.2 5.7 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 5.7 0.0 0.0 0.0 0.2 4.3 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 3.4 1.1 8.5 0.0 0.0 1.1 0.1 0.0 0.7 0.0 0.4 407.4 177.5 0.0 0.1 5.8 2.1 0.0 0.0 0.3 CPXM1 "CPX-1, CPX1, CPXM" ENSG00000088882 "Carboxypeptidase X, M14 family member 1" Q96SM3 20 2794069-2800637 "Enzymes, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 60.3" "Cell type enhanced" "Detected in many" 16 "Fibroblasts: 29.4;Leydig cells: 16.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 22 "memory B-cell: 2.3;myeloid DC: 1.4;NK-cell: 3.9;plasmacytoid DC: 1.1" "Group enriched" "Detected in many" 26 "B-cells: 2.3;dendritic cells: 1.4;NK-cells: 3.9" "Cell line enhanced" "Detected in some" "AF22: 45.9;HSkMC: 25.0;NB-4: 40.3;REH: 41.1;SH-SY5Y: 30.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "Secreted in other tissues" NA NA "unprognostic (7.48e-2)" "unprognostic (3.61e-1)" "unprognostic (6.70e-2)" "unprognostic (1.47e-2)" "unprognostic (3.41e-1)" "unprognostic (5.24e-2)" "unprognostic (1.82e-2)" "unprognostic (1.84e-2)" "unprognostic (2.98e-2)" "unprognostic (9.32e-2)" "unprognostic (7.02e-2)" "unprognostic (3.23e-2)" "prognostic unfavorable (4.62e-10)" "unprognostic (1.30e-1)" "unprognostic (1.49e-1)" "unprognostic (5.55e-3)" "unprognostic (1.27e-2)" 24.0 2.4 0.5 4.6 1.1 5.6 14.9 0.9 3.7 32.2 7.4 1.3 7.6 0.2 43.6 41.4 1.4 13.6 31.1 14.4 0.5 0.2 4.3 0.6 2.7 1.9 2.1 0.6 20.7 1.7 0.6 2.7 60.3 2.4 8.5 0.2 16.2 2.7 5.3 2.2 5.8 1.4 14.5 1.4 0.5 1.0 10.1 0.3 15.2 8.8 0.7 1.5 23.0 15.2 2.3 1.4 0.0 0.0 3.9 0.0 0.7 0.0 0.0 45.9 0.0 0.0 1.4 0.0 0.1 0.2 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.4 0.0 0.1 0.2 2.3 6.0 0.0 0.0 0.6 0.0 0.9 25.0 0.0 2.1 0.0 0.0 0.0 8.7 2.5 0.0 0.0 0.0 0.1 40.3 9.7 0.0 0.0 41.1 0.0 1.1 0.0 0.0 0.0 30.9 0.0 0.0 0.0 7.7 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 3.9 0.0 1.1 0.0 0.7 0.5 1.1 0.9 1.1 0.5 0.2 2.1 0.6 2.4 0.3 0.0 0.3 0.5 2.6 2.4 0.0 0.5 0.0 5.3 1.2 3.5 0.0 2.4 0.0 1.9 2.1 0.5 0.0 0.0 0.0 2.1 29.4 0.8 2.3 0.0 6.0 0.0 0.0 1.3 0.0 1.8 16.1 0.3 1.7 1.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 1.9 0.0 1.7 1.8 2.7 0.0 0.0 0.9 CREB3L2 "BBF2H7, TCAG_1951439" ENSG00000182158 "CAMP responsive element binding protein 3 like 2" Q70SY1 7 137874979-138002067 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation, Unfolded protein response" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.6" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 120.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015068, HPA015534" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum" NA NA "Nucleoplasm, Endoplasmic reticulum" "HPA015068: AB_1847224, HPA015534: AB_2669210" "unprognostic (8.50e-2)" "unprognostic (3.70e-2)" "unprognostic (2.77e-1)" "unprognostic (1.50e-3)" "unprognostic (9.88e-2)" "unprognostic (9.09e-2)" "unprognostic (5.17e-2)" "unprognostic (4.50e-1)" "unprognostic (4.77e-1)" "unprognostic (8.93e-2)" "unprognostic (9.48e-2)" "unprognostic (9.65e-2)" "unprognostic (2.42e-1)" "unprognostic (3.08e-3)" "unprognostic (7.65e-2)" "unprognostic (2.59e-2)" "unprognostic (1.32e-2)" 14.9 19.8 4.7 17.1 9.8 10.8 15.7 1.9 6.0 25.4 16.7 11.4 18.7 11.6 28.2 25.5 12.8 16.2 16.2 20.4 5.6 4.3 17.0 11.7 14.6 15.2 11.8 3.7 25.9 16.0 38.4 28.8 81.6 9.8 15.9 9.5 24.9 26.5 23.3 5.0 6.9 17.5 17.7 6.2 12.1 14.1 9.8 9.1 7.0 35.8 10.9 18.1 21.3 15.7 4.6 12.4 7.4 5.6 6.5 11.8 3.2 4.0 6.3 12.0 0.2 20.5 20.4 9.0 20.4 33.0 14.3 14.5 8.6 3.7 0.8 5.5 22.1 7.8 2.2 7.0 14.9 28.0 5.9 3.5 25.7 8.6 20.5 13.6 7.7 36.9 8.4 9.5 18.0 21.1 14.7 18.8 2.1 13.2 12.0 16.7 7.3 2.4 9.5 4.3 5.6 4.5 5.4 6.5 6.8 11.2 4.2 3.1 7.2 6.6 17.1 9.1 7.3 2.5 5.8 20.0 19.2 2.9 23.1 7.4 14.2 4.9 5.3 23.0 21.8 42.5 7.4 5.6 5.9 8.2 2.9 10.6 4.0 6.0 8.6 5.8 4.6 2.2 3.8 2.1 6.5 1.5 12.4 11.8 3.2 4.7 9.8 1.9 6.0 5.6 4.3 11.8 3.7 9.8 9.1 6.0 20.4 20.6 8.1 10.9 7.2 14.1 20.4 10.7 18.2 22.7 9.8 50.6 11.6 9.3 48.0 20.2 32.0 0.0 15.3 76.5 40.4 27.0 48.5 24.5 49.4 14.3 15.1 30.1 33.2 14.1 57.2 25.1 25.3 10.0 17.0 6.7 15.1 17.3 96.9 9.1 12.4 38.8 42.4 1.1 4.3 6.1 120.8 27.3 14.9 17.2 CRH "CRF, CRH1" ENSG00000147571 "Corticotropin releasing hormone" P06850 8 66176382-66178725 "Plasma proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 209.9" "Cell type enriched" "Detected in some" 6 "Syncytiotrophoblasts: 134.3" "Cancer enriched" "Detected in some" 28 "urothelial cancer: 34.5" "Region enhanced" "Detected in many" "hypothalamus: 28.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "SCLC-21H: 1.4;SuSa: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 10000 "unprognostic (1.62e-1)" "unprognostic (9.68e-2)" "unprognostic (1.00e-1)" "unprognostic (9.55e-2)" "unprognostic (7.22e-3)" 2.7 0.2 4.1 0.2 2.1 0.3 0.2 0.0 6.7 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 2.7 28.4 0.2 0.2 0.3 0.2 0.4 1.1 0.2 1.3 0.2 0.1 209.9 13.8 0.2 0.2 0.0 0.2 0.2 0.3 0.2 0.2 0.5 0.1 0.2 0.4 0.9 0.0 0.0 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.1 0.0 5.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 2.1 0.0 6.7 2.7 28.4 0.4 1.1 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 20.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 134.3 0.0 0.0 0.1 CRIM1 S52 ENSG00000150938 "Cysteine rich transmembrane BMP regulator 1" Q9NZV1 2 36355926-36551135 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 116.2" "Cell type enhanced" "Detected in many" 5 "Ito cells: 170.0;Syncytiotrophoblasts: 145.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 68.0;fHDF/TERT166: 67.0;TIME: 94.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000556 Enhanced "Intracellular and membrane" NA NA 120000 "HPA000556: AB_1078567" "unprognostic (2.15e-1)" "unprognostic (5.41e-2)" "unprognostic (6.39e-2)" "unprognostic (3.17e-3)" "unprognostic (3.88e-2)" "unprognostic (3.44e-2)" "unprognostic (1.88e-1)" "unprognostic (6.25e-2)" "unprognostic (2.32e-1)" "unprognostic (4.11e-3)" "unprognostic (8.19e-2)" "unprognostic (1.26e-1)" "prognostic favorable (9.51e-4)" "unprognostic (1.98e-2)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (6.67e-2)" 42.4 6.0 9.1 8.7 11.0 1.1 44.6 6.1 9.0 13.8 13.1 6.4 10.2 5.7 14.9 9.8 12.4 14.2 17.3 32.2 8.6 8.7 28.6 6.2 24.7 13.2 7.6 10.2 15.5 9.2 18.0 4.3 116.2 12.0 14.9 9.4 24.7 13.1 13.8 25.9 13.7 9.0 23.1 10.8 17.5 10.2 8.1 6.2 3.0 18.1 7.9 4.5 16.9 22.3 0.8 5.5 3.4 1.4 1.1 1.6 0.2 14.2 10.9 2.2 2.5 10.5 12.0 18.6 68.0 36.1 38.1 20.1 13.7 4.9 0.0 44.4 67.0 24.8 6.2 1.6 11.0 31.3 0.1 1.2 0.4 14.6 7.9 34.0 0.3 0.1 16.8 8.2 15.2 27.5 35.9 53.3 0.2 0.6 0.1 40.0 1.3 0.0 0.1 1.7 0.7 3.2 0.7 2.9 2.2 24.0 5.9 0.2 0.0 11.8 3.9 0.5 8.8 10.6 0.2 94.6 48.2 17.4 5.9 32.8 3.7 0.0 0.1 14.2 0.0 14.8 3.4 0.4 1.2 1.6 0.2 1.2 0.6 0.7 0.9 0.3 0.8 0.2 1.0 0.5 1.1 1.4 5.5 0.5 0.2 9.1 11.0 6.1 9.0 8.6 8.7 7.6 10.2 12.0 6.2 11.9 46.6 5.2 34.8 58.6 7.1 35.8 48.4 26.8 35.2 125.6 2.0 107.1 3.3 29.4 0.9 118.8 18.6 0.0 2.2 34.1 49.4 51.6 1.1 0.9 22.4 0.0 30.5 170.0 6.5 1.3 17.5 10.5 37.1 10.8 41.0 15.6 17.1 31.7 18.7 36.6 37.9 45.3 115.4 2.1 8.7 26.3 145.1 13.8 31.6 40.7 CRYBG1 "AIM1, ST4" ENSG00000112297 "Crystallin beta-gamma domain containing 1" Q9Y4K1 6 106360808-106571978 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 61.7;placenta: 96.6" "Group enriched" "Detected in many" 11 "Cytotrophoblasts: 184.0;Syncytiotrophoblasts: 501.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in some" 9 "pons and medulla: 10.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 32.1;HBEC3-KT: 40.2;hTERT-HME1: 31.1" "Region enriched" "Detected in single" 5 "olfactory region: 5.1" "Low region specificity" "Detected in single" "CAB026378, HPA030948, HPA030949" Approved Approved Nucleoplasm,Microtubules,Cytosol NA NA "Nucleoplasm, Microtubules, Cytosol" "CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671" "unprognostic (1.66e-1)" "unprognostic (3.44e-2)" "unprognostic (9.02e-3)" "unprognostic (1.13e-1)" "unprognostic (3.80e-1)" "unprognostic (1.52e-1)" "unprognostic (1.40e-1)" "unprognostic (2.27e-2)" "unprognostic (1.08e-1)" "unprognostic (1.23e-1)" "unprognostic (3.69e-3)" "unprognostic (5.61e-2)" "unprognostic (8.97e-2)" "unprognostic (3.53e-2)" "unprognostic (8.89e-2)" "unprognostic (8.60e-2)" "unprognostic (3.25e-2)" 4.6 0.8 0.6 6.8 0.7 6.5 11.3 0.6 0.9 7.4 7.4 1.6 2.5 7.6 1.5 10.8 61.7 2.0 2.0 0.9 1.1 0.6 9.8 3.6 4.0 5.6 0.7 0.7 2.0 5.5 5.0 0.9 96.6 10.3 12.6 5.9 16.0 10.2 4.3 0.8 16.6 7.6 4.4 0.8 6.5 2.5 1.8 0.5 2.3 1.8 24.6 35.8 11.5 13.1 6.8 8.7 3.1 4.4 5.7 10.9 3.9 10.6 0.0 0.0 0.0 9.0 32.1 3.3 1.5 11.8 3.4 3.2 0.7 3.8 16.7 0.7 7.3 4.8 17.2 0.1 40.2 1.7 22.7 0.7 0.0 0.5 5.2 4.2 10.1 0.0 16.0 23.5 6.5 31.1 0.0 14.7 13.2 0.5 2.4 9.2 1.2 2.9 4.0 0.1 0.0 7.1 5.0 0.1 0.1 5.4 25.3 0.7 0.0 6.5 11.1 0.1 1.0 5.5 7.7 4.2 3.9 0.5 0.0 10.6 1.8 1.4 18.2 18.4 12.8 8.3 0.3 3.8 0.4 8.1 4.4 10.9 6.8 10.5 8.9 8.7 3.8 6.7 6.3 3.1 5.7 4.4 1.0 9.9 3.9 0.6 0.7 0.6 0.9 1.1 0.6 0.7 0.7 10.3 0.5 11.9 11.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 23.9 31.4 0.0 184.0 3.3 8.8 0.0 0.0 0.0 0.0 10.8 7.2 0.0 0.0 1.1 0.0 31.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 16.4 0.0 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.0 501.8 0.0 0.0 0.0 CRYBG2 "AIM1L, FLJ38020" ENSG00000176092 "Crystallin beta-gamma domain containing 2" Q8N1P7 1 26321698-26360080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.9;placenta: 55.0" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 40.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 7.1;BEWO: 15.5;CACO-2: 25.1;CAPAN-2: 16.9;HaCaT: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA029629 Approved Nucleoplasm NA NA Nucleoplasm "HPA029629: AB_10601331" "unprognostic (2.20e-1)" "unprognostic (2.07e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (5.11e-6)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "unprognostic (6.39e-4)" "unprognostic (1.88e-3)" "unprognostic (1.83e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (3.53e-4)" "unprognostic (2.94e-2)" "unprognostic (4.83e-9)" "unprognostic (9.12e-3)" "unprognostic (3.40e-1)" "unprognostic (6.44e-2)" "unprognostic (1.63e-2)" 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 8.0 4.4 0.0 0.0 4.9 0.9 0.6 43.9 0.2 2.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 55.0 0.0 0.8 1.4 0.1 5.1 0.0 0.0 13.8 10.4 0.0 0.0 0.0 0.9 1.2 0.0 0.1 0.0 22.0 19.8 4.9 16.1 0.7 0.0 2.4 0.1 0.2 1.7 0.3 7.1 0.0 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.1 25.1 16.9 0.1 5.1 0.0 0.1 6.3 0.0 4.5 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 1.2 4.0 0.0 0.0 0.0 0.1 0.3 1.6 0.3 0.0 0.0 3.0 0.0 1.2 4.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.5 1.0 0.1 0.5 0.7 1.7 0.7 0.0 0.6 0.5 0.5 2.4 0.2 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 4.9 1.7 1.8 0.0 0.0 0.0 0.0 1.2 4.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.0 0.0 0.0 CSF2RA "alphaGMR, CD116, CSF2R" ENSG00000198223 "Colony stimulating factor 2 receptor alpha subunit" P15509 X 1268800-1310381 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 60.2;placenta: 79.5" "Cell type enhanced" "Detected in many" 26 "Cytotrophoblasts: 215.8;monocytes: 954.0;Syncytiotrophoblasts: 261.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 30.0;eosinophil: 36.0;intermediate monocyte: 17.7;myeloid DC: 31.9;neutrophil: 60.2;plasmacytoid DC: 30.5" "Group enriched" "Detected in many" 28 "dendritic cells: 31.9;granulocytes: 60.2;monocytes: 30.0" "Group enriched" "Detected in some" 7 "BEWO: 60.4;HMC-1: 18.2;SK-MEL-30: 42.3" CAB016148 Uncertain "Secreted to blood" NA NA 9400000 "CAB016148: AB_626868" "unprognostic (4.19e-2)" "prognostic favorable (2.38e-5)" "unprognostic (5.47e-2)" "unprognostic (4.33e-2)" "unprognostic (4.88e-2)" "prognostic favorable (2.81e-4)" "unprognostic (8.24e-2)" "unprognostic (2.17e-1)" "unprognostic (5.55e-2)" "unprognostic (8.48e-2)" "unprognostic (8.89e-2)" "unprognostic (3.80e-1)" "unprognostic (2.89e-2)" "unprognostic (8.91e-3)" "prognostic unfavorable (5.53e-4)" "unprognostic (3.60e-1)" "unprognostic (9.44e-2)" 8.7 2.3 11.8 11.1 11.1 8.9 17.7 3.4 9.6 3.1 2.2 0.6 0.6 2.2 4.4 0.6 2.1 2.2 5.7 3.7 15.0 4.7 2.4 1.7 11.2 8.3 18.8 6.5 3.5 1.0 0.2 2.1 79.5 13.2 1.5 3.3 0.6 3.1 1.0 0.6 1.8 3.3 2.9 25.5 12.6 1.7 0.6 16.3 0.6 2.5 0.6 10.4 4.2 1.5 0.3 31.9 60.2 30.0 1.4 0.2 10.1 0.1 3.5 0.2 0.0 0.0 0.0 60.4 0.0 0.1 0.1 0.0 1.2 0.3 0.0 3.9 0.0 3.3 0.0 0.0 0.0 0.0 1.1 0.0 0.0 2.4 0.0 0.0 1.3 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 5.6 0.5 0.5 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 1.0 0.0 42.3 5.0 2.8 5.0 0.0 0.0 1.7 0.3 0.0 0.1 0.1 0.1 0.0 5.5 0.0 2.4 30.0 36.0 0.0 17.7 0.2 0.3 0.0 0.0 31.9 0.1 0.0 0.0 60.2 1.4 8.4 30.5 0.1 10.1 11.8 11.1 3.4 9.6 15.0 4.7 18.8 6.5 13.2 16.3 0.0 8.2 11.1 1.0 6.9 0.6 1.1 5.1 4.0 5.7 1.8 0.0 215.8 0.0 0.2 0.5 1.4 0.0 0.0 1.5 101.6 5.3 0.5 9.3 0.0 66.0 0.0 0.0 1.3 66.8 0.0 0.9 146.7 8.5 954.0 0.0 0.5 0.3 0.0 0.4 0.0 1.1 6.5 2.1 0.2 0.4 4.5 261.3 0.0 0.0 2.1 CSF2RB "betaGMR, CD131, IL3RB, IL5RB" ENSG00000100368 "Colony stimulating factor 2 receptor beta common subunit" P32927 22 36913628-36940449 "CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.1;placenta: 73.6" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 32.6;granulocytes: 87.9;Macrophages: 41.6;monocytes: 29.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "basophil: 53.1;neutrophil: 20.1" "Lineage enriched" "Detected in many" 14 "granulocytes: 53.1" "Group enriched" "Detected in some" 6 "HEL: 27.0;HMC-1: 84.6" "Low region specificity" "Detected in all" HPA078677 Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA078677: AB_2732389" "unprognostic (1.67e-2)" "unprognostic (9.44e-3)" "unprognostic (1.03e-2)" "unprognostic (6.66e-3)" "unprognostic (1.51e-1)" "prognostic favorable (7.47e-5)" "unprognostic (1.86e-1)" "unprognostic (1.94e-2)" "unprognostic (4.38e-1)" "unprognostic (9.57e-2)" "unprognostic (1.33e-1)" "unprognostic (3.21e-1)" "unprognostic (1.82e-3)" "unprognostic (5.76e-2)" "unprognostic (3.65e-2)" "unprognostic (1.95e-1)" "unprognostic (8.52e-2)" 8.5 1.8 1.5 28.9 1.5 21.7 6.0 0.6 1.0 3.0 5.9 2.0 0.4 4.5 2.2 2.8 4.0 3.6 5.5 4.2 1.4 1.4 2.4 3.5 12.6 34.1 2.9 0.2 2.5 1.9 0.3 1.2 73.6 2.4 3.5 3.8 2.8 9.7 1.0 2.6 3.8 10.2 3.0 2.9 25.2 3.9 2.1 1.9 8.2 3.4 4.8 30.5 8.2 4.3 0.4 3.8 53.1 2.1 0.0 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 27.0 0.0 0.0 0.0 0.4 84.6 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 3.2 0.0 0.0 0.0 2.8 0.0 0.0 0.0 2.7 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.1 0.2 0.0 0.0 0.0 0.4 0.2 1.7 0.0 3.9 0.0 53.1 1.9 5.8 0.0 2.1 0.0 0.4 0.0 0.0 1.2 0.3 0.0 0.0 20.1 0.0 1.7 3.8 0.6 1.8 1.5 1.5 0.6 1.0 1.4 1.4 2.9 0.2 2.4 1.9 0.0 14.5 8.2 0.0 6.4 0.0 0.8 5.1 5.3 3.4 0.0 0.0 2.2 0.0 0.0 11.1 9.0 0.0 0.0 0.2 32.6 4.1 0.0 87.9 0.0 16.8 0.0 0.0 4.3 26.0 26.5 0.0 41.6 11.8 29.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 5.5 13.8 1.3 0.0 0.0 CSF3R "CD114, GCSFR" ENSG00000119535 "Colony stimulating factor 3 receptor" Q99062 1 36466043-36483278 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 167.3;bone marrow: 88.9;lymphoid tissue: 71.4;placenta: 152.7" "Cell type enhanced" "Detected in many" 27 "Alveolar cells type 2: 228.0;Cytotrophoblasts: 271.6;Syncytiotrophoblasts: 999.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "neutrophil: 167.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 167.3" "Group enriched" "Detected in some" 18 "BEWO: 34.9;NB-4: 9.4;THP-1: 22.9;U-937: 22.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017116, HPA048086" Enhanced "Intracellular and membrane" NA NA "CAB017116: , HPA048086: AB_2680257" "unprognostic (5.57e-3)" "unprognostic (8.05e-2)" "unprognostic (7.23e-2)" "unprognostic (3.87e-2)" "unprognostic (2.88e-1)" "unprognostic (2.92e-2)" "unprognostic (2.86e-2)" "unprognostic (1.35e-1)" "unprognostic (1.83e-1)" "unprognostic (5.65e-2)" "unprognostic (2.47e-1)" "unprognostic (3.44e-1)" "prognostic unfavorable (5.72e-4)" "unprognostic (6.33e-2)" "prognostic unfavorable (3.79e-4)" "unprognostic (2.03e-1)" "unprognostic (2.31e-2)" 8.5 1.5 2.9 39.5 3.2 88.9 2.4 0.7 2.9 1.1 1.1 4.2 0.4 0.6 0.7 1.1 1.2 6.9 4.3 5.6 2.6 2.0 1.7 4.5 26.9 27.5 7.2 1.1 1.1 1.3 0.3 1.1 152.7 3.8 1.3 0.5 2.1 1.6 0.5 0.6 0.3 1.6 3.1 7.1 71.4 2.2 1.4 3.3 1.1 1.0 0.4 0.9 4.6 3.9 0.0 8.2 167.3 22.1 0.2 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 34.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.7 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.1 0.0 0.0 22.1 0.6 0.0 4.8 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 167.3 0.2 1.8 0.2 0.0 10.3 2.9 3.2 0.7 2.9 2.6 2.0 7.2 1.1 3.8 3.3 23.8 228.0 2.4 0.6 0.9 0.0 1.4 0.0 12.0 18.2 0.0 0.0 271.6 0.0 0.0 0.4 1.9 0.0 0.0 0.0 49.1 3.0 0.2 17.4 0.8 60.8 0.0 0.0 3.7 146.3 0.4 0.3 62.6 0.0 3.6 0.0 0.2 0.1 0.0 0.0 0.4 0.2 0.0 0.3 0.0 0.2 0.1 999.2 0.5 0.0 2.2 CSH1 "CSA, CSMT, FLJ75407, hCS-A, PL" ENSG00000136488 "Chorionic somatomammotropin hormone 1" P0DML2 17 63894909-63896661 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "placenta: 450.4" "Group enriched" "Detected in some" 22 "Extravillous trophoblasts: 439.3;Syncytiotrophoblasts: 913.5" "Cancer enriched" "Detected in single" 8 "testis cancer: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BEWO: 12.0;SuSa: 18.9" "CAB026374, HPA043715" Enhanced "Secreted to blood" NA NA "CAB026374: , HPA043715: AB_2678632" "unprognostic (6.99e-2)" 2.6 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.0 15.7 450.4 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 1.9 0.1 1.0 0.9 0.8 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 439.3 0.0 0.0 0.0 0.0 30.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 913.5 0.0 0.0 0.0 CSH2 "CS-2, CSB, hCS-B" ENSG00000213218 "Chorionic somatomammotropin hormone 2" P0DML3 17 63872012-63873766 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "placenta: 246.2" "Cell type enriched" "Detected in some" 25 "Syncytiotrophoblasts: 230.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 25 "BEWO: 10.2;SuSa: 15.3" HPA043715 Supported "Secreted to blood" NA NA "HPA043715: AB_2678632" "unprognostic (1.68e-1)" "unprognostic (1.85e-1)" "unprognostic (1.86e-1)" 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.7 246.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.4 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 230.4 0.0 0.0 0.0 CSHL1 "CS-5, CSHP1, CSL, hCS-L, MGC149868" ENSG00000204414 "Chorionic somatomammotropin hormone like 1" Q14406 17 63909597-63918838 "Predicted intracellular proteins, Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 864 "pituitary gland: 334.1;placenta: 293.7" "Cell type enriched" "Detected in some" 16 "Syncytiotrophoblasts: 18.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 1.2;SCLC-21H: 1.3;SuSa: 1.7" "CAB025646, HPA043715" Enhanced "Secreted to blood" NA NA "CAB025646: , HPA043715: AB_2678632" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.0 334.1 293.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 18.1 0.0 0.0 0.0 CTSL "CTSL1, FLJ31037" ENSG00000135047 "Cathepsin L" P07711 9 87725519-87731393 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 237.0" "Cell type enhanced" "Detected in all" 8 "Cytotrophoblasts: 935.7;Extravillous trophoblasts: 843.2;Hofbauer cells: 1004.8;Ito cells: 672.8;Syncytiotrophoblasts: 1290.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "intermediate monocyte: 31.0;non-classical monocyte: 44.3" "Lineage enriched" "Detected in many" 10 "monocytes: 44.3" "Cell line enhanced" "Detected in many" "ASC TERT1: 201.6;HSkMC: 93.2" "CAB000459, HPA070413" Enhanced Approved "Golgi apparatus,Vesicles" "Intracellular and membrane" NA NA 17000000 "Golgi apparatus, Vesicles" "CAB000459: AB_2292484, HPA070413: " "unprognostic (1.05e-1)" "unprognostic (1.01e-1)" "unprognostic (1.24e-2)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.19e-3)" "unprognostic (8.12e-3)" "prognostic unfavorable (5.15e-5)" "unprognostic (2.09e-1)" "unprognostic (3.15e-1)" "unprognostic (6.80e-2)" "unprognostic (3.21e-1)" "prognostic favorable (4.34e-4)" "unprognostic (5.64e-3)" "unprognostic (2.26e-2)" "unprognostic (1.72e-1)" "unprognostic (7.11e-3)" 60.3 21.5 10.4 27.2 24.6 18.4 23.3 6.9 12.3 14.8 23.2 14.1 13.7 9.0 24.1 22.3 11.4 25.7 20.7 37.7 10.7 11.4 65.4 98.0 53.1 80.5 18.9 7.7 25.0 14.3 18.8 18.0 237.0 18.4 19.4 13.0 23.2 22.0 23.5 29.3 9.1 12.0 36.6 16.1 108.1 17.5 14.1 15.7 6.8 19.2 9.4 10.1 41.3 26.5 0.0 1.7 0.1 44.3 0.0 4.3 2.4 6.4 37.4 2.6 4.4 47.1 201.6 15.7 20.8 60.7 17.9 22.4 3.6 5.9 0.0 9.8 26.9 56.7 5.5 3.4 6.8 14.8 0.1 3.3 1.1 10.6 8.7 30.5 0.0 4.5 93.2 11.4 29.2 11.4 15.6 14.1 0.0 12.1 0.0 25.7 10.8 0.0 0.7 4.9 10.1 7.1 1.5 1.5 0.0 12.5 3.4 3.7 4.6 4.3 9.8 23.9 15.6 1.1 7.4 22.0 16.0 8.7 58.4 8.8 1.6 6.0 0.0 58.7 0.0 5.2 0.1 3.5 0.1 0.0 31.0 0.0 0.0 1.8 0.0 1.7 0.0 4.3 0.3 0.1 0.0 44.3 0.1 0.3 2.4 10.4 24.6 6.9 11.7 10.7 11.4 18.9 7.7 18.4 15.7 38.7 60.6 38.5 79.1 33.5 37.4 87.3 84.1 56.2 38.7 71.5 17.7 935.7 23.2 77.5 3.5 75.9 8.6 46.7 82.1 843.2 226.1 43.7 27.8 100.7 1004.8 12.7 11.1 672.8 182.1 10.4 145.3 481.4 60.8 19.8 7.7 78.6 55.2 2.9 176.0 107.8 35.6 90.5 103.2 144.4 46.2 29.6 1290.9 15.3 8.8 43.0 CXorf67 ENSG00000187690 "Chromosome X open reading frame 67" Q86X51 X 51406915-51408843 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 14.3;testis: 21.4" "Group enriched" "Detected in some" 5 "Sertoli cells: 6.5;Spermatocytes: 4.9;Spermatogonia: 15.6" "Cancer enriched" "Detected in some" 6 "testis cancer: 11.4" "Region enriched" "Detected in single" 5 "cerebellum: 2.8" "Cell type enhanced" "Detected in some" "memory B-cell: 1.1;naive CD4 T-cell: 1.2" "Group enriched" "Detected in many" 11 "B-cells: 1.1;T-cells: 1.2" "Cell line enriched" "Detected in single" 46 "U-2 OS: 27.7" "HPA004003, HPA006128" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA004003: AB_2667113, HPA006128: AB_2667517" "unprognostic (4.21e-2)" "unprognostic (6.36e-2)" "unprognostic (3.37e-2)" "unprognostic (8.58e-3)" "unprognostic (3.57e-4)" "unprognostic (1.47e-6)" "unprognostic (4.55e-2)" "unprognostic (3.06e-2)" "unprognostic (4.26e-1)" 0.1 0.2 0.3 0.2 0.6 0.1 0.1 2.8 0.4 0.1 0.1 0.1 0.1 0.0 0.3 0.4 0.1 0.1 0.1 0.1 0.3 0.5 0.1 0.1 0.2 0.2 0.2 0.1 0.7 0.1 0.0 1.5 14.3 0.1 0.4 0.1 0.1 0.9 0.2 0.1 0.2 0.2 0.1 0.4 0.7 0.1 21.4 0.1 0.1 0.2 0.1 0.1 0.1 0.1 1.1 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.7 1.2 0.4 0.1 0.0 0.0 0.0 0.0 0.1 0.3 0.6 2.8 0.4 0.3 0.5 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 6.5 0.0 4.9 15.6 0.0 1.6 0.0 0.0 0.0 CYP11A1 "CYP11A, P450SCC" ENSG00000140459 "Cytochrome P450 family 11 subfamily A member 1" P05108 15 74337759-74367740 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Steroidogenesis, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 145.3;placenta: 157.2" "Group enriched" "Detected in some" 5 "Extravillous trophoblasts: 305.6;Syncytiotrophoblasts: 1214.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 36 "basal ganglia: 14.8" "Cell type enriched" "Detected in single" 37 "basophil: 15.8" "Lineage enriched" "Detected in single" 37 "granulocytes: 15.8" "Group enriched" "Detected in some" 4 "BEWO: 44.0;HEL: 35.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA016436 Enhanced NA NA "HPA016436: AB_1847423" "unprognostic (8.89e-2)" "unprognostic (6.96e-2)" "unprognostic (4.95e-3)" "unprognostic (9.31e-2)" "unprognostic (9.42e-4)" "unprognostic (1.90e-1)" "unprognostic (1.55e-3)" "unprognostic (8.06e-2)" "unprognostic (3.04e-1)" "unprognostic (2.95e-1)" "unprognostic (1.77e-2)" "unprognostic (5.45e-2)" "unprognostic (9.66e-4)" "unprognostic (2.40e-2)" "unprognostic (2.74e-1)" "unprognostic (3.04e-2)" "unprognostic (7.95e-2)" 0.4 145.3 0.4 0.1 14.8 0.0 0.4 0.3 0.3 0.2 0.2 7.6 0.1 0.0 0.3 0.5 1.5 0.3 0.0 0.3 0.3 0.2 0.1 0.7 0.1 0.0 0.3 0.2 9.2 0.1 0.0 0.4 157.2 0.2 0.2 0.0 0.3 0.1 0.6 0.3 0.1 0.1 0.3 0.3 5.7 0.1 20.4 0.1 0.0 0.1 0.3 0.7 0.2 0.2 0.0 0.0 15.8 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.3 44.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 35.0 1.0 0.3 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 8.9 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 15.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 14.8 0.3 0.3 0.3 0.2 0.3 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 2.5 0.0 0.0 0.0 0.0 139.8 1.7 0.0 1.4 0.0 0.0 0.0 0.0 305.6 0.6 0.1 0.0 3.4 19.4 0.0 0.0 0.0 0.0 2.9 45.1 0.0 0.0 1.0 0.0 5.1 0.2 0.0 163.4 0.0 0.0 0.0 0.0 3.2 3.1 0.0 1214.3 0.0 0.0 0.0 CYP19A1 "ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM" ENSG00000137869 "Cytochrome P450 family 19 subfamily A member 1" P11511 15 51208057-51338610 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 49 "placenta: 440.1" "Cell type enriched" "Detected in some" 36 "Syncytiotrophoblasts: 1678.9" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 8 "basal ganglia: 5.9" "Cell type enriched" "Detected in single" 17 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 45.7;HDLM-2: 7.9;HSkMC: 15.3;SuSa: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000355, HPA051194" Enhanced Uncertain Mitochondria NA NA Mitochondria "CAB000355: , HPA051194: AB_2681381" "unprognostic (9.41e-2)" "unprognostic (7.44e-2)" "unprognostic (9.52e-5)" "unprognostic (6.81e-2)" "unprognostic (2.72e-1)" "unprognostic (4.25e-4)" "unprognostic (5.18e-5)" "unprognostic (1.54e-3)" "unprognostic (2.38e-2)" "unprognostic (2.52e-1)" "unprognostic (1.97e-1)" "unprognostic (5.37e-2)" "unprognostic (1.54e-5)" "unprognostic (2.52e-3)" "unprognostic (2.11e-1)" "unprognostic (1.40e-2)" "unprognostic (1.11e-1)" 9.0 4.6 0.2 0.2 5.9 0.1 2.1 0.2 0.3 0.9 0.3 0.3 0.2 0.4 0.2 0.3 0.3 0.2 0.3 1.3 0.2 0.7 0.3 0.2 0.6 0.2 0.2 0.2 4.4 0.6 0.1 0.2 440.1 0.2 0.5 0.1 0.2 0.9 1.4 0.8 2.3 0.2 0.7 0.5 0.5 0.1 3.0 0.2 0.3 3.0 0.2 0.2 1.2 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 45.7 2.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.3 0.1 3.7 0.3 0.0 0.0 15.3 0.0 0.1 1.9 0.1 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 8.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 1.4 0.6 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 5.9 0.2 0.3 0.2 0.7 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 46.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 6.9 1.4 0.0 0.0 0.0 13.4 0.0 0.0 0.0 1.6 4.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 6.5 0.3 7.7 0.2 0.0 1678.9 0.0 0.0 0.0 CYSLTR2 "CysLT(2), CYSLT2R" ENSG00000152207 "Cysteinyl leukotriene receptor 2" Q9NS75 13 48653711-48711226 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.2;ductus deferens: 25.1;placenta: 22.6;seminal vesicle: 22.4" "Cell type enhanced" "Detected in some" 12 "Macrophages: 4.3;Melanocytes: 5.0;Sertoli cells: 12.9;Smooth muscle cells: 5.1" "Group enriched" "Detected in many" 6 "melanoma: 1.8;renal cancer: 6.6;thyroid cancer: 7.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 12 "eosinophil: 37.2" "Lineage enriched" "Detected in many" 12 "granulocytes: 37.2" "Cell line enriched" "Detected in some" 43 "HDLM-2: 44.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA046528 Approved NA NA "HPA046528: AB_2679687" "unprognostic (9.83e-3)" "unprognostic (2.72e-3)" "unprognostic (1.05e-2)" "unprognostic (6.81e-2)" "unprognostic (2.94e-2)" "unprognostic (3.11e-2)" "unprognostic (1.11e-1)" "unprognostic (7.41e-3)" "unprognostic (8.33e-2)" "unprognostic (1.83e-1)" "unprognostic (5.44e-2)" "unprognostic (5.93e-2)" "unprognostic (1.88e-3)" "unprognostic (3.79e-2)" "unprognostic (4.44e-2)" "unprognostic (2.35e-2)" "unprognostic (1.18e-2)" 2.0 11.4 3.4 3.9 4.2 0.7 1.0 1.6 8.0 0.9 1.0 1.1 25.1 2.1 1.3 1.7 0.7 3.4 1.6 11.5 4.1 3.4 1.8 1.0 1.5 4.4 3.3 1.5 5.4 0.5 0.7 2.3 22.6 3.7 3.4 1.1 2.9 0.7 22.4 0.5 1.3 2.5 0.7 2.3 6.9 1.1 1.0 2.9 1.0 1.1 0.5 1.5 1.0 1.2 0.0 0.9 37.2 3.2 0.4 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.2 1.0 37.2 0.2 3.2 0.0 0.0 0.4 0.0 0.9 0.0 0.5 0.1 0.1 0.4 2.0 0.0 0.3 0.4 3.4 4.2 1.6 8.0 4.1 3.4 3.3 1.5 3.7 2.9 0.0 1.4 0.5 0.1 0.5 0.0 0.8 0.0 0.0 0.0 3.5 0.0 0.3 0.0 0.0 0.2 0.8 0.0 0.0 0.0 1.0 4.1 0.0 1.1 0.0 0.6 0.0 0.0 3.1 2.1 0.0 0.3 4.3 5.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 5.1 0.0 0.1 0.0 2.4 1.9 0.0 0.0 CYTH3 "ARNO3, cytohesin-3, GRP1, PSCD3" ENSG00000008256 "Cytohesin 3" O43739 7 6161776-6272644 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.6" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 38.8" "Cancer enhanced" "Detected in all" "melanoma: 47.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 5.9" "Group enriched" "Detected in many" 5 "dendritic cells: 1.8;NK-cells: 3.3;T-cells: 5.9" "Cell line enhanced" "Detected in many" "WM-115: 35.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013979 Uncertain Supported Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA013979: AB_1855799" "unprognostic (6.58e-2)" "unprognostic (1.37e-2)" "unprognostic (1.65e-2)" "unprognostic (5.75e-3)" "unprognostic (1.27e-3)" "unprognostic (1.27e-2)" "unprognostic (2.32e-2)" "unprognostic (2.63e-1)" "unprognostic (8.94e-2)" "unprognostic (1.81e-2)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (2.54e-2)" "unprognostic (1.73e-2)" "unprognostic (2.20e-1)" "unprognostic (4.41e-2)" "prognostic unfavorable (2.63e-5)" 24.0 9.1 10.9 6.6 14.4 6.1 22.0 14.2 17.6 10.4 16.4 7.0 5.7 15.1 13.0 8.1 13.4 12.6 13.9 21.1 11.4 7.2 8.8 3.0 14.0 5.4 9.4 10.7 11.0 6.6 9.4 7.1 66.6 9.4 6.8 6.7 17.8 8.6 8.7 12.3 15.6 18.5 15.2 8.5 7.5 9.2 26.0 6.5 2.9 20.4 10.8 5.0 7.7 16.5 0.6 1.8 0.7 0.4 3.3 5.9 0.4 21.6 5.5 5.2 3.6 24.5 29.0 7.4 12.8 11.2 12.7 12.1 8.4 10.8 2.9 7.8 25.8 16.4 20.4 3.6 9.3 8.5 0.2 5.1 0.8 6.5 1.0 11.6 0.9 1.4 20.5 4.2 6.7 9.8 5.7 2.2 4.3 3.4 0.4 9.2 3.5 0.7 3.8 3.6 2.9 7.4 3.8 14.0 1.6 9.8 2.6 3.4 6.5 7.9 27.8 22.5 4.7 1.7 6.1 8.0 8.7 23.2 9.4 7.8 1.0 0.3 3.0 2.8 2.3 35.5 0.7 0.4 0.0 2.2 0.2 5.9 0.3 1.0 2.4 0.4 0.6 0.1 1.5 0.3 3.3 0.4 1.8 0.8 0.4 10.9 14.4 14.2 17.6 11.4 7.2 9.4 10.7 9.4 6.5 14.9 8.0 2.4 1.7 13.5 4.8 16.5 2.5 2.7 3.4 3.5 7.9 12.6 5.0 3.3 9.9 14.7 7.5 0.0 2.4 7.4 14.4 3.0 12.7 1.5 9.9 14.3 2.9 16.0 2.7 12.1 15.3 4.6 30.4 1.0 5.8 8.8 6.4 5.3 12.4 1.0 1.8 38.8 24.0 19.5 10.5 9.9 12.7 5.0 6.9 1.6 CYTL1 "C17, C4orf4" ENSG00000170891 "Cytokine like 1" Q9NRR1 4 5014586-5019472 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.2" "Cell type enhanced" "Detected in some" 12 "Endothelial cells: 8.3;Fibroblasts: 15.8;granulocytes: 9.2;Hofbauer cells: 12.7;Macrophages: 5.9;Melanocytes: 8.5" "Cancer enhanced" "Detected in many" "glioma: 21.0;melanoma: 20.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "NK-cell: 18.8" "Lineage enriched" "Detected in many" 10 "NK-cells: 18.8" "Cell line enhanced" "Detected in some" "HEL: 42.6;HUVEC TERT2: 34.2;NB-4: 83.4;WM-115: 20.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067201 Supported "Nuclear membrane,Endoplasmic reticulum" "Secreted in other tissues" NA NA "Nuclear membrane, Endoplasmic reticulum" "HPA067201: AB_2732760" "unprognostic (2.35e-2)" "unprognostic (9.01e-3)" "unprognostic (3.56e-1)" "unprognostic (3.76e-2)" "unprognostic (1.14e-1)" "unprognostic (2.71e-1)" "unprognostic (2.09e-2)" "unprognostic (1.44e-1)" "unprognostic (7.10e-2)" "unprognostic (1.20e-1)" "unprognostic (1.54e-1)" "unprognostic (4.78e-2)" "prognostic unfavorable (7.43e-4)" "prognostic unfavorable (3.00e-5)" "unprognostic (2.18e-1)" "unprognostic (3.07e-2)" "prognostic unfavorable (1.25e-4)" 5.2 2.3 6.5 2.0 6.0 10.8 6.4 0.7 4.2 11.0 4.9 9.2 4.9 1.0 10.1 2.8 5.3 7.3 4.6 4.4 5.4 4.4 1.2 0.8 17.1 9.4 6.2 2.1 2.5 1.1 1.7 1.6 42.2 4.7 10.5 1.8 4.5 4.0 14.2 0.8 3.3 2.1 4.2 11.0 1.1 4.9 2.2 8.4 0.5 5.7 3.6 4.8 13.2 7.4 0.0 0.3 1.9 1.0 18.8 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.6 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.6 0.0 0.0 34.2 0.0 0.0 1.7 0.0 0.0 0.0 83.4 0.1 0.0 0.0 1.2 1.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 5.2 0.0 0.0 0.0 11.7 0.0 8.1 0.0 0.0 0.2 0.0 0.0 0.0 1.0 20.2 1.9 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.6 0.1 18.8 0.0 0.3 0.0 0.6 6.5 6.0 0.7 4.2 5.4 4.4 6.2 2.1 4.7 8.4 0.0 0.3 0.5 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 8.3 0.0 0.0 0.0 0.1 15.8 0.5 9.2 0.0 12.7 0.0 0.0 1.3 0.0 0.0 0.0 5.9 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.5 0.0 0.0 0.6 DAB2 DOC-2 ENSG00000153071 "DAB2, clathrin adaptor protein" P98082 5 39371675-39462300 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation, Endocytosis, Protein transport, Transport, Wnt signaling pathway" "Developmental protein" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 194.4" "Group enriched" "Detected in many" 5 "Hofbauer cells: 1338.9;Proximal tubular cells: 964.6;Syncytiotrophoblasts: 1107.7" "Cancer enhanced" "Detected in all" "renal cancer: 52.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "plasmacytoid DC: 26.6" "Lineage enriched" "Detected in many" 10 "dendritic cells: 26.6" "Cell line enhanced" "Detected in many" "ASC diff: 43.0;ASC TERT1: 46.3;fHDF/TERT166: 67.0;TIME: 40.3;U-138 MG: 46.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009314, HPA028888" Enhanced Enhanced "Nucleoli fibrillar center,Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "Nucleoli fibrillar center" "CAB009314: AB_638976, HPA028888: AB_2672814" "unprognostic (1.24e-1)" "unprognostic (7.28e-2)" "unprognostic (2.16e-1)" "unprognostic (1.25e-1)" "unprognostic (5.37e-3)" "unprognostic (7.01e-2)" "prognostic unfavorable (7.38e-6)" "unprognostic (3.11e-1)" "unprognostic (2.82e-1)" "unprognostic (2.78e-2)" "unprognostic (1.50e-1)" "unprognostic (1.87e-1)" "unprognostic (3.16e-2)" "prognostic unfavorable (9.67e-4)" "unprognostic (1.27e-2)" "unprognostic (2.24e-1)" "unprognostic (1.20e-1)" 51.6 44.2 2.6 12.2 3.5 0.6 21.8 6.1 2.6 16.6 14.0 4.1 4.5 3.3 16.6 34.8 10.8 9.6 13.3 25.1 2.9 3.0 75.2 6.9 22.4 31.8 4.0 2.1 12.7 11.3 3.2 3.9 194.4 4.7 11.6 14.6 14.6 12.9 5.3 12.7 9.3 10.4 16.0 5.2 21.1 7.2 8.7 2.5 7.3 10.9 8.4 7.4 17.8 14.7 0.1 26.6 2.2 2.5 0.9 1.3 7.0 0.0 1.6 2.5 5.4 43.0 46.3 3.1 27.8 28.4 11.0 18.1 20.3 0.1 0.0 1.7 67.0 10.8 0.0 0.3 1.0 15.4 0.0 0.8 3.7 36.9 6.6 10.4 0.0 4.8 28.8 0.0 17.8 3.2 17.0 32.9 1.9 0.0 0.9 18.1 0.1 0.3 0.0 1.7 0.7 3.0 1.0 6.3 0.0 7.3 0.6 0.0 0.0 3.3 1.8 15.5 4.1 0.1 0.9 40.3 46.9 5.2 5.4 2.2 0.0 0.0 0.0 16.3 3.4 6.1 2.2 1.2 0.2 1.3 2.5 0.0 0.1 0.2 0.7 3.4 0.1 0.1 1.0 1.8 0.9 0.6 26.6 0.2 7.0 2.6 3.5 6.1 2.6 2.9 3.0 4.0 2.1 4.7 2.5 35.7 35.6 25.8 1.3 12.9 0.7 50.4 61.1 9.4 7.9 90.7 66.8 112.4 167.5 58.4 0.6 97.7 30.4 23.3 1.6 14.9 120.5 7.2 24.3 2.1 1338.9 7.9 9.4 214.9 131.6 1.1 113.4 176.8 11.8 7.2 5.6 72.3 7.0 12.7 60.5 964.6 2.1 6.5 26.7 0.5 4.7 11.7 1107.7 10.8 19.2 0.7 DACT2 "bA503C24.7, C6orf116, DAPPER2" ENSG00000164488 "Dishevelled binding antagonist of beta catenin 2" Q5SW24 6 168292830-168319754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 14.2;placenta: 54.8" "Cell type enriched" "Detected in many" 5 "Syncytiotrophoblasts: 180.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 14.1" "Region enriched" "Detected in many" 8 "basal ganglia: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.5;CACO-2: 3.6;hTCEpi: 2.5;NTERA-2: 3.2;OE19: 15.1;SCLC-21H: 3.5" "Low region specificity" "Detected in many" HPA030251 Enhanced Supported NA NA "HPA030251: AB_10611108" "unprognostic (5.22e-6)" "unprognostic (3.13e-2)" "unprognostic (1.04e-2)" "prognostic favorable (1.07e-5)" "unprognostic (1.21e-1)" "unprognostic (1.41e-1)" "unprognostic (1.64e-2)" "unprognostic (1.08e-1)" "unprognostic (4.04e-1)" "unprognostic (1.31e-1)" "unprognostic (7.05e-3)" "unprognostic (2.48e-1)" "prognostic favorable (5.76e-5)" "unprognostic (1.51e-2)" "unprognostic (1.66e-2)" "unprognostic (2.03e-4)" "unprognostic (4.23e-2)" 1.0 1.3 0.5 0.4 14.2 0.0 0.4 1.5 1.4 2.3 1.1 1.2 1.0 0.9 3.7 2.2 0.7 2.2 2.9 2.7 0.9 0.5 2.2 2.4 2.0 0.4 1.1 0.9 0.9 1.6 0.0 0.4 54.8 1.7 6.1 0.4 1.6 5.3 0.5 0.4 5.6 0.8 0.8 0.7 0.4 0.5 1.0 0.7 0.9 0.4 0.4 0.8 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.6 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 15.1 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 14.2 1.5 1.4 0.9 0.5 1.1 0.9 1.7 0.7 0.0 1.3 0.0 1.8 2.7 9.8 0.5 2.5 0.0 2.3 1.8 0.0 38.3 0.0 1.5 0.0 0.1 0.0 0.0 0.2 4.7 1.1 0.8 0.0 0.0 4.6 0.0 5.1 0.0 0.0 0.0 0.0 0.0 3.3 0.0 1.1 22.6 0.4 0.0 0.0 4.9 0.7 0.0 0.0 0.0 0.0 1.3 180.9 0.0 1.8 0.0 DAPK1 "DAPK, ROCO3" ENSG00000196730 "Death associated protein kinase 1" P53355 9 87497228-87708633 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Apoptosis, Translation regulation" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 94.7" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 65.3;Ito cells: 79.2;Kupffer cells: 64.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 5.3;eosinophil: 6.9;intermediate monocyte: 11.9;myeloid DC: 4.0;non-classical monocyte: 11.7;plasmacytoid DC: 5.3" "Group enriched" "Detected in many" 55 "dendritic cells: 5.3;granulocytes: 6.9;monocytes: 11.9" "Cell line enhanced" "Detected in many" "HMC-1: 38.8;HUVEC TERT2: 22.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB037302, HPA040472, HPA048436" Approved Approved Centrosome NA NA Centrosome "CAB037302: AB_1078622, HPA040472: AB_2677001, HPA048436: AB_2680390" "unprognostic (2.55e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (2.77e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-2)" "unprognostic (1.74e-1)" "unprognostic (1.75e-1)" "unprognostic (1.88e-2)" "unprognostic (5.77e-3)" "unprognostic (2.19e-2)" "unprognostic (2.77e-3)" "unprognostic (8.31e-3)" "unprognostic (8.76e-2)" "unprognostic (2.40e-1)" "unprognostic (1.68e-1)" "unprognostic (1.09e-3)" 14.6 4.9 10.4 8.8 25.5 3.8 4.1 2.9 17.6 8.1 16.6 6.5 8.1 7.8 8.7 16.1 4.5 12.2 21.6 4.1 12.4 8.1 14.7 21.3 28.6 8.5 4.6 10.4 32.7 21.2 4.8 16.6 94.7 6.6 5.1 7.5 5.9 9.3 7.3 1.5 3.7 11.0 8.1 4.8 16.4 15.0 6.3 7.3 34.5 7.2 1.5 5.2 13.2 10.5 0.1 5.3 6.9 11.9 0.1 0.1 2.1 0.0 18.3 8.8 6.2 0.2 0.1 14.0 1.2 1.7 7.2 8.2 2.6 0.1 0.1 1.8 0.3 0.1 17.1 5.4 0.4 3.1 0.1 4.4 8.8 2.5 8.9 7.9 0.0 38.8 0.5 2.9 1.3 0.5 11.3 22.0 2.5 6.6 3.7 6.0 0.5 2.6 0.0 10.0 16.9 0.0 0.7 7.8 0.0 20.1 18.3 4.0 4.5 0.0 1.8 7.7 13.5 0.0 5.8 0.1 0.0 0.1 0.0 0.0 14.6 3.0 0.0 0.1 2.4 1.2 1.3 5.3 6.9 0.0 11.9 0.0 0.1 0.0 0.0 4.0 0.0 0.0 0.1 1.6 0.1 11.7 5.3 0.0 2.1 10.4 25.5 2.9 17.6 12.4 8.1 4.6 10.4 6.6 7.3 47.6 65.3 5.9 0.6 3.2 19.8 1.9 40.8 16.0 40.9 21.0 2.0 5.6 1.7 27.2 1.2 13.0 2.1 0.0 20.1 14.4 11.4 3.9 23.1 16.3 21.3 17.5 0.0 79.2 64.1 2.2 13.8 42.1 11.8 30.7 7.7 14.5 31.5 1.7 12.7 5.9 2.9 0.0 2.3 3.9 4.1 2.8 11.9 0.7 2.8 9.3 DEPDC1B "BRCC3, XTP1" ENSG00000035499 "DEP domain containing 1B" Q8WUY9 5 60596912-60700190 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.6;placenta: 71.5" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 17.8;Extravillous trophoblasts: 18.7;Spermatocytes: 32.0;Syncytiotrophoblasts: 39.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA038255, HPA072558" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA Yes "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA038255: AB_10669521, HPA072558: AB_2686534" "unprognostic (1.38e-1)" "unprognostic (1.99e-2)" "prognostic favorable (2.42e-4)" "prognostic unfavorable (8.55e-4)" "unprognostic (2.23e-1)" "unprognostic (7.93e-2)" "prognostic unfavorable (3.08e-4)" "prognostic unfavorable (6.93e-5)" "unprognostic (2.13e-2)" "unprognostic (8.14e-2)" "unprognostic (1.47e-3)" "unprognostic (2.44e-2)" "unprognostic (1.11e-16)" "unprognostic (1.00e-1)" "unprognostic (1.40e-1)" "unprognostic (1.53e-1)" "unprognostic (8.62e-2)" 0.6 0.6 0.6 3.7 1.5 7.9 0.6 0.8 1.4 1.2 3.3 0.6 0.1 4.8 0.9 0.5 5.2 0.4 19.0 0.4 0.8 0.8 3.3 0.9 1.0 6.9 2.3 0.7 0.6 0.5 0.0 0.3 71.5 1.4 0.5 4.6 0.4 1.3 0.1 0.2 2.1 5.1 0.5 3.2 3.3 2.0 17.0 1.2 21.6 1.5 2.3 7.6 0.9 2.2 1.0 0.6 3.3 0.3 1.4 6.4 0.9 24.0 8.2 25.0 15.2 0.5 0.8 27.4 6.5 4.4 11.5 15.0 13.6 15.3 13.7 16.1 2.0 14.9 8.0 20.0 14.6 15.5 19.5 14.5 17.1 9.4 16.9 0.4 14.4 16.7 0.5 1.5 3.7 5.4 2.2 10.6 14.7 12.2 18.8 10.1 15.1 23.2 12.6 18.4 5.2 13.3 25.8 20.3 11.7 9.3 12.0 13.9 6.4 15.3 5.5 7.2 11.7 10.2 11.5 4.9 4.9 14.4 3.9 16.5 9.5 16.6 27.1 6.1 21.2 13.6 3.3 0.3 1.7 0.5 0.0 0.4 1.0 2.2 1.5 0.6 0.1 0.3 0.3 0.0 1.4 0.0 0.1 6.4 0.9 0.6 1.5 0.8 1.4 0.8 0.8 2.3 0.7 1.4 1.2 0.0 2.6 0.8 0.8 4.1 0.0 0.0 17.8 0.0 0.0 0.0 0.0 1.9 0.0 0.3 1.4 0.1 1.7 0.0 0.2 18.7 0.4 0.5 3.5 0.0 5.2 0.0 0.0 0.0 1.2 1.8 0.3 2.2 0.0 0.0 1.0 0.2 0.7 2.0 0.0 0.5 0.0 6.5 0.4 32.0 8.7 1.8 39.2 0.0 6.3 0.3 DIO3 TXDI3 ENSG00000197406 "Iodothyronine deiodinase 3" P55073 14 101561351-101563452 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 40.9;placenta: 17.6" "Group enriched" "Detected in some" 4 "Fibroblasts: 8.0;Leydig cells: 10.0;Muller glia cells: 6.6;Peritubular cells: 7.1;Syncytiotrophoblasts: 23.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "basal ganglia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "AF22: 35.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA073684 Supported Vesicles NA NA Vesicles "HPA073684: " "unprognostic (4.52e-3)" "unprognostic (1.80e-1)" "unprognostic (3.04e-3)" "unprognostic (3.48e-1)" "unprognostic (5.16e-2)" "unprognostic (1.50e-1)" "unprognostic (4.24e-2)" "unprognostic (8.11e-2)" "unprognostic (2.58e-1)" "unprognostic (6.24e-2)" "unprognostic (2.34e-1)" "unprognostic (2.52e-1)" "unprognostic (7.46e-5)" "unprognostic (4.82e-3)" "unprognostic (2.43e-1)" "unprognostic (1.11e-4)" "unprognostic (9.80e-3)" 4.5 0.2 0.2 1.7 1.8 0.0 3.5 0.1 0.8 40.9 1.6 0.1 1.0 0.0 3.4 2.2 1.9 3.5 2.9 1.6 0.7 0.0 0.9 2.7 1.4 7.1 0.1 0.1 9.2 4.1 0.0 0.6 17.6 0.3 1.6 0.4 12.6 0.8 2.5 2.2 1.9 0.7 0.9 0.1 2.5 0.7 1.0 0.1 0.1 3.6 1.1 0.4 6.9 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 35.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.9 0.5 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.1 0.6 0.7 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.1 0.0 0.9 0.0 0.0 2.1 8.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 1.0 0.0 6.6 0.6 0.0 7.1 0.0 0.1 0.0 1.2 0.0 0.0 0.1 23.7 0.0 0.0 0.1 DKK1 "DKK-1, SK" ENSG00000107984 "Dickkopf WNT signaling pathway inhibitor 1" O94907 10 52314296-52318042 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "placenta: 153.6" "Cell type enhanced" "Detected in many" 19 "Basal glandular cells: 400.3;Glandular cells: 95.5;Pancreatic endocrine cells: 113.3;Urothelial cells: 308.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 9 "pons and medulla: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 113.4;BJ hTERT+: 62.2;CACO-2: 99.0;fHDF/TERT166: 156.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Secreted in female reproductive system" NA NA "unprognostic (5.65e-2)" "unprognostic (4.21e-2)" "unprognostic (7.09e-2)" "unprognostic (7.99e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (4.35e-8)" "unprognostic (7.93e-2)" "prognostic unfavorable (7.80e-6)" "unprognostic (1.54e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (1.27e-4)" "unprognostic (1.81e-1)" "unprognostic (1.68e-1)" "unprognostic (7.47e-3)" "unprognostic (4.05e-1)" "unprognostic (1.19e-1)" "unprognostic (2.06e-2)" 15.6 0.1 0.5 0.3 0.4 0.0 4.0 0.4 0.6 26.2 0.3 0.6 1.8 0.1 2.1 0.5 5.3 0.1 2.8 0.6 0.8 1.7 0.5 0.2 0.6 0.3 0.7 0.3 0.9 0.1 0.1 0.2 153.6 15.2 4.2 0.1 0.7 1.6 1.3 0.6 11.7 0.2 1.2 0.2 0.4 0.8 1.6 0.4 0.1 0.2 0.1 0.5 10.6 7.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 30.3 21.3 0.0 3.2 15.5 3.1 0.0 113.4 62.2 39.0 20.8 99.0 6.4 0.0 0.1 156.8 9.5 24.3 0.0 12.9 37.1 0.0 0.0 0.0 0.4 2.5 3.3 0.0 0.0 3.1 1.6 8.4 50.0 2.0 3.5 0.0 0.0 0.0 25.6 13.1 0.0 0.0 0.0 1.3 54.5 0.0 3.5 0.0 14.9 2.5 0.0 34.8 10.2 0.1 1.6 0.0 0.1 0.0 7.8 0.0 0.0 34.2 20.6 0.0 0.0 0.0 0.4 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.6 0.8 1.7 0.7 0.3 15.2 0.4 23.8 0.0 0.0 400.3 4.7 0.1 0.4 0.0 1.4 1.2 0.0 0.0 3.4 0.0 3.5 1.1 0.3 0.4 0.0 3.6 4.7 77.0 95.5 4.6 0.0 8.5 0.0 0.0 1.8 0.0 0.4 0.0 0.8 0.0 0.0 0.3 5.8 113.3 0.0 0.0 0.0 0.3 0.0 1.4 0.2 0.9 2.8 7.0 0.0 0.4 308.8 DLK1 "Delta1, FA1, pG2, Pref-1, ZOG" ENSG00000185559 "Delta like non-canonical Notch ligand 1" P80370 14 100725705-100738224 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 157.6;pituitary gland: 143.1;placenta: 244.9" "Group enriched" "Detected in many" 5 "Exocrine glandular cells: 527.9;Leydig cells: 1256.4" "Cancer enhanced" "Detected in many" "liver cancer: 28.1" "Group enriched" "Detected in some" 5 "hypothalamus: 2.6;pons and medulla: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 23.1;Hep G2: 77.0;SH-SY5Y: 91.7" "Region enhanced" "Detected in some" "hypothalamus: 65.4" "Region enhanced" "Detected in many" "midbrain: 159.6" "CAB005872, HPA062262" Enhanced Approved "Golgi apparatus" NA NA 160000 "Golgi apparatus" "CAB005872: AB_731965, HPA062262: AB_2684729" "unprognostic (2.16e-2)" "prognostic unfavorable (2.31e-4)" "unprognostic (1.49e-1)" "unprognostic (1.14e-1)" "unprognostic (4.89e-3)" "unprognostic (5.75e-2)" "unprognostic (1.87e-2)" "unprognostic (1.12e-1)" "unprognostic (5.24e-1)" "unprognostic (3.11e-2)" "unprognostic (6.57e-2)" 0.3 157.6 0.2 0.7 0.8 0.0 0.9 0.0 0.1 0.5 0.0 1.8 0.2 0.2 0.2 4.4 0.3 0.3 0.8 2.7 0.1 2.6 0.1 0.1 0.1 0.1 0.8 0.0 34.9 4.6 0.0 143.1 244.9 6.0 0.2 0.0 0.2 8.2 0.0 2.0 0.1 0.2 0.2 0.3 0.2 0.2 14.2 0.0 0.5 0.0 10.0 1.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 77.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.1 6.5 91.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.2 0.8 0.0 0.0 0.1 2.6 0.8 0.0 6.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 52.1 0.0 2.9 4.0 0.0 0.0 0.0 527.9 35.4 1.3 0.5 0.0 0.0 73.1 0.0 0.0 0.0 0.0 11.5 1256.4 0.0 0.0 0.0 0.0 0.0 6.5 0.0 162.3 0.0 0.0 58.2 0.0 6.5 56.6 0.4 88.4 0.0 0.0 0.1 DLX3 ENSG00000064195 "Distal-less homeobox 3" O60479 17 49990005-49995224 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "placenta: 47.6;skin 1: 32.4;tongue: 11.9" "Group enriched" "Detected in some" 13 "Cytotrophoblasts: 28.7;Extravillous trophoblasts: 58.3;Syncytiotrophoblasts: 80.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BEWO: 54.8;SK-BR-3: 17.6" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.20e-1)" "unprognostic (1.75e-1)" "unprognostic (3.56e-2)" "prognostic unfavorable (4.61e-4)" "unprognostic (1.95e-1)" "unprognostic (2.63e-2)" "unprognostic (1.02e-1)" "unprognostic (2.55e-1)" "unprognostic (1.77e-2)" "unprognostic (7.98e-2)" "unprognostic (1.44e-5)" "unprognostic (3.26e-2)" "unprognostic (3.11e-1)" "unprognostic (1.49e-1)" "unprognostic (2.20e-1)" "unprognostic (1.18e-1)" "unprognostic (1.28e-1)" 0.5 0.2 0.1 0.0 0.1 0.0 1.5 0.0 0.2 2.2 0.3 0.1 0.0 0.0 0.1 0.6 2.8 0.1 0.2 0.1 0.1 0.1 0.5 0.0 0.4 0.0 0.0 0.0 1.4 0.8 0.0 0.2 47.6 0.3 0.7 0.0 0.5 1.1 1.1 0.1 32.4 0.4 0.0 0.1 0.0 0.1 0.4 0.0 0.4 3.6 11.9 3.4 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.2 0.0 0.0 1.0 0.3 0.2 54.8 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.6 0.6 0.0 6.8 2.8 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.2 0.0 5.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.6 1.6 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.7 6.1 0.0 0.6 17.6 0.0 3.8 7.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.4 4.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.4 0.0 0.1 0.0 0.0 0.0 58.3 0.5 0.3 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.9 4.4 80.3 0.0 0.0 0.3 DLX4 "BP1, DLX7, DLX8, DLX9" ENSG00000108813 "Distal-less homeobox 4" Q92988 17 49968970-49974959 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 14.7;skin 1: 6.0" "Cell type enriched" "Detected in some" 5 "Extravillous trophoblasts: 67.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 18.6;CACO-2: 13.1;GAMG: 12.4;HAP1: 9.0;K-562: 10.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA059933 Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA059933: AB_2684169" "unprognostic (8.12e-2)" "unprognostic (2.48e-1)" "unprognostic (1.26e-2)" "unprognostic (2.29e-3)" "unprognostic (7.49e-2)" "unprognostic (2.71e-1)" "unprognostic (9.35e-3)" "unprognostic (2.85e-2)" "unprognostic (8.73e-2)" "unprognostic (5.93e-2)" "unprognostic (1.29e-2)" "unprognostic (4.34e-2)" "unprognostic (2.88e-13)" "unprognostic (8.79e-3)" "unprognostic (2.77e-1)" "unprognostic (5.00e-2)" "unprognostic (6.86e-2)" 0.4 0.3 0.2 1.2 0.7 0.4 0.7 0.3 0.8 0.8 0.6 0.8 0.2 0.2 0.2 0.6 1.5 0.5 0.2 0.2 0.2 0.2 0.2 0.2 1.3 0.5 0.2 0.2 0.2 0.7 0.1 0.2 14.7 1.4 0.5 0.3 0.5 2.7 0.6 0.2 6.0 1.5 0.2 0.2 0.8 0.3 0.5 0.2 0.2 0.6 3.8 1.2 0.4 0.8 0.1 0.9 0.0 1.3 1.0 0.8 0.3 0.4 1.1 0.0 0.1 0.1 0.0 18.6 0.1 0.1 0.0 0.3 13.1 0.8 0.5 2.7 0.2 12.4 1.8 9.0 0.3 0.0 3.5 4.7 0.3 4.5 1.3 0.0 0.7 3.1 0.0 2.3 0.1 0.0 0.1 0.0 2.7 10.3 0.0 0.0 2.2 0.3 4.7 0.2 2.4 0.0 0.0 4.2 0.4 0.1 0.6 1.5 0.0 0.3 1.6 0.8 2.9 3.3 3.1 0.0 0.0 0.9 0.2 0.0 0.7 0.1 0.0 0.3 2.4 0.0 0.0 0.3 0.0 0.8 1.3 0.0 0.0 0.0 0.4 0.7 0.1 0.2 0.0 0.0 1.0 1.3 0.9 0.0 0.3 0.2 0.7 0.3 0.8 0.2 0.2 0.2 0.2 1.4 0.2 6.0 0.0 0.0 0.3 2.3 0.0 2.0 0.0 2.7 0.0 0.0 0.0 10.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 67.1 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.5 14.1 0.0 0.0 0.3 DLX5 ENSG00000105880 "Distal-less homeobox 5" P56178 7 97020392-97024950 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Osteogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 17.7;placenta: 44.5;skin 1: 20.6" "Cell type enhanced" "Detected in some" 19 "Cytotrophoblasts: 128.5;Extravillous trophoblasts: 203.8;Sertoli cells: 58.2;Syncytiotrophoblasts: 263.3" "Cancer enriched" "Detected in many" 11 "endometrial cancer: 81.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 32.9;HAP1: 16.5;SuSa: 8.6" "Group enriched" "Detected in many" 4 "basal ganglia: 13.5;olfactory region: 36.5" "Region enhanced" "Detected in many" "olfactory region: 24.3" HPA005670 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA005670: AB_1078681" "unprognostic (3.99e-1)" "unprognostic (1.05e-1)" "unprognostic (2.96e-2)" "unprognostic (1.31e-3)" "unprognostic (1.76e-1)" "unprognostic (2.86e-2)" "unprognostic (6.14e-2)" "unprognostic (2.46e-2)" "unprognostic (5.89e-2)" "unprognostic (6.20e-2)" "unprognostic (1.52e-1)" "unprognostic (1.01e-2)" "unprognostic (7.43e-8)" "unprognostic (1.39e-2)" "unprognostic (3.73e-1)" "unprognostic (1.16e-1)" "unprognostic (2.55e-1)" 1.5 0.6 2.7 0.5 11.5 0.3 1.5 0.1 3.9 10.0 0.6 0.3 1.4 0.7 17.7 1.7 5.8 2.0 0.8 1.2 2.2 4.5 0.4 0.2 0.4 1.9 0.5 2.5 2.1 0.2 0.4 1.9 44.5 0.0 1.8 0.3 0.1 3.6 3.9 0.6 20.6 0.3 1.4 0.2 0.3 0.3 1.2 3.1 2.5 1.6 6.5 2.7 1.5 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 3.7 16.5 0.0 0.0 0.0 2.8 0.0 0.3 0.2 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 2.1 0.9 1.3 0.1 0.0 0.0 8.6 0.0 0.0 0.0 1.0 0.2 0.2 0.0 0.0 0.0 0.0 2.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 11.5 0.1 3.9 2.2 4.5 0.5 2.5 0.0 3.1 0.0 0.0 0.0 0.7 8.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 128.5 0.0 0.0 0.1 0.5 0.0 0.0 0.0 203.8 2.2 1.1 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 58.2 7.1 1.8 6.0 18.1 263.3 0.0 0.0 1.4 DLX6 ENSG00000006377 "Distal-less homeobox 6" P56179 7 97005548-97011039 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 23.2;placenta: 11.3;testis: 10.4" "Cell type enhanced" "Detected in some" 20 "Cytotrophoblasts: 24.7;Extravillous trophoblasts: 48.9;Sertoli cells: 12.9;Syncytiotrophoblasts: 14.5" "Cancer enriched" "Detected in many" 8 "endometrial cancer: 12.5" "Region enhanced" "Detected in many" "basal ganglia: 23.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 7.3;BEWO: 24.3;HAP1: 10.9;SH-SY5Y: 8.0;SuSa: 14.7" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "olfactory region: 44.2" "HPA030608, HPA061460" Uncertain Approved "Nuclear bodies" NA NA "Nuclear bodies" "HPA030608: AB_10600867, HPA061460: AB_2684529" "unprognostic (7.50e-2)" "unprognostic (1.91e-1)" "unprognostic (5.19e-2)" "unprognostic (8.06e-2)" "unprognostic (8.16e-2)" "unprognostic (3.05e-1)" "unprognostic (4.32e-2)" "unprognostic (2.51e-1)" "unprognostic (2.86e-1)" "unprognostic (6.56e-2)" "unprognostic (8.09e-2)" "unprognostic (1.12e-7)" "unprognostic (5.60e-2)" "unprognostic (1.99e-1)" "unprognostic (5.58e-2)" "unprognostic (8.12e-2)" 0.9 0.4 1.8 0.3 23.2 0.9 0.4 0.3 6.1 5.7 0.6 0.5 0.0 0.4 7.0 2.4 0.3 1.5 0.3 0.5 3.9 2.6 0.4 0.3 0.3 1.0 0.5 2.8 0.9 0.3 0.4 0.4 11.3 0.0 0.7 0.3 0.0 1.7 2.5 0.5 1.6 0.3 0.9 0.3 0.5 0.4 10.4 4.2 0.1 0.7 0.0 0.8 0.9 0.6 0.4 0.6 1.5 0.7 0.5 0.7 0.3 0.0 0.0 0.0 7.3 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.4 0.0 0.0 1.3 10.9 0.0 0.0 0.0 2.8 0.0 4.1 4.9 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 1.8 1.1 0.0 0.0 0.0 0.0 1.5 5.3 8.0 0.7 0.0 0.2 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.8 0.6 1.1 0.5 0.6 0.2 0.3 0.5 0.4 0.4 0.3 0.3 0.4 0.7 0.6 1.5 0.5 0.7 0.6 0.5 0.3 1.8 23.2 0.3 6.1 3.9 2.6 0.5 2.8 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.0 9.5 0.0 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 12.9 0.0 1.7 7.1 0.0 14.5 0.0 0.0 0.1 DPEP2NB ENSG00000263201 "DPEP2 neighbor" 16 68013436-68015911 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 3.6;placenta: 2.8;testis: 5.7" "Cell type enriched" "Detected in some" 46 "Syncytiotrophoblasts: 54.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 29 "eosinophil: 3.6;neutrophil: 2.1" "Lineage enriched" "Detected in single" 37 "granulocytes: 3.6" "Cell line enhanced" "Detected in some" "JURKAT: 1.7;SuSa: 1.4;U-2197: 1.5" "Not detected" "Not detected" NA NA "unprognostic (1.91e-1)" "unprognostic (3.22e-2)" 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.9 0.0 0.0 0.0 DPPA2 "CT100, PESCRG1" ENSG00000163530 "Developmental pluripotency associated 2" Q7Z7J5 3 109293788-109316517 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 4.9;testis: 9.0" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 2.7;Extravillous trophoblasts: 9.2" "Cancer enriched" "Detected in some" 41 "testis cancer: 35.8" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.2" "Group enriched" "Detected in some" 5 "BEWO: 7.6;EFO-21: 14.5;SuSa: 8.7" HPA036134 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA036134: AB_10601547" "unprognostic (2.23e-1)" "unprognostic (2.79e-1)" "unprognostic (1.81e-2)" "unprognostic (3.50e-2)" 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.1 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 14.5 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.2 0.0 8.7 0.5 0.1 0.1 0.1 2.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 DPRX ENSG00000204595 "Divergent-paired related homeobox" A6NFQ7 19 53632056-53637009 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "placenta: 4.9;skeletal muscle: 4.2" "Cell type enriched" "Detected in some" 4 "Syncytiotrophoblasts: 4.7" "Cancer enriched" "Detected in single" 20 "thyroid cancer: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.5;SuSa: 3.3" HPA043682 Uncertain NA NA "HPA043682: AB_10963073" "unprognostic (2.47e-1)" "unprognostic (1.89e-1)" 2.0 0.0 0.1 0.0 0.1 0.0 1.3 0.1 0.0 0.2 0.1 0.0 0.1 1.8 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.1 1.6 0.0 0.1 0.0 0.0 0.0 0.0 4.9 0.7 0.0 0.0 0.1 4.2 0.5 0.0 0.1 0.1 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.7 0.0 0.0 0.0 DUSP9 "MKP-4, MKP4" ENSG00000130829 "Dual specificity phosphatase 9" Q99956 X 153642492-153651326 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "kidney: 23.0;placenta: 63.1" "Group enriched" "Detected in some" 14 "Cytotrophoblasts: 876.9;Distal tubular cells: 616.8;Syncytiotrophoblasts: 1451.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "Hep G2: 90.8" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 6 "amygdala: 4.4;basal ganglia: 2.7;cerebral cortex: 3.5;hippocampal formation: 3.7;hypothalamus: 3.6" HPA003336 Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA003336: AB_1078709" "unprognostic (4.64e-2)" "unprognostic (6.48e-2)" "unprognostic (4.87e-2)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.52e-2)" "unprognostic (2.74e-3)" "unprognostic (9.36e-3)" "unprognostic (6.15e-2)" "unprognostic (2.81e-1)" "unprognostic (3.03e-1)" "unprognostic (1.29e-2)" "unprognostic (1.38e-2)" "unprognostic (2.68e-7)" "unprognostic (4.49e-2)" "unprognostic (2.08e-1)" "unprognostic (2.77e-2)" "unprognostic (5.52e-2)" 0.2 0.1 3.2 0.2 4.4 0.1 0.3 0.2 2.0 0.2 0.1 0.7 0.0 0.2 0.1 0.3 0.3 0.2 0.1 0.2 2.5 0.6 23.0 0.7 0.2 0.2 1.1 0.6 1.9 0.5 0.1 0.0 63.1 0.9 0.2 0.1 0.0 0.8 1.5 0.1 0.2 0.2 0.1 0.5 0.2 0.2 1.1 0.8 0.0 0.1 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 8.2 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.6 0.5 0.0 4.0 0.0 0.3 1.8 10.1 0.2 0.0 0.2 1.8 0.0 0.7 90.8 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.2 0.2 0.4 3.7 0.0 0.0 0.0 0.0 2.3 0.1 0.3 0.6 0.7 0.3 0.2 0.1 0.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 4.4 0.2 2.0 2.5 0.6 1.1 0.6 0.9 0.8 0.0 0.0 0.0 0.6 0.6 0.0 1.8 0.0 0.0 0.0 10.4 0.0 876.9 616.8 0.1 0.0 0.0 0.0 0.0 0.0 57.4 0.2 0.3 0.0 0.8 72.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.1 0.0 0.0 0.0 0.7 8.3 0.0 1451.1 0.0 0.0 0.9 DYSF "FER1L1, LGMD2B" ENSG00000135636 Dysferlin O75923 2 71453722-71686768 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 39.9;skeletal muscle: 53.3" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 20.1;Endothelial cells: 22.1;Ito cells: 34.4;Kupffer cells: 20.6;Syncytiotrophoblasts: 55.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "neutrophil: 19.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 19.9" "Group enriched" "Detected in some" 5 "hTERT-RPE1: 12.8;HUVEC TERT2: 32.9;LHCN-M2: 29.9;RH-30: 31.6;TIME: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002510, HPA017071, HPA021945" Enhanced Supported "Plasma membrane,Centriolar satellite" Yes No "Plasma membrane, Centriolar satellite" "CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928" "unprognostic (1.04e-1)" "unprognostic (7.66e-3)" "unprognostic (5.43e-3)" "unprognostic (1.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.42e-1)" "unprognostic (4.43e-2)" "unprognostic (1.14e-1)" "unprognostic (2.70e-1)" "unprognostic (3.21e-1)" "unprognostic (2.93e-1)" "unprognostic (6.43e-2)" "unprognostic (4.88e-3)" "unprognostic (1.22e-2)" "unprognostic (3.18e-2)" "unprognostic (1.36e-1)" "unprognostic (5.97e-3)" 6.6 2.1 1.1 7.2 1.3 18.6 7.9 1.2 2.0 1.9 6.4 0.0 3.9 1.6 4.2 4.9 5.1 3.6 3.3 20.8 1.2 2.0 4.7 13.4 9.1 17.8 2.1 0.7 4.1 1.4 2.0 2.1 39.9 7.0 4.8 1.9 3.3 1.9 3.6 53.3 1.7 3.3 12.1 1.4 26.5 3.2 1.5 0.3 0.8 4.9 8.3 1.0 8.7 11.9 0.0 0.0 19.9 2.6 0.3 0.3 0.7 0.4 0.0 1.3 1.1 0.0 0.0 2.4 0.0 0.3 0.9 0.6 0.1 0.3 0.0 4.9 0.0 1.3 1.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.9 4.2 12.8 32.9 0.0 3.1 0.0 29.9 0.0 0.0 2.2 3.2 0.0 0.3 0.0 31.6 0.0 1.0 0.0 0.0 0.0 1.5 0.2 0.0 3.3 0.1 0.3 21.5 0.1 1.5 0.1 0.4 0.0 0.0 0.0 0.0 5.2 0.0 0.0 2.6 0.0 0.3 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 19.9 0.3 0.1 0.0 0.0 0.7 1.1 1.3 1.2 2.0 1.2 2.0 2.1 0.7 7.0 0.3 3.0 13.8 0.5 0.0 2.2 0.8 20.1 0.0 1.4 2.3 0.0 0.0 5.4 0.0 0.4 4.4 22.1 0.0 0.0 0.2 2.8 1.4 0.2 2.3 9.9 11.0 0.0 0.0 34.4 20.6 4.1 0.6 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.7 0.1 6.5 3.1 0.5 0.0 1.4 55.4 0.9 0.0 0.0 EBI3 "IL27B, IL35B" ENSG00000105246 "Epstein-Barr virus induced 3" Q14213 19 4229498-4237531 "Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "placenta: 411.9" "Group enriched" "Detected in some" 7 "Extravillous trophoblasts: 389.3;monocytes: 881.9;Syncytiotrophoblasts: 281.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory B-cell: 15.5;naive B-cell: 8.5" "Group enriched" "Detected in many" 15 "B-cells: 15.5;monocytes: 4.5" "Cell line enriched" "Detected in some" 13 "HDLM-2: 68.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046635 Enhanced "Secreted to blood" NA NA 1200000 "HPA046635: AB_2679729" "unprognostic (7.26e-2)" "unprognostic (1.49e-2)" "unprognostic (9.44e-2)" "unprognostic (1.31e-1)" "unprognostic (2.59e-1)" "unprognostic (2.24e-2)" "unprognostic (1.02e-1)" "unprognostic (2.10e-2)" "unprognostic (7.78e-2)" "unprognostic (4.87e-2)" "unprognostic (4.25e-3)" "unprognostic (8.27e-2)" "prognostic unfavorable (1.04e-8)" "unprognostic (1.97e-1)" "unprognostic (2.78e-2)" "unprognostic (9.29e-2)" "unprognostic (4.67e-2)" 2.1 2.5 1.9 5.7 1.5 0.4 1.4 0.3 1.0 0.8 1.3 1.1 0.3 1.7 0.6 0.8 0.5 1.7 2.3 0.7 1.7 1.4 2.1 1.9 1.8 18.5 2.5 0.7 0.6 1.0 0.1 1.1 411.9 1.1 1.0 0.7 0.7 1.1 0.6 0.4 0.2 5.1 0.8 3.8 24.6 1.5 0.9 1.3 4.9 0.5 0.3 2.9 2.0 0.5 15.5 0.6 0.1 4.5 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.2 1.3 0.1 0.0 0.4 0.3 1.3 5.4 0.0 0.6 0.0 0.0 0.0 0.0 68.8 0.0 0.0 0.0 0.0 0.1 0.0 2.6 0.1 0.0 0.7 0.2 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.3 0.1 1.7 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 3.7 0.0 15.5 0.0 0.0 0.6 8.5 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.4 1.9 1.5 0.3 1.0 1.7 1.4 2.5 0.7 1.1 1.3 0.0 0.3 0.9 0.0 0.3 0.0 0.1 2.5 0.0 1.2 0.0 0.0 2.4 0.0 2.3 0.0 0.3 0.0 0.0 0.8 389.3 0.0 0.1 11.5 0.0 9.0 0.0 0.0 1.3 69.8 0.0 0.0 8.1 0.0 881.9 0.0 0.0 0.8 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 281.4 0.0 0.0 0.0 EDNRB "ETB, HSCR, HSCR2" ENSG00000136160 "Endothelin receptor type B" P24530 13 77895481-77975529 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Albinism, Deafness, Disease mutation, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 67.5" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 97.7;Ito cells: 106.8;Melanocytes: 104.6;Muller glia cells: 142.7;Sertoli cells: 213.4;Smooth muscle cells: 110.2" "Group enriched" "Detected in all" 7 "glioma: 41.1;melanoma: 127.7;renal cancer: 28.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "classical monocyte: 2.0;intermediate monocyte: 2.1" "Lineage enriched" "Detected in single" 21 "monocytes: 2.1" "Cell line enhanced" "Detected in some" "AF22: 25.2;ASC diff: 19.2;SK-MEL-30: 23.1;U-266/70: 15.1;WM-115: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017842, HPA027546" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "CAB017842: , HPA027546: AB_2672327" "unprognostic (7.75e-2)" "unprognostic (6.73e-2)" "unprognostic (1.41e-3)" "unprognostic (2.59e-2)" "unprognostic (8.37e-2)" "unprognostic (2.45e-3)" "unprognostic (4.17e-3)" "unprognostic (5.43e-2)" "unprognostic (1.02e-1)" "unprognostic (1.38e-2)" "unprognostic (3.40e-2)" "unprognostic (3.01e-2)" "prognostic favorable (7.20e-5)" "unprognostic (1.59e-2)" "unprognostic (3.86e-2)" "unprognostic (4.58e-2)" "unprognostic (6.77e-3)" 25.4 23.2 22.2 10.3 29.8 0.8 23.1 10.3 30.7 8.1 7.2 13.6 2.3 10.9 7.7 3.6 4.9 6.0 8.5 23.7 16.7 16.4 22.3 26.5 28.4 15.6 24.2 8.1 4.9 6.4 7.7 6.3 67.5 33.2 14.9 7.7 51.0 13.4 4.4 6.7 5.1 11.9 7.4 33.4 16.0 5.8 3.1 12.4 0.0 17.6 2.0 2.9 10.9 8.2 0.0 0.0 0.0 2.1 0.0 0.0 0.4 2.0 0.0 25.2 0.0 19.2 0.7 0.3 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 1.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 23.1 3.4 0.0 0.1 0.1 0.2 0.0 0.0 0.1 15.1 8.5 0.0 0.4 0.0 48.1 0.0 2.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22.2 29.8 10.3 11.9 16.7 16.4 24.2 8.1 33.2 12.4 11.9 38.2 0.0 1.0 13.2 3.2 7.3 0.0 2.7 4.5 0.0 5.9 14.3 0.0 0.0 2.4 97.7 0.0 0.0 0.0 10.2 27.8 2.5 5.8 0.5 10.9 0.0 0.0 106.8 21.3 1.8 73.9 9.2 104.6 0.0 0.0 142.7 0.1 0.0 2.5 0.0 3.4 213.4 110.2 0.3 1.4 6.4 4.8 0.0 0.0 1.4 EGFL6 MAEG ENSG00000198759 "EGF like domain multiple 6" Q8IUX8 X 13569605-13633575 "Predicted secreted proteins" "Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "placenta: 137.5" "Cell type enhanced" "Detected in some" 10 "Ciliated cells: 17.4;Cytotrophoblasts: 12.5;Fibroblasts: 9.4;Hofbauer cells: 14.8;Syncytiotrophoblasts: 22.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "BJ hTERT+: 9.6;NTERA-2: 3.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA001838 Enhanced "Secreted to extracellular matrix" NA NA "HPA001838: AB_2666457" "unprognostic (1.66e-1)" "unprognostic (1.32e-2)" "unprognostic (9.15e-3)" "unprognostic (3.76e-3)" "unprognostic (1.77e-2)" "prognostic favorable (9.73e-4)" "unprognostic (4.13e-3)" "unprognostic (1.37e-1)" "unprognostic (5.19e-3)" "prognostic favorable (4.95e-4)" "unprognostic (2.39e-3)" "unprognostic (1.81e-1)" "unprognostic (1.14e-9)" "unprognostic (7.10e-2)" "unprognostic (3.21e-2)" "unprognostic (1.70e-1)" "unprognostic (1.82e-3)" 16.1 0.1 0.3 0.2 0.2 0.1 2.3 0.0 0.2 0.4 4.1 0.0 0.1 0.2 0.5 0.4 3.3 0.6 1.5 0.6 0.1 0.7 0.2 0.1 18.6 0.2 0.1 0.1 0.2 0.3 0.1 1.7 137.5 0.9 0.6 0.2 27.1 0.2 0.1 0.1 0.4 0.2 2.0 0.6 0.2 0.4 0.2 0.0 0.0 0.2 0.2 0.4 4.1 1.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.4 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.1 0.7 0.1 0.1 0.9 0.0 0.0 1.3 0.0 1.3 0.9 4.9 0.3 0.0 17.4 6.8 0.0 0.0 12.5 0.0 0.0 0.3 0.3 0.0 0.0 0.0 8.1 9.4 0.1 0.0 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 7.3 0.0 0.2 0.4 22.1 0.0 0.0 3.8 EGFL7 ZNEU1 ENSG00000172889 "EGF like domain multiple 7" Q9UHF1 9 136658856-136672678 "Predicted secreted proteins" "Angiogenesis, Cell adhesion, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 112.4" "Group enriched" "Detected in many" 7 "Endothelial cells: 251.2;Hofbauer cells: 218.0;Ito cells: 521.1;Spermatogonia: 179.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 2.6;eosinophil: 4.2;intermediate monocyte: 7.7;non-classical monocyte: 6.2;plasmacytoid DC: 7.1" "Group enriched" "Detected in many" 20 "dendritic cells: 7.1;granulocytes: 4.2;monocytes: 7.7" "Cell line enhanced" "Detected in many" "EFO-21: 39.9;HUVEC TERT2: 70.6;RPMI-8226: 27.7;TIME: 65.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050716 Approved "Secreted to extracellular matrix" NA NA "HPA050716: AB_2732562" "unprognostic (1.72e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (4.22e-6)" "unprognostic (1.55e-2)" "unprognostic (2.70e-2)" "unprognostic (9.76e-3)" "unprognostic (5.03e-1)" "unprognostic (1.03e-1)" "unprognostic (4.31e-3)" "unprognostic (4.39e-2)" "unprognostic (1.14e-3)" "unprognostic (6.35e-2)" "prognostic unfavorable (5.28e-4)" "unprognostic (5.69e-2)" "unprognostic (1.74e-1)" "unprognostic (4.09e-2)" "unprognostic (4.49e-2)" 54.8 11.2 17.7 9.0 23.7 8.7 34.2 8.5 23.6 19.7 10.3 7.2 17.4 9.3 28.9 19.7 9.5 14.6 17.5 31.0 18.0 12.7 24.3 10.6 46.9 12.0 21.5 8.1 7.5 9.7 5.7 10.5 112.4 27.5 13.7 3.5 19.9 21.3 16.1 29.3 14.1 9.9 10.9 10.4 41.1 7.4 11.4 17.6 0.2 20.7 16.2 4.9 10.7 55.3 0.1 7.1 4.2 7.7 0.2 0.3 3.4 0.0 9.6 3.1 11.2 0.2 0.2 7.2 2.7 0.5 1.6 0.5 3.3 9.0 0.0 39.9 0.9 2.5 1.3 0.8 1.7 0.0 15.9 3.0 5.9 0.7 0.2 2.5 0.0 8.7 0.3 0.7 0.8 0.0 0.5 70.6 0.4 21.3 0.0 0.5 17.2 0.1 0.1 4.5 13.3 0.5 18.9 1.2 27.7 1.0 0.2 2.0 6.7 1.3 1.2 2.5 0.9 3.3 9.1 65.9 0.4 8.2 0.9 0.5 0.0 0.0 0.1 0.0 0.0 8.1 0.0 2.6 4.2 0.1 7.7 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.3 1.1 0.2 6.2 7.1 0.0 3.4 17.7 23.7 8.5 23.6 18.0 12.7 21.5 8.1 27.5 17.6 0.0 40.6 8.9 4.8 10.5 1.1 15.4 5.1 0.0 2.3 3.5 0.0 2.9 6.6 21.4 2.1 251.2 1.7 0.0 1.6 13.3 17.6 15.2 19.7 15.3 218.0 3.2 1.2 521.1 30.4 6.8 8.1 8.2 18.6 0.0 2.8 1.3 8.5 1.1 5.6 16.8 1.6 12.9 13.3 3.6 179.3 8.3 5.0 2.5 0.0 3.1 EGFR "ERBB, ERBB1" ENSG00000146648 "Epidermal growth factor receptor" P00533 7 55019021-55211628 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Host-virus interaction" "Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 102.3" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 207.2;Syncytiotrophoblasts: 315.1" "Cancer enhanced" "Detected in all" "glioma: 136.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 12 "A-431: 345.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000035, HPA001200, HPA018530, CAB068186, CAB073534" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Secreted to blood" NA NA 4740000 93000000 "Plasma membrane, Cell Junctions" "CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044" "unprognostic (2.62e-2)" "unprognostic (9.56e-3)" "unprognostic (1.59e-1)" "unprognostic (7.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (6.11e-2)" "unprognostic (4.88e-2)" "unprognostic (2.85e-2)" "unprognostic (3.30e-3)" "unprognostic (1.78e-3)" "unprognostic (1.04e-1)" "unprognostic (1.93e-3)" "unprognostic (6.98e-3)" "unprognostic (1.72e-1)" "unprognostic (6.62e-2)" "prognostic unfavorable (2.04e-5)" 16.2 8.4 4.9 7.5 6.8 0.1 39.8 5.1 8.5 13.8 7.8 3.3 10.7 3.6 8.2 11.7 15.6 8.8 8.5 4.8 6.8 2.7 7.6 23.5 14.2 2.3 4.1 3.9 10.4 10.1 1.8 2.1 102.3 5.6 10.9 6.7 9.2 15.4 12.9 10.7 32.5 6.3 15.5 3.5 3.3 7.8 5.5 5.9 3.2 12.8 15.5 8.0 10.2 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 345.9 4.4 1.1 1.5 7.1 4.4 1.2 3.4 4.6 2.1 1.6 0.8 3.7 0.2 0.8 2.9 9.0 13.9 0.0 15.3 2.5 0.1 0.2 0.0 1.9 0.2 1.8 0.0 0.0 2.1 14.0 5.3 28.6 3.1 0.2 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.3 1.3 2.2 0.0 0.6 0.0 2.6 3.7 0.0 1.3 2.9 3.5 0.7 1.2 0.3 0.8 1.0 1.9 0.5 14.9 3.2 0.0 0.3 0.2 2.6 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 6.8 5.1 6.6 6.8 2.7 4.1 3.9 5.6 5.9 89.3 37.5 4.2 67.7 76.2 1.5 7.3 53.5 16.0 59.1 21.0 5.9 207.2 0.0 30.6 4.6 10.9 15.9 23.3 21.0 36.6 45.3 37.8 0.0 77.4 24.2 0.0 4.1 6.7 7.0 2.2 118.8 1.3 16.9 2.8 25.3 106.1 41.7 17.3 125.5 14.0 2.3 77.6 23.1 1.6 2.7 78.5 315.1 0.0 20.0 46.4 ELOVL2 Ssc2 ENSG00000197977 "ELOVL fatty acid elongase 2" Q9NXB9 6 10980759-11044314 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.6;liver: 43.1;parathyroid gland: 19.9;placenta: 28.4" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 27.5;Extravillous trophoblasts: 17.8;Hepatocytes: 13.2;Sertoli cells: 19.4" "Group enriched" "Detected in many" 8 "breast cancer: 11.9;glioma: 25.8;liver cancer: 24.0;melanoma: 14.2;prostate cancer: 9.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+ RasG12V: 17.0;GAMG: 17.5;HBF TERT88: 16.4;Hep G2: 12.5;RH-30: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "prognostic favorable (6.73e-5)" "unprognostic (4.20e-1)" "unprognostic (1.64e-1)" "unprognostic (1.28e-5)" "unprognostic (4.06e-2)" "unprognostic (4.09e-3)" "unprognostic (1.89e-1)" "unprognostic (5.73e-2)" "unprognostic (1.63e-1)" "unprognostic (2.56e-1)" "unprognostic (6.92e-3)" "unprognostic (1.78e-2)" "unprognostic (1.04e-12)" "unprognostic (9.98e-4)" "unprognostic (8.86e-2)" "unprognostic (3.41e-1)" "unprognostic (9.47e-2)" 1.4 1.3 10.7 1.7 11.5 0.6 4.7 5.8 12.2 0.6 0.6 8.8 0.0 0.7 0.9 2.5 0.8 0.6 1.1 3.1 6.4 4.8 0.7 43.1 0.7 0.9 7.1 7.1 0.7 2.6 19.9 2.8 28.4 8.0 5.0 0.6 5.9 1.1 0.9 1.3 0.7 0.8 1.1 18.6 0.5 0.6 9.3 4.0 0.0 2.0 0.0 1.3 1.6 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 11.2 0.0 0.0 0.0 6.4 0.2 0.5 9.9 17.0 0.0 0.0 0.0 0.0 0.6 17.5 0.0 11.7 0.0 16.4 0.0 10.1 0.1 0.2 12.5 0.5 0.2 2.7 0.1 0.0 7.6 0.0 0.6 0.0 0.5 0.6 0.0 0.2 0.0 6.4 0.1 2.1 0.0 9.6 8.9 17.8 0.0 0.0 0.1 4.5 5.1 0.0 0.0 4.1 9.5 2.0 5.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 10.7 11.5 5.8 10.9 6.4 4.8 7.1 7.1 8.0 4.0 0.0 0.0 0.0 0.0 0.1 1.8 0.6 5.1 0.0 0.0 0.0 27.5 1.6 0.0 4.8 8.6 0.7 0.0 0.0 0.8 17.8 7.2 2.1 0.0 13.2 1.1 0.0 0.0 0.0 0.0 12.4 0.9 0.0 0.0 0.0 0.0 3.9 1.1 0.0 0.4 0.0 10.2 19.4 0.3 12.1 7.9 0.0 1.4 0.0 0.0 0.0 ENDOU "P11, PP11, PRSS26" ENSG00000111405 "Endonuclease, poly(U) specific" P21128 12 47709734-47725567 "Predicted secreted proteins" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 42.1;placenta: 86.0;tongue: 28.8" "Group enriched" "Detected in some" 6 "Suprabasal keratinocytes: 8.0;Syncytiotrophoblasts: 28.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.1" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 3.9;SK-BR-3: 8.7;SuSa: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA012388, HPA067448" Enhanced "Secreted in other tissues" NA NA "HPA012388: AB_1854860, HPA067448: AB_2685843" "unprognostic (2.61e-2)" "unprognostic (4.92e-1)" "unprognostic (2.44e-2)" "unprognostic (1.25e-2)" "unprognostic (1.09e-1)" "prognostic favorable (6.29e-4)" "unprognostic (6.50e-2)" "unprognostic (5.49e-2)" "unprognostic (2.07e-2)" "unprognostic (1.55e-1)" "unprognostic (3.99e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-1)" "unprognostic (1.34e-1)" "unprognostic (1.20e-1)" "unprognostic (1.58e-1)" "unprognostic (1.04e-1)" 0.6 0.1 1.3 0.2 1.4 0.2 1.2 0.2 1.1 7.5 0.2 0.2 0.2 0.1 0.3 0.8 42.1 0.6 0.4 0.4 0.7 0.1 0.2 0.2 0.2 0.2 0.4 0.3 0.9 0.2 0.1 0.2 86.0 0.5 0.2 0.1 0.2 9.3 0.2 0.2 13.5 0.2 0.4 0.3 0.2 0.1 0.2 0.2 0.5 0.4 28.8 21.6 0.2 10.9 0.2 0.2 0.8 0.2 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.5 2.1 1.4 0.3 1.7 1.4 1.2 0.2 0.1 3.9 0.9 0.1 0.0 0.2 0.0 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.0 0.1 0.0 0.0 0.2 1.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 8.7 0.1 8.7 0.2 0.0 0.2 0.4 0.1 1.1 0.2 2.2 2.1 0.8 0.2 0.4 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.2 1.3 1.4 0.2 0.7 0.7 0.1 0.4 0.3 0.5 0.2 0.0 0.0 0.0 0.2 1.4 0.0 1.4 0.0 0.0 1.2 0.0 0.0 0.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.6 0.2 0.0 0.0 0.3 0.0 0.0 2.5 0.0 0.0 1.4 0.0 3.3 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.7 0.0 0.0 0.0 0.0 8.0 28.7 0.0 0.0 0.1 ENPP2 "ATX, PD-IALPHA, PDNP2" ENSG00000136960 "Ectonucleotide pyrophosphatase/phosphodiesterase 2" Q13822 8 119557086-119673453 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Lipid degradation, Lipid metabolism" Hydrolase "Cancer-related genes, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 103.7;placenta: 79.0" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 38.2;Fibroblasts: 51.0;Hofbauer cells: 50.0;Intestinal endocrine cells: 51.9;Melanocytes: 43.9;Proximal tubular cells: 45.6" "Cancer enhanced" "Detected in all" "renal cancer: 46.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 26.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 26.8" "Cell line enhanced" "Detected in some" "AF22: 25.2;ASC diff: 34.5;ASC TERT1: 73.7;BJ hTERT+: 42.4;fHDF/TERT166: 27.3;HSkMC: 33.8;U-2197: 24.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023700, HPA053652" Approved Approved "Nucleoplasm,Golgi apparatus,Actin filaments" "Intracellular and membrane" NA NA 1100000000 "Nucleoplasm, Golgi apparatus" "Actin filaments" "HPA023700: AB_1848170, HPA053652: AB_2682218" "unprognostic (1.17e-2)" "unprognostic (6.29e-2)" "unprognostic (3.63e-2)" "unprognostic (3.93e-2)" "unprognostic (1.23e-1)" "unprognostic (1.37e-1)" "unprognostic (9.70e-3)" "unprognostic (7.14e-2)" "unprognostic (1.29e-1)" "unprognostic (1.26e-1)" "prognostic favorable (2.07e-5)" "unprognostic (5.54e-2)" "unprognostic (3.14e-1)" "unprognostic (2.37e-1)" "unprognostic (5.18e-2)" "unprognostic (2.37e-2)" "unprognostic (1.50e-1)" 29.9 15.4 24.0 18.2 42.0 0.7 26.2 4.4 33.3 19.6 8.1 103.7 1.7 20.8 44.8 6.4 2.9 18.7 12.7 3.6 39.8 21.5 24.9 8.9 13.5 31.0 71.5 20.9 5.3 5.2 0.9 4.1 79.0 59.7 8.5 10.6 67.6 3.4 9.2 3.0 5.4 12.1 28.9 102.4 17.3 8.3 9.7 63.9 3.6 3.7 0.8 26.1 13.4 5.7 0.2 3.8 26.8 0.1 0.2 1.8 0.3 0.0 0.0 25.2 0.0 34.5 73.7 0.0 23.2 42.4 10.0 9.6 0.0 0.0 0.0 0.3 27.3 0.0 0.0 0.5 0.0 7.1 1.8 0.7 0.0 0.0 0.6 15.4 0.0 0.1 33.8 0.2 20.4 1.0 0.1 0.1 0.0 0.0 4.1 0.5 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 20.3 0.4 24.4 0.1 0.2 0.0 0.0 17.1 0.1 0.5 26.8 0.1 5.2 0.0 0.0 0.0 0.2 0.2 0.0 0.5 0.0 1.8 0.6 0.3 0.2 0.0 3.8 0.0 0.3 24.0 42.0 4.4 33.3 39.8 21.5 71.5 20.9 59.7 63.9 11.9 5.1 3.2 0.5 9.4 1.1 1.2 38.2 6.7 1.2 1.8 0.0 3.4 1.7 0.0 34.3 16.3 0.9 0.0 0.0 1.5 51.0 0.1 5.8 0.4 50.0 0.0 51.9 19.0 12.5 3.6 2.8 8.9 43.9 0.0 0.6 3.3 1.2 0.3 3.2 45.6 1.2 0.0 5.1 1.1 0.4 4.5 5.4 0.5 0.6 0.9 EPB42 "MGC116735, MGC116737, PA" ENSG00000166947 "Erythrocyte membrane protein band 4.2" P16452 15 43197227-43221125 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape, Erythrocyte maturation" "Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 54.8;placenta: 16.1" "Cell type enriched" "Detected in many" 15 "Erythroid cells: 186.9" "Not detected" "Not detected" "Region enriched" "Detected in some" 4 "cerebellum: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 92 "HEL: 43.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040261 Supported Uncertain Nucleoplasm,Cytosol NA NA 7500000 "Nucleoplasm, Cytosol" "HPA040261: AB_10673441" "unprognostic (8.45e-2)" "unprognostic (4.66e-1)" "unprognostic (4.15e-1)" "unprognostic (1.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.99e-1)" "unprognostic (1.54e-1)" "unprognostic (1.59e-3)" "unprognostic (2.95e-1)" "unprognostic (6.05e-2)" "unprognostic (5.27e-3)" "unprognostic (1.31e-1)" "unprognostic (1.48e-5)" "unprognostic (1.70e-2)" "unprognostic (1.20e-1)" "unprognostic (5.88e-2)" "unprognostic (3.47e-3)" 7.5 0.4 0.4 0.4 0.9 54.8 1.3 4.3 1.0 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.4 0.5 0.6 1.9 0.4 0.9 0.5 0.9 5.5 0.3 0.5 0.3 0.8 0.3 0.3 0.3 16.1 0.7 0.5 0.3 0.3 0.3 0.3 1.3 1.1 1.0 0.3 0.3 5.3 0.5 2.4 0.3 0.5 1.2 0.3 0.5 1.6 4.5 0.0 0.3 0.2 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.3 0.0 4.2 0.4 0.9 4.3 1.0 0.4 0.9 0.5 0.3 0.7 0.3 0.0 0.0 0.5 1.2 1.6 3.7 0.3 2.5 0.0 0.0 0.0 5.9 3.3 0.0 0.0 7.7 0.6 1.1 186.9 0.0 1.9 1.7 1.0 4.6 0.5 1.0 6.4 0.0 1.3 0.3 8.0 2.6 0.8 1.7 0.0 0.8 2.8 0.0 1.7 0.7 0.0 7.8 6.5 1.2 12.1 3.8 2.5 5.6 4.4 0.6 1.6 EPS8L1 "DRC3, FLJ20258, MGC23164, MGC4642" ENSG00000131037 "EPS8 like 1" Q8TE68 19 55072020-55087923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.9;placenta: 45.0" "Group enriched" "Detected in many" 4 "Syncytiotrophoblasts: 357.9;Urothelial cells: 188.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 9.3;BEWO: 32.6;SK-BR-3: 10.0;T-47d: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041851, HPA043545" Uncertain Supported Cytosol NA NA Cytosol "HPA041851: AB_2677706, HPA043545: AB_2678544" "unprognostic (1.91e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (7.18e-2)" "unprognostic (9.33e-2)" "unprognostic (2.54e-2)" "unprognostic (4.61e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-1)" "unprognostic (9.43e-2)" "unprognostic (5.84e-3)" "unprognostic (2.65e-2)" "unprognostic (3.85e-3)" "unprognostic (5.04e-3)" "unprognostic (3.02e-1)" "unprognostic (5.41e-3)" "unprognostic (2.63e-1)" 1.2 0.0 0.2 2.1 0.3 0.0 1.7 0.3 0.4 7.6 2.1 0.2 1.5 2.0 1.3 1.8 40.9 6.2 6.9 0.2 0.2 0.0 4.1 0.2 1.8 0.2 0.2 0.2 1.6 4.0 1.1 1.1 45.0 0.3 2.9 0.5 0.3 6.6 2.5 0.4 18.7 1.5 0.7 0.2 0.4 23.2 0.9 0.2 1.0 6.2 12.1 16.9 1.9 12.1 0.1 3.5 5.1 0.4 1.7 0.8 0.5 9.3 0.4 0.3 0.2 0.0 0.0 32.6 0.9 0.0 0.0 0.0 2.9 7.7 0.1 1.9 0.0 0.0 4.7 0.2 0.5 0.0 0.2 0.9 0.7 0.3 0.2 0.1 1.5 6.5 0.0 1.5 0.0 0.0 0.0 0.0 0.7 3.5 0.0 0.0 4.3 0.5 1.5 0.5 4.8 0.0 0.1 0.0 3.1 0.7 0.7 0.1 2.3 0.6 10.0 0.4 0.3 15.8 1.8 0.7 0.0 0.4 0.0 0.0 1.4 1.7 0.9 2.0 0.5 1.2 2.6 0.4 5.1 0.8 0.1 0.7 0.0 0.4 0.8 0.0 0.1 0.1 0.0 0.0 1.7 0.0 3.5 0.7 0.5 0.2 0.3 0.3 0.4 0.2 0.0 0.2 0.2 0.3 0.2 8.9 6.7 0.9 18.5 1.8 0.0 2.0 5.1 5.3 11.4 29.6 0.0 28.7 11.6 18.5 1.3 3.8 22.2 0.0 9.1 18.2 2.6 37.2 10.3 0.0 7.9 0.0 2.9 8.0 1.2 3.6 1.1 2.6 20.3 8.2 28.9 0.2 62.1 35.1 0.7 0.8 0.0 25.8 14.1 0.6 2.6 3.4 357.9 2.5 9.9 188.1 EPYC "DSPG3, Pg-Lb, SLRR3B" ENSG00000083782 Epiphycan Q99645 12 90963679-91005026 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 27 "placenta: 67.1" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "ovarian cancer: 7.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "hTERT-RPE1: 8.2;U-266/70: 2.0" "Region enhanced" "Detected in single" "midbrain: 1.6" "Group enriched" "Detected in many" 5 "amygdala: 3.8;basal ganglia: 3.8;cerebral cortex: 6.2;hippocampal formation: 4.4" "HPA038212, HPA045455" Approved "Secreted to extracellular matrix" NA NA "HPA038212: AB_10672739, HPA045455: AB_2679330" "unprognostic (2.25e-1)" "unprognostic (2.08e-1)" "unprognostic (2.79e-1)" "unprognostic (4.28e-2)" "unprognostic (1.81e-2)" "unprognostic (4.07e-2)" "unprognostic (9.20e-2)" "unprognostic (3.23e-1)" "prognostic unfavorable (1.85e-4)" "unprognostic (2.77e-2)" "unprognostic (6.44e-9)" "unprognostic (2.83e-2)" "unprognostic (3.08e-1)" "unprognostic (8.68e-2)" "unprognostic (1.20e-1)" 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.8 0.4 0.1 0.2 0.4 0.5 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 2.5 0.0 0.0 0.0 67.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ERVFRD-1 "envFRD, ERVFRDE1, HERV-FRD, HERV-W/FRD, syncytin-2" ENSG00000244476 "Endogenous retrovirus group FRD member 1, envelope" P60508 6 11102489-11111732 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "placenta: 66.9" "Cell type enriched" "Detected in some" 52 "Syncytiotrophoblasts: 481.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 2.1" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 4 "SuSa: 30.4" NA NA "unprognostic (1.99e-1)" "unprognostic (3.29e-4)" "unprognostic (4.75e-2)" "unprognostic (1.80e-1)" "unprognostic (1.34e-1)" "unprognostic (2.19e-3)" "unprognostic (3.35e-1)" "unprognostic (6.44e-2)" "unprognostic (1.24e-1)" "unprognostic (1.99e-1)" "unprognostic (1.30e-2)" "unprognostic (2.78e-3)" "unprognostic (5.80e-4)" "unprognostic (3.40e-2)" "unprognostic (1.82e-1)" "unprognostic (1.95e-2)" "unprognostic (1.37e-2)" 1.4 2.0 0.1 0.1 0.1 0.1 0.8 0.2 0.2 0.5 0.8 0.1 0.1 0.3 1.3 0.8 0.7 0.2 0.5 0.5 0.1 0.0 1.5 0.7 1.5 1.0 0.1 0.1 0.1 0.1 15.8 0.1 66.9 0.1 1.2 0.2 0.7 0.9 0.5 0.1 0.9 1.9 0.8 0.1 0.1 1.0 0.3 0.1 0.6 0.2 0.9 0.3 1.5 2.2 0.5 0.0 0.3 0.1 2.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 30.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.7 0.4 0.3 2.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 2.6 0.0 0.0 0.0 0.9 0.4 0.0 0.0 1.2 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 9.3 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 481.3 0.0 0.0 0.0 ERVMER34-1 envMER34 ENSG00000226887 "Endogenous retrovirus group MER34 member 1, envelope" Q9H9K5 4 52722618-52751640 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "parathyroid gland: 32.0;placenta: 26.9" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 66.3;Extravillous trophoblasts: 80.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 28.2;hTCEpi: 20.3;RPTEC TERT1: 15.1" "HPA011423, HPA024053" Approved Approved Nucleoplasm,Cytosol "Secreted to blood" NA NA 5000000 Nucleoplasm Cytosol "HPA011423: AB_2668510, HPA024053: " "unprognostic (5.34e-2)" "unprognostic (1.29e-1)" "unprognostic (1.91e-3)" "unprognostic (5.86e-2)" "unprognostic (4.08e-4)" "prognostic unfavorable (3.55e-4)" "unprognostic (5.88e-4)" "unprognostic (5.28e-2)" "unprognostic (2.99e-2)" "unprognostic (2.39e-3)" "unprognostic (2.62e-3)" "unprognostic (4.23e-2)" "unprognostic (1.03e-2)" "unprognostic (1.32e-2)" "unprognostic (6.35e-2)" "unprognostic (1.62e-2)" "unprognostic (1.82e-1)" 0.3 1.3 1.2 0.4 0.7 0.2 2.8 0.5 3.0 1.3 0.5 0.0 1.4 0.5 0.9 1.3 3.7 0.7 0.4 6.2 0.8 1.0 4.4 0.3 1.8 1.9 0.6 0.2 3.9 1.7 32.0 0.2 26.9 0.8 0.7 0.7 0.8 1.3 3.0 0.2 1.0 0.5 0.4 1.5 1.9 1.1 1.7 0.3 0.0 2.5 3.7 1.2 1.0 1.8 0.6 0.4 1.2 0.1 0.4 0.3 0.0 4.5 0.2 0.9 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 28.2 6.0 0.0 0.6 0.1 0.4 0.3 0.0 2.0 0.0 0.0 0.2 0.0 0.0 0.2 0.4 0.0 0.0 1.3 20.3 0.0 3.0 0.0 0.0 0.0 1.6 0.0 0.1 0.3 0.0 0.0 1.9 1.8 0.8 0.0 0.0 0.0 15.1 0.4 1.2 0.3 1.9 0.8 0.0 3.0 2.5 0.4 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.1 0.5 0.3 0.1 0.2 0.3 0.3 0.2 0.1 0.6 0.3 0.2 1.1 0.4 0.1 0.4 0.2 0.0 1.2 0.7 0.5 3.0 0.8 1.0 0.6 0.2 0.8 0.3 0.0 0.0 0.0 1.1 0.5 0.0 2.4 0.0 0.0 0.0 7.0 0.0 66.3 0.0 2.3 3.2 0.1 0.0 0.0 0.7 80.6 1.3 1.2 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.5 2.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.3 0.2 0.4 0.1 14.5 0.0 0.4 1.1 ERVV-1 "ENVV1, FLJ32214, HERV-V1" ENSG00000269526 "Endogenous retrovirus group V member 1, envelope" B6SEH8 19 53013921-53016122 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "placenta: 19.7" "Cell type enriched" "Detected in some" 31 "Syncytiotrophoblasts: 218.2" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BEWO: 11.7;SuSa: 9.8" HPA076115 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA076115: " "unprognostic (1.04e-3)" "unprognostic (7.32e-3)" "unprognostic (2.97e-1)" "unprognostic (2.70e-2)" "unprognostic (1.67e-2)" "unprognostic (9.92e-2)" "unprognostic (6.75e-2)" "unprognostic (4.34e-5)" "unprognostic (3.48e-2)" "unprognostic (5.80e-2)" "unprognostic (3.18e-1)" "unprognostic (1.35e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.7 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 9.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 218.2 0.0 0.0 0.0 ERVV-2 ENVV2 ENSG00000268964 "Endogenous retrovirus group V member 2, envelope" B6SEH9 19 53044738-53051076 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 105 "placenta: 85.9" "Cell type enriched" "Detected in single" 5 "Syncytiotrophoblasts: 3.2" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 19.1;SuSa: 12.9;T-47d: 5.4" HPA076115 Approved Centrosome,Cytosol NA NA Cytosol Centrosome "HPA076115: " "unprognostic (3.14e-3)" "unprognostic (2.06e-1)" "unprognostic (1.31e-1)" "unprognostic (4.33e-9)" "unprognostic (3.01e-2)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" "unprognostic (2.60e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 85.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.9 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 ERVW-1 "envW, ERVWE1, HERV-7q, HERV-W, HERV-W-ENV, HERVW" ENSG00000242950 "Endogenous retrovirus group W member 1, envelope" Q9UQF0 7 92468380-92477986 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "placenta: 83.4" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 179.3;Syncytiotrophoblasts: 714.1" "Cancer enriched" "Detected in single" 143 "testis cancer: 31.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 2.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 34 "BEWO: 43.6;SuSa: 13.9" NA NA "unprognostic (2.85e-1)" "unprognostic (1.29e-1)" "unprognostic (2.23e-1)" "unprognostic (1.34e-2)" "unprognostic (1.79e-1)" "unprognostic (1.48e-4)" "unprognostic (4.80e-1)" "unprognostic (1.01e-1)" "unprognostic (3.11e-2)" "unprognostic (1.60e-1)" "unprognostic (1.62e-1)" "unprognostic (2.21e-1)" "unprognostic (1.76e-2)" "unprognostic (1.13e-1)" "unprognostic (2.33e-1)" "unprognostic (3.96e-2)" "unprognostic (8.02e-2)" 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.0 0.2 2.0 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 83.4 0.2 0.2 0.1 0.2 0.4 0.2 0.4 0.4 0.2 0.2 0.3 0.3 0.5 10.4 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.0 2.2 0.8 0.1 0.2 0.0 0.1 0.2 0.3 0.2 0.0 0.3 43.6 0.1 0.0 0.0 0.0 0.2 0.2 0.1 0.2 0.0 0.6 0.3 0.2 0.1 0.1 0.1 0.2 0.2 0.5 0.1 0.0 0.2 0.3 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.7 0.0 0.2 0.2 0.3 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.2 0.1 0.3 0.0 0.6 0.0 13.9 0.1 0.2 0.1 0.0 0.8 0.2 0.1 0.7 0.3 0.1 0.1 0.2 0.0 0.0 0.4 2.2 0.2 0.8 0.1 0.5 0.1 0.0 0.0 0.3 0.0 0.1 0.4 0.1 0.6 0.0 0.1 0.0 0.2 0.2 0.4 0.2 0.3 0.2 0.2 0.2 0.2 0.2 3.0 1.9 0.0 0.5 0.7 2.2 0.2 0.0 9.4 2.3 0.0 0.0 179.3 0.0 0.0 28.9 0.1 0.0 0.0 0.0 79.7 2.8 0.2 2.3 0.0 23.6 0.0 0.0 0.0 1.0 5.3 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 1.4 0.0 0.0 0.5 0.4 1.8 714.1 0.0 0.0 0.5 ESAM W117m ENSG00000149564 "Endothelial cell adhesion molecule" Q96AP7 11 124752583-124762290 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 93.0" "Cell type enhanced" "Detected in many" 12 "Endothelial cells: 198.2;Ito cells: 127.7;Sertoli cells: 148.8;Smooth muscle cells: 94.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.7;neutrophil: 5.5" "Group enriched" "Detected in many" 9 "B-cells: 6.7;granulocytes: 5.5;T-cells: 1.8" "Group enriched" "Detected in some" 10 "HEL: 53.4;HUVEC TERT2: 69.5;TIME: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051043, HPA056293" Uncertain Approved Microtubules NA NA 64000000 Microtubules "HPA051043: AB_2681323, HPA056293: AB_2683089" "unprognostic (1.52e-1)" "unprognostic (2.03e-1)" "unprognostic (1.05e-2)" "unprognostic (3.56e-1)" "unprognostic (1.41e-2)" "unprognostic (4.49e-3)" "unprognostic (2.61e-1)" "unprognostic (1.10e-1)" "unprognostic (9.05e-2)" "unprognostic (2.99e-2)" "unprognostic (3.08e-1)" "unprognostic (3.60e-1)" "unprognostic (1.54e-1)" "unprognostic (1.24e-2)" "unprognostic (5.10e-2)" "unprognostic (2.29e-1)" "unprognostic (5.06e-2)" 37.1 6.0 6.6 5.3 9.6 1.3 44.6 3.8 8.2 11.8 6.1 5.4 3.7 4.3 14.5 9.5 10.7 10.3 11.5 20.1 7.5 6.6 15.5 10.2 38.4 6.9 9.1 3.9 8.4 6.4 5.4 5.5 93.0 9.0 10.9 5.0 12.4 5.1 9.8 14.6 5.9 6.4 17.2 7.2 8.2 7.6 5.4 5.9 0.9 44.9 10.9 5.0 11.4 25.4 6.7 0.3 5.5 0.5 0.0 1.8 19.4 0.2 0.4 0.1 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 3.5 0.2 0.8 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.3 53.4 0.0 1.9 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 69.5 0.0 0.0 1.5 0.1 0.4 0.0 0.0 0.1 5.0 0.5 0.0 0.2 0.2 0.0 0.5 0.0 0.2 0.0 4.0 0.0 2.0 0.8 0.2 34.8 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 4.1 0.5 0.0 0.1 0.2 0.0 1.4 1.3 0.1 0.3 6.7 1.8 0.6 5.5 0.0 0.0 0.3 0.4 19.4 6.6 9.6 3.8 8.2 7.5 6.6 9.1 3.9 9.0 5.9 35.7 59.6 0.8 0.6 13.5 1.3 10.6 0.0 2.7 4.5 14.0 3.9 0.9 5.0 3.3 4.0 198.2 0.0 0.0 2.1 13.5 8.5 1.1 3.5 0.8 0.9 0.0 0.0 127.7 5.6 13.6 0.9 2.6 11.8 1.0 0.2 0.8 27.0 2.6 0.4 0.0 1.0 148.8 94.7 0.0 0.3 9.5 31.0 0.0 1.7 1.7 ESRRG NR3B3 ENSG00000196482 "Estrogen related receptor gamma" P62508 1 216503246-217137755 "FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 49.5;parathyroid gland: 37.2;placenta: 40.8" "Cell type enhanced" "Detected in many" 15 "Cone photoreceptor cells: 55.0;Syncytiotrophoblasts: 179.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "pons and medulla: 49.5" "Cell type enhanced" "Detected in single" "neutrophil: 1.5" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "RPMI-8226: 15.4;SH-SY5Y: 29.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044678 Uncertain Approved Nucleoplasm No NA Nucleoplasm "HPA044678: AB_10963215" "unprognostic (6.48e-2)" "unprognostic (1.11e-1)" "unprognostic (7.06e-2)" "unprognostic (7.32e-2)" "unprognostic (2.34e-1)" "unprognostic (5.48e-2)" "unprognostic (1.66e-1)" "unprognostic (1.13e-1)" "unprognostic (4.55e-2)" "unprognostic (2.88e-1)" "unprognostic (2.35e-1)" "unprognostic (1.79e-2)" "prognostic favorable (1.13e-11)" "unprognostic (3.04e-1)" "unprognostic (2.55e-1)" "unprognostic (3.65e-4)" "unprognostic (2.05e-1)" 0.5 5.1 2.8 0.4 3.3 0.2 2.9 6.9 10.3 1.4 0.7 0.7 2.2 4.0 0.5 1.5 1.4 2.1 0.8 8.3 3.2 2.6 22.0 0.8 0.7 0.4 6.8 1.7 0.8 4.4 37.2 9.9 40.8 49.5 2.6 0.4 10.7 11.0 2.4 6.3 1.5 3.7 0.9 2.6 1.0 22.2 1.0 1.5 0.0 4.6 7.2 0.4 1.0 0.7 0.4 0.2 1.5 0.0 0.2 0.1 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 15.4 2.4 1.7 5.5 29.5 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.4 0.1 0.1 1.5 0.2 0.0 0.2 0.0 0.0 2.8 3.3 6.9 10.3 3.2 2.6 6.8 1.7 49.5 1.5 0.0 2.6 0.0 3.3 0.2 26.3 45.0 7.6 18.7 1.2 22.7 55.0 29.1 46.4 3.1 4.5 0.3 0.0 0.0 2.1 3.1 1.5 8.3 0.0 0.8 3.8 46.1 7.9 0.6 0.8 4.6 0.3 0.0 8.5 0.0 0.7 12.3 0.6 0.2 0.7 23.0 34.7 0.0 1.0 1.4 0.1 0.3 179.8 0.0 0.2 1.4 EXPH5 SLAC2-B ENSG00000110723 "Exophilin 5" Q8NEV8 11 108505431-108593738 "Disease related genes, Predicted intracellular proteins" "Epidermolysis bullosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 74.9;placenta: 45.1;skin 1: 23.1" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 137.0;Basal keratinocytes: 95.7;Ciliated cells: 87.0;Club cells: 88.7" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 14 "cerebellum: 74.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 7.4;hTERT-HME1: 10.6;RT4: 18.5;SK-BR-3: 9.0" "Group enriched" "Detected in many" 4 "cerebellum: 23.5;cerebral cortex: 6.7" "Region enriched" "Detected in many" 10 "cerebellum: 64.1" NA NA "unprognostic (1.34e-3)" "unprognostic (8.36e-2)" "unprognostic (1.18e-1)" "prognostic favorable (3.42e-6)" "unprognostic (2.91e-1)" "prognostic favorable (1.46e-4)" "unprognostic (4.57e-3)" "prognostic favorable (5.12e-4)" "unprognostic (1.26e-1)" "unprognostic (3.03e-1)" "unprognostic (5.56e-3)" "unprognostic (1.33e-1)" "prognostic favorable (2.43e-4)" "unprognostic (1.18e-2)" "unprognostic (2.57e-1)" "unprognostic (3.36e-1)" "unprognostic (4.51e-1)" 0.7 0.6 0.8 1.2 2.7 0.1 2.6 74.9 1.1 3.3 3.3 1.4 0.0 0.5 0.9 2.5 9.8 1.5 0.3 0.7 1.1 0.8 3.4 6.7 4.7 0.0 1.6 1.0 0.8 1.4 9.3 2.2 45.1 5.4 1.6 3.8 0.7 6.2 0.1 0.6 23.1 1.1 0.6 2.6 0.6 2.8 1.7 2.4 0.6 1.9 7.1 5.2 1.7 1.9 0.7 0.9 3.0 0.6 3.2 2.2 0.5 3.5 0.4 0.2 0.1 0.0 0.0 3.0 0.2 0.1 0.0 0.6 0.9 5.5 0.0 0.2 0.2 0.8 7.4 5.2 1.9 0.2 0.1 1.6 1.5 0.7 0.0 0.5 0.7 0.1 0.1 3.1 0.0 10.6 0.5 0.0 1.2 2.6 0.0 2.9 0.6 0.9 0.0 0.2 5.8 2.2 0.0 0.1 0.0 0.6 18.5 1.3 0.8 0.9 9.0 0.2 1.1 6.0 0.1 0.1 0.0 2.2 0.0 1.0 0.1 0.0 0.0 0.1 0.3 0.0 2.0 0.6 0.5 0.7 0.3 0.3 0.7 1.1 0.4 0.5 0.7 2.1 2.2 3.0 3.2 0.4 0.9 0.3 0.5 0.8 2.7 74.9 1.1 1.1 0.8 1.6 1.0 5.4 2.4 137.0 48.9 0.0 11.5 95.7 0.5 3.3 5.1 87.0 88.7 19.2 13.7 31.0 3.3 4.4 6.2 2.9 12.0 0.0 4.2 3.9 6.1 19.8 1.1 21.3 3.5 0.0 4.7 1.3 0.6 1.6 0.6 3.3 5.0 1.8 33.3 0.5 3.9 11.5 0.0 3.7 1.6 0.0 1.6 1.1 0.2 63.1 45.7 1.8 19.9 16.0 F13A1 F13A ENSG00000124491 "Coagulation factor XIII A chain" P00488 6 6144085-6321013 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Acyltransferase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 110.1" "Cell type enriched" "Detected in many" 6 "Hofbauer cells: 646.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 27.6;myeloid DC: 33.7" "Group enriched" "Detected in many" 5 "dendritic cells: 33.7;monocytes: 27.6" "Cell line enhanced" "Detected in some" "AF22: 15.7;LHCN-M2: 5.8;RH-30: 29.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA001804, CAB002155" Enhanced "Secreted to blood" NA NA 1400000000 "CAB002155: AB_564077, HPA001804: AB_1078792" "unprognostic (4.44e-1)" "unprognostic (5.90e-2)" "unprognostic (2.65e-2)" "unprognostic (3.93e-2)" "unprognostic (5.02e-2)" "unprognostic (3.75e-2)" "unprognostic (5.27e-2)" "unprognostic (1.96e-1)" "unprognostic (2.68e-2)" "unprognostic (6.84e-3)" "unprognostic (4.96e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (6.61e-6)" "unprognostic (2.79e-2)" "unprognostic (1.52e-1)" "unprognostic (1.57e-1)" "unprognostic (2.54e-3)" 56.6 19.4 2.2 11.4 6.5 3.1 57.9 2.2 1.8 13.3 21.8 2.6 2.5 2.2 4.7 35.6 13.4 16.8 12.6 55.4 2.0 2.2 17.5 1.3 14.5 52.7 5.8 1.4 10.2 8.9 5.3 9.3 110.1 7.5 16.4 15.1 11.6 11.5 3.3 18.5 10.4 10.6 20.1 5.0 5.1 11.5 16.7 2.5 2.7 22.4 8.3 6.1 23.7 6.5 0.0 33.7 6.6 27.6 0.0 0.1 63.5 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 29.5 0.5 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.1 0.0 2.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.7 27.6 0.2 0.1 4.9 0.1 0.0 0.0 0.0 33.7 0.0 0.0 0.0 6.6 0.0 0.1 2.4 0.0 63.5 2.2 6.5 2.2 1.8 2.0 2.2 5.8 1.4 7.5 2.5 0.0 3.4 0.8 0.0 16.7 0.0 7.5 10.2 4.0 0.0 0.0 0.0 4.0 0.0 0.0 3.8 4.7 0.0 0.0 0.0 3.4 16.5 0.0 1.1 0.8 646.4 0.0 0.0 4.3 113.2 4.2 4.0 57.6 18.6 1.0 0.0 0.7 0.1 0.0 0.7 3.1 4.1 58.2 9.2 1.4 1.0 13.2 8.5 0.0 0.0 0.0 F5 ENSG00000198734 "Coagulation factor V" P12259 1 169514166-169586588 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.9;liver: 88.8;placenta: 32.2" "Cell type enhanced" "Detected in many" 22 "Cholangiocytes: 79.0;Cytotrophoblasts: 65.0;Hepatocytes: 221.3;Syncytiotrophoblasts: 49.8" "Cancer enriched" "Detected in many" 7 "liver cancer: 69.6" "Region enriched" "Detected in many" 11 "pons and medulla: 27.9" "Cell type enhanced" "Detected in some" "eosinophil: 8.7;neutrophil: 8.0" "Group enriched" "Detected in many" 13 "granulocytes: 8.7;monocytes: 4.2;T-cells: 7.0" "Group enriched" "Detected in some" 23 "Hep G2: 13.8;OE19: 52.9" "Group enriched" "Detected in many" 5 "basal ganglia: 2.8;hippocampal formation: 7.4;pons and medulla: 4.6;thalamus: 5.8" "Group enriched" "Detected in many" 7 "amygdala: 59.9;basal ganglia: 33.8;cerebral cortex: 88.3;hippocampal formation: 79.2;olfactory region: 58.9" HPA002036 Approved "Golgi apparatus" "Secreted to blood" NA NA 7670000000 13000000000 "Golgi apparatus" "HPA002036: AB_1078787" "unprognostic (3.67e-2)" "unprognostic (2.77e-4)" "unprognostic (5.42e-2)" "unprognostic (2.56e-4)" "unprognostic (2.03e-1)" "unprognostic (2.39e-4)" "unprognostic (3.46e-3)" "unprognostic (9.25e-3)" "unprognostic (2.02e-1)" "unprognostic (8.99e-3)" "unprognostic (6.55e-3)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "prognostic unfavorable (3.39e-4)" "unprognostic (7.15e-2)" "unprognostic (3.41e-1)" "unprognostic (4.31e-1)" 1.1 0.4 0.4 1.4 0.5 1.5 0.8 1.0 0.4 0.4 0.4 6.7 0.0 0.5 0.4 2.2 0.4 1.6 14.1 13.9 2.5 0.5 1.2 88.8 1.1 1.1 1.4 0.1 0.4 1.3 0.1 2.0 32.2 27.9 1.0 0.4 17.8 4.4 0.1 0.4 1.3 0.5 0.5 2.6 1.9 2.2 0.7 1.1 0.0 0.7 0.2 2.6 1.5 0.4 0.0 0.5 8.7 4.2 0.0 7.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.2 8.7 0.0 0.2 0.0 0.0 1.7 0.2 0.5 0.0 0.3 0.0 8.0 0.0 0.0 0.0 7.0 1.1 0.4 0.5 1.0 0.4 2.5 0.5 1.4 0.1 27.9 1.1 3.0 1.1 0.0 4.4 0.1 0.1 8.6 79.0 5.3 3.4 0.0 2.0 65.0 0.0 1.6 0.7 1.0 0.0 0.0 0.2 1.6 7.7 0.3 0.0 221.3 4.7 0.0 24.2 3.1 18.7 0.0 0.0 0.2 3.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 49.8 1.3 0.0 9.0 FAM129B "bA356B19.6, C9orf88, DKFZP434H0820, FLJ13518, FLJ22151, FLJ22298, MINERVA" ENSG00000136830 "Family with sequence similarity 129 member B" Q96TA1 9 127505339-127578989 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 95.6;placenta: 103.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 3.7;intermediate monocyte: 1.3;myeloid DC: 2.4" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;monocytes: 3.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021284, HPA021417, HPA023261, HPA024312" Enhanced Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA 1200000 "Plasma membrane, Cytosol" Nucleoplasm "HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376" "unprognostic (3.05e-3)" "unprognostic (9.47e-2)" "unprognostic (1.14e-3)" "unprognostic (4.07e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-1)" "unprognostic (3.14e-2)" "unprognostic (2.57e-3)" "unprognostic (1.40e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-3)" "unprognostic (6.45e-2)" "unprognostic (3.75e-2)" "unprognostic (1.24e-2)" "unprognostic (1.31e-1)" "unprognostic (8.40e-2)" "unprognostic (8.20e-3)" 7.8 17.9 4.5 8.4 5.6 5.1 6.7 6.5 4.2 19.1 13.9 4.2 12.3 11.9 9.6 7.3 95.6 8.9 22.9 8.2 4.8 4.1 9.9 5.5 24.0 5.1 6.9 3.1 9.3 24.8 6.8 5.7 103.7 9.1 12.8 7.2 9.4 23.6 11.7 4.1 17.3 17.1 10.5 7.0 6.8 13.8 5.4 4.2 1.3 39.8 44.6 48.8 11.8 28.3 0.0 2.4 0.5 3.7 0.0 0.5 1.7 22.1 25.3 5.1 6.7 15.6 30.4 24.0 44.1 41.0 24.4 15.1 8.0 24.5 0.0 17.5 49.8 30.1 37.0 4.4 32.6 8.1 4.2 4.7 3.8 37.5 8.3 30.8 0.1 10.8 33.2 20.5 40.1 14.1 44.9 36.6 1.4 7.1 0.2 46.1 26.1 0.2 6.2 5.3 38.1 33.3 2.6 17.3 11.6 20.9 17.8 8.2 3.8 36.0 25.7 15.6 7.6 16.9 1.2 47.3 25.1 10.9 31.5 36.4 0.4 0.8 0.0 70.6 3.6 46.3 0.5 3.7 0.0 0.2 1.3 0.0 0.0 0.5 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 1.7 4.5 5.6 6.5 4.2 4.8 4.1 6.9 3.1 9.1 4.2 65.5 43.5 0.0 30.8 28.7 0.4 4.2 38.2 10.7 36.4 36.6 0.0 59.0 3.3 72.5 1.0 28.6 94.2 0.0 92.9 33.5 19.8 56.7 28.9 1.0 21.5 0.0 21.4 28.8 11.8 1.8 29.7 23.3 21.9 2.8 41.6 12.6 107.3 42.4 47.4 1.5 1.5 12.9 32.0 0.3 1.1 32.6 101.1 2.2 37.3 104.7 FAM156B TMEM29B ENSG00000179304 "Family with sequence similarity 156 member B" Q8NDB6 X 52891306-52908560 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 34.3" "Cell type enriched" "Detected in some" 7 "Cardiomyocytes: 7.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA056640, HPA056643" Uncertain NA NA "HPA056640: AB_2683200, HPA056643: AB_2683201" "unprognostic (2.91e-1)" "unprognostic (1.31e-1)" "unprognostic (2.66e-1)" "unprognostic (3.24e-5)" "unprognostic (2.97e-1)" 6.4 7.4 6.5 10.9 6.9 5.2 7.9 13.7 12.3 4.6 5.0 5.6 13.9 5.0 8.8 9.3 4.6 8.7 5.4 6.4 10.1 5.7 5.9 4.9 5.3 3.8 4.7 11.4 7.7 5.0 3.9 13.9 34.3 5.6 6.2 4.4 7.2 6.1 9.8 5.1 20.6 4.8 7.0 5.5 7.6 4.5 4.6 2.4 3.5 7.0 3.0 4.7 5.9 5.1 1.1 8.0 1.2 7.3 3.1 2.6 3.3 3.7 7.0 4.6 6.6 5.0 4.2 13.5 3.9 6.1 5.9 4.2 3.5 3.7 3.3 2.8 11.6 4.9 4.8 7.9 6.2 1.7 1.0 8.8 2.4 13.6 14.1 17.0 2.2 2.2 9.8 6.5 6.7 5.4 8.8 5.1 9.0 2.6 2.1 7.7 8.5 5.2 12.5 5.0 6.1 12.0 3.5 4.8 5.6 7.1 4.8 4.4 5.2 3.3 8.9 4.3 10.8 5.0 5.8 4.3 3.1 3.5 6.0 4.2 4.7 6.7 6.2 4.4 9.6 1.9 0.0 4.6 1.2 1.2 7.3 1.8 1.1 0.7 1.2 8.0 1.0 2.6 0.6 1.1 3.1 6.8 4.5 2.4 3.3 6.5 6.9 13.7 12.3 10.1 5.7 4.7 11.4 5.6 2.4 0.0 0.6 0.0 0.1 0.1 0.0 7.7 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 FAM162B "bA86F4.2, C6orf189" ENSG00000183807 "Family with sequence similarity 162 member B" Q5T6X4 6 116752197-116765723 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 51.6" "Group enriched" "Detected in some" 4 "Sertoli cells: 64.7;Smooth muscle cells: 58.7" "Cancer enriched" "Detected in many" 18 "testis cancer: 32.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 7.0;BJ hTERT+: 19.0;BJ hTERT+ SV40 Large T+ RasG12V: 18.3;HHSteC: 5.3;HSkMC: 6.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "olfactory region: 6.9" "HPA036112, HPA060342" Enhanced NA NA "HPA036112: AB_10696649, HPA060342: AB_2684258" "unprognostic (1.81e-1)" "unprognostic (5.65e-3)" "unprognostic (1.54e-1)" "unprognostic (3.38e-1)" "unprognostic (5.45e-2)" "unprognostic (1.86e-5)" "unprognostic (8.29e-2)" "unprognostic (1.24e-1)" "unprognostic (4.19e-2)" "unprognostic (2.44e-2)" "unprognostic (7.32e-2)" "unprognostic (6.27e-3)" "prognostic unfavorable (2.48e-4)" "unprognostic (1.22e-2)" "unprognostic (1.72e-1)" "unprognostic (2.73e-3)" "unprognostic (4.34e-2)" 11.4 12.5 2.2 1.0 4.0 0.5 11.2 0.5 8.6 13.0 3.8 1.1 4.8 1.1 7.8 7.0 6.5 6.7 4.9 7.7 2.0 1.8 4.3 1.0 14.6 2.4 2.7 5.8 7.7 1.5 2.5 6.1 51.6 1.9 9.7 2.2 6.0 6.5 11.8 7.3 2.5 1.9 3.7 1.3 0.5 3.0 2.9 0.5 0.0 8.7 5.2 1.4 5.7 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.0 7.0 19.0 3.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 4.0 0.5 8.6 2.0 1.8 2.7 5.8 1.9 0.5 0.0 0.0 0.0 0.1 1.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 13.9 4.5 0.0 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.4 0.0 0.0 4.3 0.0 0.0 2.0 0.0 1.7 0.0 0.0 0.0 0.3 0.0 4.9 0.0 0.0 64.7 58.7 3.5 6.0 0.6 0.5 0.0 0.0 0.0 FAM184A "C6orf60, FLJ13942" ENSG00000111879 "Family with sequence similarity 184 member A" Q8NB25 6 118959763-119149387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 31.4" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 90.2;Spermatocytes: 64.6;Syncytiotrophoblasts: 222.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 15.9;HEK 293: 9.4;JURKAT: 13.4;K-562: 13.0;SCLC-21H: 10.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034571, HPA034572, HPA041955" Uncertain Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA034571: AB_10602498, HPA034572: AB_2674228, HPA041955: AB_2677768" "unprognostic (1.21e-1)" "unprognostic (4.11e-3)" "unprognostic (6.95e-2)" "unprognostic (3.40e-3)" "unprognostic (6.80e-2)" "unprognostic (1.64e-2)" "unprognostic (1.03e-1)" "unprognostic (1.18e-4)" "unprognostic (2.59e-1)" "unprognostic (3.19e-1)" "unprognostic (5.16e-4)" "unprognostic (8.38e-3)" "unprognostic (4.02e-2)" "unprognostic (9.11e-3)" "unprognostic (8.16e-3)" "unprognostic (5.70e-2)" "unprognostic (2.32e-1)" 4.0 2.8 14.2 3.7 13.7 0.6 6.1 13.9 16.0 2.8 3.0 4.6 0.4 3.8 3.9 3.6 2.6 3.9 2.3 2.4 11.3 10.5 6.7 6.4 15.3 4.9 9.1 10.0 7.1 5.1 14.2 15.4 31.4 11.9 4.0 1.9 2.7 2.9 4.1 1.2 2.3 2.6 3.1 4.6 1.0 1.7 23.2 7.1 0.1 8.5 1.1 5.8 2.1 2.0 0.5 0.0 0.0 0.2 0.3 1.9 0.0 0.1 0.2 15.9 1.6 0.2 0.2 0.0 0.5 0.3 0.5 0.8 2.1 1.2 1.1 0.0 0.2 6.0 0.0 4.9 0.0 0.2 1.2 9.4 0.5 1.4 7.0 0.1 0.0 1.5 0.3 0.2 0.1 0.0 0.3 0.0 13.4 13.0 0.5 0.2 0.3 0.3 0.0 5.3 0.6 1.2 0.0 0.0 0.0 0.1 0.1 10.4 7.7 0.5 0.5 1.5 3.0 2.1 1.8 0.2 0.8 0.4 0.1 4.0 4.0 4.3 0.3 1.2 0.0 2.0 0.0 0.0 0.0 0.2 0.2 0.6 0.5 0.2 0.0 0.0 0.1 1.5 1.2 0.0 0.3 0.0 0.0 1.9 0.0 14.2 13.7 13.9 12.9 11.3 10.5 9.1 10.0 11.9 7.1 44.7 90.2 0.0 6.1 2.2 36.7 3.9 5.1 60.2 31.8 3.5 27.5 45.2 14.9 0.8 12.9 1.9 0.1 0.0 1.0 13.5 5.0 0.9 5.8 3.4 4.9 12.7 5.8 3.1 0.3 5.4 3.4 0.8 0.0 0.0 0.0 12.5 0.5 0.0 6.7 1.3 27.8 6.5 2.3 64.6 15.4 3.0 222.8 4.1 0.4 1.0 FAM46A "C6orf37, FLJ20037" ENSG00000112773 "Family with sequence similarity 46 member A" Q96IP4 6 81491439-81752774 "Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 106.4" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 311.3;Horizontal cells: 276.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 22.1;fHDF/TERT166: 25.4;HeLa: 25.1;HL-60: 28.8;THP-1: 49.6;U-937: 22.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA051067, HPA067140" Uncertain Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA051067: , HPA067140: AB_2685788" "unprognostic (2.02e-1)" "unprognostic (3.02e-2)" "unprognostic (5.39e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (2.62e-3)" "unprognostic (5.93e-2)" "unprognostic (2.48e-2)" "unprognostic (2.53e-1)" "unprognostic (1.03e-1)" "unprognostic (1.40e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (7.18e-2)" "unprognostic (6.38e-2)" "unprognostic (9.25e-2)" "unprognostic (9.66e-2)" 10.0 7.1 1.4 4.9 1.4 64.7 5.6 2.8 0.9 14.4 17.7 1.3 24.2 5.1 12.8 20.0 4.2 8.8 17.1 19.4 1.2 4.4 3.2 11.8 5.8 2.3 1.4 0.9 20.1 3.5 6.5 20.4 106.4 3.5 16.2 5.6 4.9 49.8 45.6 4.5 7.0 32.6 15.3 2.5 5.8 13.2 6.8 1.4 1.2 7.7 6.7 3.7 13.4 31.1 12.0 12.4 22.4 22.2 8.3 6.2 6.1 1.0 1.5 1.0 0.0 22.1 9.8 1.9 8.4 6.0 5.0 7.6 15.7 0.8 0.1 0.3 25.4 3.2 0.9 0.7 1.3 3.7 0.0 1.9 0.0 25.1 2.4 6.9 28.8 2.2 4.3 0.7 3.9 0.7 16.4 0.6 0.2 0.4 0.0 3.3 4.4 0.0 20.4 0.2 8.9 1.2 0.0 9.1 0.0 0.6 1.9 1.0 1.4 3.7 1.6 2.5 3.3 0.3 49.6 1.4 5.7 1.2 2.4 2.3 0.1 0.1 0.1 8.1 22.3 2.4 16.1 14.9 22.4 6.2 15.1 3.7 8.0 2.4 3.0 12.4 12.0 4.7 4.4 7.3 8.3 22.2 4.3 2.7 6.1 1.4 1.4 2.8 0.9 1.2 4.4 1.4 0.9 3.5 1.4 59.6 92.4 0.9 134.5 49.9 25.9 0.0 45.9 21.4 102.4 0.0 70.7 30.7 0.0 0.0 0.4 20.4 311.3 23.3 0.0 89.3 98.1 34.0 210.9 34.5 26.7 276.5 183.7 6.7 35.9 0.5 95.3 46.7 62.4 0.0 64.6 75.7 0.0 105.2 37.1 0.0 45.1 25.8 43.8 0.9 5.4 31.7 135.5 20.3 33.3 105.6 FAM89A "C1orf153, MGC15887" ENSG00000182118 "Family with sequence similarity 89 member A" Q96GI7 1 231018958-231040246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 39.6;placenta: 48.3" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 143.5;Extravillous trophoblasts: 248.1;Rod photoreceptor cells: 96.4;Syncytiotrophoblasts: 232.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 52.2;SK-MEL-30: 27.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA059052, HPA059578" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" Nucleoplasm "HPA059052: AB_2683890, HPA059578: AB_2684070" "unprognostic (7.80e-2)" "unprognostic (1.20e-1)" "unprognostic (3.58e-3)" "unprognostic (1.32e-2)" "unprognostic (2.77e-1)" "unprognostic (1.41e-2)" "unprognostic (1.98e-2)" "unprognostic (1.10e-1)" "unprognostic (8.05e-3)" "unprognostic (4.85e-1)" "unprognostic (1.54e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (1.75e-5)" "unprognostic (2.87e-2)" "unprognostic (2.03e-1)" "unprognostic (2.01e-1)" "unprognostic (9.26e-2)" 39.6 12.9 8.0 3.7 8.5 3.9 32.8 3.9 5.4 5.1 3.6 4.9 2.0 1.6 5.7 2.1 3.4 2.7 4.6 4.7 7.9 11.2 8.7 5.7 10.5 6.7 14.0 2.3 4.7 15.0 4.0 4.2 48.3 13.1 4.7 2.4 12.0 3.5 3.9 4.2 14.1 1.8 3.5 10.9 9.6 3.1 2.8 8.3 0.8 3.9 5.0 3.6 4.3 9.7 1.2 0.0 4.3 0.7 0.3 3.0 0.8 0.3 4.8 2.2 4.7 5.5 1.1 52.2 2.7 2.0 1.0 1.8 7.3 4.3 0.0 0.6 1.7 6.0 2.9 4.2 0.6 0.8 14.5 10.2 2.3 0.1 0.3 21.2 1.7 12.6 18.4 9.5 0.0 4.8 0.0 2.6 5.3 18.0 3.0 0.9 1.7 1.1 3.0 3.3 4.3 1.5 5.7 7.3 5.5 3.6 5.1 2.0 5.8 0.9 0.4 27.3 5.2 0.2 10.1 0.4 8.2 0.0 0.1 5.0 6.6 7.9 4.0 2.4 3.4 16.1 4.3 0.7 0.0 0.6 0.1 1.1 1.2 0.8 1.5 0.0 0.6 1.3 3.0 0.0 0.3 0.2 0.0 0.0 0.8 8.0 8.5 3.9 5.4 7.9 11.2 14.0 2.3 13.1 8.3 0.0 1.6 2.7 15.8 26.8 32.0 3.0 2.5 0.0 1.2 0.0 72.6 143.5 3.3 2.1 1.1 20.1 0.0 0.0 2.9 248.1 6.4 12.7 4.6 10.6 41.7 7.9 0.0 5.5 13.1 1.8 2.6 3.0 20.3 0.0 0.4 22.8 4.3 0.0 1.4 4.4 96.4 0.0 2.1 3.8 8.9 28.7 232.7 2.2 0.9 13.3 FBLN1 FBLN ENSG00000077942 "Fibulin 1" P23142 22 45502238-45601135 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 287.9;vagina: 228.2" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 571.3;Extravillous trophoblasts: 448.0;Fibroblasts: 795.3;Syncytiotrophoblasts: 1016.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "pons and medulla: 29.1" "Cell type enhanced" "Detected in some" "non-classical monocyte: 5.7" "Group enriched" "Detected in many" 4 "dendritic cells: 2.9;monocytes: 5.7" "Cell line enhanced" "Detected in many" "ASC diff: 157.8;ASC TERT1: 70.0;BJ: 84.6;BJ hTERT+: 134.5;HSkMC: 115.4;RT4: 121.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001612, HPA001613, CAB004393, CAB068187" Enhanced Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 34000000000 "Endoplasmic reticulum" "CAB004393: AB_671972, CAB068187: AB_2665634, HPA001612: AB_1078825, HPA001613: AB_1078824" "unprognostic (6.62e-2)" "unprognostic (2.47e-2)" "unprognostic (1.64e-1)" "prognostic favorable (9.28e-4)" "unprognostic (1.26e-3)" "unprognostic (4.82e-2)" "unprognostic (9.79e-3)" "unprognostic (2.49e-1)" "unprognostic (6.30e-2)" "unprognostic (3.86e-2)" "unprognostic (2.84e-2)" "unprognostic (3.30e-2)" "prognostic unfavorable (3.02e-10)" "unprognostic (1.08e-3)" "unprognostic (1.46e-1)" "unprognostic (1.29e-2)" "unprognostic (3.64e-2)" 42.3 14.9 2.6 16.9 3.7 0.0 101.2 2.9 6.0 141.6 20.5 11.6 30.3 8.6 62.4 69.7 48.3 47.1 123.7 86.4 6.6 1.3 8.1 2.9 42.5 9.2 3.8 4.2 46.6 12.3 30.0 10.0 287.9 29.1 99.0 10.0 35.3 12.8 21.8 11.5 33.1 16.9 136.1 6.1 2.7 30.3 20.7 2.8 1.1 21.6 18.9 5.3 67.1 228.2 0.4 2.9 0.9 5.7 0.1 0.3 0.2 1.4 3.4 10.2 21.4 157.8 70.0 46.9 84.6 134.5 7.5 2.8 14.5 0.4 0.0 3.6 3.1 0.2 7.4 6.4 0.2 0.9 0.0 1.7 0.0 18.4 9.7 20.9 0.0 0.0 115.4 1.3 7.5 2.7 0.1 0.0 0.1 0.0 0.1 5.2 0.2 0.0 0.2 14.4 0.3 1.2 0.1 0.0 0.1 3.4 121.1 0.7 13.6 10.4 49.3 0.0 30.3 0.3 0.4 0.6 1.4 9.4 38.9 0.0 0.1 0.0 0.1 0.1 0.0 3.6 0.9 0.1 0.0 0.2 0.7 0.2 0.1 0.2 0.1 1.2 0.4 0.3 0.2 0.6 0.1 5.7 2.9 0.2 0.2 2.6 3.7 2.9 6.0 6.6 1.3 3.8 4.2 29.1 2.8 6.0 2.2 0.0 92.6 151.8 0.0 8.6 12.7 1.4 13.6 1.8 0.0 571.3 0.0 0.5 8.4 22.5 0.0 0.0 0.2 448.0 795.3 17.7 1.1 0.4 73.2 0.0 0.0 36.2 0.0 18.3 85.4 3.3 161.9 0.0 0.0 0.0 0.7 0.0 28.7 0.3 0.5 116.4 93.7 18.7 76.7 113.9 1016.7 0.0 0.2 69.1 FBN1 "FBN, MASS, MFS1, OCTD, SGS, WMS" ENSG00000166147 "Fibrillin 1" P35555 15 48408306-48645849 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Heparin-binding, Hormone" "Aortic aneurysm, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 69.8" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 91.8;Fibroblasts: 78.5;Leydig cells: 218.7;Peritubular cells: 213.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 36.9;ASC TERT1: 79.9;fHDF/TERT166: 68.5;HSkMC: 43.2;hTERT-RPE1: 35.7;U-138 MG: 35.1;U-2197: 51.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB002670, HPA017759, HPA021057, CAB058696, CAB068188" Enhanced Approved Cytosol "Secreted to blood" NA NA 540000000 Cytosol "CAB002670: , CAB058696: AB_2665596, CAB068188: AB_2665597, HPA017759: AB_1848584, HPA021057: AB_1848586" "unprognostic (3.97e-2)" "unprognostic (1.55e-2)" "unprognostic (2.40e-2)" "unprognostic (9.50e-2)" "unprognostic (1.51e-1)" "unprognostic (9.49e-2)" "unprognostic (2.00e-2)" "unprognostic (4.79e-2)" "unprognostic (7.82e-2)" "unprognostic (1.50e-2)" "unprognostic (2.78e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (7.44e-5)" "prognostic unfavorable (6.57e-4)" "unprognostic (1.25e-2)" "unprognostic (8.69e-3)" "prognostic unfavorable (5.11e-4)" 34.2 5.4 2.1 7.8 2.7 1.8 10.9 1.0 2.8 24.6 11.1 3.5 10.7 2.2 18.4 25.6 22.1 12.1 15.5 24.3 2.5 2.3 2.9 1.9 10.7 5.8 2.8 2.6 20.4 2.5 2.6 3.3 69.8 3.1 11.8 6.9 13.4 5.7 7.8 15.4 6.6 6.9 21.5 3.8 11.3 7.2 13.6 1.6 1.9 17.9 16.3 4.9 22.8 11.2 0.8 0.8 1.8 0.6 1.1 0.6 0.2 0.0 0.8 3.3 3.7 36.9 79.9 0.0 28.8 10.4 8.6 5.5 0.0 0.0 0.0 1.3 68.5 0.0 0.1 0.6 0.1 7.8 3.3 0.2 0.3 14.7 0.0 20.8 0.1 0.0 43.2 0.0 22.7 2.6 35.7 9.2 0.2 0.0 0.0 9.2 0.0 0.2 0.0 0.6 0.0 1.1 0.0 2.8 0.0 1.0 0.0 0.0 2.1 0.0 0.3 0.0 2.7 0.0 0.2 17.4 35.1 1.0 51.0 6.0 0.2 0.1 0.0 23.5 0.0 2.3 1.1 0.5 0.7 0.5 0.3 0.4 0.5 0.4 0.4 0.2 0.8 0.5 0.6 1.8 1.1 0.6 0.8 0.3 0.2 2.1 2.7 1.0 2.8 2.5 2.3 2.8 2.6 3.1 1.6 0.0 2.2 0.0 1.1 22.8 4.5 9.3 0.0 5.3 10.3 12.2 0.0 91.8 0.0 0.2 6.3 21.7 0.0 0.0 0.5 16.3 78.5 0.5 1.1 0.6 13.5 0.0 0.0 38.1 1.0 15.7 218.7 4.4 40.5 3.6 0.0 0.5 2.0 0.0 213.6 0.6 0.1 25.8 44.7 3.0 2.1 18.1 55.0 0.0 0.0 0.1 FBN2 "CCA, DA9" ENSG00000138829 "Fibrillin 2" P35556 5 128257909-128659185 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "placenta: 175.9" "Group enriched" "Detected in many" 7 "Cytotrophoblasts: 251.0;Syncytiotrophoblasts: 136.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5;non-classical monocyte: 5.0" "Lineage enriched" "Detected in many" 5 "monocytes: 5.0" "Cell line enhanced" "Detected in many" "HHSteC: 38.0;HSkMC: 27.1;hTERT-HME1: 59.9;HUVEC TERT2: 33.7" "Region enhanced" "Detected in single" "olfactory region: 2.6" "Low region specificity" "Detected in some" "HPA012853, CAB026401" Enhanced Approved Nucleoplasm,Cytosol "Secreted to extracellular matrix" NA NA 4600000 Cytosol Nucleoplasm "CAB026401: , HPA012853: AB_1848588" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (7.29e-3)" "unprognostic (1.79e-3)" "unprognostic (6.74e-2)" "unprognostic (2.33e-1)" "unprognostic (4.92e-3)" "unprognostic (9.41e-2)" "unprognostic (1.06e-2)" "unprognostic (4.66e-1)" "unprognostic (1.12e-1)" "unprognostic (8.69e-2)" "unprognostic (8.60e-5)" "unprognostic (1.04e-2)" "unprognostic (3.19e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (7.41e-5)" 0.3 7.9 0.3 1.0 0.3 1.6 0.1 0.2 0.3 1.5 0.7 0.4 1.0 0.2 2.9 0.6 1.1 0.6 0.2 6.7 0.2 0.5 0.2 0.2 0.2 1.3 0.2 0.4 0.9 0.1 0.0 1.3 175.9 0.4 1.0 0.8 6.2 0.4 0.9 0.2 0.3 0.5 0.8 0.4 0.6 0.5 4.6 0.2 0.3 0.9 0.4 0.7 0.4 1.2 0.0 1.1 0.6 5.0 0.0 0.0 0.4 0.0 4.5 16.4 0.0 2.7 4.7 3.4 17.9 0.0 15.9 11.9 0.0 0.0 0.0 0.0 23.9 0.0 2.7 10.6 2.7 14.9 0.0 4.2 0.0 7.5 0.0 38.0 2.3 0.0 27.1 1.4 6.7 59.9 5.1 33.7 0.0 0.0 0.0 9.8 0.0 0.0 0.9 7.1 0.0 5.4 5.1 5.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 14.0 0.0 5.0 0.0 6.4 12.2 18.3 0.0 0.0 0.0 0.0 1.9 0.0 6.7 0.0 2.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.0 5.0 0.0 0.0 0.4 0.3 0.3 0.2 0.3 0.2 0.5 0.2 0.4 0.4 0.2 0.0 0.3 0.0 0.1 0.0 0.0 11.3 0.0 0.0 2.3 0.0 0.0 251.0 0.0 0.0 2.7 0.4 0.0 0.0 0.0 27.7 3.3 1.5 0.0 0.0 29.6 0.0 0.0 0.0 12.9 5.3 1.1 1.8 1.7 0.0 0.0 3.1 0.1 0.0 2.1 0.0 0.0 6.5 0.2 12.7 3.8 0.4 136.7 0.0 0.0 0.1 FCGR2B "CD32, CD32B, FCG2, FCGR2" ENSG00000072694 "Fc fragment of IgG receptor IIb" P31994 1 161663147-161678654 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Host-virus interaction" "IgG-binding protein, Receptor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 53.3;placenta: 83.2" "Group enriched" "Detected in many" 5 "Ito cells: 479.4;Macrophages: 138.2" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 53.3;memory B-cell: 42.2" "Group enriched" "Detected in many" 18 "B-cells: 42.2;dendritic cells: 14.5;granulocytes: 53.3" "Cell line enhanced" "Detected in some" "Daudi: 18.7;HMC-1: 23.5;NB-4: 5.2;RPMI-8226: 8.4" "CAB007796, HPA014730" Enhanced NA NA "CAB007796: AB_562288, HPA014730: AB_2669074" "unprognostic (1.58e-1)" "unprognostic (5.14e-2)" "unprognostic (3.32e-3)" "unprognostic (3.12e-2)" "unprognostic (6.79e-3)" "unprognostic (4.05e-3)" "unprognostic (1.27e-1)" "unprognostic (4.65e-3)" "unprognostic (1.91e-1)" "unprognostic (4.72e-2)" "unprognostic (2.89e-2)" "unprognostic (3.49e-1)" "prognostic unfavorable (8.82e-4)" "unprognostic (3.51e-2)" "unprognostic (6.36e-2)" "unprognostic (4.31e-1)" "unprognostic (3.37e-1)" 11.3 2.4 0.0 2.0 0.2 0.0 4.1 0.0 0.0 1.9 3.4 0.2 0.9 0.2 2.1 2.1 2.3 3.7 0.0 0.2 2.0 9.5 5.6 2.5 0.5 0.8 0.6 0.0 0.3 83.2 0.3 2.0 3.3 0.2 0.5 2.0 4.6 3.1 4.7 6.7 1.5 0.1 1.7 5.6 3.3 1.2 42.2 14.5 53.3 1.9 0.1 0.3 2.4 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 5.2 0.1 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.1 0.1 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 2.2 0.0 53.3 1.8 5.4 0.3 1.9 0.1 42.2 0.1 0.2 14.5 34.3 0.0 0.3 11.2 0.1 1.7 0.0 0.0 2.4 0.0 4.6 57.3 0.0 4.7 0.0 1.9 5.1 0.0 2.3 0.0 0.0 0.2 0.0 0.0 4.2 1.4 0.0 23.3 0.0 0.2 2.7 0.0 2.3 2.5 7.6 0.0 0.0 479.4 63.3 2.3 0.6 138.2 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.3 0.2 2.8 0.3 4.9 0.0 0.0 FHDC1 KIAA1727 ENSG00000137460 "FH2 domain containing 1" Q9C0D6 4 152936352-152979696 "Predicted intracellular proteins" "Cilium biogenesis/degradation" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "placenta: 86.7" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 65.7;Erythroid cells: 70.0;Syncytiotrophoblasts: 66.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 24.5;RT4: 8.1;SK-BR-3: 11.4;WM-115: 8.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA008527 Uncertain NA NA "HPA008527: AB_2104099" "unprognostic (5.42e-2)" "unprognostic (8.12e-2)" "unprognostic (2.42e-2)" "unprognostic (1.99e-3)" "unprognostic (1.16e-1)" "unprognostic (2.25e-1)" "unprognostic (2.95e-4)" "unprognostic (1.37e-1)" "unprognostic (2.15e-1)" "unprognostic (1.80e-1)" "unprognostic (1.25e-2)" "unprognostic (2.40e-1)" "prognostic favorable (1.33e-5)" "unprognostic (4.04e-2)" "unprognostic (1.90e-1)" "unprognostic (9.36e-2)" "unprognostic (1.30e-1)" 0.7 0.2 0.5 2.0 4.3 11.3 1.9 2.8 4.4 2.4 4.0 0.5 1.4 3.0 1.8 1.6 8.0 1.1 4.9 0.6 0.9 0.8 1.5 0.4 7.7 0.8 0.9 0.8 1.0 1.8 7.4 3.4 86.7 1.5 6.8 4.3 6.9 4.4 1.4 0.4 11.0 6.7 1.0 0.9 4.4 4.2 1.5 0.7 0.8 15.0 4.6 8.7 1.3 3.8 0.5 0.4 2.8 0.3 1.0 0.3 0.0 4.3 0.4 0.8 0.6 0.4 0.2 24.5 0.3 0.9 1.0 0.1 0.3 2.7 0.2 0.1 0.4 0.8 0.9 0.2 1.8 0.3 0.5 0.3 0.5 2.5 0.3 0.1 0.1 0.7 0.1 2.2 0.0 0.5 1.0 0.0 0.4 1.1 0.5 0.3 2.7 0.1 0.1 5.0 0.4 0.3 0.0 0.2 0.1 4.5 8.1 4.4 0.2 1.5 11.4 1.6 5.8 1.7 0.3 0.1 0.3 0.8 2.0 1.0 0.6 0.4 0.1 0.2 0.1 8.4 0.6 0.3 0.5 0.2 0.2 0.1 0.3 0.2 0.2 0.1 0.5 0.2 0.3 2.8 1.0 0.2 0.4 0.1 0.0 0.5 4.3 2.8 1.6 0.9 0.8 0.9 0.8 1.5 0.7 14.9 65.7 0.0 2.3 5.3 0.0 0.6 5.1 5.3 21.6 3.5 2.0 10.4 0.0 0.8 1.7 0.9 7.4 70.0 2.7 11.1 1.4 6.4 3.5 0.0 1.8 0.0 13.3 0.0 0.0 0.0 0.9 0.4 0.0 0.0 7.8 0.0 5.2 7.8 0.7 0.0 0.0 0.0 0.0 0.4 0.2 6.1 66.9 0.0 6.4 2.5 FLT1 "FLT, VEGFR1" ENSG00000102755 "Fms related tyrosine kinase 1" P17948 13 28300344-28495145 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "placenta: 155.3" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 778.4;Ito cells: 284.2;Syncytiotrophoblasts: 942.6" "Cancer enhanced" "Detected in all" "renal cancer: 28.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 1.1;naive B-cell: 3.7;neutrophil: 2.1" "Group enriched" "Detected in many" 5 "B-cells: 3.7;granulocytes: 2.1" "Cell line enhanced" "Detected in some" "BJ: 17.4;BJ hTERT+: 13.8;HMC-1: 86.4;HUVEC TERT2: 15.6;WM-115: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011740, HPA014290, CAB068189, CAB068190" Enhanced Supported "Plasma membrane,Actin filaments" "Secreted to blood" NA NA 876000 54000 "Plasma membrane" "Actin filaments" "CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738" "unprognostic (3.33e-2)" "unprognostic (3.52e-3)" "unprognostic (1.13e-3)" "unprognostic (5.02e-2)" "unprognostic (3.65e-1)" "unprognostic (5.03e-2)" "unprognostic (8.25e-2)" "unprognostic (2.27e-3)" "unprognostic (9.91e-2)" "unprognostic (6.61e-2)" "unprognostic (2.33e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.19e-4)" "unprognostic (4.20e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (6.32e-2)" 18.9 4.0 9.9 4.0 14.3 1.2 13.5 8.0 15.9 7.1 4.6 3.5 1.7 3.5 7.2 2.2 3.4 4.0 6.9 18.3 11.4 7.3 10.3 7.6 12.3 2.5 10.3 3.2 5.1 5.4 13.4 3.7 155.3 13.8 5.1 3.1 9.1 3.0 5.0 12.5 2.6 3.4 7.3 9.6 7.2 4.6 6.8 10.2 0.0 19.1 3.8 2.8 7.6 9.2 3.7 0.5 2.1 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.0 17.4 13.8 6.3 3.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.6 0.0 11.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 86.4 0.1 0.0 0.0 0.2 0.0 15.6 1.4 0.4 0.0 0.0 0.0 1.0 0.8 9.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 11.4 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.5 0.2 0.0 0.1 0.0 31.0 0.2 0.1 0.1 0.1 0.1 0.0 1.1 0.1 0.1 0.0 3.7 0.4 0.4 2.1 0.2 0.1 0.5 0.2 0.2 9.9 14.3 8.0 15.9 11.4 7.3 10.3 3.2 13.8 10.2 0.0 8.9 2.2 0.5 3.7 5.9 12.6 5.1 2.7 1.2 0.0 3.9 155.4 1.7 0.0 116.6 192.1 0.0 0.0 0.0 778.4 17.5 1.1 1.1 2.1 28.1 1.6 0.0 284.2 16.1 130.7 17.3 5.3 0.0 0.0 0.0 172.0 0.0 0.0 45.6 0.0 7.3 90.5 6.6 12.9 2.8 4.3 942.6 2.9 0.0 0.5 FLT4 "PCL, VEGFR3" ENSG00000037280 "Fms related tyrosine kinase 4" P35916 5 180601506-180649624 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 56.3" "Group enriched" "Detected in some" 5 "Extravillous trophoblasts: 31.7;Ito cells: 65.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 7.7" "Lineage enriched" "Detected in single" 35 "T-cells: 7.7" "Cell line enhanced" "Detected in some" "AN3-CA: 8.3;BEWO: 10.1;HEK 293: 12.5;HUVEC TERT2: 8.1;JURKAT: 10.0;T-47d: 11.9;TIME: 12.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB000099, HPA046519, HPA067906, HPA074389" Approved Supported "Nuclear speckles,Plasma membrane,Cell Junctions" "Secreted to blood" NA NA 270000000 "Nuclear speckles, Plasma membrane" "Cell Junctions" "CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: " "unprognostic (7.35e-2)" "unprognostic (1.63e-1)" "unprognostic (9.45e-3)" "unprognostic (3.81e-1)" "unprognostic (9.26e-2)" "unprognostic (3.20e-3)" "unprognostic (1.13e-2)" "unprognostic (1.80e-2)" "unprognostic (2.19e-1)" "unprognostic (1.70e-1)" "unprognostic (2.13e-2)" "unprognostic (3.69e-1)" "unprognostic (1.88e-2)" "unprognostic (9.41e-3)" "unprognostic (1.83e-1)" "unprognostic (8.26e-2)" "unprognostic (1.32e-1)" 14.8 7.1 1.6 4.9 6.0 0.7 28.5 1.3 2.7 6.3 7.3 1.9 2.1 3.1 7.3 6.2 5.7 9.2 5.3 6.4 1.7 0.9 11.7 10.2 14.1 23.6 2.0 0.8 5.8 2.3 2.3 6.2 56.3 2.1 4.9 1.4 6.7 3.3 4.4 4.8 2.8 4.7 4.7 1.5 14.5 2.4 3.5 2.0 0.3 19.4 4.4 2.3 6.1 14.7 0.0 0.1 0.2 0.0 0.0 7.7 0.2 0.1 2.0 2.7 8.3 0.0 0.0 10.1 0.2 0.1 0.0 0.0 0.3 0.3 0.2 0.8 0.1 0.5 0.3 2.8 0.1 0.2 0.1 12.5 1.0 0.4 0.4 0.1 7.4 0.2 0.2 0.0 0.1 0.3 0.3 8.1 10.0 0.3 0.3 1.7 4.5 0.1 0.4 5.8 0.2 0.5 6.5 0.0 0.1 0.1 0.2 0.2 0.9 0.1 0.2 0.0 2.7 11.9 0.2 12.6 0.1 5.9 0.2 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.9 0.0 7.7 0.0 0.4 1.6 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.2 1.6 6.0 1.3 2.7 1.7 0.9 2.0 0.8 2.1 2.0 0.0 1.7 0.9 0.2 0.8 0.0 4.5 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.0 0.2 9.2 0.0 0.0 0.0 31.7 0.6 0.2 2.3 0.4 1.1 0.0 0.0 65.1 5.7 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 4.3 1.0 0.8 0.7 0.0 0.1 FN1 "CIG, FINC, GFND2, LETS, MSF" ENSG00000115414 "Fibronectin 1" P02751 2 215360440-215436172 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Angiogenesis, Cell adhesion, Cell shape" Heparin-binding "Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 235.4;placenta: 433.0" "Cell type enhanced" "Detected in many" 19 "Extravillous trophoblasts: 2156.8;Fibroblasts: 526.4;Hepatocytes: 963.3" "Cancer enhanced" "Detected in all" "thyroid cancer: 833.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 845.3;HSkMC: 395.4;hTERT-HME1: 232.5;hTERT-RPE1: 257.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000126, HPA027066" Enhanced "Secreted to blood" NA NA 47000000000 "CAB000126: , HPA027066: AB_10602500" "unprognostic (8.08e-2)" "unprognostic (1.09e-3)" "unprognostic (2.20e-2)" "unprognostic (3.45e-3)" "unprognostic (1.82e-2)" "unprognostic (3.47e-3)" "unprognostic (3.36e-2)" "unprognostic (5.91e-3)" "unprognostic (2.96e-2)" "unprognostic (2.91e-3)" "unprognostic (1.41e-2)" "unprognostic (2.84e-1)" "prognostic unfavorable (3.44e-8)" "prognostic unfavorable (8.82e-5)" "unprognostic (7.88e-2)" "unprognostic (7.74e-2)" "prognostic unfavorable (3.33e-4)" 20.2 4.5 3.1 13.0 5.2 0.2 13.1 2.2 4.3 21.9 57.1 4.4 235.4 3.5 25.1 27.5 37.4 26.5 20.9 57.3 3.9 2.9 5.8 166.3 81.5 7.9 4.6 5.0 16.9 3.3 1.7 3.5 433.0 6.1 17.1 25.1 5.1 10.4 141.2 9.8 7.0 13.5 114.9 4.6 1.9 21.8 9.0 2.7 9.4 5.4 17.4 2.6 64.7 16.9 0.2 0.8 0.0 0.6 0.0 0.3 0.0 0.2 1.9 2.6 0.5 107.3 845.3 0.1 43.6 29.1 44.2 31.4 26.4 1.0 0.0 0.2 144.9 1.2 4.5 0.4 99.3 23.8 0.0 0.1 0.0 0.6 82.3 77.6 0.0 0.1 395.4 0.6 104.4 232.5 257.3 51.2 0.0 0.1 0.1 88.0 0.3 0.0 0.0 1.3 0.0 0.3 0.0 0.0 0.1 1.1 0.3 0.1 0.6 5.2 2.7 28.3 119.4 0.4 0.0 98.1 63.9 6.8 70.0 8.0 0.1 0.0 0.0 76.0 0.0 16.6 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.0 0.0 0.8 0.0 0.0 3.1 5.2 2.2 4.3 3.9 2.9 4.6 5.0 6.1 2.7 62.5 83.1 7.8 3.5 48.9 5.1 27.2 35.7 24.1 28.4 15.7 0.0 51.6 0.0 4.9 1.5 166.7 0.0 0.0 8.1 2156.8 526.4 18.4 17.4 963.3 368.5 1.6 20.2 165.1 27.1 2.6 172.6 39.4 104.6 1.8 4.3 1.4 19.0 0.0 83.1 0.6 9.7 71.1 163.2 1.1 4.5 32.6 172.1 0.9 3.7 1.6 FOXI3 ENSG00000214336 "Forkhead box I3" A8MTJ6 2 88446787-88452656 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "placenta: 11.6;retina: 15.7" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 3.2;Muller glia cells: 5.6;Syncytiotrophoblasts: 2.3" "Cancer enhanced" "Detected in some" "testis cancer: 10.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "BEWO: 24.7;SuSa: 33.0" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (2.72e-1)" "unprognostic (1.20e-1)" "unprognostic (2.92e-1)" "unprognostic (6.72e-4)" "unprognostic (8.11e-3)" "unprognostic (1.36e-1)" "unprognostic (6.58e-2)" "unprognostic (5.29e-2)" "unprognostic (1.15e-1)" 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.8 11.6 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 1.9 0.5 0.9 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 24.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.0 0.0 33.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.5 0.2 0.4 0.2 0.3 0.4 0.4 0.3 0.2 0.7 0.4 0.6 1.5 0.9 0.5 0.5 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 FOXO4 "AFX1, MLLT7" ENSG00000184481 "Forkhead box O4" P98177 X 71096197-71103535 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors" "Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 98.6" "Group enriched" "Detected in many" 10 "Cytotrophoblasts: 207.8;Syncytiotrophoblasts: 257.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "BEWO: 61.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039560, HPA040232" Enhanced Supported "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "HPA039560: AB_2676572, HPA040232: AB_2676894" "unprognostic (4.64e-2)" "unprognostic (2.94e-2)" "unprognostic (2.19e-1)" "unprognostic (2.49e-1)" "unprognostic (4.79e-2)" "prognostic favorable (4.61e-4)" "unprognostic (1.09e-1)" "unprognostic (3.20e-2)" "unprognostic (1.58e-1)" "unprognostic (7.18e-2)" "unprognostic (2.13e-2)" "unprognostic (8.16e-2)" "prognostic favorable (3.46e-4)" "unprognostic (2.45e-2)" "unprognostic (2.07e-1)" "unprognostic (1.20e-1)" "unprognostic (1.75e-3)" 8.5 13.2 21.7 3.8 21.5 9.9 5.1 9.1 15.6 4.8 8.4 9.1 11.9 6.3 6.8 10.2 7.3 7.7 5.8 9.7 21.4 14.5 5.2 3.6 5.5 3.6 22.8 8.4 13.4 6.8 8.7 3.0 98.6 9.2 7.0 4.7 4.9 8.5 11.3 33.8 5.5 6.6 9.4 17.3 6.0 5.2 13.9 13.1 4.4 5.9 7.5 4.2 7.5 11.0 0.9 0.2 3.4 0.6 1.0 1.8 0.9 1.8 0.5 1.4 1.8 3.4 2.4 61.2 1.4 1.6 0.7 1.7 1.2 2.4 2.4 1.8 1.8 0.8 0.8 3.7 1.6 0.9 2.4 5.6 3.4 11.4 2.0 1.9 2.0 2.7 2.0 3.9 0.7 0.4 3.3 1.9 3.5 7.0 4.7 0.3 0.4 3.1 3.2 6.6 4.6 2.2 2.1 3.6 3.6 1.2 1.0 1.0 3.0 2.9 0.4 3.2 10.9 0.7 1.2 1.7 0.4 0.9 3.2 0.3 3.1 1.6 0.4 1.6 5.3 0.5 0.2 0.6 3.2 0.9 0.6 0.3 0.8 0.5 0.9 0.2 0.9 0.4 1.8 3.4 1.0 0.3 0.0 1.3 0.9 21.7 21.5 9.1 15.6 21.4 14.5 22.8 8.4 9.2 13.1 0.0 2.4 1.4 4.1 4.7 1.2 6.5 5.1 0.0 1.2 8.7 3.9 207.8 1.7 2.0 0.2 3.8 12.7 23.3 2.6 8.6 4.4 3.4 2.3 2.4 19.4 1.6 5.8 4.3 3.1 0.4 6.4 3.2 3.3 1.0 11.4 2.8 2.6 8.6 14.5 3.3 0.8 6.5 2.5 0.3 0.4 3.0 257.4 5.0 6.0 3.1 FOXO6 ENSG00000204060 "Forkhead box O6" A8MYZ6 1 41361922-41383590 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 7.2;placenta: 8.4" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 5.1;Muller glia cells: 7.2" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "unprognostic (3.70e-1)" "unprognostic (1.13e-1)" "unprognostic (7.35e-2)" "prognostic unfavorable (7.65e-6)" "unprognostic (5.11e-2)" "unprognostic (1.78e-1)" "unprognostic (1.54e-1)" "unprognostic (1.28e-3)" "unprognostic (2.16e-1)" "unprognostic (4.96e-2)" "unprognostic (1.71e-2)" "unprognostic (5.27e-2)" "unprognostic (6.55e-9)" "unprognostic (4.35e-2)" "unprognostic (4.28e-1)" "unprognostic (6.10e-2)" "unprognostic (8.10e-2)" 1.1 0.6 0.7 0.6 3.0 0.7 1.0 0.1 4.5 1.0 0.6 1.9 0.0 1.4 0.6 0.6 0.6 0.6 0.9 0.6 4.9 0.7 0.8 0.9 0.7 0.1 1.9 4.8 2.3 0.6 3.6 8.4 0.7 0.6 0.6 1.3 0.6 0.6 1.3 0.6 0.6 0.6 0.0 1.0 0.6 1.2 1.6 7.2 0.6 3.5 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.2 4.2 3.1 5.1 0.0 0.0 1.8 0.0 2.4 0.0 0.8 3.6 0.4 0.0 0.0 0.2 1.6 1.1 1.3 0.0 0.0 0.3 0.0 1.2 0.6 0.0 4.3 3.7 0.0 0.0 0.0 0.8 7.2 0.2 0.0 3.9 0.7 0.8 0.0 1.4 0.2 0.4 0.0 3.7 0.0 0.4 1.2 FSTL3 "FLRG, FSRP" ENSG00000070404 "Follistatin like 3" O95633 19 676365-683399 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Osteogenesis, Transcription, Transcription regulation" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "placenta: 201.0" "Cell type enriched" "Detected in many" 4 "Extravillous trophoblasts: 2939.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 36.2;hTCEpi: 40.0;SiHa: 73.8;U-2197: 38.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB024899, HPA045378" Approved Supported Nucleoplasm "Secreted in other tissues" NA Yes 6800000 Nucleoplasm "CAB024899: , HPA045378: AB_2679300" "unprognostic (9.86e-3)" "unprognostic (1.32e-3)" "prognostic unfavorable (3.01e-4)" "prognostic unfavorable (3.03e-4)" "unprognostic (2.19e-3)" "unprognostic (1.51e-3)" "unprognostic (8.64e-3)" "prognostic unfavorable (4.61e-7)" "unprognostic (9.50e-2)" "prognostic unfavorable (1.65e-4)" "unprognostic (3.50e-2)" "unprognostic (5.91e-2)" "unprognostic (1.03e-3)" "unprognostic (7.22e-3)" "unprognostic (3.07e-1)" "unprognostic (3.75e-1)" "unprognostic (5.89e-3)" 19.9 29.1 4.0 10.7 6.2 5.6 24.7 1.3 4.2 13.1 14.9 3.8 8.1 3.8 12.8 15.6 12.7 14.1 13.1 27.0 5.0 2.0 13.7 5.1 26.9 8.7 7.3 4.5 16.8 11.7 1.4 5.3 201.0 6.0 14.3 3.1 12.0 4.5 11.0 4.1 6.2 6.5 20.6 10.4 3.9 9.1 34.5 4.9 0.7 7.2 5.5 1.4 16.7 18.3 0.9 2.2 0.1 4.4 0.6 2.6 2.0 1.9 15.9 1.1 0.8 5.0 12.8 36.2 27.0 4.0 6.8 2.5 5.8 3.1 0.8 10.9 18.2 3.9 13.9 0.9 23.0 2.2 1.6 1.9 0.7 22.2 4.7 21.6 1.4 2.6 16.0 40.0 7.5 31.3 17.6 1.2 0.8 1.7 1.1 10.2 7.0 0.5 0.8 1.3 13.1 5.5 1.5 0.7 1.8 9.4 0.3 0.7 1.2 73.8 1.5 0.8 1.4 1.3 0.7 16.2 6.8 23.5 38.1 9.9 1.8 0.8 0.4 1.0 4.2 3.1 0.0 4.4 0.0 1.0 4.4 0.2 0.3 1.4 1.1 2.2 0.9 2.6 1.6 0.1 0.6 3.2 0.9 0.2 2.0 4.0 6.2 1.3 4.2 5.0 2.0 7.3 4.5 6.0 4.9 17.9 3.4 2.2 19.6 12.9 1.6 12.8 30.6 2.7 1.2 8.7 0.0 22.7 6.6 69.7 5.6 4.5 0.9 0.0 56.0 2939.6 52.2 21.7 0.0 0.9 68.4 3.2 1.2 22.1 3.8 6.5 56.7 4.0 5.0 11.8 0.9 7.8 198.1 0.0 25.1 5.6 0.5 45.3 32.5 2.3 7.7 6.8 662.4 2.9 1.7 20.7 FURIN "FUR, PACE, PCSK3, SPC1" ENSG00000140564 "Furin, paired basic amino acid cleaving enzyme" P09958 15 90868592-90883458 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "liver: 118.4;placenta: 158.9;salivary gland: 337.9" "Cell type enhanced" "Detected in many" 5 "Exocrine glandular cells: 102.2;Hepatocytes: 114.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009499, HPA067869" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 41000 "Golgi apparatus" Nucleoplasm "CAB009499: AB_2105095, HPA067869: " "unprognostic (2.46e-1)" "unprognostic (2.73e-2)" "unprognostic (7.33e-2)" "unprognostic (2.30e-2)" "unprognostic (4.11e-3)" "unprognostic (4.37e-2)" "unprognostic (8.11e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (2.24e-1)" "unprognostic (9.92e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-1)" "unprognostic (4.52e-3)" "unprognostic (4.57e-2)" "unprognostic (4.46e-2)" "unprognostic (4.27e-3)" "unprognostic (8.20e-2)" 8.3 3.3 3.0 7.5 3.6 16.6 5.9 5.0 4.4 4.1 6.6 2.8 3.5 5.7 4.9 10.8 4.7 4.4 3.9 6.9 3.1 1.8 6.4 118.4 9.5 3.1 2.8 2.7 4.2 22.5 3.8 7.2 158.9 3.5 9.3 2.2 3.0 337.9 4.7 8.7 9.0 5.9 3.1 3.0 8.2 6.0 5.3 2.9 4.8 8.9 5.5 4.1 4.4 4.3 1.5 3.3 10.3 3.3 3.1 1.9 2.0 14.4 8.8 2.0 8.9 14.5 9.4 22.7 18.2 13.9 7.5 5.3 12.9 15.8 0.5 46.8 13.2 13.5 26.0 4.0 9.4 1.6 41.6 10.3 25.3 15.8 16.8 7.7 3.5 41.7 10.6 10.6 8.5 3.9 18.3 24.0 4.2 19.3 2.5 5.0 9.9 1.3 11.4 6.3 12.2 2.6 2.2 7.7 3.3 11.7 11.0 4.0 2.7 15.4 8.4 12.8 9.9 3.0 9.2 35.4 8.5 18.2 13.0 26.6 4.5 25.6 1.2 16.2 11.4 17.2 7.5 3.3 10.3 1.9 1.1 1.4 1.5 1.2 1.2 2.1 1.0 0.6 0.8 7.4 3.1 0.7 3.3 0.9 2.0 3.0 3.6 5.0 4.4 3.1 1.8 2.8 2.7 3.5 2.9 3.0 30.9 6.7 7.5 17.2 11.9 15.0 10.2 1.4 5.7 21.0 23.6 16.5 0.0 44.3 0.4 25.5 23.8 23.3 102.2 11.4 12.3 26.5 15.1 114.9 22.3 7.9 36.4 23.4 26.1 0.2 10.3 24.1 15.1 7.2 27.3 11.7 83.4 21.8 10.3 5.6 25.2 25.8 12.5 2.3 3.4 20.1 70.5 11.7 16.1 13.9 GABRE ENSG00000102287 "Gamma-aminobutyric acid type A receptor epsilon subunit" P78334 X 151953124-151974680 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "placenta: 36.4;vagina: 27.7" "Cell type enhanced" "Detected in many" 9 "Syncytiotrophoblasts: 51.4;Urothelial cells: 32.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "hypothalamus: 21.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 4.4;EFO-21: 14.9;HeLa: 6.7;SiHa: 7.0" "Low region specificity" "Detected in many" HPA045918 Uncertain NA NA "HPA045918: AB_10961281" "unprognostic (1.33e-2)" "unprognostic (6.75e-2)" "unprognostic (3.50e-3)" "unprognostic (1.39e-3)" "unprognostic (2.43e-1)" "unprognostic (7.52e-2)" "unprognostic (5.06e-3)" "unprognostic (1.27e-1)" "unprognostic (3.58e-2)" "unprognostic (1.55e-1)" "unprognostic (6.44e-2)" "unprognostic (6.73e-2)" "prognostic unfavorable (4.05e-11)" "unprognostic (1.96e-2)" "unprognostic (1.39e-1)" "unprognostic (2.29e-2)" "unprognostic (5.28e-2)" 14.8 1.0 1.5 2.2 2.8 0.3 16.5 1.0 1.6 8.9 5.8 0.0 2.2 1.4 6.0 4.1 5.0 1.5 4.2 16.3 1.0 21.8 1.1 0.9 2.3 0.7 1.1 0.6 1.6 2.5 0.4 4.1 36.4 4.5 5.9 0.8 3.8 2.0 6.3 0.9 5.6 10.1 2.5 1.1 0.9 1.0 0.9 0.4 0.0 2.5 5.9 3.5 2.9 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 4.4 0.0 0.0 0.6 0.0 1.1 0.5 2.3 0.8 0.0 14.9 3.1 0.0 2.4 0.0 0.8 0.7 0.0 0.5 1.7 6.7 0.9 0.2 0.0 0.2 1.0 0.7 1.2 0.3 1.4 0.6 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.0 1.0 0.0 1.0 0.0 0.0 1.3 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.8 1.0 1.3 1.0 21.8 1.1 0.6 4.5 0.4 14.9 5.7 0.0 20.6 15.2 0.0 6.4 12.7 2.7 14.8 1.8 0.0 17.3 0.0 3.6 1.7 7.9 9.3 0.0 0.3 2.0 9.7 14.0 0.0 0.8 2.7 0.0 1.7 4.3 0.6 1.8 1.4 0.2 1.7 0.0 1.8 0.5 3.7 8.6 2.1 0.0 0.3 0.0 4.7 1.1 1.7 9.5 51.4 0.5 2.3 32.0 GADD45G "CR6, DDIT2, GADD45gamma, GRP17" ENSG00000130222 "Growth arrest and DNA damage inducible gamma" O95257 9 89605013-89606555 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.6" "Cell type enriched" "Detected in many" 8 "Syncytiotrophoblasts: 1345.9" "Cancer enhanced" "Detected in all" "prostate cancer: 79.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "eosinophil: 8.0" "Lineage enriched" "Detected in single" 22 "granulocytes: 8.0" "Group enriched" "Detected in some" 4 "HDLM-2: 47.8;SCLC-21H: 25.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA023606 Approved NA NA "HPA023606: AB_1849409" "unprognostic (5.84e-2)" "unprognostic (1.61e-2)" "unprognostic (1.08e-2)" "prognostic favorable (7.06e-4)" "unprognostic (4.45e-2)" "unprognostic (1.85e-1)" "unprognostic (1.77e-3)" "unprognostic (3.75e-2)" "unprognostic (7.65e-3)" "unprognostic (4.16e-3)" "prognostic favorable (3.80e-5)" "unprognostic (1.11e-1)" "unprognostic (1.63e-2)" "unprognostic (4.95e-1)" "unprognostic (3.88e-2)" "unprognostic (3.41e-1)" "unprognostic (1.22e-1)" 7.0 23.6 4.6 4.4 7.7 8.4 6.7 4.8 5.4 23.3 7.4 2.8 12.0 4.2 21.3 6.5 6.1 6.4 5.9 53.4 4.1 3.8 6.7 48.4 4.6 1.5 5.3 3.7 14.1 28.7 4.9 25.4 65.6 7.4 12.7 1.6 3.0 14.7 10.2 58.0 5.5 6.0 5.5 6.7 1.3 6.5 13.0 3.0 0.8 8.4 26.8 2.6 5.1 6.2 0.0 0.2 8.0 0.3 0.0 0.1 0.1 1.2 0.0 6.8 0.0 0.0 0.0 9.0 0.4 0.0 0.0 0.0 1.0 0.1 0.0 1.1 0.0 0.3 1.0 2.2 0.0 0.0 47.8 0.4 0.1 0.1 0.0 0.3 0.0 0.1 0.2 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.9 0.1 0.4 6.3 1.1 0.1 0.5 2.0 0.4 0.0 0.3 25.2 5.7 0.4 2.6 0.0 1.3 1.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 8.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.1 0.1 4.6 7.7 4.8 5.4 4.1 3.8 5.3 3.7 7.4 3.0 6.0 50.9 0.5 17.9 25.3 38.5 139.3 68.8 34.8 33.0 10.4 5.9 64.8 77.9 10.9 1.3 20.7 22.6 0.0 37.3 9.4 67.6 115.9 18.5 161.3 53.6 3.2 52.5 8.6 11.6 7.4 78.2 47.7 33.7 19.0 25.9 28.3 24.6 5.7 42.8 35.3 19.1 129.4 86.5 1.1 1.6 17.1 1345.9 12.1 9.3 8.4 GCM1 "GCMA, hGCMa" ENSG00000137270 "Glial cells missing homolog 1" Q9NP62 6 53126964-53148829 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "placenta: 102.4" "Group enriched" "Detected in some" 7 "Extravillous trophoblasts: 166.4;Syncytiotrophoblasts: 222.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.5" "Group enriched" "Detected in many" 8 "B-cells: 1.8;granulocytes: 4.5" "Cell line enriched" "Detected in some" 5 "BEWO: 30.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011343, HPA073469" Enhanced Approved Vesicles NA NA Vesicles "HPA011343: AB_2668489, HPA073469: " "unprognostic (2.81e-2)" "unprognostic (4.09e-2)" "unprognostic (1.89e-2)" "unprognostic (1.53e-1)" "unprognostic (3.17e-1)" "unprognostic (7.68e-2)" "unprognostic (8.47e-3)" "unprognostic (2.83e-2)" "unprognostic (2.81e-1)" "unprognostic (4.04e-2)" "unprognostic (1.42e-1)" "unprognostic (5.98e-2)" "unprognostic (1.29e-4)" "unprognostic (1.86e-1)" "unprognostic (7.42e-2)" "unprognostic (2.96e-2)" 0.3 0.3 0.1 0.1 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.0 1.5 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.2 102.4 0.1 0.2 0.0 0.1 0.1 0.1 3.1 0.0 0.4 0.1 0.1 2.2 0.0 2.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.8 0.2 4.5 0.3 0.4 0.3 0.1 0.1 0.1 0.1 0.2 0.0 0.0 30.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.1 0.0 6.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.0 0.1 0.1 0.6 0.3 2.2 0.2 0.1 0.2 0.7 0.1 0.1 0.2 1.8 0.2 0.2 4.5 0.4 0.3 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.3 1.9 0.0 0.0 0.0 0.2 166.4 0.0 0.1 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.7 0.0 0.0 0.2 0.0 0.0 0.0 222.5 0.0 0.0 0.0 GDF15 "MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB" ENSG00000130513 "Growth differentiation factor 15" Q99988 19 18374731-18389176 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 463.0" "Cell type enhanced" "Detected in many" 18 "Glandular cells: 1046.1;Syncytiotrophoblasts: 3600.0;Urothelial cells: 2603.9" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in single" 10 "pons and medulla: 6.5" "Cell type enhanced" "Detected in some" "neutrophil: 6.3" "Group enriched" "Detected in many" 5 "granulocytes: 6.3;monocytes: 2.3" "Cell line enhanced" "Detected in many" "BEWO: 72.3;Hep G2: 37.2;HHSteC: 100.5;TIME: 36.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011191, CAB062554, HPA070957" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 1260000 890000 "Golgi apparatus" "CAB062554: AB_2665632, HPA011191: AB_1078962, HPA070957: AB_2732168" "unprognostic (1.04e-1)" "unprognostic (1.89e-2)" "unprognostic (3.45e-2)" "unprognostic (3.36e-2)" "unprognostic (2.04e-2)" "unprognostic (2.39e-2)" "unprognostic (2.03e-2)" "unprognostic (2.30e-2)" "unprognostic (2.80e-1)" "unprognostic (2.89e-1)" "unprognostic (5.09e-2)" "unprognostic (1.46e-1)" "unprognostic (6.55e-3)" "unprognostic (3.81e-2)" "unprognostic (8.45e-2)" "unprognostic (1.25e-1)" "unprognostic (3.04e-3)" 13.4 2.2 0.4 1.0 0.6 0.0 13.1 0.4 0.5 3.9 13.0 1.0 1.9 1.8 5.9 1.9 2.4 1.1 13.1 1.2 0.5 0.0 64.7 24.1 12.6 0.8 0.4 0.5 2.9 21.9 0.3 2.4 463.0 6.5 25.5 11.0 1.6 2.4 5.1 13.6 1.1 1.8 4.8 1.2 1.4 12.0 2.5 0.4 0.4 5.2 0.5 0.8 47.0 2.7 0.2 0.8 6.3 2.3 0.0 0.0 0.3 0.3 16.2 1.6 0.6 3.9 3.3 72.3 5.6 3.0 0.2 3.3 0.7 5.0 0.0 10.2 0.5 16.9 0.1 0.0 2.0 0.8 0.0 0.3 0.2 1.5 37.2 100.5 0.0 6.2 8.6 24.3 15.7 10.2 0.1 17.1 0.0 24.8 0.1 3.9 3.9 0.0 0.1 0.9 5.7 9.0 0.0 0.6 0.0 11.9 15.9 0.1 0.1 0.0 0.9 20.2 6.4 0.4 0.0 36.0 0.0 1.3 0.3 0.2 0.2 0.6 0.0 9.0 0.0 4.7 0.0 1.8 2.1 0.0 1.4 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 6.3 0.0 2.3 0.0 0.0 0.3 0.4 0.6 0.4 0.5 0.5 0.0 0.4 0.5 6.5 0.4 32.8 67.9 2.2 222.2 1.1 0.0 0.4 45.9 80.3 68.2 246.0 0.0 48.7 28.2 235.7 0.0 5.8 50.0 0.0 324.0 161.2 17.1 1046.1 28.8 5.0 31.5 0.0 81.4 3.7 1.8 0.0 0.9 5.9 3.3 17.2 220.9 0.2 679.3 95.1 1.4 74.0 0.5 0.0 14.6 0.0 0.6 1.5 3600.0 0.5 186.1 2603.9 GDF6 "BMP13, KFS, KFS1, SGM1" ENSG00000156466 "Growth differentiation factor 6" Q6KF10 8 96142330-96160792 "Disease related genes, Predicted secreted proteins" Apoptosis "Cytokine, Developmental protein, Growth factor" "Disease mutation, Dwarfism, Leber congenital amaurosis, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 11.8;placenta: 16.9" "Cell type enhanced" "Detected in some" 13 "Cardiomyocytes: 2.0;Distal tubular cells: 1.7" "Cancer enhanced" "Detected in some" "renal cancer: 2.8" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.2" "Group enriched" "Detected in some" 6 "hTERT-RPE1: 15.4;LHCN-M2: 24.5;SuSa: 12.5" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.6" HPA045206 Uncertain Supported "Nucleoplasm,Nuclear membrane,Vesicles" "Secreted to blood" NA NA Vesicles "Nucleoplasm, Nuclear membrane" "HPA045206: AB_10962508" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.83e-2)" "unprognostic (9.66e-9)" "unprognostic (6.49e-2)" "unprognostic (1.47e-1)" "unprognostic (1.41e-1)" "unprognostic (3.18e-2)" "unprognostic (3.80e-3)" "unprognostic (1.09e-3)" "unprognostic (5.37e-2)" "unprognostic (8.13e-3)" "prognostic unfavorable (2.17e-4)" "unprognostic (5.88e-4)" "unprognostic (1.88e-2)" "unprognostic (2.68e-2)" "unprognostic (1.71e-1)" 2.5 0.2 1.4 1.5 0.9 0.0 0.8 0.1 1.7 0.3 1.4 0.3 1.5 0.6 3.0 0.7 0.8 1.0 6.6 11.8 0.9 1.0 0.4 0.7 0.4 1.9 0.9 0.1 2.2 1.3 0.1 0.3 16.9 1.1 0.6 0.5 2.9 0.1 2.7 0.8 0.0 1.6 1.8 0.2 0.1 1.4 1.1 1.1 0.1 1.4 0.1 0.1 3.2 2.1 0.1 1.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.8 0.4 2.9 1.9 0.0 1.7 1.5 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 2.4 0.0 0.4 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.2 0.0 15.4 0.1 0.0 0.0 0.0 24.5 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.0 0.6 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.4 0.9 0.1 1.7 0.9 1.0 0.9 0.1 1.1 1.1 0.0 0.0 0.0 0.4 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.7 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.2 0.0 0.0 0.0 GDPD5 "GDE2, PP1665" ENSG00000158555 "Glycerophosphodiester phosphodiesterase domain containing 5" Q8WTR4 11 75434640-75525903 "Predicted membrane proteins" Neurogenesis Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 37.2;placenta: 41.7" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 64.5;Cone photoreceptor cells: 139.4;Late spermatids: 125.5;Rod photoreceptor cells: 81.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.3" "Group enriched" "Detected in many" 5 "granulocytes: 9.3;T-cells: 3.1" "Cell line enhanced" "Detected in many" "EFO-21: 17.4;fHDF/TERT166: 16.6;HDLM-2: 34.0;U-2 OS: 16.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065257, HPA066762, HPA069281" Uncertain Approved "Golgi apparatus" No No "Golgi apparatus" "HPA065257: AB_2685447, HPA066762: AB_2685715, HPA069281: AB_2686107" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (2.37e-1)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.48e-1)" "unprognostic (6.12e-2)" "unprognostic (9.97e-3)" "unprognostic (4.05e-1)" "unprognostic (1.44e-1)" "unprognostic (3.49e-1)" "unprognostic (3.07e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (6.59e-9)" "unprognostic (8.64e-2)" "unprognostic (1.30e-1)" "unprognostic (4.39e-2)" "unprognostic (1.65e-1)" 16.5 6.0 3.3 3.3 4.6 7.8 8.0 23.2 7.9 3.3 3.0 3.3 1.6 2.0 6.4 3.1 1.6 3.2 3.6 2.8 3.0 1.8 2.3 2.7 5.4 4.3 3.0 2.6 2.9 13.4 0.4 7.0 41.7 4.2 3.1 1.3 18.8 15.5 4.1 5.9 2.3 3.2 4.9 3.4 37.2 1.4 11.9 5.5 2.0 2.6 1.4 3.4 3.5 11.5 1.1 1.1 9.3 1.2 0.0 3.1 0.7 1.0 3.8 1.7 1.9 1.1 0.6 5.8 1.2 1.6 0.6 0.4 5.1 2.3 7.3 17.4 16.6 4.3 2.4 2.1 1.9 0.3 34.0 1.6 1.3 5.9 10.6 1.7 0.8 5.7 1.3 1.0 0.4 0.8 1.7 13.9 6.6 2.3 3.3 0.7 2.2 1.9 3.6 3.0 1.8 5.5 2.2 0.5 1.9 0.4 1.8 0.9 0.6 2.5 9.6 4.6 2.3 1.4 3.2 4.1 3.9 16.2 3.1 1.3 0.8 0.1 1.3 0.9 4.3 0.4 9.3 1.2 0.7 2.0 0.6 2.9 1.1 2.3 1.6 0.3 0.4 1.2 1.5 0.1 0.0 0.0 1.1 3.1 0.7 3.3 4.6 23.2 7.9 3.0 1.8 3.0 2.6 4.2 5.5 6.0 0.0 0.0 0.2 0.9 64.5 2.8 0.0 1.4 1.2 0.0 139.4 2.3 0.0 3.7 37.5 1.8 0.3 0.0 8.0 0.9 3.3 0.9 4.6 1.9 1.8 4.8 0.0 21.5 4.1 125.5 5.5 3.4 5.0 1.8 0.5 5.6 5.4 0.0 2.5 0.0 81.6 0.0 1.3 4.7 7.7 1.0 38.4 2.2 0.2 0.4 GH2 "GH-V, GHL, GHV, hGH-V" ENSG00000136487 "Growth hormone 2" P01242 17 63880215-63881935 "Cancer-related genes, Predicted secreted proteins" Hormone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 309 "pituitary gland: 47.3;placenta: 138.4" "Group enriched" "Detected in some" 22 "Extravillous trophoblasts: 7.9;Syncytiotrophoblasts: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "BEWO: 13.7" HPA043715 Supported "Secreted to blood" NA NA "HPA043715: AB_2678632" "unprognostic (1.02e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.3 138.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 19.8 0.0 0.0 0.0 GJA5 CX40 ENSG00000265107 "Gap junction protein alpha 5" P36382 1 147756199-147773362 "Disease related genes, Predicted membrane proteins" "Atrial fibrillation, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "placenta: 60.6" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 113.4;Extravillous trophoblasts: 273.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SK-BR-3: 55.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB013080, HPA071370" Enhanced NA NA "CAB013080: AB_2533263, HPA071370: " "unprognostic (1.25e-1)" "unprognostic (6.34e-2)" "unprognostic (1.22e-2)" "unprognostic (2.94e-2)" "unprognostic (3.88e-2)" "unprognostic (8.95e-2)" "unprognostic (1.23e-3)" "unprognostic (5.50e-2)" "unprognostic (1.38e-1)" "unprognostic (1.16e-1)" "unprognostic (4.27e-2)" "unprognostic (7.57e-2)" "unprognostic (1.97e-2)" "unprognostic (2.44e-1)" "unprognostic (4.41e-2)" "unprognostic (3.43e-2)" "unprognostic (8.93e-2)" 8.8 0.2 0.6 1.5 1.1 0.0 2.1 0.7 0.7 2.1 2.2 0.8 2.8 0.6 1.2 1.6 1.2 2.6 1.7 15.1 0.9 7.0 0.2 9.3 0.3 0.9 0.0 2.2 0.7 0.8 0.0 60.6 1.2 1.6 0.9 2.0 0.2 3.1 1.7 0.0 1.4 2.5 0.9 1.9 0.0 1.3 0.3 0.0 2.1 0.4 0.5 2.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.0 0.1 0.0 0.0 0.0 2.3 1.8 0.9 0.9 0.2 0.0 0.1 0.0 0.6 0.3 0.0 0.1 0.0 3.8 1.5 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.1 55.6 0.0 5.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 3.0 6.2 0.5 0.0 0.0 0.0 9.4 0.0 1.4 0.0 3.5 0.0 113.4 0.0 0.0 6.1 2.1 0.0 0.0 0.0 273.7 2.1 0.0 0.0 0.0 13.6 0.0 0.0 30.1 0.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.8 4.7 1.4 0.4 0.3 26.0 0.0 0.0 0.0 GJB7 "bA136M9.1, CX25" ENSG00000164411 "Gap junction protein beta 7" Q6PEY0 6 87282978-87329278 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "fallopian tube: 12.3;pituitary gland: 10.0;placenta: 4.5" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 29.4;Cytotrophoblasts: 7.7;Extravillous trophoblasts: 4.4;Syncytiotrophoblasts: 6.1" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 6.5;HDLM-2: 10.5;MCF7: 5.8;OE19: 6.7;RT4: 5.2;SuSa: 3.6" "Low region specificity" "Detected in many" HPA014392 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014392: " "unprognostic (8.30e-2)" "unprognostic (2.45e-1)" "unprognostic (3.06e-1)" "unprognostic (4.20e-1)" "unprognostic (2.84e-1)" "unprognostic (4.07e-3)" "unprognostic (2.61e-1)" "unprognostic (5.13e-3)" "unprognostic (6.69e-3)" "unprognostic (1.59e-1)" "unprognostic (3.82e-2)" "unprognostic (4.15e-2)" "unprognostic (3.24e-1)" "unprognostic (5.64e-2)" "unprognostic (2.09e-2)" "unprognostic (3.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 12.3 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 10.0 4.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.1 0.5 0.0 0.7 0.1 1.0 0.0 0.0 1.3 0.0 2.1 0.0 0.1 0.1 0.0 0.0 6.5 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 5.8 0.0 0.1 1.8 6.7 0.0 0.2 0.0 0.0 0.0 5.2 0.1 0.0 1.2 0.0 0.0 3.6 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.1 0.6 1.3 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 29.4 0.0 0.0 0.0 7.7 0.0 0.0 0.6 0.0 0.0 0.0 0.2 4.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.2 0.1 0.0 6.1 0.0 0.2 0.1 GLDC "GCSP, NKH" ENSG00000178445 "Glycine decarboxylase" P23378 9 6532464-6645783 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 22.3;liver: 40.3;placenta: 10.6" "Cell type enhanced" "Detected in many" 17 "Cytotrophoblasts: 59.4;Extravillous trophoblasts: 35.6;Hepatocytes: 126.2;Syncytiotrophoblasts: 38.4" "Cancer enhanced" "Detected in many" "testis cancer: 41.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 66.8;CACO-2: 15.9;HMC-1: 14.5;RPTEC TERT1: 27.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002318, HPA052887" Enhanced Supported Nucleoplasm,Mitochondria NA NA 570000 Mitochondria Nucleoplasm "HPA002318: AB_1849700, HPA052887: AB_2681980" "unprognostic (6.73e-2)" "unprognostic (1.19e-1)" "unprognostic (6.50e-2)" "prognostic unfavorable (5.24e-5)" "unprognostic (1.50e-1)" "unprognostic (7.87e-2)" "unprognostic (1.81e-1)" "unprognostic (1.50e-1)" "unprognostic (2.40e-1)" "unprognostic (1.74e-1)" "unprognostic (2.47e-2)" "unprognostic (2.69e-1)" "prognostic favorable (3.50e-4)" "unprognostic (1.65e-2)" "unprognostic (1.27e-1)" "unprognostic (5.62e-3)" "unprognostic (1.17e-2)" 0.2 0.3 3.9 1.0 3.4 0.4 0.4 3.1 5.6 0.3 0.8 1.6 0.0 0.7 0.4 4.2 1.4 0.6 0.6 0.1 2.9 2.2 22.3 40.3 0.8 1.1 1.9 2.9 0.3 0.1 0.0 1.7 10.6 2.1 0.4 0.3 3.2 0.9 0.8 0.9 1.5 0.6 0.1 1.9 0.8 0.8 1.1 1.8 0.0 2.6 0.0 1.9 0.8 0.0 2.9 0.7 2.3 0.5 0.8 0.6 1.1 0.1 1.3 0.6 7.2 0.0 0.1 66.8 0.0 0.0 0.0 0.0 15.9 0.1 0.1 1.6 0.0 0.2 0.1 0.0 0.1 0.0 0.3 3.8 0.0 0.0 10.6 0.0 0.0 14.5 0.0 0.0 0.5 0.0 0.2 2.7 1.2 0.0 0.1 0.3 0.3 0.2 0.0 7.8 1.2 1.2 0.3 0.0 0.1 27.7 0.3 6.4 3.3 0.0 6.2 0.0 4.1 1.4 0.0 0.9 0.1 0.2 0.8 0.3 0.3 9.2 0.0 0.2 0.7 1.5 1.5 0.5 0.5 0.5 0.3 0.5 2.9 0.6 0.4 0.1 0.9 0.4 0.5 2.3 0.8 0.5 0.7 0.2 1.1 3.9 3.4 3.1 5.6 2.9 2.2 1.9 2.9 2.1 1.8 0.0 0.0 4.3 0.0 0.0 0.3 0.6 7.6 0.0 0.0 29.6 0.0 59.4 5.0 0.0 8.8 0.0 0.0 0.0 0.2 35.6 0.0 0.0 0.0 126.2 6.1 0.0 0.0 3.1 2.1 9.0 0.3 0.0 0.0 0.0 0.0 8.6 0.1 0.0 0.0 29.3 0.2 0.0 0.3 4.4 5.0 0.0 38.4 0.5 0.0 0.0 GM2A SAP-3 ENSG00000196743 "GM2 ganglioside activator" P17900 5 151212150-151270440 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Sphingolipid metabolism" Hydrolase "Disease mutation, Gangliosidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 108.7" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 163.9;Hofbauer cells: 98.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "B-cells: 15.9;dendritic cells: 19.0;monocytes: 19.4" "Cell line enhanced" "Detected in many" "BEWO: 44.5;HBEC3-KT: 61.5;hTCEpi: 61.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008063 Enhanced Approved Vesicles,Cytosol "Intracellular and membrane" NA NA 23000000 "Vesicles, Cytosol" "HPA008063: AB_1849842" "unprognostic (4.33e-2)" "unprognostic (8.97e-3)" "unprognostic (2.27e-1)" "unprognostic (3.01e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "prognostic unfavorable (1.77e-5)" "unprognostic (1.22e-1)" "unprognostic (1.72e-2)" "unprognostic (1.31e-2)" "unprognostic (1.50e-2)" "unprognostic (5.33e-3)" "unprognostic (9.81e-2)" "unprognostic (4.24e-2)" "unprognostic (4.42e-2)" "unprognostic (3.02e-2)" "unprognostic (1.65e-1)" 55.8 16.1 17.8 15.5 18.8 9.6 15.2 8.1 15.2 20.5 10.3 31.7 6.4 8.4 9.5 17.3 39.5 8.8 12.6 13.8 18.0 12.6 7.5 13.2 24.8 30.2 22.4 13.0 12.2 9.3 11.7 5.6 108.7 18.9 11.9 14.5 14.1 13.3 10.4 3.9 42.8 11.2 10.9 35.9 28.5 8.2 8.9 15.3 21.9 7.1 25.9 39.7 21.0 32.0 15.9 19.0 4.2 19.4 1.9 3.3 8.0 4.6 3.0 3.2 15.3 21.3 10.6 44.5 7.3 15.8 4.0 5.5 6.3 5.4 15.0 7.7 5.6 11.0 12.7 3.5 61.5 5.8 8.4 2.2 2.4 3.8 7.7 5.2 3.9 25.2 14.2 61.3 5.2 3.5 5.6 5.8 19.1 2.3 6.5 6.3 1.9 8.2 3.7 2.2 2.3 6.9 3.7 1.5 9.4 3.9 9.1 0.8 2.9 6.0 28.4 12.0 11.7 6.5 4.6 5.1 10.0 3.9 8.2 2.2 16.2 19.3 41.1 11.4 6.2 4.1 3.5 19.4 1.1 1.9 6.5 1.4 14.9 2.3 2.0 19.0 15.9 3.3 2.5 4.2 1.9 1.4 13.7 2.4 8.0 17.8 18.8 8.1 13.9 18.0 12.6 22.4 13.0 18.9 15.3 14.9 23.1 14.7 13.3 13.3 4.5 26.2 0.0 13.4 12.5 17.4 2.0 45.1 1.7 5.8 0.4 6.3 4.6 0.0 6.9 163.9 8.0 7.4 66.0 16.3 98.1 6.4 3.5 7.4 38.4 1.1 7.5 34.4 8.5 55.1 5.0 8.0 5.4 3.5 13.1 4.5 3.1 0.0 5.7 1.4 4.9 20.8 43.8 3.8 5.6 32.5 GPC3 "DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1" ENSG00000147257 "Glypican 3" P51654 X 133535745-133985895 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 262.7" "Cell type enhanced" "Detected in many" 10 "Fibroblasts: 127.3;Muller glia cells: 96.7;Syncytiotrophoblasts: 124.3" "Cancer enhanced" "Detected in all" "liver cancer: 269.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 5.0;naive CD8 T-cell: 3.5;NK-cell: 1.7" "Group enriched" "Detected in many" 12 "NK-cells: 1.7;T-cells: 5.0" "Group enriched" "Detected in some" 5 "HAP1: 54.2;Hep G2: 214.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA006316 Supported "Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "HPA006316: AB_1078994" "unprognostic (2.06e-1)" "unprognostic (2.36e-1)" "unprognostic (9.51e-2)" "unprognostic (4.17e-2)" "unprognostic (1.78e-1)" "unprognostic (1.46e-1)" "unprognostic (6.10e-2)" "unprognostic (1.17e-2)" "unprognostic (2.07e-2)" "unprognostic (3.92e-3)" "unprognostic (6.06e-2)" "unprognostic (1.71e-1)" "unprognostic (3.81e-3)" "prognostic unfavorable (4.83e-4)" "unprognostic (1.43e-1)" "unprognostic (2.21e-1)" "unprognostic (1.60e-1)" 30.1 5.9 0.4 3.6 0.7 0.0 50.2 0.6 0.4 3.3 4.5 0.5 2.2 0.5 2.5 11.7 2.0 3.4 9.2 8.0 0.4 1.1 21.2 1.1 37.0 1.9 1.6 0.4 6.0 4.6 0.3 16.9 262.7 1.6 3.6 1.0 6.3 3.8 2.3 4.1 5.5 1.8 3.3 2.1 0.9 4.0 2.1 0.3 2.3 7.2 11.2 3.0 7.6 8.0 0.0 0.2 0.0 0.0 1.7 5.0 0.6 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 54.2 0.0 0.0 0.0 2.5 0.0 0.1 214.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.5 0.0 0.0 0.0 0.0 0.0 14.8 0.7 1.8 4.4 0.0 0.0 0.0 26.0 0.0 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.5 0.2 0.0 5.0 3.5 0.0 1.7 0.0 0.0 0.0 0.6 0.4 0.7 0.6 0.4 0.4 1.1 1.6 0.4 1.6 0.3 0.0 1.7 0.0 5.4 9.3 0.2 0.3 0.0 44.2 35.2 5.2 0.0 43.0 16.6 0.3 0.9 0.5 0.3 0.0 1.3 32.7 127.3 0.9 0.0 0.0 24.0 0.0 1.7 2.5 0.0 1.3 9.8 1.4 3.3 0.0 1.5 96.7 2.2 0.2 2.8 26.9 1.9 0.0 5.0 1.6 6.1 3.4 124.3 0.0 2.1 0.5 GPR1 ENSG00000183671 "G protein-coupled receptor 1" P46091 2 206175316-206218047 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 19.1" "Group enriched" "Detected in some" 8 "Extravillous trophoblasts: 10.0;Muller glia cells: 4.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 10.7;pons and medulla: 6.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "HHSteC: 53.7;hTCEpi: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010525 Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Plasma membrane" "Nucleoplasm, Vesicles" "HPA010525: AB_1078919" "unprognostic (5.32e-2)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (2.25e-2)" "unprognostic (3.27e-5)" "unprognostic (1.36e-1)" "unprognostic (4.00e-3)" "unprognostic (1.49e-2)" "unprognostic (7.89e-2)" "unprognostic (9.94e-2)" "unprognostic (3.42e-3)" "unprognostic (5.65e-2)" "unprognostic (4.29e-4)" "unprognostic (8.48e-4)" "unprognostic (1.21e-1)" "unprognostic (2.68e-2)" "unprognostic (3.06e-3)" 2.3 5.0 0.5 0.6 10.7 0.1 1.7 0.4 1.2 4.1 0.6 4.8 1.6 0.2 1.3 0.7 6.6 1.1 2.7 3.8 1.6 0.5 0.7 0.0 0.5 3.1 0.2 0.3 3.2 0.1 0.0 0.4 19.1 6.6 0.7 0.6 1.1 1.5 0.4 1.5 6.7 0.5 2.3 0.3 0.2 0.2 1.6 1.0 0.0 0.7 2.2 1.2 3.1 7.7 0.5 0.1 1.4 0.2 0.5 0.2 0.6 0.8 0.1 0.7 0.0 0.1 3.0 0.2 5.5 9.5 3.4 2.9 0.0 0.0 0.0 0.3 2.7 0.2 0.1 0.2 0.0 1.1 0.0 0.1 0.0 1.8 0.0 53.7 0.0 0.0 2.2 24.2 4.9 7.9 4.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 2.7 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.1 2.4 1.1 0.0 0.0 0.6 0.0 0.0 0.1 4.1 1.9 4.8 0.4 0.0 0.0 0.0 1.5 0.0 0.1 1.3 0.2 0.3 0.2 0.0 0.1 0.3 0.2 0.1 0.0 0.5 0.2 0.2 1.4 0.5 0.1 0.1 0.2 0.6 0.5 10.7 0.4 1.2 1.6 0.5 0.2 0.3 6.6 1.0 0.0 0.0 0.0 0.6 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.9 0.6 0.0 0.0 0.3 GPR78 ENSG00000155269 "G protein-coupled receptor 78" Q96P69 4 8558725-8619761 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "placenta: 53.3" "Cell type enriched" "Detected in some" 5 "Extravillous trophoblasts: 4.8" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 202 "BEWO: 21.7" HPA013209 Uncertain NA NA "HPA013209: AB_10601657" "unprognostic (6.41e-2)" "unprognostic (1.77e-2)" "unprognostic (1.17e-2)" "unprognostic (2.51e-1)" "unprognostic (1.81e-2)" "unprognostic (3.70e-2)" "unprognostic (3.82e-4)" "unprognostic (6.46e-3)" "unprognostic (1.20e-1)" "unprognostic (3.80e-2)" "unprognostic (2.29e-1)" "unprognostic (4.88e-15)" "unprognostic (5.55e-3)" "unprognostic (3.93e-2)" "unprognostic (9.90e-3)" "unprognostic (8.15e-2)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 GRAMD2A GRAMD2 ENSG00000175318 "GRAM domain containing 2A" Q8IUY3 15 72159807-72197785 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 24.6;placenta: 49.2" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 65.5;Cytotrophoblasts: 93.9;Syncytiotrophoblasts: 123.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "myeloid DC: 2.3" "Lineage enriched" "Detected in single" 7 "dendritic cells: 2.3" "Group enriched" "Detected in some" 12 "BEWO: 59.5;SK-BR-3: 27.1" "Low region specificity" "Detected in many" HPA029435 Uncertain Approved "Nucleoli,Nuclear speckles,Cytosol" NA NA "Nucleoli, Nuclear speckles" Cytosol "HPA029435: AB_10601811" "unprognostic (5.70e-2)" "unprognostic (7.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.24e-1)" "unprognostic (9.51e-3)" "unprognostic (2.95e-1)" "unprognostic (9.96e-2)" "unprognostic (3.90e-3)" "unprognostic (2.80e-1)" "unprognostic (1.96e-1)" "unprognostic (2.62e-1)" "unprognostic (5.77e-2)" "unprognostic (4.45e-1)" "unprognostic (2.35e-1)" "unprognostic (6.33e-2)" "prognostic unfavorable (7.01e-4)" "unprognostic (7.29e-2)" 0.1 0.0 2.0 0.2 4.5 0.0 6.8 1.1 1.0 3.1 0.7 1.2 9.8 0.6 0.4 24.6 1.0 8.2 0.8 0.1 2.9 6.5 1.9 0.1 9.7 0.2 1.1 0.1 1.1 1.0 0.2 0.9 49.2 3.9 1.2 0.5 1.0 1.8 4.0 0.3 1.5 3.6 0.1 1.0 0.1 0.4 0.7 0.9 0.2 7.7 1.3 1.1 0.3 0.6 0.0 2.3 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 59.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.4 0.0 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 27.1 0.0 2.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 4.5 1.1 1.0 2.9 6.5 1.1 0.1 3.9 0.9 65.5 13.3 0.0 0.0 0.0 0.0 0.0 0.0 18.7 13.6 3.5 0.0 93.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 1.1 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 123.0 0.0 0.0 0.0 GRHL2 "BOM, DFNA28, FLJ13782, TFCP2L3" ENSG00000083307 "Grainyhead like transcription factor 2" Q6ISB3 8 101492432-101669726 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Corneal dystrophy, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 47.9;seminal vesicle: 42.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 29.8;Ciliated cells: 40.2;Club cells: 27.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "NK-cell: 1.2" "Lineage enriched" "Detected in single" 5 "NK-cells: 1.2" "Cell line enhanced" "Detected in some" "A-431: 15.6;CACO-2: 11.4;HaCaT: 19.1;hTCEpi: 14.9;MCF7: 13.1;OE19: 15.3;RT4: 28.1;T-47d: 33.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004820, HPA062839" Uncertain Supported Nucleoplasm NA NA Nucleoplasm "HPA004820: AB_1857928, HPA062839: AB_2684878" "prognostic unfavorable (6.43e-4)" "unprognostic (2.54e-2)" "unprognostic (4.09e-2)" "unprognostic (2.95e-2)" "unprognostic (2.68e-1)" "unprognostic (4.79e-2)" "unprognostic (1.90e-1)" "unprognostic (2.66e-1)" "unprognostic (1.64e-1)" "unprognostic (8.59e-2)" "prognostic unfavorable (6.27e-4)" "unprognostic (2.61e-2)" "unprognostic (8.29e-4)" "unprognostic (4.54e-3)" "unprognostic (2.64e-1)" "unprognostic (1.08e-1)" "unprognostic (1.03e-2)" 0.4 0.3 0.4 3.3 0.4 0.0 11.3 0.3 0.4 6.0 9.9 0.0 34.7 2.1 1.6 16.4 18.7 5.2 10.3 0.4 0.4 0.4 6.4 0.7 11.3 0.0 0.4 0.0 1.5 22.1 7.1 1.5 47.9 0.1 15.2 5.6 0.1 15.0 42.4 0.4 18.0 8.6 1.6 0.4 0.4 5.9 0.6 0.0 1.7 12.7 14.3 12.2 7.4 8.4 0.0 0.0 0.0 0.0 1.2 0.2 0.0 15.6 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 11.4 7.8 0.0 0.0 0.0 0.0 19.1 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 28.1 0.5 0.0 0.0 6.2 0.0 1.9 33.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.0 0.1 0.0 29.8 8.8 0.0 9.3 21.6 0.0 0.4 10.2 40.2 27.3 10.4 0.0 12.4 5.0 6.5 2.2 0.4 5.9 0.0 4.8 5.9 0.8 10.0 0.0 0.0 1.3 0.0 1.2 0.0 0.0 4.1 0.0 0.0 1.7 1.0 10.0 0.0 7.4 7.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 22.7 16.6 0.0 7.6 5.1 GSE1 KIAA0182 ENSG00000131149 "Gse1 coiled-coil protein" Q14687 16 85169525-85676204 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.9" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 137.4;Syncytiotrophoblasts: 152.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 43.6;K-562: 48.4;T-47d: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036365, HPA042090" Approved Approved Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "HPA036365: AB_10601762, HPA042090: " "unprognostic (1.12e-2)" "unprognostic (6.29e-2)" "unprognostic (1.12e-1)" "unprognostic (4.57e-2)" "unprognostic (5.31e-2)" "unprognostic (1.63e-1)" "unprognostic (1.76e-1)" "unprognostic (1.77e-1)" "unprognostic (2.60e-1)" "unprognostic (6.41e-2)" "prognostic favorable (5.20e-4)" "unprognostic (2.29e-3)" "unprognostic (1.32e-3)" "unprognostic (8.41e-2)" "unprognostic (8.46e-2)" "unprognostic (3.81e-1)" "unprognostic (1.88e-1)" 15.8 11.1 4.9 18.2 6.6 17.3 21.4 18.0 9.5 13.5 14.9 2.9 14.6 9.7 11.0 11.7 11.6 10.9 16.1 18.7 3.8 5.8 11.1 10.1 23.5 6.5 3.8 5.7 17.8 28.0 34.4 26.9 81.9 3.7 8.7 7.2 18.2 17.7 25.2 22.5 13.3 14.8 8.8 4.2 12.1 13.2 10.4 2.1 59.0 14.9 12.0 17.4 10.2 16.9 3.5 2.5 4.5 6.0 1.9 3.2 1.1 4.5 8.2 5.5 13.8 3.5 3.2 43.6 6.2 4.3 3.5 1.3 7.0 6.3 2.7 7.5 7.0 3.1 4.3 8.7 2.3 1.8 5.0 7.3 19.8 7.7 8.6 4.6 9.1 11.3 6.1 5.7 3.7 1.8 3.6 0.9 16.1 48.4 0.5 1.1 30.7 32.6 8.0 9.6 5.0 2.4 21.5 1.8 6.9 3.2 1.7 35.9 24.9 12.2 22.9 1.1 5.2 49.9 22.8 1.5 7.2 9.0 1.9 1.6 7.5 4.5 15.9 4.1 5.8 6.3 4.0 1.6 4.5 3.2 2.9 3.1 3.5 1.2 2.0 2.5 3.4 0.6 2.4 1.3 1.9 6.0 0.0 0.0 1.1 4.9 6.6 18.0 9.5 3.8 5.8 3.8 5.7 3.7 2.1 62.5 65.7 11.5 7.5 12.5 61.9 31.4 33.1 24.1 29.6 36.6 137.4 45.4 1.7 14.3 3.8 19.0 19.6 46.7 10.5 65.7 18.6 12.3 41.7 26.7 11.0 33.4 57.4 15.4 8.9 4.7 43.7 13.5 10.1 3.6 60.0 5.2 16.5 17.3 57.7 4.4 61.6 6.5 7.1 1.8 17.8 26.2 152.4 17.0 22.4 10.5 GSTA3 ENSG00000174156 "Glutathione S-transferase alpha 3" Q16772 6 52896639-52909685 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 36.5;fallopian tube: 32.4;placenta: 51.9" "Group enriched" "Detected in some" 8 "Cytotrophoblasts: 121.8;Syncytiotrophoblasts: 430.9" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "pons and medulla: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.1;CACO-2: 1.2;HAP1: 2.3;HEK 293: 1.2;SK-BR-3: 2.1;SuSa: 5.2" "HPA004342, HPA048934, HPA053817" Approved Supported Cytosol NA NA Cytosol "HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367" "unprognostic (7.51e-2)" "unprognostic (7.06e-3)" "unprognostic (3.10e-1)" "unprognostic (5.53e-2)" "unprognostic (4.38e-3)" "unprognostic (2.86e-3)" "unprognostic (1.81e-1)" "unprognostic (1.41e-1)" "unprognostic (1.93e-1)" "unprognostic (9.35e-2)" 0.2 36.5 0.2 0.2 0.6 0.0 0.7 0.3 0.2 0.9 0.2 1.0 0.2 0.0 0.3 6.6 0.2 32.4 0.2 0.2 0.2 0.2 0.2 0.2 1.3 0.2 0.2 0.2 3.8 0.2 1.1 0.2 51.9 2.1 0.2 0.0 0.5 0.6 0.2 0.2 12.5 0.2 0.2 0.2 0.2 1.0 6.4 0.3 0.2 0.2 0.9 0.2 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.9 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.1 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.2 0.2 0.2 0.2 0.2 2.1 0.3 0.0 0.6 0.0 0.0 0.9 0.0 0.0 0.0 33.5 10.3 0.0 0.0 121.8 0.0 0.0 0.9 0.0 0.0 0.0 0.0 6.4 0.2 0.0 1.1 0.2 13.5 0.0 0.0 0.0 0.0 1.3 1.4 0.0 23.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 8.5 430.9 0.0 0.0 0.0 GUCY1A2 "GC-SA2, GUC1A2" ENSG00000152402 "Guanylate cyclase 1 soluble subunit alpha 2" P33402 11 106674012-107018524 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" "cGMP biosynthesis" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 23.0;placenta: 23.6" "Cell type enhanced" "Detected in many" 16 "Muller glia cells: 27.1;Sertoli cells: 103.5;Smooth muscle cells: 57.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 12.5;BJ hTERT+ SV40 Large T+ RasG12V: 14.6;HBF TERT88: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB009534 Uncertain NA NA "CAB009534: AB_2279509" "unprognostic (7.53e-2)" "unprognostic (6.67e-2)" "unprognostic (7.99e-2)" "unprognostic (1.10e-1)" "unprognostic (1.08e-1)" "unprognostic (1.22e-2)" "unprognostic (1.23e-2)" "unprognostic (1.24e-1)" "unprognostic (6.53e-3)" "unprognostic (9.70e-3)" "unprognostic (8.00e-2)" "unprognostic (2.03e-1)" "prognostic unfavorable (3.02e-5)" "unprognostic (2.48e-4)" "unprognostic (1.62e-1)" "unprognostic (3.50e-2)" "unprognostic (1.09e-2)" 5.5 3.3 4.6 1.3 10.9 0.6 3.9 4.3 10.7 19.2 1.5 1.2 1.1 0.9 23.0 5.0 1.3 8.4 2.6 3.8 4.6 4.0 3.2 2.8 11.8 1.6 3.7 5.3 3.9 6.2 1.8 1.5 23.6 5.5 3.2 1.3 1.4 1.4 10.1 4.1 1.4 1.2 18.0 2.4 7.9 1.0 2.8 5.4 0.0 2.4 3.0 1.0 2.2 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 4.3 0.0 0.2 2.6 2.4 0.3 12.5 1.6 14.6 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.2 0.0 7.8 0.0 1.2 0.0 0.1 0.0 0.2 0.0 1.7 0.7 0.0 1.9 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.5 3.8 0.0 0.8 0.5 0.9 0.2 4.8 4.0 3.3 0.9 1.3 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 10.9 4.3 9.9 4.6 4.0 3.7 5.3 5.5 5.4 0.0 0.3 0.0 1.4 1.4 23.1 5.9 0.0 0.0 0.0 3.5 11.8 0.1 0.0 3.2 2.2 3.9 0.0 0.0 0.2 0.0 6.1 1.1 0.0 0.0 0.3 17.5 0.0 2.5 0.6 4.9 22.7 0.0 3.3 0.0 0.0 27.1 0.5 0.0 23.7 0.0 4.0 103.5 57.5 0.9 1.5 1.0 0.2 0.0 0.0 1.2 GULP1 "CED-6, CED6, GULP" ENSG00000144366 "GULP, engulfment adaptor PTB domain containing 1" Q9UBP9 2 188291669-188595931 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Lipid transport, Phagocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 86.0" "Cell type enhanced" "Detected in many" 7 "Intestinal endocrine cells: 131.2;Muller glia cells: 100.6;Syncytiotrophoblasts: 170.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 32.7;WM-115: 71.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020587 Enhanced Approved Vesicles NA NA Vesicles "HPA020587: AB_1850452" "unprognostic (1.95e-1)" "unprognostic (3.32e-1)" "unprognostic (3.80e-2)" "unprognostic (5.19e-2)" "unprognostic (2.12e-2)" "unprognostic (2.41e-1)" "unprognostic (8.69e-4)" "unprognostic (3.86e-2)" "unprognostic (1.06e-1)" "unprognostic (9.28e-2)" "unprognostic (8.25e-3)" "unprognostic (2.23e-1)" "prognostic favorable (4.25e-6)" "prognostic unfavorable (6.17e-4)" "unprognostic (1.29e-1)" "unprognostic (7.33e-2)" "unprognostic (3.04e-4)" 8.0 15.0 3.1 7.6 9.8 0.0 9.7 0.7 8.0 22.6 11.8 2.2 14.4 6.5 23.3 40.6 11.5 10.4 8.9 5.1 2.5 4.8 11.4 1.0 9.0 1.2 2.4 4.5 17.9 32.3 23.9 3.7 86.0 14.3 14.3 3.8 19.4 10.7 16.1 5.9 5.0 10.5 15.1 2.8 3.2 11.9 17.0 2.2 0.3 8.0 6.1 3.1 11.3 20.2 0.6 0.4 1.5 1.9 0.6 0.2 0.3 3.8 9.4 32.7 7.3 5.1 5.0 6.1 5.3 9.0 8.7 7.0 5.9 18.9 0.0 4.0 4.2 8.4 2.5 6.5 0.4 6.3 0.0 4.3 8.0 7.1 0.0 4.7 0.0 0.0 3.0 1.2 4.1 4.4 13.3 4.0 0.0 6.7 0.1 5.9 0.5 0.0 0.1 8.3 5.5 14.6 0.0 7.7 3.8 17.3 1.6 0.1 24.6 0.0 4.4 11.3 14.7 1.5 0.0 1.9 2.6 1.2 8.8 2.9 0.0 0.0 0.0 1.4 0.0 71.2 1.3 1.9 0.4 0.2 1.1 0.1 0.3 0.1 0.1 0.4 0.6 0.2 0.2 1.5 0.6 0.7 0.2 0.1 0.3 3.1 9.8 0.7 8.0 2.5 4.8 2.4 4.5 14.3 2.2 14.9 12.0 0.8 22.6 14.0 1.2 1.2 50.9 49.5 37.5 22.7 0.0 32.9 38.1 25.9 3.4 21.5 13.4 0.0 33.1 5.1 35.1 61.3 0.0 0.2 2.8 1.6 131.2 5.5 0.6 4.7 19.0 3.6 33.7 1.8 2.0 100.6 43.4 5.8 57.7 30.0 1.5 6.5 40.6 35.4 22.8 24.1 170.9 0.0 0.8 15.0 HACE1 KIAA1320 ENSG00000085382 "HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1" Q8IYU2 6 104728093-104859919 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 41.9" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 43.2;Rod photoreceptor cells: 30.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046071 Supported "Nuclear bodies,Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "Nuclear bodies" "HPA046071: AB_2679524" "unprognostic (6.32e-2)" "unprognostic (3.77e-2)" "unprognostic (2.93e-2)" "unprognostic (1.12e-2)" "unprognostic (3.75e-2)" "unprognostic (3.75e-3)" "unprognostic (1.22e-3)" "unprognostic (4.63e-2)" "unprognostic (7.41e-2)" "unprognostic (1.24e-1)" "unprognostic (1.56e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (1.12e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (1.75e-1)" 6.4 5.4 12.7 3.7 16.1 4.3 6.1 15.5 13.1 6.6 4.8 6.8 2.5 3.6 8.5 2.9 8.1 5.4 5.0 5.2 7.5 8.6 9.4 2.9 5.7 3.5 8.8 9.6 6.4 3.8 12.0 7.4 41.9 10.2 6.1 3.3 7.7 6.2 6.9 4.4 4.8 3.6 6.5 9.5 4.1 3.9 14.1 8.9 5.4 7.1 2.7 3.9 6.4 5.8 2.9 2.4 2.2 2.9 2.2 3.9 1.6 3.6 2.5 10.9 13.6 6.5 8.7 12.9 7.3 11.3 4.6 7.0 2.3 2.1 2.1 3.3 5.5 7.9 2.5 2.7 5.0 9.8 8.4 6.9 7.2 2.3 3.1 6.5 6.2 2.4 5.8 4.6 6.0 5.1 6.1 7.6 8.7 6.9 2.3 9.1 2.6 4.6 3.7 4.7 2.7 2.5 7.3 12.4 0.8 3.7 6.2 5.8 8.8 3.9 4.1 2.1 7.3 2.6 8.5 8.0 3.7 3.1 10.0 6.9 3.3 3.7 7.0 3.9 5.9 6.8 0.0 1.9 2.2 3.7 2.9 3.9 2.9 3.7 3.6 1.9 2.7 3.9 3.0 0.4 2.2 1.5 2.4 1.2 1.6 12.7 16.1 15.5 13.1 7.5 8.6 8.8 9.6 10.2 8.9 3.0 0.6 0.0 1.6 4.1 11.4 6.3 2.5 0.0 4.5 5.2 43.2 7.5 1.7 1.7 3.1 6.7 1.3 0.0 1.3 4.6 4.8 2.2 1.1 2.5 4.6 15.9 1.7 4.3 2.2 3.3 5.8 2.4 1.7 4.6 1.4 5.8 1.1 2.9 3.5 4.1 30.6 6.5 6.6 12.5 2.7 4.1 5.3 2.2 2.1 1.8 HAND2 "bHLHa26, dHand, Hed, Thing2" ENSG00000164107 "Heart and neural crest derivatives expressed 2" P61296 4 173524969-173530229 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 61.4;placenta: 62.9" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 81.1;Leydig cells: 36.5" "Cancer enhanced" "Detected in many" "pancreatic cancer: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 16 "SH-SY5Y: 120.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019591, CAB025576" Approved Approved Nucleoplasm,Vesicles NA NA Nucleoplasm Vesicles "CAB025576: , HPA019591: AB_2670199" "unprognostic (4.11e-2)" "unprognostic (7.50e-3)" "unprognostic (2.43e-2)" "unprognostic (1.25e-2)" "unprognostic (1.95e-1)" "unprognostic (2.44e-2)" "unprognostic (1.82e-1)" "unprognostic (2.24e-1)" "unprognostic (1.28e-2)" "unprognostic (2.56e-1)" "unprognostic (2.44e-1)" "unprognostic (1.35e-1)" "unprognostic (3.27e-2)" "unprognostic (4.95e-2)" "unprognostic (1.56e-1)" "unprognostic (6.39e-3)" 4.2 24.2 0.2 10.9 0.2 0.0 4.7 0.4 0.2 34.3 42.7 0.2 7.5 1.9 42.7 7.9 16.6 9.7 61.4 54.1 0.2 0.2 0.2 8.2 0.2 0.1 0.2 0.0 13.4 3.8 0.0 0.3 62.9 0.0 13.1 3.6 5.2 1.1 4.2 0.6 1.7 13.5 37.5 0.2 1.8 19.9 5.4 0.0 0.0 1.5 2.7 2.2 25.7 12.8 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 6.9 3.5 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.5 0.0 0.0 0.7 0.0 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 1.9 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 81.1 2.5 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 0.0 0.4 1.1 13.7 0.0 0.0 0.0 2.3 0.0 0.0 11.1 0.0 0.8 36.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 2.2 0.1 0.1 0.3 1.9 0.0 0.0 0.0 HAPLN1 CRTL1 ENSG00000145681 "Hyaluronan and proteoglycan link protein 1" P10915 5 83637805-83721613 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 41.8" "Cell type enhanced" "Detected in some" 20 "Cytotrophoblasts: 7.6;Extravillous trophoblasts: 9.6;Fibroblasts: 4.4;Hofbauer cells: 9.4;Syncytiotrophoblasts: 19.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "PC-3: 44.7;SuSa: 23.1;TIME: 28.3;U-2 OS: 46.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019105, HPA019482, HPA025238" Enhanced Approved Supported Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA019105: AB_1850496, HPA019482: AB_1850498, HPA025238: " "unprognostic (5.74e-4)" "unprognostic (2.94e-2)" "unprognostic (6.58e-3)" "unprognostic (2.30e-2)" "unprognostic (1.30e-1)" "unprognostic (2.76e-3)" "unprognostic (6.01e-4)" "unprognostic (2.52e-2)" "unprognostic (1.70e-1)" "unprognostic (9.04e-3)" "unprognostic (1.31e-1)" "unprognostic (2.28e-2)" "prognostic unfavorable (4.81e-9)" "unprognostic (6.87e-2)" "unprognostic (2.04e-1)" "unprognostic (8.62e-2)" "unprognostic (3.91e-2)" 0.1 0.0 5.4 1.5 3.9 0.0 0.1 0.6 4.7 0.1 4.7 0.1 0.1 3.8 0.5 0.1 1.2 0.0 0.5 1.8 3.4 1.3 0.4 0.1 0.9 0.1 1.7 0.7 0.2 0.2 0.0 0.1 41.8 1.5 4.9 5.8 1.5 0.9 0.1 0.1 0.5 9.3 0.3 0.6 0.1 2.4 0.1 0.1 0.1 0.3 0.5 0.3 0.9 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.1 0.0 0.0 28.3 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.4 3.9 0.6 4.4 3.4 1.3 1.7 0.7 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 4.4 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 HBG1 HBG-T2 ENSG00000213934 "Hemoglobin subunit gamma 1" P69891 11 5248079-5249859 "Predicted intracellular proteins" "Oxygen transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "placenta: 74.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 27 "K-562: 195.5" HPA043234 Approved NA NA "HPA043234: AB_2678378" "unprognostic (3.17e-2)" 1.5 0.1 0.5 0.1 0.6 0.4 0.1 0.5 0.4 0.2 0.1 0.2 0.2 0.1 0.1 0.1 0.1 1.1 0.5 0.4 1.2 0.9 2.6 0.1 0.7 0.2 0.1 0.1 0.4 74.0 0.1 0.1 0.2 0.2 0.9 0.1 0.1 0.1 1.1 7.0 0.5 0.2 0.8 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 195.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HBG2 HBG-T1 ENSG00000196565 "Hemoglobin subunit gamma 2" P69892 11 5253190-5505605 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Oxygen transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 41 "placenta: 553.0" "Cell type enhanced" "Detected in some" 11 "Early spermatids: 1.3;Late spermatids: 1.3;Spermatocytes: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 175 "HEL: 321.3;K-562: 334.0" "CAB016143, HPA043234" Approved NA NA "CAB016143: AB_2295004, HPA043234: AB_2678378" "unprognostic (4.48e-3)" "unprognostic (2.42e-1)" "unprognostic (6.24e-2)" "unprognostic (1.41e-1)" "unprognostic (8.94e-2)" "unprognostic (4.22e-1)" "unprognostic (5.29e-1)" "unprognostic (3.95e-2)" "unprognostic (2.99e-1)" "unprognostic (3.52e-2)" "unprognostic (4.27e-1)" "unprognostic (3.75e-2)" "unprognostic (7.70e-5)" "unprognostic (1.64e-1)" "unprognostic (2.65e-1)" "unprognostic (1.02e-1)" "unprognostic (1.20e-1)" 2.6 0.3 1.4 0.7 1.2 3.7 0.7 0.9 0.8 0.7 0.7 0.7 0.7 0.4 0.7 0.7 0.7 0.3 0.7 2.3 1.0 1.0 2.3 2.2 5.5 0.7 1.7 0.7 0.7 0.8 0.3 1.0 553.0 0.7 0.7 0.3 0.8 0.7 0.7 1.3 0.3 0.7 0.7 2.3 13.3 0.5 1.1 0.7 0.7 1.7 0.7 0.7 0.7 0.8 0.0 0.1 0.4 0.7 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 321.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 334.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 9.5 1.4 1.2 0.9 0.8 1.0 1.0 1.7 0.7 0.7 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.0 0.0 0.0 0.1 HBM "HBAP2, HBK" ENSG00000206177 "Hemoglobin subunit mu" Q6B0K9 16 153892-166768 "Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 109.8;placenta: 50.2" "Cell type enriched" "Detected in some" 740 "Erythroid cells: 12474.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 2.3" "Low region specificity" "Detected in some" NA NA 400000 "unprognostic (1.30e-1)" "unprognostic (7.59e-2)" 0.9 0.2 0.4 0.2 0.5 109.8 0.3 0.1 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.6 0.2 0.2 4.4 0.3 0.4 1.7 2.6 16.5 0.2 0.7 0.0 1.6 0.2 0.2 1.1 50.2 1.2 0.5 0.2 1.2 0.2 0.2 0.4 0.2 0.2 0.2 0.4 17.5 0.2 0.2 0.0 1.0 2.0 0.1 0.3 2.1 4.9 0.1 0.5 0.5 0.0 0.9 0.4 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.5 0.0 10.5 0.4 0.5 0.1 0.2 0.3 0.4 0.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12474.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 2.3 0.1 0.0 0.0 0.0 0.0 HBZ "HBZ-T1, HBZ1" ENSG00000130656 "Hemoglobin subunit zeta" P02008 16 152687-154503 "Predicted intracellular proteins" "Oxygen transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.9;placenta: 5.0;testis: 9.9" "Group enriched" "Detected in some" 4 "Hofbauer cells: 144.1;Late spermatids: 212.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 79 "K-562: 227.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA063268, HPA064073, HPA071726" Approved Approved Nucleoplasm,Cytosol NA NA 160000000 Cytosol Nucleoplasm "HPA063268: , HPA064073: , HPA071726: AB_2732184" "unprognostic (3.56e-1)" "unprognostic (1.32e-1)" 0.8 0.0 0.8 0.1 0.5 8.9 0.6 0.6 0.6 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 1.6 3.3 0.7 0.3 0.1 1.1 0.6 0.1 1.1 0.1 0.7 0.1 0.0 0.1 5.0 0.1 1.2 0.0 0.1 0.1 0.1 0.9 0.5 0.1 0.1 0.1 0.8 0.1 9.9 0.1 0.1 0.1 0.1 0.1 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 227.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.5 0.6 0.6 0.7 0.3 1.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 41.3 0.7 0.0 23.3 0.0 16.4 1.4 0.0 0.0 0.0 144.1 0.0 0.0 0.0 0.0 212.4 0.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.4 0.0 0.7 6.5 2.0 1.1 0.9 0.1 8.7 0.0 0.0 0.0 HEMGN "CT155, EDAG, NDR" ENSG00000136929 Hemogen Q9BXL5 9 97926791-97944856 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 71.1;placenta: 20.2;testis: 32.5" "Group enriched" "Detected in some" 149 "Early spermatids: 1388.7;Erythroid cells: 724.2;Late spermatids: 1114.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 8.2" "Group enriched" "Detected in many" 27 "granulocytes: 2.1;NK-cells: 2.9;T-cells: 8.2" "Cell line enriched" "Detected in some" 4 "K-562: 77.0" "Region enriched" "Detected in all" 5 "cerebellum: 55.9" "HPA019572, HPA019604, HPA019606" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA019572: AB_1850588, HPA019604: AB_1850590, HPA019606: AB_1850591" "unprognostic (1.94e-1)" "unprognostic (3.15e-3)" "unprognostic (2.50e-2)" "unprognostic (9.00e-3)" "unprognostic (2.12e-3)" "unprognostic (2.48e-1)" "unprognostic (6.45e-4)" "unprognostic (2.77e-1)" "unprognostic (5.74e-2)" "unprognostic (2.25e-1)" 0.3 0.2 0.2 0.4 0.2 71.1 0.2 0.2 0.3 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.3 1.0 0.2 0.2 0.3 0.9 5.4 0.5 0.2 0.0 0.6 0.2 0.0 0.3 20.2 1.1 0.2 0.0 0.1 0.2 0.0 0.2 0.2 0.2 0.0 0.3 2.8 0.2 32.5 0.0 17.1 0.3 0.2 0.5 1.4 4.8 0.0 0.1 2.1 0.1 2.9 8.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 77.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 2.1 0.1 0.0 0.4 0.1 0.8 0.0 2.3 1.1 0.1 0.0 8.2 3.3 1.0 2.9 0.0 0.0 1.2 4.4 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 1388.7 0.0 0.0 724.2 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.3 1114.5 5.5 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 6.5 0.0 7.2 3.3 0.0 0.5 0.0 0.0 0.0 HES2 bHLHb40 ENSG00000069812 "Hes family bHLH transcription factor 2" Q9Y543 1 6412418-6424670 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "esophagus: 22.6;placenta: 60.9" "Cell type enhanced" "Detected in many" 11 "Mucus-secreting cells: 46.1;Paneth cells: 29.4;Syncytiotrophoblasts: 83.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basophil: 4.9;neutrophil: 3.9" "Lineage enriched" "Detected in single" 8 "granulocytes: 4.9" "Cell line enhanced" "Detected in some" "BEWO: 10.9;HaCaT: 20.3;HBEC3-KT: 17.5;hTCEpi: 10.1;PC-3: 7.3;TIME: 29.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039462 Uncertain NA NA "HPA039462: AB_10673533" "unprognostic (1.96e-1)" "unprognostic (7.00e-2)" "unprognostic (1.66e-1)" "unprognostic (6.82e-3)" "unprognostic (1.13e-2)" "unprognostic (1.89e-1)" "unprognostic (2.56e-4)" "unprognostic (4.74e-2)" "unprognostic (7.41e-2)" "unprognostic (3.20e-2)" "unprognostic (5.63e-3)" "unprognostic (1.38e-1)" "unprognostic (7.67e-2)" "unprognostic (5.49e-2)" "unprognostic (2.07e-1)" "unprognostic (1.14e-1)" "unprognostic (1.00e-2)" 0.8 0.0 0.2 0.7 0.2 0.2 0.7 0.2 0.3 6.7 6.0 0.2 0.2 0.1 0.4 0.4 22.6 2.5 0.2 0.2 0.2 0.0 1.0 0.4 3.8 0.2 0.2 0.2 0.5 0.2 0.2 0.4 60.9 0.3 1.2 4.6 0.5 2.9 0.6 0.2 14.5 0.9 0.2 0.2 0.2 0.0 1.8 0.2 0.7 0.2 8.6 6.0 0.3 11.9 0.6 0.6 4.9 0.4 0.5 0.6 0.2 0.9 0.3 0.0 0.1 0.2 0.0 10.9 0.0 0.0 0.1 0.0 0.2 0.2 0.0 1.9 0.1 0.1 20.3 0.5 17.5 0.0 0.0 0.2 0.1 0.2 0.2 0.1 0.0 0.1 0.0 10.1 0.0 0.4 0.0 5.3 0.0 0.1 0.2 0.0 1.5 0.0 0.8 0.0 1.1 7.3 0.0 0.0 0.1 0.1 0.3 0.1 0.0 1.0 5.7 0.2 1.1 0.8 0.3 29.8 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 4.9 0.4 0.6 0.5 0.3 0.3 0.4 0.5 0.4 0.1 0.6 0.4 0.6 3.9 0.5 0.3 0.6 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.3 0.2 8.9 4.6 0.8 5.2 5.8 1.5 8.1 0.0 16.0 7.9 1.8 3.9 1.5 0.0 0.3 11.3 1.8 8.9 0.0 0.0 3.6 1.9 8.3 1.1 0.0 0.9 0.0 2.9 1.8 0.3 25.8 0.3 1.3 1.7 0.0 46.1 1.2 0.3 29.4 0.7 3.3 5.4 0.0 1.0 5.6 5.7 17.1 83.1 0.0 11.0 21.1 HEXB ENSG00000049860 "Hexosaminidase subunit beta" P07686 5 74640023-74722647 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation, Gangliosidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 174.3" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 395.6;Hofbauer cells: 319.1;Syncytiotrophoblasts: 412.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 108.4;GAMG: 90.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055409, HPA056010" Enhanced "Intracellular and membrane" NA NA 43000000 "HPA055409: AB_2682808, HPA056010: AB_2683008" "unprognostic (3.45e-1)" "unprognostic (5.84e-2)" "unprognostic (1.85e-2)" "unprognostic (8.72e-2)" "unprognostic (1.12e-2)" "unprognostic (6.44e-3)" "prognostic unfavorable (3.36e-8)" "unprognostic (2.21e-1)" "unprognostic (5.01e-2)" "unprognostic (1.58e-3)" "unprognostic (6.45e-2)" "unprognostic (2.27e-1)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (1.31e-2)" "unprognostic (9.67e-2)" "unprognostic (1.64e-2)" 48.0 21.9 7.7 13.6 11.6 11.1 26.1 7.4 11.2 25.8 34.2 9.5 18.0 21.6 22.1 77.3 20.6 17.3 28.1 46.3 7.1 9.1 30.4 44.5 40.9 19.3 8.5 6.7 22.7 30.4 21.8 14.3 174.3 9.3 22.6 26.3 21.0 34.6 13.3 21.0 15.3 33.6 21.0 8.7 20.5 20.7 16.2 6.1 10.8 33.7 15.2 15.4 24.0 19.7 8.9 59.8 23.8 65.9 7.6 16.4 42.9 20.3 16.0 5.6 18.5 108.4 33.5 18.2 25.0 81.1 24.4 53.0 18.8 26.6 0.0 19.8 20.5 90.2 16.4 6.0 25.4 32.3 11.4 10.8 2.6 15.5 14.1 31.8 2.2 22.0 29.5 15.0 25.6 17.2 38.5 27.9 6.4 7.5 33.3 26.7 20.6 2.6 5.1 5.2 19.3 7.2 6.2 8.1 26.5 16.8 18.6 3.6 4.5 19.4 13.2 24.1 10.1 13.9 15.1 16.6 16.1 4.0 29.6 23.0 15.4 26.5 0.1 36.7 20.0 29.2 14.5 65.9 18.6 14.2 24.5 16.4 8.9 11.7 13.1 59.8 5.5 11.2 10.9 23.8 7.6 14.6 18.0 13.7 42.9 7.7 11.6 7.4 11.2 7.1 9.1 8.5 6.7 9.3 6.1 38.7 35.5 39.5 70.4 39.0 9.5 18.9 63.7 20.1 18.2 27.9 7.9 395.6 16.6 123.0 1.1 60.6 71.9 0.0 111.0 143.1 100.1 65.8 69.2 62.8 319.1 9.5 21.9 83.4 134.6 1.7 78.9 151.2 69.2 83.8 50.0 34.8 68.2 51.8 67.8 65.5 10.6 45.3 54.5 0.2 1.1 28.4 412.8 37.3 76.2 54.8 HGF "DFNB39, F-TCF, HGFB, HPTA, SF" ENSG00000019991 "Hepatocyte growth factor" P14210 7 81699008-81770438 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Serine protease homolog" "Cancer-related genes, Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 116.9" "Cell type enhanced" "Detected in many" 9 "Fibroblasts: 19.8;Ito cells: 40.5;Muller glia cells: 30.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "basophil: 33.5" "Lineage enriched" "Detected in many" 4 "granulocytes: 33.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 45.8;HHSteC: 35.8;HL-60: 20.1;hTEC/SVTERT24-B: 22.5;Karpas-707: 62.0;U-87 MG: 16.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010333, HPA040360, HPA044088" Approved "Secreted to blood" NA NA 4110000 "CAB010333: AB_647965, HPA040360: AB_2676939, HPA044088: AB_2678804" "unprognostic (5.24e-2)" "unprognostic (6.77e-2)" "unprognostic (1.72e-2)" "unprognostic (5.12e-2)" "unprognostic (1.85e-2)" "unprognostic (7.45e-5)" "unprognostic (1.66e-1)" "unprognostic (9.28e-3)" "unprognostic (3.28e-2)" "unprognostic (2.97e-2)" "unprognostic (2.74e-1)" "unprognostic (5.29e-2)" "prognostic unfavorable (5.59e-4)" "unprognostic (7.90e-3)" "unprognostic (2.92e-2)" "unprognostic (1.14e-2)" "unprognostic (2.06e-2)" 6.2 10.6 1.4 2.9 1.2 4.6 4.8 0.5 4.5 5.1 4.0 0.4 2.9 1.5 5.2 3.1 2.9 4.0 7.1 9.3 3.6 1.3 7.3 27.5 15.8 2.0 1.3 1.4 3.2 1.4 1.6 4.3 116.9 1.9 10.8 1.9 2.0 2.2 3.2 1.4 0.9 1.8 15.1 6.0 6.6 2.3 2.0 0.9 0.5 5.3 1.4 1.4 10.5 21.5 0.0 2.0 33.5 7.6 0.0 0.0 1.5 0.0 0.0 0.0 0.0 5.7 45.8 0.0 0.1 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 35.8 20.1 0.1 10.8 0.0 22.5 0.0 0.0 0.5 0.0 0.0 62.0 0.1 0.0 0.0 13.9 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 16.4 4.2 0.0 33.5 6.6 1.6 0.0 7.6 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.3 0.0 6.7 0.4 0.0 1.5 1.4 1.2 0.5 4.5 3.6 1.3 1.3 1.4 1.9 0.9 0.0 5.5 0.0 0.3 0.9 0.1 0.8 2.5 0.0 1.2 0.0 0.0 4.6 0.0 0.0 11.8 6.3 0.0 0.0 0.0 3.2 19.8 0.2 1.1 0.5 17.6 0.0 0.0 40.5 14.3 1.7 17.0 5.5 1.7 3.6 0.0 30.6 0.0 0.0 10.3 0.0 0.3 12.9 13.8 0.0 0.1 0.1 10.1 0.0 0.0 0.1 HHLA1 PLA2L ENSG00000132297 "HERV-H LTR-associating 1" C9JL84 8 132061486-132111159 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "placenta: 1.3" "Cell type enhanced" "Detected in some" 26 "Alveolar cells type 2: 13.7;Ciliated cells: 2.7;Club cells: 4.5;granulocytes: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 38 "NTERA-2: 4.8;SuSa: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted - unknown location" NA NA "unprognostic (5.15e-2)" "unprognostic (1.19e-1)" "unprognostic (2.15e-1)" 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.6 0.0 2.7 4.5 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HIGD1B "CLST11240, CLST11240-15" ENSG00000131097 "HIG1 hypoxia inducible domain family member 1B" Q9P298 17 44846353-44850480 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 61.8" "Group enriched" "Detected in some" 32 "Sertoli cells: 750.3;Smooth muscle cells: 198.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079501 Uncertain "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA079501: " "unprognostic (6.85e-2)" "unprognostic (9.41e-2)" "unprognostic (3.80e-3)" "unprognostic (2.07e-1)" "unprognostic (8.46e-2)" "unprognostic (2.37e-2)" "unprognostic (4.98e-3)" "unprognostic (3.61e-1)" "unprognostic (1.18e-2)" "unprognostic (3.98e-1)" "unprognostic (6.19e-2)" "unprognostic (3.56e-1)" "unprognostic (1.61e-3)" "unprognostic (5.23e-3)" "unprognostic (8.72e-2)" "unprognostic (1.79e-2)" "unprognostic (1.52e-2)" 6.4 0.7 12.4 0.7 18.2 0.6 3.2 4.5 9.7 5.7 1.9 3.6 0.4 1.5 6.4 7.6 2.5 3.1 7.1 11.0 12.4 10.1 2.6 0.6 21.6 1.7 15.8 6.8 2.0 2.0 2.5 0.3 61.8 8.7 3.6 1.0 0.7 1.3 4.4 7.9 1.3 1.3 7.3 6.2 0.4 1.5 1.2 8.9 0.1 3.4 1.8 1.1 3.0 1.6 1.1 3.3 4.6 2.9 1.9 3.5 1.1 0.5 1.8 0.0 2.0 0.0 0.0 1.8 1.7 0.0 0.0 0.0 1.0 0.6 1.7 0.5 0.0 0.1 0.7 0.0 0.0 0.0 1.4 2.0 0.4 2.1 1.3 0.0 2.6 3.7 0.0 0.0 0.0 0.0 0.6 0.0 2.6 2.1 1.5 0.0 0.7 1.9 2.0 1.3 0.7 1.0 2.2 1.2 2.5 0.0 1.3 2.2 1.0 0.6 0.0 0.3 0.1 0.9 1.1 0.0 1.8 0.6 1.2 1.4 1.3 3.9 2.0 1.6 3.1 2.2 4.6 1.9 0.7 3.5 2.9 1.3 0.7 2.3 2.6 3.3 1.1 2.5 2.3 0.0 1.9 0.3 0.9 2.0 1.1 12.4 18.2 4.5 9.7 12.4 10.1 15.8 6.8 8.7 8.9 0.0 0.3 0.0 0.5 3.1 0.4 3.9 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.1 14.7 0.0 0.0 0.0 0.2 2.0 0.3 0.0 0.0 0.6 1.6 0.0 1.3 0.0 0.0 0.3 0.6 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 1.5 750.3 198.1 0.0 0.2 2.0 0.2 0.0 0.0 0.7 HLA-G ENSG00000204632 "Major histocompatibility complex, class I, G" P17693 6 29826967-29831125 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins" Immunity "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 66.0" "Cell type enriched" "Detected in many" 15 "Extravillous trophoblasts: 586.1" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "CAPAN-2: 1.2;SuSa: 3.9" CAB016158 Enhanced "Secreted to blood" NA NA 32800000 "CAB016158: AB_627938" "unprognostic (1.13e-2)" "unprognostic (9.95e-2)" "unprognostic (1.30e-1)" "unprognostic (3.40e-2)" "unprognostic (8.35e-2)" "unprognostic (1.35e-1)" "unprognostic (1.18e-3)" "unprognostic (2.51e-1)" "prognostic favorable (3.91e-5)" "unprognostic (6.34e-2)" "unprognostic (8.31e-2)" "unprognostic (1.78e-1)" "unprognostic (1.03e-2)" "unprognostic (6.56e-3)" "unprognostic (1.40e-1)" "unprognostic (1.52e-2)" "unprognostic (3.19e-3)" 0.2 0.1 0.0 0.5 0.1 0.2 0.3 0.1 0.1 0.2 0.5 0.1 0.0 1.2 0.2 0.6 0.1 0.1 0.2 0.3 0.2 0.0 0.5 0.2 2.8 0.7 0.1 0.1 0.3 1.9 0.1 15.2 66.0 0.1 0.2 0.2 0.3 0.4 0.6 0.2 0.2 0.8 0.1 0.2 1.2 0.9 2.2 0.2 1.3 0.4 0.2 0.2 0.2 0.3 0.3 0.3 2.2 0.9 0.2 1.2 5.7 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.6 0.9 1.2 0.7 0.5 1.2 0.3 0.1 0.5 0.3 0.3 0.6 1.2 2.2 0.2 0.6 0.1 0.5 5.7 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.2 0.0 1.1 1.4 6.4 20.3 0.0 0.8 5.1 0.0 0.0 0.0 0.0 7.8 0.0 2.8 16.1 5.2 2.6 0.0 4.7 586.1 11.7 5.5 0.0 1.1 21.9 0.0 16.8 8.0 11.0 5.3 2.3 3.3 11.8 0.0 39.2 0.0 15.5 20.1 2.5 0.2 0.0 0.0 3.3 4.7 3.0 30.7 33.9 6.9 9.7 6.7 HMGB3 "HMG2A, HMG4, MGC90319" ENSG00000029993 "High mobility group box 3" O15347 X 150980509-150990775 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Transcription, Transcription regulation" DNA-binding Microphthalmia "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 54.3" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 337.0;Extravillous trophoblasts: 539.5;Syncytiotrophoblasts: 1171.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HBEC3-KT: 108.8;U-698: 98.0" HPA062583 Enhanced Approved Nucleoplasm,Nucleoli NA NA "Nucleoplasm, Nucleoli" "HPA062583: AB_2684800" "unprognostic (2.85e-3)" "unprognostic (2.82e-2)" "unprognostic (2.16e-1)" "unprognostic (1.08e-2)" "unprognostic (1.16e-1)" "unprognostic (4.60e-2)" "unprognostic (2.66e-3)" "unprognostic (4.54e-3)" "unprognostic (2.70e-2)" "prognostic favorable (9.85e-5)" "unprognostic (6.03e-2)" "unprognostic (1.96e-2)" "prognostic favorable (6.15e-4)" "unprognostic (2.58e-2)" "unprognostic (9.29e-2)" "unprognostic (1.41e-1)" "unprognostic (1.11e-1)" 4.4 5.4 7.9 4.8 7.1 20.3 4.1 2.8 10.3 10.8 12.0 4.7 3.9 7.3 6.3 13.4 10.2 4.4 3.2 4.5 9.8 7.6 9.0 41.6 5.9 6.3 6.1 7.3 3.1 7.1 18.7 1.6 54.3 9.7 3.7 9.2 5.3 9.7 4.3 20.5 6.8 7.6 3.6 5.0 8.4 4.0 26.0 3.2 18.2 6.2 5.1 9.5 4.9 3.7 3.1 6.5 11.8 5.3 0.9 6.2 2.3 37.7 16.7 52.8 27.5 2.2 6.6 65.8 16.6 10.9 19.3 10.0 13.2 15.7 26.5 53.5 12.7 10.9 18.2 48.1 108.8 21.8 18.0 14.0 23.0 16.2 20.8 3.3 34.6 11.7 5.2 25.8 7.9 20.0 4.9 24.9 16.3 11.9 15.7 22.9 29.0 38.1 26.6 31.3 24.8 20.5 46.8 43.0 15.0 14.2 18.1 38.1 24.9 24.7 26.6 8.2 31.5 23.5 22.9 18.7 8.0 19.0 25.5 36.5 14.3 17.8 98.0 9.6 17.7 16.3 0.0 4.8 11.8 0.5 3.2 0.1 3.1 2.4 3.3 6.5 0.6 0.0 0.2 0.6 0.9 5.3 3.3 6.2 2.3 7.9 7.1 2.8 10.3 9.8 7.6 6.1 7.3 9.7 3.2 35.7 27.4 16.2 16.0 21.1 0.5 13.2 10.2 145.9 134.2 29.6 2.0 337.0 31.5 72.8 184.3 11.3 24.9 186.9 75.5 539.5 20.8 18.7 8.1 72.9 88.3 0.0 63.0 10.4 18.3 46.6 3.4 26.0 20.3 35.1 29.3 3.1 76.6 25.9 3.2 39.4 1.4 0.0 8.3 19.9 49.6 17.8 1171.0 14.0 52.8 17.0 HOPX "HOP, LAGY, NECC1, OB1, SMAP31" ENSG00000171476 "HOP homeobox" Q9BPY8 4 56647988-56681899 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 128.8;skin 1: 154.6" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 696.8;Alveolar cells type 2: 414.3;Basal keratinocytes: 368.4;Suprabasal keratinocytes: 329.7;Syncytiotrophoblasts: 269.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 68.6;NK-cell: 90.9" "Group enriched" "Detected in many" 14 "NK-cells: 90.9;T-cells: 68.6" "Cell line enhanced" "Detected in some" "HDLM-2: 13.4;HUVEC TERT2: 29.7;RT4: 22.1;TIME: 33.6;U-266/70: 11.7" "CAB018632, HPA030180" Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Nuclear bodies" Cytosol "CAB018632: AB_2120833, HPA030180: AB_10603770" "unprognostic (2.32e-1)" "unprognostic (1.81e-2)" "unprognostic (8.03e-3)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (1.78e-2)" "unprognostic (2.88e-1)" "unprognostic (7.79e-2)" "unprognostic (1.02e-1)" "unprognostic (1.03e-1)" "unprognostic (1.71e-1)" "unprognostic (1.26e-1)" "unprognostic (9.30e-5)" "unprognostic (3.40e-2)" "unprognostic (1.51e-1)" "unprognostic (7.10e-2)" "unprognostic (5.33e-2)" 1.7 5.0 24.1 5.2 13.0 2.0 23.1 4.0 28.2 26.4 3.1 3.6 3.0 3.4 2.5 106.2 90.3 2.3 6.7 5.7 20.0 8.2 2.3 0.7 112.4 3.4 12.1 12.9 1.4 1.1 2.3 1.2 128.8 15.0 4.5 1.6 1.0 19.0 12.9 3.4 154.6 3.4 20.9 11.2 2.3 3.2 9.6 1.9 1.8 65.9 93.2 66.3 6.8 37.8 5.6 0.4 1.5 0.5 90.9 68.6 38.2 0.0 0.0 0.0 0.0 2.3 7.3 2.6 0.0 0.0 0.6 0.4 0.0 0.0 5.4 0.3 0.1 1.0 1.0 0.6 0.0 0.8 13.4 0.1 0.0 0.0 0.0 0.9 0.0 0.0 1.2 5.4 1.6 0.0 1.5 29.7 0.0 0.0 0.2 1.4 0.2 0.0 0.4 0.0 1.5 0.0 0.0 0.0 0.1 0.0 22.1 0.4 0.2 0.0 0.0 0.0 2.1 0.0 0.0 33.6 0.0 0.1 0.2 0.0 11.7 0.0 0.0 1.4 0.0 0.0 0.6 0.1 0.2 68.6 0.4 37.4 5.6 17.1 30.1 0.3 4.3 3.1 21.0 1.5 90.9 0.5 0.4 1.0 38.2 24.1 13.0 4.0 28.2 20.0 8.2 12.1 12.9 15.0 1.9 696.8 414.3 13.2 36.1 368.4 1.6 11.3 0.0 20.1 221.8 1.8 0.0 1.7 1.7 0.0 27.8 9.0 0.5 0.0 0.2 4.7 21.3 17.3 9.3 0.8 3.5 0.0 8.1 5.5 16.3 34.5 2.8 8.0 33.7 62.3 1.9 104.0 2.3 0.0 2.8 0.2 4.3 32.3 77.3 2.6 10.4 329.7 269.1 177.7 0.3 25.7 HPGD SDR36C1 ENSG00000164120 "15-hydroxyprostaglandin dehydrogenase" P15428 4 174490177-174523154 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Prostaglandin metabolism" Oxidoreductase "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 193.3" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 273.6;Extravillous trophoblasts: 488.8;granulocytes: 816.1;Urothelial cells: 266.0" "Cancer enhanced" "Detected in many" "urothelial cancer: 52.4" "Region enriched" "Detected in single" 4 "pons and medulla: 3.8" "Group enriched" "Detected in many" 5 "basophil: 37.7;T-reg: 15.1" "Group enriched" "Detected in many" 71 "granulocytes: 37.7;T-cells: 15.1" "Cell line enhanced" "Detected in some" "A549: 27.7;ASC diff: 17.2;HEL: 60.6;RT4: 94.3;SuSa: 20.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004919, HPA005679" Enhanced Supported Nucleoplasm,Cytosol No NA Cytosol Nucleoplasm "HPA004919: AB_1079081, HPA005679: AB_1079080" "unprognostic (1.23e-3)" "unprognostic (1.61e-1)" "unprognostic (5.96e-2)" "unprognostic (1.25e-1)" "unprognostic (1.09e-2)" "unprognostic (2.53e-2)" "unprognostic (1.27e-1)" "unprognostic (2.23e-1)" "unprognostic (1.08e-1)" "unprognostic (4.28e-2)" "unprognostic (3.54e-3)" "unprognostic (2.34e-2)" "prognostic favorable (3.20e-4)" "unprognostic (2.44e-1)" "unprognostic (2.59e-1)" "unprognostic (1.37e-4)" "unprognostic (2.33e-2)" 5.1 2.6 0.5 7.9 0.6 0.0 24.6 0.4 0.6 23.0 73.3 0.5 2.5 22.9 13.4 7.5 32.0 4.5 10.7 1.2 0.6 0.7 8.5 63.7 22.9 7.9 0.8 0.5 2.3 0.4 0.0 0.9 193.3 3.8 20.1 8.4 4.6 3.0 1.1 1.6 15.3 64.5 9.3 0.5 2.9 36.3 1.9 0.5 5.5 0.4 5.0 7.9 61.2 31.8 0.1 0.2 37.7 0.1 0.3 15.1 1.0 0.0 27.7 0.0 0.0 17.2 1.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 2.5 2.5 0.0 0.0 0.0 0.5 60.6 2.1 0.0 0.0 0.3 0.1 0.9 0.4 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.2 15.8 1.4 2.8 0.0 0.2 5.7 94.3 0.1 0.1 0.0 0.2 0.6 20.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 37.7 0.1 5.4 3.7 0.0 5.7 0.1 1.9 1.6 0.2 0.0 0.6 1.5 0.4 0.3 0.0 0.0 15.1 1.0 0.5 0.6 0.4 0.6 0.6 0.7 0.8 0.5 3.8 0.5 14.9 46.1 5.2 57.7 15.3 3.1 0.4 43.3 5.3 20.5 21.0 0.0 25.6 18.3 2.4 1.1 0.5 273.6 0.0 86.5 488.8 12.1 51.1 816.1 165.7 20.7 0.0 8.1 18.4 16.1 0.2 18.4 10.6 72.6 1.0 48.2 0.0 26.0 217.5 0.0 68.8 0.6 0.0 6.6 0.4 0.4 19.6 47.4 50.3 31.0 266.0 HPGDS "GSTS, GSTS1, GSTS1-1, H-PGDS, PGD2, PGDS" ENSG00000163106 "Hematopoietic prostaglandin D synthase" O60760 4 94298535-94342876 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" "Isomerase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 24.8" "Group enriched" "Detected in many" 10 "granulocytes: 1000.1;Hofbauer cells: 476.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "basophil: 15.8" "Lineage enriched" "Detected in single" 25 "granulocytes: 15.8" "Group enriched" "Detected in some" 8 "HEL: 32.4;HMC-1: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA024035 Enhanced Approved Nucleoplasm,Vesicles,Cytosol NA NA 170000 "Vesicles, Cytosol" Nucleoplasm "HPA024035: AB_1855743" "unprognostic (5.71e-2)" "unprognostic (5.80e-3)" "unprognostic (1.17e-1)" "unprognostic (5.36e-3)" "unprognostic (2.76e-1)" "unprognostic (2.38e-4)" "unprognostic (1.01e-2)" "unprognostic (4.41e-3)" "unprognostic (1.35e-1)" "unprognostic (7.75e-4)" "unprognostic (1.44e-1)" "unprognostic (1.14e-1)" "unprognostic (5.15e-3)" "unprognostic (4.07e-2)" "unprognostic (6.48e-2)" "unprognostic (2.61e-2)" "unprognostic (6.14e-2)" 14.3 2.9 8.0 1.6 12.1 1.6 5.8 2.0 7.7 5.4 6.9 4.4 0.2 7.5 4.7 3.3 4.1 2.5 9.3 3.0 8.4 3.6 2.5 1.3 12.7 0.9 9.6 2.4 1.5 1.8 1.7 1.5 24.8 9.0 6.4 7.5 2.9 3.8 2.2 1.4 5.8 8.6 5.8 14.6 1.4 4.4 1.8 12.1 1.5 1.2 2.8 1.5 4.5 3.5 0.0 0.1 15.8 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 2.5 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 8.0 12.1 2.0 7.7 8.4 3.6 9.6 2.4 9.0 12.1 11.9 75.3 0.0 0.8 3.7 0.0 0.0 0.0 2.7 6.8 0.0 0.0 2.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.5 4.1 4.0 1000.1 0.0 476.4 0.0 6.8 0.0 3.9 0.0 0.3 14.5 3.3 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 0.1 4.6 4.6 0.0 0.0 0.1 HS3ST3B1 "30ST3B1, 3OST3B1" ENSG00000125430 "Heparan sulfate-glucosamine 3-sulfotransferase 3B1" Q9Y662 17 14301083-14349404 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 20.6;liver: 29.1;lymphoid tissue: 26.6;placenta: 33.5;salivary gland: 12.6" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 37.3;Hepatocytes: 32.1;Ito cells: 34.4;Syncytiotrophoblasts: 30.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 4 "cerebral cortex: 2.7;pons and medulla: 6.0" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 20.6" "Group enriched" "Detected in many" 5 "dendritic cells: 20.6;T-cells: 14.7" "Cell line enhanced" "Detected in many" "AF22: 15.5;BEWO: 11.1;Hep G2: 13.5;HSkMC: 15.4;U-251 MG: 14.2" HPA064126 Approved Vesicles NA NA Vesicles "HPA064126: AB_2685194" "unprognostic (1.74e-1)" "unprognostic (1.13e-1)" "unprognostic (2.29e-2)" "unprognostic (5.55e-3)" "unprognostic (2.85e-3)" "unprognostic (5.22e-2)" "unprognostic (5.03e-3)" "unprognostic (1.79e-1)" "unprognostic (2.93e-1)" "unprognostic (8.13e-3)" "unprognostic (8.80e-2)" "unprognostic (1.13e-1)" "unprognostic (1.02e-3)" "unprognostic (7.77e-3)" "unprognostic (9.46e-2)" "unprognostic (1.91e-1)" "unprognostic (1.54e-3)" 1.4 1.4 0.6 8.7 0.8 1.3 3.0 0.9 2.7 3.8 1.8 0.0 0.8 1.4 1.0 0.3 2.8 1.7 2.6 2.0 0.6 0.7 3.6 29.1 3.7 26.6 0.6 0.0 4.7 1.3 0.4 1.4 33.5 6.0 2.4 1.9 5.3 12.6 2.5 1.8 2.2 2.5 0.6 2.9 4.9 1.4 0.7 0.0 13.2 1.5 2.5 5.9 1.5 5.3 0.4 20.6 0.5 0.4 3.8 14.7 2.7 0.0 0.3 15.5 0.0 4.7 5.3 11.1 4.4 6.4 4.0 4.2 0.0 0.1 0.0 0.0 6.0 0.0 0.0 0.4 2.4 2.0 1.3 3.2 0.3 2.0 13.5 6.2 0.5 2.3 15.4 0.8 1.4 3.7 0.9 0.0 0.8 4.6 0.0 3.2 0.8 0.7 0.6 0.5 0.1 0.4 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.3 0.4 0.0 3.9 0.0 0.0 14.2 0.0 0.0 0.0 3.0 0.0 0.9 0.1 0.2 0.0 6.3 0.4 5.0 0.4 7.6 4.9 0.4 0.4 7.7 7.5 0.5 3.8 0.4 20.6 14.7 2.7 0.6 0.8 0.9 2.7 0.6 0.7 0.6 0.0 6.0 0.0 0.0 0.6 1.4 0.2 10.2 2.0 2.2 2.5 4.0 1.2 7.0 37.3 5.1 0.0 0.6 11.1 2.5 0.0 0.0 0.2 10.4 9.0 0.7 0.0 32.1 1.4 7.9 0.0 34.4 3.7 1.4 2.6 4.3 1.7 1.8 0.0 6.0 0.1 0.0 1.1 0.0 15.2 12.9 2.7 0.6 0.4 12.9 30.3 11.7 0.0 0.1 HSD17B1 "EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1" ENSG00000108786 "Hydroxysteroid 17-beta dehydrogenase 1" P14061 17 42549214-42555213 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "placenta: 217.6" "Cell type enriched" "Detected in many" 5 "Syncytiotrophoblasts: 1251.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 8 "BEWO: 89.7" "Low region specificity" "Detected in single" "HPA021032, HPA065296" Enhanced Supported Cytosol NA NA Cytosol "HPA021032: AB_1844345, HPA065296: AB_2685457" "unprognostic (1.13e-1)" "unprognostic (1.40e-2)" "unprognostic (1.68e-2)" "unprognostic (9.25e-2)" "unprognostic (1.73e-1)" "unprognostic (3.88e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (9.35e-2)" "unprognostic (6.04e-2)" "unprognostic (2.88e-5)" "unprognostic (2.17e-1)" "unprognostic (1.30e-1)" "unprognostic (2.60e-2)" "unprognostic (5.09e-1)" "unprognostic (4.98e-1)" "unprognostic (1.32e-2)" 2.8 1.5 2.0 1.7 2.1 1.1 1.8 2.7 3.1 1.3 1.3 1.3 1.3 1.9 1.5 1.3 4.3 1.4 1.3 1.4 2.4 1.4 1.4 1.3 1.3 1.6 2.4 1.3 5.8 2.6 0.2 1.4 217.6 1.3 1.5 0.2 1.3 2.9 1.3 3.5 4.1 1.9 1.3 1.9 2.1 2.0 2.3 1.3 1.3 1.8 1.3 1.3 1.3 1.8 6.0 5.5 7.5 8.6 6.1 5.4 5.5 1.6 1.8 0.9 4.6 0.6 0.1 89.7 1.2 0.0 0.0 0.0 1.0 0.9 0.0 1.2 0.0 1.0 2.6 0.1 0.7 0.0 2.4 2.8 1.2 1.1 1.5 0.2 1.0 1.4 0.2 2.6 0.1 0.5 1.5 0.0 1.3 1.7 0.4 0.0 1.6 1.3 1.1 0.4 0.6 0.8 1.3 1.1 0.8 0.1 1.4 1.3 1.8 0.7 9.1 1.4 1.0 11.0 0.8 1.4 1.4 1.8 1.0 0.8 2.6 1.5 0.6 0.6 0.9 1.1 3.6 7.6 7.5 4.9 8.6 5.3 5.6 5.4 5.1 5.5 6.0 5.1 4.4 7.2 6.1 5.3 4.3 3.7 5.5 2.0 2.1 2.7 1.5 2.4 1.4 2.4 1.3 1.3 1.3 0.0 2.1 0.5 6.3 2.7 8.7 2.4 2.5 4.0 2.3 5.2 11.8 250.4 19.9 1.5 1.0 4.1 3.2 0.0 4.9 23.6 3.4 13.0 2.3 5.6 26.4 9.5 4.1 4.9 0.8 1.7 1.7 0.5 1.7 1.0 2.4 9.0 2.0 2.5 3.2 10.5 8.2 0.0 2.8 0.7 2.6 6.5 1251.0 1.3 1.9 8.4 HSD17B2 "HSD17, SDR9C2" ENSG00000086696 "Hydroxysteroid 17-beta dehydrogenase 2" P37059 16 82035004-82098534 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 83.1;liver: 52.9;placenta: 110.8" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 137.6;Enterocytes: 250.1;Hepatocytes: 98.5;Paneth cells: 199.9" "Cancer enhanced" "Detected in many" "liver cancer: 10.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 22.4;Hep G2: 17.8;hTERT-HME1: 10.7;OE19: 32.8;RT4: 36.8;TIME: 20.6" "Group enriched" "Detected in some" 5 "midbrain: 2.6;pons and medulla: 3.5" "Not detected" "Not detected" "HPA021826, HPA050235" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA021826: AB_10961148, HPA050235: AB_2681059" "unprognostic (1.50e-1)" "unprognostic (2.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.48e-2)" "unprognostic (2.58e-1)" "unprognostic (1.77e-1)" "unprognostic (4.29e-2)" "unprognostic (2.60e-1)" "unprognostic (7.35e-2)" "unprognostic (6.05e-3)" "unprognostic (4.98e-2)" "unprognostic (7.35e-2)" "unprognostic (6.31e-4)" "unprognostic (5.39e-2)" "unprognostic (1.14e-1)" "unprognostic (4.30e-2)" "prognostic favorable (3.83e-4)" 0.7 0.1 0.2 4.1 0.2 0.0 3.9 0.2 0.3 0.7 41.3 0.3 0.2 71.3 0.6 0.2 1.7 0.2 13.3 0.2 0.2 0.2 2.8 52.9 1.0 0.2 0.2 0.2 0.2 16.0 0.0 0.6 110.8 0.4 3.1 9.4 21.3 9.4 0.2 0.3 1.8 83.1 1.5 0.2 0.2 3.2 0.2 0.2 0.2 0.2 1.1 1.3 21.4 6.6 1.3 1.4 3.6 1.1 1.0 0.7 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.0 22.4 0.0 0.0 4.1 0.6 0.0 4.5 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.1 17.8 0.1 0.1 0.1 0.0 1.2 0.0 10.7 0.2 0.3 0.0 0.0 0.1 3.3 0.0 0.0 0.3 0.1 32.8 8.1 0.0 0.0 0.4 0.4 36.8 0.2 0.6 0.0 1.0 0.1 0.0 0.0 0.0 20.6 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 1.6 1.1 0.6 0.7 0.5 0.4 0.6 0.4 0.4 0.3 1.3 0.4 0.6 3.6 1.0 0.6 1.4 0.3 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.2 3.0 3.8 0.0 2.7 0.3 0.1 0.4 137.6 6.7 2.3 0.0 0.0 2.1 0.0 47.5 0.1 0.2 250.1 0.0 5.5 1.5 3.1 1.8 0.0 98.5 3.0 0.0 2.9 3.1 2.4 0.8 0.0 0.0 1.7 0.0 19.3 42.0 13.6 199.9 0.0 1.0 0.6 0.0 0.3 0.0 0.0 1.0 5.4 0.0 33.8 10.0 HSD3B1 "HSD3B, HSDB3, SDR11E1" ENSG00000203857 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1" P14060 1 119507198-119515054 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism, Steroidogenesis" "Isomerase, Multifunctional enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "placenta: 231.4" "Group enriched" "Detected in some" 23 "Extravillous trophoblasts: 115.9;Syncytiotrophoblasts: 419.8" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 36.4;SuSa: 16.3" "HPA043261, HPA043264, HPA044028" Supported Approved "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" NA NA "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781" "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-1)" "prognostic favorable (4.59e-5)" 0.1 0.6 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 231.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.5 11.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 4.0 0.4 0.5 16.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 115.9 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 419.8 0.0 0.0 0.0 HTR1B "5-HT1B, 5-HT1DB, HTR1D2, S12" ENSG00000135312 "5-hydroxytryptamine receptor 1B" P28222 6 77461753-77463773 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.8;placenta: 14.2;stomach 1: 10.2" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "basal ganglia: 11.8" "Cell type enriched" "Detected in single" 17 "basophil: 1.6" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.6" "Group enriched" "Detected in some" 15 "HUVEC TERT2: 41.8;TIME: 18.4" "Region enriched" "Detected in many" 4 "basal ganglia: 34.5" HPA028808 Enhanced Supported "Plasma membrane" NA NA "Plasma membrane" "HPA028808: AB_2672782" "unprognostic (3.86e-2)" "unprognostic (3.56e-1)" "unprognostic (7.68e-2)" "unprognostic (2.58e-1)" "unprognostic (1.88e-1)" "unprognostic (1.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.11e-1)" "unprognostic (8.96e-2)" "unprognostic (4.03e-1)" "unprognostic (1.77e-2)" "unprognostic (1.24e-1)" "unprognostic (1.10e-3)" "unprognostic (3.08e-2)" "unprognostic (2.81e-2)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" 2.2 1.5 1.3 1.1 11.8 0.3 2.4 0.4 3.7 2.9 0.6 0.1 0.0 0.6 1.1 1.0 1.4 0.8 2.8 0.4 1.0 2.1 0.9 0.3 1.1 0.3 1.2 0.9 1.1 0.5 0.3 0.5 14.2 3.0 1.6 0.4 0.3 1.3 1.2 0.9 0.5 0.4 4.1 0.6 0.4 10.2 1.5 0.6 0.0 0.5 0.0 0.3 2.6 1.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.4 1.1 0.8 41.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 11.8 0.4 3.7 1.0 2.1 1.2 0.9 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HTR1F "5-HT1F, HTR1EL" ENSG00000179097 "5-hydroxytryptamine receptor 1F" P30939 3 87990696-87993835 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "placenta: 5.7" "Group enriched" "Detected in some" 10 "Muller glia cells: 19.5;Sertoli cells: 19.4;Smooth muscle cells: 11.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 16 "basophil: 3.2" "Lineage enriched" "Detected in single" 16 "granulocytes: 3.2" "Group enriched" "Detected in some" 6 "A549: 1.2;K-562: 4.5;LHCN-M2: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005555 Uncertain NA NA "HPA005555: AB_1856708" "unprognostic (1.66e-1)" "unprognostic (2.62e-1)" "unprognostic (2.58e-1)" "unprognostic (9.03e-2)" "unprognostic (1.09e-1)" "unprognostic (1.01e-2)" "unprognostic (4.78e-1)" "unprognostic (1.58e-1)" "unprognostic (2.77e-2)" "unprognostic (2.24e-1)" "unprognostic (1.33e-1)" "unprognostic (9.80e-2)" "unprognostic (2.67e-6)" "unprognostic (1.25e-4)" "unprognostic (1.55e-2)" "unprognostic (3.33e-2)" "unprognostic (3.31e-2)" 2.8 0.5 0.7 0.0 0.6 1.5 1.6 0.0 1.8 1.4 0.0 0.0 1.2 0.3 0.1 0.4 0.1 0.3 0.6 0.4 0.6 0.0 0.9 0.1 0.8 0.4 0.7 0.3 1.4 5.7 0.4 0.0 0.1 1.0 0.6 0.4 0.0 1.3 0.3 1.7 0.0 0.3 1.5 0.5 0.6 0.7 0.1 0.2 3.2 0.0 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.5 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.7 0.0 0.0 19.5 0.1 0.0 0.0 0.0 1.0 19.4 11.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 HTR2B "5-HT(2B), 5-HT2B" ENSG00000135914 "5-hydroxytryptamine receptor 2B" P41595 2 231108230-231125118 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 26.0" "Cell type enhanced" "Detected in some" 14 "Cone photoreceptor cells: 3.9;Ito cells: 5.5;monocytes: 10.8;Peritubular cells: 4.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "basophil: 3.8;T-reg: 2.9" "Group enriched" "Detected in many" 29 "granulocytes: 3.8;T-cells: 2.9" "Group enriched" "Detected in some" 4 "HHSteC: 7.0;HSkMC: 13.3;SK-MEL-30: 24.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA012867, HPA063658" Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA012867: AB_1856710, HPA063658: AB_2685079" "unprognostic (1.86e-1)" "unprognostic (3.55e-2)" "unprognostic (1.20e-3)" "unprognostic (1.45e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-1)" "unprognostic (1.53e-2)" "unprognostic (1.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.15e-4)" "unprognostic (3.59e-1)" "unprognostic (2.17e-2)" "unprognostic (1.42e-3)" "unprognostic (7.44e-4)" "unprognostic (1.81e-1)" "unprognostic (1.17e-1)" "unprognostic (1.14e-2)" 2.3 17.9 0.2 5.8 0.3 0.7 4.1 0.3 0.6 17.8 7.3 0.2 1.7 1.0 14.9 9.5 5.7 1.9 0.8 4.6 0.3 0.3 5.6 2.5 1.8 0.5 0.3 0.4 4.3 0.3 0.3 0.4 26.0 0.9 2.6 1.5 1.8 0.5 1.0 0.2 0.2 6.3 12.8 0.3 0.4 5.2 3.3 0.3 2.4 6.8 1.0 0.4 4.9 0.8 0.0 0.1 3.8 0.0 0.0 2.9 0.0 0.1 0.2 0.0 0.1 0.4 3.6 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.0 0.1 0.3 13.3 0.0 0.0 0.0 0.0 2.5 1.1 0.1 0.0 0.0 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.1 24.4 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.8 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 2.9 0.0 0.2 0.3 0.3 0.6 0.3 0.3 0.3 0.4 0.9 0.3 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.0 2.7 0.0 0.0 3.9 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.6 0.1 0.3 0.0 0.0 0.9 2.6 1.6 0.0 5.5 1.2 0.0 0.6 0.0 0.0 10.8 0.0 0.0 0.1 0.0 4.9 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 HTRA4 FLJ90724 ENSG00000169495 "HtrA serine peptidase 4" P83105 8 38974164-38988662 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "placenta: 55.2" "Cell type enriched" "Detected in some" 9 "Extravillous trophoblasts: 319.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 23 "BEWO: 72.8" "Region enhanced" "Detected in some" "hippocampal formation: 2.3" "Low region specificity" "Detected in some" HPA045402 Enhanced "Secreted in female reproductive system" NA NA "HPA045402: AB_2679316" "unprognostic (1.20e-1)" "unprognostic (5.83e-4)" "unprognostic (8.02e-2)" "unprognostic (2.13e-2)" "unprognostic (8.20e-2)" "unprognostic (2.42e-2)" "unprognostic (1.80e-1)" "unprognostic (7.40e-3)" "unprognostic (1.40e-1)" "unprognostic (5.14e-4)" "unprognostic (1.01e-1)" "unprognostic (8.68e-2)" "unprognostic (1.42e-1)" "unprognostic (4.58e-1)" "unprognostic (5.19e-3)" "unprognostic (2.39e-3)" "unprognostic (1.19e-3)" 2.6 1.1 0.2 0.3 0.2 3.4 0.9 0.2 0.4 1.2 0.5 0.2 1.9 0.0 2.3 0.5 0.5 0.1 0.2 0.2 0.2 0.0 0.2 0.2 4.3 1.0 0.2 0.2 0.4 0.3 0.4 0.5 55.2 0.4 0.5 0.3 1.8 0.8 0.5 0.6 0.4 0.6 0.3 1.8 2.5 0.1 0.4 0.2 0.2 0.6 0.2 0.8 0.5 0.9 3.1 2.2 2.5 1.0 1.0 1.7 0.0 0.1 0.1 0.1 0.2 0.3 0.2 72.8 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.3 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 3.1 0.1 0.2 0.0 0.3 0.2 0.1 0.1 0.2 0.1 0.1 0.1 0.3 0.1 1.5 0.8 2.3 1.4 0.7 1.7 1.5 1.3 1.2 0.6 3.1 1.3 1.4 2.5 1.0 1.0 2.2 1.4 0.0 0.2 0.2 0.2 0.4 0.2 0.0 0.2 0.2 0.4 0.2 0.0 0.0 0.0 1.1 0.1 0.5 0.4 0.0 0.0 0.0 0.0 2.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 319.8 0.2 1.2 0.0 0.0 10.7 1.6 0.0 2.5 0.3 0.0 0.0 1.5 1.7 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 33.8 0.0 0.2 0.7 HYAL4 ENSG00000106302 "Hyaluronoglucosaminidase 4" Q2M3T9 7 123828983-123877478 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "placenta: 7.1;skeletal muscle: 8.3" "Group enriched" "Detected in some" 7 "Cytotrophoblasts: 4.0;Extravillous trophoblasts: 5.9;Spermatogonia: 2.8;Syncytiotrophoblasts: 1.8" "Cancer enriched" "Detected in single" 48 "testis cancer: 8.4" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 4.5;CAPAN-2: 7.2;RT4: 17.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA029453 Uncertain NA NA "HPA029453: AB_10601432" "unprognostic (5.19e-5)" "unprognostic (4.18e-2)" "unprognostic (4.82e-2)" "unprognostic (2.20e-1)" "unprognostic (4.14e-2)" "unprognostic (2.60e-1)" "unprognostic (8.24e-2)" "unprognostic (5.26e-2)" "unprognostic (8.15e-3)" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.19e-1)" "unprognostic (2.57e-1)" "unprognostic (2.57e-1)" "unprognostic (5.55e-3)" 0.1 0.3 0.0 0.0 0.0 0.7 0.2 0.0 0.5 0.0 0.1 0.0 0.1 0.4 0.4 0.2 0.0 0.4 0.0 0.0 0.6 0.1 0.4 0.0 0.0 0.1 0.6 0.0 0.1 7.1 0.2 0.0 1.2 0.0 8.3 1.4 0.2 0.0 0.1 1.0 0.2 3.4 0.4 1.5 1.0 0.1 1.3 0.6 3.3 0.6 1.0 0.9 0.1 0.3 0.6 0.1 0.4 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 7.2 0.3 0.4 0.0 0.7 1.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.1 0.1 0.3 0.0 0.1 0.2 0.1 0.0 17.0 0.2 0.1 0.0 1.0 0.0 1.4 0.4 0.2 2.4 0.1 0.4 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.5 0.4 0.6 0.5 0.5 0.4 0.5 0.5 0.2 1.3 0.7 0.9 3.3 1.0 0.6 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 5.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.8 0.0 1.8 0.0 0.0 0.1 IDO1 "IDO, INDO" ENSG00000131203 "Indoleamine 2,3-dioxygenase 1" P14902 8 39902275-39928444 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Immunity, Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 77.7;placenta: 33.2" "Cell type enriched" "Detected in some" 552 "monocytes: 4555.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 17 "eosinophil: 77.7" "Lineage enriched" "Detected in many" 17 "granulocytes: 77.7" "Cell line enriched" "Detected in some" 7 "EFO-21: 36.6" "Region enriched" "Detected in single" 13 "basal ganglia: 30.5" "Low region specificity" "Detected in all" "HPA023072, HPA023149, HPA027772, CAB072820" Enhanced Supported Nucleoplasm,Vesicles,Mitochondria,Cytosol NA NA Cytosol "Nucleoplasm, Vesicles, Mitochondria" "CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222" "unprognostic (1.68e-2)" "unprognostic (1.71e-2)" "unprognostic (4.08e-3)" "unprognostic (7.21e-3)" "unprognostic (1.90e-1)" "unprognostic (1.09e-2)" "unprognostic (1.86e-1)" "unprognostic (3.06e-2)" "prognostic favorable (5.27e-4)" "prognostic favorable (3.32e-4)" "unprognostic (3.59e-2)" "unprognostic (2.74e-1)" "prognostic unfavorable (1.12e-7)" "unprognostic (4.18e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.97e-2)" 8.7 0.2 0.9 11.2 0.9 0.0 1.4 0.9 0.9 4.0 1.5 0.9 0.9 2.6 2.6 0.9 1.2 0.6 1.3 1.0 0.9 0.0 0.9 0.9 16.8 14.1 0.9 0.9 0.9 0.9 0.0 0.9 33.2 0.9 1.6 2.1 1.9 0.9 0.9 2.5 0.3 5.9 0.9 2.0 6.2 2.2 0.9 0.9 0.9 7.2 0.9 8.9 2.3 0.9 0.0 4.6 77.7 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.5 2.6 0.1 0.3 0.0 36.6 0.0 1.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.2 0.0 0.1 0.0 0.1 0.0 4.5 0.1 77.7 0.0 0.2 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.9 0.9 0.9 0.9 0.9 0.0 0.9 0.9 0.9 0.9 0.0 0.3 0.0 0.0 0.3 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.0 0.0 2.5 2.6 0.9 0.0 0.0 6.7 0.0 0.2 0.4 0.0 0.0 0.8 0.0 0.0 0.0 8.2 1.3 0.0 6.0 0.0 4555.6 0.0 3.0 0.6 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.4 IDO2 INDOL1 ENSG00000188676 "Indoleamine 2,3-dioxygenase 2" Q6ZQW0 8 39934614-40016391 "Predicted intracellular proteins" "Immunity, Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "liver: 9.7;placenta: 21.5" "Cell type enhanced" "Detected in some" 24 "Early spermatids: 16.8;Late spermatids: 5.3;monocytes: 25.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "myeloid DC: 1.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.9" "Cell line enhanced" "Detected in some" "EFO-21: 1.0;U-266/70: 1.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA054911 Approved Cytosol NA NA Cytosol "HPA054911: " "unprognostic (2.00e-3)" "unprognostic (2.34e-5)" "unprognostic (2.22e-3)" "unprognostic (4.41e-3)" "unprognostic (5.37e-2)" "unprognostic (3.69e-5)" "unprognostic (1.19e-1)" "unprognostic (4.73e-3)" "unprognostic (1.20e-2)" "unprognostic (2.78e-1)" "unprognostic (4.11e-3)" "unprognostic (2.25e-1)" "unprognostic (6.47e-7)" "unprognostic (3.25e-2)" "unprognostic (1.96e-3)" "unprognostic (3.35e-2)" "unprognostic (3.08e-3)" 0.1 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 9.7 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 21.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 1.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.0 5.3 0.3 0.0 0.0 25.2 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.0 IFI6 "6-16, FAM14C, G1P3, IFI-6-16, IFI616" ENSG00000126709 "Interferon alpha inducible protein 6" P09912 1 27666061-27672218 "Predicted membrane proteins" "Antiviral defense, Apoptosis, Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 225.6" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 3308.6;Extravillous trophoblasts: 1015.8;Syncytiotrophoblasts: 3573.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 134.5;BJ hTERT+ SV40 Large T+ RasG12V: 157.3;EFO-21: 54.1;SK-MEL-30: 95.5" "Low region specificity" "Detected in all" HPA005543 Approved Approved Mitochondria NA NA Mitochondria "HPA005543: AB_1849342" "unprognostic (4.31e-1)" "unprognostic (1.03e-1)" "unprognostic (1.54e-1)" "unprognostic (1.04e-1)" "unprognostic (2.70e-1)" "unprognostic (6.96e-2)" "unprognostic (9.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.06e-1)" "unprognostic (6.77e-3)" "unprognostic (5.04e-2)" "unprognostic (1.64e-2)" "unprognostic (1.92e-3)" "unprognostic (1.81e-1)" "unprognostic (8.40e-2)" "unprognostic (3.42e-2)" "unprognostic (1.72e-2)" 32.3 27.5 24.9 13.5 28.2 37.3 10.9 14.2 36.1 11.4 13.8 22.9 6.5 16.5 26.8 68.0 8.6 11.9 113.9 19.3 23.0 42.3 44.8 23.5 31.6 5.8 20.0 17.0 14.1 21.3 5.9 60.1 225.6 34.3 13.9 10.1 31.6 111.4 10.1 7.4 5.4 12.5 17.0 26.0 27.3 35.4 15.4 6.8 24.8 35.2 7.9 9.7 7.8 7.6 9.7 19.4 84.9 58.6 15.8 27.5 16.8 1.4 0.4 2.2 1.4 7.3 4.0 9.0 4.7 21.7 134.5 157.3 0.7 5.7 0.5 54.1 2.1 35.6 0.5 0.5 1.0 4.4 11.1 1.8 3.4 1.1 0.4 1.9 1.1 4.5 4.3 0.1 8.1 0.1 2.1 1.2 3.1 0.2 9.5 1.5 0.4 4.1 14.5 0.4 2.7 4.5 2.8 1.2 1.3 1.1 0.0 3.2 2.9 5.8 1.3 95.5 0.7 0.6 4.4 2.1 1.2 1.9 0.9 0.8 11.3 6.4 0.3 2.4 10.1 3.5 29.3 44.4 39.4 22.7 58.6 22.4 9.7 23.0 20.7 19.4 8.0 24.3 23.6 84.9 15.8 38.8 2.0 27.5 16.8 24.9 28.2 14.2 36.1 23.0 42.3 20.0 17.0 34.3 6.8 131.0 105.4 20.9 17.6 20.8 10.1 13.4 73.9 88.3 37.5 61.1 9.8 3308.6 16.6 186.8 2.9 139.0 7.0 0.0 304.1 1015.8 142.9 71.5 60.2 43.3 628.8 3.2 56.0 68.2 47.6 8.5 102.4 129.6 67.4 56.9 22.2 79.9 144.2 8.7 192.3 28.3 5.5 109.9 38.2 1.7 0.9 19.6 3573.6 51.2 8.0 13.6 IFIT1B "bA149I23.6, IFIT1L" ENSG00000204010 "Interferon induced protein with tetratricopeptide repeats 1B" Q5T764 10 89378056-89385205 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "bone marrow: 23.2;placenta: 14.6" "Cell type enriched" "Detected in single" 1635 "Erythroid cells: 163.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 2.1;BJ hTERT+ SV40 Large T+ RasG12V: 1.7" HPA062924 Approved NA NA "HPA062924: AB_2684906" "unprognostic (2.59e-1)" "unprognostic (3.13e-1)" "unprognostic (6.62e-3)" "unprognostic (4.55e-2)" "unprognostic (4.11e-2)" "unprognostic (9.34e-2)" "unprognostic (1.76e-1)" "unprognostic (6.86e-2)" 0.4 0.0 0.2 0.0 0.2 23.2 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.2 0.3 0.1 0.2 0.5 4.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 14.6 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.6 0.0 0.1 0.0 0.7 0.2 0.0 0.0 0.6 0.0 0.2 0.0 0.9 0.2 0.0 0.1 2.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 2.1 1.7 0.0 0.1 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.2 0.0 0.0 2.4 0.2 0.2 0.0 0.1 0.3 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 163.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGDCC3 "HsT18880, PUNC" ENSG00000174498 "Immunoglobulin superfamily DCC subclass member 3" Q8IVU1 15 65327127-65378040 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.8;parathyroid gland: 16.6;placenta: 12.2" "Cell type enhanced" "Detected in some" 18 "Cone photoreceptor cells: 31.4;Cytotrophoblasts: 90.9;Late spermatids: 38.7;Syncytiotrophoblasts: 34.6" "Cancer enhanced" "Detected in many" "testis cancer: 5.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 42.7;CACO-2: 10.7;Hep G2: 33.7;SuSa: 17.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA015713 Uncertain Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA015713: " "unprognostic (7.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.24e-2)" "unprognostic (7.25e-3)" "unprognostic (6.67e-2)" "unprognostic (7.35e-3)" "unprognostic (3.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-2)" "unprognostic (4.56e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.77e-5)" "unprognostic (4.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-2)" 0.2 0.6 3.5 0.4 2.1 0.2 1.7 10.8 4.6 1.0 0.5 3.3 0.0 0.3 1.6 0.4 0.2 1.4 0.4 0.4 3.2 2.6 0.6 0.2 0.3 0.2 2.5 1.7 1.7 0.3 16.6 2.9 12.2 2.6 0.5 0.3 0.6 0.2 0.5 0.5 0.4 0.3 0.6 2.2 0.3 0.4 4.7 2.7 3.7 1.7 0.0 0.2 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 42.7 1.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 10.7 0.1 0.0 0.1 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.4 0.0 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.6 0.0 0.0 0.0 17.7 1.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 2.1 10.8 4.6 3.2 2.6 2.5 1.7 2.6 2.7 0.0 0.0 0.0 0.2 0.0 4.0 0.5 0.0 0.0 0.0 1.8 31.4 90.9 0.0 0.0 18.8 0.0 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.0 6.1 0.0 0.0 0.0 0.0 38.7 0.6 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.4 0.0 1.6 0.0 0.0 0.9 12.6 0.0 34.6 0.0 0.0 0.0 IGF2 "C11orf43, FLJ44734, IGF-II" ENSG00000167244 "Insulin like growth factor 2" P01344 11 2129112-2149603 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Carbohydrate metabolism, Glucose metabolism, Osteogenesis" "Growth factor, Hormone, Mitogen" "Cancer-related genes, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "placenta: 330.5" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 871.9;Extravillous trophoblasts: 2792.3;Syncytiotrophoblasts: 1348.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 115.4;Hep G2: 79.2;LHCN-M2: 45.5;RH-30: 56.5;SH-SY5Y: 68.8" "Low region specificity" "Detected in all" "HPA007556, HPA007993" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 609000000 1700000000 Vesicles "Nucleoplasm, Cytosol" "HPA007556: AB_2667860, HPA007993: AB_1851474" "unprognostic (1.54e-1)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" "unprognostic (7.08e-2)" "unprognostic (2.30e-3)" "unprognostic (2.59e-1)" "prognostic favorable (7.12e-4)" "unprognostic (7.92e-2)" "unprognostic (2.59e-2)" "unprognostic (1.68e-2)" "unprognostic (3.69e-2)" "unprognostic (1.85e-1)" "unprognostic (1.79e-3)" "unprognostic (2.00e-2)" "unprognostic (8.98e-2)" "unprognostic (8.93e-3)" "unprognostic (5.78e-2)" 16.6 8.0 1.3 4.5 2.0 0.5 23.3 2.3 1.9 23.4 5.0 3.4 4.7 1.0 9.9 32.0 5.2 17.2 4.5 20.5 1.5 1.6 8.1 39.7 1.9 1.1 3.5 1.6 20.4 5.5 0.7 5.0 330.5 7.6 10.4 1.0 33.2 2.6 6.7 21.9 1.7 2.3 7.5 17.0 2.0 3.2 12.4 0.2 1.8 2.6 14.5 1.8 15.2 14.1 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 15.2 0.1 0.4 0.0 115.4 0.0 0.0 1.1 0.0 0.3 0.0 0.1 0.9 1.1 0.0 0.0 0.0 0.0 79.2 20.3 0.0 0.0 24.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 45.5 0.3 0.0 0.1 0.1 0.0 0.2 0.0 56.5 0.1 0.0 0.1 4.5 68.8 0.0 0.0 0.0 12.0 0.5 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.0 1.3 2.0 2.3 1.4 1.5 1.6 3.5 1.6 7.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 871.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2792.3 0.0 0.0 0.0 0.0 192.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1348.9 0.0 0.0 0.0 IGF2BP1 IMP-1 ENSG00000159217 "Insulin like growth factor 2 mRNA binding protein 1" Q9NZI8 17 48997412-49055650 "Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "placenta: 17.6;testis: 17.8" "Cell type enhanced" "Detected in some" 15 "Extravillous trophoblasts: 31.6;Spermatocytes: 17.9;Spermatogonia: 21.1" "Cancer enriched" "Detected in many" 16 "testis cancer: 28.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 36.1;CACO-2: 56.9;Hep G2: 26.7;K-562: 28.8;NTERA-2: 28.9;REH: 33.0;SuSa: 28.8" "Not detected" "Not detected" "HPA021367, HPA062273" Enhanced Supported Cytosol NA NA Cytosol "HPA021367: AB_1851480, HPA062273: AB_2684733" "unprognostic (6.79e-4)" "unprognostic (2.76e-1)" "unprognostic (4.86e-3)" "unprognostic (2.30e-6)" "unprognostic (1.95e-2)" "unprognostic (9.11e-3)" "unprognostic (1.80e-2)" "unprognostic (1.01e-2)" "unprognostic (9.55e-3)" "unprognostic (2.58e-1)" "unprognostic (2.86e-2)" "unprognostic (5.91e-2)" "unprognostic (2.80e-6)" "unprognostic (2.58e-2)" "unprognostic (1.55e-1)" "unprognostic (2.32e-3)" "unprognostic (1.47e-1)" 0.1 0.1 0.0 0.9 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.1 0.3 0.5 0.1 0.3 0.1 0.1 0.0 0.1 17.6 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.1 17.8 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 36.1 0.0 1.3 1.9 25.9 2.0 0.0 2.9 5.0 56.9 0.9 2.9 0.2 0.2 0.8 0.0 22.2 0.0 5.2 0.0 13.1 21.6 7.7 26.7 1.7 11.3 5.8 2.6 0.0 0.7 0.0 1.0 6.0 4.0 28.8 0.0 4.0 0.2 0.0 9.5 28.9 0.0 0.0 33.0 11.9 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.8 28.8 0.0 3.2 0.1 0.0 0.3 3.0 0.0 0.0 0.0 19.4 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 6.0 0.6 0.0 0.3 0.1 0.0 3.6 0.0 1.4 1.2 0.0 0.0 2.1 0.0 0.0 3.5 0.3 0.0 0.0 0.0 31.6 1.2 0.2 1.1 0.0 5.4 0.0 0.0 0.0 0.0 3.8 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 17.9 21.1 0.1 2.4 0.0 0.0 0.3 IGF2BP2 IMP-2 ENSG00000073792 "Insulin like growth factor 2 mRNA binding protein 2" Q9Y6M1 3 185643739-185825056 "Plasma proteins, Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 43.0" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 118.2;Rod photoreceptor cells: 160.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 60.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017126, HPA035145" Enhanced Enhanced Cytosol NA NA Cytosol "CAB017126: , HPA035145: AB_2674491" "unprognostic (7.49e-2)" "unprognostic (1.17e-1)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.32e-1)" "prognostic unfavorable (5.12e-5)" "unprognostic (2.46e-3)" "unprognostic (8.25e-3)" "unprognostic (4.17e-1)" "unprognostic (3.45e-2)" "prognostic unfavorable (7.37e-5)" "unprognostic (1.77e-1)" "unprognostic (1.25e-1)" "unprognostic (9.45e-2)" "unprognostic (2.46e-1)" "unprognostic (1.71e-2)" "unprognostic (4.94e-3)" 7.9 8.9 1.0 6.4 1.9 7.6 4.9 8.6 1.6 6.5 16.4 1.6 1.5 11.3 7.6 4.8 3.7 8.3 8.1 9.9 1.7 1.4 8.0 2.6 14.0 4.0 2.8 0.7 6.7 11.3 7.6 2.9 43.0 4.5 4.9 11.6 16.9 9.0 1.6 3.2 4.3 21.4 3.3 3.7 5.8 9.9 5.1 1.5 2.4 8.6 3.2 3.3 6.2 12.5 0.0 5.5 0.9 3.3 1.3 0.0 1.2 28.3 2.4 27.8 5.2 15.2 24.0 17.0 15.0 21.2 23.3 28.0 20.4 8.0 0.0 22.3 12.6 29.9 12.9 13.0 21.8 37.9 0.0 13.4 8.1 0.1 14.1 32.5 0.2 0.0 17.5 11.6 15.5 60.3 12.2 21.4 2.1 7.9 0.0 17.0 0.2 0.0 6.8 20.3 4.8 10.3 2.9 11.0 8.5 15.1 0.1 1.7 0.2 1.1 0.0 26.7 28.8 2.2 18.9 32.4 8.1 17.7 10.1 17.2 0.1 0.0 0.0 8.0 0.0 11.3 0.9 3.0 0.5 0.0 2.8 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.2 1.3 3.3 1.0 0.0 1.2 1.0 1.9 8.6 1.6 1.7 1.4 2.8 0.7 4.5 1.5 11.9 12.3 0.0 21.8 17.5 3.2 13.6 28.1 48.2 35.2 24.4 15.7 1.7 3.3 33.9 118.2 12.2 59.3 23.3 22.6 14.2 28.3 47.6 2.3 0.0 13.3 1.6 34.2 44.2 10.5 64.7 4.9 7.4 13.5 4.6 42.1 30.6 38.8 84.6 0.4 7.6 160.2 0.0 8.6 2.8 7.0 12.8 5.3 0.0 34.5 53.7 IGF2BP3 "CT98, IMP-3, IMP3" ENSG00000136231 "Insulin like growth factor 2 mRNA binding protein 3" O00425 7 23310209-23470467 "Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "placenta: 74.0" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 68.4;Extravillous trophoblasts: 72.8;Hofbauer cells: 30.1;Syncytiotrophoblasts: 65.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 49.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA002037, HPA076951" Enhanced Supported Cytosol NA NA Cytosol "HPA002037: AB_1851483, HPA076951: " "unprognostic (5.72e-2)" "unprognostic (3.12e-1)" "unprognostic (7.25e-2)" "unprognostic (3.56e-3)" "unprognostic (1.45e-1)" "unprognostic (3.00e-2)" "unprognostic (2.64e-3)" "unprognostic (3.18e-2)" "unprognostic (2.60e-3)" "unprognostic (3.67e-1)" "unprognostic (1.02e-5)" "unprognostic (8.76e-2)" "unprognostic (0.00e+0)" "unprognostic (1.43e-1)" "unprognostic (7.95e-2)" "unprognostic (2.87e-4)" "unprognostic (7.51e-3)" 0.4 0.2 0.3 0.9 0.2 0.3 0.2 0.2 0.3 0.4 0.3 0.4 0.1 0.0 0.2 1.3 4.8 0.7 0.1 0.5 0.3 0.2 0.2 0.3 1.2 3.4 0.2 0.0 0.2 1.5 0.0 0.2 74.0 0.7 0.2 0.0 0.3 0.7 0.1 0.2 0.2 0.3 0.0 1.2 1.0 0.2 6.5 0.0 11.4 0.6 0.2 6.0 0.2 0.6 1.2 0.4 1.5 1.5 0.0 0.2 3.0 13.8 4.1 31.1 9.2 4.9 13.2 19.0 2.3 10.5 5.8 7.3 13.1 11.0 10.4 12.6 6.1 26.0 9.1 13.4 10.2 10.3 1.6 5.3 5.5 11.1 10.9 15.3 10.0 3.9 13.4 7.2 4.4 1.9 34.8 49.8 5.9 25.2 0.0 14.1 0.0 6.1 6.7 24.8 10.6 12.8 9.5 10.4 13.4 11.5 1.2 8.2 17.9 1.4 0.0 11.6 37.1 0.0 1.9 20.0 5.6 0.3 12.1 6.0 0.0 4.4 16.5 22.4 11.2 21.5 0.0 1.5 0.0 0.1 0.8 0.0 1.2 0.0 0.0 0.4 0.9 0.2 0.0 1.5 0.0 0.0 0.0 0.0 3.0 0.3 0.2 0.2 0.3 0.3 0.2 0.2 0.0 0.7 0.0 0.0 0.0 1.7 0.6 0.2 0.5 0.3 0.0 4.0 0.0 0.0 0.0 68.4 0.0 1.1 21.3 0.1 0.0 0.0 0.2 72.8 0.5 0.2 3.5 0.0 30.1 1.6 0.0 1.3 0.0 16.9 2.0 1.3 3.3 0.0 0.0 0.3 0.8 0.0 0.0 0.0 1.7 0.0 0.4 1.9 1.5 0.4 65.7 0.0 0.0 0.5 IGFBP1 "AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12" ENSG00000146678 "Insulin like growth factor binding protein 1" P08833 7 45888357-45893668 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Growth factor binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "liver: 157.6;placenta: 292.3" "Cell type enriched" "Detected in some" 23 "Hepatocytes: 863.0" "Cancer enriched" "Detected in many" 29 "liver cancer: 385.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "Hep G2: 18.0;U-2197: 29.5;U-87 MG: 51.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB004445, HPA046972, HPA050640" Enhanced Approved "Golgi apparatus" "Secreted to blood" NA NA 28100000 22000000 "Golgi apparatus" "CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197" "unprognostic (8.66e-3)" "unprognostic (1.45e-1)" "unprognostic (9.41e-2)" "unprognostic (7.80e-2)" "unprognostic (7.04e-2)" "unprognostic (2.93e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.89e-2)" "unprognostic (2.09e-3)" "unprognostic (8.95e-2)" "prognostic unfavorable (6.90e-11)" "prognostic unfavorable (6.64e-4)" "unprognostic (7.20e-2)" "unprognostic (7.98e-2)" "unprognostic (3.43e-1)" 0.4 0.0 0.1 0.1 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.0 10.7 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.2 157.6 0.1 0.0 0.1 0.0 9.3 0.0 0.0 0.2 292.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.9 0.1 0.5 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 18.0 0.1 0.3 0.0 0.0 0.2 3.9 0.0 0.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 29.5 0.0 0.0 0.0 0.0 51.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 38.2 0.0 1.2 0.0 0.0 0.7 0.0 6.7 0.1 0.0 0.0 23.3 0.0 2.0 1.0 0.0 0.0 863.0 1.6 0.0 3.4 9.2 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.9 0.0 0.0 0.0 IGFBP3 "BP-53, IBP3" ENSG00000146674 "Insulin like growth factor binding protein 3" P17936 7 45912245-45921874 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Growth factor binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 320.7" "Cell type enhanced" "Detected in many" 19 "Basal keratinocytes: 406.6;Extravillous trophoblasts: 1874.7;Urothelial cells: 581.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 28.9" "Lineage enriched" "Detected in many" 5 "dendritic cells: 28.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 422.0;U-2197: 175.0;U-87 MG: 90.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" CAB010360 Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 3250000000 5600000000 Vesicles "Nucleoplasm, Cytosol" "CAB010360: AB_2233528" "unprognostic (4.46e-3)" "unprognostic (4.84e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.30e-1)" "unprognostic (1.15e-1)" "unprognostic (6.54e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (8.14e-3)" "unprognostic (3.31e-2)" "unprognostic (2.03e-1)" "unprognostic (9.67e-3)" "unprognostic (2.80e-1)" "prognostic unfavorable (5.07e-7)" "unprognostic (2.36e-2)" "unprognostic (4.14e-2)" "unprognostic (2.37e-3)" "unprognostic (2.63e-1)" 47.4 1.6 4.4 10.6 2.7 0.0 52.1 2.7 4.1 44.3 21.3 1.7 3.2 6.9 58.4 8.1 11.7 14.9 5.4 41.6 4.4 2.6 11.1 80.4 11.7 12.7 3.7 1.9 49.2 2.2 0.6 19.2 320.7 4.1 22.5 6.1 9.1 6.4 9.3 13.9 23.9 10.2 22.9 3.8 18.7 8.3 12.1 3.1 2.2 5.6 8.6 8.3 32.0 26.3 0.0 28.9 0.0 0.0 0.0 6.0 1.7 9.6 2.9 5.7 0.0 4.3 1.8 0.0 42.1 7.6 3.6 1.9 0.0 7.8 0.0 13.4 422.0 1.8 23.2 0.0 0.1 1.5 0.0 0.0 0.0 1.0 0.0 1.1 0.0 0.0 14.8 0.6 0.7 2.7 5.7 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 3.9 2.6 20.8 0.6 1.6 14.6 0.5 0.7 13.3 0.0 0.0 0.0 41.7 0.0 175.0 2.3 0.6 0.0 0.0 90.6 0.0 14.0 0.0 0.0 0.0 5.2 0.0 4.3 0.0 6.0 5.6 0.0 0.0 2.8 4.7 0.0 0.0 0.0 28.9 0.3 1.7 4.4 2.7 2.7 4.1 4.4 2.6 3.7 1.9 4.1 3.1 3.0 4.6 0.0 95.2 406.6 0.6 9.7 7.6 33.5 117.2 216.3 0.0 45.9 10.0 71.8 0.8 62.6 0.4 0.0 1.7 1874.7 137.7 80.4 1.1 1.7 72.5 0.0 263.4 181.7 8.2 1.9 266.9 3.0 15.1 12.6 1.6 0.4 19.7 2.9 6.3 0.7 0.6 0.0 28.8 0.4 0.4 213.8 129.0 8.2 0.6 581.2 IGSF3 "EWI-3, MGC117164, V8" ENSG00000143061 "Immunoglobulin superfamily member 3" O75054 1 116574399-116667755 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 42.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 62.5;WM-115: 60.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036305, HPA036306" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA036305: AB_2675050, HPA036306: AB_10671245" "unprognostic (9.87e-2)" "unprognostic (3.64e-1)" "unprognostic (9.51e-2)" "prognostic unfavorable (1.98e-4)" "unprognostic (2.97e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (4.03e-6)" "unprognostic (9.40e-2)" "unprognostic (4.41e-1)" "unprognostic (2.42e-1)" "prognostic unfavorable (2.03e-4)" "unprognostic (4.18e-1)" "prognostic favorable (2.87e-6)" "unprognostic (5.29e-2)" "unprognostic (4.23e-2)" "unprognostic (2.57e-1)" "unprognostic (1.08e-1)" 1.4 1.5 1.9 1.2 5.1 0.1 7.7 2.5 8.3 5.8 5.7 1.5 3.0 6.7 2.5 6.5 22.0 1.7 3.5 7.9 1.8 2.8 10.7 0.8 7.4 0.3 1.8 2.8 0.7 4.5 1.4 2.7 42.9 4.1 5.1 5.1 7.8 9.3 5.5 1.1 16.1 12.9 2.4 1.7 0.5 7.3 3.6 0.9 6.2 8.1 9.0 9.3 8.2 9.8 0.0 0.2 0.3 0.6 0.0 0.7 0.2 5.4 9.3 7.2 1.8 1.6 3.5 19.3 0.0 0.2 0.7 0.2 5.3 3.1 0.0 2.9 0.0 4.0 15.2 3.2 7.5 0.3 62.5 2.3 2.9 3.6 0.1 0.0 0.2 5.7 0.4 5.9 0.0 1.3 1.3 0.0 1.0 0.9 0.0 0.1 19.1 0.2 0.1 4.5 3.3 0.2 2.2 8.8 0.0 5.5 6.8 4.2 12.8 2.2 21.5 13.7 14.4 7.2 0.3 0.0 1.2 4.3 0.0 5.6 0.0 0.3 0.0 0.5 0.1 60.3 0.0 0.6 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.2 1.9 5.1 2.5 8.3 1.8 2.8 1.8 2.8 4.1 0.9 14.9 25.2 0.0 7.0 17.4 1.9 14.4 12.7 8.1 5.7 14.0 0.0 10.1 3.3 13.2 1.8 2.1 14.7 0.0 1.7 24.6 6.6 7.2 1.1 0.0 1.9 6.4 2.9 1.8 1.6 2.1 1.1 0.9 8.5 5.4 5.5 12.8 11.2 8.6 0.0 11.3 0.5 0.0 2.1 0.5 4.3 24.2 11.1 0.0 7.1 9.6 IL1RAP "C3orf13, IL-1RAcP, IL1R3" ENSG00000196083 "Interleukin 1 receptor accessory protein" Q9NPH3 3 190514051-190659750 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 36.5;liver: 91.8;placenta: 35.9" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 100.2;Hepatocytes: 172.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "neutrophil: 36.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 36.5" "Cell line enhanced" "Detected in many" "SK-MEL-30: 72.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035293 Uncertain Approved Vesicles,Cytosol "Secreted to blood" NA NA 260000000 "Vesicles, Cytosol" "HPA035293: AB_10671511" "unprognostic (6.48e-2)" "unprognostic (1.02e-1)" "unprognostic (3.04e-2)" "unprognostic (1.04e-2)" "unprognostic (1.37e-1)" "unprognostic (8.84e-3)" "unprognostic (2.35e-2)" "unprognostic (6.60e-2)" "unprognostic (2.62e-1)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (1.72e-1)" "prognostic unfavorable (2.16e-7)" "unprognostic (4.02e-3)" "unprognostic (9.06e-2)" "unprognostic (5.72e-2)" "prognostic unfavorable (6.29e-4)" 3.4 1.7 3.7 5.2 4.5 7.8 2.8 0.8 6.0 2.9 1.8 3.4 0.7 1.1 2.6 1.7 9.1 3.2 5.7 3.3 7.4 2.9 1.9 91.8 6.3 12.6 3.5 2.5 2.2 2.0 1.0 1.4 35.9 5.5 2.1 1.4 1.6 4.7 2.0 1.2 5.8 1.5 3.1 6.3 7.1 2.3 1.0 2.9 2.3 2.2 3.8 3.4 3.3 4.4 0.9 1.4 36.5 2.2 0.1 1.3 0.5 3.9 1.0 1.6 0.2 2.9 2.4 3.1 1.7 3.5 4.1 4.0 1.7 8.8 0.7 18.3 4.8 9.5 10.2 0.9 17.1 5.7 0.7 1.0 0.8 1.7 4.2 6.1 5.8 2.8 3.2 7.0 5.9 18.9 8.6 1.8 1.8 0.1 0.0 1.9 1.8 0.5 2.6 2.6 1.7 1.8 2.8 2.5 1.4 1.5 4.2 0.3 0.0 8.0 4.4 72.7 1.6 2.9 4.2 2.4 3.2 3.2 9.7 7.9 1.5 0.0 0.1 5.4 5.3 18.6 3.5 1.5 8.5 0.7 1.7 1.3 0.9 0.8 0.9 1.4 0.9 0.8 0.5 36.5 0.1 2.2 0.2 0.8 0.5 3.7 4.5 0.8 6.0 7.4 2.9 3.5 2.5 5.5 2.9 0.0 14.3 1.4 14.3 39.8 5.4 4.0 43.3 2.7 20.5 3.5 7.9 3.1 0.0 6.5 2.3 7.1 1.3 0.0 6.4 100.2 7.0 5.6 7.0 172.7 6.9 0.0 5.2 8.0 33.0 0.0 4.0 18.3 8.5 1.0 1.3 0.9 14.8 0.0 2.5 0.8 0.6 0.0 3.1 0.0 0.6 32.5 20.3 2.5 1.2 12.8 IL1RL1 "DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1" ENSG00000115602 "Interleukin 1 receptor like 1" Q01638 2 102311502-102352037 "Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "kidney: 49.7;lung: 77.2;placenta: 95.0" "Cell type enriched" "Detected in many" 11 "granulocytes: 477.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 7.9" "Group enriched" "Detected in many" 5 "basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6" "Group enriched" "Detected in some" 59 "basophil: 17.1;eosinophil: 17.0" "Lineage enriched" "Detected in single" 59 "granulocytes: 17.1" "Group enriched" "Detected in some" 6 "HHSteC: 55.4;HMC-1: 82.4;HUVEC TERT2: 40.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007406, HPA007917" Uncertain Supported "Plasma membrane,Focal adhesion sites,Cytosol" "Secreted to blood" NA NA 19100000 1700000 "Plasma membrane" "Focal adhesion sites, Cytosol" "HPA007406: AB_1079128, HPA007917: AB_1079129" "unprognostic (7.25e-2)" "unprognostic (9.72e-2)" "unprognostic (1.44e-1)" "unprognostic (3.28e-2)" "unprognostic (5.28e-2)" "unprognostic (1.98e-2)" "unprognostic (3.25e-3)" "unprognostic (2.07e-1)" "unprognostic (2.77e-1)" "unprognostic (4.50e-2)" "unprognostic (8.58e-2)" "unprognostic (9.74e-2)" "unprognostic (1.44e-1)" "unprognostic (1.32e-2)" "unprognostic (1.60e-2)" "unprognostic (1.17e-1)" "unprognostic (4.60e-3)" 10.7 7.5 1.4 2.0 11.4 0.9 6.9 0.5 6.6 2.6 3.1 0.1 0.1 1.3 1.7 0.9 2.7 0.8 7.8 16.6 5.6 1.8 49.7 6.2 77.2 1.4 3.8 0.0 0.7 2.8 0.8 1.8 95.0 14.6 1.9 2.3 1.0 0.7 5.7 2.8 1.1 2.0 3.3 5.0 1.0 6.7 0.8 0.3 0.0 5.6 0.7 0.9 6.0 2.6 0.0 0.0 17.1 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 3.4 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 1.3 0.1 0.0 0.0 9.7 0.1 0.1 55.4 0.4 82.4 1.1 0.3 1.3 8.9 0.1 40.2 0.0 0.2 0.1 0.1 0.0 0.1 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.1 0.1 0.1 17.1 0.0 17.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.4 11.4 0.5 6.6 5.6 1.8 3.8 0.0 14.6 0.3 8.9 22.8 0.0 15.1 7.6 0.0 1.8 0.0 12.0 13.6 1.8 0.0 0.0 0.0 0.0 0.2 29.2 0.0 0.0 0.4 0.1 4.2 8.9 477.2 0.0 0.0 0.0 0.0 44.2 0.3 0.9 0.9 11.2 3.3 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.2 38.8 5.2 0.0 0.0 4.4 0.0 4.3 0.0 11.1 IL22RA2 "CRF2-S1, IL-22BP" ENSG00000164485 "Interleukin 22 receptor subunit alpha 2" Q969J5 6 137143820-137173648 "Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "breast: 6.9;lymphoid tissue: 6.2;placenta: 11.5" "Cell type enriched" "Detected in single" 6 "Syncytiotrophoblasts: 1.5" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "HL-60: 2.8;U-937: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA030582, CAB034906" Uncertain "Secreted to blood" NA NA 40500000 "CAB034906: AB_2124501, HPA030582: AB_10600716" "unprognostic (1.09e-1)" "unprognostic (7.97e-4)" "unprognostic (1.32e-3)" "unprognostic (1.24e-2)" "unprognostic (4.03e-3)" "unprognostic (1.11e-1)" "unprognostic (4.51e-1)" "unprognostic (1.92e-1)" "unprognostic (1.07e-1)" "unprognostic (1.10e-1)" "unprognostic (7.58e-2)" "unprognostic (1.32e-1)" "unprognostic (1.62e-1)" "unprognostic (6.61e-2)" 0.1 0.0 0.1 2.5 0.1 0.0 6.9 0.1 0.1 0.3 0.2 0.1 0.1 0.2 0.1 0.1 0.5 0.0 0.2 0.3 0.1 0.0 0.1 0.1 0.1 2.0 0.1 0.1 0.1 0.1 0.0 0.1 11.5 0.1 0.2 0.5 0.1 0.1 0.1 0.1 1.4 1.5 0.1 0.1 1.9 0.3 0.1 0.1 0.1 0.1 0.1 6.2 0.8 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 IL2RB "CD122, IL15RB" ENSG00000100385 "Interleukin 2 receptor subunit beta" P14784 22 37125838-37175054 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 51.6;lymphoid tissue: 35.0;placenta: 58.5" "Group enriched" "Detected in many" 8 "Extravillous trophoblasts: 80.1;T-cells: 97.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 14.7;NK-cell: 51.6" "Group enriched" "Detected in many" 32 "NK-cells: 51.6;T-cells: 14.7" "Cell line enriched" "Detected in some" 8 "HDLM-2: 106.6" "Region enriched" "Detected in single" 7 "basal ganglia: 1.6" "Low region specificity" "Detected in single" HPA062657 Enhanced NA NA "HPA062657: AB_2684822" "unprognostic (3.38e-3)" "unprognostic (1.21e-2)" "prognostic favorable (6.76e-4)" "prognostic favorable (3.18e-5)" "unprognostic (2.44e-2)" "unprognostic (9.69e-3)" "unprognostic (2.60e-1)" "unprognostic (5.22e-2)" "unprognostic (1.03e-3)" "unprognostic (5.37e-2)" "unprognostic (1.09e-1)" "unprognostic (2.74e-1)" "prognostic unfavorable (3.50e-7)" "unprognostic (4.63e-2)" "unprognostic (7.96e-2)" "unprognostic (3.94e-3)" "unprognostic (2.46e-2)" 2.2 1.0 0.8 20.5 0.8 12.3 1.6 0.6 0.7 1.3 5.5 0.6 1.4 1.8 4.3 2.8 2.6 1.8 5.8 3.7 0.7 0.8 1.9 6.0 7.4 20.8 0.8 0.2 1.5 1.0 0.0 1.1 58.5 0.7 3.5 1.8 2.9 3.7 2.1 0.9 4.0 7.3 0.6 1.1 35.0 2.3 1.1 0.2 21.0 2.1 1.8 28.7 4.0 1.5 0.3 0.0 1.0 0.1 51.6 14.7 7.9 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 106.6 0.1 0.2 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.2 0.0 0.0 2.8 0.0 0.1 7.7 13.2 0.0 0.1 0.0 0.1 1.0 0.0 0.1 14.7 0.1 8.1 0.1 3.3 8.2 0.0 0.3 1.1 4.3 0.3 51.6 0.1 0.0 6.8 7.9 0.8 0.8 0.6 0.7 0.7 0.8 0.8 0.2 0.7 0.2 3.0 11.6 1.5 0.8 2.9 0.0 1.1 0.0 1.4 1.2 1.8 0.0 0.4 0.0 0.0 1.7 0.0 0.0 0.0 0.2 80.1 1.1 0.1 9.3 1.0 2.1 0.0 0.0 8.6 1.6 0.9 0.3 0.5 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 1.0 97.0 0.0 0.0 INHA ENSG00000123999 "Inhibin alpha subunit" P05111 2 219569162-219575713 "Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 24.2;ovary: 31.5;placenta: 39.3;testis: 77.6" "Cell type enriched" "Detected in many" 9 "Syncytiotrophoblasts: 276.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "basal ganglia: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.5;HEL: 5.6;SK-BR-3: 12.8;SuSa: 6.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB000047, HPA019141, HPA048834" Enhanced Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA Vesicles "Golgi apparatus" "CAB000047: AB_322161, HPA019141: AB_1851789, HPA048834: " "unprognostic (8.90e-3)" "unprognostic (2.91e-2)" "unprognostic (2.82e-1)" "unprognostic (7.55e-2)" "unprognostic (1.02e-3)" "unprognostic (1.45e-1)" "unprognostic (3.57e-1)" "unprognostic (9.61e-3)" "unprognostic (4.15e-3)" "unprognostic (6.71e-2)" "unprognostic (3.73e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (4.03e-5)" "unprognostic (4.85e-2)" "unprognostic (7.20e-2)" "unprognostic (1.93e-1)" "unprognostic (4.43e-2)" 0.5 24.2 0.8 0.5 8.4 0.0 0.5 1.7 0.9 0.5 0.5 1.4 0.5 0.0 0.5 1.2 0.5 0.6 0.6 4.8 0.8 0.9 0.5 0.5 0.5 0.5 0.5 0.6 31.5 6.5 0.2 1.5 39.3 0.6 0.5 0.0 0.5 0.9 0.7 0.5 1.1 0.5 0.5 0.5 0.5 0.1 77.6 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 2.5 0.8 0.2 4.5 0.5 0.4 0.7 0.2 0.3 4.3 0.0 0.3 1.0 0.7 2.6 0.3 0.7 0.0 0.0 0.8 5.6 2.0 3.0 0.4 0.0 0.0 0.9 1.3 0.0 0.7 2.5 0.0 0.0 3.3 0.0 0.1 3.0 0.0 0.2 1.7 0.2 1.1 0.1 0.2 0.0 0.7 0.3 0.4 1.0 1.6 12.8 0.4 6.6 0.8 0.0 0.1 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 8.4 1.7 0.9 0.8 0.9 0.5 0.6 0.6 0.5 0.0 0.0 0.0 0.1 0.0 3.4 1.4 0.0 0.0 0.0 7.0 2.0 6.0 0.0 1.5 0.7 0.0 0.0 0.0 7.9 29.6 0.2 0.0 0.0 0.0 2.3 6.4 0.0 1.3 0.3 4.1 3.7 0.0 0.0 0.0 0.0 3.3 3.3 0.0 1.4 0.0 0.0 0.0 0.0 1.1 0.4 0.0 276.8 0.0 0.0 0.0 INHBA ENSG00000122641 "Inhibin beta A subunit" P08476 7 41667168-41705834 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Growth factor, Hormone" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "placenta: 148.2" "Cell type enhanced" "Detected in many" 17 "Leydig cells: 127.4;Smooth muscle cells: 270.9;Syncytiotrophoblasts: 149.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 1.8;non-classical monocyte: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 19.2;hTEC/SVTERT24-B: 58.9;hTERT-HME1: 24.3;hTERT-RPE1: 36.3;TIME: 30.4;U-138 MG: 45.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "Secreted to blood" NA NA 290000 "unprognostic (4.11e-3)" "prognostic unfavorable (1.46e-5)" "unprognostic (4.22e-2)" "unprognostic (1.08e-1)" "unprognostic (5.18e-2)" "prognostic unfavorable (4.34e-4)" "unprognostic (2.05e-2)" "prognostic unfavorable (7.72e-4)" "unprognostic (1.44e-1)" "unprognostic (1.31e-1)" "unprognostic (1.23e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (7.91e-8)" "unprognostic (6.22e-3)" "unprognostic (1.11e-2)" "unprognostic (3.25e-2)" "unprognostic (3.18e-3)" 1.7 1.0 1.2 3.6 3.7 6.6 1.3 0.7 3.5 1.7 1.5 0.8 1.3 0.3 13.6 4.2 3.8 1.6 17.3 9.3 1.9 1.6 2.0 7.9 26.4 0.6 1.2 0.7 5.2 1.2 0.0 0.8 148.2 4.8 2.4 0.2 1.4 4.3 3.8 1.2 2.9 0.8 3.8 8.7 0.4 1.5 3.9 1.3 0.4 1.5 2.6 0.7 4.8 1.8 0.2 0.7 1.8 1.3 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.8 1.9 0.0 4.6 0.5 2.5 0.8 0.0 0.1 0.0 0.3 1.7 3.0 3.8 0.0 19.2 2.5 1.2 0.0 0.0 0.0 0.0 3.7 0.0 0.0 1.8 1.1 58.9 24.3 36.3 2.0 0.0 0.1 0.0 5.9 0.0 0.0 0.1 0.4 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.8 0.1 0.0 1.7 0.0 0.0 30.4 45.9 13.3 4.9 4.8 0.0 0.0 0.0 1.8 0.0 0.1 0.1 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 1.8 0.0 1.3 0.0 0.0 0.3 1.2 3.7 0.7 1.3 1.9 1.6 1.2 0.7 4.8 1.3 3.0 17.8 0.5 7.8 15.3 0.0 4.8 0.0 4.0 5.7 0.0 0.0 0.4 0.0 4.5 0.5 3.1 0.0 0.0 1.6 2.6 14.6 5.6 7.0 11.4 1.4 0.0 0.0 1.3 2.7 1.9 127.4 45.7 13.5 46.9 0.0 12.6 10.6 0.0 21.9 0.0 0.9 0.0 270.9 0.5 0.1 7.9 149.2 0.0 0.0 2.3 INSL4 EPIL ENSG00000120211 "Insulin like 4" Q14641 9 5231419-5235304 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "placenta: 88.0" "Cell type enriched" "Detected in some" 11 "Syncytiotrophoblasts: 2990.3" "Cancer enhanced" "Detected in some" "lung cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "A549: 23.6" HPA065145 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA065145: " "unprognostic (9.77e-2)" "unprognostic (2.02e-1)" "unprognostic (4.66e-1)" "unprognostic (7.74e-2)" 0.1 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 1.8 0.1 0.0 0.0 0.2 0.0 0.1 0.8 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 88.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.1 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.0 0.1 0.0 0.0 23.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 269.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 34.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2990.3 0.0 0.0 0.0 ISM2 "FLJ32147, TAIL1, THSD3" ENSG00000100593 "Isthmin 2" Q6H9L7 14 77474394-77498850 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "placenta: 193.8" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 240.2;Extravillous trophoblasts: 440.1;Syncytiotrophoblasts: 148.4" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "basal ganglia: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 15 "BEWO: 91.4" "Not detected" "Not detected" "HPA039314, HPA039742" Supported Supported Nucleoplasm "Secreted in female reproductive system" NA NA Nucleoplasm "HPA039314: AB_10673239, HPA039742: AB_10673427" "unprognostic (5.69e-2)" "unprognostic (9.17e-3)" "unprognostic (2.58e-2)" "unprognostic (1.41e-3)" "unprognostic (3.73e-2)" "unprognostic (2.34e-1)" "unprognostic (2.16e-2)" "unprognostic (3.09e-3)" "unprognostic (2.11e-1)" "unprognostic (4.13e-1)" "unprognostic (8.10e-2)" "unprognostic (1.42e-2)" "unprognostic (9.36e-2)" "unprognostic (1.83e-1)" "unprognostic (5.67e-2)" "unprognostic (3.95e-1)" 0.7 0.0 0.2 0.2 4.2 0.0 0.1 0.1 0.3 1.1 0.2 0.1 0.3 0.1 2.7 0.9 0.2 0.5 0.1 0.1 0.1 0.8 0.6 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.1 0.5 193.8 0.2 3.2 0.0 0.2 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.4 0.2 0.1 0.2 0.1 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 91.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.2 0.1 0.3 0.1 0.8 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.4 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 240.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 440.1 0.3 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.4 0.0 148.4 0.0 0.0 0.0 ITIH5 MGC10848 ENSG00000123243 "Inter-alpha-trypsin inhibitor heavy chain family member 5" 10 7559270-7666998 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 58.6" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 223.5;Sertoli cells: 77.6;Smooth muscle cells: 89.6;Syncytiotrophoblasts: 185.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "WM-115: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA038305 Approved Approved "Golgi apparatus,Vesicles" "Secreted to blood" NA NA "Golgi apparatus" Vesicles "HPA038305: AB_10670662" "unprognostic (1.28e-1)" "unprognostic (1.98e-1)" "unprognostic (3.11e-3)" "unprognostic (6.80e-2)" "unprognostic (1.80e-1)" "unprognostic (5.84e-3)" "unprognostic (1.63e-1)" "unprognostic (2.55e-2)" "unprognostic (1.53e-1)" "unprognostic (2.90e-1)" "unprognostic (5.80e-3)" "unprognostic (6.11e-2)" "unprognostic (1.36e-1)" "unprognostic (6.79e-3)" "unprognostic (2.00e-2)" "unprognostic (4.50e-2)" "unprognostic (3.48e-2)" 42.6 2.4 3.7 15.2 5.0 0.0 33.7 2.9 5.1 8.1 9.4 3.6 4.4 4.1 12.0 8.6 6.9 3.4 18.8 4.8 4.4 4.0 5.3 2.3 6.9 3.2 4.4 4.3 7.2 4.4 1.4 3.1 58.6 4.6 11.0 5.3 12.7 3.4 16.2 4.7 4.1 5.7 37.5 3.9 2.2 5.6 4.0 2.2 0.0 6.4 5.2 5.5 24.0 11.7 0.8 0.4 1.4 0.5 0.5 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.3 8.3 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 7.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 48.0 1.4 0.3 0.3 0.4 0.4 0.5 0.4 0.6 0.4 0.2 0.8 0.6 0.5 1.0 0.5 0.5 0.4 0.5 0.1 3.7 5.0 2.9 5.1 4.4 4.0 4.4 4.3 4.6 2.2 3.0 2.4 0.0 2.3 10.1 1.3 4.0 5.1 1.4 6.8 0.0 2.0 223.5 0.0 15.3 1.6 30.5 0.0 0.0 0.3 45.7 53.7 1.2 2.3 0.0 18.1 0.0 0.0 1.8 0.0 1.6 4.9 3.3 13.5 1.0 0.0 25.4 0.5 0.0 14.5 1.0 2.1 77.6 89.6 1.9 7.5 7.8 185.6 0.0 0.0 1.4 JAM2 "C21orf43, CD322, JAM-B, JAMB, VE-JAM" ENSG00000154721 "Junctional adhesion molecule 2" P57087 21 25639272-25717562 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.7" "Cell type enhanced" "Detected in many" 20 "Cardiomyocytes: 31.9;Endothelial cells: 151.0;Ito cells: 49.7" "Cancer enriched" "Detected in all" 9 "glioma: 27.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 18.2;BJ hTERT+: 11.6;HDLM-2: 11.3;hTERT-RPE1: 16.2;U-138 MG: 13.1;U-87 MG: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028789, HPA077346" Supported "Nucleoplasm,Plasma membrane" NA NA 17000 "Plasma membrane" Nucleoplasm "HPA028789: AB_2732443, HPA077346: AB_2732341" "unprognostic (1.42e-1)" "unprognostic (6.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (1.53e-2)" "unprognostic (7.51e-4)" "unprognostic (2.61e-2)" "unprognostic (4.55e-1)" "unprognostic (1.02e-1)" "unprognostic (3.46e-2)" "unprognostic (3.81e-1)" "unprognostic (8.86e-2)" "unprognostic (5.71e-3)" "unprognostic (2.18e-1)" "unprognostic (2.20e-1)" "unprognostic (4.85e-3)" 16.6 17.2 13.8 8.4 18.9 1.5 14.6 9.9 23.4 18.1 14.7 14.5 8.0 7.5 20.5 13.5 13.3 12.0 14.4 21.9 13.5 12.5 6.5 3.5 17.1 4.6 17.6 13.5 18.9 3.9 5.8 7.7 66.7 18.5 12.0 9.7 11.1 5.5 18.0 8.4 6.9 9.2 21.8 23.0 2.8 9.7 25.8 12.2 0.6 9.5 10.1 6.3 13.5 15.1 3.1 1.9 1.9 0.7 2.8 1.1 0.4 0.0 0.0 18.2 0.1 0.7 0.2 0.4 0.5 11.6 1.5 5.5 0.0 0.0 0.1 0.0 0.2 7.0 0.0 1.6 0.0 3.4 11.3 0.5 0.1 0.0 0.0 0.0 0.0 0.1 1.0 0.0 1.3 0.0 16.2 0.0 0.4 0.0 0.2 5.6 0.1 0.3 0.1 5.7 0.1 0.0 2.1 3.7 0.0 0.0 0.0 0.3 2.7 0.1 0.2 0.0 0.2 0.6 0.1 0.0 13.1 1.2 0.1 1.8 1.5 0.0 0.0 9.6 0.1 0.5 1.4 0.7 0.3 0.4 0.5 0.6 0.3 0.4 0.9 0.4 3.1 0.7 1.1 1.9 2.8 0.6 1.9 0.2 0.4 13.8 18.9 9.9 20.5 13.5 12.5 17.6 13.5 18.5 12.2 0.0 2.9 1.4 1.4 6.6 1.5 31.9 0.0 1.4 0.0 3.5 13.7 0.3 0.0 0.3 12.9 151.0 0.0 0.0 0.2 2.2 18.5 1.2 0.0 0.0 1.0 0.0 0.0 49.7 2.2 13.2 9.2 1.4 15.1 0.0 0.0 0.9 0.1 0.0 23.0 0.0 3.6 0.0 7.6 4.8 3.9 5.8 0.7 0.0 0.0 0.7 KANK4 "ANKRD38, KIAA0172" ENSG00000132854 "KN motif and ankyrin repeat domains 4" Q5T7N3 1 62236979-62319414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.2;pancreas: 18.4;parathyroid gland: 20.4;placenta: 14.4" "Cell type enhanced" "Detected in some" 18 "Cytotrophoblasts: 22.8;Exocrine glandular cells: 7.3;Extravillous trophoblasts: 14.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 23.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 23.5;Hep G2: 9.8;SuSa: 21.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA014030 Uncertain Uncertain Microtubules,Cytosol NA NA Cytosol Microtubules "HPA014030: AB_2128155" "unprognostic (1.66e-2)" "unprognostic (1.90e-3)" "unprognostic (2.65e-2)" "unprognostic (1.11e-3)" "unprognostic (2.27e-2)" "unprognostic (1.48e-2)" "unprognostic (6.31e-2)" "unprognostic (1.66e-2)" "unprognostic (3.58e-2)" "unprognostic (1.54e-1)" "unprognostic (3.85e-3)" "unprognostic (1.30e-1)" "unprognostic (4.08e-3)" "unprognostic (9.06e-2)" "unprognostic (1.97e-1)" "unprognostic (3.31e-2)" "unprognostic (7.74e-6)" 10.6 0.7 0.9 1.0 3.1 0.1 3.1 0.5 2.2 0.6 1.2 8.9 1.0 0.4 0.3 1.0 0.4 0.7 0.6 0.6 1.9 2.7 1.7 3.6 2.9 0.1 11.1 0.1 0.4 18.4 20.4 0.4 14.4 23.2 1.8 1.2 2.6 10.4 0.8 0.5 0.8 0.6 0.2 13.4 0.8 2.4 1.0 4.9 0.1 0.7 0.8 0.2 0.4 0.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 23.5 0.1 0.0 0.1 0.0 3.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.7 9.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.7 0.4 0.0 21.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 3.1 0.5 2.2 1.9 2.7 11.1 0.1 23.2 4.9 0.0 0.0 0.0 2.3 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 22.8 0.0 0.1 0.2 0.0 0.0 0.0 7.3 14.9 0.8 0.0 0.0 0.5 2.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.3 0.0 3.5 0.2 0.3 0.0 1.7 0.0 0.1 0.0 4.6 0.0 0.6 0.0 KATNBL1 "C15orf29, FLJ22557" ENSG00000134152 "Katanin regulatory subunit B1 like 1" Q9H079 15 34140674-34210096 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 75.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 46.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 46.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062573 Approved Supported "Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle" Yes No "Midbody, Mitotic spindle" "Nucleoplasm, Cleavage furrow" "HPA062573: AB_2684796" "unprognostic (5.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.35e-2)" "unprognostic (2.91e-2)" "unprognostic (2.01e-2)" "unprognostic (1.38e-1)" "unprognostic (1.14e-1)" "unprognostic (1.75e-1)" "unprognostic (1.01e-1)" "unprognostic (5.16e-2)" "unprognostic (3.94e-3)" "unprognostic (8.00e-3)" "prognostic unfavorable (4.60e-5)" "unprognostic (2.71e-2)" "unprognostic (7.23e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" 13.2 7.9 16.2 14.0 22.6 9.1 22.7 16.7 26.0 11.7 12.2 10.7 10.5 9.6 13.5 12.5 28.8 10.9 10.2 9.0 11.2 9.0 9.1 10.9 20.2 10.7 13.8 10.3 10.9 14.3 8.7 10.4 75.0 15.0 11.9 13.6 8.9 10.5 9.0 7.4 19.7 9.4 16.1 17.8 12.0 11.0 11.0 12.8 7.5 8.3 8.6 12.3 10.2 19.1 9.1 10.2 46.0 6.8 4.3 8.9 4.5 17.7 15.6 24.9 16.6 20.2 20.2 18.5 24.2 14.7 19.4 19.4 8.8 9.9 8.7 15.9 15.7 27.4 23.5 12.1 13.9 23.0 17.8 6.5 15.3 16.5 10.4 14.0 16.0 16.7 12.0 20.5 13.1 26.0 20.2 34.7 22.4 16.3 18.3 26.4 8.7 10.0 13.2 18.2 22.9 12.4 15.5 15.1 8.1 17.9 24.0 14.1 12.6 14.8 10.9 7.1 25.8 13.5 19.2 19.9 26.4 13.6 23.4 19.1 11.4 15.3 17.9 23.7 17.5 19.6 16.5 6.8 10.3 7.0 6.3 8.9 8.5 7.7 7.2 7.4 9.1 8.6 7.6 46.0 4.3 4.0 10.2 6.3 4.5 16.2 22.6 16.7 26.0 11.2 9.0 13.8 10.3 15.0 12.8 35.7 25.1 24.1 50.0 36.7 53.1 11.8 28.1 44.2 34.2 24.4 49.1 52.9 28.2 51.7 63.2 41.9 19.0 0.0 47.3 69.4 32.9 72.1 42.8 18.4 34.4 63.5 23.0 32.5 28.5 42.2 29.4 37.7 30.4 56.9 30.5 52.5 80.0 38.6 31.1 34.2 40.0 58.2 43.0 37.0 44.8 47.4 150.1 31.6 35.9 104.3 KCNN4 "hIKCa1, hKCa4, hSK4, IK, KCa3.1" ENSG00000104783 "Potassium calcium-activated channel subfamily N member 4" O15554 19 43766533-43781257 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Immunity, Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 45.7;salivary gland: 82.3" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 196.8;Syncytiotrophoblasts: 638.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 27.8;hTERT-RPE1: 24.5;SK-BR-3: 27.5;WM-115: 70.6" "Region enhanced" "Detected in single" "olfactory region: 2.3" "Not detected" "Not detected" "HPA053841, HPA059622" Approved NA NA "HPA053841: AB_2682278, HPA059622: AB_2684085" "unprognostic (1.23e-2)" "unprognostic (3.22e-2)" "unprognostic (4.29e-1)" "unprognostic (3.74e-3)" "prognostic unfavorable (2.68e-4)" "unprognostic (1.98e-2)" "unprognostic (7.33e-2)" "unprognostic (1.42e-2)" "unprognostic (2.48e-3)" "unprognostic (4.12e-2)" "prognostic unfavorable (4.56e-4)" "unprognostic (9.96e-3)" "prognostic unfavorable (1.05e-14)" "unprognostic (3.70e-2)" "unprognostic (2.17e-2)" "unprognostic (7.50e-2)" "prognostic favorable (1.75e-4)" 3.0 0.1 0.5 12.2 2.5 6.5 5.6 0.4 0.5 8.0 5.7 0.7 6.4 2.0 0.9 2.9 2.6 2.6 8.8 0.6 1.4 0.5 0.8 0.3 2.6 5.7 1.7 0.6 1.3 0.3 0.0 0.3 45.7 1.5 11.0 3.8 0.8 82.3 6.8 0.7 10.8 10.0 2.0 1.1 8.4 13.6 0.9 1.0 9.1 0.7 3.6 17.3 10.3 2.4 18.7 14.4 1.9 15.8 0.0 6.9 5.2 5.1 9.6 0.0 0.0 0.0 0.8 13.5 0.2 0.7 0.5 0.1 0.1 27.8 1.5 2.2 0.2 3.2 4.1 0.0 9.8 1.4 9.3 0.0 6.8 12.5 0.2 0.0 0.0 0.1 0.0 1.2 0.6 4.4 24.5 0.0 0.0 1.5 0.8 0.1 5.0 1.5 5.2 0.0 21.9 10.3 4.6 0.1 5.1 8.5 14.4 0.0 0.0 13.8 27.5 8.1 0.6 0.0 5.5 0.3 3.8 19.7 0.1 11.1 0.0 0.3 0.6 13.1 1.2 70.6 1.9 10.2 0.0 0.3 15.8 0.4 18.7 5.1 2.6 14.4 9.4 3.4 3.2 0.5 0.0 8.6 0.4 6.9 5.2 0.5 2.5 0.4 0.5 1.4 0.5 1.7 0.6 1.5 1.0 0.0 3.4 27.2 43.3 2.5 0.1 0.4 7.6 0.0 6.8 1.8 3.9 196.8 0.0 3.0 0.7 2.8 4.2 23.3 3.5 6.8 2.8 66.7 0.0 0.0 43.0 0.0 0.0 0.0 7.5 0.0 0.0 28.3 20.3 0.0 5.9 0.0 37.2 16.9 0.0 0.0 0.3 0.0 1.0 0.0 1.3 1.9 638.3 6.5 43.7 53.5 KDELC2 MGC33424 ENSG00000178202 "KDEL motif containing 2" Q7Z4H8 11 108472105-108498432 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.0" "Cell type enhanced" "Detected in many" 4 "Fibroblasts: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039315, HPA039817, HPA066134" Approved Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA Nucleoplasm Vesicles "HPA039315: AB_10960861, HPA039817: AB_10966564, HPA066134: AB_2685624" "unprognostic (1.29e-1)" "unprognostic (2.80e-1)" "unprognostic (3.62e-1)" "unprognostic (7.65e-3)" "unprognostic (6.56e-3)" "unprognostic (1.02e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (6.04e-2)" "unprognostic (3.49e-3)" "unprognostic (1.49e-1)" "unprognostic (6.00e-3)" "unprognostic (4.08e-3)" "unprognostic (1.66e-3)" "unprognostic (1.85e-2)" "unprognostic (1.31e-1)" "unprognostic (1.90e-1)" "prognostic unfavorable (6.27e-5)" 20.8 7.8 4.2 12.7 4.7 2.7 19.7 3.6 3.2 27.2 11.1 4.8 9.7 4.1 21.8 21.1 16.1 17.6 18.0 13.3 4.1 4.2 11.4 13.5 12.5 10.0 4.6 2.7 25.6 9.5 19.8 5.1 65.0 4.6 20.6 8.0 13.4 13.0 14.5 8.1 6.9 7.3 24.4 5.0 9.9 8.9 9.5 4.4 10.0 9.2 8.7 6.5 19.5 20.0 0.9 2.0 0.2 1.5 4.5 4.6 1.0 3.1 3.6 14.2 14.5 24.0 27.9 13.7 14.2 13.2 20.3 22.1 17.3 23.6 0.0 8.8 18.4 22.5 2.4 10.7 0.3 21.5 5.6 8.3 5.3 4.0 8.0 9.7 13.9 0.0 16.0 4.5 10.7 0.3 12.4 17.1 0.0 11.9 0.1 30.6 2.3 8.9 8.0 6.2 3.4 10.5 0.4 22.2 0.0 3.7 8.9 3.0 9.1 26.7 1.8 3.9 6.8 12.8 5.3 17.0 39.3 7.8 3.3 14.7 0.1 0.0 0.0 10.1 14.6 31.1 0.1 0.3 0.0 4.6 1.5 3.9 0.5 2.3 3.8 1.1 0.9 2.4 3.6 0.2 4.5 0.7 2.0 1.9 1.0 4.2 4.7 3.6 3.2 4.1 4.2 4.6 2.7 4.6 4.4 3.0 10.1 3.2 5.2 10.3 9.9 5.0 2.5 10.7 9.1 15.7 5.9 21.7 1.7 2.2 0.9 11.2 1.5 0.0 6.3 13.2 35.1 7.9 3.5 9.7 14.2 0.0 1.7 14.7 2.4 0.0 26.2 6.9 5.0 3.6 8.3 3.8 4.2 3.5 29.4 5.2 6.0 12.9 16.7 0.5 1.0 8.3 17.7 8.5 6.8 2.3 KISS1 ENSG00000170498 "KiSS-1 metastasis suppressor" Q15726 1 204190341-204196486 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "placenta: 267.2" "Cell type enriched" "Detected in many" 41 "Syncytiotrophoblasts: 1117.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 9.2" "Group enriched" "Detected in some" 8 "basal ganglia: 11.3;hypothalamus: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "BJ: 55.9;U-2 OS: 22.8" "Low region specificity" "Detected in all" "CAB017775, HPA035542" Enhanced Approved Vesicles "Secreted in female reproductive system" NA NA Vesicles "CAB017775: , HPA035542: AB_2674677" "unprognostic (9.64e-2)" "unprognostic (1.78e-2)" "unprognostic (1.86e-2)" "unprognostic (1.18e-2)" "unprognostic (3.89e-1)" "unprognostic (6.87e-2)" "unprognostic (1.87e-1)" "unprognostic (3.28e-2)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (1.63e-1)" "unprognostic (8.98e-12)" "unprognostic (2.25e-1)" "unprognostic (2.91e-2)" "unprognostic (1.76e-1)" "prognostic favorable (6.29e-6)" 0.2 0.0 0.2 0.2 11.3 0.0 0.2 1.0 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 4.2 1.1 2.7 0.5 0.2 0.2 0.2 0.2 0.4 0.1 2.5 267.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.5 0.2 0.2 0.7 1.4 3.6 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 55.9 0.7 1.0 0.2 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.1 0.0 0.0 22.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 11.3 1.0 0.2 0.2 4.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 4.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 3.3 27.0 0.3 5.1 0.0 4.0 4.1 0.4 1.8 0.0 2.9 14.5 0.0 0.0 1.3 0.0 3.1 0.3 0.0 0.0 0.0 0.6 0.0 2.9 0.8 0.0 1.2 0.0 0.0 0.1 0.1 0.4 0.0 1117.8 0.0 1.9 2.2 KL ENSG00000133116 Klotho Q9UEF7 13 33016433-33066145 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Glycosidase, Hormone, Hydrolase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 64.3;parathyroid gland: 76.9;placenta: 25.5" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 99.7" "Group enriched" "Detected in many" 6 "prostate cancer: 5.9;renal cancer: 17.8" "Region enhanced" "Detected in some" "pons and medulla: 11.6" "Cell type enhanced" "Detected in single" "classical monocyte: 1.0" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HMC-1: 5.1;SK-BR-3: 9.6" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 510000 "unprognostic (1.32e-1)" "unprognostic (3.10e-1)" "unprognostic (2.35e-1)" "unprognostic (2.73e-3)" "unprognostic (3.37e-1)" "unprognostic (1.15e-4)" "unprognostic (3.06e-2)" "unprognostic (6.50e-2)" "unprognostic (2.22e-2)" "unprognostic (2.60e-1)" "prognostic favorable (4.44e-4)" "unprognostic (9.46e-2)" "prognostic favorable (1.29e-9)" "unprognostic (4.76e-3)" "unprognostic (1.91e-1)" "unprognostic (2.86e-2)" "unprognostic (1.07e-1)" 4.8 0.6 0.8 0.9 4.3 0.1 7.4 0.0 0.8 0.7 2.1 3.3 0.2 1.0 1.0 3.2 0.8 0.7 0.9 0.9 2.4 0.8 64.3 0.2 10.4 0.9 0.5 0.3 0.4 1.6 76.9 0.3 25.5 11.6 3.3 0.4 0.3 0.7 1.0 0.9 0.4 3.2 0.7 0.4 3.1 1.9 0.6 0.3 0.0 1.4 1.3 0.3 1.5 1.1 0.0 0.0 0.0 1.0 0.3 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 9.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.8 4.3 0.0 0.8 2.4 0.8 0.5 0.3 11.6 0.3 0.0 0.3 0.0 0.1 0.1 0.0 0.8 0.0 1.4 1.2 12.2 0.0 0.1 5.0 0.0 1.7 1.8 0.9 0.0 0.0 0.1 0.7 4.4 0.0 0.0 2.1 0.0 15.6 0.0 0.8 0.0 0.3 0.7 0.0 1.0 0.0 0.0 0.0 0.0 0.4 99.7 0.0 0.0 0.3 0.5 0.2 0.1 0.1 0.0 0.6 0.1 KLF1 EKLF ENSG00000105610 "Kruppel like factor 1" Q13351 19 12884422-12887199 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 30.6;lymphoid tissue: 7.0;placenta: 9.0" "Cell type enriched" "Detected in some" 146 "Erythroid cells: 350.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "classical monocyte: 1.7;intermediate monocyte: 4.7;non-classical monocyte: 2.9" "Lineage enriched" "Detected in single" 8 "monocytes: 4.7" "Group enriched" "Detected in some" 28 "HEL: 23.1;K-562: 55.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA051850 Enhanced Supported Nucleoplasm NA NA Nucleoplasm "HPA051850: AB_2616460" "unprognostic (1.17e-1)" "unprognostic (1.38e-4)" "unprognostic (2.96e-1)" "unprognostic (1.17e-3)" "unprognostic (7.13e-2)" "unprognostic (3.90e-4)" "unprognostic (3.25e-2)" "unprognostic (3.19e-2)" "unprognostic (1.97e-1)" "unprognostic (1.08e-2)" "unprognostic (6.51e-2)" "unprognostic (7.71e-2)" "unprognostic (2.69e-3)" "unprognostic (1.05e-1)" "unprognostic (1.06e-1)" "unprognostic (3.76e-1)" "unprognostic (2.44e-1)" 0.0 0.0 0.5 0.0 0.3 30.6 0.0 0.1 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 1.0 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.2 9.0 0.3 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 7.0 0.0 0.1 0.0 0.0 0.8 1.2 0.0 0.6 0.0 0.3 0.5 0.5 4.7 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 23.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.4 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.2 4.7 0.0 0.3 0.0 0.1 0.5 0.1 0.1 0.2 0.5 0.0 2.9 0.0 0.0 1.6 0.5 0.3 0.1 0.4 0.2 0.1 0.2 0.0 0.3 0.0 0.0 0.0 2.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 350.4 0.0 1.2 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 KLF14 BTEB5 ENSG00000266265 "Kruppel like factor 14" 7 130731235-130734061 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adipose tissue: 2.3;pancreas: 1.8;placenta: 2.9" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 1.4;Early spermatids: 3.2;Late spermatids: 3.0" "Cancer enriched" "Detected in single" 6 "melanoma: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.0;BJ hTERT+: 4.0;RH-30: 4.4;SK-MEL-30: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA044729 Uncertain NA NA "HPA044729: AB_10960356" "unprognostic (4.49e-2)" "unprognostic (2.62e-1)" "unprognostic (2.07e-2)" "unprognostic (1.53e-1)" "unprognostic (1.92e-1)" "unprognostic (9.90e-3)" "unprognostic (7.98e-2)" "unprognostic (5.30e-3)" "unprognostic (7.14e-2)" "unprognostic (1.60e-1)" "unprognostic (1.95e-2)" "unprognostic (7.03e-3)" "unprognostic (3.63e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-2)" 2.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 2.9 0.0 0.0 0.0 0.0 1.6 0.3 0.0 0.5 0.5 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.1 0.0 3.0 0.8 4.0 1.3 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.1 4.4 0.0 0.0 0.0 0.8 0.0 0.4 0.0 1.7 0.0 0.5 0.0 0.0 0.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 KMO ENSG00000117009 "Kynurenine 3-monooxygenase" O15229 1 241532134-241595642 "Enzymes, Predicted membrane proteins" "Pyridine nucleotide biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 20.3;liver: 58.6;placenta: 26.0" "Cell type enhanced" "Detected in many" 23 "Hepatocytes: 43.2;Proximal tubular cells: 45.1;Syncytiotrophoblasts: 150.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 79 "classical monocyte: 5.2;intermediate monocyte: 14.7;memory B-cell: 16.1;myeloid DC: 5.3;naive B-cell: 20.3;non-classical monocyte: 14.7;plasmacytoid DC: 11.1" "Group enriched" "Detected in many" 97 "B-cells: 20.3;dendritic cells: 11.1;monocytes: 14.7" "Cell line enhanced" "Detected in some" "Daudi: 5.4;RPMI-8226: 7.8;RPTEC TERT1: 20.0;SK-BR-3: 10.4;U-698: 8.3" "Region enriched" "Detected in single" 4 "thalamus: 1.3" "Not detected" "Not detected" "HPA031115, HPA056942" Enhanced NA NA "HPA031115: AB_10601924, HPA056942: AB_2683281" "unprognostic (4.27e-2)" "unprognostic (3.35e-2)" "unprognostic (3.95e-2)" "unprognostic (7.48e-3)" "unprognostic (8.37e-3)" "unprognostic (2.63e-1)" "unprognostic (9.79e-2)" "unprognostic (3.65e-1)" "unprognostic (2.42e-1)" "unprognostic (4.75e-3)" "unprognostic (8.07e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (6.49e-8)" "unprognostic (1.60e-2)" "unprognostic (3.65e-2)" "unprognostic (3.36e-2)" "unprognostic (6.81e-2)" 3.7 0.6 0.5 3.3 0.6 0.3 2.4 0.2 0.9 0.3 0.4 0.2 0.0 0.0 2.7 0.1 0.3 0.4 0.5 0.4 0.8 0.4 14.2 58.6 6.5 3.2 0.3 0.3 0.4 0.3 0.0 0.4 26.0 0.3 0.4 0.3 0.3 0.5 0.0 0.2 0.3 1.0 0.1 0.5 8.0 0.4 0.6 0.1 0.7 0.4 0.1 4.5 1.4 0.3 20.3 11.1 0.1 14.7 0.0 0.0 2.8 0.1 1.6 0.1 0.0 0.0 0.2 0.2 0.1 0.1 0.2 0.4 0.0 0.2 5.4 0.4 0.0 0.1 2.2 0.0 0.2 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.5 0.2 0.2 0.7 0.1 0.1 0.5 0.0 0.4 0.1 0.8 0.0 0.2 0.0 2.3 0.9 0.8 0.4 1.4 0.1 7.8 20.0 4.1 0.3 0.1 0.0 10.4 0.0 2.1 4.0 1.7 0.0 0.0 0.1 0.1 1.4 0.3 0.5 8.3 0.2 2.0 1.6 0.0 5.2 0.1 0.0 14.7 0.0 16.1 0.0 0.0 5.3 20.3 0.0 0.0 0.1 0.0 14.7 11.1 0.0 2.8 0.5 0.6 0.2 0.9 0.8 0.4 0.3 0.3 0.3 0.1 0.0 0.3 22.3 0.0 0.9 0.0 0.4 2.5 0.0 0.0 0.0 0.0 3.0 5.0 2.2 3.5 0.0 0.0 0.0 0.2 1.6 0.5 0.3 0.0 43.2 7.1 0.0 0.0 1.3 17.4 0.4 0.0 18.4 0.0 3.6 0.0 0.0 2.5 0.0 0.0 45.1 0.0 0.0 0.0 0.5 0.1 1.3 150.6 0.0 0.0 0.0 KRBOX1 ENSG00000240747 "KRAB box domain containing 1" C9JBD0 3 42809483-42942792 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 8 "placenta: 78.4;testis: 68.5" "Cell type enriched" "Detected in many" 7 "Spermatocytes: 1048.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "NK-cell: 9.0" "Lineage enriched" "Detected in many" 5 "NK-cells: 9.0" "Cell line enhanced" "Detected in some" "BJ hTERT+: 10.6;CAPAN-2: 22.9;EFO-21: 11.2;GAMG: 17.6;hTEC/SVTERT24-B: 16.1;hTERT-HME1: 10.8;U-2197: 31.8" HPA046901 Approved "Nucleoplasm,Golgi apparatus" NA NA Nucleoplasm "Golgi apparatus" "HPA046901: AB_2797232" "unprognostic (2.62e-1)" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.53e-3)" "unprognostic (7.63e-3)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (3.46e-2)" "unprognostic (2.27e-1)" "unprognostic (5.64e-2)" "unprognostic (2.95e-2)" "unprognostic (9.66e-2)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (1.31e-1)" "unprognostic (2.28e-1)" 1.1 1.8 1.6 0.3 2.1 0.3 1.4 2.1 2.3 1.9 1.6 1.8 1.2 0.8 2.6 5.4 2.1 1.9 1.2 2.3 1.4 1.2 1.4 0.3 0.7 0.7 1.4 1.2 3.2 2.3 0.3 1.9 78.4 1.6 1.6 1.0 2.3 2.1 2.7 0.5 2.5 1.0 2.3 1.8 0.7 1.1 68.5 0.6 0.2 2.5 1.1 0.8 1.2 1.1 0.8 1.7 1.2 1.2 9.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.1 10.6 0.0 0.0 0.0 22.9 0.0 11.2 0.8 17.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 4.5 0.0 16.1 10.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 8.2 0.0 31.8 0.0 3.4 1.1 0.0 1.7 0.0 0.6 0.0 0.6 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.8 0.3 0.9 0.0 9.0 1.2 1.7 0.5 0.2 1.6 2.1 2.1 2.3 1.4 1.2 1.4 1.2 1.6 0.6 0.0 1.6 0.0 2.5 0.0 6.5 4.8 5.1 1.4 3.4 5.2 2.0 9.4 16.6 4.1 134.8 0.4 0.7 0.0 10.5 8.6 1.6 1.5 0.0 0.5 2.0 1.6 0.0 1.3 0.0 72.9 18.7 0.0 0.0 0.0 0.8 12.4 6.2 1.9 12.7 1.7 7.4 12.9 3.3 1048.9 159.2 0.0 7.6 0.0 1.7 0.8 KRT18 ENSG00000111057 "Keratin 18" P05783 12 52948871-52952901 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cell cycle, Host-virus interaction" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 268.7" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 6515.6;Exocrine glandular cells: 4232.0;Extravillous trophoblasts: 4401.0;Pancreatic endocrine cells: 4358.9;Syncytiotrophoblasts: 6392.2" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "pons and medulla: 10.0" "Cell type enriched" "Detected in many" 5 "basophil: 28.6" "Lineage enriched" "Detected in many" 5 "granulocytes: 28.6" "Cell line enhanced" "Detected in many" "A549: 228.6;BEWO: 144.3;CACO-2: 251.4;CAPAN-2: 182.6;MCF7: 334.7;SK-BR-3: 185.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000008, CAB000030, HPA001605" Enhanced Supported Cytosol NA NA 140000000 Cytosol "CAB000008: , CAB000030: , HPA001605: AB_2666381" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (3.31e-1)" "unprognostic (1.63e-2)" "unprognostic (1.25e-1)" "unprognostic (7.26e-3)" "unprognostic (4.09e-3)" "prognostic unfavorable (5.06e-4)" "unprognostic (8.81e-2)" "unprognostic (4.17e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (3.05e-1)" "unprognostic (1.04e-1)" "unprognostic (1.27e-1)" "unprognostic (2.19e-1)" "unprognostic (1.11e-2)" "unprognostic (1.13e-2)" 23.3 4.8 1.0 31.0 1.1 0.0 24.1 2.9 1.2 28.6 45.4 1.3 66.3 35.0 6.6 55.3 22.4 21.7 147.4 6.8 1.1 2.5 61.9 181.0 39.6 2.8 1.2 1.0 13.7 162.9 8.2 39.8 268.7 10.0 29.3 57.0 14.1 121.1 49.9 1.3 6.5 83.6 3.9 1.4 4.4 36.0 9.5 0.8 4.2 83.4 10.8 20.9 21.5 10.8 4.1 1.0 28.6 0.1 1.0 5.9 1.6 76.6 228.6 0.0 0.3 0.0 0.0 144.3 11.6 14.2 15.1 4.3 251.4 182.6 0.0 32.5 12.6 7.9 18.8 3.2 88.6 9.1 0.0 5.4 0.7 37.4 69.1 39.1 0.0 0.0 0.5 8.3 13.2 18.2 43.2 16.1 0.1 18.5 0.0 0.0 334.7 0.1 1.4 18.6 107.6 17.3 0.1 0.0 8.7 73.6 46.3 2.6 0.1 18.9 185.1 0.7 116.4 97.7 0.2 5.1 0.2 17.6 0.2 2.6 0.0 0.2 0.1 0.0 0.0 1.4 28.6 0.1 1.1 0.2 0.1 1.1 2.1 2.3 0.6 1.0 4.1 5.9 2.1 1.5 1.0 0.0 0.0 0.2 1.6 1.0 1.1 2.9 1.2 1.1 2.5 1.2 1.0 10.0 0.8 801.0 239.7 47.5 1382.6 13.2 0.0 4.9 1332.4 459.0 466.3 591.5 0.0 2872.9 233.8 6515.6 0.9 56.4 1517.2 0.0 4232.0 4401.0 68.2 910.9 48.4 492.5 270.7 1.6 616.3 87.8 9.9 2.3 9.8 37.0 197.4 71.3 2268.9 5.8 4358.9 1644.8 0.0 407.9 0.5 0.0 45.3 1.6 5.9 5.8 6392.2 10.7 1202.1 1262.3 KRT19 "CK19, K19, K1CS, MGC15366" ENSG00000171345 "Keratin 19" P08727 17 41523617-41528308 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 205.3;intestine: 184.9;placenta: 179.4" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 4255.4;Enterocytes: 4014.8;Extravillous trophoblasts: 5684.1;Pancreatic endocrine cells: 4513.8;Urothelial cells: 5295.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 4 "NK-cell: 2.7" "Lineage enriched" "Detected in single" 4 "NK-cells: 2.7" "Cell line enhanced" "Detected in many" "CAPAN-2: 102.7;HBEC3-KT: 154.6;MCF7: 114.1;RT4: 164.2;SK-BR-3: 290.2;T-47d: 195.5" "Not detected" "Not detected" "CAB000031, HPA002465" Enhanced Supported "Intermediate filaments" NA NA 330000000 "Intermediate filaments" "CAB000031: AB_2234418, HPA002465: AB_1079179" "unprognostic (1.09e-1)" "unprognostic (1.83e-1)" "unprognostic (3.86e-2)" "unprognostic (1.59e-2)" "unprognostic (2.24e-2)" "unprognostic (1.13e-1)" "unprognostic (2.29e-1)" "unprognostic (2.80e-2)" "unprognostic (3.14e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (6.82e-5)" "unprognostic (1.90e-2)" "prognostic unfavorable (2.98e-5)" "unprognostic (3.52e-2)" "unprognostic (2.14e-1)" "unprognostic (3.08e-2)" "unprognostic (2.35e-2)" 9.8 1.6 0.7 22.8 0.9 0.0 50.1 2.9 0.8 37.4 126.7 1.0 38.0 37.8 9.9 53.0 102.1 19.5 205.3 2.3 0.8 0.2 35.0 2.1 50.6 0.7 0.8 0.8 16.7 7.5 1.2 2.6 179.4 1.3 39.2 40.1 1.8 103.0 46.3 0.7 15.8 184.9 11.7 0.6 0.6 69.1 6.4 0.7 33.3 4.9 21.2 89.2 77.0 35.4 0.0 0.0 0.0 0.0 2.7 0.6 0.2 0.1 18.0 0.0 0.3 0.0 0.1 62.8 21.6 0.0 0.6 0.1 51.6 102.7 0.0 21.2 10.3 0.0 55.0 0.0 154.6 0.1 0.0 0.5 0.0 11.6 35.3 1.6 0.0 4.4 0.0 28.1 0.4 0.0 0.0 1.3 0.0 7.4 0.1 0.0 114.1 0.2 0.1 0.9 68.3 26.1 0.1 0.0 0.3 70.9 164.2 2.1 0.0 0.1 290.2 0.0 15.0 195.5 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.2 0.7 0.9 2.9 0.8 0.8 0.2 0.8 0.8 1.3 0.7 625.3 180.1 0.5 3332.5 4.6 0.0 1.4 746.5 641.1 757.5 846.2 0.0 833.1 1.7 4255.4 0.1 5.4 4014.8 0.0 2348.9 5684.1 55.9 1574.4 94.4 0.0 159.5 0.0 348.1 0.6 1.8 0.7 35.1 13.4 180.5 52.3 1103.8 0.6 4513.8 2781.1 83.4 4.2 0.0 0.0 4.6 0.2 0.7 1.0 1779.2 1.0 1201.4 5295.6 KRT23 "CK23, DKFZP434G032, HAIK1, K23, MGC26158" ENSG00000108244 "Keratin 23" Q9C075 17 40922696-40937634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 128.3;salivary gland: 99.8;skin 1: 48.2" "Cell type enhanced" "Detected in many" 24 "Basal glandular cells: 835.0;Cytotrophoblasts: 634.9;Glandular cells: 639.4;Syncytiotrophoblasts: 3253.9;Urothelial cells: 1153.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 12 "neutrophil: 30.1" "Lineage enriched" "Detected in single" 70 "granulocytes: 30.1" "Cell line enhanced" "Detected in some" "HBEC3-KT: 21.1;Hep G2: 13.1;SuSa: 7.6;T-47d: 36.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA012050, HPA016959, CAB017091" Approved Approved "Intermediate filaments,Cytosol" NA NA 170000 "Intermediate filaments" Cytosol "CAB017091: , HPA012050: AB_1852226, HPA016959: AB_1852228" "unprognostic (1.62e-1)" "unprognostic (5.29e-2)" "unprognostic (4.35e-2)" "unprognostic (6.18e-3)" "unprognostic (1.45e-2)" "unprognostic (2.83e-1)" "unprognostic (5.22e-2)" "unprognostic (6.84e-3)" "unprognostic (2.74e-1)" "unprognostic (2.15e-2)" "unprognostic (8.96e-2)" "unprognostic (1.56e-1)" "unprognostic (8.22e-2)" "unprognostic (6.78e-2)" "unprognostic (1.40e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (8.26e-4)" 0.3 0.0 0.2 0.5 0.2 0.5 10.0 0.3 0.3 9.8 0.2 0.2 2.1 0.0 1.1 1.2 2.5 1.5 4.5 0.2 0.2 0.0 0.3 0.6 1.1 0.6 0.2 0.2 0.6 1.2 0.0 0.9 128.3 0.2 6.9 0.0 0.3 99.8 2.8 0.3 48.2 0.2 0.3 0.2 1.0 0.0 9.1 0.2 2.0 0.3 11.7 9.5 2.3 3.2 0.0 0.0 30.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.0 0.0 0.0 0.3 2.1 0.0 0.3 0.0 0.0 0.6 0.0 21.1 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 7.6 36.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.3 0.2 0.0 0.2 0.2 0.2 0.2 0.0 2.2 0.0 835.0 4.0 0.0 0.3 20.4 21.4 10.3 3.5 0.0 634.9 1.7 211.1 47.4 0.7 0.0 0.0 0.7 68.7 0.5 639.4 0.0 0.0 56.0 0.0 6.8 0.0 0.0 5.4 0.6 0.7 5.0 7.2 0.0 11.8 19.4 0.0 0.7 0.0 0.2 0.0 0.4 29.7 0.7 7.0 3253.9 0.0 0.0 1153.1 KRT24 "FLJ20261, MGC138169, MGC138173" ENSG00000167916 "Keratin 24" Q2M2I5 17 40697991-40703750 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 62.1;lymphoid tissue: 68.9;placenta: 48.6" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 4.0;Extravillous trophoblasts: 1.2;Leydig cells: 2.8;Syncytiotrophoblasts: 3.3" "Cancer enhanced" "Detected in some" "head and neck cancer: 15.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 24 "T-reg: 2.4" "Lineage enriched" "Detected in single" 24 "T-cells: 2.4" "Cell line enriched" "Detected in single" 14 "SK-BR-3: 12.8" "Region enriched" "Detected in single" 18 "cerebellum: 1.1" "Not detected" "Not detected" HPA022978 Uncertain Approved "Intermediate filaments,Cytosol" No NA "Intermediate filaments, Cytosol" "HPA022978: AB_1852230" "unprognostic (2.74e-2)" "unprognostic (1.05e-2)" "unprognostic (1.45e-1)" "unprognostic (3.16e-2)" "unprognostic (2.47e-1)" "unprognostic (3.75e-1)" "unprognostic (2.74e-1)" "unprognostic (2.95e-1)" "unprognostic (3.37e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 9.2 4.1 0.0 0.0 0.0 0.7 9.3 62.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 48.6 0.0 0.1 3.1 0.0 1.2 0.8 0.1 0.1 0.2 3.4 0.1 0.1 1.1 0.1 0.0 0.0 0.1 1.4 68.9 0.6 3.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 12.8 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 KRT7 "CK7, K2C7, K7, SCL" ENSG00000135480 "Keratin 7" P08729 12 52232520-52252186 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 156.6;salivary gland: 142.6;thyroid gland: 199.7" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 3055.9;Exocrine glandular cells: 1910.6;Extravillous trophoblasts: 3534.8;Pancreatic endocrine cells: 3941.8;Urothelial cells: 1796.1" "Cancer enhanced" "Detected in many" "urothelial cancer: 560.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "intermediate monocyte: 3.8" "Lineage enriched" "Detected in single" 5 "monocytes: 3.8" "Cell line enhanced" "Detected in some" "BEWO: 120.3;HBEC3-KT: 267.7;hTERT-HME1: 108.0;RT4: 319.2;SiHa: 251.7;SK-BR-3: 147.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000028, HPA007272, HPA007315" Enhanced Supported "Intermediate filaments,Cytosol" NA NA 350000000 "Intermediate filaments" Cytosol "CAB000028: AB_2134589, HPA007272: AB_1079181, HPA007315: " "unprognostic (2.71e-3)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (2.22e-2)" "unprognostic (8.59e-2)" "unprognostic (1.27e-1)" "unprognostic (5.44e-3)" "unprognostic (2.74e-1)" "prognostic unfavorable (9.42e-5)" "prognostic unfavorable (7.78e-5)" "unprognostic (4.54e-2)" "prognostic favorable (2.77e-9)" "unprognostic (2.82e-1)" "unprognostic (1.43e-2)" "unprognostic (3.28e-1)" "unprognostic (3.98e-3)" 3.5 0.2 0.2 0.6 0.2 0.0 43.1 0.2 0.2 7.8 0.5 0.1 18.0 0.0 1.7 9.6 14.4 11.7 27.1 1.2 0.2 0.2 35.0 4.3 63.2 0.0 0.2 0.2 3.3 15.1 1.7 2.1 156.6 0.6 23.1 0.0 0.1 142.6 67.3 0.4 10.7 0.3 4.3 0.3 0.2 2.3 4.3 0.0 0.4 199.7 6.1 16.3 58.2 22.3 0.0 0.8 0.0 3.8 0.0 0.0 0.2 0.1 101.9 0.0 0.0 0.1 0.0 120.3 21.9 0.0 11.5 1.0 0.3 72.7 0.0 0.0 7.5 0.0 80.2 0.0 267.7 0.5 0.1 0.0 0.0 54.7 0.3 2.5 0.0 0.0 0.0 16.7 0.0 108.0 0.0 11.5 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.0 0.1 0.0 0.2 1.6 66.1 319.2 0.1 0.1 251.7 147.0 0.0 1.2 5.6 0.0 87.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.0 607.4 92.0 0.0 937.0 3.2 0.0 0.8 743.9 127.2 357.2 342.0 0.0 1328.4 114.4 3055.9 12.2 11.7 0.2 0.0 1910.6 3534.8 10.3 851.4 3.5 0.9 166.7 0.0 6.3 7.4 5.2 97.2 3.4 6.2 124.9 61.3 2.1 0.0 3941.8 0.0 0.4 2.8 0.0 0.0 7.2 0.7 0.5 1.9 1206.3 1.8 0.6 1796.1 KRTAP26-1 ENSG00000197683 "Keratin associated protein 26-1" Q6PEX3 21 30319124-30320316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 56 "placenta: 59.4;skin 1: 19.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 59.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KRTAP5-6 KRTAP5.6 ENSG00000205864 "Keratin associated protein 5-6" Q6L8G9 11 1697195-1697755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "liver: 6.7;placenta: 2.6;skin 1: 2.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 21 "liver cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 1.4;SK-BR-3: 1.8" NA NA "prognostic favorable (6.04e-5)" "unprognostic (3.70e-1)" "unprognostic (2.93e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.4 0.0 1.8 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KYNU ENSG00000115919 Kynureninase Q16719 2 142877498-143055832 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 35.9;liver: 41.1;placenta: 34.3" "Cell type enhanced" "Detected in many" 18 "Macrophages: 94.5;monocytes: 360.7;Syncytiotrophoblasts: 87.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 18 "classical monocyte: 28.7;intermediate monocyte: 35.9;memory B-cell: 19.7;myeloid DC: 28.4;naive B-cell: 12.7;non-classical monocyte: 29.2;plasmacytoid DC: 19.9" "Group enriched" "Detected in many" 21 "B-cells: 19.7;dendritic cells: 28.4;monocytes: 35.9" "Cell line enhanced" "Detected in some" "A549: 37.9;GAMG: 62.8;HeLa: 42.3;Hep G2: 25.7;hTEC/SVTERT24-B: 22.2;U-87 MG: 66.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA031686 Enhanced Supported Nucleoplasm,Cytosol NA NA 360000 Cytosol Nucleoplasm "HPA031686: AB_2673995" "unprognostic (2.58e-2)" "unprognostic (3.39e-3)" "unprognostic (1.21e-2)" "unprognostic (5.94e-2)" "unprognostic (1.65e-2)" "unprognostic (9.04e-2)" "unprognostic (5.36e-3)" "unprognostic (3.58e-3)" "unprognostic (4.88e-2)" "unprognostic (3.35e-2)" "unprognostic (2.87e-3)" "unprognostic (1.51e-1)" "unprognostic (1.40e-3)" "unprognostic (3.33e-3)" "unprognostic (3.65e-2)" "unprognostic (5.24e-2)" "unprognostic (1.64e-1)" 9.0 3.7 2.2 11.0 3.7 3.9 15.4 0.6 1.7 3.0 1.2 1.3 0.8 0.2 1.1 2.6 5.6 1.5 4.4 3.8 1.4 1.1 8.4 41.1 12.7 13.7 2.9 0.4 1.7 1.0 0.2 1.6 34.3 2.7 1.9 1.2 1.5 3.0 0.8 0.7 1.5 2.7 2.0 6.3 16.0 2.4 7.0 2.6 2.7 2.2 1.7 13.0 12.4 2.6 19.7 28.4 1.3 35.9 0.4 0.1 11.1 0.0 37.9 0.1 0.1 0.0 0.1 0.1 0.0 1.0 0.0 0.0 0.6 0.5 2.2 0.1 0.0 62.8 0.1 0.0 0.0 0.0 0.1 0.0 0.8 42.3 25.7 0.5 0.1 0.2 3.6 3.1 22.2 0.1 0.0 0.0 0.0 0.1 0.2 0.3 19.3 0.0 2.3 0.1 0.0 0.1 0.0 0.2 0.1 0.6 19.6 0.1 0.0 21.0 3.1 0.2 0.2 10.5 5.4 0.3 1.2 0.1 18.5 0.0 0.1 0.0 0.0 66.4 4.4 0.1 0.1 28.7 0.5 0.1 35.9 0.1 19.7 0.1 0.1 28.4 12.7 0.1 0.0 1.3 0.4 29.2 19.9 0.1 11.1 2.2 3.7 0.6 1.7 1.4 1.1 2.9 0.4 2.7 2.6 3.0 2.4 22.6 0.5 3.5 0.1 1.2 5.1 2.7 10.3 3.5 3.9 2.8 5.0 12.1 34.6 2.9 0.0 0.0 7.8 1.5 3.3 0.8 0.0 44.8 38.5 9.5 0.0 3.1 59.7 39.6 1.7 94.5 1.7 360.7 0.0 0.2 37.4 0.0 0.4 23.0 0.5 6.5 1.3 40.0 8.0 2.8 87.5 0.0 0.0 4.2 L1TD1 "ECAT11, FLJ10884" ENSG00000240563 "LINE1 type transposase domain containing 1" Q5T7N2 1 62194831-62212328 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.2;placenta: 34.0" "Cell type enhanced" "Detected in many" 16 "Cytotrophoblasts: 82.1;Syncytiotrophoblasts: 23.6" "Cancer enriched" "Detected in some" 14 "testis cancer: 120.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "non-classical monocyte: 8.1" "Lineage enriched" "Detected in single" 17 "monocytes: 8.1" "Group enriched" "Detected in some" 22 "NTERA-2: 68.4;SuSa: 53.8" "HPA028501, HPA030064" Enhanced Vesicles NA NA Vesicles "HPA028501: AB_10599287, HPA030064: AB_10600538" "unprognostic (2.03e-2)" "unprognostic (7.88e-2)" "unprognostic (1.07e-1)" "unprognostic (1.86e-1)" "unprognostic (3.51e-1)" "unprognostic (2.29e-1)" "unprognostic (2.46e-1)" "unprognostic (4.03e-1)" "unprognostic (1.09e-1)" "unprognostic (9.23e-2)" "unprognostic (4.04e-2)" "unprognostic (4.61e-2)" "unprognostic (1.52e-5)" "unprognostic (3.49e-2)" "unprognostic (2.43e-1)" "unprognostic (5.75e-2)" "unprognostic (1.95e-1)" 0.6 0.8 0.2 18.2 0.4 0.0 0.7 0.4 0.2 1.6 6.9 0.0 0.3 0.1 0.3 0.4 0.4 0.4 0.3 0.3 0.2 0.2 0.4 0.2 3.1 1.6 0.2 0.1 1.3 0.3 0.0 0.4 34.0 0.7 2.4 1.6 1.5 0.7 0.1 0.6 0.3 0.6 0.5 0.2 2.9 0.4 8.5 0.0 0.4 2.4 0.1 0.1 1.6 1.3 0.4 0.3 0.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.1 0.7 0.0 6.0 15.4 0.0 0.5 0.3 2.5 0.3 0.0 10.7 13.6 0.0 5.9 82.1 0.0 0.0 0.3 0.7 0.2 0.0 0.3 20.0 2.1 0.3 1.1 0.0 6.6 3.2 10.2 0.0 0.8 0.4 1.7 2.0 0.0 0.0 4.4 0.3 0.4 0.9 17.3 0.0 3.9 0.0 0.9 0.7 13.2 0.1 23.6 1.9 0.6 0.2 LAIR2 CD306 ENSG00000167618 "Leukocyte associated immunoglobulin like receptor 2" Q6ISS4 19 54497879-54510687 "CD markers, Predicted intracellular proteins, Predicted secreted proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 12.8;lymphoid tissue: 19.6;pituitary gland: 7.1;placenta: 15.5" "Cell type enriched" "Detected in some" 9 "Extravillous trophoblasts: 233.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "T-reg: 12.8" "Lineage enriched" "Detected in single" 21 "T-cells: 12.8" "Group enriched" "Detected in some" 5 "BEWO: 6.9;Hep G2: 3.3" "Secreted - unknown location" NA NA "unprognostic (1.99e-3)" "unprognostic (7.49e-2)" "unprognostic (4.19e-2)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (4.86e-4)" "unprognostic (1.06e-2)" "unprognostic (8.37e-2)" "unprognostic (1.16e-1)" "unprognostic (3.93e-1)" "unprognostic (2.21e-1)" "unprognostic (9.52e-2)" "unprognostic (3.68e-9)" "unprognostic (1.21e-2)" "unprognostic (3.15e-3)" "unprognostic (3.40e-5)" "unprognostic (6.71e-2)" 0.9 0.5 0.6 5.9 1.7 1.6 0.5 0.2 1.3 0.4 0.6 1.3 0.0 0.4 0.5 1.3 0.7 0.5 1.3 0.4 1.4 3.0 0.6 0.8 3.2 12.3 0.6 0.5 0.2 0.9 0.1 7.1 15.5 1.3 0.8 1.3 0.4 0.5 0.4 0.6 0.5 1.2 0.5 1.5 6.6 1.0 1.2 0.4 19.6 0.5 0.0 2.0 0.3 0.3 0.0 0.0 0.1 0.1 0.6 12.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.7 0.3 0.1 0.0 1.1 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 3.0 2.0 0.0 0.0 0.8 2.7 0.1 0.6 0.1 0.0 12.8 1.8 0.6 1.7 0.2 1.3 1.4 3.0 0.6 0.5 1.3 0.4 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 233.4 0.5 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 26.9 24.5 0.0 0.0 LAMA2 LAMM ENSG00000196569 "Laminin subunit alpha 2" P24043 6 128883141-129516569 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 65.7;placenta: 71.2" "Cell type enhanced" "Detected in many" 16 "Cardiomyocytes: 76.7;Leydig cells: 170.6;Peritubular cells: 210.7;Sertoli cells: 116.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.2" "Group enriched" "Detected in many" 15 "NK-cells: 2.2;T-cells: 2.2" "Cell line enhanced" "Detected in some" "ASC diff: 66.7;ASC TERT1: 48.6;HHSteC: 14.5;HSkMC: 40.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB040310, CAB078182" Enhanced "Secreted to extracellular matrix" NA NA 38000000 "CAB040310: , CAB078182: AB_2665829" "unprognostic (1.17e-1)" "unprognostic (5.87e-2)" "unprognostic (2.17e-2)" "unprognostic (3.17e-1)" "unprognostic (1.29e-1)" "unprognostic (1.67e-1)" "unprognostic (1.65e-2)" "unprognostic (9.73e-2)" "unprognostic (3.67e-2)" "unprognostic (2.44e-3)" "unprognostic (1.55e-1)" "unprognostic (1.08e-1)" "unprognostic (4.04e-2)" "unprognostic (1.24e-3)" "unprognostic (6.16e-2)" "unprognostic (5.41e-3)" "prognostic unfavorable (3.65e-5)" 35.3 7.4 1.7 3.5 8.1 0.9 38.9 6.4 3.8 22.0 10.4 1.7 6.3 2.0 13.3 12.8 17.1 17.7 13.6 65.7 2.1 1.5 3.6 3.8 17.1 8.8 4.7 3.3 33.0 5.4 2.1 7.0 71.2 6.2 8.2 4.2 3.5 9.4 7.5 26.1 8.2 7.2 26.8 6.9 7.3 10.2 16.7 5.4 0.0 9.6 9.2 1.4 18.5 22.1 0.1 0.1 0.0 0.0 2.2 2.2 0.1 0.0 0.0 0.7 0.0 66.7 48.6 0.0 6.5 2.4 0.1 0.1 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 40.8 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.2 11.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.7 0.3 0.0 0.0 2.2 0.0 0.0 0.4 0.0 0.7 0.0 0.0 0.0 1.8 0.0 2.2 0.0 1.0 1.1 0.1 0.1 0.0 0.5 0.0 2.2 0.0 0.0 0.5 0.1 1.7 8.1 6.4 3.8 2.1 1.5 4.7 3.3 6.2 5.4 0.0 0.3 0.0 2.3 3.3 0.8 76.7 0.0 5.3 1.2 0.0 0.0 1.9 0.0 1.4 6.0 5.7 0.0 0.0 0.2 1.5 36.3 0.1 0.0 0.0 2.7 0.0 0.0 5.5 0.0 4.7 170.6 1.3 1.7 0.0 0.0 14.2 0.6 0.0 210.7 0.4 1.0 116.4 8.2 1.4 0.7 2.5 3.2 1.3 0.0 0.7 LAMA3 "BM600-150kDa, epiligrin, kalinin-165kDa, LAMNA, nicein-150kDa" ENSG00000053747 "Laminin subunit alpha 3" Q16787 18 23689443-23955066 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Epidermolysis bullosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 70.8" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 107.2;Pancreatic endocrine cells: 340.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "HBEC3-KT: 154.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA009309, CAB010757" Uncertain Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" NA NA 810000 "Endoplasmic reticulum" "CAB010757: AB_477162, HPA009309: AB_1079224" "unprognostic (1.49e-2)" "unprognostic (2.14e-2)" "unprognostic (6.36e-2)" "unprognostic (3.82e-3)" "unprognostic (2.08e-1)" "unprognostic (1.11e-1)" "unprognostic (1.83e-1)" "unprognostic (2.28e-3)" "unprognostic (1.59e-1)" "unprognostic (7.09e-3)" "prognostic unfavorable (3.58e-6)" "unprognostic (1.98e-1)" "unprognostic (2.36e-1)" "unprognostic (3.15e-1)" "unprognostic (9.91e-3)" "unprognostic (3.98e-2)" "unprognostic (1.13e-1)" 8.2 0.9 2.9 8.2 1.9 0.0 16.7 0.6 2.3 18.2 13.3 2.4 5.4 11.2 19.1 9.5 12.4 7.8 8.1 2.7 1.8 1.5 3.1 1.3 26.2 7.0 2.4 0.9 5.8 3.1 10.3 2.3 70.8 1.6 8.7 5.2 5.7 14.9 9.1 2.2 20.7 27.8 10.2 1.3 0.8 19.7 3.8 0.5 3.3 1.8 9.7 8.0 11.5 15.2 0.0 0.0 0.8 0.0 0.0 1.3 0.2 17.3 2.2 0.0 0.0 0.9 0.2 0.0 0.3 0.2 0.1 0.2 0.7 20.1 0.0 2.3 0.2 0.0 31.7 0.0 154.2 0.1 0.0 1.2 0.0 0.6 0.3 0.1 0.0 0.0 0.2 17.3 0.1 18.3 0.1 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 5.4 2.0 0.3 0.0 0.0 6.8 2.0 0.0 0.3 0.7 0.3 0.0 0.0 0.6 0.2 1.6 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.2 2.9 1.9 0.6 2.3 1.8 1.5 2.4 0.9 1.6 0.5 107.2 23.7 0.5 53.6 27.8 3.8 2.0 5.1 13.4 23.9 1.8 0.0 0.1 0.0 30.0 3.7 2.8 50.4 0.0 30.6 0.2 2.0 16.7 5.7 0.8 0.2 0.0 7.9 1.8 0.0 2.8 5.5 1.1 1.7 1.0 11.0 0.0 340.7 31.6 3.2 0.0 1.9 6.5 19.6 3.1 1.9 8.7 0.1 0.7 6.6 15.4 LAMB4 ENSG00000091128 "Laminin subunit beta 4" A4D0S4 7 108023548-108130356 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "esophagus: 13.8;placenta: 26.2;skin 1: 31.1;tongue: 21.6" "Cell type enhanced" "Detected in some" 22 "Basal keratinocytes: 31.0;Early spermatids: 8.6;Late spermatids: 7.6;Suprabasal keratinocytes: 12.0" "Cancer enhanced" "Detected in single" "renal cancer: 0.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "BEWO: 6.1;HMC-1: 3.6" "Low region specificity" "Detected in many" "HPA020242, HPA024247" Approved "Secreted to extracellular matrix" NA NA "HPA020242: AB_2670388, HPA024247: AB_2671496" "unprognostic (7.41e-2)" "unprognostic (1.79e-1)" "unprognostic (4.85e-2)" "unprognostic (1.77e-1)" "unprognostic (3.79e-2)" "unprognostic (6.29e-4)" "unprognostic (8.90e-3)" "unprognostic (1.84e-1)" "unprognostic (2.59e-1)" "unprognostic (1.03e-1)" "unprognostic (3.03e-3)" "unprognostic (3.27e-2)" "unprognostic (1.23e-4)" "unprognostic (4.82e-2)" "unprognostic (2.26e-1)" "unprognostic (1.17e-1)" "unprognostic (2.02e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.2 13.8 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 31.1 0.2 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.1 21.6 2.0 0.1 0.1 0.6 0.5 1.6 0.3 1.0 0.4 0.2 0.0 0.9 0.3 0.1 0.6 0.5 6.1 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.8 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.4 0.1 0.0 3.6 1.0 0.2 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.3 0.4 0.0 0.7 0.0 0.0 0.2 0.4 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 1.6 0.3 0.1 0.4 0.1 0.2 0.2 0.2 0.2 0.1 0.6 0.3 0.2 1.6 1.0 0.2 0.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.9 5.0 0.0 8.6 0.1 0.0 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.2 2.2 0.3 12.0 1.1 0.0 0.0 0.0 LAMC3 DKFZp434E202 ENSG00000050555 "Laminin subunit gamma 3" Q9Y6N6 9 131009082-131094473 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 50.8;testis: 32.5" "Group enriched" "Detected in some" 5 "Leydig cells: 109.6;Peritubular cells: 342.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 5.2;EFO-21: 20.5;Hep G2: 7.4;SiHa: 7.6;U-2 OS: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA022814 Enhanced "Secreted to extracellular matrix" NA NA 240000 "HPA022814: AB_2670960" "unprognostic (9.77e-2)" "unprognostic (1.90e-1)" "unprognostic (9.55e-3)" "unprognostic (2.09e-1)" "unprognostic (2.15e-1)" "unprognostic (1.22e-2)" "unprognostic (1.38e-2)" "unprognostic (2.28e-3)" "unprognostic (6.27e-2)" "unprognostic (1.83e-1)" "unprognostic (1.58e-1)" "unprognostic (3.38e-1)" "unprognostic (1.27e-1)" "unprognostic (1.44e-1)" "unprognostic (1.63e-1)" "unprognostic (3.34e-1)" "unprognostic (7.83e-2)" 1.3 9.5 1.0 0.9 2.0 0.6 1.6 0.8 3.0 23.5 1.3 2.4 2.2 1.0 6.0 5.1 1.2 1.2 9.1 0.9 1.4 1.0 8.8 3.7 15.6 0.6 1.7 2.1 1.3 3.3 0.9 8.8 50.8 3.6 7.0 0.7 7.5 1.8 4.9 0.7 6.2 0.6 10.7 1.9 17.0 1.0 32.5 0.8 0.0 1.1 2.4 0.5 13.8 12.4 0.7 0.2 1.7 0.3 0.3 0.8 0.1 0.0 0.7 5.2 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 20.5 0.0 0.4 0.0 0.4 0.0 0.0 0.0 2.5 0.0 0.8 7.4 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 0.0 0.0 2.9 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.5 0.1 7.6 0.0 3.3 0.6 0.0 0.6 0.0 0.0 6.4 0.2 0.0 0.0 0.1 0.4 0.0 0.1 0.0 1.2 0.3 0.3 0.2 0.0 0.2 0.7 0.5 0.1 0.2 0.4 0.8 0.5 1.7 0.3 0.1 0.2 0.5 0.1 1.0 2.0 0.8 3.0 1.4 1.0 1.7 2.1 3.6 0.8 0.0 0.0 0.0 0.0 6.1 0.0 1.1 0.0 0.0 0.0 1.8 0.0 0.8 0.0 0.0 1.6 0.3 0.0 0.0 0.0 0.6 36.3 0.0 0.0 0.0 1.3 0.0 0.0 3.7 0.0 3.4 109.6 0.0 10.1 0.0 0.0 0.0 0.1 0.0 342.3 0.0 0.0 45.3 6.6 0.6 3.2 3.9 0.8 0.0 0.0 0.0 LARGE2 "FLJ35207, GYLTL1B, PP5656" ENSG00000165905 "LARGE xylosyl- and glucuronyltransferase 2" Q8N3Y3 11 45921621-45929096 "Predicted intracellular proteins" "Glycosyltransferase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 38.9;placenta: 29.6" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 128.7;Syncytiotrophoblasts: 97.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "pons and medulla: 2.1" "Cell type enhanced" "Detected in some" "memory B-cell: 3.5;naive B-cell: 5.8" "Lineage enriched" "Detected in many" 5 "B-cells: 5.8" "Cell line enhanced" "Detected in some" "BEWO: 17.8;NTERA-2: 16.7;SK-BR-3: 12.0;T-47d: 36.4" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA056621 Approved "Intracellular and membrane" NA NA "HPA056621: AB_2683194" "unprognostic (9.82e-2)" "unprognostic (3.63e-2)" "unprognostic (3.65e-2)" "unprognostic (2.43e-2)" "unprognostic (6.20e-2)" "unprognostic (4.46e-3)" "unprognostic (1.36e-1)" "unprognostic (3.93e-2)" "unprognostic (1.52e-1)" "unprognostic (2.87e-1)" "unprognostic (3.30e-2)" "unprognostic (6.94e-2)" "prognostic favorable (3.04e-12)" "unprognostic (2.31e-1)" "unprognostic (9.77e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-2)" 0.2 1.4 0.2 2.8 0.2 0.1 2.8 0.2 0.4 3.5 0.8 0.8 16.0 0.6 1.6 8.3 10.5 2.5 0.4 0.4 0.4 0.1 12.2 1.7 2.5 2.8 0.2 0.2 1.8 38.9 9.5 6.6 29.6 2.1 5.8 0.2 14.8 20.7 12.7 0.2 11.1 2.3 0.7 0.2 1.6 5.2 1.2 0.2 2.0 8.1 3.9 8.1 1.3 3.7 5.8 0.0 0.1 0.0 0.8 1.1 0.2 0.6 0.8 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 4.2 0.3 0.0 0.4 0.0 0.4 4.0 0.0 7.6 0.0 0.0 2.4 0.0 0.5 4.6 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 1.0 4.8 0.0 0.0 1.3 0.1 0.0 16.7 6.0 0.5 0.4 0.0 1.5 0.2 0.3 4.9 0.5 0.1 12.0 0.0 1.0 36.4 0.0 0.0 0.1 5.5 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.1 3.5 0.3 0.9 0.0 5.8 0.2 0.4 0.1 0.8 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.4 0.4 0.1 0.2 0.2 2.1 0.2 3.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 7.0 0.0 128.7 3.3 3.5 0.0 0.0 0.0 0.0 5.5 5.5 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 97.1 0.0 0.0 0.0 LEP "OB, OBS" ENSG00000174697 Leptin P41159 7 128241284-128257628 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes, Diabetes mellitus, Disease mutation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 15 "adipose tissue: 85.2;breast: 63.7;placenta: 24.3" "Cell type enriched" "Detected in some" 28 "Syncytiotrophoblasts: 361.5" "Cancer enhanced" "Detected in some" "breast cancer: 1.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "neutrophil: 3.8" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.8" "Group enriched" "Detected in some" 11 "BEWO: 5.6;HSkMC: 2.3;SuSa: 7.1" "Not detected" "Not detected" "Not detected" "Not detected" CAB010490 Approved "Secreted to blood" NA NA 17000000 26000000 "CAB010490: AB_2296951" "unprognostic (8.19e-3)" "unprognostic (5.33e-1)" "unprognostic (1.60e-4)" "unprognostic (1.19e-1)" "unprognostic (7.99e-3)" "unprognostic (1.83e-1)" "unprognostic (6.56e-3)" "unprognostic (1.98e-2)" "unprognostic (1.42e-2)" "unprognostic (2.45e-2)" "unprognostic (2.63e-1)" "unprognostic (1.02e-3)" "unprognostic (2.83e-1)" "unprognostic (1.92e-1)" "unprognostic (2.23e-2)" "unprognostic (6.84e-2)" 85.2 0.3 0.0 1.5 0.0 0.0 63.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.7 0.0 0.0 0.1 0.0 0.4 2.0 0.0 0.0 0.1 0.7 0.0 0.0 24.3 0.0 0.0 0.1 0.0 0.4 0.0 0.6 1.1 0.4 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 1.5 2.1 0.4 0.4 3.8 0.5 0.5 0.3 0.2 0.0 0.2 0.1 0.3 0.2 0.0 5.6 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 2.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.1 0.2 0.1 0.3 0.1 7.1 0.2 0.1 0.0 0.2 0.2 0.4 0.2 0.2 0.1 0.2 0.3 0.1 0.3 0.9 0.5 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.1 0.4 0.2 0.3 3.8 0.5 0.4 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.2 0.1 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 361.5 0.0 0.0 0.1 LGALS13 "PLAC8, PP13" ENSG00000105198 "Galectin 13" Q9UHV8 19 39602501-39607476 "Predicted intracellular proteins" Apoptosis Hemagglutinin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "placenta: 58.9" "Cell type enriched" "Detected in some" 19 "Syncytiotrophoblasts: 267.5" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Group enriched" "Detected in some" 7 "cerebellum: 1.5;hypothalamus: 1.2;midbrain: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 73 "SuSa: 7.3" HPA046803 Supported Nucleoplasm NA NA Nucleoplasm "HPA046803: AB_10965990" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 58.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.5 0.2 0.0 1.2 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 4.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 14.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 267.5 0.0 0.0 0.0 LGALS14 "CLC2, PPL13" ENSG00000006659 "Galectin 14" Q8TCE9 19 39704306-39709444 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "placenta: 110.8" "Cell type enriched" "Detected in some" 72 "Syncytiotrophoblasts: 74.1" "Cancer enriched" "Detected in single" 16 "liver cancer: 5.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Group enriched" "Detected in some" 5 "EFO-21: 5.5;U-266/70: 12.8" HPA065180 Supported Nucleoplasm NA NA Nucleoplasm "HPA065180: " "unprognostic (1.95e-1)" 0.0 0.2 0.1 0.1 0.1 0.2 1.1 0.1 0.3 1.5 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.2 0.0 0.2 110.8 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.6 0.2 0.0 0.3 0.3 0.1 1.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.6 0.0 0.0 3.2 0.6 0.3 0.0 0.4 0.7 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.3 0.5 0.0 5.5 0.1 0.1 0.8 0.1 0.0 0.3 1.9 0.2 0.1 1.0 0.4 0.0 0.2 1.2 0.0 0.3 0.3 0.4 0.7 0.0 0.5 0.1 1.4 0.0 0.5 0.2 0.3 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.2 0.4 0.3 0.1 0.4 0.2 0.8 0.1 0.2 0.0 0.6 0.8 1.0 0.3 12.8 0.7 0.1 0.4 0.3 0.3 0.6 0.0 0.2 0.1 0.0 0.1 0.0 0.9 0.0 0.0 0.1 3.2 0.2 0.6 0.0 0.0 0.3 0.0 0.6 0.1 0.1 0.1 0.3 0.1 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.1 0.0 0.0 0.0 LGALS16 ENSG00000249861 "Galectin 16" A8MUM7 19 39655894-39660647 "Predicted intracellular proteins" Apoptosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "placenta: 14.2" "Cell type enriched" "Detected in some" 76 "Syncytiotrophoblasts: 852.8" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Region enhanced" "Detected in some" "cerebellum: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 105 "BEWO: 5.5;SuSa: 16.1" NA NA 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 2.6 0.5 0.1 1.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 852.8 0.0 0.0 0.0 LGR5 "FEX, GPR49, GPR67, HG38" ENSG00000139292 "Leucine rich repeat containing G protein-coupled receptor 5" O75473 12 71439770-71586310 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.3;fallopian tube: 19.9;placenta: 21.6;skeletal muscle: 26.6" "Cell type enhanced" "Detected in some" 23 "Cytotrophoblasts: 46.3;Syncytiotrophoblasts: 22.1;Undifferentiated cells: 11.5" "Group enriched" "Detected in many" 7 "colorectal cancer: 16.8;endometrial cancer: 26.8;ovarian cancer: 9.8;stomach cancer: 6.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.1" "Lineage enriched" "Detected in single" 10 "B-cells: 1.1" "Group enriched" "Detected in some" 5 "Hep G2: 16.2;SH-SY5Y: 47.7" "Region enriched" "Detected in some" 8 "olfactory region: 41.8" "Low region specificity" "Detected in many" HPA012530 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Golgi apparatus" Nucleoplasm "HPA012530: AB_1849329" "unprognostic (5.19e-2)" "unprognostic (3.79e-1)" "unprognostic (3.30e-1)" "unprognostic (1.02e-2)" "unprognostic (1.59e-1)" "unprognostic (2.49e-3)" "unprognostic (1.52e-1)" "prognostic favorable (5.09e-4)" "unprognostic (1.46e-1)" "unprognostic (2.60e-1)" "unprognostic (3.71e-1)" "unprognostic (8.10e-2)" "unprognostic (2.01e-5)" "unprognostic (1.50e-1)" "unprognostic (1.69e-1)" "unprognostic (2.28e-2)" "unprognostic (6.25e-3)" 2.3 2.2 3.5 0.8 18.1 0.4 2.1 0.9 9.5 2.2 4.2 24.5 0.0 6.1 4.9 1.7 0.6 19.9 0.8 0.8 5.0 3.4 0.9 1.4 1.4 0.4 32.3 5.1 1.5 0.6 1.0 2.0 21.6 10.8 1.8 4.6 0.9 3.1 9.0 26.6 4.0 6.5 0.7 15.0 0.6 2.9 0.7 25.7 0.0 0.9 0.9 2.1 0.7 1.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 0.4 16.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 5.3 0.7 1.0 0.0 0.0 0.0 6.5 0.1 47.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 18.1 0.9 9.5 5.0 3.4 32.3 5.1 10.8 25.7 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 46.3 0.0 0.0 0.3 0.1 0.4 0.0 0.0 1.7 1.7 0.0 0.0 0.4 5.5 0.0 4.7 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.1 22.1 0.0 11.5 0.0 LIN28B "CSDD2, FLJ16517" ENSG00000187772 "Lin-28 homolog B" Q6ZN17 6 104936616-105083332 "Predicted intracellular proteins" "RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "placenta: 51.9" "Cell type enhanced" "Detected in some" 13 "Cytotrophoblasts: 66.0;Extravillous trophoblasts: 67.8;Syncytiotrophoblasts: 46.7" "Cancer enriched" "Detected in single" 25 "testis cancer: 12.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AF22: 14.1;BEWO: 73.1;Hep G2: 12.2;K-562: 23.6;NTERA-2: 12.9;SuSa: 13.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA036630, HPA061745" Enhanced Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Nucleoplasm, Nucleoli" Cytosol "HPA036630: AB_10669911, HPA061745: AB_2684601" "unprognostic (2.00e-4)" "unprognostic (6.75e-2)" "unprognostic (2.02e-1)" "unprognostic (2.57e-2)" "unprognostic (1.59e-2)" "unprognostic (4.10e-2)" 0.1 0.1 1.2 0.0 0.8 0.3 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.3 0.0 0.1 0.1 0.1 0.5 0.8 0.0 0.0 0.0 1.0 51.9 1.2 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 5.8 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.7 2.1 0.4 0.2 0.5 0.3 0.0 0.9 14.1 2.8 0.0 0.0 73.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.8 0.0 8.8 0.0 0.0 0.0 6.8 10.1 0.0 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 0.3 0.0 0.0 1.5 1.7 12.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.3 0.0 0.0 1.1 13.5 0.0 2.9 0.3 0.0 1.5 0.0 0.0 4.3 6.0 0.0 0.0 0.0 0.0 1.6 0.4 0.2 0.5 0.4 0.3 0.5 0.3 0.1 0.2 0.7 0.1 0.2 2.1 0.2 0.4 0.7 0.2 0.3 1.2 0.8 0.1 1.3 0.9 1.3 0.5 0.8 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 5.9 66.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 67.8 0.0 0.0 0.0 0.0 8.0 1.6 0.0 0.0 0.0 17.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.4 6.5 0.0 5.8 9.2 0.0 46.7 0.0 0.0 0.0 LIPG EDL ENSG00000101670 "Lipase G, endothelial type" Q9Y5X9 18 49560699-49599182 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 37.0;placenta: 44.7;thyroid gland: 84.3" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 56.9;Extravillous trophoblasts: 60.0;Hepatocytes: 66.8" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 20.9" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 31.4;HaCaT: 48.1;RPTEC TERT1: 32.0;TIME: 62.4" "Group enriched" "Detected in many" 5 "amygdala: 3.7;basal ganglia: 2.1;cerebral cortex: 2.9;hippocampal formation: 1.8;olfactory region: 1.9" "Low region specificity" "Detected in many" HPA016966 Uncertain "Secreted to blood" NA NA 657000000 170000 "HPA016966: AB_1852893" "unprognostic (2.20e-2)" "unprognostic (3.36e-3)" "unprognostic (1.16e-1)" "unprognostic (4.25e-3)" "unprognostic (6.38e-2)" "unprognostic (1.36e-1)" "unprognostic (5.72e-2)" "unprognostic (4.55e-3)" "unprognostic (9.93e-2)" "unprognostic (1.44e-1)" "unprognostic (6.44e-2)" "unprognostic (8.74e-2)" "unprognostic (2.98e-1)" "unprognostic (8.68e-2)" "unprognostic (5.64e-2)" "unprognostic (1.54e-1)" "unprognostic (1.35e-1)" 1.5 0.4 0.8 4.7 0.7 0.1 0.8 2.0 0.7 0.4 5.6 3.9 15.0 1.9 0.4 3.1 1.0 0.5 4.3 1.2 1.1 0.9 5.2 37.0 4.4 0.7 1.1 0.1 0.5 1.0 0.0 0.6 44.7 1.4 1.0 2.2 8.3 0.6 24.6 2.6 1.1 7.6 2.2 1.4 0.4 1.4 5.8 0.4 0.3 84.3 2.1 0.5 2.0 0.6 1.2 0.6 2.1 0.6 1.7 0.8 0.1 0.5 0.0 13.8 31.4 0.1 0.0 0.2 0.1 1.4 0.0 0.0 13.6 4.9 0.0 7.6 0.0 9.6 48.1 2.0 9.8 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.2 1.4 11.1 4.9 9.6 0.1 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.3 0.1 0.0 0.0 0.7 32.0 3.7 0.2 0.0 0.2 0.3 0.0 1.8 0.0 0.0 62.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.6 0.4 0.7 0.4 0.4 0.8 0.5 0.5 0.2 1.2 0.8 0.7 2.1 1.7 0.4 0.6 0.4 0.1 0.8 0.7 2.0 0.5 1.1 0.9 1.1 0.1 1.4 0.4 0.0 1.4 0.0 4.8 1.5 0.8 1.7 25.5 0.0 3.4 14.0 56.9 4.7 0.0 3.2 8.0 1.4 9.5 0.0 1.2 60.0 1.0 8.4 0.0 66.8 1.6 0.0 13.3 4.9 1.9 6.0 0.3 0.0 1.7 1.0 3.4 1.0 7.7 2.9 0.0 1.0 2.4 0.0 0.7 1.0 0.8 2.3 16.2 0.7 6.2 9.9 LNPEP "CAP, IRAP, P-LAP, PLAP" ENSG00000113441 "Leucyl and cystinyl aminopeptidase" Q9UIQ6 5 96935394-97037515 "Enzymes, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 104.4" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 117.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043642 Approved "Intracellular and membrane" NA NA 390000 "HPA043642: AB_10964137" "unprognostic (1.52e-1)" "unprognostic (5.39e-2)" "unprognostic (7.78e-2)" "unprognostic (1.53e-2)" "unprognostic (6.38e-2)" "unprognostic (6.59e-3)" "unprognostic (6.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.11e-1)" "unprognostic (3.54e-3)" "unprognostic (6.24e-2)" "unprognostic (2.08e-1)" "unprognostic (3.28e-1)" "unprognostic (4.13e-3)" "unprognostic (1.46e-1)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" 9.8 4.7 5.6 12.0 7.3 13.2 7.7 23.3 12.9 6.3 7.6 6.9 7.8 4.2 8.2 4.4 10.2 6.6 4.3 10.1 5.2 5.6 7.6 4.3 6.9 15.9 7.7 8.8 8.2 5.9 13.8 9.7 104.4 9.1 7.9 6.8 3.9 7.8 7.7 13.2 14.0 9.0 6.6 7.5 10.0 8.5 3.3 7.7 23.6 7.2 2.9 15.8 8.9 7.7 4.1 3.5 5.0 12.8 11.2 7.9 4.3 5.3 6.2 2.8 2.9 17.1 8.2 3.3 5.5 7.3 6.5 9.9 5.2 8.7 26.5 10.4 7.4 18.3 7.1 3.6 10.4 6.8 9.4 2.0 6.6 4.5 3.6 4.4 7.6 9.1 6.3 6.4 9.4 6.9 7.0 6.8 5.9 2.8 17.6 7.4 4.7 9.0 5.3 0.6 1.7 3.3 6.5 10.6 4.0 23.2 11.1 5.5 1.4 6.7 5.9 3.3 2.8 18.1 10.0 13.5 9.5 5.3 7.5 8.3 3.8 8.8 24.2 8.4 7.2 4.3 5.0 3.3 4.4 7.9 5.5 6.8 3.1 5.9 6.1 3.5 4.1 5.9 6.4 4.1 11.2 12.8 3.3 5.1 4.3 5.6 7.3 23.3 12.9 5.2 5.6 7.7 8.8 9.1 7.7 32.8 42.4 53.7 16.7 52.8 57.3 58.2 17.8 22.7 20.5 34.9 117.8 9.5 5.0 14.0 2.4 31.5 15.8 0.0 12.3 21.8 30.1 24.6 24.4 14.1 14.7 22.3 24.6 33.7 46.5 3.8 30.5 38.3 20.3 12.6 27.8 43.8 15.9 14.0 43.9 9.1 35.8 25.8 24.7 21.4 23.1 41.3 22.9 70.5 21.5 19.9 LRRC15 LIB ENSG00000172061 "Leucine rich repeat containing 15" Q8TF66 3 194355247-194369743 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 48.1" "Cell type enhanced" "Detected in some" 17 "Basal keratinocytes: 1.6;Suprabasal keratinocytes: 1.3" "Cancer enhanced" "Detected in many" "breast cancer: 25.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 48.9;U-138 MG: 9.5;U-87 MG: 26.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA035503 Uncertain Approved "Vesicles,Plasma membrane" NA NA 1800000 Vesicles "Plasma membrane" "HPA035503: AB_10961253" "unprognostic (3.20e-2)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (6.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (3.53e-2)" "unprognostic (3.97e-2)" "unprognostic (1.88e-3)" "unprognostic (1.22e-8)" "unprognostic (5.81e-2)" "unprognostic (1.11e-1)" "unprognostic (5.62e-3)" "unprognostic (7.54e-3)" 3.3 0.5 0.5 3.1 0.6 0.0 5.3 0.5 0.5 4.6 2.1 0.2 0.0 0.4 3.5 0.3 1.0 1.3 2.0 1.8 0.5 0.5 0.5 0.5 2.5 0.8 0.5 0.0 3.1 0.8 0.0 0.5 48.1 0.3 0.6 4.2 0.7 1.6 0.0 1.0 9.1 0.8 0.7 0.5 1.3 1.9 0.9 0.0 1.1 1.8 7.7 7.7 2.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.0 0.1 0.0 0.0 0.4 48.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.5 1.6 1.2 0.0 0.0 0.0 0.0 26.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 LRRC36 FLJ11004 ENSG00000159708 "Leucine rich repeat containing 36" Q1X8D7 16 67326798-67385203 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 11.7;placenta: 9.3;testis: 31.9" "Group enriched" "Detected in many" 5 "Alveolar cells type 2: 68.2;Early spermatids: 152.0;Late spermatids: 96.7;Spermatocytes: 48.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in some" 10 "plasmacytoid DC: 11.7" "Lineage enriched" "Detected in many" 10 "dendritic cells: 11.7" "Cell line enhanced" "Detected in some" "HBF TERT88: 1.5;hTEC/SVTERT24-B: 4.7;JURKAT: 4.3;TIME: 3.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA058479 Enhanced NA NA "HPA058479: AB_2683728" "unprognostic (4.59e-2)" "unprognostic (6.84e-2)" "unprognostic (2.17e-2)" "unprognostic (2.26e-5)" "unprognostic (5.27e-2)" "unprognostic (4.32e-2)" "unprognostic (5.29e-2)" "unprognostic (3.26e-2)" "unprognostic (1.99e-2)" "unprognostic (1.65e-1)" "unprognostic (3.32e-3)" "unprognostic (4.49e-2)" "unprognostic (1.36e-1)" "unprognostic (1.26e-1)" "unprognostic (3.70e-1)" "unprognostic (1.99e-1)" "unprognostic (3.88e-2)" 0.2 0.1 0.3 0.0 1.5 0.0 0.2 0.5 0.4 0.3 0.1 0.0 0.0 0.0 0.4 2.3 0.1 2.6 0.3 0.1 1.2 0.4 0.3 0.1 4.3 0.2 0.2 0.0 0.3 2.0 0.0 1.2 9.3 2.5 0.1 0.4 0.5 0.2 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.4 31.9 0.2 0.0 0.2 0.0 0.1 0.1 0.1 0.0 11.7 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.5 0.4 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 4.7 0.0 0.0 0.1 4.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.3 1.5 0.5 0.4 1.2 0.4 0.2 0.0 2.5 0.2 3.0 68.2 0.0 0.4 0.2 0.4 0.8 0.0 18.7 1.2 0.0 0.0 0.0 0.0 0.4 152.0 0.5 0.4 0.0 0.0 0.1 0.6 0.1 8.1 0.0 0.2 0.0 2.4 0.0 0.0 96.7 2.0 0.8 6.8 0.0 0.7 1.9 0.1 0.0 1.4 1.1 0.1 0.0 0.0 48.3 10.6 0.3 0.2 0.0 1.3 0.1 LUM "LDC, SLRR2D" ENSG00000139329 Lumican P51884 12 91102629-91111831 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "placenta: 344.8" "Group enriched" "Detected in many" 8 "Fibroblasts: 1406.2;Leydig cells: 371.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 103 "basophil: 10.2" "Lineage enriched" "Detected in single" 103 "granulocytes: 10.2" "Cell line enriched" "Detected in some" 5 "BJ hTERT+: 186.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001522, CAB025783" Supported "Secreted to extracellular matrix" NA NA 59000000000 "CAB025783: , HPA001522: AB_1079285" "unprognostic (5.54e-2)" "unprognostic (2.27e-1)" "unprognostic (3.32e-1)" "unprognostic (2.75e-1)" "unprognostic (1.65e-1)" "unprognostic (8.38e-2)" "unprognostic (1.09e-1)" "unprognostic (2.87e-1)" "unprognostic (4.08e-2)" "unprognostic (1.19e-1)" "unprognostic (1.65e-2)" "unprognostic (2.20e-2)" "prognostic unfavorable (1.75e-6)" "unprognostic (5.25e-3)" "unprognostic (2.27e-2)" "unprognostic (2.38e-2)" "unprognostic (2.06e-2)" 44.8 25.3 0.8 15.1 0.7 0.0 19.7 0.7 0.7 56.7 26.9 0.7 28.1 5.1 64.8 77.8 28.1 12.2 76.6 48.8 0.8 0.7 26.9 6.4 77.1 32.0 0.9 0.6 73.0 9.1 0.7 2.7 344.8 2.8 77.4 13.3 1.4 5.6 9.9 9.1 8.3 24.0 48.7 4.0 1.3 8.2 30.9 0.3 1.7 18.1 32.3 11.5 65.3 20.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 23.0 11.3 0.0 37.8 186.6 1.5 2.3 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 18.0 0.0 0.0 15.6 0.0 3.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.0 1.6 0.0 0.0 0.0 1.6 0.4 1.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.7 0.7 0.8 0.7 0.9 0.6 2.8 0.3 11.9 51.4 0.0 1.2 86.7 0.0 10.1 0.0 1.4 9.1 0.0 2.0 47.4 0.0 0.8 2.4 11.6 0.0 0.0 0.0 27.5 1406.2 2.2 17.4 0.4 58.5 0.0 0.0 93.9 0.8 2.9 371.9 3.6 111.3 1.8 0.0 75.5 3.0 0.0 42.1 0.2 2.8 0.0 68.4 0.2 0.9 87.6 70.3 0.0 0.0 4.2 LVRN "APQ, AQPEP, FLJ90650, TAQPEP" ENSG00000172901 Laeverin Q6Q4G3 5 115962454-116027619 "Enzymes, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 75.1" "Cell type enhanced" "Detected in some" 20 "Early spermatids: 25.5;Extravillous trophoblasts: 21.0;Late spermatids: 42.0;Syncytiotrophoblasts: 8.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 2.4;ASC TERT1: 3.9;CAPAN-2: 1.8;SiHa: 1.5;U-266/70: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA053254 Enhanced "Intracellular and membrane" NA NA "HPA053254: AB_2682092" "unprognostic (1.47e-1)" "unprognostic (3.38e-3)" "unprognostic (5.81e-2)" "unprognostic (2.97e-3)" "unprognostic (5.38e-2)" "unprognostic (1.32e-1)" "unprognostic (2.59e-3)" "unprognostic (1.88e-2)" "unprognostic (2.23e-1)" "unprognostic (2.23e-2)" "unprognostic (3.83e-3)" "unprognostic (1.22e-1)" "unprognostic (1.67e-7)" "unprognostic (1.05e-2)" "unprognostic (5.94e-2)" "unprognostic (6.53e-2)" "unprognostic (3.31e-2)" 10.6 0.1 0.0 0.5 0.0 0.1 3.9 0.0 0.0 0.3 1.4 0.0 0.4 0.1 0.0 0.0 1.8 0.2 0.4 1.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.1 75.1 0.0 0.7 0.4 0.0 0.6 1.2 1.3 1.0 1.7 0.5 0.0 0.0 0.4 0.3 0.0 0.0 0.3 1.7 0.1 0.7 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.1 2.4 3.9 0.9 0.2 0.3 0.1 0.3 0.0 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 1.2 0.1 0.0 0.9 0.0 0.0 0.2 0.3 1.3 0.4 0.0 0.0 0.3 0.1 0.6 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 1.5 0.0 0.0 0.6 0.0 0.0 0.0 0.3 0.3 0.0 0.6 1.6 0.1 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 25.5 0.0 0.0 0.0 0.0 21.0 0.2 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 42.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.2 0.0 8.9 0.0 0.0 0.0 LY6G6C "C6orf24, G6c, NG24" ENSG00000204421 "Lymphocyte antigen 6 family member G6C" O95867 6 31718648-31721845 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "lymphoid tissue: 24.8;placenta: 26.5;skin 1: 89.7;tongue: 56.1" "Cell type enhanced" "Detected in some" 26 "Early spermatids: 10.2;Late spermatids: 8.8;Suprabasal keratinocytes: 56.1;Syncytiotrophoblasts: 17.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.3;HaCaT: 1.9;MCF7: 2.4;OE19: 1.2;SuSa: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (1.21e-1)" "unprognostic (3.05e-2)" "unprognostic (1.68e-1)" "unprognostic (4.85e-3)" "unprognostic (2.59e-3)" "unprognostic (1.35e-1)" "unprognostic (9.03e-2)" "unprognostic (1.79e-1)" "unprognostic (4.13e-1)" "unprognostic (1.76e-3)" "unprognostic (2.85e-1)" "unprognostic (8.80e-7)" "unprognostic (1.33e-2)" "unprognostic (2.56e-1)" "unprognostic (6.09e-2)" "unprognostic (9.38e-2)" 0.1 0.1 0.0 0.1 0.1 0.1 1.9 0.0 0.1 2.5 0.1 0.0 0.0 0.1 0.4 0.1 5.4 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 26.5 0.0 0.1 0.1 0.0 2.4 0.1 0.2 89.7 0.0 0.1 0.0 0.1 0.1 0.2 0.0 1.8 0.1 56.1 24.8 0.1 4.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.7 0.4 0.1 0.0 0.1 0.0 1.9 0.0 0.2 0.1 0.0 0.2 0.8 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.4 0.0 0.2 0.0 0.4 0.1 0.0 0.0 2.4 0.1 0.9 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.1 1.5 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 4.1 0.0 0.1 0.0 1.4 0.0 0.0 0.0 1.6 0.0 0.0 10.2 0.1 0.7 0.0 0.0 1.0 0.6 1.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 2.1 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 56.1 17.0 0.0 1.7 2.3 LYPD5 FLJ30469 ENSG00000159871 "LY6/PLAUR domain containing 5" Q6UWN5 19 43795929-43827206 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "placenta: 39.6;skin 1: 39.8;tongue: 34.7" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 25.8;Late spermatids: 48.7;Melanocytes: 16.9;Syncytiotrophoblasts: 18.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 8.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.8" "Group enriched" "Detected in many" 4 "monocytes: 3.8;T-cells: 1.2" "Cell line enhanced" "Detected in some" "A-431: 5.9;BEWO: 9.1;HaCaT: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042511, HPA054670" Approved Approved Nucleoplasm,Cytosol No NA "Nucleoplasm, Cytosol" "HPA042511: AB_10794279, HPA054670: AB_2682567" "unprognostic (4.27e-3)" "prognostic favorable (5.84e-4)" "unprognostic (4.63e-2)" "unprognostic (8.42e-3)" "unprognostic (4.80e-2)" "unprognostic (2.91e-3)" "unprognostic (3.96e-1)" "unprognostic (7.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" "unprognostic (1.40e-3)" "unprognostic (1.19e-1)" "unprognostic (1.83e-3)" "unprognostic (8.30e-2)" "unprognostic (2.02e-1)" "unprognostic (7.53e-3)" "unprognostic (4.08e-2)" 1.5 1.2 3.4 2.1 7.9 0.7 4.2 2.4 8.8 5.7 1.4 3.5 0.5 1.2 1.3 2.4 7.8 1.6 1.9 1.3 3.9 4.8 0.9 1.0 3.4 1.4 4.5 4.0 0.8 0.9 1.1 1.4 39.6 9.3 1.3 1.5 0.7 2.1 1.5 0.7 39.8 1.1 1.9 3.3 5.9 1.3 7.4 2.7 0.6 1.4 34.7 3.4 2.4 5.4 0.4 0.0 0.5 3.8 0.0 1.2 0.5 5.9 0.0 0.3 0.0 0.1 0.0 9.1 0.5 0.0 0.8 1.0 0.7 2.1 0.3 1.1 0.7 2.3 9.5 0.0 1.1 0.5 1.0 0.0 0.2 0.6 0.0 2.5 0.1 0.1 2.9 2.6 0.4 1.1 0.0 0.3 0.2 0.1 0.3 0.0 0.3 0.2 0.1 0.6 3.1 1.9 0.0 0.1 0.1 0.6 0.9 0.7 0.2 1.2 1.4 0.0 1.9 0.6 0.2 0.8 0.0 1.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.7 0.0 1.2 0.0 0.0 3.8 0.3 0.0 0.8 0.1 0.0 0.4 0.4 1.2 0.5 0.0 1.4 0.0 0.0 0.5 3.4 7.9 2.4 8.8 3.9 4.8 4.5 4.0 9.3 2.7 0.0 0.0 0.0 2.6 3.2 1.5 0.6 0.0 1.4 0.0 0.0 0.0 0.9 3.3 0.4 25.8 1.7 0.0 0.0 0.8 7.4 0.2 1.4 0.0 0.0 2.0 0.0 0.0 0.6 0.0 48.7 0.3 0.7 16.9 0.0 1.8 1.0 0.4 0.2 1.1 0.0 0.6 0.0 0.1 1.1 2.6 2.5 18.1 0.0 0.4 5.1 LYPD6 MGC52057 ENSG00000187123 "LY6/PLAUR domain containing 6" Q86Y78 2 149329985-149474148 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 17.7;placenta: 22.7" "Group enriched" "Detected in many" 33 "Early spermatids: 54.3;Late spermatids: 174.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 18.6;fHDF/TERT166: 23.9;HBF TERT88: 13.1;LHCN-M2: 23.7;RT4: 19.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042805 Enhanced Approved Cytosol "Secreted in other tissues" NA NA Cytosol "HPA042805: AB_10794159" "unprognostic (1.77e-1)" "unprognostic (1.01e-1)" "unprognostic (7.23e-3)" "unprognostic (1.64e-2)" "unprognostic (3.25e-1)" "unprognostic (6.49e-3)" "unprognostic (6.97e-3)" "unprognostic (1.72e-1)" "unprognostic (2.73e-2)" "prognostic favorable (3.59e-4)" "unprognostic (4.14e-3)" "unprognostic (6.75e-2)" "unprognostic (7.33e-4)" "unprognostic (1.39e-1)" "unprognostic (1.94e-1)" "unprognostic (1.09e-1)" "prognostic favorable (2.72e-4)" 2.6 1.0 8.7 1.8 7.9 0.4 14.6 3.3 8.2 2.0 4.4 4.3 1.1 2.8 4.0 1.0 1.2 2.9 17.7 1.4 6.2 11.5 3.4 0.8 1.3 0.8 6.2 5.3 1.4 3.2 2.6 0.9 22.7 7.2 2.5 4.1 2.8 0.8 2.6 0.7 1.4 5.6 4.7 5.1 1.3 6.2 4.5 2.6 0.0 0.6 0.0 2.3 4.4 1.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 3.5 18.6 0.0 0.0 0.2 7.6 3.3 9.6 6.1 0.1 1.5 0.0 0.4 23.9 4.7 1.9 2.7 0.0 13.1 0.0 0.9 0.0 4.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 5.8 0.1 0.1 0.0 0.0 0.0 23.7 3.0 0.0 1.7 2.7 1.6 2.2 0.0 10.3 0.0 1.2 19.5 0.7 3.4 5.1 5.8 0.6 6.3 0.7 0.3 0.0 0.2 3.0 0.2 4.1 0.0 0.0 0.0 1.8 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 8.7 7.9 3.3 8.2 6.2 11.5 6.2 5.3 7.2 2.6 0.0 0.0 0.0 0.5 0.1 1.9 0.3 2.5 1.4 3.4 0.0 0.0 0.0 3.3 2.2 54.3 0.2 1.0 0.0 0.7 0.2 0.4 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 174.5 2.8 0.0 0.0 0.0 2.5 3.5 3.3 0.0 0.4 0.0 3.2 0.0 0.1 0.7 1.1 0.0 0.2 0.0 1.9 1.1 MAFF hMafF ENSG00000185022 "MAF bZIP transcription factor F" Q9ULX9 22 38200767-38216511 "Predicted intracellular proteins, Transcription factors" "Stress response, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 114.6" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 289.5;Glandular cells: 257.7;Syncytiotrophoblasts: 400.7;Urothelial cells: 321.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 16.9;neutrophil: 5.9;NK-cell: 14.1" "Group enriched" "Detected in many" 7 "granulocytes: 16.9;NK-cells: 14.1" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 31.3;SK-MEL-30: 37.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB025341, HPA055371" Approved Approved Nucleoplasm,Mitochondria No No Nucleoplasm Mitochondria "CAB025341: , HPA055371: AB_2682797" "prognostic favorable (4.32e-4)" "unprognostic (2.54e-1)" "unprognostic (1.07e-1)" "unprognostic (2.67e-1)" "unprognostic (1.99e-2)" "unprognostic (2.13e-3)" "unprognostic (5.06e-3)" "unprognostic (3.42e-3)" "unprognostic (7.83e-3)" "unprognostic (5.36e-3)" "unprognostic (1.23e-3)" "unprognostic (2.44e-1)" "unprognostic (3.24e-2)" "unprognostic (2.84e-1)" "unprognostic (4.08e-2)" "unprognostic (1.07e-1)" "unprognostic (2.68e-2)" 45.8 15.4 5.0 10.7 10.7 18.8 32.9 4.1 10.4 16.5 14.7 5.1 6.4 5.1 17.1 4.9 21.5 18.3 27.2 17.2 5.2 5.4 8.6 16.5 31.5 2.9 9.8 1.5 24.5 12.4 3.5 6.2 114.6 12.6 20.1 6.9 5.9 8.8 34.0 60.7 14.3 8.6 15.0 6.5 4.2 13.9 6.9 8.4 0.9 11.3 10.3 8.2 28.6 34.4 0.6 0.9 16.9 2.2 14.1 2.2 1.2 7.5 1.2 1.7 2.6 2.7 8.7 7.9 15.3 21.2 7.8 8.4 2.2 6.2 0.2 1.5 6.5 11.8 5.1 0.4 6.1 13.3 1.4 0.2 0.8 0.8 1.9 7.3 0.5 2.7 3.7 10.2 31.3 17.4 7.0 16.4 0.8 1.5 7.3 6.1 1.7 0.3 2.0 1.2 8.4 6.2 0.5 1.4 1.5 7.9 11.6 0.9 1.4 2.3 6.1 37.2 4.4 1.3 0.6 21.4 9.9 7.3 7.3 5.1 2.7 2.8 0.3 15.0 0.6 6.2 16.9 0.3 0.2 2.2 0.5 2.1 0.6 1.2 1.5 0.9 0.4 1.6 1.2 5.9 14.1 2.2 0.1 0.5 1.2 5.0 10.7 4.1 10.4 5.2 5.4 9.8 1.5 12.6 8.4 50.6 43.7 7.5 289.5 111.8 2.2 13.7 33.1 29.4 33.0 10.4 0.0 30.6 6.6 37.6 0.4 35.0 98.6 0.0 21.5 52.9 80.2 257.7 21.9 5.0 23.2 0.0 100.5 14.7 7.8 0.0 9.2 26.4 55.6 17.2 43.3 16.8 51.3 62.0 3.5 2.4 2.0 19.4 116.4 0.9 1.0 90.2 400.7 27.7 35.7 321.4 MAFK "NFE2U, P18" ENSG00000198517 "MAF bZIP transcription factor K" O60675 7 1530714-1543043 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 62.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-2 OS: 34.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026820, HPA060841" Enhanced Enhanced Nucleoplasm No No Nucleoplasm "CAB026820: , HPA060841: AB_2684377" "unprognostic (6.82e-2)" "unprognostic (3.71e-3)" "unprognostic (1.49e-2)" "unprognostic (2.55e-1)" "unprognostic (6.44e-3)" "unprognostic (1.19e-1)" "unprognostic (9.44e-2)" "unprognostic (2.28e-2)" "unprognostic (1.22e-2)" "unprognostic (1.45e-2)" "unprognostic (2.81e-1)" "unprognostic (1.40e-1)" "unprognostic (2.83e-2)" "unprognostic (1.08e-2)" "unprognostic (1.24e-1)" "unprognostic (5.59e-2)" "unprognostic (2.14e-1)" 15.7 14.3 12.6 12.4 20.1 16.3 13.0 4.2 12.5 9.3 18.0 13.5 6.7 18.2 14.7 5.0 10.1 10.2 12.7 30.9 13.2 11.8 10.5 10.9 18.7 8.7 19.7 11.0 7.2 34.9 6.0 8.7 62.4 14.5 16.1 5.1 6.7 11.0 12.0 26.8 12.8 16.8 26.1 12.1 11.3 13.2 4.1 13.1 22.8 9.1 9.7 7.5 13.7 19.0 1.9 5.1 3.6 1.7 1.5 2.6 1.4 20.0 14.4 0.5 2.1 1.6 2.0 11.0 13.3 7.6 3.2 2.3 10.3 5.5 4.7 4.9 3.3 21.9 15.6 1.2 3.8 1.4 7.2 10.5 2.7 18.4 7.5 3.7 6.4 8.7 2.0 5.0 5.4 4.1 4.0 2.9 14.8 7.0 2.6 1.5 13.2 7.2 23.1 4.6 4.9 14.6 10.9 0.5 7.9 3.0 8.3 6.2 2.3 8.0 23.8 5.8 3.3 9.2 8.6 6.9 5.0 34.8 25.0 7.2 5.0 1.5 7.8 6.6 8.9 7.0 1.7 1.6 3.6 2.1 0.8 2.3 1.4 1.2 2.5 0.7 1.9 2.6 2.0 2.2 1.5 1.7 5.1 2.2 1.4 12.6 20.1 4.2 12.5 13.2 11.8 19.7 11.0 14.5 13.1 38.7 21.2 5.1 38.8 56.7 1.8 2.4 12.7 9.4 15.9 29.6 2.0 7.9 1.7 12.6 2.8 17.5 32.5 0.0 12.9 7.1 20.6 51.3 9.2 11.6 9.5 11.1 22.2 10.4 16.3 3.8 4.4 14.9 18.6 5.4 21.7 7.5 30.7 26.8 2.8 2.1 0.6 12.9 22.7 0.5 4.7 50.4 65.2 8.6 13.4 64.3 MAGEA10 "CT1.10, MAGE10, MGC10599" ENSG00000124260 "MAGE family member A10" P43363 X 152133310-152138578 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 48.7" "Group enriched" "Detected in some" 5 "Cytotrophoblasts: 4.0;Sertoli cells: 6.5;Spermatocytes: 12.1;Spermatogonia: 8.9;Syncytiotrophoblasts: 9.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "GAMG: 42.1" "HPA003333, HPA070780" Approved Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA003333: AB_10962837, HPA070780: AB_2686310" "unprognostic (1.92e-1)" "unprognostic (1.06e-1)" "unprognostic (2.02e-1)" "unprognostic (6.95e-2)" "unprognostic (9.91e-2)" "unprognostic (5.97e-3)" "unprognostic (1.11e-1)" "unprognostic (1.25e-1)" 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.1 48.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.6 0.1 0.0 0.0 0.1 0.0 6.6 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.9 0.8 2.6 0.8 1.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 42.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.9 0.0 0.2 0.0 7.0 2.6 0.8 0.7 0.4 0.7 0.4 0.7 0.5 0.4 0.3 0.9 0.6 0.7 2.6 1.2 0.5 0.8 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 12.1 8.9 0.0 9.4 0.0 0.0 0.0 MAGEA4 "CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MGC21336" ENSG00000147381 "MAGE family member A4" P43358 X 151912509-151925170 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Tumor antigen" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 32 "placenta: 12.1;testis: 23.5" "Cell type enriched" "Detected in some" 7 "Spermatogonia: 190.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 62.8;AN3-CA: 39.2;HMC-1: 74.8;U-2 OS: 20.0;U-266/84: 116.4" "HPA021942, CAB040535" Enhanced Approved "Nuclear speckles,Cytosol" NA NA "Nuclear speckles" Cytosol "CAB040535: , HPA021942: AB_1853490" "unprognostic (7.90e-3)" "unprognostic (6.66e-3)" "unprognostic (5.39e-1)" "unprognostic (1.36e-1)" "unprognostic (5.81e-2)" "unprognostic (2.94e-2)" "unprognostic (4.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.8 0.0 0.0 39.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 74.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 20.0 0.0 0.3 15.9 116.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 10.7 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 3.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 0.0 23.4 190.5 0.0 27.6 0.0 0.0 0.0 MAGEA8 "CT1.8, MAGE8, MGC2182" ENSG00000156009 "MAGE family member A8" P43361 X 149881141-149885835 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "placenta: 24.6" "Group enriched" "Detected in some" 8 "Cytotrophoblasts: 61.9;Extravillous trophoblasts: 27.4;Syncytiotrophoblasts: 65.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 24 "U-2 OS: 19.5;U-266/70: 36.3" HPA003998 Enhanced NA NA "HPA003998: AB_10965020" "unprognostic (6.81e-2)" "unprognostic (7.56e-2)" "unprognostic (1.02e-1)" "unprognostic (3.07e-3)" "unprognostic (1.62e-1)" "unprognostic (1.07e-2)" "unprognostic (2.27e-1)" "unprognostic (1.49e-1)" "unprognostic (1.84e-1)" "unprognostic (1.50e-2)" "unprognostic (5.89e-2)" "unprognostic (2.49e-2)" "unprognostic (5.07e-3)" "unprognostic (1.69e-2)" "unprognostic (2.95e-1)" "unprognostic (2.80e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 24.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 5.1 0.0 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 36.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.5 3.0 0.0 65.0 0.0 0.0 0.0 MAN1A2 MAN1B ENSG00000198162 "Mannosidase alpha class 1A member 2" O60476 1 117367449-117528872 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 122.4" "Cell type enhanced" "Detected in all" 7 "Extravillous trophoblasts: 201.3;Syncytiotrophoblasts: 318.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034559, HPA057364" Enhanced Enhanced "Golgi apparatus" NA NA 1100000 "Golgi apparatus" "HPA034559: AB_10671229, HPA057364: AB_2683419" "unprognostic (2.24e-1)" "unprognostic (1.20e-1)" "unprognostic (2.92e-3)" "unprognostic (2.15e-1)" "unprognostic (3.11e-2)" "unprognostic (9.70e-2)" "unprognostic (1.95e-2)" "unprognostic (8.01e-2)" "unprognostic (8.19e-3)" "prognostic favorable (4.08e-4)" "unprognostic (1.41e-1)" "unprognostic (4.38e-2)" "unprognostic (6.84e-2)" "unprognostic (1.45e-1)" "unprognostic (7.39e-2)" "unprognostic (1.17e-1)" "unprognostic (5.08e-2)" 11.1 9.7 13.9 9.1 15.8 3.8 9.7 11.9 15.2 14.4 10.7 8.5 9.4 8.1 15.8 10.7 11.5 12.2 9.2 11.0 11.2 9.2 11.8 16.4 8.1 9.9 12.0 13.9 11.2 27.4 21.7 9.6 122.4 11.3 11.2 9.5 8.3 11.1 10.5 10.5 7.5 9.0 13.7 10.4 10.4 10.3 10.1 14.4 16.1 19.4 6.9 9.8 13.6 9.8 3.7 4.4 4.0 2.7 6.0 9.8 2.4 14.4 6.3 10.8 9.3 14.2 17.1 34.6 12.0 18.8 5.4 5.1 4.8 8.3 10.8 22.3 15.4 5.1 8.6 5.0 10.2 12.2 13.5 7.6 6.4 8.9 5.3 8.6 10.0 14.8 11.5 11.0 8.3 7.3 10.0 16.1 7.6 10.3 16.7 11.3 28.1 6.1 3.2 5.5 7.3 6.6 5.5 23.5 7.4 7.5 19.7 5.9 8.6 11.9 12.8 9.4 14.7 6.3 6.4 15.3 12.2 10.1 8.6 12.2 11.4 7.7 7.3 16.2 8.0 29.0 1.3 2.7 4.0 5.2 2.1 6.2 3.3 4.3 4.3 2.3 3.7 3.6 5.2 2.1 6.0 1.7 4.4 9.8 2.4 13.9 15.8 11.9 15.2 11.2 9.2 12.0 13.9 11.3 14.4 35.7 30.2 42.7 29.6 27.5 59.3 85.6 35.7 42.8 40.9 41.8 21.6 40.9 14.9 26.4 27.9 33.3 25.6 23.3 52.0 201.3 31.7 37.6 15.1 78.0 25.6 41.3 20.8 34.4 30.7 15.9 49.8 22.8 38.8 12.6 32.4 40.2 36.9 21.0 61.5 21.5 39.0 38.8 29.1 63.9 52.5 30.2 318.2 30.5 26.4 37.2 MAP1LC3C ATG8J ENSG00000197769 "Microtubule associated protein 1 light chain 3 gamma" Q9BXW4 1 241995490-241999073 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 17.9" "Cell type enhanced" "Detected in single" 17 "granulocytes: 1.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 5 "SuSa: 26.1" "Low region specificity" "Detected in all" HPA072670 Supported "Cytoplasmic bodies" NA NA "Cytoplasmic bodies" "HPA072670: AB_2686546" "unprognostic (2.27e-2)" "unprognostic (1.74e-1)" "unprognostic (9.44e-3)" "prognostic unfavorable (1.34e-7)" "unprognostic (1.08e-1)" "unprognostic (4.72e-2)" "unprognostic (3.41e-2)" "unprognostic (3.73e-2)" "unprognostic (1.04e-1)" "unprognostic (2.42e-1)" "unprognostic (1.69e-1)" "unprognostic (1.39e-1)" "unprognostic (2.89e-3)" "unprognostic (6.17e-3)" "unprognostic (1.26e-1)" "unprognostic (8.65e-2)" "unprognostic (7.73e-2)" 12.2 0.8 0.5 1.4 0.7 0.1 13.4 0.5 0.9 0.3 4.4 0.2 0.7 0.4 0.5 1.9 8.9 3.5 1.5 1.8 0.3 0.1 0.7 0.4 9.0 5.4 0.5 0.3 4.4 0.4 0.5 2.0 17.9 0.6 0.7 0.5 4.7 7.8 0.2 5.7 5.5 2.6 0.9 0.9 1.4 4.3 1.2 0.5 0.1 2.3 7.1 5.0 6.5 3.5 1.0 0.8 2.6 2.5 0.4 0.5 0.1 0.1 0.0 5.2 0.0 0.2 5.0 3.3 0.1 0.0 0.2 0.2 0.4 0.0 0.0 3.0 1.4 0.3 0.0 0.1 0.1 0.1 0.0 0.9 0.2 0.2 0.1 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.1 1.6 0.1 0.0 0.0 1.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 26.1 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 2.6 0.6 0.4 0.4 1.2 0.3 0.6 0.3 0.5 0.2 1.0 0.2 0.4 1.2 0.4 2.5 0.8 0.1 0.1 0.5 0.7 0.5 0.9 0.3 0.1 0.5 0.3 0.6 0.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 MATN3 "EDM5, HOA" ENSG00000132031 "Matrilin 3" O15232 2 19992111-20012694 "Disease related genes, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 19.5;placenta: 16.6" "Group enriched" "Detected in some" 6 "Alveolar cells type 1: 35.7;Sertoli cells: 25.8;Smooth muscle cells: 11.4" "Cancer enhanced" "Detected in all" "pancreatic cancer: 13.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 5 "Hep G2: 56.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA051250 Approved "Endoplasmic reticulum,Golgi apparatus" "Secreted to extracellular matrix" NA NA "Endoplasmic reticulum, Golgi apparatus" "HPA051250: AB_2681406" "unprognostic (3.47e-1)" "prognostic unfavorable (1.41e-4)" "unprognostic (7.57e-2)" "unprognostic (2.75e-2)" "unprognostic (1.71e-1)" "unprognostic (1.33e-2)" "prognostic unfavorable (8.62e-5)" "unprognostic (1.27e-1)" "unprognostic (4.84e-2)" "unprognostic (7.40e-2)" "unprognostic (3.20e-2)" "unprognostic (2.54e-2)" "unprognostic (2.11e-2)" "prognostic unfavorable (4.74e-5)" "unprognostic (2.51e-1)" "unprognostic (7.04e-2)" "unprognostic (3.15e-2)" 2.4 1.3 6.6 1.0 5.1 0.3 3.4 1.8 7.9 4.1 1.0 2.4 2.6 0.9 2.7 1.8 1.4 2.6 3.4 0.9 6.2 4.9 4.1 0.4 19.5 0.7 8.6 3.7 1.1 1.3 0.4 0.3 16.6 7.4 2.7 1.0 1.9 0.8 7.2 0.5 0.9 0.8 2.8 7.9 0.7 2.8 1.6 6.0 0.0 1.7 0.0 0.7 1.8 1.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.5 1.9 6.5 0.0 1.9 4.1 0.4 0.8 0.4 2.6 3.4 1.8 1.1 0.0 0.3 0.6 2.5 0.4 0.1 5.0 3.8 0.0 0.1 0.0 0.4 56.1 0.4 0.0 0.0 8.8 0.3 2.9 0.7 1.8 3.5 0.0 0.0 0.0 5.5 0.9 0.0 0.0 2.0 0.0 0.9 0.0 0.0 0.0 7.9 1.7 0.0 0.8 4.2 0.7 2.4 11.6 7.7 0.0 1.9 3.9 4.8 0.1 0.4 0.0 0.0 0.0 0.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 5.1 1.8 7.9 6.2 4.9 8.6 3.7 7.4 6.0 35.7 2.1 0.0 0.3 0.2 0.0 0.2 0.0 2.7 2.3 1.8 0.0 0.0 0.0 0.2 0.4 1.4 0.0 0.0 0.2 1.6 2.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 3.3 0.0 0.0 0.0 0.7 0.0 4.2 0.3 0.0 25.8 11.4 0.0 1.5 0.1 0.1 0.0 0.0 0.1 MB21D2 C3orf59 ENSG00000180611 "Mab-21 domain containing 2" Q8IYB1 3 192796815-192918161 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 34.9" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 55.7;Syncytiotrophoblasts: 92.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 6.6;T-reg: 5.5" "Lineage enriched" "Detected in single" 10 "T-cells: 6.6" "Cell line enhanced" "Detected in many" "HDLM-2: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044026 Approved Approved Cytosol NA NA Cytosol "HPA044026: AB_10962840" "unprognostic (3.52e-2)" "unprognostic (1.02e-1)" "unprognostic (3.06e-1)" "prognostic unfavorable (3.74e-5)" "unprognostic (2.42e-2)" "prognostic unfavorable (9.94e-4)" "unprognostic (2.76e-2)" "unprognostic (3.50e-2)" "unprognostic (1.53e-1)" "unprognostic (2.46e-1)" "unprognostic (2.84e-2)" "unprognostic (1.57e-1)" "unprognostic (1.30e-3)" "unprognostic (5.94e-3)" "unprognostic (1.95e-1)" "unprognostic (3.80e-2)" "unprognostic (3.28e-2)" 5.7 6.0 4.4 4.4 6.9 1.6 5.1 11.1 10.9 5.8 6.9 5.6 2.7 12.0 7.3 2.9 3.2 5.3 10.1 7.6 3.9 5.0 5.8 2.3 5.9 3.1 4.4 3.5 6.5 2.8 5.6 8.6 34.9 4.6 4.9 4.3 4.0 3.1 3.9 4.9 8.6 15.7 7.8 3.5 3.0 5.1 11.4 3.3 1.2 3.3 2.5 2.5 8.7 5.0 0.3 0.6 0.0 0.6 0.0 6.6 1.8 9.9 1.4 2.4 7.3 1.5 2.3 4.4 7.2 6.7 13.0 7.8 6.4 1.6 0.0 4.3 17.6 5.4 4.4 5.6 1.8 14.2 43.0 3.1 1.2 0.7 0.7 2.9 0.1 0.6 3.0 2.8 3.6 2.2 1.0 2.5 1.2 0.0 0.6 2.2 7.3 0.1 0.0 5.1 5.4 17.8 0.2 4.0 2.0 3.0 5.7 3.8 1.9 1.5 4.9 0.7 5.2 7.7 0.1 0.8 2.4 7.3 4.3 13.7 19.1 15.1 0.0 1.7 1.5 3.3 0.0 0.3 0.0 0.3 0.6 2.9 0.3 6.6 1.7 0.6 0.0 4.2 1.2 0.0 0.0 0.0 0.0 5.5 1.8 4.4 6.9 11.1 10.9 3.9 5.0 4.4 3.5 4.6 3.3 6.0 0.3 0.9 0.8 8.1 10.6 1.0 0.0 1.4 1.2 0.0 2.0 55.7 0.0 5.2 0.1 4.8 2.9 0.0 0.2 7.2 7.6 0.7 0.0 0.0 5.0 7.9 9.8 9.8 4.3 1.3 2.8 10.7 13.5 22.6 2.4 1.0 1.6 5.8 5.6 8.4 0.7 12.9 4.7 2.1 19.4 7.5 92.3 1.3 2.5 0.9 MBNL3 "CHCR, FLJ11316, MBLX39, MBXL" ENSG00000076770 "Muscleblind like splicing regulator 3" Q9NUK0 X 132369317-132489968 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 67.0" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 253.9;Hepatocytes: 109.0;Syncytiotrophoblasts: 287.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 39.8;Hep G2: 54.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA001584 Enhanced Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA001584: AB_1079326" "unprognostic (3.38e-2)" "unprognostic (1.40e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (1.57e-4)" "unprognostic (1.87e-1)" "unprognostic (2.67e-3)" "unprognostic (8.74e-2)" "unprognostic (3.46e-2)" "unprognostic (2.19e-2)" "unprognostic (5.77e-3)" "unprognostic (4.36e-3)" "unprognostic (1.65e-1)" "unprognostic (1.07e-1)" "unprognostic (1.67e-1)" "unprognostic (2.43e-1)" "unprognostic (8.28e-2)" "unprognostic (2.37e-1)" 6.6 10.4 1.8 14.7 1.9 5.1 7.5 0.9 1.6 3.8 5.9 2.8 10.8 4.0 4.8 25.8 9.6 4.6 4.6 14.2 1.6 1.9 5.6 23.5 12.0 16.2 3.0 1.1 5.5 10.4 2.4 6.3 67.0 1.8 5.4 4.7 2.8 5.5 6.1 1.6 5.5 9.7 6.7 3.5 15.2 5.2 23.8 1.9 18.6 3.5 7.9 10.8 8.3 8.3 18.1 12.3 7.2 14.0 13.4 12.5 6.2 2.2 0.0 2.8 0.4 0.5 1.2 5.2 0.1 1.0 0.3 0.0 39.8 7.4 10.4 0.2 0.4 0.3 2.5 6.5 2.6 0.2 1.0 2.5 9.3 8.6 54.6 0.5 10.3 3.4 0.5 2.4 0.0 1.2 0.0 0.3 6.6 0.8 3.0 0.5 6.1 17.6 3.9 0.4 8.8 0.5 16.8 3.5 5.9 1.9 6.0 1.0 3.5 4.8 2.8 1.4 5.2 1.0 2.7 1.2 2.1 0.4 2.7 2.1 6.0 4.0 15.3 0.4 7.0 6.6 7.2 5.9 3.7 12.5 6.9 11.1 15.0 7.7 8.6 6.2 18.1 7.8 8.7 0.9 13.4 14.0 12.3 1.5 6.2 1.8 1.9 0.9 1.6 1.6 1.9 3.0 1.1 1.8 1.9 3.0 5.0 11.9 1.8 7.8 0.3 8.9 45.9 6.7 6.8 10.4 0.0 253.9 3.3 1.3 4.2 2.4 8.8 46.7 4.7 36.5 5.1 1.2 8.1 109.0 25.7 0.0 6.4 6.7 23.7 6.2 21.3 5.6 6.8 1.0 11.4 0.3 1.2 0.0 47.7 5.9 1.8 0.0 1.2 0.9 1.2 7.4 287.8 10.0 8.3 3.3 MEST PEG1 ENSG00000106484 "Mesoderm specific transcript" Q5EB52 7 130486171-130506465 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 63.8;placenta: 193.5" "Group enriched" "Detected in many" 8 "Cytotrophoblasts: 680.5;Syncytiotrophoblasts: 836.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD8 T-cell: 18.8" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "AN3-CA: 525.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005623 Approved "Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Golgi apparatus, Cytosol" "HPA005623: AB_1079364" "unprognostic (6.14e-2)" "unprognostic (5.06e-3)" "unprognostic (9.82e-2)" "unprognostic (1.64e-3)" "unprognostic (3.02e-1)" "unprognostic (1.88e-1)" "unprognostic (9.36e-3)" "unprognostic (1.12e-1)" "unprognostic (7.81e-2)" "unprognostic (6.22e-2)" "unprognostic (1.16e-1)" "unprognostic (2.89e-1)" "prognostic unfavorable (6.20e-5)" "unprognostic (7.09e-2)" "unprognostic (1.05e-1)" "unprognostic (2.30e-1)" "unprognostic (1.67e-2)" 44.9 26.0 7.8 4.7 12.9 3.4 63.8 2.6 22.7 2.4 7.5 3.4 1.1 7.9 7.3 4.6 2.6 5.2 6.6 3.7 7.9 8.0 6.7 13.7 18.8 4.1 3.3 9.0 7.8 13.0 2.5 15.4 193.5 15.5 4.1 6.1 8.4 7.0 2.5 2.2 2.1 7.2 5.3 3.2 22.4 3.0 10.1 3.3 2.0 4.3 2.5 1.9 4.5 3.7 3.1 6.7 8.6 2.0 2.7 18.8 5.3 3.2 1.7 8.5 525.5 0.1 0.0 0.0 3.5 1.6 3.7 1.7 10.1 4.9 1.6 1.2 0.1 3.2 0.4 0.1 0.0 1.4 0.0 0.0 2.8 2.7 1.6 14.5 0.1 0.0 0.2 0.1 2.7 0.0 18.9 1.4 0.0 3.1 0.0 7.1 4.5 0.3 3.5 5.3 4.8 0.8 0.0 94.6 1.0 4.0 3.0 30.0 0.0 3.1 10.2 0.0 9.0 0.3 2.4 1.4 1.2 0.0 11.7 0.2 0.1 0.3 0.0 4.5 0.0 0.4 8.6 1.9 6.2 0.7 2.0 1.7 3.1 2.0 1.4 6.7 2.8 7.6 18.8 1.1 2.7 1.2 0.3 0.1 5.3 7.8 12.9 2.6 22.7 7.9 8.0 3.3 9.0 15.5 3.3 6.0 3.8 2.4 36.0 3.9 9.1 0.6 17.8 4.0 5.7 15.7 3.9 680.5 10.0 19.8 53.5 3.4 10.9 0.0 35.4 99.2 31.1 18.0 0.0 15.8 79.5 1.6 28.4 35.6 7.7 27.3 78.6 1.9 1.7 1.0 19.5 40.4 28.9 28.1 12.7 9.2 19.9 19.4 5.2 33.9 38.5 0.5 836.0 0.0 33.2 16.5 MFAP2 "MAGP, MAGP-1" ENSG00000117122 "Microfibril associated protein 2" P55001 1 16974502-16980835 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 51.7" "Cell type enhanced" "Detected in many" 15 "Extravillous trophoblasts: 148.9;Fibroblasts: 84.5;Leydig cells: 49.8;Peritubular cells: 60.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "gdT-cell: 2.1" "Lineage enriched" "Detected in single" 7 "T-cells: 2.1" "Cell line enhanced" "Detected in many" "ASC diff: 48.7;ASC TERT1: 50.2;HUVEC TERT2: 51.4;SH-SY5Y: 43.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA007354 Enhanced "Secreted to extracellular matrix" NA NA "HPA007354: AB_1079365" "unprognostic (5.10e-2)" "unprognostic (3.81e-2)" "unprognostic (2.62e-1)" "unprognostic (2.92e-2)" "unprognostic (4.86e-1)" "unprognostic (1.53e-3)" "unprognostic (3.72e-3)" "unprognostic (2.21e-1)" "unprognostic (1.85e-2)" "unprognostic (1.98e-1)" "unprognostic (9.45e-3)" "unprognostic (9.12e-2)" "prognostic unfavorable (2.52e-8)" "unprognostic (2.18e-3)" "unprognostic (1.34e-1)" "unprognostic (1.93e-1)" "unprognostic (5.66e-3)" 13.1 1.6 0.2 6.0 0.4 0.0 20.8 0.4 0.8 24.8 5.0 0.5 6.7 1.6 28.7 14.0 5.7 6.6 29.7 29.6 0.6 0.3 3.4 0.8 12.5 1.2 0.3 1.0 23.6 33.9 0.0 4.7 51.7 1.8 16.9 1.7 15.4 6.9 5.0 4.6 10.9 4.3 18.3 2.9 1.3 3.5 10.4 0.3 0.7 3.8 7.4 3.3 10.3 13.2 0.3 0.0 0.0 0.1 0.0 2.1 0.2 0.0 0.0 19.0 0.0 48.7 50.2 1.2 4.8 20.0 7.5 14.7 4.3 0.2 0.0 16.6 16.7 0.0 0.0 1.3 1.5 3.0 0.0 14.8 0.0 7.0 0.4 4.6 0.0 0.0 20.5 3.7 21.1 8.4 23.3 51.4 0.0 0.0 3.1 3.7 2.3 0.0 0.0 22.1 0.1 0.1 0.2 0.0 0.6 0.2 0.0 1.0 43.1 1.6 7.2 1.8 15.6 2.4 2.5 14.2 13.1 27.4 10.6 0.5 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.4 0.8 0.6 0.3 0.3 1.0 1.8 0.3 0.0 1.7 0.0 5.7 6.0 0.0 0.4 2.5 1.4 7.9 3.5 0.0 3.9 0.0 0.9 13.1 0.6 0.0 0.0 0.7 148.9 84.5 1.0 0.0 0.0 6.7 0.0 9.7 1.8 0.0 4.5 49.8 0.9 16.9 0.0 0.3 26.5 3.2 0.0 60.1 0.0 0.8 0.0 4.1 1.1 8.1 5.5 24.3 0.0 0.0 0.8 MFAP5 "MAGP2, MP25" ENSG00000197614 "Microfibril associated protein 5" Q13361 12 8637346-8662888 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Aortic aneurysm, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 128.1" "Cell type enriched" "Detected in many" 4 "Extravillous trophoblasts: 937.0" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 50.0;BJ: 18.1;EFO-21: 43.9;HeLa: 16.6;SuSa: 42.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA010553 Enhanced "Secreted to extracellular matrix" NA NA 3800000 "HPA010553: AB_1853843" "unprognostic (1.80e-1)" "unprognostic (1.11e-2)" "unprognostic (4.25e-2)" "unprognostic (4.84e-2)" "unprognostic (1.44e-1)" "unprognostic (6.05e-2)" "unprognostic (2.15e-3)" "unprognostic (1.10e-1)" "unprognostic (1.64e-1)" "unprognostic (8.79e-2)" "unprognostic (8.63e-3)" "unprognostic (3.05e-1)" "unprognostic (4.41e-7)" "prognostic unfavorable (6.87e-4)" "unprognostic (8.81e-2)" "unprognostic (2.05e-2)" "prognostic unfavorable (5.81e-4)" 44.3 3.2 0.6 3.3 0.7 0.3 21.8 0.5 0.5 71.5 11.2 0.5 18.2 1.4 78.4 34.0 31.3 9.0 6.8 16.5 0.7 0.6 1.9 3.0 3.3 3.3 0.6 0.4 4.7 1.4 0.2 1.7 128.1 0.7 7.6 11.0 0.9 6.0 13.5 19.6 13.0 9.0 37.0 3.4 1.0 7.9 12.3 0.3 1.0 13.1 35.0 4.5 46.3 21.1 1.1 1.2 5.3 2.4 0.6 1.2 0.8 0.4 1.6 0.4 0.7 8.7 3.7 50.0 18.1 0.3 0.2 0.3 0.6 0.3 0.1 43.9 5.6 0.4 2.5 0.1 3.7 0.0 0.1 0.1 0.4 16.6 0.5 0.1 0.3 0.2 2.5 1.3 2.1 0.0 0.9 0.0 0.5 0.7 1.0 15.1 0.2 0.5 0.2 0.9 0.2 0.8 0.3 0.4 1.8 1.8 0.7 0.2 0.2 0.5 0.2 0.3 42.1 6.9 0.2 0.6 3.2 6.3 13.2 0.8 0.6 0.5 0.5 1.7 0.2 0.0 5.3 2.4 2.0 0.7 1.9 1.2 0.4 0.4 0.4 1.2 1.1 1.2 0.5 3.1 0.6 1.4 1.0 0.1 0.8 0.6 0.7 0.5 0.5 0.7 0.6 0.6 0.4 0.7 0.3 11.9 4.3 0.0 0.4 20.5 0.2 5.2 0.0 2.7 3.4 0.0 0.0 70.9 0.0 0.0 0.3 4.4 0.0 0.0 0.0 937.0 96.1 0.0 0.0 0.0 24.9 0.0 0.0 7.4 1.9 0.2 56.7 3.6 11.8 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.6 0.0 20.2 0.0 0.0 15.7 210.9 0.0 0.0 0.1 MFSD2A "FLJ14490, MFSD2" ENSG00000168389 "Major facilitator superfamily domain containing 2A" Q8NA29 1 39955112-39969968 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Symport, Transport" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 96.9;liver: 87.9;placenta: 111.3;seminal vesicle: 121.2" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 112.2;Enterocytes: 112.9;Hepatocytes: 268.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "classical monocyte: 9.3;intermediate monocyte: 4.6;myeloid DC: 10.3;plasmacytoid DC: 16.7" "Group enriched" "Detected in many" 11 "dendritic cells: 16.7;monocytes: 9.3" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 18.9;THP-1: 59.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043107 Uncertain Approved "Plasma membrane,Cytosol,Cytoplasmic bodies" NA NA Cytosol "Plasma membrane, Cytoplasmic bodies" "HPA043107: AB_10794387" "unprognostic (2.20e-1)" "unprognostic (1.15e-1)" "unprognostic (5.23e-3)" "unprognostic (1.06e-1)" "unprognostic (1.30e-1)" "unprognostic (6.92e-2)" "unprognostic (2.61e-2)" "unprognostic (2.45e-2)" "unprognostic (1.60e-1)" "unprognostic (4.33e-1)" "unprognostic (2.85e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.22e-6)" "unprognostic (9.26e-2)" "unprognostic (4.11e-1)" "unprognostic (1.09e-1)" "prognostic favorable (2.33e-4)" 2.0 0.9 6.0 1.6 7.2 3.3 6.2 2.4 6.5 1.6 5.6 4.3 96.9 6.4 4.3 45.0 5.0 1.5 1.2 0.7 7.6 6.1 7.2 87.9 15.8 1.1 7.5 2.6 0.8 0.5 0.3 3.0 111.3 7.8 1.0 2.5 2.0 1.7 121.2 0.3 27.0 20.4 1.8 7.3 0.8 1.0 17.7 2.3 0.2 2.9 4.7 1.7 2.6 4.6 1.1 16.7 0.9 9.3 0.1 0.1 2.3 2.1 0.9 4.5 6.8 3.2 0.6 0.0 2.0 4.0 4.6 5.5 0.2 1.2 13.3 1.2 1.0 3.2 5.3 4.4 7.7 3.6 1.7 2.1 1.6 0.0 0.0 10.7 2.3 7.9 3.6 4.8 18.9 7.8 0.8 1.1 4.1 0.0 3.4 2.0 0.2 3.6 3.6 3.6 7.4 1.6 2.5 6.6 3.0 0.7 6.3 1.6 2.4 1.6 11.4 1.1 0.4 0.5 59.5 0.7 1.0 2.0 3.4 8.7 0.6 1.2 2.9 10.6 9.0 3.3 0.0 9.3 0.9 0.1 4.6 0.1 1.1 0.0 0.1 10.3 0.2 0.0 0.0 0.5 0.1 0.8 16.7 0.0 2.3 6.0 7.2 2.4 6.5 7.6 6.1 7.5 2.6 7.8 2.3 17.9 112.2 11.5 13.4 46.9 1.9 0.6 12.7 12.0 31.8 15.7 0.0 0.3 0.0 3.2 0.6 6.7 112.9 0.0 22.5 6.5 9.7 5.7 17.3 268.3 6.4 0.0 1.2 10.4 12.4 0.9 0.6 11.4 0.0 2.8 16.4 41.8 16.3 3.5 0.4 3.7 1.8 0.0 3.4 1.1 1.0 47.9 43.9 2.2 10.0 23.0 MFSD2B ENSG00000205639 "Major facilitator superfamily domain containing 2B" A6NFX1 2 24010081-24063321 "Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 17.4;brain: 7.5;placenta: 7.5" "Cell type enhanced" "Detected in many" 11 "Erythroid cells: 46.7;Glandular cells: 24.5;Urothelial cells: 32.0" "Not detected" "Not detected" "Region enriched" "Detected in single" 16 "basal ganglia: 7.5" "Cell type enriched" "Detected in some" 4 "basophil: 5.5" "Lineage enriched" "Detected in single" 25 "granulocytes: 5.5" "Group enriched" "Detected in some" 14 "HEL: 13.1;K-562: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA044145 Enhanced NA NA "HPA044145: AB_2678833" "unprognostic (5.67e-2)" "unprognostic (1.25e-3)" "unprognostic (1.84e-1)" "unprognostic (5.35e-5)" "unprognostic (2.82e-1)" "unprognostic (1.74e-1)" "unprognostic (4.26e-2)" "unprognostic (7.47e-2)" "unprognostic (2.12e-1)" "unprognostic (3.42e-2)" "unprognostic (9.21e-3)" "unprognostic (1.90e-2)" "unprognostic (6.87e-6)" "unprognostic (7.76e-2)" "unprognostic (1.39e-1)" "unprognostic (1.91e-1)" "unprognostic (1.72e-1)" 0.2 0.1 0.1 0.6 7.5 17.4 0.2 0.1 0.3 0.3 0.4 0.0 1.1 0.3 0.5 0.3 0.1 0.2 0.2 0.5 0.1 0.4 0.1 0.4 3.2 0.1 0.3 0.0 0.1 0.1 0.1 0.1 7.5 0.3 1.2 0.2 0.2 1.0 0.1 0.5 0.2 0.2 0.1 0.3 2.3 0.2 2.0 0.0 0.1 0.1 0.0 0.4 0.8 1.8 0.0 0.2 5.5 0.0 0.2 0.0 3.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 5.6 0.0 0.6 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.2 0.0 0.2 0.0 3.4 0.1 7.5 0.1 0.3 0.1 0.4 0.3 0.0 0.3 0.0 0.0 2.2 1.5 12.3 9.0 0.6 3.9 2.5 0.0 0.0 0.0 3.9 5.7 3.3 1.2 0.5 1.4 0.9 46.7 1.6 3.6 1.8 24.5 4.7 0.0 2.8 0.0 1.2 0.0 0.8 0.2 0.0 1.1 0.0 0.0 3.3 0.2 6.3 2.9 0.0 0.0 1.3 0.0 0.9 0.6 2.5 9.8 6.3 1.5 4.7 32.0 MMP11 STMY3 ENSG00000099953 "Matrix metallopeptidase 11" P24347 22 23768226-23784316 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "endometrium 1: 44.1;placenta: 119.6" "Cell type enhanced" "Detected in many" 15 "Extravillous trophoblasts: 34.6;Syncytiotrophoblasts: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 7.8" "Group enriched" "Detected in many" 5 "B-cells: 2.4;dendritic cells: 7.8" "Cell line enhanced" "Detected in some" "AN3-CA: 18.7;hTERT-RPE1: 9.7;REH: 7.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002593, HPA068864" Approved "Secreted to extracellular matrix" NA NA "CAB002593: , HPA068864: AB_2686051" "unprognostic (1.06e-1)" "unprognostic (3.08e-1)" "unprognostic (1.83e-1)" "unprognostic (1.84e-3)" "unprognostic (2.77e-2)" "unprognostic (6.73e-2)" "unprognostic (2.14e-2)" "unprognostic (5.15e-1)" "unprognostic (2.73e-2)" "unprognostic (2.20e-1)" "unprognostic (1.89e-3)" "unprognostic (7.04e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (8.05e-2)" "unprognostic (6.78e-2)" "unprognostic (1.10e-1)" "unprognostic (1.68e-2)" 1.7 0.6 0.2 1.0 0.6 0.1 1.6 1.0 0.5 13.4 1.8 0.4 0.4 1.9 44.1 1.1 0.8 2.2 2.0 3.1 0.5 0.0 1.7 0.5 0.7 1.8 0.4 0.2 7.7 1.1 0.2 0.3 119.6 0.5 1.4 1.0 0.8 2.5 0.4 0.5 2.0 4.0 2.7 0.3 0.9 0.7 3.4 0.2 2.6 0.5 0.6 0.9 1.6 2.1 2.4 7.8 0.0 0.0 0.0 1.0 0.1 0.1 0.0 2.3 18.7 2.8 4.2 0.0 0.2 5.0 0.6 0.4 0.0 0.6 0.6 3.5 1.3 0.9 0.1 1.0 0.0 0.2 0.0 0.3 0.0 0.0 1.0 2.1 0.0 0.0 2.7 0.4 0.5 0.0 9.7 2.9 0.2 0.3 0.0 0.6 0.1 0.0 0.0 0.6 0.5 0.1 7.8 0.0 0.2 0.3 0.0 2.9 5.0 1.9 0.3 0.0 3.0 1.7 0.0 1.3 0.3 0.0 0.7 0.0 0.1 0.0 2.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.4 1.0 0.3 0.0 0.0 0.0 7.8 0.0 0.1 0.2 0.6 1.0 0.5 0.5 0.0 0.4 0.2 0.5 0.2 0.0 4.5 0.8 0.8 0.9 0.4 4.3 2.5 1.4 0.0 0.0 0.0 0.3 1.7 5.9 6.6 0.2 0.0 0.0 0.6 34.6 5.7 0.4 1.1 0.0 0.7 0.0 1.7 1.3 0.0 8.0 0.6 0.0 1.7 0.0 0.8 0.5 1.6 0.0 0.4 2.2 0.6 0.0 2.0 1.1 2.7 0.5 15.6 0.0 0.8 0.3 MORC4 "FLJ11565, ZCW4, ZCWCC2" ENSG00000133131 "MORC family CW-type zinc finger 4" Q8TE76 X 106813871-107000244 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "placenta: 94.5" "Group enriched" "Detected in many" 5 "Alveolar cells type 1: 122.1;Alveolar cells type 2: 98.4;Ciliated cells: 111.1;Club cells: 109.2;Cytotrophoblasts: 213.9;granulocytes: 61.5;Syncytiotrophoblasts: 215.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 44.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA000395, HPA015547, HPA050250" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: AB_2681063" "prognostic unfavorable (3.56e-5)" "unprognostic (3.30e-3)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (1.40e-1)" "unprognostic (6.29e-3)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.30e-2)" "unprognostic (5.56e-2)" "unprognostic (8.59e-2)" "unprognostic (1.60e-1)" "unprognostic (1.60e-2)" "unprognostic (6.57e-2)" "unprognostic (4.89e-2)" "unprognostic (8.69e-2)" 8.7 20.0 3.2 6.0 4.8 5.1 6.2 4.9 3.6 8.0 5.3 4.6 12.7 4.6 8.8 8.5 6.8 7.3 6.7 5.3 4.3 2.8 4.9 9.7 6.0 2.2 4.9 2.2 12.3 9.1 6.0 4.9 94.5 5.8 7.7 4.9 4.2 8.7 8.8 9.4 8.6 4.9 7.4 5.4 2.6 5.6 12.5 5.0 2.3 7.6 7.5 5.2 6.3 15.1 6.0 4.6 10.5 3.8 2.8 4.0 0.7 11.0 44.0 4.4 10.1 13.4 15.5 22.9 10.7 11.4 5.4 7.0 23.3 5.0 1.7 5.6 11.0 9.3 8.7 14.7 9.4 6.5 2.5 8.5 2.7 14.9 9.8 9.9 1.9 5.6 8.2 9.1 7.4 10.8 32.3 4.8 1.7 1.5 16.7 12.1 9.7 4.0 2.7 3.9 29.5 16.7 1.9 8.8 1.9 17.5 8.8 3.8 4.8 13.0 12.8 8.4 6.5 7.6 1.9 5.0 8.7 8.8 17.2 5.9 4.7 6.1 4.3 9.3 1.7 6.3 10.5 3.8 3.1 3.7 3.0 3.2 3.3 3.6 2.8 1.6 6.0 4.0 3.4 8.2 2.8 3.6 4.6 2.6 0.7 3.2 4.8 4.9 3.6 4.3 2.8 4.9 2.2 5.8 5.0 122.1 98.4 2.2 12.9 15.5 4.5 2.2 7.6 111.1 109.2 5.2 3.9 213.9 18.3 8.8 0.8 5.0 3.9 0.0 6.4 21.9 23.8 19.4 61.5 16.2 20.2 1.6 1.7 8.6 1.3 0.9 10.3 4.8 11.8 0.0 8.8 5.8 6.7 4.9 11.0 9.0 7.5 25.8 8.6 5.4 24.3 14.1 215.6 6.4 8.4 11.7 MORN3 ENSG00000139714 "MORN repeat containing 3" Q6PF18 12 121648742-121672631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "placenta: 30.1;testis: 51.5" "Cell type enriched" "Detected in many" 5 "Late spermatids: 1766.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "BEWO: 12.6;CACO-2: 6.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038709, HPA038710" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA038709: AB_2676164, HPA038710: AB_2676165" "prognostic favorable (1.16e-4)" "unprognostic (2.70e-3)" "unprognostic (5.56e-2)" "unprognostic (5.13e-2)" "unprognostic (7.38e-3)" "unprognostic (3.46e-3)" "unprognostic (7.44e-2)" "unprognostic (3.70e-2)" "unprognostic (4.31e-2)" "unprognostic (3.09e-2)" "unprognostic (3.65e-3)" "unprognostic (3.11e-2)" "unprognostic (1.39e-2)" "unprognostic (3.06e-1)" "unprognostic (2.21e-1)" "unprognostic (8.85e-2)" "unprognostic (1.18e-1)" 0.3 0.2 1.2 0.5 1.4 0.9 0.3 0.3 1.6 0.4 0.3 0.3 0.3 0.2 0.3 1.4 0.3 5.6 0.4 0.3 1.4 1.2 0.4 0.3 1.0 1.4 0.3 0.3 0.3 0.4 3.4 0.7 30.1 0.3 0.3 0.0 0.3 0.3 0.3 0.3 2.5 0.3 0.3 0.3 0.8 0.8 51.5 0.3 0.3 0.5 0.3 0.6 0.3 0.3 1.2 1.2 3.1 0.6 2.2 2.3 0.6 0.1 0.2 0.4 0.2 0.0 0.3 12.6 0.2 0.0 0.1 0.1 6.8 0.3 0.2 0.2 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.5 0.3 0.4 0.3 0.4 0.9 0.1 0.3 0.3 0.0 0.1 0.2 0.8 0.2 0.3 0.1 0.2 0.8 0.6 0.2 0.0 0.1 0.3 0.0 0.1 0.4 0.2 1.1 1.1 0.1 0.2 0.0 0.5 0.9 0.1 0.1 0.2 0.2 0.3 0.1 0.2 0.1 0.4 0.9 0.3 0.1 2.3 0.6 0.4 2.1 0.3 2.0 0.8 2.3 1.3 0.2 1.2 2.1 1.4 3.1 2.2 0.5 1.2 2.0 0.6 1.2 1.4 0.3 1.2 1.4 1.2 0.3 0.3 0.3 0.3 3.0 2.2 0.5 1.1 2.9 1.1 1.1 5.1 50.9 11.4 1.8 0.0 0.2 6.6 3.3 357.0 1.5 0.0 0.0 1.2 0.4 1.3 0.3 2.3 0.0 0.8 0.0 0.0 0.6 0.0 1766.8 8.6 0.1 0.0 1.8 0.0 3.7 1.7 0.0 8.9 0.8 1.7 0.0 0.0 7.0 5.6 3.4 6.1 3.3 0.1 1.0 MSMP "PC-3, PSMP" ENSG00000215183 "Microseminoprotein, prostate associated" Q1L6U9 9 35752990-35756613 "Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Inflammatory response" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.9;pituitary gland: 6.0;placenta: 5.7" "Group enriched" "Detected in some" 67 "Early spermatids: 95.5;Late spermatids: 142.6" "Not detected" "Not detected" "Region enhanced" "Detected in some" "midbrain: 3.9" "Cell type enhanced" "Detected in some" "basophil: 3.2" "Group enriched" "Detected in many" 5 "granulocytes: 3.2;NK-cells: 1.2;T-cells: 1.3" "Group enriched" "Detected in some" 7 "HUVEC TERT2: 35.1;PC-3: 44.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA055174 Uncertain Supported Vesicles,Cytosol "Secreted in male reproductive system" No No Vesicles Cytosol "HPA055174: AB_2682726" 0.5 0.0 1.2 1.1 0.6 0.0 0.8 0.0 0.7 0.2 0.8 0.6 0.0 0.0 0.1 0.0 0.0 0.5 1.9 0.0 0.1 0.1 0.4 0.0 0.4 0.9 3.9 0.0 0.0 0.0 0.0 6.0 5.7 0.8 0.7 0.5 0.0 0.0 0.3 1.3 0.5 1.5 0.3 2.2 0.0 0.1 0.6 0.0 0.0 1.3 0.0 0.2 0.1 0.1 0.0 0.1 3.2 0.3 1.2 1.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.3 0.2 0.3 1.3 0.0 0.0 0.0 0.1 0.0 0.7 1.1 0.0 1.2 0.3 0.1 0.3 0.4 1.2 0.6 0.0 0.6 0.1 0.1 3.9 0.0 0.8 0.0 0.0 0.6 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.2 95.5 0.3 0.0 0.0 1.8 0.1 0.2 1.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 142.6 0.3 0.0 1.7 0.0 0.0 0.8 1.3 0.0 0.7 0.2 0.6 0.0 0.0 0.7 0.4 0.1 0.2 0.0 0.0 1.1 MSX2 "CRS2, FPP, HOX8, MSH, PFM, PFM1" ENSG00000120149 "Msh homeobox 2" P35548 5 174724533-174730893 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Osteogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 44.7;urinary bladder: 18.2" "Group enriched" "Detected in many" 16 "Cytotrophoblasts: 123.2;Syncytiotrophoblasts: 195.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "BEWO: 84.9" "Region enriched" "Detected in single" 7 "cerebellum: 6.9" "Low region specificity" "Detected in some" HPA005652 Uncertain Supported "Nuclear speckles" NA NA "Nuclear speckles" "HPA005652: AB_1079418" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (1.84e-1)" "prognostic favorable (8.43e-5)" "unprognostic (2.50e-2)" "unprognostic (1.22e-2)" "unprognostic (3.13e-1)" "prognostic unfavorable (6.93e-4)" "unprognostic (2.08e-2)" "unprognostic (1.60e-1)" "unprognostic (2.51e-2)" "unprognostic (7.26e-2)" "unprognostic (1.36e-4)" "unprognostic (7.64e-3)" "unprognostic (5.06e-2)" "unprognostic (2.12e-6)" "unprognostic (1.43e-2)" 2.0 0.4 0.3 0.4 0.5 0.0 7.6 6.3 1.6 2.6 0.9 2.0 0.0 0.3 6.2 0.2 0.9 1.1 1.5 1.7 2.5 0.5 0.3 0.1 0.9 0.1 1.5 1.2 0.4 0.6 9.4 0.5 44.7 7.2 6.3 0.1 6.6 0.9 0.8 2.1 6.4 0.9 10.4 6.6 1.1 2.6 5.2 1.3 0.0 0.8 0.2 0.3 18.2 2.4 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.1 1.0 0.3 0.8 0.0 0.0 84.9 0.5 0.9 0.2 0.0 14.4 5.9 0.0 2.2 0.0 5.2 1.6 4.5 1.6 0.0 0.0 2.8 0.0 0.3 0.0 0.6 0.0 0.8 1.0 1.2 0.8 0.9 0.0 0.0 0.0 0.0 0.0 1.2 6.9 0.0 0.1 0.6 9.6 2.2 0.0 2.3 0.0 1.0 9.0 0.0 0.6 0.0 11.2 0.7 19.3 6.7 0.0 0.0 0.2 1.4 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.1 0.3 0.5 6.3 1.6 2.5 0.5 1.5 1.2 7.2 1.3 0.0 0.0 0.0 2.4 8.5 0.0 0.8 0.0 0.0 0.0 0.0 0.0 123.2 0.0 0.6 0.1 0.5 0.5 0.0 0.0 7.6 5.0 2.6 4.6 0.0 9.9 0.0 0.0 0.6 0.6 0.2 0.0 0.0 1.7 0.0 1.0 1.2 0.8 0.0 0.0 0.0 0.0 0.0 3.1 1.1 4.9 9.9 195.5 0.0 0.4 8.3 MTNR1B ENSG00000134640 "Melatonin receptor 1B" P49286 11 92969720-92985066 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.0;lymphoid tissue: 1.9;placenta: 4.5;testis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "GAMG: 10.6;SuSa: 2.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "midbrain: 0.8;pons and medulla: 1.2" HPA074024 Supported NA NA "HPA074024: " "unprognostic (3.61e-1)" "unprognostic (1.43e-1)" 0.1 0.0 0.3 0.0 3.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MUC15 ENSG00000169550 "Mucin 15, cell surface associated" Q8N387 11 26559033-26572233 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 265.1;placenta: 56.8;thyroid gland: 77.8" "Cell type enhanced" "Detected in many" 25 "Alveolar cells type 1: 101.3;Ciliated cells: 164.6;Syncytiotrophoblasts: 556.9" "Cancer enriched" "Detected in many" 11 "thyroid cancer: 56.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.8;K-562: 9.7;SK-BR-3: 16.6;SuSa: 11.3;U-266/70: 6.5;U-266/84: 17.4" "Group enriched" "Detected in some" 4 "cerebellum: 1.3;thalamus: 1.5" "Low region specificity" "Detected in many" "HPA026110, HPA073304" Enhanced "Intracellular and membrane" NA NA "HPA026110: AB_1854200, HPA073304: " "unprognostic (1.49e-1)" "unprognostic (2.08e-3)" "unprognostic (7.71e-5)" "unprognostic (5.09e-3)" "unprognostic (2.77e-2)" "unprognostic (3.04e-2)" "unprognostic (6.58e-2)" "unprognostic (1.12e-1)" "unprognostic (9.44e-3)" "unprognostic (1.98e-1)" "unprognostic (7.27e-3)" "unprognostic (4.96e-3)" "unprognostic (1.09e-1)" "unprognostic (5.70e-2)" "unprognostic (4.54e-3)" 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 3.9 0.0 0.0 9.3 0.0 0.1 265.1 11.0 1.0 0.1 0.1 0.0 0.0 5.2 0.1 4.8 0.1 0.0 0.0 0.1 1.8 0.0 2.1 56.8 0.0 0.8 0.0 0.0 14.4 1.0 0.0 12.0 0.0 0.0 0.0 0.0 0.2 4.1 0.0 1.1 77.8 8.1 1.7 3.0 6.5 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.0 0.0 0.0 3.5 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.6 0.0 16.6 0.0 11.3 0.1 0.0 0.0 0.0 2.5 0.0 0.0 6.5 17.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.3 20.9 0.0 12.3 3.1 0.0 0.0 0.0 164.6 64.8 47.1 0.0 52.1 26.6 3.0 0.4 0.0 0.0 0.0 0.0 15.5 0.5 0.6 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 26.0 556.9 0.0 0.0 10.5 MYCN "bHLHe37, MYCNOT, N-myc, NMYC" ENSG00000134323 "MYCN proto-oncogene, bHLH transcription factor" P04198 2 15940564-15947007 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 16.8" "Cell type enriched" "Detected in some" 8 "Extravillous trophoblasts: 75.4" "Cancer enhanced" "Detected in many" "testis cancer: 45.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.9;BEWO: 70.2;HMC-1: 16.9;NTERA-2: 26.6;RH-30: 18.6;SuSa: 12.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057420 Approved Nucleoplasm,Nucleoli NA NA Nucleoli Nucleoplasm "HPA057420: AB_2683434" "unprognostic (8.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (2.07e-2)" "unprognostic (4.11e-1)" "unprognostic (2.46e-2)" "unprognostic (1.23e-2)" "unprognostic (3.03e-2)" "unprognostic (1.81e-1)" "unprognostic (3.35e-3)" "unprognostic (3.09e-2)" "unprognostic (2.09e-1)" "unprognostic (1.12e-3)" "unprognostic (8.89e-2)" "unprognostic (2.47e-1)" "unprognostic (4.90e-2)" "unprognostic (1.23e-1)" 0.9 1.9 5.1 1.8 5.5 1.6 1.2 1.4 8.4 3.1 1.2 12.1 0.0 3.0 1.9 0.8 1.3 1.4 2.6 2.3 7.0 4.7 6.0 1.5 1.6 2.9 6.0 2.2 10.3 0.7 0.4 0.7 16.8 6.8 0.6 1.3 1.1 6.6 0.7 1.0 2.4 1.7 0.9 8.9 0.9 8.5 6.5 4.0 5.7 5.1 2.3 3.5 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 70.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 26.6 0.6 0.0 0.0 18.6 3.5 0.0 0.9 0.2 4.7 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 5.5 1.4 7.0 7.0 4.7 6.0 2.2 6.8 4.0 0.0 0.0 0.0 0.1 0.5 2.6 0.7 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 1.2 0.2 0.0 0.0 0.0 75.4 0.6 0.0 0.0 0.5 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.2 0.0 0.4 2.1 0.1 0.0 0.0 0.5 3.6 0.0 9.6 0.0 0.2 0.0 MYH13 MyHC-eo ENSG00000006788 "Myosin heavy chain 13" Q9UKX3 17 10300865-10373130 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "placenta: 1.9;skeletal muscle: 5.2;stomach 1: 4.8" "Group enriched" "Detected in some" 18 "Cardiomyocytes: 7.2;Spermatogonia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "U-2 OS: 8.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" NA NA "unprognostic (8.86e-2)" "unprognostic (2.45e-2)" "unprognostic (7.81e-2)" "unprognostic (3.95e-1)" "unprognostic (8.35e-2)" "unprognostic (1.42e-2)" "unprognostic (7.50e-3)" "unprognostic (3.15e-2)" "unprognostic (1.08e-1)" "unprognostic (8.74e-2)" "unprognostic (3.40e-9)" "unprognostic (2.44e-2)" "unprognostic (1.08e-1)" "unprognostic (2.06e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.9 0.1 0.1 0.0 0.1 0.1 0.1 5.2 0.0 0.8 0.1 0.1 0.4 4.8 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.0 0.0 0.0 0.0 0.0 MYLIP "IDOL, MIR" ENSG00000007944 "Myosin regulatory light chain interacting protein" Q8WY64 6 16129125-16148248 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 84.0" "Cell type enhanced" "Detected in many" 7 "Syncytiotrophoblasts: 294.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 33.8" "Low region specificity" "Detected in all" NA NA "unprognostic (1.54e-1)" "unprognostic (4.84e-3)" "unprognostic (2.79e-1)" "unprognostic (9.65e-3)" "unprognostic (1.07e-1)" "unprognostic (2.07e-2)" "unprognostic (1.11e-2)" "prognostic favorable (6.44e-6)" "unprognostic (2.75e-2)" "unprognostic (2.67e-2)" "unprognostic (5.44e-3)" "unprognostic (1.03e-2)" "prognostic favorable (3.67e-4)" "unprognostic (1.42e-2)" "unprognostic (1.47e-1)" "unprognostic (2.35e-1)" "prognostic favorable (4.11e-5)" 23.4 12.5 7.3 10.3 10.6 44.2 19.5 5.4 11.4 28.5 14.4 18.9 16.4 7.5 31.8 16.1 12.1 22.2 19.1 9.0 8.6 6.1 13.1 3.5 19.0 19.4 12.9 8.8 22.3 10.5 9.8 6.1 84.0 7.4 20.1 9.7 20.2 16.2 20.9 20.6 16.7 15.7 18.0 7.0 23.5 14.8 15.2 12.2 8.8 39.1 10.9 15.7 19.0 33.7 4.9 1.4 14.2 2.3 3.2 8.4 1.5 2.0 4.1 1.7 2.0 17.3 4.6 4.5 1.4 3.4 3.5 7.6 11.5 2.1 9.2 7.4 2.2 2.4 5.1 8.1 2.5 3.0 3.3 8.4 6.2 4.3 2.1 2.5 4.2 6.1 7.4 3.3 1.8 1.4 1.7 8.0 2.0 17.8 10.9 1.3 7.7 0.1 20.8 4.9 4.9 3.7 2.1 7.9 33.8 3.7 24.6 8.6 3.7 1.8 18.8 9.5 14.8 3.5 10.4 2.3 1.6 4.0 1.2 3.6 10.1 4.4 4.9 1.0 12.3 5.5 8.5 2.3 11.1 8.4 2.2 7.3 4.9 5.3 5.9 1.4 4.9 5.9 5.4 14.2 3.2 2.0 0.7 3.2 1.5 7.3 10.6 5.4 11.4 8.6 6.1 12.9 8.8 7.4 12.2 20.8 36.3 30.2 28.3 87.0 7.3 74.2 35.7 21.4 18.2 21.0 0.0 113.9 8.3 14.9 36.7 33.1 32.6 0.0 16.2 65.2 75.2 27.4 35.7 1.0 27.7 11.1 80.9 34.4 42.6 12.5 35.6 21.9 75.9 26.2 35.2 15.3 8.1 32.3 58.0 18.8 6.6 135.8 92.6 59.7 17.5 73.4 294.6 88.3 34.8 26.9 N4BP3 LZTS4 ENSG00000145911 "NEDD4 binding protein 3" O15049 5 178113443-178126087 "Predicted intracellular proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 31.5" "Cell type enriched" "Detected in many" 4 "Extravillous trophoblasts: 120.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 4.0;naive B-cell: 4.0;naive CD8 T-cell: 2.6;plasmacytoid DC: 4.4" "Group enriched" "Detected in many" 18 "B-cells: 4.0;dendritic cells: 4.4;T-cells: 2.6" "Cell line enhanced" "Detected in many" "BEWO: 8.0;MCF7: 10.9;RH-30: 10.9;SK-BR-3: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030972, HPA030973, HPA061387" Approved Supported Nucleoplasm,Centrosome NA NA Nucleoplasm Centrosome "HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: " "unprognostic (1.84e-1)" "unprognostic (1.70e-2)" "unprognostic (4.96e-3)" "unprognostic (6.64e-3)" "unprognostic (2.06e-1)" "unprognostic (3.18e-3)" "unprognostic (1.88e-6)" "unprognostic (1.45e-1)" "unprognostic (1.61e-1)" "unprognostic (1.92e-2)" "unprognostic (3.28e-3)" "unprognostic (9.55e-2)" "prognostic favorable (2.38e-4)" "unprognostic (2.62e-1)" "unprognostic (1.16e-1)" "unprognostic (1.22e-1)" "unprognostic (1.06e-1)" 6.6 1.3 1.9 2.6 2.1 3.5 13.9 6.5 4.3 2.5 1.8 0.7 0.5 0.8 1.1 0.6 16.2 1.5 1.3 3.2 1.8 2.6 2.5 0.2 8.4 4.0 2.1 1.2 1.4 1.1 10.1 2.5 31.5 3.1 2.0 0.6 1.5 9.5 1.3 5.7 7.8 1.9 1.3 1.2 5.9 3.1 1.4 1.3 0.4 2.0 4.7 11.2 4.9 3.8 4.0 4.4 0.0 0.0 0.2 2.6 0.5 0.0 0.0 1.2 0.9 0.1 0.0 8.0 0.0 0.0 0.0 0.0 1.7 0.6 0.7 1.1 0.0 0.1 2.5 0.2 0.0 0.0 1.2 0.4 2.1 0.8 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 6.4 0.7 1.3 0.5 0.0 10.9 0.1 0.1 6.0 1.8 0.0 6.0 10.9 2.7 0.6 1.2 0.9 0.4 0.3 38.8 2.5 1.6 1.4 0.0 1.2 0.0 0.9 0.0 0.0 1.7 1.2 6.8 0.0 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.3 4.0 0.2 0.2 0.0 4.0 0.9 2.6 0.0 0.2 0.0 4.4 0.0 0.5 1.9 2.1 6.5 4.3 1.8 2.6 2.1 1.2 3.1 1.3 3.0 1.1 5.9 11.5 8.4 27.3 1.5 2.5 0.0 0.0 1.8 11.8 1.7 11.6 3.4 0.1 4.0 2.6 0.0 0.7 120.1 0.9 9.9 4.6 0.0 2.0 1.6 4.1 0.0 0.0 0.4 0.6 1.1 11.8 1.8 1.8 1.9 4.7 5.3 1.8 0.3 8.9 0.0 0.9 0.1 6.9 5.9 19.3 1.0 1.9 10.6 NAA11 "ARD1B, ARD2, hARD2" ENSG00000156269 "N(alpha)-acetyltransferase 11, NatA catalytic subunit" Q9BSU3 4 79225694-79326050 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 166 "placenta: 32.1;testis: 30.5" "Group enriched" "Detected in some" 11 "Cytotrophoblasts: 16.7;Early spermatids: 21.1;Extravillous trophoblasts: 13.6;Late spermatids: 20.7;Spermatocytes: 14.4;Spermatogonia: 15.0;Syncytiotrophoblasts: 11.1" "Cancer enhanced" "Detected in some" "testis cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "GAMG: 14.7;K-562: 8.8;U-266/70: 25.1;U-266/84: 8.0" "Not detected" "Not detected" HPA035922 Approved Supported "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Centrosome, Cytosol" "HPA035922: AB_10673490" "unprognostic (7.37e-2)" "unprognostic (7.58e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (4.67e-1)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 32.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 30.5 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 25.1 8.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 21.1 0.0 0.0 0.0 0.0 13.6 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 20.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 14.4 15.0 0.0 11.1 0.0 0.0 0.0 NCMAP "C1orf130, FLJ42528, MP11" ENSG00000184454 "Non-compact myelin associated protein" Q5T1S8 1 24556111-24609328 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 28.8;placenta: 21.2" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 2: 15.3;Ductal cells: 15.9;Exocrine glandular cells: 41.1;Pancreatic endocrine cells: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.1;RPTEC TERT1: 3.4;T-47d: 8.1;U-266/70: 6.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA013656 Uncertain NA NA "HPA013656: AB_2275006" "unprognostic (3.38e-2)" "unprognostic (3.52e-2)" "unprognostic (2.79e-1)" "prognostic favorable (2.83e-6)" "unprognostic (3.26e-2)" "unprognostic (1.98e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" "unprognostic (4.14e-1)" "unprognostic (1.73e-1)" "unprognostic (2.41e-2)" "unprognostic (1.04e-1)" "unprognostic (3.28e-3)" "unprognostic (9.88e-2)" "unprognostic (9.53e-2)" "unprognostic (1.63e-2)" "unprognostic (7.27e-3)" 0.6 0.2 0.6 0.5 0.7 0.6 4.6 0.2 0.7 1.3 7.0 1.3 0.0 6.3 0.5 1.8 0.5 1.1 15.0 0.5 0.8 0.6 2.2 5.8 4.7 0.2 1.0 0.1 0.2 28.8 0.0 9.1 21.2 0.8 2.1 0.2 1.3 13.4 0.0 0.6 0.6 7.5 0.2 2.2 0.3 5.7 0.2 1.1 0.2 5.3 0.7 1.4 0.9 0.3 1.4 1.0 2.7 0.9 0.7 0.8 0.1 0.2 4.1 0.1 0.1 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.2 1.8 0.4 1.1 0.0 0.1 0.3 0.6 0.0 0.0 0.2 0.1 0.4 0.3 1.9 0.0 0.2 0.4 0.0 0.2 0.1 0.0 0.3 0.0 0.3 0.2 0.5 0.0 0.4 0.2 0.4 0.2 1.5 0.0 0.4 0.1 1.1 3.4 1.1 0.4 0.3 0.2 0.3 0.0 1.1 8.1 0.2 0.5 0.2 0.3 0.5 0.2 6.4 0.8 0.1 0.1 0.2 0.3 2.7 0.9 0.6 0.5 0.3 0.4 0.8 0.5 0.4 0.2 1.4 0.7 0.8 2.0 0.7 0.4 1.0 0.3 0.1 0.6 0.7 0.2 0.7 0.8 0.6 1.0 0.1 0.8 1.1 3.0 15.3 0.0 1.7 0.0 0.0 1.1 0.0 1.4 2.3 3.5 3.9 1.0 0.0 15.9 0.0 0.0 0.7 0.0 41.1 0.2 0.4 2.8 1.1 1.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.3 1.8 0.6 3.2 14.2 1.4 0.0 0.7 0.4 0.0 0.3 0.0 0.2 0.1 7.8 0.0 0.8 1.7 NECTIN3 "CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRL3, PVRR3" ENSG00000177707 "Nectin cell adhesion molecule 3" Q9NQS3 3 111070071-111275563 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 94.2" "Cell type enriched" "Detected in some" 4 "Syncytiotrophoblasts: 98.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7" "Lineage enriched" "Detected in single" 4 "T-cells: 1.7" "Cell line enhanced" "Detected in many" "AF22: 33.5;TIME: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009869, HPA011038" Approved Approved "Cell Junctions,Cytosol" NA NA 20000000 Cytosol "Cell Junctions" "CAB009869: AB_2284699, HPA011038: AB_1079719" "unprognostic (3.76e-2)" "unprognostic (3.81e-3)" "unprognostic (1.74e-1)" "unprognostic (1.97e-2)" "unprognostic (1.02e-1)" "unprognostic (9.77e-2)" "unprognostic (3.26e-3)" "unprognostic (3.77e-1)" "unprognostic (7.58e-2)" "unprognostic (3.94e-2)" "unprognostic (5.33e-2)" "unprognostic (7.04e-2)" "prognostic favorable (9.82e-7)" "unprognostic (2.01e-1)" "unprognostic (1.97e-1)" "unprognostic (2.67e-1)" "unprognostic (1.05e-1)" 5.6 4.0 5.4 4.4 6.0 0.0 4.5 1.3 8.9 4.6 12.6 6.5 2.8 17.8 5.0 2.2 3.5 5.4 4.4 4.8 6.3 5.0 6.9 16.4 5.6 1.9 6.0 4.1 9.2 4.7 1.9 1.9 94.2 5.5 6.9 12.6 10.7 3.4 4.8 2.3 1.8 18.9 7.2 8.9 1.8 13.2 27.6 4.5 0.4 24.1 2.0 1.4 5.4 7.7 0.1 0.0 0.3 0.0 0.2 1.7 0.7 0.0 10.1 33.5 2.2 13.6 25.2 2.0 22.0 23.3 13.7 11.7 9.3 4.7 0.0 7.3 31.3 7.6 0.1 9.3 3.2 25.2 0.2 2.5 0.0 3.6 0.7 23.0 1.6 0.3 12.7 1.4 9.0 8.7 12.3 11.5 0.4 0.0 8.8 29.5 0.0 2.2 0.0 9.4 3.1 3.6 0.0 16.6 0.0 8.5 5.3 0.8 6.1 0.4 0.0 4.6 11.7 0.3 0.1 47.5 17.4 7.2 3.1 13.1 4.9 0.0 0.0 11.0 0.0 16.0 0.0 0.0 0.3 0.1 0.0 1.2 0.0 1.7 1.0 0.0 0.1 0.3 0.4 0.0 0.2 0.0 0.0 0.1 0.7 5.4 6.0 1.3 8.9 6.3 5.0 6.0 4.1 5.5 4.5 23.8 7.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 5.7 12.2 0.0 3.3 0.0 3.9 0.0 0.0 0.0 0.0 16.4 7.6 0.0 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 13.3 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 98.1 0.0 0.0 0.0 NECTIN4 "LNIR, nectin-4, PRR4, PVRL4" ENSG00000143217 "Nectin cell adhesion molecule 4" Q96NY8 1 161070995-161089599 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.1;placenta: 46.6;skin 1: 39.3" "Cell type enriched" "Detected in some" 7 "Syncytiotrophoblasts: 321.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basophil: 1.5;eosinophil: 1.2;neutrophil: 3.6" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.6" "Cell line enhanced" "Detected in some" "BEWO: 28.2;HaCaT: 18.2;MCF7: 11.4;OE19: 11.8;SK-BR-3: 23.7;T-47d: 15.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA010775 Enhanced Supported "Plasma membrane" "Secreted in other tissues" No No 11000 "Plasma membrane" "HPA010775: AB_1079720" "unprognostic (1.09e-3)" "unprognostic (1.52e-1)" "unprognostic (3.51e-1)" "unprognostic (1.11e-2)" "unprognostic (5.69e-3)" "unprognostic (2.09e-2)" "unprognostic (6.69e-3)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-3)" "unprognostic (1.13e-1)" "unprognostic (2.24e-8)" "unprognostic (2.98e-2)" "unprognostic (2.43e-1)" "unprognostic (3.68e-2)" "unprognostic (4.97e-2)" 0.2 0.1 0.1 0.8 0.1 0.1 7.7 0.1 0.1 9.8 0.6 0.1 5.4 0.2 1.5 3.7 40.1 1.4 5.6 0.1 0.1 0.1 1.3 0.2 3.1 0.0 0.1 0.0 0.5 4.4 0.0 0.3 46.6 0.1 7.8 0.7 0.1 13.5 5.5 0.1 39.3 0.4 2.0 0.1 0.1 4.5 0.2 0.0 0.5 0.1 22.7 23.1 12.6 18.5 0.2 0.3 3.6 0.1 0.1 0.2 0.0 5.2 0.1 0.0 0.0 0.0 0.0 28.2 0.0 0.0 0.0 0.1 0.0 7.1 0.0 0.1 0.0 0.0 18.2 0.0 0.6 0.1 0.0 0.2 0.0 0.4 5.3 0.0 0.0 0.3 0.0 7.2 1.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.1 0.1 23.7 0.0 3.3 15.3 0.0 0.0 0.0 1.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.1 1.2 0.2 0.0 0.1 0.2 0.2 0.0 0.3 0.2 0.1 0.1 3.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 6.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 18.7 14.8 15.7 0.0 24.1 0.0 34.7 0.0 0.0 0.0 0.0 26.2 43.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.8 0.0 0.0 47.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 321.3 0.0 0.0 0.0 NFE2L3 Nrf3 ENSG00000050344 "Nuclear factor, erythroid 2 like 3" Q9Y4A8 7 26152240-26187125 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 54.9" "Group enriched" "Detected in many" 14 "Cytotrophoblasts: 226.3;Syncytiotrophoblasts: 584.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 44.0;NTERA-2: 36.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA055889 Enhanced Approved Nucleoplasm,Vesicles "Intracellular and membrane" NA NA "Nucleoplasm, Vesicles" "HPA055889: AB_2682958" "unprognostic (4.99e-2)" "unprognostic (3.11e-1)" "unprognostic (4.36e-3)" "unprognostic (5.37e-2)" "unprognostic (8.41e-2)" "unprognostic (4.00e-3)" "unprognostic (7.29e-3)" "unprognostic (1.87e-1)" "unprognostic (2.12e-1)" "unprognostic (9.88e-2)" "prognostic unfavorable (6.62e-5)" "unprognostic (2.32e-1)" "prognostic unfavorable (7.58e-12)" "prognostic favorable (2.14e-4)" "unprognostic (2.40e-1)" "unprognostic (8.25e-2)" "unprognostic (4.13e-3)" 3.5 2.5 0.8 7.8 1.2 1.6 4.1 6.2 1.6 1.8 6.7 4.0 2.4 6.2 1.9 1.7 3.1 2.4 7.1 3.6 1.3 1.1 4.2 2.3 5.8 6.9 2.5 0.8 1.7 7.5 0.0 2.1 54.9 2.1 3.7 4.0 2.1 7.7 0.4 3.4 8.2 7.1 0.8 3.7 10.4 5.6 2.5 1.5 11.2 1.6 1.5 8.9 3.1 2.1 1.4 2.8 0.8 1.1 1.1 2.6 0.4 12.7 1.1 0.5 1.3 0.0 0.0 44.0 2.5 5.0 4.9 9.1 8.4 22.3 0.9 16.8 0.2 18.6 2.7 1.9 4.3 11.3 8.7 2.7 1.7 1.8 6.1 3.4 1.5 17.0 0.4 0.5 2.0 0.7 7.3 11.4 3.6 2.6 22.6 1.0 1.7 1.0 2.7 36.9 3.5 4.5 1.5 0.1 6.3 6.7 12.6 4.0 4.7 0.0 1.0 0.4 12.8 0.6 0.9 23.9 0.4 0.7 0.2 10.2 13.8 21.9 1.0 0.0 5.5 17.0 0.0 1.1 0.0 0.5 1.1 1.6 1.0 2.1 1.0 2.8 1.4 1.2 0.7 0.8 1.1 0.3 0.9 2.6 0.4 0.8 1.2 6.2 1.6 1.3 1.1 2.5 0.8 2.1 1.5 6.0 3.2 0.8 2.8 1.5 1.2 1.4 17.8 1.4 5.7 10.4 0.0 226.3 0.0 9.8 0.7 3.8 3.3 0.0 4.7 28.3 2.3 3.6 27.6 0.0 21.3 0.0 1.2 3.1 12.9 0.0 0.0 11.1 1.7 5.4 6.5 0.9 11.2 4.3 0.0 0.3 1.3 0.0 1.0 0.3 5.7 1.4 584.2 4.9 8.3 5.4 NFE4 NF-E4 ENSG00000230257 "Nuclear factor, erythroid 4" 7 102973437-102988856 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "blood: 20.8;placenta: 15.7" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 1.1;Cone photoreceptor cells: 2.0" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in some" 48 "eosinophil: 9.1;neutrophil: 20.8" "Lineage enriched" "Detected in single" 66 "granulocytes: 20.8" "Group enriched" "Detected in some" 4 "BEWO: 23.5;HUVEC TERT2: 28.9" NA NA "unprognostic (6.56e-2)" "unprognostic (1.36e-1)" "unprognostic (2.34e-1)" "unprognostic (3.40e-2)" "unprognostic (9.31e-3)" "unprognostic (7.47e-2)" "unprognostic (4.97e-2)" "unprognostic (2.19e-2)" "unprognostic (7.68e-2)" "unprognostic (5.51e-2)" "unprognostic (3.36e-9)" "unprognostic (1.31e-2)" "unprognostic (1.46e-1)" "unprognostic (5.84e-2)" "unprognostic (8.71e-3)" 0.2 1.9 0.2 0.4 0.2 2.6 0.2 0.2 2.2 0.2 0.2 0.2 0.2 0.3 0.2 2.2 0.5 0.0 0.4 0.6 0.2 0.2 0.2 1.2 0.6 0.2 0.2 1.1 0.6 0.0 0.2 15.7 0.2 0.2 0.0 0.2 0.2 0.2 0.2 1.7 0.2 0.2 0.2 2.5 0.1 1.5 0.2 0.2 1.5 2.9 0.2 0.2 0.2 0.1 0.1 20.8 0.1 0.0 0.3 0.0 0.2 0.2 0.8 0.2 0.0 0.0 23.5 0.2 0.0 0.0 0.0 1.1 0.6 0.6 0.3 0.0 0.2 0.3 0.0 0.0 0.1 0.1 1.5 5.7 4.2 0.1 0.3 2.1 0.3 0.2 0.0 0.8 0.0 0.6 28.9 0.7 2.6 0.4 0.6 0.3 1.0 1.8 0.3 0.2 0.3 0.9 0.5 0.2 0.0 0.5 0.9 0.3 0.3 0.4 0.0 3.4 0.5 0.6 0.3 1.0 2.9 1.5 0.2 0.8 5.9 0.3 1.8 6.1 0.6 0.0 0.1 9.1 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.2 20.8 0.0 0.1 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 NIPAL1 "DKFZp686A06115, NPAL1" ENSG00000163293 "NIPA like domain containing 1" Q6NVV3 4 47914142-48040173 "Predicted membrane proteins" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 30.8" "Cell type enhanced" "Detected in many" 5 "Collecting duct cells: 40.1;Paneth cells: 31.6;Urothelial cells: 36.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 11.0;CAPAN-2: 9.9;HaCaT: 13.1;HBEC3-KT: 9.4;RT4: 15.1" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA036765 Uncertain Approved "Golgi apparatus" NA NA "Golgi apparatus" "HPA036765: AB_10672366" "unprognostic (3.03e-1)" "unprognostic (4.55e-2)" "unprognostic (2.34e-3)" "unprognostic (2.18e-2)" "unprognostic (1.12e-2)" "unprognostic (3.57e-1)" "unprognostic (9.55e-2)" "unprognostic (4.16e-3)" "unprognostic (1.75e-1)" "unprognostic (1.12e-2)" "unprognostic (3.71e-3)" "unprognostic (1.34e-1)" "unprognostic (9.03e-7)" "unprognostic (2.55e-1)" "unprognostic (3.73e-1)" "unprognostic (1.92e-1)" "unprognostic (2.19e-1)" 0.5 0.4 0.4 5.4 1.4 0.0 2.2 0.8 0.7 3.6 9.1 0.1 0.0 3.3 0.4 6.3 18.5 1.1 1.8 0.6 0.7 0.7 4.6 10.7 0.5 0.0 0.4 0.2 0.8 6.6 2.9 5.5 30.8 0.7 3.0 8.9 1.2 5.3 0.6 0.7 17.1 12.6 1.0 0.6 0.4 4.3 0.8 0.3 0.2 2.0 9.8 11.2 4.2 5.3 1.0 1.4 1.4 0.8 0.6 0.9 0.0 11.0 0.2 0.0 0.0 0.0 0.0 1.8 2.1 2.0 1.6 2.8 6.6 9.9 0.0 1.5 0.0 2.9 13.1 1.9 9.4 4.1 0.1 2.4 0.0 0.1 0.4 0.0 0.1 0.1 0.1 3.5 0.1 2.3 2.7 0.5 0.7 0.1 0.0 2.3 4.2 0.1 0.1 1.7 7.6 2.9 0.0 0.0 0.0 5.6 15.1 1.0 0.3 1.0 3.7 1.6 0.9 2.4 0.0 4.2 0.1 3.9 0.0 0.2 0.1 0.1 0.0 0.2 0.0 4.2 0.9 0.8 0.5 0.8 0.4 0.6 0.4 0.5 0.3 0.1 1.0 0.7 0.9 1.4 0.6 0.5 1.4 0.3 0.0 0.4 1.4 0.8 0.7 0.7 0.7 0.4 0.2 0.7 0.3 8.9 6.7 0.0 22.7 12.8 0.1 2.6 0.0 2.7 14.8 40.1 0.0 1.6 0.0 8.8 0.5 0.3 27.6 0.0 5.8 1.0 1.3 24.9 0.0 10.4 0.3 0.0 11.1 0.6 0.0 0.0 0.0 0.2 1.7 1.0 27.4 0.5 10.3 31.6 0.0 1.0 3.8 0.0 2.1 1.0 1.5 28.9 3.0 0.7 29.9 36.3 NLRP10 "CLR11.1, NALP10, NOD8, PAN5, Pynod" ENSG00000182261 "NLR family pyrin domain containing 10" Q86W26 11 7959424-7965426 "Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "placenta: 13.2;skin 1: 10.5" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 18.0;BJ: 5.5;HBF TERT88: 7.8;LHCN-M2: 3.4" "Region enhanced" "Detected in some" "olfactory region: 2.6" "HPA039498, HPA040101" Uncertain Approved "Nucleoplasm,Nuclear membrane" NA NA Nucleoplasm "Nuclear membrane" "HPA039498: AB_10795679, HPA040101: AB_10795519" "unprognostic (4.06e-1)" "unprognostic (4.34e-1)" "unprognostic (9.78e-3)" "unprognostic (2.87e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 18.0 0.0 0.0 0.0 0.0 0.2 0.0 5.5 2.7 1.3 2.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 2.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NNAT Peg5 ENSG00000053438 Neuronatin Q16517 20 37521215-37523693 "Predicted membrane proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 7 "brain: 117.2;pituitary gland: 165.1;placenta: 69.1" "Group enriched" "Detected in many" 9 "Early spermatids: 30.8;Late spermatids: 51.7;Muller glia cells: 77.7" "Group enriched" "Detected in many" 16 "glioma: 87.5;testis cancer: 55.0;urothelial cancer: 37.4" "Region enhanced" "Detected in all" "basal ganglia: 117.2" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 22 "SH-SY5Y: 127.5" "Low region specificity" "Detected in all" NA NA "unprognostic (1.18e-2)" "unprognostic (7.41e-3)" "unprognostic (1.85e-2)" "unprognostic (1.04e-2)" "prognostic unfavorable (9.66e-4)" "unprognostic (7.08e-2)" "unprognostic (1.42e-1)" "unprognostic (2.36e-1)" "unprognostic (4.05e-2)" "unprognostic (7.52e-2)" "unprognostic (4.94e-2)" "unprognostic (1.64e-2)" "unprognostic (1.77e-1)" "unprognostic (5.91e-2)" "unprognostic (1.96e-1)" "unprognostic (1.15e-3)" "unprognostic (5.90e-2)" 17.0 11.6 35.4 2.6 117.2 2.3 3.5 4.9 68.4 2.3 7.0 11.1 0.0 3.4 4.6 2.5 2.6 2.8 4.2 1.7 35.0 21.4 1.4 1.1 1.7 1.9 4.9 14.0 1.3 1.6 1.0 165.1 69.1 7.9 2.4 3.9 1.5 3.4 1.5 8.0 3.8 3.2 4.4 2.1 1.8 2.1 2.9 3.8 0.2 1.5 0.0 1.1 3.3 0.6 0.7 0.7 0.3 0.3 0.0 1.0 0.0 0.3 0.2 2.2 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.3 0.1 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.3 0.6 0.1 0.1 0.5 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.3 0.0 0.1 0.9 0.1 0.1 0.0 0.2 0.0 0.6 0.0 0.0 3.2 0.3 127.5 0.1 0.7 0.0 0.1 0.2 0.0 0.1 0.9 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.7 0.1 1.0 0.3 0.0 0.0 0.7 0.0 0.0 35.4 117.2 4.9 41.0 35.0 21.4 4.9 14.0 7.9 3.8 0.0 0.0 0.0 0.7 3.5 3.7 0.0 0.0 1.4 1.2 0.0 0.0 0.5 0.0 0.0 30.8 0.0 0.0 0.0 0.0 0.4 1.0 2.2 1.1 0.0 1.4 0.0 0.0 0.0 0.0 51.7 0.6 0.0 1.7 0.0 0.0 77.7 0.0 0.0 1.1 0.0 6.0 0.0 0.4 1.1 3.8 0.9 0.2 0.0 0.0 2.3 NOG "SYM1, SYNS1" ENSG00000183691 Noggin Q13253 17 56593699-56595590 "Disease related genes, Predicted secreted proteins" "Chondrogenesis, Differentiation" "Developmental protein" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.8;placenta: 37.1;retina: 18.6" "Cell type enriched" "Detected in single" 11 "Extravillous trophoblasts: 8.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "naive CD4 T-cell: 32.8;naive CD8 T-cell: 15.1" "Lineage enriched" "Detected in single" 81 "T-cells: 32.8" "Cell line enhanced" "Detected in some" "EFO-21: 51.0;LHCN-M2: 15.5;NB-4: 11.3;PC-3: 15.4;U-2 OS: 15.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA061318 Approved "Secreted to blood" NA NA "HPA061318: AB_2684478" "unprognostic (1.49e-1)" "unprognostic (1.17e-2)" "unprognostic (1.49e-5)" "prognostic favorable (6.66e-4)" "unprognostic (4.69e-2)" "unprognostic (5.23e-3)" "unprognostic (1.26e-2)" "unprognostic (3.06e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (6.86e-5)" "unprognostic (2.88e-1)" "unprognostic (1.14e-6)" "unprognostic (8.39e-2)" "unprognostic (1.40e-1)" "unprognostic (5.00e-1)" "unprognostic (1.65e-1)" 0.9 0.3 4.9 2.0 7.2 0.7 0.5 0.9 8.3 5.5 0.6 1.8 0.4 0.5 0.8 6.3 0.4 0.4 0.3 0.4 3.8 3.1 0.8 0.4 1.0 3.3 1.9 2.7 0.3 0.5 0.3 0.8 37.1 1.1 1.4 0.4 18.6 0.4 2.9 3.6 0.4 0.7 0.5 0.8 1.5 0.8 1.6 1.8 1.7 0.3 0.0 1.1 0.9 3.1 0.0 0.1 0.4 0.1 0.2 32.8 1.7 2.4 0.0 0.1 0.0 0.1 0.0 0.0 1.3 1.4 0.5 0.5 0.1 0.4 0.0 51.0 0.6 2.0 0.2 0.8 0.1 1.4 0.0 0.9 0.0 1.9 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 15.5 0.0 0.4 11.3 1.0 0.0 15.4 6.7 4.7 0.0 1.2 0.0 0.1 0.0 2.6 0.0 0.0 4.3 0.0 0.2 0.3 0.9 15.8 0.1 1.1 0.0 0.0 0.1 0.0 1.2 0.0 0.3 0.0 0.1 0.2 0.1 0.1 0.0 1.9 0.2 0.0 0.0 32.8 15.1 0.4 0.2 0.1 0.1 1.3 1.7 4.9 7.2 0.9 2.5 3.8 3.1 1.9 2.7 1.1 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 8.9 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.7 0.0 0.0 0.0 NOTUM ENSG00000185269 "Notum, palmitoleoyl-protein carboxylesterase" Q6P988 17 81952507-81961840 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "placenta: 127.4" "Cell type enriched" "Detected in some" 47 "Extravillous trophoblasts: 865.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "Hep G2: 96.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA022851 Approved "Endoplasmic reticulum" "Secreted in female reproductive system" NA NA 59000 "Endoplasmic reticulum" "HPA022851: " "unprognostic (1.49e-1)" "unprognostic (1.55e-1)" "unprognostic (1.23e-2)" "unprognostic (4.80e-3)" "unprognostic (1.97e-1)" "unprognostic (9.02e-3)" "unprognostic (3.01e-2)" "unprognostic (1.01e-2)" "unprognostic (6.49e-2)" "unprognostic (8.72e-2)" "unprognostic (1.40e-1)" "unprognostic (2.01e-2)" "unprognostic (4.48e-6)" "unprognostic (1.76e-1)" "unprognostic (9.88e-2)" "unprognostic (1.22e-3)" "unprognostic (1.00e-1)" 0.2 0.1 1.1 0.2 1.2 0.1 0.2 0.3 1.0 0.2 0.2 0.2 0.5 0.6 1.0 1.3 0.3 0.2 0.3 0.3 0.5 0.9 0.8 10.4 1.8 0.2 0.7 0.4 0.2 0.2 0.0 0.2 127.4 0.6 0.4 0.0 0.2 0.3 0.2 4.9 2.4 0.2 0.2 0.3 0.3 0.9 3.0 0.5 0.2 0.2 0.3 0.2 1.3 1.3 0.7 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.4 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.2 0.5 0.6 96.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 0.0 0.0 0.1 0.0 0.0 0.0 15.6 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.3 0.9 0.4 1.4 0.5 0.0 1.1 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 1.2 0.3 1.0 0.5 0.9 0.7 0.4 0.6 0.5 0.0 3.0 0.0 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 865.2 2.3 0.0 0.0 0.9 17.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.8 0.0 18.4 0.0 0.0 0.0 NOX5 "NOX5A, NOX5B" ENSG00000255346 "NADPH oxidase 5" Q96PH1 15 68930525-69062743 "Predicted membrane proteins, Transporters" "Angiogenesis, Electron transport, Ion transport, Transport" "Ion channel, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "lymphoid tissue: 19.1;placenta: 11.1;testis: 43.7" "Group enriched" "Detected in some" 4 "Early spermatids: 14.7;Late spermatids: 9.0;Spermatocytes: 4.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 2.4;BJ hTERT+ SV40 Large T+ RasG12V: 2.5;EFO-21: 3.2" "Low region specificity" "Detected in many" NA NA "unprognostic (2.33e-1)" "unprognostic (1.63e-2)" "unprognostic (6.11e-2)" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (4.91e-3)" "unprognostic (6.80e-2)" "unprognostic (5.50e-3)" "unprognostic (3.48e-2)" "unprognostic (2.08e-1)" "unprognostic (1.41e-1)" "unprognostic (8.21e-2)" "unprognostic (4.58e-3)" "unprognostic (2.71e-3)" "unprognostic (4.81e-2)" "unprognostic (1.59e-1)" "unprognostic (1.54e-1)" 1.5 1.0 0.8 0.4 2.3 0.4 1.5 0.8 1.2 3.0 0.9 0.9 5.3 0.4 1.5 2.5 1.1 1.1 1.1 1.6 0.8 0.9 1.4 0.5 0.6 1.1 1.3 0.1 1.2 0.6 0.5 1.9 11.1 2.7 2.1 0.9 1.1 0.6 2.3 0.9 0.8 1.0 2.3 1.3 19.1 0.9 43.7 0.5 0.2 1.4 0.2 0.6 1.5 1.0 0.4 0.1 0.4 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 2.4 0.6 2.0 2.5 1.3 1.5 0.0 3.2 0.4 0.1 0.0 0.0 0.1 1.6 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.5 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.7 1.1 0.0 0.0 0.7 0.6 1.5 0.0 0.1 0.3 1.3 0.0 1.7 0.0 0.1 0.6 2.0 0.2 0.9 0.3 0.0 0.1 0.2 0.2 0.4 0.2 0.0 0.1 0.3 0.0 0.9 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.8 2.3 0.8 1.2 0.8 0.9 1.3 0.1 2.7 0.5 0.0 0.0 0.0 0.1 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 14.7 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 9.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.6 0.0 0.0 4.3 1.3 0.0 1.5 0.0 0.0 0.0 NPW PPL8 ENSG00000183971 "Neuropeptide W" Q8N729 16 2009926-2020755 "Predicted intracellular proteins, Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "liver: 49.0;placenta: 17.7" "Cell type enriched" "Detected in many" 5 "Intestinal endocrine cells: 152.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "NB-4: 17.1;PC-3: 9.5;RPMI-8226: 29.9;SCLC-21H: 52.0" "Low region specificity" "Detected in single" HPA064874 Approved "Secreted to blood" NA NA "HPA064874: AB_2685378" "unprognostic (7.54e-2)" "unprognostic (4.45e-3)" "unprognostic (3.20e-1)" "unprognostic (4.31e-3)" "unprognostic (8.85e-2)" "unprognostic (1.54e-1)" "unprognostic (1.56e-1)" "unprognostic (1.27e-1)" "unprognostic (3.06e-1)" "unprognostic (2.20e-2)" "unprognostic (6.26e-3)" "unprognostic (2.37e-1)" "unprognostic (1.81e-5)" "unprognostic (6.53e-3)" "unprognostic (1.26e-1)" "unprognostic (4.41e-1)" "unprognostic (3.43e-2)" 0.9 0.6 0.6 1.3 0.8 2.3 0.4 0.6 1.6 1.6 1.3 0.0 3.1 1.4 5.9 3.0 0.9 1.1 0.7 0.3 0.5 0.9 1.0 49.0 0.4 1.3 0.4 0.7 1.0 2.0 0.3 5.9 17.7 1.2 1.5 0.7 1.1 0.5 3.4 0.3 2.3 0.7 0.6 0.5 2.8 6.0 4.3 0.4 3.7 0.8 0.9 1.0 0.6 1.3 1.6 2.0 4.7 2.1 1.6 1.8 0.6 0.1 0.8 0.1 1.1 0.1 0.0 0.2 0.3 0.1 0.2 0.4 1.9 0.6 0.2 0.0 0.3 0.2 0.3 0.5 0.2 0.2 0.7 1.0 0.0 1.2 0.6 0.8 0.1 0.0 0.5 0.5 0.3 0.8 0.0 0.0 0.9 2.9 0.6 0.0 0.5 0.1 17.1 0.7 0.6 9.5 3.3 0.0 29.9 0.1 0.0 52.0 4.2 0.4 0.9 0.1 0.2 2.2 1.4 0.6 0.1 0.2 0.1 0.0 1.4 0.4 0.4 0.2 0.4 0.1 3.6 2.1 1.9 0.6 1.3 1.8 1.4 0.3 0.2 2.0 1.6 0.9 0.3 4.7 1.6 0.6 1.1 1.1 0.6 0.6 0.8 0.6 1.6 0.5 0.9 0.4 0.7 1.2 0.4 0.0 0.0 1.9 2.8 1.8 0.8 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.6 0.1 2.6 0.0 0.2 0.6 0.8 6.4 9.2 30.0 2.1 0.0 152.5 0.6 0.3 1.7 2.0 0.1 3.3 0.0 23.4 0.0 2.2 3.6 2.1 0.5 0.3 0.0 1.0 3.8 26.6 1.9 1.4 0.8 3.0 3.2 NRK DKFZp686A17109 ENSG00000123572 "Nik related kinase" Q7Z2Y5 X 105822543-105958610 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 42.2;placenta: 64.8" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 56.0;Leydig cells: 105.0;Syncytiotrophoblasts: 56.8" "Cancer enriched" "Detected in some" 8 "testis cancer: 6.1" "Region enriched" "Detected in single" 10 "cerebellum: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 30.7;HSkMC: 5.9;RH-30: 7.0;RPTEC TERT1: 18.9;SuSa: 23.1" "Region enriched" "Detected in single" 28 "cerebellum: 16.0" "Low region specificity" "Detected in many" HPA017238 Uncertain Approved Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA017238: AB_1854645" "unprognostic (2.64e-4)" "unprognostic (9.82e-2)" "unprognostic (5.98e-3)" "unprognostic (5.52e-2)" "unprognostic (3.87e-2)" "unprognostic (2.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-2)" "unprognostic (1.35e-2)" "unprognostic (6.08e-2)" "unprognostic (3.24e-2)" "unprognostic (5.28e-3)" "unprognostic (1.47e-3)" "unprognostic (1.14e-1)" "unprognostic (4.28e-2)" "unprognostic (6.80e-3)" 2.6 12.7 0.4 2.7 0.4 0.0 0.8 4.3 0.3 3.5 1.5 0.1 4.6 0.0 4.3 15.6 1.6 1.3 7.5 2.9 0.4 0.4 9.9 0.4 0.5 0.0 0.3 0.0 42.2 0.5 0.0 2.9 64.8 0.2 22.0 0.1 0.0 2.1 1.6 0.4 0.4 0.5 2.8 0.4 0.3 0.9 10.6 0.0 0.0 0.5 3.1 0.3 1.9 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 5.9 0.0 0.0 0.0 1.9 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 7.0 0.0 18.9 0.3 0.0 0.1 0.0 1.0 0.0 23.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 4.3 0.3 0.4 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 56.0 16.6 0.2 0.9 0.3 0.0 0.0 0.0 7.2 0.5 0.3 0.0 0.0 6.1 0.0 0.0 0.0 0.0 1.1 105.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.1 0.0 0.0 0.0 0.6 1.4 0.0 56.8 0.0 0.0 0.1 OC90 PLA2L ENSG00000253117 "Otoconin 90" Q02509 8 132024220-132059380 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.5;lymphoid tissue: 1.1;placenta: 1.3;retina: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 47 "SK-MEL-30: 4.7" "Secreted in other tissues" NA NA "unprognostic (1.92e-1)" "unprognostic (2.93e-1)" 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.4 0.2 0.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ODAPH "AI2A4, C4orf26, FLJ23657" ENSG00000174792 "Odontogenesis associated phosphoprotein" Q17RF5 4 75556048-75565885 "Disease related genes, Predicted secreted proteins" "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 10.4;placenta: 34.3" "Group enriched" "Detected in some" 8 "Extravillous trophoblasts: 6.2;Syncytiotrophoblasts: 22.5" "Cancer enhanced" "Detected in some" "head and neck cancer: 1.1" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 20 "basophil: 10.4" "Lineage enriched" "Detected in single" 24 "granulocytes: 10.4" "Cell line enriched" "Detected in some" 5 "HDLM-2: 31.1" "Secreted in other tissues" NA NA "unprognostic (1.13e-1)" "unprognostic (4.45e-3)" "unprognostic (3.78e-1)" "unprognostic (1.66e-1)" "unprognostic (6.12e-2)" "unprognostic (2.12e-2)" "unprognostic (1.75e-2)" "unprognostic (2.44e-1)" "unprognostic (3.87e-2)" "unprognostic (5.30e-2)" "unprognostic (3.43e-1)" "unprognostic (1.17e-7)" "unprognostic (8.31e-2)" "unprognostic (2.70e-2)" "unprognostic (8.40e-4)" "unprognostic (6.53e-3)" 0.3 0.1 1.5 0.4 1.9 0.6 0.2 1.2 0.9 0.3 0.2 0.2 0.2 0.1 0.3 0.4 0.4 0.1 0.3 0.2 1.9 1.5 0.3 0.4 0.3 0.5 2.4 0.2 0.4 0.2 0.0 1.3 34.3 0.7 0.2 0.5 0.2 0.2 0.3 1.6 0.9 0.3 0.2 2.7 0.4 0.3 0.8 0.4 0.2 0.2 0.2 0.7 0.2 0.2 0.4 0.1 10.4 0.2 0.2 0.3 0.1 0.6 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.2 31.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 1.4 0.0 1.3 0.1 0.1 0.0 0.0 1.4 0.1 0.4 5.6 0.0 0.1 0.3 0.2 0.0 10.4 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.5 0.2 0.1 0.1 0.1 0.1 1.5 1.9 1.2 0.9 1.9 1.5 2.4 0.2 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 6.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 OLAH "FLJ11106, SAST, THEDC1" ENSG00000152463 "Oleoyl-ACP hydrolase" Q9NV23 10 15032227-15073852 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "placenta: 61.3;testis: 24.0" "Cell type enriched" "Detected in some" 10 "Early spermatids: 347.4" "Group enriched" "Detected in some" 7 "testis cancer: 3.6;thyroid cancer: 0.8" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 4 "neutrophil: 6.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 6.6" "Cell line enhanced" "Detected in some" "HSkMC: 5.8;hTCEpi: 7.4;LHCN-M2: 5.6;SK-BR-3: 8.8;SuSa: 4.8;U-266/70: 4.9" "HPA037947, HPA037948" Enhanced NA NA "HPA037947: AB_10795028, HPA037948: AB_10805352" "unprognostic (2.01e-1)" "unprognostic (6.12e-2)" "unprognostic (8.20e-3)" "unprognostic (4.04e-3)" "unprognostic (1.92e-1)" "unprognostic (8.09e-2)" "unprognostic (7.12e-2)" "unprognostic (5.12e-2)" "unprognostic (4.55e-1)" "unprognostic (3.74e-2)" "unprognostic (4.70e-1)" "unprognostic (1.69e-1)" "unprognostic (5.22e-10)" "unprognostic (4.55e-2)" "unprognostic (2.09e-1)" "unprognostic (5.11e-2)" "unprognostic (9.78e-2)" 1.0 1.1 0.2 0.2 0.7 1.2 5.2 0.3 0.7 0.8 0.5 0.3 0.1 0.0 0.2 0.4 2.7 1.4 1.1 0.8 0.2 0.2 0.8 0.4 1.9 4.3 0.9 0.1 0.2 0.1 0.1 1.5 61.3 0.4 0.1 0.0 0.3 3.0 0.1 0.5 0.4 0.3 0.1 0.5 8.0 0.2 24.0 0.3 0.2 1.2 0.1 0.3 0.3 1.1 0.5 1.1 6.6 0.4 1.0 0.6 0.1 0.2 0.6 0.7 0.5 0.3 1.1 2.2 0.4 0.4 0.2 0.1 0.4 0.0 0.2 0.0 0.0 0.6 0.2 0.0 0.2 0.7 0.4 0.2 0.3 0.4 0.0 0.9 0.0 0.6 5.8 7.4 0.9 0.1 0.1 0.7 0.2 0.5 0.3 5.6 0.0 0.5 0.7 0.7 0.2 0.4 0.7 1.3 1.8 0.0 0.0 0.0 0.4 0.3 8.8 0.1 4.8 0.2 0.5 1.0 0.1 2.9 1.3 0.1 4.9 1.6 0.4 2.7 0.5 0.0 1.4 0.4 0.4 0.4 0.2 0.3 0.2 0.6 0.2 0.2 0.5 0.3 0.3 6.6 1.0 0.2 1.1 0.4 0.1 0.2 0.7 0.3 0.3 0.2 0.2 0.9 0.1 0.4 0.3 3.0 1.1 0.0 0.2 0.2 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.9 347.4 0.0 0.0 0.0 0.0 1.4 0.5 0.3 0.0 0.0 0.1 0.0 0.0 0.0 2.2 35.4 4.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 7.8 0.0 0.7 6.5 0.4 1.7 1.7 0.3 9.5 0.5 0.0 0.1 OLIG3 "Bhlhb7, bHLHe20" ENSG00000177468 "Oligodendrocyte transcription factor 3" Q7RTU3 6 137492202-137494250 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.7;esophagus: 1.4;placenta: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "pons and medulla: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 2.9;NTERA-2: 4.8;SuSa: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA018303, CAB024865" Uncertain NA NA "CAB024865: , HPA018303: AB_1854796" "unprognostic (1.07e-3)" "unprognostic (1.44e-1)" "unprognostic (2.77e-1)" "unprognostic (2.03e-1)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 1.8 3.7 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OLR1 "CLEC8A, LOX-1, SCARE1" ENSG00000173391 "Oxidized low density lipoprotein receptor 1" P78380 12 10158301-10172138 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity, Inflammatory response" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.5;lung: 46.8;placenta: 53.4" "Group enriched" "Detected in many" 7 "Cytotrophoblasts: 386.0;Hofbauer cells: 209.3;Macrophages: 102.1;Syncytiotrophoblasts: 387.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.9" "Group enriched" "Detected in many" 6 "dendritic cells: 5.9;granulocytes: 3.3;monocytes: 1.5" "Cell line enhanced" "Detected in some" "CACO-2: 32.7;HaCaT: 17.2;HHSteC: 34.6;hTCEpi: 15.9;SiHa: 65.9;SK-BR-3: 26.2" "Low region specificity" "Detected in all" HPA050798 Approved "Nucleoplasm,Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 1060000 "Nucleoplasm, Plasma membrane" Vesicles "HPA050798: AB_2756318" "unprognostic (2.30e-1)" "unprognostic (3.16e-2)" "unprognostic (1.58e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "prognostic unfavorable (8.24e-5)" "unprognostic (6.34e-2)" "unprognostic (6.07e-3)" "unprognostic (5.40e-2)" "unprognostic (2.64e-1)" "unprognostic (1.97e-2)" "unprognostic (3.51e-1)" "unprognostic (1.08e-1)" "unprognostic (4.94e-3)" "unprognostic (3.47e-2)" "unprognostic (1.48e-2)" "unprognostic (1.42e-1)" 2.0 1.9 6.0 14.1 10.3 10.6 2.0 1.3 10.2 1.9 0.5 21.3 0.0 0.8 1.0 0.9 0.5 1.2 3.9 1.1 8.5 6.7 6.9 1.8 46.8 0.5 16.4 4.4 0.4 1.6 2.8 1.9 53.4 12.3 1.4 0.7 0.2 2.0 0.7 0.4 0.5 0.8 1.2 28.5 0.6 1.4 2.8 10.5 0.0 1.5 0.0 0.6 4.3 0.4 0.5 5.9 3.3 1.5 0.3 0.3 1.1 1.8 0.1 0.0 0.1 0.0 0.0 4.5 3.1 0.5 2.0 0.7 32.7 0.0 0.4 0.0 4.2 0.1 17.2 0.0 0.1 1.3 0.0 0.0 0.0 1.6 0.0 34.6 0.0 0.0 0.2 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.1 0.0 65.9 26.2 0.0 4.9 7.3 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.0 1.5 2.7 0.2 0.2 0.3 0.3 0.3 0.2 5.9 0.5 0.3 0.3 3.3 0.3 0.4 0.8 0.2 1.1 6.0 10.3 1.3 7.4 8.5 6.7 16.4 4.4 12.3 10.5 26.8 30.9 0.0 0.2 1.3 0.4 0.0 2.5 12.0 7.9 0.0 0.0 386.0 0.0 0.0 9.4 1.2 0.0 0.0 0.0 8.5 1.3 0.0 14.0 0.8 209.3 0.0 0.0 0.0 21.9 7.6 0.3 102.1 0.0 36.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 387.3 0.0 0.0 0.0 OR10J3 OR10J3P ENSG00000196266 "Olfactory receptor family 10 subfamily J member 3" Q5JRS4 1 159313670-159314659 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in single" "placenta: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "LHCN-M2: 5.6" HPA042963 Uncertain NA NA "HPA042963: AB_10961176" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR10Q1 ENSG00000180475 "Olfactory receptor family 10 subfamily Q member 1" Q8NGQ4 11 58227882-58228918 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "pancreas: 1.3;placenta: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HHSteC: 1.2" "Not detected" "Not detected" HPA046968 Uncertain NA NA "HPA046968: AB_2679881" "unprognostic (4.82e-1)" "unprognostic (6.34e-2)" "unprognostic (4.37e-1)" 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 1.3 0.0 0.0 1.4 0.0 0.3 0.6 0.0 0.7 0.2 0.5 0.4 0.0 0.1 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR1E1 "HGM071, OR13-66, OR17-2, OR17-32, OR1E5, OR1E6, OR1E9P" ENSG00000180016 "Olfactory receptor family 1 subfamily E member 1" P30953 17 3397104-3398410 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 1.7;placenta: 1.5;testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.7" "Not detected" "Not detected" NA NA "unprognostic (1.12e-1)" "unprognostic (1.33e-1)" 0.4 0.1 0.2 0.0 0.4 0.0 0.6 0.0 0.1 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.0 0.3 0.3 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.9 0.0 1.4 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR51E1 "GPR136, GPR164, OR51E1P, OR52A3P" ENSG00000180785 "Olfactory receptor family 51 subfamily E member 1" Q8TCB6 11 4643420-4655488 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "placenta: 10.0;prostate: 12.1" "Group enriched" "Detected in some" 6 "Intestinal endocrine cells: 20.4;Sertoli cells: 25.8" "Cancer enriched" "Detected in many" 21 "prostate cancer: 34.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 114 "SCLC-21H: 14.4" "Low region specificity" "Detected in many" "CAB019995, HPA051439" Approved NA NA "CAB019995: AB_10283600, HPA051439: AB_2681487" "unprognostic (6.67e-3)" "unprognostic (2.34e-3)" "unprognostic (9.71e-2)" "unprognostic (4.87e-5)" "unprognostic (3.55e-2)" "unprognostic (9.80e-3)" "unprognostic (1.76e-1)" "unprognostic (2.30e-3)" "unprognostic (2.00e-2)" "unprognostic (3.94e-3)" "unprognostic (7.36e-2)" "unprognostic (6.15e-2)" "prognostic unfavorable (1.23e-6)" "unprognostic (2.72e-3)" "unprognostic (1.12e-1)" "unprognostic (1.61e-1)" "unprognostic (2.86e-1)" 7.6 0.0 0.6 1.9 0.8 0.0 5.1 0.1 0.6 0.9 2.6 0.1 0.1 0.4 2.5 0.3 0.8 0.8 0.7 4.8 0.1 0.2 1.6 0.1 0.1 1.9 0.6 0.1 1.0 0.1 0.2 1.0 10.0 0.6 12.1 1.1 0.8 4.4 0.8 2.4 0.3 2.1 1.3 1.8 0.1 0.9 0.3 0.1 0.1 0.9 0.9 0.4 1.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.1 0.6 0.1 0.2 0.6 0.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 2.3 0.0 0.0 0.1 0.0 20.4 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 25.8 3.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 OR5H14 ENSG00000236032 "Olfactory receptor family 5 subfamily H member 14" A6NHG9 3 98147479-98156614 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 2.1;placenta: 2.1" "Group enriched" "Detected in some" 17 "Collecting duct cells: 1.8;Early spermatids: 1.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.1" "Low cell line specificity" "Detected in some" NA NA 0.1 0.1 0.1 0.0 0.1 1.5 0.1 0.1 0.2 0.4 0.1 0.0 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.7 0.1 0.2 0.1 0.2 0.1 0.0 0.1 2.1 0.1 0.0 0.3 0.0 0.1 0.9 0.1 0.0 0.1 0.1 0.1 1.5 0.1 0.0 0.2 0.1 0.4 0.4 2.1 0.4 0.4 0.4 0.0 0.6 0.6 0.6 0.6 0.3 0.1 0.5 0.8 0.5 0.1 0.0 0.9 0.5 0.3 0.4 0.0 0.6 0.9 0.1 0.3 0.0 0.5 0.6 0.6 1.0 0.7 0.2 0.4 0.5 0.1 0.7 0.2 0.0 0.5 0.0 1.1 0.3 1.4 0.0 1.0 0.3 0.7 0.7 0.3 1.1 0.7 0.2 0.4 0.1 1.0 0.3 0.5 0.4 0.4 0.5 1.1 0.6 0.3 0.1 0.6 1.1 0.9 0.4 0.8 0.8 0.7 0.5 0.3 0.5 2.1 0.4 0.4 0.4 0.2 0.3 0.2 0.3 0.2 0.1 0.4 0.3 0.3 1.4 0.4 0.2 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 P2RY1 "P2Y1, SARCC" ENSG00000169860 "Purinergic receptor P2Y1" P47900 3 152834693-152841439 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Blood coagulation, Hemostasis" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1;placenta: 24.7" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 22.9;Kupffer cells: 17.8;Muller glia cells: 16.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 29.1" "Group enriched" "Detected in some" 5 "basophil: 7.0;non-classical monocyte: 4.1" "Group enriched" "Detected in many" 6 "granulocytes: 7.0;monocytes: 4.1" "Cell line enriched" "Detected in some" 5 "HEL: 30.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA015577 Enhanced NA NA "HPA015577: AB_1854882" "unprognostic (3.30e-1)" "unprognostic (4.52e-2)" "unprognostic (2.68e-2)" "unprognostic (4.76e-2)" "unprognostic (9.70e-2)" "unprognostic (1.40e-3)" "unprognostic (3.32e-2)" "unprognostic (2.53e-1)" "unprognostic (5.14e-1)" "unprognostic (2.58e-1)" "unprognostic (4.68e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (2.04e-7)" "unprognostic (1.36e-1)" "unprognostic (8.98e-2)" "unprognostic (7.33e-2)" "unprognostic (3.20e-2)" 2.9 1.7 4.7 5.9 29.1 4.8 2.0 3.1 6.3 6.7 8.7 4.9 0.6 3.3 8.5 0.8 19.4 2.3 2.2 2.9 8.4 2.3 1.1 1.6 10.4 2.1 1.8 6.1 9.6 3.6 0.5 2.3 24.7 2.4 8.0 6.9 2.6 5.6 2.6 7.1 8.8 6.1 4.8 3.8 2.4 1.7 1.3 3.3 3.0 1.5 9.9 3.5 3.0 9.5 0.0 0.9 7.0 4.1 0.0 0.0 0.2 0.0 0.5 4.8 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.4 6.0 0.0 0.0 0.5 0.0 0.7 1.0 2.6 0.8 0.2 0.0 2.3 30.3 0.0 0.0 0.0 3.5 2.8 0.4 6.0 0.0 0.3 2.4 0.0 1.0 0.9 0.0 0.0 0.0 0.5 0.1 4.4 0.0 3.7 0.0 0.1 0.8 0.0 2.0 0.8 0.0 0.0 0.0 0.6 1.1 0.0 1.6 0.0 0.5 1.2 0.0 2.5 0.0 0.0 0.0 3.1 0.0 3.5 7.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 4.1 0.9 0.0 0.2 4.7 29.1 3.1 6.3 8.4 2.3 1.8 6.1 2.4 3.3 0.0 0.3 0.8 6.8 1.6 8.2 6.3 22.9 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.1 0.6 10.5 0.0 0.0 0.2 2.7 6.6 9.3 0.2 6.2 0.0 0.0 12.9 17.8 0.0 13.8 6.3 0.0 0.0 8.4 16.6 1.1 10.5 5.6 0.0 1.0 0.0 0.5 0.5 0.4 1.8 0.1 0.0 6.6 4.2 P2RY6 P2Y6 ENSG00000171631 "Pyrimidinergic receptor P2Y6" Q15077 11 73264505-73298617 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 36.4;lymphoid tissue: 31.1;placenta: 38.0" "Group enriched" "Detected in many" 8 "Cytotrophoblasts: 107.7;Syncytiotrophoblasts: 227.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "myeloid DC: 10.9;plasmacytoid DC: 36.4" "Lineage enriched" "Detected in many" 20 "dendritic cells: 36.4" "Cell line enhanced" "Detected in some" "AN3-CA: 33.7;EFO-21: 10.6;MCF7: 15.7;SK-BR-3: 27.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074751 Enhanced NA NA "HPA074751: " "unprognostic (2.55e-2)" "unprognostic (1.12e-1)" "unprognostic (2.04e-2)" "unprognostic (5.54e-3)" "unprognostic (4.18e-3)" "unprognostic (1.94e-2)" "unprognostic (3.93e-3)" "unprognostic (4.00e-3)" "unprognostic (1.86e-4)" "unprognostic (3.08e-1)" "unprognostic (1.25e-2)" "unprognostic (2.18e-1)" "prognostic unfavorable (2.50e-7)" "unprognostic (1.48e-2)" "unprognostic (1.38e-3)" "unprognostic (7.67e-2)" "unprognostic (1.05e-1)" 2.5 1.8 2.7 8.3 3.5 0.8 1.5 0.5 3.2 2.5 2.1 3.1 0.0 3.0 1.2 2.6 2.9 1.6 2.4 2.7 1.8 1.0 6.2 3.7 3.0 4.8 2.3 1.7 2.1 1.7 0.5 2.7 38.0 2.8 2.1 2.2 5.9 2.0 0.9 2.9 0.9 4.9 3.4 3.8 31.1 1.9 0.8 3.5 3.3 5.0 1.8 3.1 4.1 1.6 0.0 36.4 0.1 1.8 1.5 0.1 1.0 0.7 8.0 0.0 33.7 0.0 0.0 6.9 0.1 0.0 0.1 0.1 7.2 0.1 0.0 10.6 0.3 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.7 3.8 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.2 0.1 15.7 0.1 1.3 0.1 0.1 0.0 0.0 0.0 1.0 5.5 0.0 0.1 0.5 1.4 27.2 0.0 0.6 6.4 1.5 0.1 1.3 0.1 1.1 0.1 0.3 0.0 0.0 1.3 2.2 0.0 0.0 1.1 0.0 0.0 1.8 0.1 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.1 1.5 0.6 36.4 0.0 1.0 2.7 3.5 0.5 3.2 1.8 1.0 2.3 1.7 2.8 3.5 0.0 1.1 1.5 0.3 0.1 0.0 0.8 0.0 1.4 0.0 8.7 0.0 107.7 3.3 2.4 0.4 2.2 0.0 0.0 13.1 7.5 0.2 0.2 0.0 0.0 17.0 0.0 0.0 1.8 3.9 1.7 0.0 9.7 0.0 21.6 0.0 0.6 9.6 0.0 0.0 7.0 0.0 0.0 0.8 0.0 0.0 0.4 227.8 0.0 0.0 0.1 PAEP "GD, GdA, GdF, GdS, MGC138509, MGC142288, PAEG, PEP, PP14" ENSG00000122133 "Progestagen associated endometrial protein" P09466 9 135561756-135566955 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "ductus deferens: 176.9;endometrium 1: 79.9;placenta: 105.3" "Group enriched" "Detected in some" 20 "Club cells: 7.9;Ductal cells: 4.2" "Cancer enriched" "Detected in many" 8 "melanoma: 275.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 5.8" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.8" "Cell line enriched" "Detected in some" 7 "SK-MEL-30: 22.0" "CAB016762, HPA020108, HPA029473" Enhanced "Secreted in female reproductive system" NA NA "CAB016762: , HPA020108: AB_1855595, HPA029473: AB_10610147" "unprognostic (3.39e-2)" "unprognostic (8.47e-3)" "unprognostic (6.84e-2)" "unprognostic (3.46e-2)" "unprognostic (3.20e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (6.61e-6)" "unprognostic (1.27e-2)" "unprognostic (1.72e-1)" "unprognostic (3.95e-3)" "unprognostic (1.93e-3)" "prognostic unfavorable (0.00e+0)" "prognostic unfavorable (5.46e-4)" "unprognostic (4.24e-1)" "unprognostic (4.98e-2)" 0.3 0.1 0.1 0.2 0.1 0.4 0.3 0.1 0.2 1.3 0.1 0.0 176.9 0.2 79.9 0.1 0.1 5.0 0.0 0.1 0.1 0.3 0.1 0.3 0.4 0.0 0.1 0.0 0.8 0.1 0.0 0.2 105.3 0.0 1.1 0.0 0.0 0.2 13.9 0.1 1.1 0.1 0.0 0.1 0.2 2.0 0.5 0.0 0.0 0.1 0.0 0.0 0.8 0.1 1.3 1.3 5.8 0.9 0.8 0.8 0.3 0.1 0.5 0.0 0.1 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.7 0.5 0.4 0.0 0.9 0.9 0.0 0.0 0.0 0.4 0.0 0.0 0.5 1.6 2.3 0.0 0.5 0.0 0.1 0.0 0.0 0.2 0.1 0.2 3.1 0.5 0.0 0.3 0.0 0.7 0.5 0.0 0.0 0.2 0.2 0.4 0.0 0.2 0.5 0.2 0.1 0.2 22.0 0.7 0.4 0.2 0.0 0.1 1.1 0.3 0.1 1.0 2.1 0.2 0.3 0.4 0.5 5.8 0.9 0.6 0.6 0.5 0.5 0.6 0.8 0.6 0.3 1.3 0.7 0.8 4.0 0.8 0.8 1.3 0.3 0.3 0.1 0.1 0.1 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 7.9 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PAGE4 "CT16.7, GAGEC1, PAGE-4" ENSG00000101951 "PAGE family member 4" O60829 X 49829260-49833973 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "epididymis: 129.2;placenta: 199.4;prostate: 58.4" "Group enriched" "Detected in some" 10 "Cytotrophoblasts: 11201.2;Syncytiotrophoblasts: 7128.6" "Group enriched" "Detected in some" 17 "liver cancer: 14.8;prostate cancer: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 7.0;U-266/70: 8.6;U-266/84: 31.4" "Not detected" "Not detected" HPA023880 Enhanced Approved "Golgi apparatus,Vesicles" NA NA Vesicles "Golgi apparatus" "HPA023880: AB_1854930" "unprognostic (8.56e-2)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (4.82e-3)" "unprognostic (5.37e-2)" 0.2 0.7 0.5 0.1 0.1 0.0 0.1 0.2 0.2 0.6 0.1 0.2 5.7 0.0 6.6 129.2 0.1 6.8 0.1 0.1 0.4 0.5 0.8 0.1 0.2 0.1 0.1 0.2 0.9 0.1 0.0 0.6 199.4 0.2 58.4 0.0 0.1 0.1 9.8 0.8 0.1 0.1 2.4 0.2 0.1 0.1 2.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 7.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.1 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.6 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.2 0.2 0.4 0.5 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 11201.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 341.9 0.2 0.3 0.0 0.0 908.5 0.0 0.0 0.0 0.0 6.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.4 2.3 0.0 7128.6 0.0 0.0 0.0 PAPPA "ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1" ENSG00000182752 "Pappalysin 1" Q13219 9 116153804-116402322 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 86 "placenta: 484.6" "Group enriched" "Detected in many" 6 "Collecting duct cells: 157.1;Proximal tubular cells: 39.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 19.3;ASC TERT1: 14.8;HSkMC: 53.2;U-138 MG: 13.9" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "midbrain: 10.4;olfactory region: 4.1;pons and medulla: 8.3;thalamus: 4.8" "HPA001667, CAB016724" Enhanced "Secreted in female reproductive system" NA NA 41000 "CAB016724: , HPA001667: AB_1854960" "unprognostic (3.25e-1)" "unprognostic (6.18e-6)" "unprognostic (2.47e-1)" "unprognostic (6.49e-2)" "unprognostic (2.01e-2)" "unprognostic (1.14e-1)" "unprognostic (1.13e-1)" "unprognostic (5.42e-3)" "unprognostic (5.44e-2)" "unprognostic (3.87e-2)" "unprognostic (6.87e-3)" "unprognostic (8.25e-2)" "unprognostic (8.00e-3)" "unprognostic (2.37e-3)" "unprognostic (2.48e-1)" "unprognostic (4.01e-1)" "unprognostic (1.02e-3)" 4.8 2.3 0.5 1.0 0.5 0.0 0.8 0.4 0.6 3.6 2.4 0.6 1.0 0.1 3.5 1.0 3.6 2.0 1.1 3.7 0.4 0.0 4.3 0.5 2.4 0.7 0.4 0.4 1.4 0.7 5.6 0.7 484.6 0.7 1.4 0.9 0.9 0.5 1.2 0.5 1.1 0.9 2.4 0.6 0.6 1.0 0.8 0.5 0.4 1.3 1.0 1.0 2.3 3.4 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 5.5 8.4 0.0 19.3 14.8 0.0 4.5 8.0 1.2 2.1 0.0 0.0 0.0 0.0 3.1 0.4 0.6 0.0 0.0 6.0 0.0 0.0 0.9 4.6 0.0 9.4 0.0 0.0 53.2 0.0 6.2 0.7 10.3 0.0 0.0 0.2 0.0 1.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.6 0.0 0.0 2.7 0.0 0.0 10.7 13.9 0.7 0.4 0.5 0.0 0.0 0.0 9.9 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.4 0.6 0.4 0.0 0.4 0.4 0.7 0.5 0.0 1.0 0.0 0.2 2.6 5.0 2.2 0.0 0.0 2.3 157.1 11.8 0.3 8.3 5.8 14.3 0.7 0.0 0.0 0.8 7.4 16.4 0.6 1.1 0.0 0.4 0.0 0.0 5.5 0.0 12.7 13.3 0.3 1.7 0.0 0.0 2.3 0.5 0.0 8.1 39.6 2.7 0.0 8.2 1.7 0.4 1.0 11.7 0.0 0.0 0.1 PAPPA2 "PAPP-A2, PAPPE, PLAC3" ENSG00000116183 "Pappalysin 2" Q9BXP8 1 176463171-176845605 "Enzymes, Predicted membrane proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 35 "placenta: 406.4" "Group enriched" "Detected in many" 7 "Intestinal endocrine cells: 135.4;Muller glia cells: 47.6;Syncytiotrophoblasts: 61.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-87 MG: 21.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018412, HPA018430" Enhanced Approved "Endoplasmic reticulum,Vesicles" "Secreted in female reproductive system" NA NA "Endoplasmic reticulum, Vesicles" "HPA018412: AB_1854962, HPA018430: AB_1854961" "unprognostic (2.90e-1)" "unprognostic (1.58e-1)" "unprognostic (1.07e-1)" "unprognostic (3.61e-2)" "unprognostic (9.04e-2)" "unprognostic (1.60e-3)" "unprognostic (1.36e-1)" "unprognostic (2.45e-1)" "unprognostic (1.00e-2)" "unprognostic (3.54e-2)" "unprognostic (1.29e-2)" "unprognostic (4.39e-2)" "unprognostic (2.85e-2)" "unprognostic (1.52e-4)" "unprognostic (1.85e-1)" "unprognostic (8.18e-4)" "unprognostic (4.35e-2)" 0.6 0.0 0.6 0.2 0.2 0.0 3.0 0.8 0.3 5.0 0.6 0.2 0.2 0.0 0.3 0.2 0.2 0.2 1.1 0.2 0.2 0.1 11.6 0.7 0.2 0.2 0.2 0.2 0.2 1.5 0.0 1.2 406.4 0.3 0.2 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.3 0.5 0.2 1.0 0.3 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.3 4.6 2.2 3.8 0.9 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.8 0.5 0.5 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.3 1.7 1.4 0.1 0.6 0.3 0.4 0.0 21.2 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.8 0.3 0.2 0.1 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.6 0.0 0.0 0.0 5.2 0.0 0.8 10.0 0.0 1.9 0.0 0.0 0.0 0.2 11.6 0.6 0.0 0.0 0.2 1.2 0.0 135.4 0.0 0.0 1.3 10.6 0.0 0.0 0.0 0.2 47.6 1.2 0.0 10.3 0.3 1.1 6.5 0.5 1.2 1.9 0.0 61.9 0.0 0.0 0.0 PCDH10 "KIAA1400, OL-PCDH" ENSG00000138650 "Protocadherin 10" Q9P2E7 4 133149315-133208606 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 48.0;placenta: 31.1;seminal vesicle: 23.6" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 16.2;Muller glia cells: 8.7;Smooth muscle cells: 4.7" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-RPE1: 6.9;HUVEC TERT2: 16.1;MOLT-4: 13.4;TIME: 32.0;U-138 MG: 8.6;U-251 MG: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011220, HPA073462" Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" No NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA011220: AB_1855041, HPA073462: AB_2686605" "unprognostic (7.20e-2)" "unprognostic (8.74e-3)" "unprognostic (4.30e-2)" "unprognostic (8.12e-5)" "unprognostic (8.33e-2)" "unprognostic (3.20e-1)" "unprognostic (5.27e-3)" "unprognostic (4.51e-1)" "unprognostic (3.83e-2)" "unprognostic (1.15e-1)" "unprognostic (9.30e-3)" "unprognostic (8.72e-2)" "unprognostic (1.45e-1)" "unprognostic (8.68e-4)" "unprognostic (8.88e-2)" "unprognostic (6.31e-2)" "unprognostic (2.16e-4)" 1.9 7.6 17.9 1.5 35.5 1.2 1.3 1.7 48.0 3.3 1.5 23.2 4.5 1.3 3.1 1.9 1.6 2.6 1.9 1.8 17.5 12.6 3.7 1.3 2.0 1.2 13.2 16.3 4.1 1.4 1.2 1.7 31.1 13.6 14.7 1.5 1.3 1.8 23.6 1.2 1.3 1.7 2.0 6.8 1.2 1.3 2.9 19.2 0.9 1.5 0.0 1.2 3.6 3.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 5.2 0.0 0.1 0.0 0.0 5.0 2.7 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.5 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 6.9 16.1 0.0 0.2 0.0 2.4 0.0 13.4 0.0 0.0 0.0 0.1 0.3 0.2 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 32.0 8.6 0.0 0.0 7.3 0.0 0.0 0.0 0.6 0.0 4.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.9 35.5 1.7 27.7 17.5 12.6 13.2 16.3 13.6 19.2 0.0 1.1 0.0 0.2 0.1 16.2 2.0 0.0 0.0 1.2 0.0 0.0 0.7 1.7 0.0 3.3 1.0 0.0 0.0 0.0 0.7 1.6 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.4 0.0 2.3 0.0 4.7 1.8 0.7 0.3 2.4 0.0 0.0 0.4 PCDH12 VE-cadherin-2 ENSG00000113555 "Protocadherin 12" Q9NPG4 5 141943585-141969741 "Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Disease mutation, Epilepsy, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 17.9" "Group enriched" "Detected in some" 5 "Endothelial cells: 24.8;Hofbauer cells: 25.9;Ito cells: 56.4" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "non-classical monocyte: 7.0" "Lineage enriched" "Detected in single" 35 "monocytes: 7.0" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 14.2;Karpas-707: 35.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA051242 Uncertain "Secreted to blood" NA NA 720000 "HPA051242: AB_2681402" "unprognostic (6.62e-2)" "unprognostic (6.94e-2)" "unprognostic (4.74e-3)" "unprognostic (4.12e-2)" "unprognostic (3.99e-1)" "unprognostic (3.25e-1)" "unprognostic (4.35e-1)" "unprognostic (1.88e-2)" "unprognostic (4.29e-2)" "unprognostic (2.76e-1)" "unprognostic (9.99e-2)" "unprognostic (3.87e-1)" "prognostic unfavorable (2.56e-4)" "unprognostic (1.11e-2)" "unprognostic (5.21e-2)" "unprognostic (9.37e-2)" "unprognostic (9.33e-2)" 7.9 2.9 0.5 0.7 0.6 0.0 3.1 2.2 0.6 1.3 0.8 0.7 1.3 0.0 0.7 1.2 1.8 4.6 0.5 0.4 3.7 2.1 9.0 0.7 0.4 0.9 0.6 1.4 2.5 17.9 1.1 0.4 0.6 1.0 1.6 0.5 1.0 2.6 0.3 11.3 1.0 0.1 4.8 0.1 2.1 1.1 0.1 0.2 0.0 7.0 0.0 0.1 0.2 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.3 0.8 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.2 14.2 0.1 0.0 35.1 0.0 0.0 0.0 0.2 0.3 0.0 0.1 0.3 0.1 1.5 0.0 0.1 0.2 0.3 0.0 0.0 0.2 0.1 0.0 0.9 0.9 0.2 0.0 0.5 0.0 0.2 0.1 0.0 0.2 5.7 1.2 0.0 0.4 0.0 0.0 1.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.1 0.2 0.0 1.4 0.0 0.0 0.6 1.0 4.4 0.0 0.0 0.0 0.0 2.0 0.2 3.3 0.0 1.4 24.8 0.0 0.0 0.0 0.2 0.2 0.0 1.1 0.0 25.9 0.0 0.0 56.4 7.5 0.8 0.0 0.1 1.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.3 0.5 0.0 0.0 0.1 PDPN "aggrus, Gp38, GP40, PA2.26, T1A-2" ENSG00000162493 Podoplanin Q86YL7 1 13583465-13617957 "Predicted membrane proteins" "Cell shape" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 71.8" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 1: 98.3;Fibroblasts: 108.5;monocytes: 202.8;Muller glia cells: 85.7;Peritubular cells: 59.1" "Cancer enhanced" "Detected in many" "testis cancer: 102.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.1" "Cell line enhanced" "Detected in some" "AF22: 30.3;EFO-21: 72.6;HAP1: 50.4;HHSteC: 44.7;NTERA-2: 23.3;SuSa: 25.2;TIME: 48.3" "HPA007534, HPA007949, CAB008376" Enhanced Supported "Plasma membrane,Cell Junctions,Mitochondria" NA NA "Plasma membrane" "Cell Junctions, Mitochondria" "CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: " "unprognostic (1.75e-1)" "unprognostic (3.19e-2)" "unprognostic (6.03e-2)" "unprognostic (3.61e-2)" "unprognostic (2.73e-2)" "unprognostic (1.05e-2)" "unprognostic (3.85e-2)" "unprognostic (5.23e-2)" "unprognostic (9.21e-2)" "unprognostic (1.29e-1)" "unprognostic (1.13e-2)" "unprognostic (1.92e-2)" "unprognostic (5.62e-3)" "unprognostic (9.20e-3)" "unprognostic (1.21e-1)" "unprognostic (3.29e-2)" "unprognostic (2.78e-2)" 27.7 2.0 6.3 29.8 10.9 0.5 30.3 5.0 6.7 21.4 12.8 11.0 4.1 2.5 16.8 15.3 8.9 19.8 23.7 18.6 5.7 6.5 1.9 0.8 17.8 10.4 10.0 2.4 18.4 3.9 0.7 2.3 71.8 13.5 11.3 6.4 26.6 6.0 8.6 21.9 10.0 7.6 18.6 17.5 0.7 15.1 9.7 7.9 3.2 5.7 9.7 9.9 27.3 28.9 0.4 0.2 3.1 0.4 0.3 0.4 0.1 0.0 0.0 30.3 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 72.6 1.7 0.0 0.1 50.4 9.0 0.0 0.1 9.2 0.0 0.0 0.0 44.7 0.0 0.0 6.1 16.8 3.8 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 25.2 0.0 0.1 48.3 8.5 7.3 0.1 0.0 0.0 0.0 0.1 18.1 0.0 0.0 1.0 0.4 0.6 0.2 0.2 0.2 0.4 0.3 0.3 0.2 0.4 0.4 0.3 3.1 0.3 0.2 0.2 0.2 0.1 6.3 10.9 5.0 4.8 5.7 6.5 10.0 2.4 13.5 7.9 98.3 9.1 0.0 29.7 12.9 1.2 6.9 0.0 6.7 29.6 0.0 3.9 1.8 0.0 0.4 0.5 7.4 0.0 0.0 0.0 1.6 108.5 3.5 1.1 0.0 6.5 0.0 0.0 7.4 0.0 0.4 18.7 4.1 6.8 202.8 0.0 85.7 0.5 0.0 59.1 0.0 2.8 0.0 6.2 0.9 8.6 6.0 2.4 0.0 0.0 3.4 PECAM1 CD31 ENSG00000261371 "Platelet and endothelial cell adhesion molecule 1" 17 64319415-64413776 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 77.7;blood: 88.4;placenta: 65.7" "Cell type enhanced" "Detected in many" 23 "Endothelial cells: 481.1;Ito cells: 205.6;Kupffer cells: 91.8" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 88.4" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "HUVEC TERT2: 121.0;TIME: 83.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004690 Enhanced NA NA "HPA004690: AB_1078462" "unprognostic (2.79e-1)" "unprognostic (2.14e-1)" "unprognostic (2.79e-2)" "unprognostic (2.76e-1)" "unprognostic (1.34e-1)" "unprognostic (4.42e-3)" "unprognostic (2.84e-1)" "unprognostic (2.37e-1)" "unprognostic (2.57e-1)" "unprognostic (7.25e-2)" "unprognostic (4.53e-2)" "unprognostic (9.68e-2)" "prognostic unfavorable (8.98e-5)" "unprognostic (9.72e-3)" "unprognostic (9.57e-2)" "unprognostic (1.56e-1)" "unprognostic (4.16e-2)" 77.7 2.5 2.2 10.2 3.3 3.8 26.5 1.2 3.6 14.2 9.2 1.6 3.7 3.5 15.2 7.6 12.3 4.7 12.2 13.8 2.2 13.4 3.5 50.2 10.7 3.0 0.3 7.4 2.3 2.7 1.2 65.7 3.7 10.2 4.9 4.6 2.9 3.0 21.2 2.0 4.8 11.6 2.8 13.9 3.4 6.4 2.0 7.8 15.7 10.0 7.8 15.2 16.2 5.0 21.0 53.3 88.4 5.2 10.0 24.2 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.2 0.3 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 121.0 5.3 0.3 9.1 0.0 0.0 4.9 1.2 0.0 0.0 1.3 0.2 2.4 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.4 83.3 0.1 0.0 0.1 0.0 0.5 0.9 1.0 0.2 1.0 0.0 6.2 34.8 28.9 2.8 57.2 2.7 3.6 0.3 6.7 21.0 5.0 5.4 10.0 53.3 5.2 88.4 12.0 0.2 24.2 14.9 44.7 12.6 0.5 0.0 0.0 17.1 0.0 13.4 5.7 8.7 0.0 0.4 0.0 0.2 0.6 481.1 0.0 0.0 0.2 3.5 1.1 1.0 8.1 0.9 47.0 0.0 0.0 205.6 91.8 0.5 2.3 71.5 0.0 12.6 0.0 0.1 0.1 0.0 1.8 0.5 0.9 0.0 0.3 0.1 0.2 0.0 0.7 20.3 0.0 0.9 PEG10 "HB-1, KIAA1051, Mar2, Mart2, MEF3L, RGAG3, RTL2, SIRH1" ENSG00000242265 "Paternally expressed 10" Q86TG7 7 94656325-94669695 "Predicted intracellular proteins" "Apoptosis, Differentiation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 67.5;brain: 143.8;pituitary gland: 102.6;placenta: 171.4" "Group enriched" "Detected in many" 13 "Cytotrophoblasts: 1669.7;Syncytiotrophoblasts: 2388.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 143.8" "Cell type enhanced" "Detected in some" "memory B-cell: 2.1;naive B-cell: 2.6;NK-cell: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 95.0;HAP1: 123.3;Hep G2: 95.0;SCLC-21H: 60.4" "Region enhanced" "Detected in many" "hypothalamus: 130.3" "Low region specificity" "Detected in all" "HPA021324, HPA029915, HPA051038" Enhanced Approved Nucleoplasm,Cytosol NA NA Cytosol Nucleoplasm "HPA021324: AB_1855181, HPA029915: AB_2673250, HPA051038: AB_2630372" "unprognostic (1.03e-1)" "unprognostic (2.98e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (8.15e-4)" "unprognostic (1.06e-1)" "unprognostic (5.70e-3)" "unprognostic (9.70e-3)" "unprognostic (2.61e-3)" "unprognostic (5.43e-2)" "unprognostic (1.68e-2)" "unprognostic (1.99e-2)" "unprognostic (3.23e-1)" "unprognostic (1.37e-2)" "unprognostic (1.66e-2)" "unprognostic (5.48e-2)" "unprognostic (6.01e-2)" "unprognostic (2.40e-2)" 2.3 67.5 32.0 2.1 143.8 1.4 10.6 25.6 16.8 4.2 2.1 7.4 0.0 1.5 3.3 1.9 2.0 5.1 2.4 1.8 21.0 47.0 4.0 2.0 7.3 2.9 13.1 21.3 27.0 5.4 2.3 102.6 171.4 27.4 2.2 1.9 1.8 4.3 2.2 1.9 1.4 1.6 2.6 14.4 1.8 2.1 19.8 11.1 1.5 5.4 0.0 2.3 1.8 1.0 2.6 0.0 0.0 0.0 2.7 0.7 0.2 2.6 13.4 95.0 40.1 2.0 3.6 5.5 7.3 4.3 5.2 7.1 22.3 4.4 0.2 0.2 8.4 10.8 0.8 123.3 5.2 7.3 0.3 13.0 0.0 15.3 95.0 1.5 15.1 0.0 8.0 1.7 13.0 9.0 4.6 3.1 0.0 0.0 29.8 10.2 0.6 0.0 0.0 43.5 2.2 8.5 5.7 30.4 7.9 23.9 9.9 60.4 3.4 0.0 2.0 7.2 24.9 12.9 0.0 0.0 4.2 0.2 0.5 5.5 8.0 5.3 11.8 9.4 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.7 0.0 2.6 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.2 32.0 143.8 25.6 14.4 21.0 47.0 13.1 21.3 27.4 11.1 142.9 64.2 2.4 7.4 0.7 70.4 25.2 7.6 16.0 126.3 15.7 7.9 1669.7 54.7 10.7 2.8 2.4 0.0 0.0 4.3 85.1 27.1 7.0 2.3 2.9 150.9 35.0 58.0 2.5 0.0 11.4 8.3 1.4 13.5 0.0 0.7 118.3 4.2 0.0 3.9 10.0 25.7 6.5 12.5 16.4 5.1 0.6 2388.4 0.5 0.1 0.6 PEG3 "KIAA0287, ZKSCAN22, ZNF904, ZSCAN24" ENSG00000198300 "Paternally expressed 3" Q9GZU2 19 56810083-56840728 "Predicted intracellular proteins, Transcription factors" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.0;ovary: 106.4;placenta: 49.8" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 267.6;Horizontal cells: 139.8;Peritubular cells: 103.3;Syncytiotrophoblasts: 399.0" "Cancer enhanced" "Detected in many" "testis cancer: 9.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 1.3;plasmacytoid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.3" "Group enriched" "Detected in some" 5 "BEWO: 32.2;Hep G2: 65.4;RH-30: 22.4" "Low region specificity" "Detected in all" HPA026070 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA026070: AB_10603328" "unprognostic (1.38e-2)" "unprognostic (1.90e-2)" "unprognostic (1.20e-1)" "unprognostic (7.12e-2)" "unprognostic (1.58e-1)" "unprognostic (4.84e-2)" "unprognostic (4.84e-2)" "unprognostic (4.44e-2)" "unprognostic (9.16e-2)" "unprognostic (1.21e-1)" "unprognostic (1.82e-3)" "unprognostic (9.92e-2)" "unprognostic (2.48e-5)" "unprognostic (6.92e-3)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.56e-4)" "unprognostic (6.68e-3)" 2.0 29.8 10.1 1.0 51.0 0.5 4.5 9.8 22.4 4.1 2.4 5.9 0.0 0.7 9.1 2.6 1.7 5.8 1.2 2.3 9.7 9.6 1.8 2.1 1.7 0.7 3.5 16.0 106.4 1.9 7.3 24.6 49.8 21.3 1.8 1.2 0.4 2.3 2.5 1.7 1.8 1.7 4.1 4.8 1.6 2.0 12.3 7.3 0.0 2.7 0.0 2.7 2.6 2.0 0.0 1.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.1 0.0 22.4 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 10.1 51.0 9.8 22.4 9.7 9.6 3.5 16.0 21.3 7.3 0.0 5.8 0.0 1.7 4.2 19.4 12.3 2.5 4.0 3.4 1.8 7.9 267.6 1.7 0.7 24.4 2.6 0.0 0.0 0.0 33.5 7.8 1.7 0.0 2.9 29.8 139.8 0.0 4.9 0.6 15.2 54.4 1.0 13.5 0.0 0.0 18.1 0.5 0.0 103.3 0.8 11.8 12.9 7.3 26.9 17.4 2.3 399.0 0.0 0.0 0.7 PGF "D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760" ENSG00000119630 "Placental growth factor" P49763 14 74941834-74955784 "Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 177.3" "Group enriched" "Detected in many" 16 "Extravillous trophoblasts: 1478.5;Syncytiotrophoblasts: 1775.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "BEWO: 93.4;HUVEC TERT2: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA041624 Approved Nucleoplasm,Mitochondria,Cytosol "Secreted to blood" No No 20800 Nucleoplasm "Mitochondria, Cytosol" "HPA041624: AB_10794522" "unprognostic (1.67e-2)" "unprognostic (4.62e-2)" "unprognostic (9.25e-3)" "unprognostic (1.34e-3)" "unprognostic (8.67e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (7.26e-2)" "unprognostic (1.48e-1)" "unprognostic (4.45e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-3)" "prognostic unfavorable (1.33e-6)" "unprognostic (2.52e-3)" "unprognostic (1.20e-1)" "unprognostic (3.49e-2)" "unprognostic (1.14e-1)" 4.3 2.7 1.9 4.4 2.4 0.0 4.3 1.6 3.5 13.1 2.3 2.3 4.0 1.3 2.9 6.3 3.9 9.2 3.4 5.1 2.4 4.1 3.1 2.6 3.6 4.9 2.9 2.0 3.8 1.9 5.4 2.0 177.3 4.6 7.5 1.1 3.5 3.8 6.7 3.3 6.0 4.3 4.6 1.7 1.2 1.7 3.3 2.0 1.4 24.2 4.4 2.9 5.1 5.9 0.7 0.7 1.1 1.0 0.0 2.4 0.2 0.3 0.3 0.3 0.3 0.4 0.0 93.4 0.8 0.8 0.4 0.5 2.2 0.1 0.0 2.0 0.6 0.0 0.1 0.4 4.2 0.3 0.0 0.5 0.0 0.0 2.2 0.3 0.0 2.4 1.1 1.0 1.7 0.4 0.1 44.0 0.0 0.0 0.0 12.4 0.1 0.0 0.1 0.4 0.0 0.7 0.0 11.6 0.0 0.1 0.2 7.0 3.8 0.0 0.1 1.6 5.9 0.0 0.1 8.9 0.0 2.3 0.0 3.7 0.0 0.0 0.1 1.4 0.1 0.1 0.0 0.2 1.1 2.4 1.0 0.0 0.7 0.3 0.7 0.3 0.3 0.6 1.0 0.0 0.0 0.8 0.7 0.5 0.2 1.9 2.4 1.6 2.2 2.4 4.1 2.9 2.0 4.6 2.0 8.9 5.8 0.8 13.0 21.9 0.8 2.8 0.0 1.4 7.9 0.0 13.7 75.1 0.0 0.9 0.1 15.8 0.5 0.0 0.4 1478.5 42.9 3.3 5.8 0.0 33.1 0.0 6.8 7.4 0.3 0.6 12.0 4.5 20.3 0.0 1.1 1.9 0.6 0.2 18.4 0.4 7.5 103.5 62.6 0.2 3.4 17.1 1775.1 0.9 1.7 4.7 PHACTR2 "C6orf56, KIAA0680" ENSG00000112419 "Phosphatase and actin regulator 2" O75167 6 143536845-143831185 "Predicted intracellular proteins" "Actin-binding, Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 60.1" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 199.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "TIME: 36.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031719, HPA031720, HPA031725" Approved NA NA "HPA031719: AB_10696055, HPA031720: AB_10670553, HPA031725: AB_10610279" "unprognostic (3.25e-3)" "unprognostic (1.07e-1)" "unprognostic (4.39e-2)" "unprognostic (5.25e-2)" "unprognostic (1.90e-2)" "unprognostic (8.38e-2)" "unprognostic (3.19e-2)" "unprognostic (9.92e-2)" "unprognostic (7.46e-2)" "unprognostic (3.61e-2)" "unprognostic (2.49e-1)" "unprognostic (2.80e-1)" "prognostic favorable (1.99e-4)" "unprognostic (3.60e-1)" "unprognostic (5.08e-2)" "unprognostic (9.92e-2)" "unprognostic (1.17e-1)" 14.6 28.1 6.6 10.8 4.1 5.4 13.3 2.8 5.2 10.9 10.2 4.6 12.0 5.8 12.3 7.9 16.7 6.6 11.0 17.6 6.3 3.8 6.2 13.0 16.1 10.0 4.4 5.3 8.6 4.2 11.0 8.0 60.1 13.0 10.6 6.8 18.7 9.7 8.9 9.8 4.4 10.7 8.4 3.8 11.9 9.1 7.2 2.7 2.6 12.0 8.9 8.8 8.6 10.5 0.5 3.6 6.9 3.9 3.6 14.3 1.8 9.3 5.9 1.6 11.8 1.7 3.7 6.8 7.9 12.0 3.4 4.3 10.3 4.2 0.5 21.5 22.6 2.4 2.8 0.9 7.8 4.1 7.7 3.7 15.3 6.6 6.0 2.8 3.9 4.7 5.1 4.4 3.4 11.3 5.3 20.8 2.9 4.3 0.0 5.5 10.3 0.5 0.9 12.0 3.3 1.7 1.4 11.8 0.1 4.2 8.4 2.3 2.3 8.8 11.7 0.1 6.3 4.4 5.7 36.1 15.8 8.3 6.8 5.1 0.1 0.0 0.1 3.9 4.1 1.4 4.5 3.9 6.9 3.9 2.8 14.3 0.5 4.7 5.1 3.6 0.2 2.9 2.0 2.0 3.6 2.8 3.6 5.7 1.8 6.6 4.1 2.8 5.2 6.3 3.8 4.4 5.3 13.0 2.7 199.5 74.0 12.8 13.8 21.5 17.3 67.7 30.6 62.9 89.9 21.0 2.0 63.3 11.6 24.0 10.1 116.8 34.9 0.0 19.6 43.1 109.6 43.7 38.1 25.2 32.0 95.3 20.7 163.2 98.4 15.9 95.5 36.8 23.6 80.2 16.0 7.3 34.1 19.5 112.8 21.3 2.8 97.0 46.7 3.0 1.2 15.1 43.9 34.1 24.4 10.6 PHLDA2 "BWR1C, HLDA2, IPL, TSSC3" ENSG00000181649 "Pleckstrin homology like domain family A member 2" Q53GA4 11 2928273-2929455 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 163.9" "Cell type enhanced" "Detected in many" 18 "Cytotrophoblasts: 3794.0;Syncytiotrophoblasts: 8329.2;Urothelial cells: 2915.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "myeloid DC: 8.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 83.8;PC-3: 68.1;SK-MEL-30: 53.5;WM-115: 73.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA003994 Uncertain Nucleoli NA NA Nucleoli "HPA003994: AB_1855311" "unprognostic (1.90e-1)" "unprognostic (3.13e-2)" "unprognostic (9.93e-3)" "unprognostic (6.16e-2)" "unprognostic (4.28e-2)" "unprognostic (8.01e-3)" "prognostic unfavorable (4.22e-5)" "unprognostic (1.24e-3)" "unprognostic (3.84e-2)" "unprognostic (8.35e-2)" "unprognostic (1.67e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (2.63e-6)" "unprognostic (2.83e-1)" "unprognostic (6.13e-2)" "unprognostic (2.16e-2)" "unprognostic (1.59e-1)" 3.8 1.1 0.5 3.6 0.7 1.4 7.7 0.3 1.4 5.6 7.9 0.5 1.7 5.9 2.3 5.5 20.3 2.4 15.6 1.5 0.5 1.9 4.8 3.7 3.9 0.8 1.3 0.5 1.8 4.6 1.2 1.2 163.9 1.9 8.0 1.4 0.8 5.3 2.0 0.8 9.6 7.4 1.9 1.0 1.8 11.1 1.0 0.5 0.2 3.5 24.7 15.1 6.1 8.7 1.5 8.2 0.0 4.9 0.0 3.9 1.5 9.4 8.4 0.3 0.1 0.1 1.7 9.1 21.0 5.3 3.0 2.2 3.4 18.7 0.0 10.3 2.3 6.9 11.7 0.0 8.3 0.3 83.8 2.8 0.0 4.5 2.1 6.9 0.0 5.0 2.8 3.8 2.5 2.0 1.7 2.5 0.0 1.8 0.1 1.2 29.8 0.0 1.4 3.4 4.7 68.1 0.0 0.0 5.7 6.1 2.9 0.9 0.0 6.7 4.6 53.5 0.4 1.4 0.8 13.9 6.7 3.6 9.4 7.1 0.1 0.1 0.0 5.5 1.4 73.4 0.0 4.9 0.0 0.7 3.0 0.8 1.5 3.9 0.9 8.2 0.0 1.0 0.2 0.0 0.0 0.6 0.0 1.4 1.5 0.5 0.7 0.3 1.4 0.5 1.9 1.3 0.5 1.9 0.5 17.9 37.7 0.5 1363.4 350.5 0.0 4.8 48.4 16.0 48.9 41.8 0.0 3794.0 8.3 172.2 2.1 8.7 316.4 0.0 128.2 1743.3 110.0 1372.9 82.9 3.4 356.1 0.0 189.0 11.6 9.2 0.4 3.4 47.2 97.8 17.2 122.2 0.0 313.5 273.8 2.8 0.3 0.1 51.8 311.1 0.5 4.5 599.1 8329.2 3.8 109.0 2915.8 PHLDB2 "FLJ21791, LL5b, LL5beta" ENSG00000144824 "Pleckstrin homology like domain family B member 2" Q86SQ0 3 111732497-111976517 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 104.0" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 138.6;Basal keratinocytes: 222.0;Smooth muscle cells: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 32.4;HaCaT: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA035146, HPA035147" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035146: AB_10600927, HPA035147: AB_2674492" "unprognostic (2.83e-2)" "unprognostic (4.93e-3)" "unprognostic (2.15e-2)" "unprognostic (8.01e-2)" "unprognostic (1.00e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (5.14e-2)" "unprognostic (2.20e-2)" "unprognostic (1.43e-1)" "unprognostic (9.03e-2)" "unprognostic (2.00e-2)" "unprognostic (3.53e-1)" "prognostic favorable (7.03e-8)" "unprognostic (3.24e-3)" "unprognostic (3.47e-2)" "unprognostic (1.53e-1)" "unprognostic (2.83e-1)" 15.5 3.8 1.3 13.2 1.9 0.4 9.9 1.6 2.9 13.9 22.8 1.4 8.4 2.8 17.4 10.1 10.7 10.7 9.1 21.7 1.3 1.2 36.6 24.6 14.4 2.2 2.1 1.9 8.5 6.4 0.9 5.3 104.0 7.1 16.7 4.4 6.9 7.0 14.3 6.0 5.8 6.5 49.3 2.4 7.9 11.4 4.3 0.4 1.7 5.9 6.8 2.3 33.8 17.8 1.0 1.0 0.4 0.1 1.7 5.6 1.3 32.4 3.6 20.4 0.0 6.6 10.9 8.4 18.8 9.2 12.5 14.8 10.2 2.4 0.0 19.8 7.2 12.6 33.8 0.3 12.1 22.8 0.5 0.4 0.0 8.7 3.3 7.2 0.0 0.1 12.8 7.2 8.6 16.0 14.1 20.0 0.3 0.0 0.1 3.7 0.0 1.3 0.0 8.2 0.3 6.3 2.8 26.3 0.0 7.4 7.8 0.5 1.5 18.5 0.3 1.9 11.7 0.6 0.1 17.4 3.4 28.6 9.0 4.5 1.7 0.0 0.0 3.4 0.0 6.4 0.2 0.0 0.0 5.2 0.0 3.7 0.4 3.6 5.6 0.1 1.0 0.0 2.3 0.4 1.7 0.1 1.0 0.8 1.3 1.3 1.9 1.6 2.9 1.3 1.2 2.1 1.9 7.1 0.4 74.5 9.8 2.4 138.6 222.0 0.1 94.0 25.5 5.3 12.5 31.4 2.0 21.1 19.9 56.7 10.2 32.4 0.0 0.0 17.6 42.7 33.9 48.7 6.9 28.4 3.0 0.0 10.4 43.6 3.2 3.9 13.3 3.2 21.9 1.8 3.4 0.0 37.0 0.0 21.2 28.0 0.3 12.9 129.6 0.3 2.1 100.2 55.8 7.0 1.4 85.9 PITX2 "ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS" ENSG00000164093 "Paired like homeodomain 2" Q99697 4 110617423-110642123 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 30.4;retina: 53.5;skeletal muscle: 28.8" "Cell type enhanced" "Detected in some" 9 "Cardiomyocytes: 12.7;Cytotrophoblasts: 5.5;Enterocytes: 6.5;Extravillous trophoblasts: 5.4;Hofbauer cells: 6.6;Spermatogonia: 5.6;Syncytiotrophoblasts: 8.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 16 "hypothalamus: 2.1;midbrain: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 18.1;HEK 293: 8.0;LHCN-M2: 18.6;RH-30: 15.7" "Region enhanced" "Detected in single" "hypothalamus: 9.8" "Region enhanced" "Detected in single" "hypothalamus: 5.1" "HPA050074, HPA062728" Enhanced Nucleoplasm NA NA Nucleoplasm "HPA050074: AB_2681005, HPA062728: AB_2684851" "unprognostic (1.08e-1)" "unprognostic (1.23e-2)" "unprognostic (9.29e-2)" "unprognostic (9.24e-2)" "unprognostic (1.68e-1)" "unprognostic (1.14e-2)" "unprognostic (9.61e-4)" "unprognostic (3.22e-2)" "unprognostic (1.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.16e-1)" "unprognostic (2.77e-1)" "unprognostic (1.11e-15)" "unprognostic (6.97e-3)" "unprognostic (1.43e-1)" "unprognostic (5.98e-2)" "unprognostic (9.91e-2)" 0.6 0.1 0.0 18.6 0.0 0.1 0.3 0.0 0.1 1.1 3.0 0.0 0.3 0.1 0.1 1.3 2.7 0.2 1.1 3.5 0.0 2.1 0.3 0.1 0.1 0.1 1.1 0.0 0.1 0.5 0.1 12.5 30.4 0.0 8.3 0.3 53.5 9.3 0.2 28.8 0.9 3.4 15.9 0.0 0.1 0.5 0.3 0.0 0.0 0.1 16.8 0.4 19.4 5.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 1.9 0.0 0.7 1.9 1.6 3.0 0.6 0.3 2.0 1.5 18.1 0.0 0.0 3.9 3.7 2.4 0.3 0.1 0.0 1.1 0.0 8.0 0.0 1.4 0.0 6.7 0.0 3.8 2.1 0.1 0.3 0.0 0.6 0.0 2.0 0.5 0.0 18.6 0.5 2.0 0.0 0.3 0.0 0.3 0.0 15.7 0.0 0.3 2.5 0.0 0.0 1.4 2.5 0.2 0.3 0.1 0.0 0.0 2.5 5.9 0.0 2.9 0.0 0.1 0.8 1.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 12.7 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 6.5 0.0 0.3 5.4 4.5 0.2 0.0 0.0 6.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.9 0.0 1.3 0.0 0.0 1.7 1.2 5.6 0.1 8.8 0.0 1.2 0.0 PKIB PRKACN2 ENSG00000135549 "CAMP-dependent protein kinase inhibitor beta" Q9C010 6 122471917-122726373 "Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 91.6;placenta: 140.9" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 457.3;Enterocytes: 299.8;Extravillous trophoblasts: 381.2;Syncytiotrophoblasts: 802.7" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "cerebellum: 91.6" "Cell type enriched" "Detected in some" 11 "myeloid DC: 22.3" "Lineage enriched" "Detected in many" 11 "dendritic cells: 22.3" "Cell line enhanced" "Detected in many" "AF22: 20.0;MCF7: 22.6;OE19: 24.5;PC-3: 31.8;RPTEC TERT1: 52.0;SCLC-21H: 44.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "cerebellum: 92.0;olfactory region: 58.4" HPA030156 Approved NA NA "HPA030156: AB_10602816" "unprognostic (1.59e-2)" "unprognostic (1.82e-1)" "unprognostic (1.99e-2)" "unprognostic (1.57e-3)" "unprognostic (1.39e-1)" "unprognostic (9.45e-2)" "prognostic unfavorable (4.72e-7)" "unprognostic (1.94e-2)" "unprognostic (5.88e-2)" "unprognostic (3.91e-2)" "unprognostic (1.26e-1)" "unprognostic (3.58e-2)" "prognostic favorable (2.47e-7)" "unprognostic (1.82e-1)" "unprognostic (1.37e-1)" "unprognostic (2.57e-1)" "unprognostic (1.48e-1)" 0.8 2.0 3.3 7.3 3.7 0.0 8.8 91.6 2.3 1.8 33.0 1.0 1.0 5.4 0.9 1.2 1.6 1.8 2.3 0.5 2.8 4.5 0.9 2.6 2.0 0.9 6.1 2.2 0.5 2.3 18.9 22.3 140.9 17.7 2.0 23.6 5.6 2.8 1.2 0.5 3.1 12.0 1.2 2.8 0.8 12.2 1.2 0.7 1.6 1.0 1.3 2.5 1.8 0.7 0.1 22.3 0.0 1.9 1.4 0.5 0.5 0.0 0.7 20.0 0.1 0.1 0.0 17.5 0.0 0.2 0.0 0.3 0.1 0.8 0.0 0.1 0.0 1.0 0.0 0.0 0.4 0.2 0.1 1.0 0.3 1.1 0.4 0.0 0.0 3.4 0.1 0.3 0.3 4.3 9.6 0.1 0.1 5.8 0.1 0.0 22.6 0.0 0.1 8.2 24.5 31.8 0.1 3.0 0.1 52.0 2.8 44.3 0.0 0.0 4.7 0.5 11.5 3.3 0.4 1.7 0.0 13.5 0.0 1.6 0.0 0.0 0.0 13.2 0.4 0.1 0.0 0.4 0.0 0.0 1.9 0.5 0.0 0.0 0.0 22.3 0.1 0.3 0.1 0.0 1.4 0.1 0.3 0.2 0.5 3.3 3.7 91.6 2.3 2.8 4.5 6.1 2.2 17.7 0.7 3.0 3.8 2.7 2.1 17.5 14.0 0.3 5.1 97.7 13.6 1.8 3.9 457.3 16.6 18.6 103.5 1.5 299.8 0.0 30.1 381.2 7.1 14.7 38.1 3.8 46.4 6.4 94.2 1.8 40.2 208.8 1.1 124.0 42.2 40.5 65.2 9.4 67.0 45.5 0.4 3.3 47.6 6.5 4.0 2.7 5.4 14.9 802.7 3.2 47.0 4.7 PLAC1 "CT92, OOSP2L" ENSG00000170965 "Placenta specific 1" Q9HBJ0 X 134565838-134764322 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 29 "placenta: 90.4" "Cell type enhanced" "Detected in some" 14 "Leydig cells: 5.2;Peritubular cells: 7.4;Spermatogonia: 2.7;Syncytiotrophoblasts: 8.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 18.7;hTCEpi: 14.7;hTERT-HME1: 6.0" "Not detected" "Not detected" HPA063425 Enhanced "Secreted in female reproductive system" NA NA "HPA063425: AB_2685012" "unprognostic (2.93e-1)" "unprognostic (2.50e-3)" "unprognostic (2.89e-4)" "unprognostic (1.35e-7)" "unprognostic (3.83e-3)" "unprognostic (2.07e-2)" "unprognostic (1.63e-2)" "unprognostic (1.26e-1)" "unprognostic (2.01e-1)" "unprognostic (4.28e-2)" "unprognostic (1.48e-2)" "unprognostic (2.87e-2)" "unprognostic (3.33e-16)" "unprognostic (7.64e-3)" "unprognostic (4.03e-2)" "unprognostic (1.61e-1)" "unprognostic (1.91e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.1 90.4 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.5 0.0 0.0 0.1 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.8 0.0 1.1 0.0 0.2 1.1 0.3 0.3 1.0 0.0 1.7 0.2 0.1 1.7 0.3 0.4 18.7 0.0 0.1 0.2 2.3 0.0 0.0 0.8 14.7 0.1 6.0 0.1 2.2 0.1 0.1 1.6 0.1 0.9 0.0 0.2 0.0 1.2 2.4 0.0 0.3 3.2 0.0 0.0 2.9 0.0 0.0 3.5 0.6 2.2 0.1 0.0 0.0 0.4 0.7 0.2 0.0 0.4 0.0 0.3 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 5.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.4 0.0 0.0 0.0 0.0 0.9 2.7 0.0 8.9 0.0 0.0 0.0 PLAGL1 "LOT1, ZAC" ENSG00000118495 "PLAG1 like zinc finger 1" Q9UM63 6 143940300-144064599 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 95.0" "Cell type enhanced" "Detected in many" 7 "Fibroblasts: 117.4;Leydig cells: 128.3;Peritubular cells: 91.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 35.7;ASC TERT1: 29.1;RH-30: 36.3" "Low region specificity" "Detected in all" HPA055706 Supported "Nuclear bodies,Golgi apparatus,Vesicles" No No "Nuclear bodies" "Golgi apparatus, Vesicles" "HPA055706: AB_2682893" "unprognostic (4.74e-3)" "unprognostic (8.35e-3)" "unprognostic (5.43e-2)" "unprognostic (1.74e-3)" "unprognostic (5.09e-2)" "unprognostic (1.95e-1)" "unprognostic (9.32e-2)" "unprognostic (6.17e-2)" "unprognostic (3.49e-2)" "unprognostic (5.02e-2)" "unprognostic (1.78e-3)" "unprognostic (2.07e-1)" "prognostic unfavorable (4.94e-6)" "prognostic unfavorable (6.61e-4)" "unprognostic (4.69e-2)" "unprognostic (5.17e-3)" "unprognostic (4.93e-3)" 14.6 28.5 2.3 14.8 4.3 7.7 12.3 2.0 7.6 12.9 8.9 4.6 10.0 3.9 19.5 16.3 12.4 7.7 13.0 9.0 5.1 1.5 6.8 1.5 12.1 8.2 2.6 2.2 16.0 11.2 5.2 45.6 95.0 3.6 12.6 8.6 19.3 11.7 7.3 4.5 23.1 7.9 16.8 3.8 6.8 10.9 6.8 2.0 3.9 5.6 24.2 12.0 14.2 18.4 4.1 10.3 16.4 8.1 1.7 1.4 2.3 0.0 1.6 35.7 0.0 14.1 29.1 0.1 12.2 7.9 6.1 12.7 0.1 1.9 0.8 6.1 10.6 1.6 0.0 0.2 4.3 12.0 0.9 1.6 15.1 17.8 0.2 4.7 13.5 3.0 21.9 1.6 5.3 4.7 7.9 12.0 5.6 1.5 0.2 7.2 2.1 5.6 6.3 5.9 0.0 1.1 6.8 36.3 0.0 11.4 0.3 3.2 3.5 17.6 0.0 0.0 11.3 0.0 16.8 6.9 0.0 13.0 28.2 13.2 3.1 3.0 0.1 9.4 5.6 0.7 3.4 8.1 16.4 1.0 6.2 1.0 2.7 0.9 1.4 10.3 4.1 0.7 1.2 14.8 1.7 1.9 4.6 1.3 2.3 2.3 4.3 2.0 7.6 5.1 1.5 2.6 2.2 3.6 2.0 47.6 38.2 8.2 12.9 19.3 2.0 6.5 2.5 6.7 18.2 5.2 0.0 4.5 6.6 10.3 1.6 12.8 9.3 0.0 9.8 10.9 117.4 33.9 18.4 0.0 18.0 7.9 16.0 9.2 25.4 1.7 128.3 19.1 8.5 37.9 27.2 1.0 10.6 22.4 91.2 11.6 0.4 12.9 27.6 0.7 0.6 37.9 8.2 5.7 24.3 13.2 PLAU "UPA, URK" ENSG00000122861 "Plasminogen activator, urokinase" P00749 10 73909177-73917497 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation" "Hydrolase, Protease, Serine protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 48.4" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 550.8;Pancreatic endocrine cells: 366.2;Urothelial cells: 779.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "myeloid DC: 2.4;neutrophil: 4.5;plasmacytoid DC: 4.5" "Group enriched" "Detected in many" 11 "dendritic cells: 4.5;granulocytes: 4.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 70.3;LHCN-M2: 67.8;RPTEC TERT1: 257.8;U-251 MG: 69.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA070796 Supported "Secreted to blood" NA NA 647000 58000 "HPA070796: " "unprognostic (1.96e-2)" "unprognostic (2.99e-2)" "unprognostic (7.40e-2)" "prognostic favorable (3.38e-4)" "unprognostic (4.73e-2)" "prognostic unfavorable (2.70e-4)" "unprognostic (1.39e-2)" "prognostic unfavorable (4.04e-4)" "unprognostic (2.26e-1)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (1.61e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (2.83e-1)" "unprognostic (3.37e-2)" "unprognostic (1.51e-2)" "unprognostic (1.77e-2)" 26.7 2.4 1.0 15.5 2.1 11.3 9.7 1.6 1.5 6.9 5.8 2.9 4.9 3.8 10.7 21.2 9.1 6.5 10.7 14.3 1.3 1.0 23.3 2.3 23.4 5.5 1.6 1.5 6.8 3.7 3.6 1.8 48.4 3.1 7.5 6.7 4.5 10.6 5.0 12.2 9.0 8.1 8.4 2.5 23.8 7.8 5.8 1.3 4.8 10.9 11.6 8.2 16.3 9.3 0.1 4.5 4.5 0.4 0.0 0.0 0.3 13.3 7.1 3.0 0.1 0.2 5.1 0.1 8.1 37.9 3.3 5.2 0.1 70.3 0.0 15.0 1.1 35.0 9.2 0.0 13.5 3.8 0.7 0.0 0.0 0.3 0.1 6.2 1.2 2.6 13.5 1.6 22.6 8.7 37.6 9.4 0.0 0.0 0.0 67.8 0.0 0.0 1.7 0.8 0.0 18.7 0.0 9.2 0.0 257.8 10.5 0.0 0.0 0.0 0.3 0.2 2.2 0.0 1.8 23.8 0.2 1.7 1.7 69.2 0.0 0.1 0.1 18.2 2.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.0 4.5 0.0 0.0 4.5 0.0 0.3 1.0 2.1 1.6 1.5 1.3 1.0 1.6 1.5 3.1 1.3 3.0 5.8 0.5 550.8 33.2 0.0 2.4 0.0 1.4 10.3 27.9 0.0 17.1 58.0 65.4 0.5 11.7 0.0 0.0 18.1 16.5 18.1 169.7 31.1 0.0 38.5 0.0 3.4 6.2 3.9 0.0 2.3 31.5 6.8 41.5 0.0 0.0 366.2 0.0 0.0 0.7 0.0 6.5 25.9 0.0 0.1 25.7 14.6 0.5 0.9 779.6 PLCXD2 FLJ31579 ENSG00000240891 "Phosphatidylinositol specific phospholipase C X domain containing 2" Q0VAA5 3 111674676-111846447 "Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 16.0" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 57.6;Distal tubular cells: 135.9;Hepatocytes: 132.8;Proximal tubular cells: 94.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.2" "Group enriched" "Detected in many" 5 "dendritic cells: 7.2;NK-cells: 2.1;T-cells: 3.6" "Cell line enhanced" "Detected in many" "HBF TERT88: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055947 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA055947: AB_2682981" "unprognostic (2.68e-1)" "unprognostic (6.43e-2)" "unprognostic (7.26e-2)" "unprognostic (2.42e-1)" "unprognostic (3.09e-2)" "unprognostic (2.76e-2)" "unprognostic (1.36e-1)" "unprognostic (4.64e-1)" "unprognostic (3.47e-1)" "unprognostic (1.99e-2)" "unprognostic (3.38e-2)" "unprognostic (2.04e-1)" "prognostic favorable (1.23e-7)" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "prognostic favorable (2.99e-4)" 1.5 1.0 1.9 3.4 5.8 9.6 1.2 5.8 10.9 1.6 2.8 0.4 0.0 6.1 1.0 0.6 1.8 1.2 1.9 1.5 3.6 2.5 2.5 4.1 2.0 5.9 2.9 6.8 1.1 2.3 0.4 4.1 16.0 10.3 1.5 3.6 4.1 2.0 0.7 1.2 1.5 5.9 0.9 2.9 3.5 2.1 4.2 1.1 3.1 3.2 0.5 4.8 1.9 1.6 0.9 7.2 0.6 0.0 2.1 3.6 0.6 3.0 2.7 2.6 1.2 0.1 0.1 0.8 5.3 2.5 5.0 4.4 1.9 1.5 2.2 2.7 0.2 1.6 7.5 1.1 5.1 9.7 0.6 1.3 0.5 5.0 1.7 0.4 0.7 2.6 0.0 1.0 1.6 3.0 4.7 2.8 2.9 0.1 5.4 0.6 0.3 1.5 0.5 0.9 2.0 6.8 1.4 3.8 2.0 2.4 3.1 0.6 4.6 1.1 0.7 1.1 3.1 0.4 0.2 2.6 1.1 6.8 0.5 1.0 6.5 0.9 0.4 0.5 0.4 0.3 0.6 0.0 0.0 3.6 0.0 3.5 0.5 1.9 3.5 0.3 0.9 0.9 2.0 0.2 2.1 0.0 7.2 1.7 0.6 1.9 5.8 5.8 10.9 3.6 2.5 2.9 6.8 10.3 1.1 17.9 2.1 0.5 6.9 0.1 0.7 1.9 28.1 0.0 1.2 57.6 3.9 0.0 135.9 36.1 11.5 0.0 1.3 0.0 43.6 0.0 0.1 3.8 0.0 132.8 0.0 6.4 24.1 0.0 1.6 8.9 0.3 0.0 0.0 0.0 4.9 0.0 45.8 0.0 0.4 94.0 3.7 0.0 0.0 0.5 0.4 0.1 0.0 2.2 1.1 12.2 PLEKHG6 "FLJ10665, MYOGEF" ENSG00000008323 "Pleckstrin homology and RhoGEF domain containing G6" Q3KR16 12 6310436-6328506 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 43.4;placenta: 39.6" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 64.9;Extravillous trophoblasts: 43.1;Paneth cells: 35.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "neutrophil: 2.5;plasmacytoid DC: 3.9" "Group enriched" "Detected in many" 7 "dendritic cells: 3.9;granulocytes: 2.5" "Cell line enhanced" "Detected in some" "BEWO: 56.1;CACO-2: 17.8;CAPAN-2: 9.8;OE19: 16.9;RT4: 18.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041459, HPA058230" Uncertain Supported "Cell Junctions,Centrosome" NA NA "Cell Junctions" Centrosome "HPA041459: AB_10794518, HPA058230: AB_2683645" "unprognostic (1.67e-1)" "unprognostic (9.93e-3)" "unprognostic (1.44e-1)" "unprognostic (8.03e-3)" "unprognostic (5.84e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (9.20e-2)" "unprognostic (1.22e-1)" "unprognostic (3.13e-1)" "unprognostic (3.68e-2)" "unprognostic (1.72e-1)" "unprognostic (6.95e-2)" "unprognostic (1.18e-1)" "unprognostic (2.44e-1)" "unprognostic (4.18e-2)" "unprognostic (5.73e-2)" 7.5 0.2 0.3 8.9 0.7 1.0 15.8 0.3 0.4 4.4 30.3 0.4 1.1 19.4 0.6 1.6 19.9 0.5 6.7 1.2 0.3 0.0 1.1 2.5 1.8 0.3 0.3 0.3 0.6 4.5 1.9 3.3 39.6 0.5 2.6 9.6 0.7 8.8 2.3 0.3 6.7 43.4 0.5 0.3 0.4 5.7 0.5 0.3 0.5 3.4 11.3 8.6 6.8 8.6 0.3 3.9 2.5 0.2 0.1 0.4 0.1 0.2 2.1 0.2 0.0 1.1 0.1 56.1 0.1 0.0 0.1 0.1 17.8 9.8 0.1 0.1 0.0 0.0 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.5 3.5 0.2 0.2 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 2.7 0.0 0.2 4.6 16.9 0.3 0.0 0.0 0.1 0.0 18.9 0.1 0.0 0.4 8.4 0.1 4.2 2.7 0.0 0.4 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.2 0.6 0.2 0.1 0.1 0.1 0.1 0.2 0.0 0.3 0.1 0.4 2.5 0.1 0.1 3.9 0.1 0.1 0.3 0.7 0.3 0.4 0.3 0.0 0.3 0.3 0.5 0.3 0.0 0.0 0.0 5.7 4.4 0.0 0.3 5.1 0.0 0.0 1.8 0.0 13.8 0.0 8.3 1.1 0.3 64.9 0.0 1.6 43.1 1.1 6.7 0.0 2.1 2.4 0.0 8.1 0.0 0.0 1.5 2.3 0.0 0.0 0.0 18.6 0.9 2.5 35.4 0.7 0.7 0.0 0.0 3.1 0.2 0.5 6.0 20.0 0.0 20.6 16.8 PODNL1 "FLJ23447, SLRR5B" ENSG00000132000 "Podocan like 1" Q6PEZ8 19 13931187-13953392 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 24.5" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 34.2;Leydig cells: 17.0;Peritubular cells: 35.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 8.8;HSkMC: 16.2;hTERT-RPE1: 25.7;SiHa: 13.0;U-2 OS: 9.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA042807 Approved "Secreted - unknown location" NA NA "HPA042807: AB_10795514" "unprognostic (1.24e-1)" "unprognostic (4.94e-2)" "unprognostic (8.08e-3)" "unprognostic (2.13e-1)" "prognostic unfavorable (5.61e-8)" "unprognostic (1.78e-1)" "unprognostic (1.86e-2)" "unprognostic (3.68e-1)" "unprognostic (2.02e-1)" "unprognostic (3.08e-3)" "unprognostic (4.37e-2)" "unprognostic (1.01e-1)" "unprognostic (0.00e+0)" "unprognostic (3.94e-3)" "unprognostic (1.79e-1)" "unprognostic (4.99e-2)" "prognostic unfavorable (4.49e-4)" 2.4 1.6 2.2 3.5 4.1 2.2 4.5 7.9 3.2 6.7 2.3 3.0 2.2 1.9 1.7 2.5 8.7 1.7 5.9 4.4 2.0 7.5 1.4 1.0 3.8 1.3 4.2 2.3 3.1 2.5 0.7 4.7 24.5 5.0 6.1 1.5 11.1 4.2 4.1 3.7 12.7 2.7 2.6 3.8 1.3 3.0 7.6 2.1 0.8 2.4 14.9 3.9 4.8 9.9 0.9 3.4 1.3 1.7 1.0 0.8 0.6 0.4 0.5 0.5 0.3 0.8 2.1 0.1 5.5 3.3 1.1 2.2 0.4 0.6 0.3 0.4 8.8 0.2 2.1 0.2 0.2 0.6 2.0 0.9 1.1 0.4 0.1 6.8 0.3 0.7 16.2 1.0 1.5 0.2 25.7 0.0 0.1 0.5 0.4 2.2 3.5 0.3 0.3 0.2 0.4 0.5 0.2 0.1 0.0 0.4 0.1 1.0 0.6 13.0 0.1 0.4 0.6 0.1 0.6 1.0 2.7 9.4 0.7 0.3 0.4 0.0 0.1 1.1 1.2 0.2 0.7 1.7 0.7 0.8 1.4 0.3 0.9 0.6 0.3 3.4 0.5 0.4 0.3 1.3 1.0 0.2 0.5 0.2 0.6 2.2 4.1 7.9 3.2 2.0 7.5 4.2 2.3 5.0 2.1 0.0 0.3 0.0 0.8 1.1 34.2 1.2 0.0 0.0 1.2 0.0 2.0 0.4 0.0 0.1 1.2 1.0 1.1 0.0 0.0 0.1 7.7 0.4 0.0 0.0 7.5 1.6 0.0 0.6 1.5 1.6 17.0 1.1 1.7 0.0 1.3 1.6 0.4 6.2 35.7 0.0 4.0 0.0 0.5 0.7 0.5 3.8 0.7 0.0 1.1 1.2 PRG2 "BMPG, MBP, proMBP" ENSG00000186652 "Proteoglycan 2, pro eosinophil major basic protein" P13727 11 57386794-57390657 "Plasma proteins, Predicted intracellular proteins" Immunity "Antibiotic, Antimicrobial, Heparin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "placenta: 322.3" "Cell type enhanced" "Detected in some" 19 "Erythroid cells: 23.3;Extravillous trophoblasts: 16.4;granulocytes: 5.8;Hofbauer cells: 6.6;Syncytiotrophoblasts: 5.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 28 "basophil: 9.1" "Lineage enriched" "Detected in single" 92 "granulocytes: 9.1" "Group enriched" "Detected in some" 63 "HL-60: 143.5;HMC-1: 228.2;NB-4: 453.7" "Not detected" "Not detected" HPA038515 Supported "Intracellular and membrane" NA NA 130000000 "HPA038515: AB_10675800" "unprognostic (7.32e-2)" "unprognostic (1.68e-1)" "unprognostic (3.39e-2)" "unprognostic (3.49e-1)" "unprognostic (8.62e-4)" "unprognostic (4.77e-3)" "unprognostic (3.20e-2)" "unprognostic (4.17e-2)" "unprognostic (2.26e-2)" "unprognostic (5.19e-3)" "unprognostic (2.17e-1)" "unprognostic (1.40e-11)" "unprognostic (4.26e-2)" "unprognostic (4.52e-3)" "unprognostic (6.47e-2)" "unprognostic (2.32e-1)" 1.5 0.0 0.1 0.1 0.1 16.9 0.9 0.1 0.2 0.2 0.1 0.2 0.1 0.0 0.1 0.1 0.6 0.0 0.2 0.3 0.1 0.0 0.1 2.8 2.2 0.1 0.1 0.1 0.1 0.3 0.0 0.4 322.3 0.1 0.1 0.0 0.1 0.5 0.1 0.3 1.8 0.1 0.1 0.1 6.8 0.1 0.1 0.1 1.6 0.4 0.1 0.2 0.1 0.2 0.0 0.0 9.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 143.5 228.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 453.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 0.0 0.0 0.0 23.3 0.0 16.4 0.0 0.0 5.8 0.0 6.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.0 0.0 0.0 PRKCZ PKC2 ENSG00000067606 "Protein kinase C zeta" Q05513 1 2050470-2185395 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.6;placenta: 93.0" "Group enriched" "Detected in many" 4 "Late spermatids: 539.8;Syncytiotrophoblasts: 926.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "eosinophil: 15.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.0" "Cell line enhanced" "Detected in many" "BEWO: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021851 Enhanced Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA021851: AB_1855433" "unprognostic (1.25e-2)" "unprognostic (2.61e-1)" "unprognostic (5.10e-2)" "unprognostic (1.14e-2)" "unprognostic (2.08e-1)" "unprognostic (3.61e-2)" "unprognostic (1.73e-2)" "unprognostic (5.13e-2)" "unprognostic (1.18e-1)" "unprognostic (3.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" "prognostic favorable (1.64e-9)" "unprognostic (3.57e-2)" "unprognostic (3.27e-2)" "unprognostic (1.39e-1)" "unprognostic (7.85e-2)" 1.2 7.8 15.9 3.0 31.8 1.4 3.9 39.8 43.6 3.2 8.6 17.1 2.3 20.0 1.7 5.5 10.1 6.5 3.1 6.4 15.5 6.4 11.3 6.8 22.3 5.0 12.2 23.6 1.9 8.5 9.8 12.0 93.0 27.3 5.8 7.5 2.6 7.0 3.0 0.4 8.8 18.4 1.2 8.4 6.9 6.1 17.5 13.5 0.6 14.1 0.9 5.0 4.0 4.6 0.4 0.3 15.0 0.3 0.8 2.6 0.3 7.3 4.7 1.7 8.7 0.0 0.0 23.0 0.5 0.2 5.5 0.3 11.9 16.0 0.0 14.6 1.8 4.8 12.9 9.9 12.3 3.9 0.5 11.0 0.0 7.6 15.8 1.6 0.0 5.7 0.3 7.4 0.0 4.2 0.0 0.0 1.9 3.2 0.1 0.1 9.0 0.4 0.0 3.3 20.2 11.4 0.0 0.0 2.5 9.4 7.8 12.0 9.7 6.0 13.4 2.5 14.9 9.4 2.0 0.0 0.0 6.9 0.0 0.0 3.5 0.6 0.1 0.6 0.1 8.3 0.3 0.0 15.0 0.6 0.3 2.6 0.3 1.0 0.6 0.0 0.4 0.8 0.4 1.2 0.8 0.0 0.3 0.8 0.3 15.9 31.8 39.8 43.6 15.5 6.4 12.2 23.6 27.3 13.5 113.2 71.1 0.8 10.2 11.6 22.8 1.2 2.5 21.4 26.1 7.0 3.9 84.1 6.6 10.9 181.6 6.0 56.7 0.0 9.3 48.8 3.1 16.4 8.1 12.5 12.7 58.8 9.8 6.7 1.0 539.8 8.9 3.3 6.8 5.4 22.1 15.6 12.2 31.6 8.1 19.0 21.6 0.0 2.2 15.8 26.8 11.7 926.6 7.7 25.3 11.9 PRLR ENSG00000113494 "Prolactin receptor" P16471 5 35048756-35230589 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.3;placenta: 45.7;seminal vesicle: 42.7" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 26.1;Proximal tubular cells: 41.8;Syncytiotrophoblasts: 40.4" "Cancer enriched" "Detected in many" 9 "breast cancer: 20.6" "Region enriched" "Detected in many" 7 "pons and medulla: 54.3" "Group enriched" "Detected in some" 4 "classical monocyte: 2.7;intermediate monocyte: 2.8" "Lineage enriched" "Detected in single" 11 "monocytes: 2.8" "Cell line enriched" "Detected in some" 18 "T-47d: 93.7" "Low region specificity" "Detected in many" "Intracellular and membrane" NA NA "unprognostic (3.81e-2)" "unprognostic (2.41e-1)" "unprognostic (2.37e-2)" "unprognostic (6.04e-2)" "unprognostic (5.05e-2)" "unprognostic (8.21e-2)" "unprognostic (3.99e-2)" "unprognostic (7.94e-2)" "unprognostic (4.89e-2)" "unprognostic (1.67e-3)" "unprognostic (4.84e-4)" "unprognostic (2.50e-3)" "unprognostic (4.15e-3)" "unprognostic (1.89e-1)" "unprognostic (1.12e-1)" "unprognostic (9.84e-5)" "unprognostic (1.24e-1)" 0.5 13.3 1.8 0.2 5.6 0.3 13.3 0.4 1.4 23.5 5.3 10.7 36.6 3.5 25.1 10.0 1.1 2.1 2.0 0.6 7.6 2.4 17.8 5.9 0.6 0.0 0.6 0.2 3.2 4.3 11.5 15.7 45.7 54.3 3.2 3.0 0.5 1.8 42.7 0.4 2.6 10.1 6.4 0.7 0.4 3.3 2.0 0.4 0.1 0.5 0.5 0.0 1.4 6.2 0.0 0.2 0.1 2.8 0.0 0.0 0.3 0.0 0.0 0.1 0.7 0.0 0.7 0.1 0.4 0.3 0.8 0.3 0.1 0.0 0.0 0.0 0.5 0.3 0.0 1.0 0.0 0.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.4 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.2 0.0 0.2 93.7 0.7 0.0 0.5 0.5 0.1 0.3 0.0 0.0 0.0 0.9 0.0 0.2 0.1 2.7 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 1.8 5.6 0.4 1.4 7.6 2.4 0.6 0.2 54.3 0.4 0.0 1.3 0.0 0.3 2.6 0.0 0.8 2.5 0.0 0.0 3.5 0.0 26.1 6.6 0.8 0.0 0.2 12.7 0.0 4.4 2.6 3.5 2.2 0.0 9.7 7.5 0.0 8.2 0.6 1.3 0.0 8.1 0.6 0.0 9.0 16.5 0.0 2.4 20.9 12.0 41.8 0.0 0.0 3.8 0.0 0.1 4.4 40.4 0.0 19.8 0.1 PROCR "CCD41, CD201, EPCR" ENSG00000101000 "Protein C receptor" Q9UNN8 20 35172073-35216240 "Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Blood coagulation, Hemostasis" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 77.8" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 89.9;Sertoli cells: 168.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 66.3;HUVEC TERT2: 103.3;TIME: 61.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039461 Enhanced NA NA 1600000000 "HPA039461: AB_10673359" "unprognostic (1.51e-1)" "unprognostic (1.03e-1)" "unprognostic (4.12e-2)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (4.69e-2)" "unprognostic (4.69e-2)" "unprognostic (1.84e-1)" "unprognostic (1.52e-1)" "unprognostic (4.76e-2)" "unprognostic (5.22e-2)" "unprognostic (4.27e-1)" "prognostic unfavorable (7.62e-6)" "unprognostic (3.37e-2)" "unprognostic (2.29e-1)" "unprognostic (1.05e-1)" "unprognostic (2.19e-2)" 51.0 11.9 2.3 10.1 3.2 4.4 24.6 2.9 2.3 16.8 25.0 3.1 14.1 8.7 27.7 44.5 19.4 17.3 13.4 27.4 2.7 2.4 11.7 3.8 10.6 30.3 3.1 2.1 19.3 11.5 2.7 4.7 77.8 7.4 15.5 12.3 16.4 4.2 14.0 17.7 10.4 14.0 20.0 5.8 22.1 10.4 9.1 2.0 0.6 12.1 13.0 3.9 25.8 14.9 1.6 7.3 4.1 1.7 3.4 14.6 2.0 2.5 14.9 0.0 1.6 16.4 13.4 3.4 3.5 15.2 5.8 11.3 19.1 12.9 0.4 10.9 3.5 16.1 8.1 3.4 22.1 4.8 0.1 4.6 5.4 3.6 0.7 4.0 0.2 66.3 11.4 8.3 27.2 22.7 8.5 103.3 0.1 1.9 0.7 5.9 0.8 0.1 0.2 2.1 3.1 15.3 0.1 2.8 0.0 9.8 0.9 0.4 0.2 1.9 4.0 3.1 1.9 1.3 0.8 61.1 14.9 7.5 5.6 5.8 0.0 0.1 0.1 17.1 5.5 3.1 4.1 1.5 0.9 8.3 1.7 14.6 1.0 2.6 5.2 7.3 1.6 0.7 6.3 4.1 3.4 1.4 1.2 2.0 2.0 2.3 3.2 2.9 2.3 2.7 2.4 3.1 2.1 7.4 2.0 0.0 15.9 0.5 14.5 12.4 0.4 1.6 0.0 2.7 7.9 5.2 0.0 9.5 1.7 26.8 0.3 47.6 1.4 0.0 14.7 89.9 27.3 3.7 59.2 1.5 20.7 1.6 5.8 47.9 1.2 1.0 14.4 7.7 3.3 2.8 0.0 0.2 13.9 0.0 2.5 4.2 0.4 168.1 43.8 3.7 7.2 7.3 57.7 6.7 1.6 9.0 PRR5-ARHGAP8 ENSG00000248405 "PRR5-ARHGAP8 readthrough" 22 44702233-44862706 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.5;placenta: 17.9" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 1: 3.0;Collecting duct cells: 5.2;Pancreatic endocrine cells: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 2.4" "Lineage enriched" "Detected in single" 15 "T-cells: 2.4" "Cell line enhanced" "Detected in some" "BEWO: 5.1;CACO-2: 3.3;HEK 293: 5.5;MCF7: 3.6;U-266/70: 10.6" NA NA "unprognostic (1.83e-1)" "unprognostic (1.17e-1)" "unprognostic (1.81e-1)" "unprognostic (5.52e-2)" "unprognostic (3.65e-2)" "unprognostic (6.61e-3)" "unprognostic (3.29e-2)" "unprognostic (1.77e-2)" "unprognostic (2.35e-1)" "unprognostic (2.75e-2)" "unprognostic (2.53e-2)" "unprognostic (6.47e-3)" "unprognostic (9.28e-8)" "unprognostic (8.64e-2)" "unprognostic (9.91e-2)" "unprognostic (2.41e-2)" "unprognostic (3.45e-1)" 1.5 0.5 0.8 2.0 0.8 0.9 3.9 0.6 0.9 4.8 3.1 0.0 1.4 2.3 2.6 7.7 3.7 2.8 2.5 0.5 0.7 0.8 5.7 0.9 1.9 10.6 0.6 0.0 2.6 3.1 3.6 4.2 17.9 0.6 3.4 1.5 4.0 4.9 4.1 0.5 1.6 4.9 0.7 0.6 17.5 1.6 4.3 0.2 3.8 5.6 4.3 7.5 1.8 6.2 0.0 0.0 0.0 0.1 0.0 2.4 0.0 2.1 0.0 0.0 0.1 0.0 0.0 5.1 0.0 2.1 0.0 0.0 3.3 0.5 0.0 0.2 0.0 0.0 1.2 0.8 2.3 0.0 0.0 5.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 1.8 0.4 0.0 0.0 0.0 0.8 0.3 1.2 0.4 0.0 0.0 1.5 0.0 0.1 2.0 0.0 0.0 0.0 0.7 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.4 0.0 0.8 0.8 0.6 0.7 0.7 0.8 0.6 0.0 0.6 0.2 3.0 1.0 0.0 0.5 0.3 0.0 0.0 0.0 1.4 1.2 5.2 0.0 0.5 1.7 1.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.6 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.4 0.9 PSG1 "CD66f, PBG1, PSBG1, PSGGA" ENSG00000231924 "Pregnancy specific beta-1-glycoprotein 1" P11464 19 42866464-42879822 "CD markers, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 362 "placenta: 497.6" "Cell type enriched" "Detected in some" 130 "Syncytiotrophoblasts: 173.1" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 18 "U-2197: 98.0" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" "unprognostic (2.02e-1)" "unprognostic (3.54e-1)" "unprognostic (2.44e-7)" "unprognostic (2.28e-2)" 1.3 0.0 0.1 0.0 0.1 0.0 0.6 0.5 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 497.6 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.2 0.0 1.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.2 1.4 0.3 0.5 0.0 0.0 0.0 0.0 4.8 1.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 5.4 0.0 0.0 0.1 0.0 0.0 98.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 1.0 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.5 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 173.1 0.0 0.0 0.0 PSG11 "MGC22484, PSG13, PSG14" ENSG00000243130 "Pregnancy specific beta-1-glycoprotein 11" Q9UQ72 19 43007656-43026512 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 220 "placenta: 151.1" "Cell type enriched" "Detected in single" 172 "Syncytiotrophoblasts: 135.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "U-2197: 19.7" "HPA042240, HPA046327" Enhanced "Secreted in female reproductive system" NA NA "HPA042240: AB_10797384, HPA046327: AB_2679624" "unprognostic (2.58e-1)" 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 151.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 135.4 0.0 0.0 0.0 PSG2 "CEA, PSBG2, PSG1, PSGGB" ENSG00000242221 "Pregnancy specific beta-1-glycoprotein 2" P11465 19 43064211-43083045 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 102 "placenta: 75.3" "Cell type enriched" "Detected in some" 35 "Syncytiotrophoblasts: 671.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 6.5;fHDF/TERT166: 14.0;HBF TERT88: 21.8;SuSa: 6.1;U-2197: 28.0" "Secreted in female reproductive system" NA NA "unprognostic (1.02e-2)" 0.4 0.0 0.2 0.0 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 75.3 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.7 0.0 0.2 0.0 0.1 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 1.1 0.6 2.9 0.0 0.0 0.0 0.0 14.0 0.8 0.3 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.3 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.8 0.2 0.0 0.0 0.0 0.0 19.2 0.3 0.5 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 671.0 0.0 0.0 0.6 PSG3 ENSG00000221826 "Pregnancy specific beta-1-glycoprotein 3" Q16557 19 42721638-42740569 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 146 "placenta: 495.8" "Cell type enriched" "Detected in some" 171 "Syncytiotrophoblasts: 1321.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "hTERT-RPE1: 1.7;SuSa: 3.5;U-2197: 5.0" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 495.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.7 0.4 0.1 0.0 0.0 0.0 0.5 0.6 0.6 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 3.5 6.3 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1321.0 0.0 0.0 0.0 PSG4 ENSG00000243137 "Pregnancy specific beta-1-glycoprotein 4" Q00888 19 43192702-43207299 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 348.5" "Cell type enriched" "Detected in some" 54 "Syncytiotrophoblasts: 463.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 107.6;U-2197: 29.2" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" "unprognostic (4.29e-2)" "unprognostic (5.18e-2)" "unprognostic (9.49e-2)" "unprognostic (2.52e-2)" "unprognostic (3.63e-2)" "unprognostic (1.94e-1)" "unprognostic (2.07e-2)" "unprognostic (1.70e-1)" "unprognostic (7.75e-2)" "unprognostic (8.82e-3)" "unprognostic (1.03e-3)" "unprognostic (1.68e-2)" "unprognostic (2.85e-1)" "unprognostic (2.57e-1)" 0.6 0.4 0.2 0.5 0.2 0.0 1.4 0.2 0.2 0.2 8.2 0.2 0.2 0.0 0.2 0.2 1.2 0.0 0.2 0.2 0.2 0.0 2.0 0.2 0.2 0.2 0.2 0.2 0.2 2.0 49.1 0.6 348.5 0.2 0.6 5.8 0.2 4.4 0.2 0.2 6.3 0.2 0.2 0.2 0.2 1.1 0.2 0.2 0.2 0.2 0.3 0.3 0.2 1.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.5 0.0 0.3 107.6 0.8 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.6 11.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.1 3.0 0.0 0.0 0.8 0.4 1.1 29.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 3.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 4.9 0.0 0.0 0.0 0.0 0.0 8.5 0.2 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 463.1 0.0 0.0 0.3 PSG5 "FL-NCA-3, PSG" ENSG00000204941 "Pregnancy specific beta-1-glycoprotein 5" Q15238 19 43166256-43186536 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 73 "placenta: 171.3" "Cell type enriched" "Detected in some" 41 "Syncytiotrophoblasts: 605.9" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 8 "BJ: 52.4;fHDF/TERT166: 180.6" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" "unprognostic (1.59e-1)" "unprognostic (3.38e-2)" "unprognostic (4.69e-2)" "unprognostic (1.62e-2)" "unprognostic (2.18e-1)" "unprognostic (2.04e-1)" "unprognostic (1.75e-2)" "unprognostic (1.12e-2)" "unprognostic (2.62e-2)" "unprognostic (1.03e-1)" "unprognostic (7.92e-2)" 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 0.1 171.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.2 0.0 0.4 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 2.0 0.5 0.6 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 52.4 15.1 0.8 7.3 0.0 0.0 0.0 0.0 180.6 0.2 2.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.4 0.7 0.4 0.5 0.6 0.5 0.5 0.2 1.0 0.7 0.5 2.0 0.6 0.4 0.5 0.4 0.0 0.0 0.1 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 1.8 0.0 5.3 0.0 4.3 0.8 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 605.9 0.0 0.0 0.0 PSG6 ENSG00000170848 "Pregnancy specific beta-1-glycoprotein 6" Q00889 19 42902079-42919563 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 124 "placenta: 330.8" "Cell type enriched" "Detected in some" 204 "Syncytiotrophoblasts: 304.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 27 "neutrophil: 2.6" "Lineage enriched" "Detected in single" 27 "granulocytes: 2.6" "Cell line enriched" "Detected in some" 17 "U-2197: 57.9" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" "unprognostic (4.23e-1)" 0.1 0.1 0.2 0.0 0.1 0.8 0.1 0.4 0.1 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 330.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.2 0.4 0.0 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 57.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 304.0 0.0 0.0 0.0 PSG7 ENSG00000221878 "Pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene)" 19 42924132-42937178 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "placenta: 23.1" "Cell type enriched" "Detected in some" 105 "Syncytiotrophoblasts: 135.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 4.0;fHDF/TERT166: 2.8;HBF TERT88: 5.9;U-2197: 4.8" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.9 0.2 1.3 0.0 0.0 0.0 0.0 2.8 0.9 0.1 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 135.5 0.0 0.0 0.0 PSG8 ENSG00000124467 "Pregnancy specific beta-1-glycoprotein 8" Q9UQ74 19 42752686-42855691 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 88 "placenta: 142.2" "Cell type enriched" "Detected in some" 12 "Syncytiotrophoblasts: 28.7" "Cancer enriched" "Detected in single" 17 "thyroid cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.8;CAPAN-2: 1.1;HBF TERT88: 1.3;SuSa: 1.7;U-2197: 2.5" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" "unprognostic (1.85e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.2 142.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.4 0.0 0.0 1.1 0.0 0.1 0.1 0.7 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.5 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 2.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.7 0.0 0.0 0.0 PSG9 "PSG11, PSGII" ENSG00000183668 "Pregnancy specific beta-1-glycoprotein 9" Q00887 19 43211791-43269530 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 205 "placenta: 299.0" "Cell type enriched" "Detected in some" 109 "Syncytiotrophoblasts: 231.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.4" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "BJ: 5.0;GAMG: 16.0;HBF TERT88: 9.2;SuSa: 11.0;U-2197: 9.5" HPA046327 Supported "Secreted in female reproductive system" NA NA "HPA046327: AB_2679624" "unprognostic (9.32e-2)" "unprognostic (3.28e-1)" "unprognostic (2.15e-1)" 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.6 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.2 299.0 0.0 0.2 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.4 0.2 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.0 2.8 4.4 2.3 0.1 0.1 0.0 0.2 1.3 16.0 0.3 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.5 11.0 4.2 0.0 0.2 0.1 2.1 9.5 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.5 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 231.8 0.0 0.0 0.0 PSKH2 ENSG00000147613 "Protein serine kinase H2" Q96QS6 8 86048373-86088621 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "kidney: 1.9;placenta: 1.2;testis: 2.0" "Cell type enhanced" "Detected in single" 35 "Rod photoreceptor cells: 1.3" "Cancer enhanced" "Detected in single" "testis cancer: 0.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 18 "HEL: 14.3" "HPA015095, HPA056839" Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytosol" "HPA015095: AB_1855815, HPA056839: " "unprognostic (1.77e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PTGES "MGST-IV, MGST1-L1, MGST1L1, PIG12, TP53I12" ENSG00000148344 "Prostaglandin E synthase" O14684 9 129738331-129753047 "Enzymes, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 59.8;placenta: 51.7;seminal vesicle: 182.9" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 118.4;Extravillous trophoblasts: 226.1;Fibroblasts: 92.9;Syncytiotrophoblasts: 231.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "basophil: 16.8" "Lineage enriched" "Detected in many" 5 "granulocytes: 16.8" "Cell line enhanced" "Detected in many" "ASC diff: 30.0;BEWO: 31.9;GAMG: 57.8;HaCaT: 41.7;SK-BR-3: 30.6;U-2197: 79.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA045064 Enhanced Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA045064: AB_10795889" "unprognostic (2.92e-3)" "unprognostic (1.09e-1)" "prognostic unfavorable (2.32e-4)" "unprognostic (2.54e-2)" "unprognostic (1.94e-3)" "unprognostic (1.25e-1)" "unprognostic (5.38e-3)" "unprognostic (1.24e-3)" "unprognostic (2.92e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (7.97e-5)" "unprognostic (2.22e-1)" "unprognostic (4.66e-2)" "unprognostic (9.78e-3)" "unprognostic (3.19e-2)" "unprognostic (1.30e-1)" "unprognostic (5.20e-2)" 17.0 0.6 1.1 6.2 1.7 3.0 16.7 1.1 1.8 11.9 4.2 0.8 59.8 1.2 2.0 9.1 8.7 2.7 4.1 4.2 2.1 3.5 3.9 0.4 3.5 3.1 1.3 0.7 2.7 0.6 6.3 0.7 51.7 2.1 11.2 2.0 2.9 16.3 182.9 2.5 19.8 3.7 4.8 1.4 1.3 3.4 9.9 0.6 2.3 1.7 6.6 14.1 14.5 15.0 0.0 0.1 16.8 3.2 0.0 0.0 0.1 0.2 18.7 0.0 8.9 30.0 10.4 31.9 1.4 12.3 0.2 0.3 0.9 13.7 0.0 0.5 3.4 57.8 41.7 0.1 1.4 0.1 0.0 0.1 0.0 13.3 0.0 0.7 0.0 0.0 6.1 9.7 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.2 8.9 1.6 0.0 0.0 0.0 1.0 19.9 0.1 0.7 16.7 30.6 0.1 1.3 16.0 0.0 0.0 0.0 0.0 79.1 0.0 0.0 0.0 0.0 15.7 0.0 0.1 16.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 3.2 0.0 0.0 0.1 1.1 1.7 1.1 1.8 2.1 3.5 1.3 0.7 2.1 0.6 0.0 0.0 0.0 8.2 15.9 0.0 0.0 0.0 0.0 4.5 3.5 0.0 118.4 1.7 10.6 0.4 0.3 0.0 0.0 1.0 226.1 92.9 6.9 1.1 0.0 15.4 0.0 7.0 0.0 0.0 0.0 0.3 3.8 13.5 12.6 6.4 0.0 5.7 0.0 0.0 0.5 0.0 0.0 11.2 0.3 0.0 37.6 231.0 0.0 0.3 38.2 QSOX1 QSCN6 ENSG00000116260 "Quiescin sulfhydryl oxidase 1" O00391 1 180154834-180204030 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 172.2" "Cell type enriched" "Detected in many" 8 "Extravillous trophoblasts: 1528.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 197.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA056243 Supported "Golgi apparatus,Vesicles" "Secreted to extracellular matrix" NA NA 3200000000 "Golgi apparatus" Vesicles "HPA056243: AB_2683077" "unprognostic (1.13e-1)" "unprognostic (2.62e-3)" "unprognostic (2.46e-1)" "unprognostic (2.49e-2)" "unprognostic (2.00e-2)" "unprognostic (2.73e-1)" "unprognostic (5.47e-2)" "unprognostic (2.22e-1)" "unprognostic (3.94e-1)" "unprognostic (3.12e-2)" "unprognostic (5.07e-2)" "unprognostic (2.80e-3)" "prognostic unfavorable (1.86e-5)" "unprognostic (3.25e-1)" "unprognostic (2.14e-1)" "unprognostic (3.53e-2)" "unprognostic (1.40e-1)" 15.9 18.7 8.0 14.5 9.5 30.1 12.6 7.3 13.6 23.5 25.3 13.8 24.9 19.8 17.8 44.9 36.8 18.9 91.9 54.4 10.1 9.0 15.4 23.1 42.3 19.5 8.5 9.1 46.5 59.8 6.2 13.5 172.2 13.4 28.0 24.5 12.1 20.6 19.4 18.4 12.3 19.0 33.9 15.5 13.4 52.8 50.3 9.1 6.7 7.8 18.2 18.3 35.8 26.1 2.9 19.2 20.4 25.5 8.0 7.1 11.4 42.1 6.0 1.4 18.0 18.4 38.1 71.7 44.9 45.4 38.4 27.1 0.7 13.6 0.6 27.9 35.9 5.3 9.2 1.7 12.1 18.8 2.5 2.7 1.3 3.5 1.8 197.7 4.6 13.0 20.3 5.5 40.9 49.1 50.6 56.5 3.1 1.9 6.6 25.2 7.3 0.9 8.6 4.9 29.2 17.3 1.8 3.3 1.1 6.3 12.0 5.2 5.3 13.1 17.9 8.7 3.4 3.2 21.9 66.5 48.1 18.9 32.2 37.9 4.8 7.9 1.1 18.3 14.8 14.4 5.8 25.5 9.5 7.1 14.7 5.3 2.9 4.8 5.0 19.2 1.8 4.4 4.3 20.4 8.0 13.1 3.9 5.5 11.4 8.0 9.5 7.3 13.6 10.1 9.0 8.5 9.1 13.4 9.1 53.6 87.2 7.8 26.2 12.2 9.8 43.7 68.8 14.7 43.3 68.0 23.6 13.2 0.0 189.3 48.3 38.6 47.7 0.0 114.6 1528.4 54.2 30.1 25.3 1.5 63.8 6.4 44.4 101.9 45.4 16.5 164.5 43.6 42.2 44.1 163.8 43.9 172.2 143.8 66.8 9.5 6.5 32.3 17.5 20.9 25.4 8.7 129.1 15.0 96.4 58.0 RAB3B ENSG00000169213 "RAB3B, member RAS oncogene family" P20337 1 51907956-51990764 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.2;placenta: 37.6;prostate: 20.0" "Cell type enhanced" "Detected in many" 17 "Alveolar cells type 1: 137.0;Alveolar cells type 2: 101.3;Intestinal endocrine cells: 282.2" "Group enriched" "Detected in many" 6 "prostate cancer: 19.4;testis cancer: 6.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 44.6;BJ hTERT+: 17.3;fHDF/TERT166: 16.1;HBF TERT88: 15.3;TIME: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003159, CAB023293" Enhanced Approved "Cell Junctions" NA NA "Cell Junctions" "CAB023293: , HPA003159: AB_1856005" "unprognostic (1.10e-1)" "unprognostic (2.20e-3)" "unprognostic (5.43e-3)" "unprognostic (1.65e-2)" "unprognostic (1.82e-1)" "unprognostic (1.38e-2)" "unprognostic (1.20e-2)" "unprognostic (8.77e-3)" "unprognostic (2.79e-1)" "unprognostic (2.81e-1)" "unprognostic (2.42e-2)" "unprognostic (1.06e-1)" "unprognostic (1.03e-2)" "unprognostic (2.02e-3)" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.15e-2)" 0.4 5.8 16.6 1.4 8.5 0.8 1.8 2.0 13.8 0.4 3.1 0.9 0.0 1.6 0.5 0.8 0.5 0.7 2.7 0.4 9.9 15.8 1.4 1.3 0.5 0.5 4.5 9.3 3.2 2.1 0.4 13.7 37.6 18.2 20.0 4.4 0.1 0.8 0.6 1.0 3.7 1.9 0.9 1.4 0.5 2.7 0.8 1.3 0.0 0.5 0.0 0.6 0.6 0.4 1.1 0.8 2.1 0.5 0.5 0.4 0.0 0.6 3.0 0.4 0.5 0.1 0.8 0.0 44.6 17.3 9.0 4.4 3.6 1.3 0.2 0.7 16.1 1.3 0.0 5.5 4.6 15.3 0.0 0.4 0.0 0.2 1.2 0.7 0.0 0.0 0.4 0.1 14.9 3.4 5.6 2.8 0.4 0.1 0.1 9.9 0.1 0.0 0.0 7.2 0.8 0.4 0.1 0.0 0.0 1.4 0.2 1.5 0.4 0.0 0.1 0.0 9.3 0.0 0.1 34.6 8.8 3.2 0.1 14.5 0.0 0.2 0.1 8.0 0.0 0.3 1.1 0.5 0.3 0.4 0.3 0.3 0.6 0.3 0.4 0.1 1.1 0.4 0.4 2.1 0.5 0.5 0.8 0.2 0.0 16.6 8.5 2.0 13.8 9.9 15.8 4.5 9.3 18.2 1.3 137.0 101.3 0.9 5.2 2.2 2.4 0.6 15.3 52.2 51.2 0.0 2.0 0.6 3.3 4.0 1.9 0.5 1.3 0.0 15.3 0.2 0.9 19.1 7.0 0.4 0.3 0.0 282.2 0.0 2.6 1.0 0.6 0.9 1.7 1.0 6.1 24.2 59.3 0.3 1.1 0.0 3.5 0.0 0.4 1.9 4.8 1.3 3.3 0.7 1.5 2.6 RAI14 "DKFZp564G013, KIAA1334, NORPEG, RAI13" ENSG00000039560 "Retinoic acid induced 14" Q9P0K7 5 34656237-34832627 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 64.4" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 166.4;Early spermatids: 198.0;Late spermatids: 250.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 59.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036949, HPA036950" Supported Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA Nucleoplasm "Actin filaments, Cytosol" "HPA036949: AB_10670568, HPA036950: AB_10669721" "unprognostic (7.63e-2)" "unprognostic (9.86e-2)" "unprognostic (4.87e-2)" "unprognostic (1.40e-1)" "unprognostic (3.38e-2)" "unprognostic (4.75e-2)" "unprognostic (5.49e-2)" "unprognostic (6.18e-2)" "unprognostic (6.28e-2)" "unprognostic (2.62e-1)" "unprognostic (8.18e-2)" "unprognostic (4.58e-2)" "prognostic unfavorable (9.75e-4)" "prognostic unfavorable (2.05e-4)" "unprognostic (1.33e-1)" "unprognostic (4.81e-2)" "unprognostic (4.34e-2)" 5.6 4.5 3.9 8.3 5.9 0.5 5.1 4.4 3.2 23.3 9.1 5.5 14.1 2.5 29.2 8.2 8.8 6.8 8.8 3.6 4.4 3.5 7.7 11.2 10.4 5.1 6.9 1.5 9.5 4.8 6.4 2.7 64.4 5.6 10.4 4.0 8.2 8.4 10.8 2.0 7.6 3.6 34.7 17.0 21.2 6.0 26.6 5.7 2.1 6.7 2.7 3.8 22.5 14.9 0.8 0.6 2.5 0.8 2.5 3.3 0.3 2.7 10.8 12.5 8.3 6.7 23.5 16.0 32.7 26.4 18.9 19.0 8.2 3.5 0.6 13.1 16.0 20.7 1.8 14.2 24.1 41.1 0.0 6.8 4.5 10.2 5.0 20.8 0.1 0.4 21.9 7.6 33.9 27.1 31.2 59.9 1.0 6.3 0.2 24.6 2.2 0.4 0.1 9.7 1.6 10.5 3.9 19.1 0.1 22.0 15.6 3.3 1.8 19.3 2.9 8.8 19.1 3.3 0.5 38.5 30.8 16.5 7.5 14.2 0.7 0.0 0.0 26.0 0.0 11.9 2.5 0.8 0.3 3.3 0.3 0.4 0.5 1.0 0.2 0.2 0.8 0.3 0.6 1.6 2.5 0.1 0.6 0.1 0.3 3.9 5.9 4.4 3.2 4.4 3.5 6.9 1.5 5.6 5.7 98.3 166.4 1.7 20.2 10.6 1.9 3.3 5.1 24.1 95.5 33.2 64.8 23.9 6.6 30.0 198.0 51.8 3.2 0.0 24.7 59.3 26.2 11.8 3.5 21.9 6.5 14.3 1.7 16.5 2.4 250.8 66.7 4.2 5.0 1.8 0.8 18.5 39.1 1.9 29.7 18.0 4.7 0.0 17.3 8.1 12.4 13.8 130.6 2.5 2.3 63.1 RASA1 "CM-AVM, GAP, p120, p120GAP, p120RASGAP, RASA" ENSG00000145715 "RAS p21 protein activator 1" P20936 5 87267888-87391931 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 13 "placenta: 260.6" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 169.8;Syncytiotrophoblasts: 407.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007789, HPA036393, HPA064556" Enhanced NA NA 7900 "CAB007789: AB_598183, HPA036393: AB_2675097, HPA064556: AB_2685285" "unprognostic (1.57e-1)" "unprognostic (7.63e-2)" "unprognostic (1.88e-3)" "unprognostic (2.14e-1)" "unprognostic (1.23e-1)" "unprognostic (1.38e-2)" "unprognostic (6.88e-2)" "unprognostic (8.38e-3)" "unprognostic (2.23e-1)" "unprognostic (1.07e-2)" "unprognostic (4.12e-3)" "unprognostic (1.03e-1)" "unprognostic (3.98e-2)" "unprognostic (1.59e-2)" "unprognostic (5.39e-2)" "unprognostic (1.65e-1)" "unprognostic (1.30e-3)" 12.4 8.8 12.3 8.9 12.8 6.4 11.4 17.3 16.3 11.3 8.1 8.6 9.3 6.9 12.4 11.4 10.2 9.5 9.3 7.2 12.0 10.9 8.7 6.5 8.4 9.2 10.1 13.8 15.9 8.2 20.3 12.2 260.6 9.3 8.0 9.8 9.6 10.6 9.6 6.9 9.7 10.0 9.0 9.4 13.7 7.4 14.4 10.0 10.7 14.4 5.7 9.6 11.3 9.8 2.0 1.3 3.1 2.6 8.1 3.5 1.1 11.7 6.5 11.5 7.3 9.8 14.4 8.9 18.7 12.1 11.6 19.1 4.4 31.0 7.6 4.5 20.4 13.2 5.5 5.3 15.2 35.1 7.4 4.2 5.6 5.6 4.8 9.9 4.1 6.8 8.1 9.7 32.5 18.4 19.4 16.1 4.3 3.1 16.4 39.8 7.1 5.0 6.1 5.9 2.5 12.3 6.3 26.0 11.2 10.0 10.2 7.0 7.6 6.9 8.9 9.9 11.1 8.0 6.4 23.8 14.8 6.5 7.6 23.3 5.7 5.9 7.7 21.6 8.6 10.5 3.1 1.3 1.4 2.0 2.6 3.5 1.4 2.4 1.9 1.1 2.0 2.1 1.9 1.7 8.1 2.4 1.3 3.0 1.1 12.3 12.8 17.3 16.3 12.0 10.9 10.1 13.8 9.3 10.0 11.9 12.0 2.9 5.9 13.3 23.6 5.6 5.1 14.7 12.5 15.7 27.5 169.8 5.0 9.8 4.8 14.0 10.7 0.0 6.8 47.6 15.3 9.3 8.1 10.5 40.5 30.2 15.5 19.0 22.7 3.6 13.0 12.2 13.5 10.8 13.7 12.2 17.6 15.9 12.7 8.8 17.6 0.0 10.3 33.3 14.9 15.3 407.7 13.1 12.1 7.9 RGPD1 RGP1 ENSG00000187627 "RANBP2-like and GRIP domain containing 1" P0DJD0 2 86907953-87013976 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "cervix, uterine: 10.4;placenta: 8.0;testis: 17.7" "Cell type enhanced" "Detected in some" 17 "Cardiomyocytes: 1.6;Early spermatids: 1.9;granulocytes: 3.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 8.8;MOLT-4: 13.2;NTERA-2: 4.0;RPMI-8226: 2.9;SuSa: 7.7" "HPA049497, HPA051675, HPA067564" Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Nuclear membrane, Vesicles" "HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862" "unprognostic (8.24e-2)" "unprognostic (6.05e-2)" "unprognostic (6.41e-2)" "unprognostic (1.39e-2)" "unprognostic (9.06e-2)" "unprognostic (6.28e-2)" "unprognostic (1.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.30e-1)" "unprognostic (1.88e-5)" "unprognostic (2.23e-1)" "unprognostic (2.22e-2)" "unprognostic (5.36e-3)" "unprognostic (1.99e-2)" 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.1 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 3.0 0.0 0.1 0.2 0.2 1.7 1.1 4.8 8.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.3 0.3 17.7 0.2 0.5 0.0 0.1 1.3 0.0 0.1 0.0 1.1 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 13.2 0.2 4.0 0.2 0.0 0.1 0.1 2.9 0.0 0.0 0.1 0.8 0.2 0.0 0.0 7.7 0.0 0.0 0.0 0.6 0.1 0.1 0.0 1.1 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 1.3 0.5 0.7 0.0 0.2 0.1 0.8 0.0 1.1 0.0 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.4 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 RHOBTB1 KIAA0740 ENSG00000072422 "Rho related BTB domain containing 1" O94844 10 60869438-61001440 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 50.9;skeletal muscle: 63.5" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 127.6;Horizontal cells: 316.2;Syncytiotrophoblasts: 252.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 1.6;NK-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 34.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA040205, HPA040226" Approved Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA040205: AB_2676883, HPA040226: AB_10795377" "unprognostic (1.25e-1)" "unprognostic (2.72e-2)" "unprognostic (6.69e-3)" "unprognostic (2.63e-2)" "unprognostic (1.08e-1)" "unprognostic (1.34e-1)" "unprognostic (3.22e-3)" "unprognostic (1.64e-1)" "unprognostic (2.25e-1)" "unprognostic (4.31e-1)" "unprognostic (1.39e-1)" "unprognostic (5.53e-2)" "unprognostic (8.54e-3)" "unprognostic (1.38e-1)" "unprognostic (1.79e-1)" "unprognostic (7.16e-2)" "unprognostic (2.57e-2)" 7.6 9.8 2.7 2.0 5.8 0.5 4.5 0.8 5.0 8.8 4.7 7.2 16.5 3.4 10.2 4.9 1.9 6.8 6.3 6.6 3.7 2.5 20.5 3.4 5.4 1.4 6.7 2.3 6.9 6.0 7.4 2.2 50.9 4.6 4.9 2.6 13.3 1.4 20.3 63.5 1.9 3.5 7.7 3.8 7.4 11.7 8.5 5.7 0.6 2.3 5.2 0.9 5.0 5.2 0.5 1.6 0.7 0.6 1.3 0.0 1.3 0.1 6.2 9.5 0.0 4.5 4.0 0.0 2.7 2.5 2.3 3.5 0.3 0.1 0.0 11.7 14.5 1.1 0.1 2.8 0.8 2.7 0.0 2.5 0.5 4.5 34.5 4.9 0.7 0.2 5.7 1.6 1.4 1.4 8.8 10.8 2.0 5.1 0.0 10.1 0.2 2.6 0.0 4.1 0.1 4.1 2.3 13.3 3.2 7.5 0.3 2.6 10.2 3.3 3.6 3.6 6.2 0.7 1.2 9.6 4.4 11.7 0.1 3.0 0.0 0.0 0.0 2.2 2.0 2.4 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.5 0.0 0.0 0.7 1.3 0.6 0.0 0.0 1.3 2.7 5.8 0.8 5.0 3.7 2.5 6.7 2.3 4.6 5.7 14.9 8.3 0.0 0.8 1.5 2.7 24.9 2.5 12.0 3.4 1.8 127.6 49.5 1.7 3.2 49.1 7.1 0.6 0.0 13.6 3.6 9.0 1.0 0.0 1.8 10.1 316.2 7.9 16.5 12.3 26.5 7.5 3.2 1.7 0.0 6.7 20.9 14.1 3.4 4.6 30.1 26.0 6.5 4.1 1.6 1.0 1.3 252.8 0.0 2.3 0.2 RHOBTB3 KIAA0878 ENSG00000164292 "Rho related BTB domain containing 3" O94955 5 95713522-95824383 "Predicted intracellular proteins" Transport Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 86.0" "Cell type enhanced" "Detected in many" 6 "Leydig cells: 367.9;Muller glia cells: 260.1;Peritubular cells: 295.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 10.1" "Group enriched" "Detected in many" 4 "granulocytes: 10.1;T-cells: 2.9" "Cell line enhanced" "Detected in many" "EFO-21: 49.0;HaCaT: 62.3;SuSa: 64.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000265 Uncertain Vesicles NA NA Vesicles "HPA000265: " "unprognostic (1.68e-1)" "unprognostic (9.60e-2)" "unprognostic (5.62e-2)" "unprognostic (1.31e-3)" "unprognostic (1.84e-1)" "unprognostic (3.39e-2)" "unprognostic (7.37e-2)" "unprognostic (4.28e-1)" "unprognostic (6.00e-3)" "unprognostic (9.29e-2)" "unprognostic (9.15e-2)" "unprognostic (3.64e-1)" "unprognostic (1.56e-3)" "unprognostic (7.01e-3)" "unprognostic (1.15e-1)" "unprognostic (3.23e-1)" "unprognostic (8.21e-2)" 38.7 21.4 27.0 6.4 25.8 4.0 12.8 11.8 23.1 16.4 12.0 26.9 11.8 8.2 7.5 15.5 9.8 7.8 11.0 17.6 26.2 12.8 16.4 11.5 9.5 3.6 20.1 21.3 46.6 59.2 24.1 11.0 86.0 13.0 16.4 11.7 21.7 21.0 12.2 15.3 7.4 9.0 11.2 18.2 6.0 12.1 12.4 21.3 1.8 11.1 4.1 1.6 10.9 12.8 0.8 1.2 10.1 1.5 0.5 2.9 0.9 9.8 4.0 9.9 10.5 37.3 21.6 0.1 17.3 16.4 6.7 10.6 19.1 1.8 0.0 49.0 8.8 17.6 62.3 5.3 1.2 11.6 0.4 6.8 3.4 37.9 5.5 29.4 0.8 4.9 35.0 0.9 10.0 0.1 28.8 5.1 3.0 13.5 2.6 26.7 2.8 1.0 2.7 3.7 6.2 6.2 1.4 19.4 1.2 5.6 7.1 17.5 22.7 13.5 5.9 16.0 64.3 4.5 4.9 8.2 9.0 38.9 6.0 6.5 2.6 5.0 0.4 2.8 0.2 14.8 0.1 0.9 10.1 2.9 0.5 1.2 0.8 2.1 2.5 0.2 0.2 2.9 0.6 0.7 0.5 1.5 1.2 1.1 0.9 27.0 25.8 11.8 18.6 26.2 12.8 20.1 21.3 13.0 21.3 163.8 14.1 3.7 50.7 9.6 69.6 74.7 38.2 41.5 47.8 134.3 19.6 42.1 51.4 57.7 7.8 11.7 11.8 0.0 94.5 117.9 62.8 65.1 97.1 69.3 27.2 6.4 88.2 13.5 15.6 6.5 367.9 11.7 40.5 4.6 63.7 260.1 55.3 49.1 295.9 3.4 33.3 32.3 54.7 1.7 1.9 24.0 96.3 10.1 77.7 76.4 RSPO2 MGC35555 ENSG00000147655 "R-spondin 2" Q6UXX9 8 107899316-108083648 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction, Wnt signaling pathway" "Developmental protein, Heparin-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.0;placenta: 20.1" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 1.4;Late spermatids: 2.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "intermediate monocyte: 1.6" "Lineage enriched" "Detected in single" 17 "monocytes: 1.6" "Cell line enhanced" "Detected in some" "HEK 293: 3.6;HEL: 3.3;NTERA-2: 2.0;U-138 MG: 3.6;U-266/70: 10.7" "Group enriched" "Detected in some" 7 "amygdala: 8.2;cerebral cortex: 18.2;hippocampal formation: 23.2" "Group enriched" "Detected in many" 5 "amygdala: 23.3;cerebral cortex: 18.0;hippocampal formation: 24.1;midbrain: 33.2" "HPA024764, CAB025900, HPA053068" Uncertain "Secreted in other tissues" NA NA "CAB025900: , HPA024764: AB_10603236, HPA053068: AB_2682031" "unprognostic (1.10e-2)" "unprognostic (2.18e-1)" "unprognostic (3.97e-2)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (1.19e-1)" "unprognostic (8.33e-3)" "unprognostic (1.82e-1)" "unprognostic (9.48e-2)" "unprognostic (1.31e-1)" "unprognostic (1.40e-1)" "unprognostic (8.45e-2)" "unprognostic (1.95e-2)" "unprognostic (1.17e-2)" 0.4 0.5 3.9 1.4 6.3 0.5 0.2 1.9 27.0 3.6 12.0 4.2 3.6 5.1 0.3 3.6 8.9 0.2 4.8 0.5 5.8 10.5 0.2 1.1 9.3 0.2 15.7 5.4 1.1 0.2 0.2 2.8 20.1 2.0 11.6 10.1 15.5 0.2 3.4 0.3 0.3 5.8 0.7 1.3 0.2 8.3 2.0 1.7 0.0 0.2 0.0 0.2 2.2 1.2 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 3.6 0.2 0.1 0.0 10.7 0.0 0.0 1.1 0.4 0.0 0.0 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 6.3 1.9 27.0 5.8 10.5 15.7 5.4 2.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.8 0.0 0.0 0.0 RTL1 "HUR1, Mar1, MART1, PEG11, SIRH2" ENSG00000254656 "Retrotransposon Gag like 1" A6NKG5 14 100880655-100884847 "Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 5.0;brain: 7.6;placenta: 8.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "melanoma: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 31 "SH-SY5Y: 121.1" "Region enhanced" "Detected in single" "hypothalamus: 2.1" "HPA066979, HPA077601" Enhanced Approved Cytosol No NA Cytosol "HPA066979: AB_2685759, HPA077601: " "unprognostic (1.61e-1)" "unprognostic (3.30e-1)" "unprognostic (1.26e-1)" "unprognostic (1.42e-3)" "unprognostic (2.10e-1)" 0.0 5.0 0.2 0.0 0.9 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 7.6 0.0 0.0 0.0 0.0 1.8 1.3 0.1 0.0 0.3 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 121.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RXFP1 "LGR7, RXFPR1" ENSG00000171509 "Relaxin/insulin like family peptide receptor 1" Q9HBX9 4 158315311-158653372 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.7;placenta: 12.2" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 9 "endometrial cancer: 3.9" "Group enriched" "Detected in many" 6 "basal ganglia: 10.4;cerebral cortex: 18.5;olfactory region: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 24.2;HEL: 8.0;RPTEC TERT1: 11.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA027067 Approved NA NA "HPA027067: AB_10602127" "unprognostic (3.07e-3)" "unprognostic (3.02e-3)" "unprognostic (1.05e-1)" "unprognostic (2.53e-3)" "unprognostic (2.97e-2)" "unprognostic (4.15e-3)" "unprognostic (6.13e-2)" "unprognostic (6.18e-3)" "unprognostic (3.01e-1)" "unprognostic (5.14e-6)" "unprognostic (8.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.33e-4)" "unprognostic (3.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.31e-1)" "unprognostic (6.22e-3)" 0.5 6.5 2.1 0.5 10.4 0.2 0.4 0.4 19.7 4.0 0.5 0.0 1.1 0.3 9.0 1.6 0.5 1.3 1.2 0.4 2.0 1.7 2.9 2.1 5.1 0.7 0.8 12.4 0.8 0.6 0.2 0.6 12.2 0.0 1.0 0.3 0.6 0.4 4.2 0.4 0.4 0.9 1.3 0.4 0.6 0.6 0.6 0.0 0.0 2.4 0.0 0.6 0.5 2.2 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.1 10.4 0.4 18.5 2.0 1.7 0.8 12.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.1 0.1 0.0 0.0 0.0 SCARB1 "CD36L1, CLA-1, CLA1, SR-BI, SRB1" ENSG00000073060 "Scavenger receptor class B member 1" Q8WTV0 12 124776856-124882668 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 173.1;liver: 93.7;placenta: 65.9" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 105.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 24.9" "Group enriched" "Detected in many" 5 "dendritic cells: 24.9;monocytes: 6.5" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066285, CAB070124, HPA072449" Enhanced Approved "Vesicles,Lysosomes,Rods & Rings" NA NA Vesicles "Lysosomes, Rods & Rings" "CAB070124: AB_10107658, HPA066285: AB_2685649, HPA072449: AB_2732201" "unprognostic (9.70e-3)" "unprognostic (4.94e-3)" "unprognostic (1.32e-1)" "unprognostic (4.79e-2)" "unprognostic (1.65e-3)" "unprognostic (4.21e-3)" "prognostic unfavorable (1.83e-5)" "prognostic unfavorable (4.02e-4)" "unprognostic (2.30e-1)" "unprognostic (1.09e-1)" "unprognostic (1.80e-2)" "unprognostic (4.99e-2)" "prognostic unfavorable (1.49e-5)" "unprognostic (3.50e-1)" "unprognostic (1.49e-1)" "unprognostic (1.81e-1)" "unprognostic (4.13e-1)" 21.2 173.1 7.9 3.5 21.4 1.8 25.0 4.3 10.1 4.7 28.6 13.4 1.1 8.8 4.3 3.5 2.8 4.7 8.0 3.2 7.4 5.1 2.2 93.7 5.8 5.3 6.3 5.1 14.3 2.9 3.3 4.4 65.9 9.4 4.3 4.9 10.7 8.6 2.3 3.0 6.3 21.3 4.4 5.7 5.0 2.7 7.7 11.4 0.5 4.0 1.1 5.6 3.6 10.0 3.1 24.9 1.2 6.5 0.2 0.4 2.5 9.3 22.6 7.4 29.1 4.9 10.5 0.0 6.6 7.5 8.2 5.2 27.0 29.9 27.0 19.0 4.4 13.4 14.2 18.8 44.3 3.9 12.9 18.9 7.6 22.4 43.5 16.6 13.0 6.6 17.9 9.0 15.6 11.1 14.0 22.3 4.9 14.3 11.6 1.5 18.5 4.0 17.4 6.7 11.6 23.4 16.9 5.9 53.9 0.7 13.1 13.9 5.4 35.8 48.4 33.5 4.5 27.1 14.7 2.1 1.3 8.8 6.6 10.1 2.7 1.1 4.4 5.3 15.8 12.8 0.0 6.5 0.0 0.2 3.7 0.2 3.1 0.1 0.4 8.2 1.7 0.1 0.1 1.2 0.2 0.5 24.9 0.0 2.5 7.9 21.4 4.3 10.1 7.4 5.1 6.3 5.1 9.4 11.4 3.0 2.4 18.5 3.1 4.9 5.0 4.8 12.7 4.0 1.2 3.5 27.5 8.8 3.3 5.1 13.9 11.2 9.2 23.3 6.6 9.3 5.9 10.5 1.1 105.2 42.5 15.9 10.3 15.4 14.0 10.8 8.3 10.1 45.5 5.4 14.0 52.5 5.9 14.2 4.9 2.4 7.4 0.0 2.1 27.8 1.7 2.8 36.3 2.5 8.8 3.8 SCIN KIAA1905 ENSG00000006747 Scinderin Q9Y6U3 7 12570577-12660179 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;intestine: 31.7;kidney: 30.3;placenta: 46.0" "Cell type enhanced" "Detected in many" 14 "Collecting duct cells: 317.6;Early spermatids: 90.6;Enterocytes: 121.7;Paneth cells: 111.2" "Cancer enhanced" "Detected in many" "renal cancer: 13.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 38.6;SK-BR-3: 41.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA020518, HPA024264" Enhanced Enhanced "Plasma membrane" No No "Plasma membrane" "HPA020518: AB_1856619, HPA024264: AB_1856621" "unprognostic (3.68e-1)" "unprognostic (4.98e-2)" "unprognostic (5.05e-1)" "unprognostic (2.47e-1)" "unprognostic (1.50e-1)" "unprognostic (5.98e-2)" "unprognostic (3.64e-5)" "unprognostic (1.31e-2)" "unprognostic (3.09e-1)" "unprognostic (3.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.24e-1)" "prognostic favorable (4.26e-8)" "unprognostic (3.87e-1)" "unprognostic (4.99e-2)" "unprognostic (3.13e-2)" "unprognostic (3.18e-1)" 4.1 1.0 14.5 2.3 30.3 1.0 0.9 1.5 13.3 1.2 11.2 7.5 1.0 16.2 1.2 0.7 14.5 3.6 2.0 0.5 11.1 4.2 30.3 0.6 3.4 0.6 22.8 2.3 0.8 0.9 1.1 3.1 46.0 20.0 2.3 10.2 0.6 9.0 1.0 0.6 2.5 31.7 1.0 27.9 0.6 12.2 4.3 23.4 0.0 1.0 2.7 8.2 5.5 1.1 4.5 1.5 3.5 1.5 2.1 1.9 0.8 0.1 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.1 0.5 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.0 0.1 0.0 0.1 0.1 8.5 0.2 0.2 0.1 0.6 0.1 2.2 1.3 0.1 0.2 0.0 38.6 1.4 1.7 0.0 0.4 41.8 0.0 0.3 4.4 0.3 0.0 0.1 0.3 0.8 0.1 1.4 0.1 0.1 0.0 0.1 0.1 3.5 1.5 1.0 1.7 1.3 1.5 4.5 1.5 1.4 1.0 2.5 1.6 1.9 2.5 2.1 1.4 1.5 1.0 0.8 14.5 30.3 1.5 13.3 11.1 4.2 22.8 2.3 20.0 23.4 0.0 20.5 0.0 1.3 2.5 0.4 0.8 7.6 22.7 6.8 317.6 0.0 14.0 69.6 0.7 90.6 0.7 121.7 0.0 0.2 3.7 1.3 4.5 38.2 0.0 76.4 0.0 8.7 0.0 0.6 64.0 0.3 3.1 10.1 2.8 36.1 0.5 5.2 111.2 1.1 1.8 2.5 0.0 0.0 3.9 5.4 5.6 55.0 0.0 13.5 7.1 SCN11A "NaN, Nav1.9, SCN12A, SNS-2" ENSG00000168356 "Sodium voltage-gated channel alpha subunit 11" Q9UI33 3 38845769-38950561 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel, Voltage-gated channel" "Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 7.5;placenta: 5.2" "Cell type enhanced" "Detected in some" 8 "Ciliated cells: 4.0;Early spermatids: 5.4;Sertoli cells: 6.5;Spermatocytes: 3.9;Spermatogonia: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.8;HDLM-2: 5.0;SCLC-21H: 1.1;SuSa: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA036746, HPA036747" Uncertain NA NA "HPA036746: AB_10696785, HPA036747: AB_2675287" "unprognostic (6.11e-2)" "unprognostic (5.16e-1)" "unprognostic (1.66e-1)" "unprognostic (4.75e-2)" "unprognostic (4.21e-2)" "unprognostic (2.34e-2)" "unprognostic (2.79e-2)" "unprognostic (5.66e-2)" "unprognostic (4.44e-2)" "unprognostic (5.21e-2)" "unprognostic (2.30e-4)" "unprognostic (1.91e-2)" "unprognostic (5.43e-2)" "unprognostic (5.02e-2)" "unprognostic (2.95e-1)" "unprognostic (3.12e-2)" "unprognostic (8.30e-4)" 0.9 0.2 0.8 0.5 0.8 0.0 0.6 0.1 0.3 0.0 1.1 0.4 0.0 1.4 0.0 0.1 0.1 0.0 0.4 0.5 0.4 0.3 0.0 0.2 0.4 0.0 0.1 0.0 0.4 5.2 0.1 1.3 0.0 0.0 0.1 0.8 1.0 0.5 0.6 7.5 0.0 2.6 0.1 0.1 3.4 0.1 0.2 0.4 0.9 0.1 0.1 0.2 0.0 0.0 0.0 1.8 0.0 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.1 0.1 5.0 0.4 0.1 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.5 1.1 0.6 0.0 0.0 0.0 1.3 0.0 0.2 0.3 0.0 0.1 0.0 0.0 0.7 0.1 0.3 0.0 0.0 0.1 0.7 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.9 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.8 0.0 4.0 1.2 0.0 0.0 0.2 0.0 0.0 5.4 0.6 0.0 0.0 0.2 0.0 0.6 0.3 0.0 0.2 0.3 0.0 0.0 2.5 0.0 1.0 0.0 0.0 1.7 0.0 0.0 0.7 0.1 0.0 0.0 0.1 0.4 6.5 0.9 3.9 6.0 0.6 0.2 0.0 0.0 0.9 SDC1 "CD138, SDC, SYND1, syndecan" ENSG00000115884 "Syndecan 1" P18827 2 20200797-20225433 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 113.2;placenta: 228.8" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 298.1;Hepatocytes: 520.4;Urothelial cells: 356.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 17 "memory B-cell: 3.9" "Lineage enriched" "Detected in single" 40 "B-cells: 3.9" "Cell line enhanced" "Detected in many" "HBEC3-KT: 62.1;hTCEpi: 57.5;U-251 MG: 59.2;U-266/70: 61.4;U-266/84: 129.2" "Group enriched" "Detected in some" 4 "cerebellum: 10.7;olfactory region: 5.9" "Not detected" "Not detected" "CAB002424, HPA006185, HPA067477" Enhanced Approved "Focal adhesion sites" "Secreted to blood" NA NA 63100000 1600000 "Focal adhesion sites" "CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: " "prognostic unfavorable (2.22e-4)" "unprognostic (6.80e-3)" "unprognostic (6.80e-2)" "unprognostic (7.84e-2)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.15e-1)" "unprognostic (4.02e-2)" "unprognostic (6.32e-2)" "unprognostic (1.70e-1)" "unprognostic (3.66e-1)" "unprognostic (2.27e-3)" "unprognostic (1.79e-1)" "unprognostic (1.63e-1)" "unprognostic (1.94e-2)" "unprognostic (4.27e-1)" "unprognostic (1.62e-2)" "unprognostic (1.52e-1)" 0.8 3.4 0.5 5.4 0.6 0.0 4.5 0.8 0.7 21.4 18.3 0.5 3.5 14.3 2.3 8.7 103.7 1.6 55.3 0.3 0.4 0.5 68.5 113.2 15.8 6.3 1.9 0.4 1.6 7.0 0.6 0.6 228.8 0.7 13.3 6.2 1.5 16.0 5.2 0.5 69.5 21.9 4.3 0.4 3.7 16.3 2.6 0.4 1.5 3.5 62.3 48.4 30.0 37.7 3.9 0.0 0.0 0.0 0.0 0.0 0.5 31.4 17.6 5.6 14.0 1.5 0.2 17.7 8.8 8.5 8.2 7.0 3.7 19.2 0.0 3.2 6.2 4.5 31.1 2.4 62.1 5.5 0.1 1.6 0.0 1.6 18.8 1.3 1.3 0.1 0.8 57.5 7.4 17.6 11.5 0.9 0.0 0.7 12.3 4.4 18.8 0.0 0.3 5.0 24.0 34.2 0.6 2.0 23.8 10.6 47.2 1.6 13.1 6.6 44.8 2.0 2.3 4.4 0.3 1.3 32.7 10.5 1.2 59.2 61.4 129.2 0.1 9.8 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.6 0.8 0.7 0.4 0.5 1.9 0.4 0.7 0.4 86.4 91.4 3.0 135.6 101.2 0.1 0.8 298.1 2.7 63.7 40.1 0.0 2.4 26.6 54.9 0.0 1.1 102.7 23.3 19.0 43.0 9.7 42.4 5.8 520.4 2.2 20.6 10.4 6.7 9.6 0.0 0.6 5.4 20.3 1.0 72.0 0.0 67.3 73.7 1.1 68.3 0.0 0.0 7.1 0.7 12.8 200.1 209.7 4.4 66.5 356.0 SEMA3B "LUCA-1, SemA, sema5, SEMAA, semaV" ENSG00000012171 "Semaphorin 3B" Q13214 3 50267558-50277546 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 147.6" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 151.8;Enterocytes: 193.7;Syncytiotrophoblasts: 93.4" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "eosinophil: 3.3" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.3" "Cell line enhanced" "Detected in many" "HeLa: 23.0;Hep G2: 34.8;SK-BR-3: 18.1;WM-115: 56.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA030651 Uncertain "Secreted in other tissues" NA NA 29000 "HPA030651: AB_10602224" "prognostic favorable (1.27e-4)" "unprognostic (6.48e-2)" "unprognostic (5.40e-2)" "unprognostic (1.07e-1)" "unprognostic (1.68e-1)" "unprognostic (4.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.83e-2)" "unprognostic (2.21e-2)" "unprognostic (2.28e-1)" "unprognostic (1.85e-2)" "unprognostic (4.27e-1)" "unprognostic (7.99e-2)" "unprognostic (7.78e-2)" "unprognostic (3.89e-1)" "unprognostic (8.87e-3)" "unprognostic (1.69e-2)" 3.3 18.8 2.5 2.0 7.4 0.0 1.0 0.3 9.2 9.2 6.0 18.6 2.3 13.3 4.4 3.5 2.5 3.4 5.6 3.4 3.6 7.7 0.0 8.1 0.0 12.9 4.9 2.6 5.6 3.5 0.0 147.6 8.2 2.8 2.8 8.5 1.2 6.8 1.5 0.5 19.7 3.9 5.9 0.3 11.9 0.5 9.5 0.0 1.6 0.6 0.0 1.9 0.6 0.0 0.4 3.3 0.0 0.0 0.0 0.0 4.0 2.6 0.2 2.6 0.2 0.3 0.6 5.3 7.3 1.5 2.6 2.0 10.1 0.0 4.9 5.1 0.0 0.6 0.1 8.5 0.6 0.0 0.2 0.0 23.0 34.8 5.8 0.0 0.2 1.7 0.1 1.7 1.3 6.8 0.0 0.0 0.0 0.6 0.2 7.2 0.0 0.2 0.3 7.5 1.4 0.1 0.4 0.1 2.5 0.4 0.3 1.2 1.3 18.1 2.7 0.8 1.3 0.0 0.1 0.4 5.3 1.4 1.7 1.4 0.0 0.0 2.7 0.0 56.5 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 151.8 18.1 2.7 7.9 0.0 3.7 11.6 43.3 9.4 34.2 61.1 0.0 3.3 1.7 32.0 9.1 3.6 193.7 0.0 20.4 0.9 22.9 9.4 11.5 0.9 1.7 0.0 9.9 8.0 2.6 14.9 3.7 1.3 0.0 1.0 31.6 18.8 31.2 56.1 2.8 45.3 1.6 6.5 2.1 4.9 4.7 0.0 93.4 0.0 25.9 27.1 SEMA6D "FLJ11598, KIAA1479" ENSG00000137872 "Semaphorin 6D" Q8NFY4 15 47184101-47774223 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.8;placenta: 36.7" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 47.6;Cone photoreceptor cells: 108.0;Enterocytes: 37.0;Horizontal cells: 74.7" "Cancer enhanced" "Detected in many" "glioma: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 13.4;SCLC-21H: 11.9;SH-SY5Y: 11.0;SuSa: 13.2;U-266/70: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043109 Approved "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 480000 "Plasma membrane" "Golgi apparatus" "HPA043109: AB_10793941" "unprognostic (2.00e-1)" "unprognostic (4.62e-2)" "unprognostic (3.10e-2)" "unprognostic (3.83e-3)" "unprognostic (1.38e-1)" "unprognostic (3.85e-2)" "unprognostic (1.98e-1)" "unprognostic (2.17e-3)" "unprognostic (1.24e-1)" "unprognostic (5.36e-2)" "unprognostic (7.96e-4)" "unprognostic (1.42e-1)" "prognostic favorable (5.96e-5)" "unprognostic (3.74e-2)" "unprognostic (8.56e-2)" "unprognostic (3.30e-3)" "unprognostic (2.39e-4)" 5.3 1.9 10.3 3.7 16.7 0.8 5.3 5.4 17.1 5.3 14.7 15.3 4.3 18.9 2.1 2.9 2.0 5.2 4.0 8.3 10.3 11.2 14.2 3.0 8.2 2.2 14.0 13.6 25.0 14.8 16.2 6.1 36.7 15.9 4.8 12.0 10.0 4.4 8.5 15.6 3.1 40.8 3.4 12.7 2.5 3.4 2.6 11.0 0.2 6.3 1.5 1.1 3.1 9.6 0.5 0.0 1.9 0.6 0.0 0.8 0.0 0.0 0.0 2.2 0.0 1.3 1.1 0.2 0.5 13.4 0.3 0.0 0.3 0.1 1.8 0.0 3.4 0.0 7.0 2.8 0.9 0.0 0.9 1.6 0.0 4.1 0.0 3.6 0.0 0.1 1.0 7.3 0.0 0.4 0.0 0.9 4.8 0.1 2.9 0.4 0.7 2.2 0.5 4.2 0.0 0.0 1.3 0.0 2.0 1.0 0.9 11.9 11.0 0.1 0.9 3.7 13.2 0.4 0.0 0.0 6.2 0.3 0.2 0.0 8.8 0.0 2.0 1.6 0.2 1.6 0.0 0.6 0.0 0.5 0.0 0.0 0.5 0.3 0.8 0.0 0.0 0.1 0.2 1.9 0.0 0.0 0.0 0.0 0.0 10.3 16.7 5.4 17.1 10.3 11.2 14.0 13.6 15.9 11.0 47.6 1.0 0.0 4.0 1.8 3.3 9.4 0.0 0.0 3.4 10.4 108.0 14.7 5.0 1.0 0.1 6.7 37.0 0.0 0.2 1.2 6.7 0.9 3.5 0.8 2.3 74.7 16.7 4.9 0.0 0.0 21.6 0.0 8.5 0.0 2.6 14.3 0.4 6.0 12.7 0.2 2.0 0.0 12.2 0.7 5.1 1.0 3.9 0.0 9.8 1.4 SEMA7A "CD108, H-Sema-L, SEMAL" ENSG00000138623 "Semaphorin 7A (John Milton Hagen blood group)" O75326 15 74409289-74433958 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins" "Differentiation, Inflammatory response, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;lymphoid tissue: 34.7;placenta: 54.0" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 64.8;Extravillous trophoblasts: 51.6;monocytes: 49.5;Pancreatic endocrine cells: 55.5;Rod photoreceptor cells: 57.4;Syncytiotrophoblasts: 139.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 8.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.9" "Cell line enhanced" "Detected in many" "HMC-1: 101.9;hTEC/SVTERT24-B: 40.0;U-251 MG: 58.8;U-87 MG: 34.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008210, HPA042273" Uncertain Uncertain Vesicles NA NA 29000000 Vesicles "HPA008210: , HPA042273: AB_10806234" "unprognostic (2.00e-1)" "unprognostic (2.72e-1)" "unprognostic (2.02e-2)" "unprognostic (5.81e-2)" "unprognostic (6.49e-2)" "unprognostic (8.61e-2)" "unprognostic (2.54e-2)" "unprognostic (4.18e-3)" "unprognostic (1.33e-1)" "unprognostic (1.39e-1)" "unprognostic (5.18e-3)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.45e-11)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "unprognostic (6.25e-2)" "unprognostic (2.57e-2)" 2.2 1.9 5.4 10.4 13.8 12.8 1.4 22.9 27.3 1.3 1.8 19.9 1.4 2.7 4.3 1.8 3.2 1.2 3.3 1.4 10.8 5.7 1.4 1.5 4.4 19.0 28.5 5.7 5.9 0.9 6.4 1.9 54.0 28.6 1.4 1.8 7.8 1.7 3.5 1.4 4.7 6.0 2.0 36.4 34.7 3.7 23.6 15.4 9.0 1.1 0.4 19.7 4.6 1.7 1.4 1.8 8.9 0.0 0.8 0.2 0.0 5.8 0.0 1.7 0.5 2.2 7.6 14.6 27.1 10.9 5.7 8.8 2.3 9.6 0.0 1.6 12.2 4.6 1.7 0.5 1.7 5.9 0.4 0.3 10.6 0.0 2.9 0.5 0.3 101.9 5.3 0.0 40.0 2.2 14.4 0.0 0.7 6.0 3.7 18.5 0.4 1.4 3.4 1.9 0.1 4.1 0.2 1.2 1.5 2.4 2.5 0.1 0.1 0.2 4.9 2.2 1.6 0.3 2.1 1.0 10.7 7.1 5.1 58.8 0.6 0.4 0.1 34.3 1.2 0.5 3.9 0.0 8.9 0.2 0.0 0.2 1.4 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.8 0.0 1.8 0.0 0.0 5.4 13.8 22.9 27.3 10.8 5.7 28.5 5.7 28.6 15.4 3.0 0.0 2.7 0.5 0.3 10.9 0.8 0.0 0.0 2.3 1.8 64.8 20.3 0.0 17.3 0.5 2.4 0.0 0.0 12.1 51.6 0.8 1.9 8.1 0.8 6.4 1.6 0.0 0.6 0.8 1.5 3.4 1.2 8.5 49.5 0.0 4.2 55.5 0.0 1.8 0.0 57.4 0.0 0.9 0.7 0.4 1.3 139.1 2.5 0.0 25.3 SERPINB2 "HsT1201, PAI2, PLANH2" ENSG00000197632 "Serpin family B member 2" P05120 18 63871692-63903890 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Plasminogen activation" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 70.6;placenta: 222.1" "Cell type enhanced" "Detected in many" 27 "Basal keratinocytes: 1993.2;Suprabasal keratinocytes: 920.9;Syncytiotrophoblasts: 367.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 26.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 16.3;eosinophil: 7.6" "Lineage enriched" "Detected in many" 4 "granulocytes: 16.3" "Cell line enhanced" "Detected in some" "GAMG: 33.9;HaCaT: 81.3;U-138 MG: 97.3;U-2197: 147.8" "Region enriched" "Detected in single" 14 "cerebellum: 2.9" "Low region specificity" "Detected in all" "HPA015480, HPA076608" Enhanced "Intracellular and membrane" NA NA 110000 "HPA015480: AB_1855456, HPA076608: " "unprognostic (2.11e-1)" "unprognostic (1.74e-1)" "unprognostic (5.46e-2)" "unprognostic (1.36e-4)" "unprognostic (1.17e-1)" "unprognostic (1.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.92e-1)" "unprognostic (9.69e-2)" "unprognostic (3.76e-3)" "unprognostic (1.90e-1)" "unprognostic (4.33e-6)" "unprognostic (3.89e-2)" "unprognostic (3.94e-1)" "unprognostic (3.29e-1)" "prognostic unfavorable (1.55e-5)" 6.0 0.0 0.1 2.9 0.2 8.7 2.6 0.2 0.1 6.4 0.8 0.1 0.1 0.0 0.7 0.4 70.6 3.1 0.1 0.4 0.1 0.0 0.1 0.1 0.9 0.1 0.1 0.1 0.6 0.3 0.0 0.1 222.1 0.2 0.3 0.0 0.1 11.3 0.2 0.3 25.7 0.2 0.3 0.1 0.3 0.1 0.2 0.1 0.9 0.2 49.0 37.7 1.1 13.8 0.0 0.2 16.3 3.9 0.0 0.0 1.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 19.7 21.0 0.7 1.5 0.1 0.0 0.0 0.0 0.7 33.9 81.3 0.0 16.7 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.6 9.7 4.4 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 1.6 97.3 0.0 147.8 0.0 0.0 0.0 0.0 2.6 0.2 11.3 16.3 3.9 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.1 0.2 0.2 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.3 0.0 2.4 1993.2 0.0 0.4 0.0 21.4 34.2 0.0 0.0 3.1 0.0 76.7 0.0 0.5 0.0 0.0 6.1 1.5 3.5 3.8 0.0 0.0 2.8 0.0 0.0 0.0 5.6 0.0 0.0 59.8 89.4 2.8 0.0 0.0 100.0 0.0 0.0 0.0 0.0 0.0 26.8 0.0 0.0 920.9 367.4 0.0 0.0 42.5 SERPINE1 "PAI, PAI1, PLANH1" ENSG00000106366 "Serpin family E member 1" P05121 7 101127089-101139266 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 253.6" "Cell type enhanced" "Detected in many" 22 "Pancreatic endocrine cells: 138.9;Syncytiotrophoblasts: 545.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 20 "NK-cell: 10.8" "Lineage enriched" "Detected in single" 20 "NK-cells: 10.8" "Cell line enhanced" "Detected in many" "BJ: 142.8;HUVEC TERT2: 165.7;LHCN-M2: 160.0;TIME: 409.8;U-138 MG: 195.1;U-251 MG: 171.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA050039, CAB068501" Uncertain Approved Cytosol "Secreted to blood" No No 142000000 14000000 Cytosol "CAB068501: AB_1642775, HPA050039: AB_2680997" "unprognostic (5.02e-2)" "prognostic unfavorable (5.01e-4)" "prognostic unfavorable (2.82e-4)" "unprognostic (2.10e-2)" "unprognostic (9.04e-3)" "prognostic unfavorable (2.84e-5)" "unprognostic (6.80e-3)" "prognostic unfavorable (4.41e-6)" "unprognostic (2.33e-1)" "unprognostic (1.45e-1)" "unprognostic (2.88e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (5.88e-8)" "prognostic unfavorable (3.27e-6)" "unprognostic (1.05e-1)" "unprognostic (4.33e-2)" "prognostic unfavorable (5.51e-4)" 45.5 14.0 1.1 16.7 1.8 0.1 11.4 0.5 1.5 13.3 7.0 3.4 3.3 1.2 6.6 14.4 6.8 9.3 69.6 29.2 1.5 0.6 7.8 65.3 56.3 3.3 4.1 1.8 19.7 24.7 1.4 2.6 253.6 5.9 7.6 0.9 2.3 2.4 6.2 12.4 4.1 2.3 13.5 4.1 5.8 6.6 8.6 2.2 0.6 11.3 3.7 2.8 71.7 18.1 0.2 0.4 0.5 0.2 10.8 0.3 1.0 3.0 2.6 0.0 0.2 32.7 65.2 3.7 142.8 27.0 72.1 63.0 0.3 0.2 0.1 34.2 45.4 99.7 0.7 0.0 11.0 74.4 0.1 0.0 0.0 0.2 2.4 65.8 0.0 0.1 25.5 4.4 110.5 58.1 39.1 165.7 0.0 0.2 0.1 160.0 0.0 0.0 0.0 0.7 0.0 1.7 0.0 0.2 0.1 0.2 1.2 0.0 0.0 11.7 3.2 0.3 18.0 0.1 0.4 409.8 195.1 8.5 66.4 171.5 0.0 0.1 0.1 48.7 0.0 1.8 0.5 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.3 0.3 0.2 0.0 0.1 0.2 10.8 0.0 0.4 0.0 1.0 1.1 1.8 0.5 1.5 1.5 0.6 4.1 1.8 5.9 2.2 0.0 11.4 0.0 30.0 35.5 0.4 1.9 7.6 8.1 7.9 5.2 0.0 34.4 0.0 22.9 0.0 53.9 0.0 0.0 3.8 35.1 24.7 5.4 10.3 90.0 15.2 0.0 5.1 60.2 4.7 0.4 16.4 7.5 6.8 1.8 0.0 0.3 138.9 0.0 11.3 0.0 0.2 38.8 16.5 0.0 0.0 21.7 545.0 0.7 0.0 5.9 SERPINE2 "GDN, nexin, PI7, PN1, PNI" ENSG00000135919 "Serpin family E member 2" P07093 2 223975112-224039319 "Plasma proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein, Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 257.0" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 422.0;Fibroblasts: 240.4;Leydig cells: 371.6" "Cancer enriched" "Detected in all" 9 "melanoma: 271.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "naive CD4 T-cell: 10.5;naive CD8 T-cell: 5.3;NK-cell: 16.5" "Group enriched" "Detected in many" 13 "NK-cells: 16.5;T-cells: 10.5" "Cell line enhanced" "Detected in many" "BJ: 84.0;fHDF/TERT166: 358.5;SK-MEL-30: 159.8;WM-115: 123.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in female reproductive system" NA NA 490000 "unprognostic (1.73e-1)" "unprognostic (7.08e-3)" "unprognostic (8.49e-2)" "unprognostic (7.78e-3)" "unprognostic (2.57e-3)" "unprognostic (5.57e-2)" "unprognostic (1.49e-2)" "unprognostic (7.43e-3)" "unprognostic (4.41e-1)" "unprognostic (7.12e-2)" "unprognostic (7.56e-3)" "unprognostic (2.40e-1)" "unprognostic (1.97e-3)" "unprognostic (1.23e-2)" "unprognostic (1.31e-1)" "unprognostic (6.18e-2)" "prognostic unfavorable (6.48e-5)" 8.0 5.8 34.7 18.0 30.6 2.2 4.8 14.9 35.2 8.6 6.1 13.0 0.1 7.4 5.1 4.4 9.7 6.0 11.9 24.5 21.9 25.3 10.6 3.3 3.2 7.7 33.0 14.4 38.4 2.9 1.3 2.0 257.0 25.2 6.6 6.2 4.9 3.1 2.8 3.2 3.5 6.0 28.1 23.0 7.8 2.7 14.2 11.9 1.6 6.2 3.2 10.8 18.3 6.9 1.0 0.1 0.3 0.0 16.5 10.5 2.2 0.1 4.5 1.6 1.8 69.0 26.0 0.2 84.0 48.1 6.8 6.5 0.2 0.3 0.0 1.8 358.5 10.8 0.2 0.2 5.7 5.9 0.0 1.4 0.9 3.0 1.2 3.4 0.7 0.0 7.5 3.9 19.4 29.3 17.6 0.5 0.3 0.0 0.0 23.4 0.2 0.1 0.2 3.1 1.7 5.0 0.5 1.4 3.4 63.0 5.2 2.4 0.4 15.9 0.0 159.8 23.3 0.0 0.3 59.2 40.2 5.5 12.2 3.9 0.3 0.7 0.0 25.7 0.6 123.2 0.0 0.0 0.0 0.6 0.0 0.3 0.7 0.4 0.5 0.0 1.0 10.5 5.3 0.3 16.5 0.0 0.1 0.5 2.2 34.7 30.6 14.9 29.8 21.9 25.3 33.0 14.4 25.2 11.9 0.0 0.6 0.0 11.6 20.7 2.8 2.5 0.0 0.0 3.4 7.0 0.0 84.2 10.0 10.3 2.1 23.4 3.1 0.0 28.7 422.0 240.4 9.5 2.3 0.0 40.3 0.0 23.1 26.4 0.0 4.7 371.6 4.6 135.0 5.4 4.1 1.5 16.3 13.3 93.0 144.4 3.3 12.9 15.9 4.3 27.4 12.7 112.0 10.9 1.8 5.4 SGPP1 ENSG00000126821 "Sphingosine-1-phosphate phosphatase 1" Q9BX95 14 63684214-63728039 "Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 49.4" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 48.8;Kupffer cells: 53.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 23.9;U-698: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053149, HPA064908" Approved Supported Nucleoplasm NA NA Nucleoplasm "HPA053149: AB_2682057, HPA064908: AB_2797270" "unprognostic (1.57e-2)" "unprognostic (1.04e-2)" "unprognostic (5.40e-3)" "unprognostic (7.82e-2)" "unprognostic (9.09e-2)" "unprognostic (4.30e-2)" "unprognostic (6.49e-3)" "unprognostic (1.35e-2)" "unprognostic (1.64e-1)" "unprognostic (7.41e-2)" "unprognostic (1.51e-1)" "unprognostic (3.27e-1)" "unprognostic (8.59e-2)" "unprognostic (1.41e-1)" "unprognostic (1.92e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-3)" 10.5 12.1 12.1 15.7 11.6 4.3 7.6 14.3 12.9 9.2 9.6 15.1 3.9 6.2 8.4 10.3 5.7 5.9 8.9 5.5 13.1 12.6 24.7 29.4 10.3 18.5 13.0 7.0 7.4 14.1 15.5 6.4 49.4 11.1 9.0 8.7 6.7 5.7 7.0 4.4 4.8 8.9 7.9 19.6 16.5 5.8 8.2 9.8 15.4 7.8 3.7 19.1 8.6 7.3 3.2 0.5 8.8 3.3 0.5 2.0 0.5 10.5 3.4 1.7 4.8 6.2 5.8 20.3 8.7 6.1 5.4 6.1 1.5 6.0 23.9 2.6 4.4 4.5 11.3 2.7 5.1 8.8 9.3 3.1 2.2 2.0 2.4 7.6 3.9 6.9 4.2 8.3 4.7 7.5 5.5 2.6 4.5 1.2 0.7 7.8 3.9 4.5 0.0 1.1 1.7 7.3 1.1 4.7 1.9 8.6 5.3 1.0 2.8 6.1 5.7 4.5 5.4 7.4 1.4 2.9 7.6 5.2 5.3 4.3 5.7 3.5 31.1 5.5 0.0 3.2 8.8 0.3 2.8 1.0 2.3 1.0 3.2 1.0 0.7 0.5 0.8 1.5 1.1 0.4 0.5 3.3 0.3 2.0 0.5 12.1 11.6 14.3 12.9 13.1 12.6 13.0 7.0 11.1 9.8 11.9 14.4 11.2 4.9 8.7 3.5 3.2 25.5 2.7 3.4 48.8 0.0 19.1 0.0 5.2 1.6 5.4 6.7 0.0 7.7 24.8 16.2 8.0 10.5 37.6 19.7 9.5 17.9 8.0 53.2 0.8 5.8 20.6 16.9 3.6 9.4 7.3 11.2 11.6 15.9 20.9 5.1 6.5 19.4 6.7 2.7 11.8 27.6 7.5 8.1 4.8 SH2D5 ENSG00000189410 "SH2 domain containing 5" Q6ZV89 1 20719732-20732837 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 19.5;placenta: 14.8;testis: 9.4" "Cell type enhanced" "Detected in some" 12 "Basal keratinocytes: 4.2;Suprabasal keratinocytes: 1.9;Syncytiotrophoblasts: 4.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 3.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HBEC3-KT: 25.3;hTERT-HME1: 32.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA030182 Approved Cytosol NA NA Cytosol "HPA030182: AB_10670431" "unprognostic (2.32e-1)" "unprognostic (2.80e-2)" "unprognostic (3.85e-2)" "unprognostic (5.37e-3)" "unprognostic (1.20e-4)" "unprognostic (4.41e-2)" "unprognostic (1.80e-6)" "unprognostic (1.11e-3)" "unprognostic (2.07e-1)" "unprognostic (9.43e-3)" "unprognostic (1.21e-2)" "unprognostic (1.45e-1)" "unprognostic (1.77e-2)" "unprognostic (2.55e-2)" "unprognostic (2.34e-1)" "unprognostic (1.14e-1)" "unprognostic (1.51e-2)" 0.4 0.9 4.5 1.3 19.5 0.4 0.3 0.5 19.2 0.6 0.5 0.3 0.0 1.2 1.4 0.3 0.5 0.5 0.6 0.3 3.9 4.1 0.4 0.3 0.4 0.3 1.5 7.3 1.7 0.3 0.6 0.1 14.8 2.1 0.5 0.3 0.0 0.4 1.8 0.3 0.6 0.5 1.2 0.3 0.4 0.6 9.4 0.7 0.0 2.1 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 9.7 3.9 0.8 0.0 0.0 0.0 0.1 4.6 6.6 4.6 3.1 1.6 1.6 0.0 1.2 1.4 10.0 0.4 3.3 25.3 1.9 0.0 1.7 0.0 0.5 1.2 3.8 0.0 0.0 0.2 5.3 8.6 32.4 1.6 0.1 0.8 0.0 0.0 1.9 0.9 0.5 0.0 1.5 0.5 5.0 0.1 0.1 0.2 4.8 0.6 1.5 0.2 0.3 0.1 1.5 0.7 0.0 0.0 0.0 5.6 9.9 8.3 2.2 0.0 0.0 0.4 1.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 4.5 19.5 0.5 12.3 3.9 4.1 1.5 7.3 2.1 0.7 0.0 0.0 0.0 1.0 4.2 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.9 1.9 4.2 0.0 0.0 0.3 SH3TC2 "CMT4C, KIAA1985" ENSG00000169247 "SH3 domain and tetratricopeptide repeats 2" Q8TF17 5 148923639-149063163 "Disease related genes, Predicted intracellular proteins" "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 32.1;placenta: 22.7;testis: 14.4" "Cell type enhanced" "Detected in many" 14 "Rod photoreceptor cells: 24.7;Syncytiotrophoblasts: 10.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 6.2;RT4: 9.9;SK-MEL-30: 8.9;WM-115: 9.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA037683, HPA037684" Uncertain Approved Nucleoplasm,Cytosol No No "Nucleoplasm, Cytosol" "HPA037683: AB_2675608, HPA037684: AB_10672603" "unprognostic (6.30e-2)" "unprognostic (4.07e-2)" "unprognostic (4.22e-2)" "unprognostic (5.52e-2)" "unprognostic (1.70e-1)" "unprognostic (1.92e-2)" "unprognostic (2.49e-1)" "unprognostic (2.17e-4)" "unprognostic (2.18e-2)" "unprognostic (4.53e-1)" "unprognostic (6.21e-3)" "unprognostic (2.20e-1)" "unprognostic (2.21e-1)" "unprognostic (6.48e-2)" "unprognostic (1.84e-1)" "unprognostic (6.62e-2)" "unprognostic (1.40e-1)" 1.3 0.8 3.3 0.8 15.4 1.2 1.4 0.9 8.6 2.2 1.0 32.1 0.0 0.6 1.0 1.7 2.0 1.3 1.3 3.7 6.0 3.0 0.6 0.7 1.0 0.7 22.7 4.6 0.6 0.5 0.8 0.5 22.7 12.0 0.9 1.8 0.0 1.4 1.4 1.5 1.1 0.7 1.3 12.9 1.0 0.7 14.4 15.6 0.0 0.8 0.0 1.0 2.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.7 0.2 0.0 0.0 0.0 0.1 0.1 2.9 1.3 0.5 0.2 6.2 5.1 0.0 5.6 0.3 1.7 4.3 0.0 4.1 0.3 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.2 0.4 2.0 1.8 1.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 3.1 5.7 0.0 3.9 0.0 2.1 9.9 0.0 0.0 0.0 0.3 8.9 0.2 0.0 0.0 0.3 0.2 1.1 0.2 3.5 0.0 0.0 0.0 0.2 1.3 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.3 15.4 0.9 8.6 6.0 3.0 22.7 4.6 12.0 15.6 3.0 5.9 0.0 0.6 0.8 1.1 1.7 2.5 1.4 4.5 0.0 3.9 0.7 0.0 0.7 4.8 1.4 0.0 0.0 0.2 0.2 0.9 1.0 2.3 0.0 0.3 0.0 0.0 1.3 2.4 1.5 0.3 0.0 0.0 0.0 0.0 1.9 1.2 0.0 0.0 0.0 24.7 0.0 0.4 1.4 0.8 0.6 10.0 0.0 0.0 2.6 SIAH1 hSIAH1 ENSG00000196470 "Siah E3 ubiquitin protein ligase 1" Q8IUQ4 16 48356364-48448402 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 102.6" "Group enriched" "Detected in many" 5 "Cytotrophoblasts: 161.7;Syncytiotrophoblasts: 624.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018724 Enhanced Uncertain Nucleoplasm,Mitochondria NA NA Mitochondria Nucleoplasm "CAB018724: AB_2188865" "unprognostic (7.08e-2)" "unprognostic (1.16e-1)" "unprognostic (4.88e-2)" "unprognostic (1.07e-1)" "unprognostic (2.92e-3)" "unprognostic (1.25e-2)" "unprognostic (7.93e-3)" "unprognostic (1.12e-2)" "unprognostic (9.22e-3)" "unprognostic (3.26e-1)" "unprognostic (8.02e-2)" "unprognostic (7.84e-3)" "unprognostic (7.67e-3)" "unprognostic (4.38e-2)" "unprognostic (4.00e-1)" "unprognostic (9.55e-2)" "unprognostic (1.26e-2)" 20.6 11.4 11.9 11.0 13.5 19.2 25.5 15.5 16.6 14.6 13.1 15.0 6.5 12.8 16.8 13.4 12.7 12.9 12.9 11.4 12.6 11.6 12.1 17.5 13.9 10.0 12.8 11.6 16.7 11.4 13.1 9.1 102.6 14.1 14.2 12.2 32.1 13.2 12.1 17.0 16.6 16.0 18.6 12.7 11.3 12.5 17.9 13.0 17.5 14.5 9.3 11.5 15.9 14.8 12.6 8.3 21.9 5.2 5.3 6.1 3.5 8.6 7.8 16.9 15.1 14.6 12.8 17.3 8.1 11.0 12.1 5.9 5.9 11.3 11.2 9.0 10.2 8.4 10.1 11.6 11.8 14.9 4.5 9.4 6.0 6.1 15.4 20.4 5.9 9.3 15.3 21.3 7.0 16.4 13.5 10.1 10.5 9.7 10.7 9.8 5.9 15.9 12.1 20.6 9.6 12.1 18.6 25.4 11.8 11.2 10.9 19.3 17.1 24.0 12.0 20.7 15.2 7.6 13.7 10.7 12.9 11.7 7.0 8.6 14.0 5.8 20.6 9.6 7.4 11.6 6.9 5.2 21.9 2.7 2.2 3.0 12.6 3.0 4.2 8.3 12.1 6.1 4.5 2.9 5.3 1.3 7.9 1.6 3.5 11.9 13.5 15.5 16.6 12.6 11.6 12.8 11.6 14.1 13.0 11.9 11.9 16.4 51.3 76.1 18.3 12.0 10.2 9.4 10.3 15.7 7.9 161.7 26.6 21.4 60.8 27.0 18.8 0.0 19.9 25.3 52.6 43.7 4.6 19.5 29.5 33.4 21.7 28.8 18.3 53.9 21.0 23.2 47.2 38.7 18.3 30.7 19.2 14.4 18.4 21.1 16.5 19.4 37.1 68.6 47.5 66.1 624.0 13.4 16.7 38.7 SIGLEC6 "CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6" ENSG00000105492 "Sialic acid binding Ig like lectin 6" O43699 19 51519525-51531856 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "placenta: 87.4" "Group enriched" "Detected in some" 12 "Cytotrophoblasts: 56.9;granulocytes: 52.1;Syncytiotrophoblasts: 157.8" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 6.5;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 33 "B-cells: 6.5;dendritic cells: 6.8;granulocytes: 2.3" "Cell line enriched" "Detected in some" 7 "HMC-1: 103.0" "HPA008945, HPA009084, HPA018198" Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA008945: , HPA009084: AB_1079967, HPA018198: AB_1856868" "unprognostic (1.97e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-3)" "unprognostic (9.31e-3)" "unprognostic (8.46e-4)" "unprognostic (2.91e-1)" "unprognostic (2.02e-2)" "unprognostic (2.64e-1)" "unprognostic (8.96e-2)" "unprognostic (2.03e-1)" "unprognostic (6.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.15e-2)" "unprognostic (4.42e-2)" "unprognostic (3.28e-2)" "unprognostic (5.57e-3)" 1.8 0.0 0.0 5.6 0.0 0.1 0.8 0.0 0.1 1.2 1.7 0.0 0.3 0.9 2.0 1.2 1.5 0.5 8.6 0.4 0.0 0.0 0.4 0.1 4.2 1.5 0.0 0.0 0.1 0.3 0.1 0.1 87.4 0.0 3.7 1.5 0.5 1.4 1.0 0.2 1.3 6.0 3.1 0.0 1.3 1.7 1.0 0.0 0.3 0.2 1.0 2.6 2.2 1.9 6.5 6.8 2.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.2 103.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 1.4 2.8 0.0 0.0 0.0 0.1 0.0 6.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 52.1 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.8 0.0 0.0 0.0 SKP2 "FBL1, FBXL1, p45" ENSG00000145604 "S-phase kinase associated protein 2" Q13309 5 36151989-36184319 "Cancer-related genes, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 49.1" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 117.2;Extravillous trophoblasts: 184.7;Syncytiotrophoblasts: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 75.1;RH-30: 94.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013491, CAB013533, HPA051196, HPA054633" Approved Supported Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "CAB013491: AB_2533074, CAB013533: , HPA051196: AB_2681383, HPA054633: AB_2682550" "unprognostic (2.32e-2)" "unprognostic (2.87e-1)" "unprognostic (1.26e-1)" "unprognostic (5.74e-2)" "unprognostic (9.56e-2)" "unprognostic (1.52e-2)" "unprognostic (1.21e-3)" "unprognostic (2.22e-1)" "prognostic unfavorable (3.72e-7)" "prognostic favorable (8.57e-4)" "unprognostic (5.06e-2)" "unprognostic (2.71e-1)" "prognostic unfavorable (4.77e-15)" "unprognostic (2.50e-2)" "unprognostic (3.73e-1)" "unprognostic (1.63e-1)" "unprognostic (2.19e-1)" 6.5 6.9 7.8 8.0 7.5 12.9 6.5 11.5 9.0 7.5 7.7 10.3 3.7 10.2 9.9 6.3 13.5 8.1 4.9 4.1 7.3 5.1 4.2 14.0 5.8 9.4 8.8 7.4 7.7 6.1 3.9 12.5 49.1 6.5 7.2 9.5 6.1 6.3 5.4 3.4 7.6 7.7 6.4 7.4 9.4 5.3 3.9 7.4 19.5 5.0 7.5 11.7 7.9 8.4 6.5 16.0 14.7 7.9 7.7 8.5 5.0 7.6 3.8 16.2 18.0 3.9 6.4 75.1 9.9 7.5 25.4 19.2 21.0 6.0 11.0 2.7 8.0 4.6 8.0 18.0 12.5 27.3 4.9 10.4 6.4 14.1 9.9 1.9 14.2 2.9 5.8 3.3 4.6 3.2 2.6 7.0 9.9 11.0 2.5 9.1 3.7 16.5 8.2 14.7 7.5 5.8 16.3 94.3 7.0 1.8 8.0 13.9 16.6 31.0 6.8 4.3 12.4 6.8 8.0 3.2 9.5 11.0 3.5 6.8 3.2 3.0 13.6 4.3 17.5 6.8 10.3 7.9 14.7 5.4 7.2 8.5 5.6 5.7 5.8 16.0 6.5 7.9 6.0 1.5 7.7 4.1 4.3 5.3 5.0 7.8 7.5 11.5 9.0 7.3 5.1 8.8 7.4 6.5 7.4 20.8 9.9 6.7 3.2 3.3 7.4 1.1 2.5 6.7 0.0 1.8 9.8 117.2 1.7 2.4 0.4 3.6 2.3 0.0 2.6 184.7 4.7 0.7 2.3 8.6 29.3 0.0 2.9 1.3 9.2 0.0 3.7 2.6 1.7 7.2 3.6 2.3 2.6 3.5 6.0 1.1 6.8 0.0 2.3 0.7 4.0 3.4 70.1 6.4 7.4 0.9 SLC13A4 "SUT-1, SUT1" ENSG00000164707 "Solute carrier family 13 member 4" Q9UKG4 7 135681237-135729258 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 85.4;placenta: 44.8;retina: 23.5" "Cell type enriched" "Detected in some" 7 "Syncytiotrophoblasts: 657.3" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "pons and medulla: 85.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HDLM-2: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048582 Enhanced NA NA "HPA048582: AB_2680450" "unprognostic (2.40e-1)" "unprognostic (2.51e-1)" "unprognostic (9.70e-3)" "unprognostic (1.78e-1)" "unprognostic (7.69e-2)" "unprognostic (3.96e-6)" "unprognostic (3.33e-2)" "unprognostic (1.32e-1)" "unprognostic (8.56e-3)" "unprognostic (9.23e-2)" "unprognostic (2.89e-1)" "unprognostic (1.87e-1)" "unprognostic (2.30e-6)" "unprognostic (1.53e-1)" "unprognostic (3.07e-2)" "unprognostic (2.00e-1)" "unprognostic (6.73e-2)" 0.3 0.4 0.7 0.3 1.4 0.3 0.4 4.0 8.9 1.2 0.3 34.0 0.0 0.3 0.4 0.3 4.1 0.8 0.4 0.4 12.3 0.8 0.3 0.4 0.4 0.3 1.4 5.4 0.4 0.5 0.4 1.4 44.8 85.4 0.3 0.3 23.5 1.0 0.4 0.3 0.4 0.3 0.4 5.1 0.3 0.3 5.4 0.5 0.0 0.3 0.0 1.9 0.3 1.8 0.0 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 25.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 2.1 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 1.4 4.0 8.9 12.3 0.8 1.4 5.4 85.4 0.5 0.0 0.0 0.0 0.5 0.0 2.6 1.6 0.0 6.7 0.0 0.0 3.9 99.4 0.0 0.1 0.4 0.3 0.0 0.0 0.0 5.3 1.1 0.4 0.0 0.0 13.1 3.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.2 0.1 657.3 0.0 0.0 0.3 SLC16A4 "MCT4, MCT5" ENSG00000168679 "Solute carrier family 16 member 4" O15374 1 110362848-110391082 "Predicted membrane proteins" "Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 61.4;placenta: 76.5" "Group enriched" "Detected in many" 4 "Collecting duct cells: 68.0;Proximal tubular cells: 176.8" "Cancer enhanced" "Detected in all" "renal cancer: 35.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.0" "Group enriched" "Detected in many" 4 "B-cells: 5.0;granulocytes: 1.3" "Cell line enhanced" "Detected in many" "BEWO: 11.6;BJ hTERT+: 11.7;CAPAN-2: 17.3;HHSteC: 11.6;hTERT-RPE1: 25.2;SK-MEL-30: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046986, HPA060163" Approved Approved "Microtubules,Cytokinetic bridge,Cytosol" NA NA "Microtubules, Cytosol" "Cytokinetic bridge" "HPA046986: AB_2679892, HPA060163: " "unprognostic (2.04e-1)" "unprognostic (1.69e-1)" "unprognostic (2.56e-1)" "unprognostic (2.77e-3)" "unprognostic (1.53e-1)" "unprognostic (2.22e-1)" "unprognostic (2.00e-2)" "unprognostic (7.94e-2)" "unprognostic (2.29e-1)" "unprognostic (1.81e-1)" "unprognostic (1.70e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.69e-4)" "unprognostic (3.68e-2)" "unprognostic (9.16e-2)" "unprognostic (1.71e-2)" "unprognostic (9.46e-2)" 3.8 2.4 1.9 2.1 2.8 0.6 3.4 2.3 1.7 2.7 4.5 2.9 2.7 4.7 2.3 11.9 4.3 2.4 9.6 4.0 2.6 2.1 61.4 7.9 6.1 1.4 2.7 1.4 21.3 0.8 0.5 3.5 76.5 6.9 3.7 0.9 17.3 1.9 3.2 1.1 0.8 14.0 1.8 3.6 2.0 2.5 4.0 1.8 0.0 8.0 1.3 1.3 3.1 3.0 5.0 0.1 1.3 0.6 0.0 0.7 0.3 0.2 5.5 1.2 1.8 4.0 7.8 11.6 3.0 11.7 1.0 2.9 1.7 17.3 0.3 3.3 9.4 0.1 0.3 0.0 1.1 1.1 0.3 1.4 0.3 1.1 1.7 11.6 0.3 0.3 5.7 0.1 1.7 0.1 25.2 2.4 0.4 0.2 0.6 1.9 0.5 0.2 0.3 0.3 0.0 0.2 0.1 0.8 0.1 2.0 0.2 0.7 0.4 0.3 5.6 17.8 5.6 0.3 0.0 0.2 0.7 0.4 0.2 0.8 0.3 0.0 0.9 0.6 0.2 3.2 0.0 0.6 0.3 0.5 0.2 0.2 5.0 0.6 0.1 0.1 1.0 0.6 0.7 1.3 0.0 0.2 0.0 0.2 0.3 1.9 2.8 2.3 1.7 2.6 2.1 2.7 1.4 6.9 1.8 11.9 17.3 3.2 5.2 2.7 11.1 1.1 15.3 0.0 5.7 68.0 5.9 28.5 3.3 2.9 0.4 4.4 1.3 23.3 0.8 29.3 13.9 2.7 4.7 4.5 3.7 3.2 3.4 3.1 1.0 1.1 16.7 0.8 10.1 1.0 0.9 2.3 1.3 0.2 11.0 176.8 17.7 0.0 5.2 3.0 2.0 3.1 29.4 4.6 0.5 5.0 SLC19A3 THTR2 ENSG00000135917 "Solute carrier family 19 member 3" Q9BZV2 2 227683763-227718031 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 48.2;breast: 78.2;placenta: 27.5" "Group enriched" "Detected in many" 8 "Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 134.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 8.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 14.3;BEWO: 7.4;CACO-2: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038898 Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA038898: AB_10673481" "unprognostic (3.37e-2)" "unprognostic (3.59e-5)" "unprognostic (1.95e-3)" "unprognostic (1.24e-2)" "unprognostic (1.22e-1)" "unprognostic (6.82e-2)" "unprognostic (1.93e-2)" "unprognostic (1.67e-1)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" "unprognostic (4.67e-2)" "unprognostic (3.12e-3)" "unprognostic (7.28e-2)" "unprognostic (8.20e-2)" "unprognostic (1.68e-1)" "unprognostic (1.71e-2)" "unprognostic (7.01e-3)" 48.2 0.6 2.2 1.8 2.4 1.2 78.2 1.5 1.9 0.5 6.1 1.0 0.5 7.7 0.6 0.4 0.6 0.6 8.9 1.9 2.3 2.4 2.1 16.0 5.6 1.3 3.0 0.7 0.9 1.3 0.2 0.3 27.5 2.6 0.5 1.6 0.7 0.9 0.2 0.7 1.6 4.5 0.5 2.6 0.5 0.5 0.6 1.5 0.0 0.5 0.4 0.4 1.0 2.3 2.6 1.8 8.6 1.8 4.3 1.1 0.4 0.3 1.6 0.3 1.0 14.3 0.4 7.4 0.1 0.2 0.3 0.6 18.7 0.5 0.4 0.2 0.1 4.6 0.5 0.5 0.5 0.8 0.1 1.2 0.1 1.0 0.8 1.7 0.2 0.2 3.3 0.4 0.1 0.9 0.3 0.0 0.3 0.2 0.9 0.0 1.8 0.1 0.7 3.2 0.6 0.3 0.3 0.2 0.2 0.2 0.3 1.1 0.1 0.6 2.1 0.5 2.7 0.3 0.2 0.5 0.5 0.5 4.2 0.4 0.2 0.1 0.7 1.4 0.3 0.5 8.6 1.8 1.7 1.0 1.2 0.6 1.6 0.8 0.9 0.4 2.6 1.0 1.1 6.1 4.3 1.1 1.8 0.4 0.4 2.2 2.4 1.5 1.9 2.3 2.4 3.0 0.7 2.6 1.5 8.9 3.2 0.0 0.4 0.0 2.9 0.3 0.0 0.0 0.0 1.8 0.0 45.5 1.7 1.7 0.3 0.5 6.4 0.0 0.0 7.0 0.9 0.3 0.0 11.4 4.6 0.0 1.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.8 0.6 0.0 0.0 2.2 0.1 0.0 1.0 0.0 0.1 0.0 134.3 0.0 5.6 0.3 SLC22A11 OAT4 ENSG00000168065 "Solute carrier family 22 member 11" Q9NSA0 11 64555626-64572875 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "epididymis: 22.2;kidney: 47.6;placenta: 64.7" "Group enriched" "Detected in some" 17 "Cytotrophoblasts: 554.5;Syncytiotrophoblasts: 1271.5" "Group enriched" "Detected in some" 14 "liver cancer: 3.7;renal cancer: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.8;CACO-2: 1.1;Hep G2: 3.4;SuSa: 1.9" "Not detected" "Not detected" HPA026076 Enhanced NA NA "HPA026076: AB_1854756" "unprognostic (8.21e-5)" "unprognostic (3.29e-2)" "unprognostic (3.57e-1)" "unprognostic (1.57e-1)" "unprognostic (3.20e-2)" "unprognostic (4.57e-3)" "unprognostic (3.48e-1)" "unprognostic (1.93e-1)" "unprognostic (4.86e-2)" "unprognostic (4.51e-2)" "unprognostic (7.56e-2)" "unprognostic (1.13e-1)" "prognostic favorable (3.68e-5)" "unprognostic (4.62e-2)" "unprognostic (6.52e-2)" "unprognostic (3.50e-2)" "unprognostic (8.24e-3)" 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 4.4 0.0 0.1 22.2 0.1 0.1 0.0 0.1 0.1 0.1 47.6 0.4 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.1 64.7 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.2 0.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 554.5 5.0 0.0 1.0 0.0 0.0 0.0 0.3 13.6 0.6 0.0 0.0 0.0 44.6 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 54.2 0.0 0.0 0.0 0.0 0.1 0.0 1271.5 0.0 0.0 0.0 SLC25A35 FLJ40217 ENSG00000125434 "Solute carrier family 25 member 35" Q3KQZ1 17 8287763-8295343 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 44.4" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 27.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051720 Uncertain Approved Vesicles,Mitochondria NA NA "Vesicles, Mitochondria" "HPA051720: AB_2681584" "unprognostic (4.73e-2)" "unprognostic (1.36e-3)" "unprognostic (1.21e-2)" "prognostic favorable (3.37e-7)" "unprognostic (1.61e-2)" "unprognostic (1.20e-1)" "unprognostic (3.52e-2)" "unprognostic (5.27e-2)" "unprognostic (2.58e-1)" "unprognostic (8.30e-2)" "unprognostic (8.96e-3)" "unprognostic (1.18e-1)" "prognostic favorable (1.14e-6)" "unprognostic (5.31e-3)" "unprognostic (2.34e-1)" "unprognostic (1.00e-1)" "prognostic favorable (1.91e-5)" 6.8 8.2 4.0 10.2 8.3 7.4 8.1 2.6 6.0 13.0 7.2 11.1 18.2 8.3 14.1 11.6 5.3 8.6 7.5 4.4 8.2 3.7 14.4 4.4 7.2 8.2 8.9 5.2 3.4 9.6 6.6 12.9 44.4 9.2 8.2 7.9 11.3 6.2 24.9 3.4 4.2 7.2 6.0 9.7 9.4 9.8 20.2 7.2 9.0 9.1 4.1 7.1 7.2 4.6 3.8 7.2 9.0 11.1 3.2 5.6 2.9 4.5 12.5 2.1 9.4 7.2 2.8 5.2 2.9 2.7 3.3 3.6 1.5 11.7 5.2 3.1 3.4 6.7 10.1 2.7 3.6 1.8 2.8 3.3 4.4 9.2 1.8 2.7 0.5 11.9 5.9 2.1 6.2 1.1 2.3 5.1 6.1 1.2 1.8 2.7 2.5 4.7 2.4 0.7 3.1 4.2 5.1 1.5 2.3 2.5 11.6 1.1 2.8 8.6 5.2 3.7 2.3 11.6 3.3 6.7 2.2 1.7 5.3 2.5 4.0 2.4 1.8 5.7 7.8 5.6 4.5 7.3 9.0 5.5 11.1 4.3 2.6 4.8 5.6 7.2 3.8 1.7 3.5 1.4 3.2 7.8 3.6 4.9 2.9 4.0 8.3 2.6 6.0 8.2 3.7 8.9 5.2 9.2 7.2 0.0 4.8 5.4 1.5 0.7 3.7 1.2 2.5 0.0 1.2 10.4 7.9 7.3 10.0 2.4 2.4 2.2 2.5 0.0 6.2 2.0 1.3 1.8 4.7 2.4 5.9 1.6 8.6 2.5 3.7 3.6 1.4 2.7 0.0 8.2 2.7 6.8 2.6 3.1 1.1 5.7 8.9 0.0 0.7 27.9 0.7 0.3 14.5 3.8 3.0 1.1 SLC2A1 "CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR" ENSG00000117394 "Solute carrier family 2 member 1" P11166 1 42925375-42959176 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Cancer-related genes, Cataract, Disease mutation, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 194.0" "Cell type enhanced" "Detected in many" 20 "Cytotrophoblasts: 686.5;Extravillous trophoblasts: 412.9;Syncytiotrophoblasts: 2076.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 44.8;CACO-2: 72.7;Hep G2: 49.6" "Low region specificity" "Detected in all" "CAB002759, HPA031345, HPA058494" Enhanced Supported Enhanced "Plasma membrane" No No 36000000 "Plasma membrane" "CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734" "unprognostic (3.60e-2)" "unprognostic (5.85e-3)" "unprognostic (7.59e-2)" "unprognostic (1.31e-2)" "unprognostic (4.10e-3)" "unprognostic (3.22e-2)" "prognostic unfavorable (3.65e-8)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.10e-1)" "unprognostic (4.84e-2)" "prognostic unfavorable (4.39e-5)" "unprognostic (1.87e-1)" "prognostic unfavorable (4.55e-9)" "unprognostic (1.11e-1)" "unprognostic (9.49e-2)" "unprognostic (1.17e-1)" "prognostic unfavorable (4.05e-4)" 4.2 3.7 12.4 3.9 16.9 45.2 4.1 6.7 15.5 15.2 4.8 15.1 4.3 2.4 7.6 3.4 28.8 8.5 8.6 5.0 15.4 13.7 7.6 2.1 2.4 5.3 18.2 5.0 3.4 3.7 7.3 2.9 194.0 15.5 5.2 3.3 44.2 8.4 7.9 1.8 42.1 2.9 2.5 17.8 3.4 5.5 2.5 12.5 1.8 4.0 11.5 12.0 22.2 24.5 8.4 14.7 1.3 0.2 3.0 7.5 2.7 10.7 15.6 12.8 3.2 1.5 0.5 44.8 7.1 15.4 8.8 12.9 72.7 30.1 4.1 21.2 2.1 6.2 10.1 2.8 16.5 3.9 2.4 2.6 6.7 9.0 49.6 4.5 3.6 1.9 1.9 12.7 5.5 5.9 26.0 1.4 3.5 15.0 0.9 3.9 19.2 1.7 2.5 8.2 5.3 3.9 1.6 4.1 5.7 8.0 5.2 6.8 4.8 8.3 26.3 3.1 19.2 1.1 4.6 3.2 8.0 5.8 1.4 16.0 0.7 1.5 2.5 15.8 2.6 6.5 0.3 0.2 1.3 7.5 0.2 6.9 8.4 4.1 5.1 2.9 7.3 3.2 4.7 1.0 3.0 0.1 14.7 4.7 2.7 12.4 16.9 6.7 15.5 15.4 13.7 18.2 5.0 15.5 12.5 0.0 2.6 23.8 35.5 254.3 8.1 23.0 25.5 28.1 9.1 26.2 62.8 686.5 5.0 47.8 4.0 9.9 16.8 303.7 10.3 412.9 42.1 25.5 5.8 1.3 74.8 4.8 17.6 0.6 1.3 0.0 7.2 3.2 20.3 61.3 13.7 394.9 72.4 18.7 13.8 1.6 31.1 0.0 20.2 0.0 1.7 208.3 2076.2 17.3 9.0 98.7 SLC30A2 ZNT2 ENSG00000158014 "Solute carrier family 30 member 2" Q9BRI3 1 26037252-26046133 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 78.0;placenta: 20.0" "Cell type enhanced" "Detected in many" 16 "Cytotrophoblasts: 23.2;Exocrine glandular cells: 18.5;Proximal tubular cells: 27.2;Syncytiotrophoblasts: 71.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 19.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "BEWO: 4.7;RPTEC TERT1: 10.6;WM-115: 6.5" "Region enriched" "Detected in single" 5 "olfactory region: 1.5" "Not detected" "Not detected" HPA017979 Approved Vesicles NA NA Vesicles "HPA017979: AB_1857085" "unprognostic (4.87e-2)" "unprognostic (6.70e-2)" "unprognostic (3.79e-2)" "unprognostic (1.79e-3)" "unprognostic (1.11e-1)" "unprognostic (2.37e-2)" "unprognostic (2.25e-2)" "unprognostic (2.59e-1)" "unprognostic (3.67e-2)" "unprognostic (1.02e-1)" "unprognostic (6.99e-2)" "unprognostic (1.10e-1)" "prognostic favorable (2.86e-6)" "unprognostic (9.38e-2)" "unprognostic (3.50e-2)" "unprognostic (1.17e-1)" "unprognostic (3.01e-2)" 0.1 0.7 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.6 0.0 1.3 1.1 0.1 0.1 4.0 2.2 0.1 0.1 10.4 0.1 0.2 0.1 0.1 0.1 0.1 78.0 0.1 0.1 20.0 0.1 0.3 0.0 2.0 1.0 1.4 1.7 0.4 0.6 0.1 0.1 0.1 0.1 0.4 0.1 0.1 12.8 0.2 0.1 0.5 0.1 1.5 1.1 3.1 1.0 1.5 0.9 0.4 0.2 0.2 0.2 1.0 0.3 0.1 4.7 0.4 0.2 0.1 0.1 0.9 1.0 0.2 0.9 0.1 0.2 0.9 0.2 0.3 0.1 0.6 0.3 0.6 0.7 0.1 0.1 0.6 0.7 0.0 0.2 0.1 0.1 0.3 0.0 0.3 0.6 1.5 0.1 0.8 0.5 0.9 0.8 0.4 0.2 0.3 0.7 0.7 10.6 0.4 0.9 0.5 0.6 1.1 0.4 1.6 0.7 0.5 0.6 0.7 1.2 0.6 0.3 1.1 0.6 0.8 0.5 0.6 6.5 3.1 1.0 0.4 0.9 0.4 0.5 0.7 0.6 0.8 0.2 1.5 0.6 0.8 3.1 1.5 0.5 1.1 0.5 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.0 4.0 0.0 0.7 0.3 2.4 5.1 15.3 0.0 0.0 8.7 0.0 23.2 5.0 6.8 0.0 0.5 0.4 0.0 18.5 2.4 0.6 0.6 4.6 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 1.8 0.1 0.5 5.4 0.0 0.0 27.2 1.8 6.5 0.9 0.2 0.4 0.6 71.2 0.0 0.6 0.7 SLC38A9 FLJ90709 ENSG00000177058 "Solute carrier family 38 member 9" Q8NBW4 5 55625845-55773194 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 44.2" "Cell type enhanced" "Detected in many" 20 "Cytotrophoblasts: 168.8;Early spermatids: 189.6;Syncytiotrophoblasts: 518.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043785, HPA061702" Uncertain Supported Vesicles NA NA Vesicles "HPA043785: AB_10961859, HPA061702: " "unprognostic (4.80e-2)" "unprognostic (1.18e-1)" "unprognostic (3.26e-2)" "prognostic unfavorable (7.24e-5)" "unprognostic (2.49e-1)" "unprognostic (8.19e-2)" "unprognostic (8.35e-2)" "unprognostic (7.95e-2)" "unprognostic (5.47e-2)" "unprognostic (9.44e-2)" "unprognostic (1.74e-1)" "unprognostic (4.87e-1)" "unprognostic (4.18e-3)" "unprognostic (1.76e-1)" "unprognostic (2.25e-1)" "unprognostic (2.84e-2)" "unprognostic (1.12e-1)" 7.2 6.3 8.2 6.9 8.0 5.2 6.8 9.9 9.7 6.4 7.5 9.2 6.7 6.6 7.5 5.9 9.0 5.8 7.1 3.9 6.2 6.4 6.7 13.5 6.4 8.4 9.4 6.4 6.9 18.2 10.1 11.8 44.2 8.6 5.9 8.5 6.7 7.6 5.3 5.2 6.2 7.1 7.2 8.8 8.9 7.7 15.8 8.5 13.3 7.1 5.7 11.4 8.7 6.9 10.8 10.8 7.4 11.8 8.9 10.0 6.4 8.1 8.3 6.9 9.3 9.6 9.9 49.9 6.8 9.6 8.3 13.7 13.3 11.2 13.3 11.6 5.6 13.6 10.1 9.3 8.0 10.9 7.1 8.7 4.2 8.9 8.9 15.4 7.5 5.1 12.0 9.7 9.2 10.8 6.0 9.3 8.7 9.1 8.9 7.7 6.9 9.4 7.2 12.8 3.1 7.5 7.2 11.6 13.4 11.2 6.5 3.8 6.1 7.0 4.3 11.6 10.1 9.4 15.3 12.6 1.7 5.6 12.2 7.1 9.6 19.6 8.0 4.3 7.7 4.7 4.8 11.8 7.4 7.8 10.2 10.0 10.8 6.3 9.0 10.8 6.2 9.2 7.7 2.9 8.9 7.5 10.8 8.1 6.4 8.2 8.0 9.9 9.7 6.2 6.4 9.4 6.4 8.6 8.5 6.0 1.9 9.5 3.9 2.9 5.4 2.0 15.3 4.0 7.9 8.7 7.9 168.8 1.7 7.8 189.6 6.8 4.0 0.0 9.9 52.8 5.4 4.1 2.3 18.4 23.0 1.6 4.1 9.8 10.6 73.4 6.9 8.2 5.0 8.2 5.0 5.1 9.5 7.0 4.6 5.7 7.9 6.5 4.5 14.0 4.3 3.0 518.4 8.7 5.2 4.2 SLC43A2 MGC34680 ENSG00000167703 "Solute carrier family 43 member 2" Q8N370 17 1569267-1628886 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 92.7" "Group enriched" "Detected in many" 6 "Cytotrophoblasts: 312.2;Syncytiotrophoblasts: 788.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021564 Enhanced NA NA "HPA021564: AB_1857169" "unprognostic (5.95e-3)" "unprognostic (4.45e-2)" "unprognostic (1.72e-1)" "unprognostic (2.42e-2)" "unprognostic (2.58e-2)" "unprognostic (2.80e-2)" "unprognostic (1.05e-2)" "unprognostic (5.02e-2)" "unprognostic (6.49e-2)" "unprognostic (2.80e-1)" "prognostic favorable (1.05e-6)" "unprognostic (1.96e-1)" "prognostic favorable (5.40e-5)" "unprognostic (1.84e-1)" "unprognostic (4.14e-2)" "unprognostic (1.01e-1)" "unprognostic (2.20e-1)" 5.5 2.7 5.4 13.7 5.7 12.2 3.6 14.8 11.9 2.6 2.6 5.0 2.1 7.0 2.1 4.1 1.4 5.9 3.9 1.6 5.6 7.2 15.8 3.0 6.8 8.3 5.1 3.8 2.3 1.6 1.5 6.2 92.7 5.8 2.8 2.4 4.9 4.0 3.5 23.2 1.3 11.6 4.7 3.5 8.9 2.8 1.5 1.3 5.0 5.8 2.2 3.5 5.0 1.3 1.3 3.1 15.0 5.4 0.5 0.3 2.0 0.9 2.6 0.8 7.6 1.6 1.3 10.4 0.5 0.3 1.8 0.8 15.5 1.7 4.5 5.2 0.8 0.7 1.8 4.6 0.9 0.3 0.0 0.4 0.8 2.3 3.9 1.9 0.1 1.4 1.6 1.4 1.1 0.5 0.2 7.3 0.5 1.9 0.0 0.3 3.6 9.2 0.9 0.8 2.4 0.3 2.6 0.0 5.3 3.5 8.9 3.1 1.6 2.3 6.3 0.2 3.4 6.3 5.4 9.5 0.2 1.1 2.0 0.6 0.5 9.4 2.2 0.4 0.9 0.2 2.5 5.4 5.3 0.3 4.6 0.1 1.3 0.2 0.2 3.1 1.2 0.2 0.2 15.0 0.5 4.5 1.7 0.2 2.0 5.4 5.7 14.8 11.9 5.6 7.2 5.1 3.8 5.8 1.3 14.9 40.5 18.3 5.4 4.2 22.8 2.7 15.3 21.4 22.7 34.9 23.6 312.2 16.6 21.0 2.9 4.5 16.2 0.0 6.3 29.6 10.2 7.2 11.5 1.3 81.4 19.1 10.9 16.5 88.0 1.9 10.0 84.8 0.0 73.9 12.2 23.6 6.4 21.6 8.5 19.3 35.8 0.0 5.7 3.1 3.2 3.8 788.9 3.8 10.0 4.2 SLC4A1 "AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR" ENSG00000004939 "Solute carrier family 4 member 1 (Diego blood group)" P02730 17 44248385-44268141 "Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Anion exchange, Ion transport, Transport" "Blood group antigen" "Disease mutation, Elliptocytosis, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 95.7;placenta: 32.7" "Cell type enriched" "Detected in some" 66 "Erythroid cells: 1261.4" "Cancer enriched" "Detected in single" 91 "renal cancer: 16.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebellum: 0.4" "Low region specificity" "Detected in all" "HPA015584, CAB034438, HPA063911" Enhanced NA NA 160000000 "CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151" "unprognostic (1.36e-1)" "unprognostic (1.42e-1)" "unprognostic (3.36e-1)" "unprognostic (2.44e-2)" "unprognostic (2.32e-2)" "unprognostic (1.56e-2)" "unprognostic (1.55e-1)" "unprognostic (1.59e-1)" "unprognostic (1.68e-1)" "unprognostic (1.58e-1)" "unprognostic (6.72e-3)" "unprognostic (1.19e-1)" "unprognostic (9.28e-3)" "unprognostic (1.93e-2)" "unprognostic (2.18e-1)" "unprognostic (1.94e-1)" "unprognostic (2.13e-1)" 0.9 0.1 0.3 0.2 0.4 95.7 0.2 0.8 0.2 0.1 0.1 0.6 0.0 0.2 0.1 0.4 0.6 0.2 0.2 2.6 0.2 0.3 18.6 1.3 12.9 0.8 0.6 0.1 2.8 0.1 0.0 0.6 32.7 0.9 0.6 0.1 1.2 0.1 0.1 1.2 0.2 0.1 0.0 1.0 8.4 0.1 0.3 0.0 0.7 1.9 0.0 0.2 3.9 11.8 1.8 1.4 6.3 1.2 2.9 1.5 0.7 1.3 0.5 1.4 1.7 0.6 0.7 1.0 0.3 0.4 0.3 0.8 1.4 3.2 0.7 0.6 0.3 0.4 1.4 0.5 0.5 1.1 1.3 1.3 1.7 1.6 2.2 0.0 0.8 2.3 0.8 0.5 0.8 0.8 0.5 0.2 0.6 4.8 3.5 0.4 0.6 1.0 3.5 0.9 0.7 0.5 2.5 0.7 1.9 0.3 0.8 2.2 1.0 1.3 1.4 0.5 0.7 2.5 1.8 1.0 2.4 2.1 1.4 1.4 1.0 2.3 1.1 1.6 2.2 1.1 6.1 1.0 2.0 1.1 0.9 1.0 1.1 1.0 0.9 0.5 1.8 1.5 1.2 6.3 2.9 1.2 1.4 0.7 0.7 0.3 0.4 0.8 0.2 0.2 0.3 0.6 0.1 0.9 0.0 6.0 1.1 0.0 0.9 0.0 0.4 0.7 0.0 0.0 1.2 19.2 0.0 0.3 3.3 0.0 0.5 0.0 0.0 1261.4 0.0 0.9 0.3 0.4 0.0 0.0 1.3 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.9 0.4 0.0 0.7 0.0 0.0 0.5 SLC52A1 "FLJ10060, GPCR42, GPR172B, hRFT1, PAR2, RFVT1" ENSG00000132517 "Solute carrier family 52 member 1" Q9NWF4 17 5032600-5052009 "Disease related genes, Predicted membrane proteins" Transport "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 25.6;placenta: 34.6" "Cell type enriched" "Detected in some" 5 "Syncytiotrophoblasts: 685.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 4.5;BEWO: 3.8;EFO-21: 3.6;HMC-1: 9.0;SK-BR-3: 5.1;T-47d: 3.0" NA NA "unprognostic (8.81e-3)" "prognostic favorable (9.54e-4)" "unprognostic (9.34e-2)" "unprognostic (7.30e-4)" "unprognostic (6.31e-2)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (3.82e-3)" "unprognostic (1.72e-1)" "unprognostic (2.36e-1)" "unprognostic (1.15e-1)" "unprognostic (7.19e-2)" "unprognostic (5.17e-5)" "unprognostic (1.37e-1)" "unprognostic (1.03e-1)" "unprognostic (4.07e-2)" "unprognostic (6.60e-2)" 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.3 0.6 1.0 20.0 0.2 0.6 24.4 0.5 0.1 1.5 0.8 0.1 0.1 0.1 0.1 0.2 0.1 0.5 0.1 0.1 0.1 0.2 0.1 1.0 0.1 34.6 0.3 1.4 0.1 0.1 0.5 0.3 0.1 7.4 25.6 0.1 0.1 0.6 0.0 0.7 0.1 0.6 0.2 0.4 0.7 2.5 1.0 1.4 0.6 3.7 0.6 1.4 1.2 0.3 0.2 4.5 0.1 0.2 0.2 0.2 3.8 0.0 0.0 0.6 0.6 0.1 0.2 0.3 3.6 0.1 0.7 0.4 0.0 0.3 0.1 0.1 0.2 0.0 0.7 0.3 0.1 0.1 9.0 0.1 0.1 0.2 0.1 0.2 0.2 0.7 0.1 1.2 0.0 0.3 0.5 0.4 0.4 0.1 0.2 0.1 0.0 0.3 0.1 1.4 0.1 0.3 0.8 5.1 0.1 0.2 3.0 1.4 0.6 0.3 1.1 0.1 0.2 0.3 0.1 0.3 0.2 0.1 0.5 2.6 0.6 0.9 0.7 0.4 0.6 0.6 0.9 1.2 0.2 1.4 1.1 0.8 3.7 1.4 0.4 0.6 0.5 0.3 0.1 0.2 0.3 0.6 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.3 0.0 1.3 1.0 0.0 0.6 0.0 8.1 0.0 0.0 0.0 134.6 0.0 0.0 0.1 0.1 5.7 0.0 0.0 10.3 1.1 0.3 0.0 0.0 13.6 0.0 1.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.9 0.9 1.5 685.8 0.0 1.1 0.7 SLC5A6 SMVT ENSG00000138074 "Solute carrier family 5 member 6" Q9Y289 2 27199587-27212958 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.0;placenta: 51.7" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 98.8;Extravillous trophoblasts: 89.2;monocytes: 78.5;Syncytiotrophoblasts: 190.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 69.3;SK-BR-3: 74.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036958 Approved Approved "Plasma membrane" NA NA "Plasma membrane" "HPA036958: AB_10672343" "unprognostic (5.85e-2)" "unprognostic (8.32e-3)" "unprognostic (1.38e-1)" "unprognostic (2.61e-3)" "unprognostic (9.38e-2)" "unprognostic (7.14e-2)" "unprognostic (3.20e-3)" "unprognostic (7.92e-2)" "unprognostic (6.96e-2)" "unprognostic (9.80e-2)" "unprognostic (2.05e-2)" "unprognostic (7.46e-2)" "prognostic unfavorable (3.60e-7)" "unprognostic (2.40e-3)" "unprognostic (1.20e-2)" "unprognostic (4.56e-3)" "unprognostic (4.18e-2)" 20.9 4.6 5.0 7.6 8.5 8.5 15.9 7.9 8.1 4.0 6.4 5.6 6.4 10.9 7.4 36.7 5.5 5.9 6.3 3.5 5.3 5.7 5.9 64.0 6.0 6.4 7.0 8.1 5.6 6.0 4.5 4.2 51.7 7.1 4.8 6.6 5.6 6.7 10.6 7.9 4.6 7.6 4.9 4.4 4.8 4.8 17.5 6.1 5.8 5.1 4.3 13.0 4.6 10.1 6.8 10.0 2.0 9.0 6.3 10.4 5.8 16.7 17.4 11.1 14.6 10.3 3.7 69.3 6.1 4.1 9.3 6.4 25.6 6.0 11.6 9.3 3.3 10.1 9.4 23.7 7.0 6.5 9.0 13.9 20.6 7.4 39.2 12.2 26.4 10.8 12.9 6.0 11.4 8.9 2.6 8.3 9.5 30.1 4.8 5.9 34.4 8.9 12.9 32.0 19.4 6.4 15.1 13.1 16.8 5.3 16.1 9.4 13.9 6.6 74.6 8.8 11.3 16.6 5.7 3.8 10.3 14.1 6.2 16.3 8.0 18.3 18.5 5.6 18.6 14.4 0.1 6.5 2.0 8.5 7.3 10.4 6.8 8.3 8.2 9.7 6.7 8.5 10.1 0.3 6.3 9.0 10.0 8.2 5.8 5.0 8.5 7.9 8.1 5.3 5.7 7.0 8.1 7.1 6.1 0.0 4.1 13.4 6.8 7.1 4.5 5.9 7.6 4.0 2.3 7.0 3.9 98.8 1.7 9.6 11.6 3.8 6.0 0.0 7.0 89.2 5.4 7.1 0.0 36.0 19.5 11.1 5.2 7.4 10.0 25.3 6.6 6.5 0.0 78.5 6.8 3.9 6.2 2.9 13.1 3.6 3.4 12.9 5.9 31.1 18.5 5.5 190.6 7.5 13.3 6.4 SLC6A2 "NAT1, NET, NET1, SLC6A5" ENSG00000103546 "Solute carrier family 6 member 2" P23975 16 55655604-55706192 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 20.4;placenta: 41.8" "Group enriched" "Detected in some" 5 "Early spermatids: 3.2;Extravillous trophoblasts: 6.9;Late spermatids: 3.7;Spermatocytes: 10.4;Syncytiotrophoblasts: 4.7" "Cancer enhanced" "Detected in some" "liver cancer: 1.9" "Region enriched" "Detected in single" 27 "pons and medulla: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 30 "SH-SY5Y: 107.1" "Region enriched" "Detected in some" 4 "pons and medulla: 8.2" "Region enriched" "Detected in single" 32 "pons and medulla: 23.1" "HPA004057, HPA076311, CAB078195" Enhanced Supported Approved Mitochondria,Cytosol NA NA Cytosol Mitochondria "CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307" "unprognostic (9.58e-3)" "unprognostic (5.48e-2)" "unprognostic (1.26e-4)" "unprognostic (4.07e-1)" "unprognostic (4.16e-1)" "unprognostic (8.38e-2)" "unprognostic (2.97e-2)" "unprognostic (3.29e-1)" "unprognostic (2.31e-1)" "unprognostic (3.27e-1)" "unprognostic (2.12e-2)" "unprognostic (2.95e-2)" "unprognostic (1.72e-1)" "unprognostic (6.02e-2)" "unprognostic (8.48e-2)" "unprognostic (1.43e-2)" 2.4 20.4 0.3 0.1 0.1 0.0 1.8 0.1 0.3 3.2 0.3 0.3 0.1 0.0 4.5 7.2 0.8 0.4 0.4 0.1 0.1 0.0 0.4 1.0 0.5 0.1 0.1 0.1 0.2 0.1 0.0 0.1 41.8 9.7 0.5 0.1 0.1 1.6 1.7 0.1 11.4 0.4 1.0 0.2 0.1 0.2 8.3 0.2 0.1 0.2 0.9 0.5 0.5 1.7 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 107.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.3 0.1 0.0 0.1 0.1 9.7 0.2 0.0 0.0 0.0 0.1 1.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 6.9 0.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.1 0.4 4.7 0.0 0.0 0.0 SLC7A4 "CAT-4, HCAT3, VH" ENSG00000099960 "Solute carrier family 7 member 4" O43246 22 21028718-21032840 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 19.6;testis: 29.1" "Cell type enhanced" "Detected in some" 8 "Alveolar cells type 1: 6.0;Cytotrophoblasts: 9.1;granulocytes: 4.6;Mucus-secreting cells: 7.9;Syncytiotrophoblasts: 8.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.4;naive CD8 T-cell: 2.4" "Group enriched" "Detected in many" 18 "NK-cells: 1.0;T-cells: 2.4" "Cell line enriched" "Detected in some" 21 "BEWO: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA031023 Enhanced NA NA "HPA031023: AB_10669669" "unprognostic (1.02e-3)" "unprognostic (4.34e-2)" "unprognostic (6.75e-2)" "unprognostic (1.27e-1)" "unprognostic (3.82e-2)" "unprognostic (1.04e-2)" "unprognostic (1.58e-1)" "unprognostic (3.91e-2)" "unprognostic (3.68e-2)" "unprognostic (2.51e-2)" "unprognostic (2.58e-2)" "unprognostic (1.21e-3)" "unprognostic (9.69e-2)" "unprognostic (2.87e-1)" "unprognostic (1.62e-1)" "unprognostic (1.32e-2)" "unprognostic (4.00e-3)" 2.7 3.5 2.2 0.4 3.8 0.1 2.6 6.0 5.9 2.8 1.8 0.4 1.4 1.7 1.5 0.7 8.5 1.6 4.1 1.2 2.7 7.1 0.2 0.3 1.4 1.2 2.4 4.3 0.3 0.4 0.1 5.1 19.6 2.4 4.1 1.4 3.3 4.3 5.3 0.6 1.9 2.0 0.6 0.6 0.9 2.4 29.1 0.4 0.2 0.1 1.3 2.1 2.4 0.7 0.0 0.0 0.0 0.0 1.0 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 57.3 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.4 0.0 0.2 1.2 0.0 0.0 0.1 2.4 0.0 1.0 0.0 0.0 0.0 0.8 2.2 3.8 6.0 5.9 2.7 7.1 2.4 4.3 2.4 0.4 6.0 3.4 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.1 0.0 0.1 0.0 0.4 2.8 0.1 0.4 4.6 0.0 1.2 0.0 1.2 1.8 0.0 1.3 1.7 0.0 0.0 0.0 7.9 1.8 0.6 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.2 0.0 8.5 0.0 0.6 0.1 SOX14 SOX28 ENSG00000168875 "SRY-box 14" O95416 3 137764284-137766338 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.4;placenta: 15.1;prostate: 3.1" "Cell type enriched" "Detected in some" 4 "Cytotrophoblasts: 12.6" "Cancer enhanced" "Detected in many" "prostate cancer: 2.8" "Group enriched" "Detected in many" 15 "hypothalamus: 5.4;midbrain: 1.6;pons and medulla: 4.4;thalamus: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "hypothalamus: 2.1;midbrain: 5.9" "Group enriched" "Detected in many" 7 "midbrain: 10.3;pons and medulla: 5.6;thalamus: 16.5" NA NA "unprognostic (1.43e-1)" "unprognostic (1.63e-1)" "unprognostic (1.88e-2)" "unprognostic (2.49e-3)" "unprognostic (5.08e-1)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 5.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.4 15.1 4.4 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 5.4 1.6 0.0 4.4 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 1.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 SP6 "Epfn, KLF14" ENSG00000189120 "Sp6 transcription factor" Q3SY56 17 47844908-47855874 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 33.7;placenta: 24.7;seminal vesicle: 26.2" "Group enriched" "Detected in some" 9 "Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 82.6" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "cerebellum: 1.3;pons and medulla: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "BEWO: 45.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024516, HPA044469" Supported "Nucleoplasm,Mitotic spindle,Centrosome" Yes No Nucleoplasm "Mitotic spindle, Centrosome" "HPA024516: AB_10960551, HPA044469: AB_10966430" "unprognostic (3.06e-2)" "unprognostic (4.32e-2)" "unprognostic (1.07e-2)" "unprognostic (7.55e-3)" "unprognostic (6.79e-2)" "unprognostic (4.57e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.11e-6)" "unprognostic (1.22e-1)" "unprognostic (8.72e-2)" "unprognostic (3.92e-3)" "unprognostic (1.63e-1)" "unprognostic (9.59e-3)" "prognostic favorable (6.39e-4)" "unprognostic (3.33e-1)" "unprognostic (9.93e-2)" "prognostic favorable (5.72e-4)" 0.9 1.0 0.1 0.5 0.0 0.0 3.8 1.3 0.2 1.7 1.8 0.1 33.7 1.5 0.4 4.1 5.8 1.1 0.4 0.4 0.1 0.1 0.9 0.1 3.6 0.5 0.1 0.0 3.6 0.4 2.0 0.2 24.7 1.1 6.9 0.7 0.2 1.0 26.2 0.1 14.9 5.3 0.3 0.3 0.9 0.3 0.4 0.0 0.8 1.3 5.6 3.6 5.3 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.2 0.4 0.0 0.0 0.0 0.0 45.4 0.2 0.2 0.9 0.2 9.5 0.9 0.0 0.3 0.0 0.6 1.3 0.0 1.6 0.2 0.1 0.3 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.9 0.1 0.1 0.1 2.2 0.0 0.0 0.8 0.0 0.0 0.0 3.9 0.8 0.0 0.0 0.0 0.2 5.7 1.4 0.0 0.0 5.8 0.0 8.7 2.3 0.0 3.0 0.2 1.3 0.0 0.2 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.3 0.2 0.1 0.1 0.1 0.0 1.1 0.0 0.0 0.0 0.0 1.9 0.1 0.0 0.3 0.0 0.0 0.0 1.8 0.0 45.5 0.0 0.7 0.0 0.3 6.9 0.0 0.7 1.6 0.3 1.6 0.0 0.0 3.6 0.0 1.7 1.3 0.0 0.0 0.3 0.0 0.0 0.0 2.4 0.0 1.3 2.9 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.6 82.6 0.0 2.7 5.1 SPESP1 SP-ESP ENSG00000258484 "Sperm equatorial segment protein 1" Q6UW49 15 68818221-68946811 "Predicted intracellular proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "placenta: 14.2;testis: 54.3" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 242.1;Spermatocytes: 320.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 11.1;BJ hTERT+ SV40 Large T+ RasG12V: 11.7;HBF TERT88: 13.7;HMC-1: 8.4;OE19: 9.5;RPTEC TERT1: 16.5;SCLC-21H: 12.5;WM-115: 19.4" "Not detected" "Not detected" "HPA045936, HPA051040" Enhanced "Intracellular and membrane" NA NA 13000 "HPA045936: AB_2679504, HPA051040: AB_2681322" "unprognostic (1.14e-1)" "unprognostic (1.43e-1)" "unprognostic (1.73e-3)" "unprognostic (9.82e-2)" "unprognostic (1.59e-1)" "unprognostic (1.42e-2)" "unprognostic (1.06e-1)" "unprognostic (5.96e-2)" "unprognostic (2.79e-1)" "unprognostic (2.40e-1)" "unprognostic (8.99e-2)" "unprognostic (1.10e-2)" "unprognostic (1.16e-2)" "unprognostic (2.68e-2)" "unprognostic (1.15e-1)" "unprognostic (1.75e-1)" "unprognostic (9.67e-2)" 2.3 2.7 1.5 0.7 3.3 0.4 2.3 1.1 1.9 1.1 1.5 1.6 4.8 0.9 1.5 4.7 2.0 1.5 2.6 2.8 1.5 1.5 2.2 1.0 1.1 1.9 2.1 0.5 2.7 1.4 0.2 2.9 14.2 3.8 2.7 0.9 1.8 1.7 3.1 1.6 1.0 0.9 2.0 3.2 1.8 1.4 54.3 1.1 0.8 2.2 0.7 0.6 2.9 0.8 1.4 2.6 3.7 4.3 0.7 2.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 11.1 11.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 13.7 3.0 0.0 0.0 0.0 0.0 4.0 0.0 8.4 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 1.7 0.0 0.0 2.0 9.5 0.0 0.0 0.9 0.0 16.5 0.1 12.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 19.4 3.7 4.3 1.3 0.8 3.4 2.0 1.4 1.5 1.1 2.6 1.3 1.3 1.7 1.9 0.7 2.5 1.5 1.4 1.8 1.5 3.3 1.1 1.9 1.5 1.5 2.1 0.5 3.8 1.1 0.0 0.0 0.0 2.8 1.6 0.8 3.5 0.0 2.7 0.0 7.0 3.9 58.4 1.7 2.0 242.1 2.9 0.0 0.0 2.4 4.6 6.1 2.5 0.0 1.5 6.6 0.0 1.7 0.0 1.3 51.2 19.5 1.9 5.0 1.0 0.1 5.7 1.0 0.0 8.1 3.5 5.1 45.3 4.7 320.9 70.5 1.9 51.9 0.0 0.0 0.9 SPIRE2 "KIAA1832, spir-2" ENSG00000204991 "Spire type actin nucleation factor 2" Q8WWL2 16 89818179-89871319 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 40.6" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 40.0;Mucus-secreting cells: 37.2;Paneth cells: 34.2;Syncytiotrophoblasts: 58.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 21.5;T-47d: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041413, HPA049415" Uncertain Approved "Nucleoplasm,Vesicles,Intermediate filaments" NA NA Nucleoplasm "Vesicles, Intermediate filaments" "HPA041413: AB_2677464, HPA049415: AB_2680755" "unprognostic (2.92e-1)" "unprognostic (1.39e-1)" "unprognostic (6.07e-3)" "unprognostic (6.96e-2)" "unprognostic (7.40e-2)" "unprognostic (7.31e-2)" "prognostic unfavorable (9.77e-5)" "unprognostic (2.10e-1)" "unprognostic (7.75e-2)" "unprognostic (5.34e-2)" "unprognostic (1.08e-2)" "unprognostic (6.95e-3)" "unprognostic (7.21e-3)" "unprognostic (6.65e-2)" "unprognostic (1.30e-1)" "unprognostic (3.27e-2)" "unprognostic (1.59e-2)" 1.5 2.1 7.2 3.9 9.3 2.2 1.7 19.5 11.2 2.1 14.8 2.1 5.9 10.9 2.5 3.2 2.5 9.1 7.6 0.8 6.2 7.8 1.9 4.0 3.2 1.0 5.5 6.1 1.6 3.0 8.4 18.4 40.6 7.4 3.5 11.7 2.7 2.2 5.0 1.2 2.0 12.6 1.9 2.5 1.5 20.2 3.8 1.4 0.0 5.0 0.9 1.3 6.4 4.9 2.1 1.6 5.5 1.4 1.7 1.2 0.6 0.2 6.2 3.9 3.3 1.1 0.7 13.2 2.1 1.2 2.9 1.2 2.4 6.6 4.1 0.9 0.6 3.1 6.6 1.7 0.2 0.9 1.6 7.6 0.8 5.1 6.3 1.0 0.2 1.4 1.4 1.5 0.9 0.8 0.3 0.1 0.3 6.3 1.2 0.8 9.2 0.1 1.4 4.3 21.5 3.8 3.1 1.4 0.9 1.5 6.3 10.3 5.3 8.6 3.8 3.7 3.4 14.2 2.2 0.3 1.7 3.7 2.4 1.8 0.5 2.6 0.4 2.6 1.5 3.5 4.6 1.4 0.9 1.1 0.7 0.8 1.2 0.9 0.7 0.3 2.1 1.2 1.2 5.5 1.7 1.3 1.6 0.5 0.6 7.2 9.3 19.5 11.2 6.2 7.8 5.5 6.1 7.4 1.4 6.0 3.7 0.8 3.6 0.8 11.1 2.0 7.6 5.3 1.2 12.2 3.9 11.0 3.3 1.2 2.4 0.5 40.0 0.0 0.3 2.8 1.3 4.5 0.0 1.8 2.2 22.3 15.1 0.0 1.8 1.7 0.9 1.1 0.0 0.0 37.2 2.4 1.0 34.2 1.8 0.8 10.1 0.0 1.0 4.6 8.4 0.5 58.9 0.8 30.5 25.1 SPP1 "BNSP, BSPI, ETA-1, OPN" ENSG00000118785 "Secreted phosphoprotein 1" P10451 4 87975650-87983426 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Biomineralization, Cell adhesion" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 303.9;kidney: 700.7;placenta: 331.0" "Cell type enriched" "Detected in many" 9 "Hofbauer cells: 50179.8" "Cancer enhanced" "Detected in all" "glioma: 1690.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "neutrophil: 19.2" "Lineage enriched" "Detected in single" 192 "granulocytes: 19.2" "Cell line enhanced" "Detected in some" "EFO-21: 218.9;Hep G2: 107.8;RPTEC TERT1: 477.9" "Region enhanced" "Detected in all" "pons and medulla: 331.4" "Low region specificity" "Detected in all" "HPA027540, HPA027541" Enhanced Enhanced "Golgi apparatus" "Secreted to blood" NA NA 114000000 54000000 "Golgi apparatus" "HPA027540: AB_10600222, HPA027541: AB_10601446" "unprognostic (4.74e-2)" "prognostic unfavorable (9.52e-4)" "unprognostic (1.13e-3)" "unprognostic (2.04e-1)" "unprognostic (2.31e-2)" "unprognostic (6.96e-3)" "prognostic unfavorable (2.84e-6)" "unprognostic (2.46e-3)" "unprognostic (7.86e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (4.31e-2)" "unprognostic (2.55e-1)" "unprognostic (7.19e-2)" "unprognostic (1.57e-1)" "unprognostic (3.48e-1)" "unprognostic (2.63e-2)" 20.7 4.1 25.5 8.3 42.7 1.1 8.7 4.3 61.0 4.7 2.7 27.3 0.0 2.1 17.3 2.3 1.5 4.2 303.9 2.6 37.2 26.4 700.7 3.9 3.2 2.0 97.0 9.1 3.1 23.6 1.3 1.5 331.0 52.3 2.4 1.9 3.9 7.3 3.9 2.5 1.1 2.1 5.6 147.9 2.1 2.0 2.4 58.9 0.0 1.7 0.0 1.6 5.3 0.3 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 6.2 0.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 218.9 0.1 17.1 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 107.8 0.0 0.3 0.2 0.0 0.0 1.5 0.0 5.5 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.9 10.1 0.0 0.0 0.1 0.0 51.4 477.9 0.0 0.0 0.0 0.0 0.0 14.4 21.2 0.0 0.2 0.0 0.5 1.1 0.0 1.1 0.0 0.3 0.4 20.0 0.0 20.4 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 0.0 25.5 42.7 4.3 28.8 37.2 26.4 97.0 9.1 52.3 58.9 3.0 6.6 20.0 2.2 1.3 34.3 4.3 1834.4 2.7 0.0 2071.0 25.5 256.7 850.5 3124.6 0.0 17.5 0.0 0.0 59.8 221.1 15.4 0.3 0.0 2.9 50179.8 742.1 0.0 6.7 63.8 0.4 0.9 93.6 1.7 120.8 0.0 3889.3 343.9 0.0 0.0 5328.4 135.9 0.0 4.4 0.3 0.2 0.9 558.5 1.5 0.0 12.7 SPTLC3 "C20orf38, FLJ11112, hLCB2b, LCB2B, SPTLC2L" ENSG00000172296 "Serine palmitoyltransferase long chain base subunit 3" Q9NUV7 20 13008979-13169103 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "placenta: 154.0" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 22.9;Syncytiotrophoblasts: 38.6" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "pons and medulla: 10.5" "Group enriched" "Detected in some" 5 "MAIT T-cell: 3.0;NK-cell: 4.1" "Group enriched" "Detected in many" 13 "NK-cells: 4.1;T-cells: 3.0" "Cell line enhanced" "Detected in many" "Karpas-707: 16.4;RPTEC TERT1: 21.8;U-2197: 15.2;U-87 MG: 28.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA044247, HPA048079" Enhanced Approved Microtubules NA NA Microtubules "HPA044247: AB_2678872, HPA048079: AB_2680252" "unprognostic (6.81e-2)" "unprognostic (7.76e-2)" "unprognostic (4.46e-2)" "unprognostic (1.25e-3)" "unprognostic (5.43e-2)" "unprognostic (2.12e-1)" "unprognostic (5.70e-2)" "unprognostic (7.99e-2)" "unprognostic (9.51e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (5.08e-2)" "prognostic favorable (4.51e-7)" "unprognostic (2.80e-2)" "unprognostic (1.01e-1)" "unprognostic (1.17e-1)" "unprognostic (3.18e-1)" 3.2 4.5 1.3 1.6 2.2 0.0 4.3 1.7 1.7 4.3 5.0 2.2 4.4 8.3 4.8 9.6 5.6 3.4 5.8 4.8 2.0 1.5 15.6 11.9 5.7 0.7 2.5 2.2 4.3 3.8 10.2 4.2 154.0 10.5 4.5 3.8 3.8 7.8 5.8 1.0 25.1 9.0 3.0 6.9 1.9 2.2 4.2 1.4 5.7 24.3 3.6 1.9 4.8 6.0 0.0 0.2 0.1 0.0 4.1 3.0 0.2 0.7 1.1 0.9 0.0 7.1 10.3 5.5 0.0 1.5 1.0 4.1 8.9 4.5 0.0 0.5 0.2 9.0 12.2 0.0 3.4 1.4 0.0 0.0 0.0 2.8 12.6 0.6 0.0 0.1 5.8 10.7 4.0 1.4 3.8 0.7 2.1 0.0 16.4 11.5 0.2 0.0 0.0 0.0 1.0 1.4 1.1 2.0 7.2 21.8 8.7 0.0 0.1 0.1 1.1 0.0 1.6 9.1 0.2 1.6 4.6 1.5 15.2 1.0 0.1 0.0 0.0 28.8 0.0 0.0 0.1 0.0 0.0 0.5 0.0 3.0 0.0 0.4 0.1 0.0 0.0 0.7 0.1 0.1 4.1 0.0 0.2 0.0 0.2 1.3 2.2 1.7 1.7 2.0 1.5 2.5 2.2 10.5 1.4 6.0 18.2 0.0 4.8 2.2 0.0 15.1 5.1 4.0 6.8 8.7 0.0 22.9 6.6 2.2 15.0 2.2 4.9 0.0 3.8 10.5 7.2 3.4 1.1 18.7 2.5 0.0 0.0 0.6 2.5 8.5 3.4 0.9 0.0 0.0 4.7 13.6 2.5 8.0 2.5 11.9 0.0 0.0 0.3 0.9 0.1 1.9 38.6 1.3 6.1 1.8 ST3GAL4 "CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ" ENSG00000110080 "ST3 beta-galactoside alpha-2,3-sialyltransferase 4" Q11206 11 126355640-126440344 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 74.2" "Cell type enriched" "Detected in many" 9 "Syncytiotrophoblasts: 804.9" "Cancer enhanced" "Detected in all" "melanoma: 57.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 31.3;neutrophil: 22.8;plasmacytoid DC: 29.6" "Group enriched" "Detected in many" 11 "dendritic cells: 29.6;granulocytes: 31.3" "Cell line enhanced" "Detected in many" "SK-MEL-30: 45.3;WM-115: 102.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA049827 Approved "Intracellular and membrane" NA NA "HPA049827: AB_2680900" "unprognostic (8.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.92e-2)" "unprognostic (6.93e-2)" "unprognostic (8.33e-2)" "unprognostic (3.80e-2)" "unprognostic (2.71e-3)" "unprognostic (1.90e-3)" "unprognostic (2.62e-1)" "unprognostic (1.80e-2)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" "unprognostic (3.16e-3)" "unprognostic (2.79e-2)" "unprognostic (1.28e-1)" "unprognostic (8.36e-3)" "unprognostic (8.78e-3)" 7.8 38.0 6.2 6.5 12.2 7.8 12.9 4.0 13.6 8.3 27.0 26.4 5.1 2.0 6.0 42.1 25.5 6.0 11.4 26.5 8.6 6.2 16.7 11.5 12.4 9.0 18.7 9.0 39.3 5.1 0.8 5.6 74.2 13.8 12.1 31.5 35.7 14.4 8.0 1.9 5.6 3.8 11.0 23.0 17.0 4.8 18.8 12.4 2.2 6.1 4.3 10.1 21.1 13.2 0.1 29.6 31.3 2.6 1.2 1.7 1.8 4.9 4.1 3.2 2.7 9.5 7.9 8.0 5.7 11.1 5.2 3.6 2.4 8.5 1.4 4.3 9.0 17.7 7.7 6.7 3.7 4.1 5.3 1.9 12.6 10.2 2.7 6.2 15.0 25.8 6.3 6.0 7.8 12.4 9.6 6.9 5.5 7.8 3.8 6.4 20.2 4.7 15.4 2.0 31.9 26.8 4.9 9.9 0.6 1.2 14.2 6.1 3.9 6.3 38.2 45.3 2.2 13.3 10.0 2.5 12.5 2.8 8.8 10.7 0.3 0.8 0.7 5.7 23.0 102.8 31.3 1.6 0.2 1.7 2.6 1.6 0.1 0.6 1.1 6.6 0.0 0.1 0.8 22.8 1.2 1.2 29.6 0.0 1.8 6.2 12.2 4.0 13.6 8.6 6.2 18.7 9.0 13.8 12.4 8.9 1.1 3.7 5.3 9.4 4.2 26.6 7.6 1.4 4.5 29.6 9.8 90.3 41.4 4.3 1.1 9.8 34.8 0.0 5.6 59.0 44.0 13.8 41.5 8.9 16.2 4.8 5.1 36.8 4.1 3.8 70.5 7.2 74.2 10.8 43.5 5.0 7.3 93.0 88.1 3.4 8.3 12.9 23.6 1.4 3.8 5.8 804.9 12.2 8.8 13.1 STH MAPTIT ENSG00000256762 Saitohin Q8IWL8 17 45999250-45999694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.2;breast: 1.9;placenta: 1.6;skeletal muscle: 2.5" "Group enriched" "Detected in some" 8 "Bipolar cells: 2.7;Cone photoreceptor cells: 2.0;Horizontal cells: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 1.1;HDLM-2: 3.2;PC-3: 1.0;RPMI-8226: 1.0;RT4: 1.7" NA NA "unprognostic (1.24e-1)" "unprognostic (3.22e-1)" 0.0 0.0 0.8 0.0 1.3 0.0 1.9 4.1 4.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.2 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 1.6 0.2 0.0 0.5 0.0 2.5 0.7 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 1.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 STRA6 FLJ12541 ENSG00000137868 "Stimulated by retinoic acid 6" Q9BX79 15 74179466-74212267 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport Receptor "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "cervix, uterine: 22.7;placenta: 88.6;retina: 42.8" "Cell type enhanced" "Detected in some" 16 "Extravillous trophoblasts: 11.0;Leydig cells: 6.4;Syncytiotrophoblasts: 22.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 16.6;CAPAN-2: 47.1;SH-SY5Y: 29.3;WM-115: 70.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA040839 Approved NA NA "HPA040839: AB_10794881" "unprognostic (1.20e-2)" "unprognostic (4.99e-2)" "unprognostic (3.71e-2)" "unprognostic (3.55e-3)" "unprognostic (1.37e-1)" "unprognostic (2.09e-2)" "unprognostic (4.38e-3)" "unprognostic (1.67e-2)" "unprognostic (9.16e-2)" "unprognostic (1.21e-1)" "unprognostic (5.35e-2)" "unprognostic (3.89e-1)" "unprognostic (7.91e-13)" "unprognostic (2.90e-2)" "unprognostic (2.03e-1)" "unprognostic (1.51e-2)" "unprognostic (1.91e-1)" 0.2 1.6 0.2 0.5 0.3 0.0 1.1 0.2 0.5 22.7 0.1 0.3 1.6 0.0 6.9 2.8 1.0 5.0 0.7 0.3 0.4 0.2 7.3 0.0 0.3 1.1 0.1 0.3 0.6 0.2 0.0 5.3 88.6 0.7 5.0 0.0 42.8 0.6 2.6 0.1 0.4 0.2 0.3 1.5 0.3 0.1 2.8 0.1 0.9 0.2 1.4 1.9 1.8 2.3 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.2 16.6 1.0 0.0 0.0 0.0 2.8 0.5 0.1 0.0 0.0 5.7 47.1 0.0 11.4 0.0 0.4 1.6 0.9 0.0 0.0 0.0 0.1 1.4 0.6 1.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 3.0 0.2 1.5 0.0 0.0 0.2 0.0 0.0 0.0 1.5 8.9 29.3 0.0 1.7 0.0 1.9 0.1 0.0 0.0 0.1 3.9 0.3 0.7 0.1 0.1 0.0 0.3 0.0 70.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.4 0.4 0.2 0.1 0.3 0.7 0.1 0.0 0.0 0.0 1.0 0.3 0.0 1.0 0.0 4.0 3.4 0.0 0.0 2.0 1.7 0.2 1.2 0.4 0.0 0.0 0.0 11.0 0.9 0.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.2 6.4 0.0 1.7 0.0 0.0 0.0 2.8 0.0 3.9 4.1 0.0 0.0 0.4 0.5 0.4 0.0 22.1 0.0 0.0 0.9 STS "ARSC, ARSC1" ENSG00000101846 "Steroid sulfatase" P08842 X 7219456-7354810 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Pregnancy, Steroid metabolism" Hydrolase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "placenta: 258.8" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 34.3;Syncytiotrophoblasts: 78.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 20.3;RPMI-8226: 25.9;U-266/70: 43.0;U-698: 18.0" HPA002904 Enhanced NA NA "HPA002904: AB_1080116" "unprognostic (1.09e-1)" "unprognostic (3.90e-2)" "unprognostic (1.44e-2)" "unprognostic (2.75e-1)" "unprognostic (6.72e-2)" "unprognostic (1.94e-2)" "unprognostic (2.62e-1)" "unprognostic (1.84e-1)" "unprognostic (8.23e-2)" "unprognostic (4.67e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (4.05e-2)" "unprognostic (2.78e-2)" "unprognostic (2.77e-1)" "unprognostic (2.56e-1)" "unprognostic (1.92e-2)" "unprognostic (1.34e-1)" 10.3 2.2 3.0 2.2 3.9 0.0 4.1 2.3 9.0 3.4 3.5 2.3 2.2 0.8 2.4 2.2 2.2 2.6 4.1 3.6 3.9 4.0 2.5 4.7 5.0 2.2 3.8 2.4 2.4 2.2 1.6 2.2 258.8 2.4 2.9 3.0 2.3 2.2 3.3 4.0 2.3 2.4 3.8 2.4 2.2 6.7 2.2 2.3 2.2 2.4 2.2 2.2 4.9 2.7 0.9 1.9 1.9 4.7 1.0 0.7 1.0 4.1 1.3 2.8 0.9 20.3 10.5 15.0 8.4 3.0 2.3 2.1 7.4 3.9 7.7 1.6 6.1 1.8 1.0 1.6 1.4 2.3 0.6 3.2 0.4 4.7 2.1 1.1 1.1 4.4 3.4 0.2 1.4 0.8 1.5 3.4 0.6 0.4 8.1 6.0 0.9 0.6 1.0 1.0 0.0 1.9 1.1 1.6 25.9 5.7 6.0 2.0 1.7 1.7 3.0 0.9 4.8 1.3 0.4 6.0 9.1 0.5 11.6 1.3 43.0 0.0 18.0 2.1 0.9 2.4 0.0 3.2 0.6 0.5 4.7 0.2 0.6 0.2 0.3 1.9 0.9 0.1 0.5 1.9 1.0 2.5 0.3 0.7 1.0 3.0 3.9 2.3 9.0 3.9 4.0 3.8 2.4 2.4 2.3 11.9 2.1 1.5 1.7 0.8 3.1 5.0 2.5 0.0 1.2 1.8 0.0 34.3 0.0 6.9 0.1 4.3 4.1 0.0 17.1 18.7 4.1 7.6 6.9 7.4 6.6 1.6 3.5 2.5 5.9 0.0 2.6 2.7 1.7 2.8 2.3 3.1 8.7 7.4 6.3 1.4 0.8 0.0 4.7 0.0 1.4 0.9 78.6 0.0 2.2 7.4 SVEP1 "bA427L11.3, C9orf13, FLJ13529, POLYDOM" ENSG00000165124 "Sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1" Q4LDE5 9 110365251-110579880 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "placenta: 141.1" "Group enriched" "Detected in some" 6 "Fibroblasts: 33.2;Leydig cells: 38.9;Syncytiotrophoblasts: 56.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 6.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC diff: 51.6;ASC TERT1: 30.0;BJ hTERT+: 21.1;HHSteC: 18.9;HSkMC: 23.4" "Low region specificity" "Detected in some" "Region enriched" "Detected in some" 7 "cerebellum: 31.1" "HPA020610, HPA021520" Enhanced "Intracellular and membrane" NA NA 160000000 "HPA020610: AB_2197021, HPA021520: AB_1855533" "unprognostic (4.47e-2)" "unprognostic (6.01e-2)" "unprognostic (1.62e-2)" "unprognostic (1.04e-2)" "unprognostic (2.31e-1)" "unprognostic (2.62e-2)" "unprognostic (9.13e-3)" "unprognostic (1.32e-1)" "unprognostic (2.08e-2)" "unprognostic (3.31e-3)" "unprognostic (2.25e-1)" "unprognostic (1.51e-1)" "unprognostic (4.11e-2)" "prognostic unfavorable (8.33e-4)" "unprognostic (9.84e-2)" "unprognostic (2.21e-1)" "unprognostic (1.55e-3)" 18.8 2.5 1.0 3.9 1.8 0.0 11.9 6.7 0.9 7.1 8.6 0.5 3.6 0.6 6.1 7.8 4.7 4.4 5.4 4.4 1.1 0.7 2.1 1.5 8.6 5.8 1.1 0.5 4.2 2.7 2.2 0.7 141.1 0.7 4.3 3.1 1.5 2.2 1.3 7.4 3.5 3.3 5.7 0.6 3.4 3.6 4.0 0.9 0.0 3.5 2.3 1.3 9.6 7.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 51.6 30.0 0.0 5.4 21.1 0.4 0.6 0.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 4.1 0.3 0.0 0.1 0.0 0.4 0.0 18.9 0.0 1.0 23.4 0.0 4.1 1.1 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 2.5 0.7 0.0 3.8 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.4 0.8 0.0 2.5 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 1.8 6.7 0.9 1.1 0.7 1.1 0.5 0.7 0.9 0.0 0.3 0.0 0.5 5.0 0.0 1.2 7.6 0.0 0.0 0.0 0.0 7.6 0.0 0.6 0.2 2.1 0.0 0.0 0.2 1.1 33.2 0.2 0.0 0.0 2.7 0.0 0.0 3.1 0.0 0.0 38.9 0.0 6.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.1 0.1 1.4 2.9 56.3 0.0 0.0 0.1 SYDE1 "7h3, FLJ13511, SYD1" ENSG00000105137 "Synapse defective Rho GTPase homolog 1" Q6ZW31 19 15107403-15114988 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 60.0" "Cell type enhanced" "Detected in many" 12 "Extravillous trophoblasts: 126.4;Sertoli cells: 84.1;Syncytiotrophoblasts: 112.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-138 MG: 41.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013328 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA013328: AB_1848705" "unprognostic (9.99e-2)" "unprognostic (3.73e-2)" "unprognostic (8.17e-3)" "unprognostic (1.65e-2)" "unprognostic (6.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.07e-2)" "unprognostic (2.46e-2)" "unprognostic (2.96e-1)" "unprognostic (5.01e-3)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (5.63e-7)" "unprognostic (1.82e-2)" "unprognostic (7.57e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (8.27e-4)" 15.6 7.7 3.5 5.9 4.3 0.1 19.9 2.0 3.5 19.5 13.9 4.4 3.8 4.3 18.6 6.8 10.7 12.2 10.5 9.3 4.0 1.8 9.6 3.3 9.4 4.9 3.1 2.4 17.9 4.6 2.3 3.8 60.0 5.0 11.8 2.9 22.0 3.3 13.6 5.9 4.4 5.7 14.2 2.5 7.6 7.9 7.4 4.3 0.9 8.2 5.8 2.8 12.9 12.8 0.2 0.3 0.0 0.0 0.0 0.5 0.0 4.1 6.4 3.5 9.0 7.9 7.3 2.7 17.5 12.9 17.2 14.7 1.4 2.5 0.0 11.6 17.6 5.9 2.6 2.7 3.1 9.7 0.1 3.0 0.6 11.9 2.8 15.0 0.0 0.0 12.7 2.3 10.3 4.7 10.5 3.1 0.0 0.0 0.0 12.8 2.0 0.0 0.0 5.7 0.1 6.6 0.0 8.6 0.0 4.2 0.5 0.1 6.9 9.8 6.0 11.7 3.5 0.7 0.4 6.6 41.5 12.6 19.0 18.8 0.0 0.1 0.0 11.2 0.0 17.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 4.3 2.0 3.5 4.0 1.8 3.1 2.4 5.0 4.3 3.0 1.4 0.5 0.6 2.2 0.3 3.9 2.5 0.0 1.2 1.8 0.0 4.9 0.0 3.9 8.8 12.6 0.0 0.0 0.3 126.4 14.7 0.5 0.0 0.0 3.0 1.6 0.0 19.0 1.3 12.0 27.3 0.8 13.5 0.0 0.0 13.2 1.5 0.0 39.6 5.5 0.4 84.1 29.9 1.2 0.5 2.3 112.5 0.0 0.0 0.1 SYNPO KIAA1029 ENSG00000171992 Synaptopodin Q8N3V7 5 150601080-150659220 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 66.1;placenta: 63.4;skeletal muscle: 222.7" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 219.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "memory B-cell: 2.9;naive B-cell: 3.3" "Lineage enriched" "Detected in single" 27 "B-cells: 3.3" "Cell line enhanced" "Detected in many" "BEWO: 26.4;EFO-21: 21.8;HUVEC TERT2: 21.3;TIME: 51.7;U-87 MG: 45.9" "Group enriched" "Detected in many" 6 "amygdala: 75.9;basal ganglia: 61.9;cerebral cortex: 93.2;hippocampal formation: 69.5;olfactory region: 42.1" "Low region specificity" "Detected in all" "CAB033265, HPA034631, CAB037325, HPA071347" Enhanced Approved "Nucleoplasm,Actin filaments,Cytosol" NA NA "Nucleoplasm, Cytosol" "Actin filaments" "CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: AB_2732179" "unprognostic (2.09e-2)" "unprognostic (7.72e-3)" "unprognostic (3.95e-2)" "unprognostic (2.78e-3)" "unprognostic (3.07e-2)" "unprognostic (1.66e-2)" "unprognostic (1.76e-1)" "unprognostic (1.41e-2)" "unprognostic (1.90e-1)" "unprognostic (1.21e-1)" "unprognostic (1.17e-1)" "unprognostic (4.86e-2)" "prognostic unfavorable (1.53e-6)" "unprognostic (1.23e-1)" "unprognostic (5.72e-2)" "unprognostic (2.21e-2)" "unprognostic (6.35e-2)" 17.3 14.6 17.7 4.4 18.9 0.6 5.7 1.4 24.9 4.3 5.5 2.4 0.8 6.6 5.1 4.8 6.7 4.4 6.8 66.1 16.6 4.0 15.8 7.8 11.7 2.4 4.5 5.6 23.3 6.8 2.5 2.8 63.4 3.7 7.6 4.1 16.4 2.6 6.7 222.7 1.8 7.6 8.2 4.8 14.5 4.7 17.4 3.9 0.5 4.0 5.7 2.6 6.2 17.0 3.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 7.0 0.0 0.1 1.0 0.9 26.4 4.0 5.5 1.4 1.1 6.2 2.8 0.0 21.8 5.7 8.7 2.6 0.0 3.9 0.5 0.0 0.0 0.0 10.6 1.3 6.0 0.0 0.2 1.1 6.3 1.5 1.1 8.2 21.3 0.0 0.0 0.0 1.3 0.4 0.0 0.2 0.8 2.6 3.4 0.1 0.2 0.0 1.0 0.5 2.5 11.7 5.8 6.4 0.2 9.7 0.4 1.9 51.7 5.2 16.3 0.1 1.0 0.2 0.0 0.3 45.9 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.7 18.9 1.4 24.9 16.6 4.0 4.5 5.6 3.7 3.9 32.8 13.5 0.9 2.8 4.0 1.3 219.1 35.7 5.3 14.8 7.0 2.0 9.9 0.0 44.4 1.6 40.9 50.6 0.0 30.5 5.8 12.3 1.6 0.0 38.0 1.9 0.0 13.3 42.4 6.7 1.9 2.6 1.1 5.0 41.5 9.9 6.1 29.3 25.9 26.2 3.3 0.6 45.3 32.0 0.7 0.4 1.9 21.6 1.3 9.1 3.0 SYTL5 ENSG00000147041 "Synaptotagmin like 5" Q8TDW5 X 38006582-38128819 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 17.0" "Cell type enhanced" "Detected in some" 11 "Club cells: 5.7;Mucus-secreting cells: 10.5;Syncytiotrophoblasts: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 19 "non-classical monocyte: 1.8" "Lineage enriched" "Detected in single" 19 "monocytes: 1.8" "Cell line enhanced" "Detected in some" "CACO-2: 5.6;MCF7: 5.2;OE19: 7.5;SK-MEL-30: 13.4;SuSa: 19.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA026074 Uncertain Approved Nucleoplasm,Microtubules,Cytosol NA NA Nucleoplasm "Microtubules, Cytosol" "HPA026074: AB_1857697" "unprognostic (3.60e-2)" "unprognostic (1.71e-1)" "unprognostic (2.35e-1)" "unprognostic (6.68e-2)" "unprognostic (3.09e-3)" "unprognostic (3.22e-2)" "unprognostic (2.01e-2)" "unprognostic (1.94e-1)" "unprognostic (1.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.10e-1)" "unprognostic (6.72e-2)" "unprognostic (1.30e-2)" "unprognostic (5.21e-2)" "unprognostic (1.51e-1)" "unprognostic (1.47e-2)" "unprognostic (2.96e-2)" 0.5 6.0 10.5 3.4 11.0 0.0 2.9 0.5 2.5 7.0 7.3 0.5 0.5 2.3 2.6 1.0 12.2 0.2 2.9 0.9 9.2 8.9 1.0 6.1 2.4 0.5 2.4 0.5 0.5 6.4 0.0 1.1 17.0 0.5 2.0 3.5 1.5 7.1 1.7 0.5 0.0 14.3 3.9 1.3 0.8 13.8 0.7 0.5 0.7 0.9 1.2 5.9 1.3 0.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 5.6 1.3 0.0 0.0 0.5 2.1 0.6 0.0 0.0 0.0 0.0 0.6 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.7 0.1 0.0 0.1 0.1 0.2 5.2 0.0 0.0 2.3 7.5 0.0 0.0 1.9 0.0 0.0 0.4 2.9 0.0 0.3 1.1 13.4 19.0 0.0 0.0 0.0 0.1 4.5 0.0 3.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 10.5 11.0 0.5 2.5 9.2 8.9 2.4 0.5 0.5 0.5 0.0 1.3 0.0 0.2 0.0 0.0 0.3 0.0 1.4 5.7 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.1 0.0 0.8 3.1 0.1 0.9 0.0 0.9 0.2 0.0 2.9 0.6 0.0 0.0 0.6 0.0 0.0 0.0 10.5 0.0 3.5 2.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.6 0.6 TAC3 "NKB, NKNB, ZNEUROK1" ENSG00000166863 "Tachykinin 3" Q9UHF0 12 57010000-57028883 "Disease related genes, Predicted secreted proteins" Neuropeptide "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 133.5" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 6.9;Extravillous trophoblasts: 8.1;Syncytiotrophoblasts: 15.3" "Cancer enriched" "Detected in many" 7 "urothelial cancer: 40.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "K-562: 15.0;SuSa: 15.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045919 Supported Supported Approved Vesicles "Secreted in female reproductive system" NA NA Vesicles "HPA045919: AB_10960533" "unprognostic (4.53e-2)" "unprognostic (1.97e-2)" "unprognostic (8.41e-2)" "unprognostic (3.00e-2)" "unprognostic (3.61e-2)" "unprognostic (1.76e-2)" "unprognostic (5.99e-2)" "unprognostic (8.41e-2)" "unprognostic (1.34e-1)" "unprognostic (2.03e-1)" "unprognostic (5.28e-2)" "unprognostic (4.71e-14)" "unprognostic (1.58e-2)" "unprognostic (1.76e-1)" "unprognostic (1.01e-1)" "unprognostic (2.39e-1)" 0.5 0.6 3.9 1.5 20.0 0.8 0.5 0.0 11.0 0.5 1.2 0.1 0.0 1.5 0.6 0.5 0.5 0.5 0.6 0.5 4.4 9.5 0.5 0.5 0.5 0.5 0.8 2.1 0.5 0.7 0.5 0.0 133.5 1.5 0.5 1.0 0.3 0.5 0.5 0.5 0.7 3.2 2.0 9.4 0.5 8.1 0.8 0.2 0.0 0.5 0.0 0.6 2.2 0.5 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.5 0.0 0.0 1.4 0.0 1.1 0.3 0.0 2.9 0.0 0.8 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.3 15.0 0.4 0.0 0.0 0.0 0.2 2.0 0.6 0.0 0.0 0.0 0.0 0.0 1.5 2.5 0.7 0.0 0.9 0.0 15.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.9 20.0 0.0 11.0 4.4 9.5 0.8 2.1 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 8.1 0.0 0.0 0.0 0.0 2.0 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 15.3 0.0 1.7 0.0 TBX4 ENSG00000121075 "T-box 4" P57082 17 61452404-61485110 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lung: 31.1;placenta: 17.0;prostate: 15.0;smooth muscle: 26.0;urinary bladder: 18.6" "Group enriched" "Detected in some" 7 "Early spermatids: 5.7;Late spermatids: 11.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 5.4;Hep G2: 2.2;OE19: 2.2;THP-1: 10.7" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "basal ganglia: 1.6" "CAB032413, HPA044457" Uncertain Approved Vesicles NA NA Vesicles "CAB032413: AB_2200705, HPA044457: AB_2678948" "unprognostic (1.03e-2)" "unprognostic (2.05e-2)" "unprognostic (1.43e-1)" "unprognostic (1.63e-3)" "unprognostic (6.07e-2)" "unprognostic (3.80e-2)" "unprognostic (1.25e-2)" "unprognostic (4.14e-2)" "unprognostic (7.77e-3)" "unprognostic (7.41e-2)" "unprognostic (6.83e-2)" "unprognostic (1.38e-1)" "unprognostic (1.46e-8)" "unprognostic (1.92e-1)" "unprognostic (4.41e-2)" "unprognostic (6.15e-2)" "unprognostic (5.39e-2)" 0.5 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.0 0.6 15.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 26.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 18.6 4.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.9 0.1 0.0 0.1 5.4 0.5 0.4 0.5 1.9 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.3 0.0 0.8 0.0 0.0 2.2 0.5 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.2 0.1 0.0 0.2 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.5 0.2 0.0 10.7 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 TBX5 HOS ENSG00000089225 "T-box 5" Q99593 12 114353931-114408442 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Atrial fibrillation, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 44.5;lung: 14.0;placenta: 19.7" "Cell type enriched" "Detected in some" 11 "Cardiomyocytes: 62.0" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "hippocampal formation: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 13.1;BJ hTERT+: 29.2;BJ hTERT+ SV40 Large T+: 6.8;BJ hTERT+ SV40 Large T+ RasG12V: 8.3;HAP1: 11.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA008786, HPA064683" Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA008786: AB_10601720, HPA064683: AB_2685320" "unprognostic (3.09e-2)" "unprognostic (1.53e-1)" "unprognostic (3.79e-2)" "unprognostic (2.75e-1)" "unprognostic (1.62e-1)" "unprognostic (1.42e-1)" "unprognostic (1.66e-1)" "unprognostic (1.09e-1)" "unprognostic (8.67e-2)" "unprognostic (3.36e-7)" "unprognostic (2.29e-2)" "unprognostic (1.68e-2)" "unprognostic (7.34e-2)" "unprognostic (4.38e-3)" 2.2 0.1 0.1 0.0 0.1 0.0 3.8 0.8 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.1 6.4 0.1 0.0 44.5 2.2 0.1 0.1 0.1 14.0 1.6 0.1 0.1 0.1 0.1 0.0 0.1 19.7 0.5 5.4 0.0 1.4 0.1 0.0 0.1 0.5 0.1 6.6 0.2 0.1 0.1 0.1 0.0 0.0 1.0 0.0 0.0 6.5 1.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 13.1 29.2 6.8 8.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 11.5 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.8 0.2 2.2 0.1 0.1 0.1 0.5 0.0 0.0 1.1 0.0 0.0 0.1 3.6 62.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 TCAF2C ENSG00000283528 "TRPM8 channel associated factor 2C" 7 143639230-143647646 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 2.2;parathyroid gland: 1.9;placenta: 1.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.2;T-reg: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 1.1;OE19: 1.5;U-266/70: 3.9;U-266/84: 1.8" "HPA038756, HPA038758" Uncertain Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA038756: AB_10960427, HPA038758: AB_10960353" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 2.2 0.0 0.0 1.8 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.9 1.8 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TCL1B TML1 ENSG00000213231 "T cell leukemia/lymphoma 1B" O95988 14 95686417-95692643 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 13.0;lymphoid tissue: 5.4;placenta: 12.7;testis: 7.3" "Cell type enriched" "Detected in some" 13 "Syncytiotrophoblasts: 60.8" "Cancer enriched" "Detected in single" 72 "testis cancer: 8.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "naive B-cell: 13.0;plasmacytoid DC: 5.9" "Group enriched" "Detected in many" 23 "B-cells: 13.0;dendritic cells: 5.9" "Cell line enriched" "Detected in some" 7 "U-698: 104.8" "Not detected" "Not detected" HPA053163 Uncertain Approved Cytosol NA NA Cytosol "HPA053163: AB_2682064" "unprognostic (1.55e-1)" 0.1 0.2 0.1 0.9 0.1 2.5 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 1.4 0.4 0.1 0.0 0.1 0.1 0.1 1.1 0.1 0.1 5.3 0.1 0.0 0.2 0.1 0.0 0.1 12.7 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.1 1.8 0.1 7.3 0.0 0.0 0.1 0.0 5.4 0.1 0.1 13.0 5.9 0.3 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 104.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.3 0.4 0.0 5.9 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.7 0.0 60.8 0.0 0.0 0.0 TDRP "C8orf42, INM01, TDRP1, TDRP2" ENSG00000180190 "Testis development related protein" Q86YL5 8 489792-545781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 41.9" "Cell type enhanced" "Detected in many" 12 "Cytotrophoblasts: 125.8;Syncytiotrophoblasts: 227.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 28.9;HBEC3-KT: 13.9;hTERT-RPE1: 12.3;SuSa: 14.8" "Low region specificity" "Detected in all" HPA008462 Approved Supported Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA008462: AB_1845777" "unprognostic (1.17e-1)" "unprognostic (1.88e-1)" "unprognostic (5.51e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (2.13e-1)" "unprognostic (3.72e-3)" "unprognostic (4.13e-2)" "unprognostic (1.08e-1)" "prognostic favorable (9.37e-4)" "unprognostic (1.74e-1)" "unprognostic (3.43e-2)" "unprognostic (5.46e-4)" "unprognostic (2.38e-2)" "unprognostic (2.98e-2)" "unprognostic (1.50e-1)" 5.7 9.0 7.7 6.1 13.1 0.5 11.0 10.4 9.2 8.5 4.9 3.6 8.4 2.3 9.4 9.8 5.7 12.9 9.9 3.7 7.4 10.3 14.3 9.4 9.6 3.9 6.3 3.6 13.0 13.7 15.2 11.1 41.9 8.4 12.5 2.8 17.7 6.2 12.3 2.3 3.3 2.8 5.0 4.6 2.6 3.6 8.1 3.2 3.0 22.7 3.2 6.3 9.9 12.8 0.4 0.0 0.0 0.1 0.0 0.2 1.1 4.8 4.9 8.6 0.0 0.0 0.0 28.9 2.8 1.7 2.7 2.4 0.0 0.0 0.0 1.2 0.9 2.7 1.0 0.0 13.9 3.4 0.0 0.4 0.0 0.0 7.2 3.3 0.0 2.1 3.4 11.1 0.0 5.2 12.3 0.4 0.0 0.6 0.0 2.9 0.0 0.0 0.0 10.2 0.0 1.0 0.0 0.0 0.0 9.0 7.3 2.6 4.1 0.0 8.7 2.1 14.8 2.9 0.0 0.1 0.1 0.9 0.0 0.2 0.0 0.0 0.0 0.8 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 7.7 13.1 10.4 7.5 7.4 10.3 6.3 3.6 8.4 3.2 20.8 9.6 0.9 22.5 20.8 15.6 4.1 10.2 32.1 14.8 17.4 2.0 125.8 36.5 9.2 51.1 18.0 0.0 0.0 4.2 49.4 8.3 25.0 0.0 17.5 11.0 9.5 7.5 7.4 3.8 11.1 6.6 1.9 8.5 0.0 1.5 8.3 4.4 0.0 6.0 15.4 11.0 19.4 16.0 21.2 5.9 6.0 227.6 0.0 0.0 9.2 TFAP2A "AP-2, AP2TF, TFAP2" ENSG00000137203 "Transcription factor AP-2 alpha" P05549 6 10393186-10419659 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 130.5;retina: 48.1" "Cell type enhanced" "Detected in many" 17 "Cytotrophoblasts: 245.7;Extravillous trophoblasts: 224.5;Syncytiotrophoblasts: 585.5" "Cancer enhanced" "Detected in many" "melanoma: 45.6" "Region enhanced" "Detected in single" "cerebellum: 2.2" "Cell type enriched" "Detected in single" 10 "myeloid DC: 1.0" "Lineage enriched" "Detected in single" 10 "dendritic cells: 1.0" "Cell line enhanced" "Detected in many" "AN3-CA: 28.0;HDLM-2: 31.3;hTCEpi: 30.2;SuSa: 31.6" "Region enhanced" "Detected in single" "cerebellum: 4.3" "Region enhanced" "Detected in single" "cerebellum: 8.6" "CAB000326, HPA056871" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000326: AB_667767, HPA056871: AB_2683262" "unprognostic (5.97e-2)" "unprognostic (2.18e-1)" "unprognostic (1.31e-2)" "unprognostic (1.14e-1)" "unprognostic (3.87e-2)" "unprognostic (1.27e-1)" "unprognostic (7.62e-5)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.45e-1)" "unprognostic (2.76e-2)" "unprognostic (3.33e-3)" "unprognostic (2.82e-1)" "unprognostic (1.40e-11)" "unprognostic (1.46e-2)" "unprognostic (2.14e-1)" "unprognostic (1.72e-4)" "unprognostic (2.25e-2)" 0.4 0.3 0.3 0.0 0.3 0.0 19.0 2.2 0.5 4.4 0.8 0.0 18.7 0.2 0.5 17.8 18.3 0.4 1.7 0.7 0.3 0.2 6.4 0.2 0.5 0.1 0.2 0.2 0.3 0.3 0.0 0.4 130.5 0.6 5.8 0.2 48.1 19.4 26.7 0.2 36.0 0.4 0.1 0.4 0.2 0.7 1.6 0.0 0.1 0.4 16.6 9.9 2.4 9.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 16.3 6.3 0.0 28.0 0.1 0.0 6.0 12.1 9.3 9.9 9.8 0.6 6.1 0.9 1.6 3.5 5.7 17.5 1.5 20.7 9.5 31.3 15.8 0.1 14.8 0.0 0.0 0.4 0.4 0.0 30.2 0.0 22.0 5.6 0.0 0.3 0.9 0.0 0.1 3.6 0.0 5.1 0.1 1.0 7.8 1.7 1.5 0.6 5.6 6.6 4.1 0.1 14.9 26.2 23.8 31.6 17.3 0.5 0.0 3.0 0.8 2.1 7.6 0.0 1.4 0.2 1.6 0.5 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 2.2 0.3 0.3 0.2 0.2 0.2 0.6 0.0 0.0 0.0 0.0 37.5 116.1 3.1 2.2 0.0 8.1 15.9 29.6 2.0 245.7 6.6 2.0 4.6 0.8 0.0 0.0 0.3 224.5 5.3 38.8 0.0 0.0 17.7 76.3 1.2 0.0 0.0 2.1 0.6 0.2 118.1 0.0 0.5 2.4 2.2 0.0 0.0 0.2 4.2 0.0 2.1 3.9 11.8 120.9 585.5 0.0 0.4 39.3 TFAP2C "AP2-GAMMA, ERF1, hAP-2g, TFAP2G" ENSG00000087510 "Transcription factor AP-2 gamma" Q92754 20 56629302-56639283 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 53.9;skin 1: 32.5" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 117.7;Cytotrophoblasts: 77.5;Extravillous trophoblasts: 49.1;Suprabasal keratinocytes: 130.6;Syncytiotrophoblasts: 88.3" "Cancer enhanced" "Detected in many" "testis cancer: 54.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "BEWO: 45.8;MCF7: 38.8;SK-BR-3: 73.8;T-47d: 20.6;WM-115: 27.1" "Region enriched" "Detected in single" 13 "olfactory region: 2.9" "Low region specificity" "Detected in many" "CAB016061, CAB016079, HPA055179, HPA057076" Enhanced Supported Nucleoplasm Yes NA Nucleoplasm "CAB016061: AB_667770, CAB016079: AB_2199447, HPA055179: AB_2682729, HPA057076: AB_2683329" "unprognostic (1.74e-2)" "prognostic favorable (6.90e-4)" "unprognostic (2.24e-2)" "unprognostic (2.02e-2)" "unprognostic (1.52e-2)" "unprognostic (6.75e-2)" "unprognostic (2.54e-2)" "unprognostic (8.26e-2)" "unprognostic (2.97e-1)" "unprognostic (1.61e-1)" "unprognostic (3.14e-3)" "unprognostic (2.63e-1)" "unprognostic (9.04e-5)" "unprognostic (2.31e-1)" "unprognostic (1.85e-1)" "unprognostic (6.71e-2)" "unprognostic (3.28e-2)" 1.1 0.3 0.7 0.2 0.4 0.0 16.1 0.4 0.9 17.3 2.4 0.2 7.7 0.0 3.7 3.4 19.6 1.6 2.0 0.4 1.4 0.2 0.7 0.1 2.8 0.0 0.2 0.5 0.3 1.6 0.0 0.6 53.9 0.4 5.7 0.7 1.9 19.7 7.9 1.0 32.5 0.3 0.6 0.4 0.1 0.3 0.7 0.2 0.3 4.2 21.0 10.1 2.1 11.1 0.1 0.2 0.8 0.1 0.2 0.2 0.0 2.9 3.7 0.0 0.0 0.0 0.0 45.8 4.7 8.6 6.0 1.1 0.7 0.0 0.0 0.3 3.1 3.2 10.0 6.4 1.3 4.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.4 0.0 5.1 1.7 1.7 0.0 0.0 1.9 0.0 0.7 0.0 38.8 4.7 0.2 2.2 2.3 4.9 0.0 0.0 1.6 0.0 2.3 1.2 0.0 3.1 73.8 4.8 7.1 20.6 1.0 0.0 3.9 0.1 2.0 3.5 0.0 0.0 0.0 0.9 0.0 27.1 0.4 0.1 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.8 0.2 0.1 0.2 0.1 0.0 0.7 0.4 0.4 0.9 1.4 0.2 0.2 0.5 0.4 0.2 0.0 7.4 0.0 26.2 117.7 0.4 0.9 0.0 5.3 4.5 8.7 0.0 77.5 0.0 0.2 0.2 1.0 0.0 0.0 0.0 49.1 11.3 18.8 0.0 0.0 6.8 0.0 2.9 1.3 0.3 0.0 0.0 0.9 20.3 0.0 1.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 3.6 0.0 1.5 130.6 88.3 0.0 1.7 12.8 TFPI "EPI, LACI, TFI, TFPI1" ENSG00000003436 "Tissue factor pathway inhibitor" P10646 2 187464230-187565760 "Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 98.2;placenta: 192.3" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 1654.1;Ito cells: 765.5;Syncytiotrophoblasts: 735.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.5;plasmacytoid DC: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 56.4;HUVEC TERT2: 106.1;LHCN-M2: 65.0;TIME: 63.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA005575, CAB020842" Supported "Secreted to blood" NA NA 95000000 "CAB020842: , HPA005575: AB_1080290" "unprognostic (8.75e-2)" "prognostic unfavorable (2.02e-4)" "unprognostic (7.95e-2)" "unprognostic (4.99e-2)" "unprognostic (2.32e-2)" "unprognostic (1.48e-1)" "unprognostic (3.05e-1)" "unprognostic (5.63e-2)" "unprognostic (3.86e-3)" "unprognostic (9.22e-2)" "unprognostic (2.43e-2)" "unprognostic (2.72e-2)" "unprognostic (7.05e-2)" "unprognostic (3.39e-3)" "unprognostic (4.05e-2)" "unprognostic (4.49e-2)" "unprognostic (5.81e-2)" 52.8 5.0 1.3 5.2 2.2 1.6 18.5 1.9 2.4 22.8 32.1 0.3 7.2 12.8 13.3 14.8 25.9 12.5 15.0 14.0 1.2 1.1 35.6 98.2 89.7 40.2 2.4 1.0 17.3 7.7 0.9 4.9 192.3 2.3 18.2 6.9 3.8 6.0 3.8 15.8 6.6 37.0 13.6 5.4 16.5 7.7 13.7 1.6 3.4 22.6 10.4 4.0 30.0 14.7 1.5 5.1 5.5 0.6 1.0 0.6 4.9 5.1 3.6 4.1 0.1 32.9 39.4 0.0 9.3 22.2 6.1 9.4 3.3 27.6 0.0 3.7 7.2 11.0 0.3 1.2 0.4 15.9 0.2 1.0 1.6 11.1 28.0 56.4 0.1 0.0 18.0 0.7 32.8 8.8 13.6 106.1 0.0 4.1 0.1 65.0 4.8 0.6 0.1 2.6 0.0 9.0 0.0 5.8 0.0 10.3 0.2 0.0 0.0 7.6 0.2 0.4 12.7 0.1 0.0 63.5 4.4 4.1 8.6 1.8 0.0 0.1 0.0 35.4 0.0 5.0 5.5 0.6 0.5 0.5 0.3 0.2 0.9 0.4 0.2 0.5 1.5 0.5 0.6 2.6 1.0 0.3 5.1 0.2 4.9 1.3 2.2 1.9 2.4 1.2 1.1 2.4 1.0 2.3 1.6 32.8 262.9 24.4 2.5 18.4 0.7 8.4 191.1 58.9 112.6 36.6 0.0 45.9 11.6 114.4 16.0 204.3 1.7 23.3 242.7 1654.1 163.0 4.2 12.8 338.6 44.3 1.6 101.1 765.5 77.7 9.8 159.0 19.5 25.3 57.7 1.2 31.4 108.2 2.9 65.7 100.4 1.1 213.4 163.5 1.1 0.4 16.2 735.3 15.4 1.3 6.0 TFPI2 "PP5, REF1, TFPI-2" ENSG00000105825 "Tissue factor pathway inhibitor 2" P48307 7 93885397-93890991 "Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "placenta: 1024.1" "Group enriched" "Detected in many" 4 "Ductal cells: 708.9;Syncytiotrophoblasts: 1826.6" "Cancer enhanced" "Detected in all" "renal cancer: 65.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 182.0;hTEC/SVTERT24-B: 90.4;U-138 MG: 87.8;U-2197: 78.3;U-87 MG: 148.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB010142, HPA049158" Enhanced "Secreted to extracellular matrix" NA NA "CAB010142: AB_628166, HPA049158: AB_2680659" "prognostic favorable (8.33e-7)" "unprognostic (2.20e-2)" "unprognostic (2.10e-2)" "prognostic favorable (5.42e-4)" "unprognostic (5.19e-3)" "unprognostic (3.98e-2)" "unprognostic (1.38e-1)" "unprognostic (2.72e-2)" "unprognostic (1.15e-2)" "unprognostic (6.86e-2)" "unprognostic (7.54e-3)" "unprognostic (7.01e-2)" "prognostic unfavorable (8.53e-4)" "unprognostic (3.38e-3)" "unprognostic (3.65e-2)" "unprognostic (1.97e-1)" "unprognostic (7.91e-2)" 21.5 14.6 0.6 5.1 0.7 0.0 4.8 0.6 0.6 1.0 1.0 0.6 0.9 0.0 4.8 1.3 0.7 5.4 2.2 3.3 0.6 1.5 4.7 3.1 3.5 0.6 0.6 0.6 14.9 10.0 0.0 4.4 1024.1 0.9 2.2 0.1 58.2 0.7 0.8 1.0 0.0 0.6 1.2 0.6 0.7 1.5 0.8 0.6 1.5 0.6 0.7 0.6 1.9 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 9.9 3.1 0.0 7.1 1.2 0.0 13.0 2.3 1.3 1.0 0.0 0.0 0.0 182.0 3.0 3.0 1.0 0.0 13.9 2.0 0.1 0.0 0.0 0.8 0.0 37.0 0.0 0.0 0.6 0.7 90.4 6.5 15.2 31.1 0.0 0.0 0.1 16.4 0.0 0.0 0.0 0.8 0.0 2.3 0.0 0.0 0.0 3.5 0.3 0.0 8.1 0.0 1.0 0.0 2.4 0.0 0.1 44.9 87.8 0.7 78.3 0.1 0.0 0.1 0.3 148.8 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.6 0.7 0.6 0.6 0.6 1.5 0.6 0.6 0.9 0.6 3.0 3.8 0.8 195.2 0.6 15.8 0.4 5.1 5.3 43.3 301.8 37.3 13.6 0.0 708.9 0.0 24.6 0.0 0.0 35.5 197.3 81.4 72.9 0.0 0.8 15.1 3.2 0.0 115.4 5.6 0.0 1.4 1.0 3.3 29.7 0.0 14.5 39.4 0.0 0.0 1.0 104.5 0.0 40.6 0.1 0.2 1.3 1826.6 0.0 0.0 22.3 TFRC "CD71, p90, TFR1" ENSG00000072274 "Transferrin receptor" P02786 3 196027183-196082189 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Endocytosis, Host-virus interaction" "Host cell receptor for virus entry, Receptor, Transducer" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 110.0" "Cell type enhanced" "Detected in many" 10 "Erythroid cells: 560.6;Syncytiotrophoblasts: 420.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000153, HPA028598" Enhanced Supported Endosomes,Lysosomes "Secreted to blood" NA NA 1310000000 14000000 "Endosomes, Lysosomes" "CAB000153: AB_2533029, HPA028598: AB_10601599" "unprognostic (2.95e-2)" "prognostic unfavorable (3.67e-4)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" "unprognostic (6.75e-2)" "unprognostic (7.88e-3)" "prognostic unfavorable (1.15e-4)" "unprognostic (6.92e-2)" "unprognostic (3.30e-3)" "unprognostic (4.35e-2)" "unprognostic (1.34e-2)" "unprognostic (1.14e-2)" "unprognostic (3.63e-3)" "unprognostic (3.65e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (2.96e-4)" "unprognostic (2.62e-2)" 24.3 11.9 11.9 20.6 11.3 73.8 7.6 9.6 17.8 11.8 25.0 9.5 3.8 11.9 12.1 7.5 18.5 11.7 11.4 18.7 9.5 8.3 15.3 13.6 28.1 8.1 7.4 9.5 50.0 7.8 18.0 6.9 110.0 26.5 7.2 19.4 8.5 8.3 5.0 25.6 9.9 37.4 10.9 13.2 7.9 10.0 8.3 6.1 14.3 7.0 10.5 12.9 11.2 8.0 5.7 7.5 2.2 12.4 1.8 6.5 2.1 22.2 20.2 9.3 18.9 20.6 12.0 58.3 31.8 24.2 22.4 37.2 49.3 20.5 22.8 60.4 11.8 49.0 34.3 31.9 10.5 27.5 109.0 10.8 86.4 17.3 22.9 16.3 70.8 17.5 13.5 10.4 19.3 17.4 6.4 7.4 12.6 36.0 21.9 17.5 20.6 23.2 15.0 28.4 29.3 41.5 12.3 13.8 27.3 20.1 56.3 21.3 8.8 30.7 80.8 7.2 16.1 78.4 14.8 9.5 26.7 21.7 23.3 47.6 6.2 48.1 35.6 31.2 19.2 16.1 0.0 1.6 2.2 2.5 7.9 1.7 5.7 2.7 1.7 3.7 3.2 2.5 1.9 0.3 1.8 12.4 7.5 6.5 2.1 11.9 11.3 9.6 17.8 9.5 8.3 7.4 9.5 26.5 6.1 41.7 27.2 29.6 33.6 53.5 48.1 81.5 45.9 28.1 26.1 19.2 139.4 104.0 0.0 43.1 2.6 17.8 72.1 560.6 36.6 18.5 33.8 15.8 22.0 94.1 70.3 12.7 53.9 6.7 33.3 3.9 10.6 89.7 16.9 72.1 50.0 17.3 38.9 52.6 8.1 9.1 42.4 25.8 34.8 22.3 19.3 31.2 420.4 21.8 70.2 22.9 TGM2 TGC ENSG00000198959 "Transglutaminase 2" P21980 20 38127387-38166578 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 187.6;placenta: 212.7" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 276.1;Ito cells: 326.6;Pancreatic endocrine cells: 240.4;Syncytiotrophoblasts: 312.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.5;memory B-cell: 1.9;myeloid DC: 2.4" "Group enriched" "Detected in many" 23 "B-cells: 1.9;dendritic cells: 2.4;monocytes: 2.5" "Group enriched" "Detected in many" 4 "CAPAN-2: 155.5;EFO-21: 52.3;hTERT-RPE1: 102.6;HUVEC TERT2: 70.7;TIME: 92.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002598, HPA021019, HPA029518" Enhanced Approved "Plasma membrane,Cytosol" Yes No 1700000 Cytosol "Plasma membrane" "CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133" "unprognostic (7.80e-2)" "unprognostic (1.51e-1)" "unprognostic (5.22e-2)" "unprognostic (1.40e-2)" "unprognostic (1.56e-2)" "unprognostic (5.61e-3)" "unprognostic (2.81e-1)" "unprognostic (3.32e-3)" "unprognostic (3.29e-2)" "unprognostic (9.78e-3)" "prognostic unfavorable (2.97e-4)" "unprognostic (6.99e-2)" "prognostic unfavorable (1.67e-7)" "unprognostic (1.60e-2)" "unprognostic (1.93e-2)" "unprognostic (6.70e-2)" "unprognostic (6.40e-2)" 33.3 9.5 6.0 18.3 8.1 1.0 7.7 4.3 7.5 94.3 12.6 4.0 4.7 8.4 54.6 21.7 15.8 58.7 62.8 77.1 7.5 3.4 25.3 187.6 61.2 16.4 6.9 3.0 18.7 5.0 5.2 25.6 212.7 8.5 33.6 6.3 57.4 1.9 17.1 19.3 0.7 12.8 43.9 5.7 20.4 13.6 7.4 6.4 0.8 17.0 3.4 3.1 38.2 21.6 1.9 2.4 0.0 2.5 0.0 0.0 0.2 6.3 4.7 0.0 0.1 4.9 0.5 2.4 9.6 4.6 0.0 0.1 7.8 155.5 0.0 52.3 0.1 11.1 0.1 0.0 22.5 0.3 0.0 0.0 1.0 0.2 3.4 20.3 0.0 0.0 0.5 0.0 4.1 0.0 102.6 70.7 0.0 2.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.9 0.0 0.0 0.1 22.6 0.0 0.8 3.3 0.2 0.0 92.1 0.1 5.9 0.7 4.5 0.0 0.0 0.0 6.3 0.0 1.8 0.0 0.2 0.0 0.0 2.5 0.0 1.9 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.0 8.1 4.3 7.5 7.5 3.4 6.9 3.0 8.5 6.4 8.9 28.9 15.2 9.8 0.5 0.0 156.9 48.4 16.0 27.3 14.0 2.0 276.1 3.3 184.1 2.3 166.8 4.2 93.5 124.7 21.8 45.8 45.4 2.3 137.1 49.2 0.0 0.0 326.6 22.9 3.5 1.1 11.4 0.0 10.8 0.0 0.4 240.4 0.0 5.6 19.0 0.5 0.0 65.7 0.5 4.9 0.0 312.9 1.3 0.4 12.3 THSD7A KIAA0960 ENSG00000005108 "Thrombospondin type 1 domain containing 7A" Q9UPZ6 7 11370357-11832198 "Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 22.5" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 104.8;Cone photoreceptor cells: 106.0;Horizontal cells: 197.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 76 "basophil: 7.5" "Lineage enriched" "Detected in single" 76 "granulocytes: 7.5" "Cell line enhanced" "Detected in some" "A549: 9.7;HUVEC TERT2: 6.5;REH: 6.6;SH-SY5Y: 9.9;THP-1: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000923 Supported "Secreted to blood" NA NA 3000000 "HPA000923: AB_1080271" "unprognostic (3.01e-1)" "unprognostic (7.90e-2)" "unprognostic (3.09e-2)" "unprognostic (1.96e-1)" "unprognostic (5.88e-1)" "unprognostic (3.33e-2)" "unprognostic (1.44e-1)" "unprognostic (9.66e-2)" "unprognostic (1.11e-1)" "unprognostic (1.42e-2)" "unprognostic (2.07e-1)" "unprognostic (8.75e-2)" "prognostic favorable (2.24e-6)" "unprognostic (2.13e-3)" "unprognostic (1.66e-1)" "unprognostic (2.28e-2)" "unprognostic (3.33e-2)" 9.6 2.2 4.7 2.1 5.7 0.6 5.2 2.0 7.2 8.4 2.7 1.0 0.9 1.2 8.3 2.7 1.7 4.8 6.2 2.1 3.8 4.7 17.7 2.0 3.0 1.2 4.6 3.6 6.4 1.4 2.6 9.4 22.5 3.5 8.4 2.1 4.4 1.7 5.5 0.9 1.7 1.5 5.9 4.3 2.3 1.7 2.2 1.9 0.0 4.9 2.5 1.1 4.5 6.8 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 9.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 1.7 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 1.5 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 6.6 0.0 0.0 0.3 0.1 0.7 9.9 0.0 0.3 0.0 1.6 0.1 17.9 3.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 5.7 2.0 7.2 3.8 4.7 4.6 3.6 3.5 1.9 20.8 8.0 0.0 1.6 2.4 104.8 1.1 22.9 0.0 4.5 52.4 106.0 14.0 6.6 5.5 1.0 31.5 0.0 0.0 1.9 4.9 9.8 2.1 0.0 1.0 2.0 197.0 40.1 21.5 1.9 0.2 22.5 0.8 11.8 0.0 0.0 22.3 4.4 1.5 1.4 8.6 7.4 0.0 1.4 1.7 0.4 2.0 43.4 0.0 0.5 0.6 TIMP2 CSC-21K ENSG00000035862 "TIMP metallopeptidase inhibitor 2" P16035 17 78852977-78925387 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 269.8" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 344.4;Leydig cells: 327.4;Peritubular cells: 724.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.3" "Group enriched" "Detected in many" 4 "granulocytes: 13.3;monocytes: 5.0" "Cell line enhanced" "Detected in many" "ASC diff: 126.3;ASC TERT1: 155.4;BJ hTERT+: 88.3;fHDF/TERT166: 96.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010203 Approved "Secreted to extracellular matrix" NA NA 83000000 "CAB010203: AB_2204966" "unprognostic (1.03e-1)" "unprognostic (1.71e-2)" "unprognostic (9.81e-2)" "unprognostic (1.76e-3)" "unprognostic (3.24e-2)" "unprognostic (3.05e-1)" "unprognostic (4.31e-1)" "unprognostic (1.63e-2)" "unprognostic (1.39e-1)" "unprognostic (4.73e-2)" "unprognostic (3.97e-2)" "unprognostic (1.13e-1)" "unprognostic (1.08e-1)" "unprognostic (1.38e-3)" "unprognostic (4.62e-2)" "unprognostic (2.05e-1)" "unprognostic (2.77e-3)" 75.2 35.1 30.9 17.7 18.9 3.4 45.6 4.6 25.8 95.8 40.5 36.8 28.2 12.9 87.9 41.5 37.4 39.8 72.3 38.5 23.2 29.6 21.1 12.2 38.4 15.4 25.3 23.2 182.4 14.4 15.8 17.2 269.8 34.0 44.6 20.3 49.7 16.9 51.6 24.5 38.4 22.0 70.7 32.6 37.9 24.2 51.7 26.1 28.4 25.3 24.0 11.3 60.2 58.1 0.2 2.1 13.3 5.0 0.2 0.3 0.8 15.0 7.6 8.6 16.4 126.3 155.4 4.6 53.3 88.3 26.1 20.8 2.7 26.4 0.0 18.8 96.8 28.7 3.0 2.6 2.3 27.4 0.3 1.5 0.0 15.4 4.2 37.5 0.2 0.1 61.0 1.1 25.7 4.1 67.7 34.5 4.9 0.0 0.0 26.8 1.7 15.4 2.6 1.5 3.0 11.3 10.5 19.8 6.4 16.6 0.2 4.4 27.1 33.3 15.8 67.9 10.9 8.0 3.7 40.9 70.0 13.4 40.6 9.2 7.8 6.4 0.1 16.0 2.8 33.7 0.0 5.0 6.8 0.0 3.3 0.0 0.1 0.1 0.0 2.1 0.2 0.3 0.3 13.3 0.2 3.8 1.4 0.1 0.8 30.9 18.9 4.6 25.8 23.2 29.6 25.3 23.2 34.0 26.1 104.2 39.6 4.5 8.0 87.8 30.2 35.8 50.9 0.0 22.7 24.4 7.9 2.7 0.0 76.1 113.2 98.4 11.2 0.0 19.1 82.6 213.2 14.6 6.9 3.2 177.9 3.2 7.5 284.2 170.2 344.4 327.4 101.4 261.5 11.8 7.5 36.2 71.2 1.5 724.5 0.6 11.7 90.5 173.1 5.9 4.5 66.4 12.4 4.9 1.5 6.0 TIMP3 SFD ENSG00000100234 "TIMP metallopeptidase inhibitor 3" P35625 22 32801701-32863043 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Sensory transduction, Vision" "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 392.5;retina: 247.1" "Cell type enhanced" "Detected in many" 10 "Leydig cells: 1295.0;Peritubular cells: 1818.1;Sertoli cells: 2289.5;Smooth muscle cells: 1077.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "NK-cell: 2.2" "Lineage enriched" "Detected in single" 6 "NK-cells: 2.2" "Cell line enhanced" "Detected in many" "ASC diff: 57.0;BJ: 127.4;BJ hTERT+: 56.3;fHDF/TERT166: 115.8;WM-115: 97.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to extracellular matrix" NA NA "unprognostic (4.98e-2)" "unprognostic (1.77e-3)" "unprognostic (1.60e-1)" "unprognostic (8.53e-4)" "unprognostic (1.67e-2)" "unprognostic (1.05e-2)" "unprognostic (7.01e-2)" "unprognostic (3.22e-2)" "unprognostic (8.42e-2)" "prognostic unfavorable (1.90e-5)" "unprognostic (3.92e-1)" "unprognostic (1.95e-1)" "prognostic favorable (1.50e-4)" "unprognostic (2.66e-3)" "unprognostic (1.44e-2)" "unprognostic (2.55e-3)" "unprognostic (3.11e-2)" 130.4 44.6 8.7 15.8 10.1 0.1 103.3 5.1 12.1 68.3 25.4 13.5 27.8 4.5 65.1 47.4 40.2 51.9 39.9 75.0 10.2 8.5 54.0 14.1 115.4 31.3 11.4 8.7 25.3 11.8 15.6 21.6 392.5 19.1 44.2 12.6 247.1 24.3 55.0 22.7 22.9 16.2 58.3 7.2 35.1 22.9 43.2 7.1 1.2 48.9 29.4 10.1 37.5 38.3 0.4 0.0 0.0 0.0 2.2 0.0 0.0 2.0 0.0 1.8 0.3 57.0 32.1 0.1 127.4 56.3 10.4 12.4 2.2 0.0 0.0 3.1 115.8 0.4 1.9 0.3 5.2 15.1 0.0 1.5 15.7 2.7 5.5 22.4 0.0 6.6 5.3 13.3 18.5 1.0 0.3 0.0 0.0 0.0 0.1 4.8 0.1 0.0 0.5 0.2 0.0 0.0 0.0 0.3 0.0 0.2 10.4 1.3 1.8 2.6 0.0 33.5 31.0 0.0 0.1 0.0 0.8 2.8 27.1 2.0 0.0 0.0 0.0 26.0 0.0 97.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 8.7 10.1 5.1 12.1 10.2 8.5 11.4 8.7 19.1 7.1 339.5 47.1 4.5 518.2 68.7 3.1 194.1 5.1 12.0 26.1 48.8 3.9 374.1 3.3 1.3 11.5 516.3 0.0 0.0 0.6 213.4 444.0 99.6 85.6 98.5 105.1 3.2 1.7 734.7 49.2 29.3 1295.0 27.8 72.6 1.0 0.0 169.4 1.1 0.0 1818.1 11.1 3.5 2289.5 1077.9 6.5 5.1 49.3 676.6 10.0 0.2 134.4 TINAGL1 "ARG1, LCN7, LIECG3, P3ECSL, TINAGRP" ENSG00000142910 "Tubulointerstitial nephritis antigen like 1" Q9GZM7 1 31576485-31587686 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 128.4" "Cell type enhanced" "Detected in many" 15 "Cytotrophoblasts: 1103.3;Syncytiotrophoblasts: 1627.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 4.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 58.8;CAPAN-2: 32.1;EFO-21: 74.1;HaCaT: 32.2;HBEC3-KT: 37.9;HUVEC TERT2: 31.4;TIME: 67.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA048695 Approved "Secreted to extracellular matrix" NA NA 170000 "HPA048695: AB_2680497" "unprognostic (1.27e-1)" "unprognostic (2.94e-2)" "unprognostic (7.53e-2)" "unprognostic (1.80e-3)" "unprognostic (2.74e-1)" "unprognostic (1.72e-3)" "unprognostic (8.29e-3)" "unprognostic (6.02e-3)" "unprognostic (4.18e-1)" "unprognostic (6.96e-2)" "unprognostic (7.02e-3)" "unprognostic (1.22e-1)" "prognostic favorable (3.65e-6)" "unprognostic (7.42e-2)" "unprognostic (6.64e-2)" "prognostic favorable (9.64e-4)" "unprognostic (3.43e-2)" 43.0 8.4 2.2 11.6 3.4 0.8 60.0 0.8 4.4 30.2 22.0 2.9 14.2 12.0 25.7 23.4 23.7 17.0 36.1 52.6 3.4 2.3 53.3 14.7 24.4 12.8 3.9 3.3 15.5 7.4 3.2 5.6 128.4 5.0 19.4 7.9 12.0 24.2 20.0 19.6 7.6 15.9 22.5 2.7 34.3 16.3 10.3 2.1 0.8 30.7 11.0 6.4 39.8 20.0 1.1 0.6 4.8 0.5 1.5 0.8 0.0 16.7 0.0 0.0 0.1 0.1 0.0 58.8 2.6 0.3 0.1 0.0 7.9 32.1 0.0 74.1 2.3 1.2 32.2 0.0 37.9 0.0 0.1 0.0 0.0 1.4 2.0 0.8 0.0 0.1 0.0 6.9 0.0 1.4 0.0 31.4 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 9.1 1.0 0.0 0.0 0.0 10.2 12.9 0.0 0.1 6.8 22.7 0.7 3.6 1.3 0.0 67.1 0.0 17.0 0.1 0.5 0.0 0.1 0.2 0.0 0.0 0.6 4.8 0.5 0.5 0.8 0.3 0.5 0.4 0.6 0.5 0.1 1.1 0.8 0.8 2.7 1.5 0.5 0.6 0.5 0.0 2.2 3.4 0.8 4.4 3.4 2.3 3.9 3.3 5.0 2.1 8.9 7.2 5.3 91.5 9.7 0.0 41.9 38.2 1.4 7.9 125.6 0.0 1103.3 1.7 361.6 1.2 133.2 75.1 0.0 83.6 184.7 19.9 41.9 14.9 1.1 78.0 0.0 10.9 249.8 10.8 0.4 6.9 5.7 21.9 3.6 27.7 0.3 206.9 37.7 3.9 67.7 0.4 420.4 356.4 0.2 0.9 5.6 1627.5 6.4 49.2 157.0 TINCR "FLJ90734, LINC00036, NCRNA00036, onco-lncRNA-16, PLAC2" ENSG00000223573 "TINCR ubiquitin domain containing" 19 5558167-5578349 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "placenta: 50.0;skin 1: 45.0" "Cell type enhanced" "Detected in many" 17 "Basal keratinocytes: 41.2;Cytotrophoblasts: 48.9;Extravillous trophoblasts: 85.0;Suprabasal keratinocytes: 80.7;Syncytiotrophoblasts: 171.1" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "BEWO: 28.1;HaCaT: 18.6;MCF7: 7.5;SK-BR-3: 29.5" "Low region specificity" "Detected in single" NA NA "unprognostic (4.75e-2)" "unprognostic (2.99e-2)" "unprognostic (7.78e-2)" "unprognostic (1.78e-3)" "unprognostic (3.69e-1)" "unprognostic (2.54e-3)" "unprognostic (3.38e-2)" "unprognostic (3.95e-1)" "unprognostic (3.07e-1)" "unprognostic (1.66e-2)" "unprognostic (8.87e-2)" "unprognostic (1.24e-1)" "unprognostic (0.00e+0)" "unprognostic (4.22e-2)" "unprognostic (1.16e-1)" "unprognostic (3.63e-2)" "unprognostic (7.32e-2)" 0.0 0.4 1.0 0.0 0.7 0.6 1.7 0.0 1.0 1.7 0.4 0.0 0.0 0.0 0.0 0.5 5.6 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 1.8 50.0 0.6 1.5 0.6 0.1 0.2 0.0 0.0 45.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 5.3 3.8 0.3 0.4 2.4 3.0 5.7 1.1 1.6 1.3 0.3 1.0 0.8 0.1 0.2 0.3 0.5 28.1 0.1 0.0 0.0 0.1 0.4 3.3 0.2 0.3 0.1 0.3 18.6 0.4 0.2 0.2 0.3 0.6 0.2 1.0 0.2 0.1 0.3 0.3 0.2 6.1 0.1 0.1 0.2 0.0 1.5 0.1 0.5 0.0 7.5 0.1 0.4 0.5 0.7 1.4 0.6 0.2 0.6 0.0 1.9 0.4 0.1 2.0 29.5 2.9 2.8 3.5 0.2 0.0 0.3 0.2 0.6 0.0 0.7 0.2 0.5 0.1 0.3 0.6 5.0 1.1 1.2 1.0 0.7 0.7 1.9 0.9 0.9 0.3 2.4 1.0 1.3 5.7 1.6 0.9 3.0 1.0 0.3 11.9 1.7 0.0 4.8 41.2 3.4 0.9 2.5 1.4 2.3 1.8 0.0 48.9 10.0 0.0 0.2 1.1 0.4 0.0 0.4 85.0 2.6 4.8 0.0 0.0 5.7 0.0 1.7 1.8 2.7 0.0 0.6 1.2 6.8 0.0 2.7 3.8 0.1 5.1 0.7 0.1 2.4 0.0 1.2 0.5 1.9 80.7 171.1 0.0 0.4 8.3 TLE6 "FLJ14009, GRG6" ENSG00000104953 "Transducin like enhancer of split 6" Q9H808 19 2977446-2995184 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 18.8" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 7.5;Collecting duct cells: 12.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 4 "hypothalamus: 3.1" "Cell type enhanced" "Detected in some" "NK-cell: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 14.3;SK-BR-3: 11.4;U-266/70: 12.1;U-698: 12.7;U-937: 9.5" NA NA "unprognostic (1.32e-1)" "unprognostic (1.28e-2)" "unprognostic (1.63e-5)" "unprognostic (4.05e-3)" "unprognostic (4.36e-2)" "unprognostic (4.58e-2)" "unprognostic (3.85e-2)" "unprognostic (1.24e-1)" "unprognostic (4.85e-3)" "unprognostic (8.00e-2)" "unprognostic (2.62e-3)" "unprognostic (1.52e-1)" "unprognostic (3.31e-4)" "unprognostic (3.34e-1)" "unprognostic (2.81e-1)" "unprognostic (1.92e-2)" "unprognostic (7.60e-3)" 1.8 1.4 0.6 1.2 0.4 0.0 4.8 0.4 0.7 1.4 1.6 0.4 7.7 0.9 2.1 7.1 1.0 1.2 1.1 3.4 0.4 3.1 3.3 5.3 3.4 1.0 0.6 0.4 0.4 2.2 3.9 2.3 18.8 0.7 1.6 1.9 2.7 7.5 5.3 0.8 0.7 1.2 1.2 1.4 1.5 1.6 4.0 0.4 0.9 10.2 0.4 1.5 1.8 0.7 2.3 0.7 0.0 0.4 3.1 1.2 0.6 3.8 5.0 0.1 2.0 0.0 0.0 14.3 0.0 0.0 0.2 0.9 0.0 1.1 6.6 1.0 0.4 1.2 0.0 1.9 1.0 0.2 5.5 0.9 0.0 0.1 0.6 0.6 0.1 1.2 0.9 0.7 0.0 0.1 1.1 0.9 4.8 1.1 0.0 0.4 2.6 0.0 0.3 0.0 7.1 1.0 4.0 0.3 5.4 1.3 1.0 0.3 1.3 0.4 11.4 4.6 0.4 3.2 0.6 0.8 0.4 0.7 0.3 0.3 12.1 7.9 12.7 2.8 9.5 0.4 0.0 0.3 0.0 0.1 0.0 0.0 1.6 0.6 0.6 0.7 2.3 0.0 0.5 0.0 3.1 0.4 0.0 1.2 0.6 0.6 0.4 0.4 0.7 0.4 3.1 0.6 0.4 0.7 0.4 0.0 7.5 0.5 1.9 0.1 1.9 1.2 5.1 0.0 2.3 12.2 0.0 5.5 6.6 0.8 0.5 0.0 0.1 0.0 0.9 7.4 0.5 0.5 0.0 0.8 1.2 0.0 3.5 0.6 0.3 1.5 0.3 0.0 5.0 0.0 2.5 4.8 1.5 0.0 0.4 0.6 0.8 0.0 0.4 0.1 5.5 0.0 7.2 0.0 0.8 0.9 TLR3 CD283 ENSG00000164342 "Toll like receptor 3" O15455 4 186069152-186088069 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Inflammatory response, Innate immunity" "Receptor, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 48.1" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 46.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 7.6;memory CD8 T-cell: 8.0" "Group enriched" "Detected in many" 7 "dendritic cells: 2.5;T-cells: 8.0" "Cell line enhanced" "Detected in many" "ASC diff: 11.6;ASC TERT1: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 18.0;CAPAN-2: 28.0;HSkMC: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB025658 Enhanced "Intracellular and membrane" NA NA "CAB025658: " "unprognostic (2.13e-2)" "unprognostic (2.15e-1)" "unprognostic (7.26e-2)" "unprognostic (7.47e-3)" "unprognostic (1.10e-1)" "unprognostic (1.81e-1)" "unprognostic (6.39e-3)" "unprognostic (1.56e-2)" "unprognostic (9.28e-2)" "unprognostic (2.25e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (1.17e-1)" "unprognostic (4.72e-3)" "unprognostic (1.18e-1)" "unprognostic (4.52e-3)" "unprognostic (3.89e-2)" "unprognostic (1.83e-1)" 11.9 10.7 3.1 6.8 5.0 0.0 11.1 1.7 3.5 9.9 20.1 3.0 6.8 13.4 5.6 7.3 12.9 7.8 8.6 7.7 3.5 2.6 12.4 11.2 12.2 1.0 3.3 1.9 8.9 8.2 4.8 2.7 48.1 3.0 11.3 9.5 5.0 8.5 10.2 2.3 3.8 34.9 6.5 8.0 7.0 8.2 5.8 4.2 1.2 11.8 7.6 3.0 10.3 14.6 0.0 2.5 0.5 0.0 0.7 8.0 1.1 1.9 0.5 0.3 0.0 11.6 12.1 0.9 0.1 8.4 5.1 18.0 0.0 28.0 0.0 1.1 1.2 10.2 2.9 0.0 5.8 0.9 10.7 0.1 1.7 0.5 0.0 5.1 1.8 0.7 11.9 2.2 6.8 0.3 3.1 2.4 1.8 0.0 0.0 2.9 0.0 2.0 0.0 0.9 0.0 1.0 2.6 0.0 0.1 4.9 2.7 0.0 0.1 1.5 1.2 2.3 0.1 0.3 0.0 1.7 0.9 0.6 0.0 1.2 0.0 0.0 0.0 2.4 1.2 2.0 0.5 0.0 0.0 7.6 0.0 4.3 0.0 1.8 8.0 2.5 0.0 1.2 3.9 0.3 0.7 0.0 0.0 0.2 1.1 3.1 5.0 1.7 3.5 3.5 2.6 3.3 1.9 3.0 4.2 17.9 5.6 1.3 3.2 3.4 0.0 0.8 17.8 2.7 11.4 14.0 0.0 16.9 0.0 6.4 46.2 3.2 14.4 0.0 8.7 4.6 4.0 2.6 2.3 6.4 2.3 0.0 1.2 6.7 0.3 3.8 7.8 2.5 0.0 0.0 6.7 3.8 6.2 8.6 3.5 5.4 0.4 0.0 1.4 0.0 0.4 0.9 16.4 0.0 4.5 5.0 TMEM139 FLJ90586 ENSG00000178826 "Transmembrane protein 139" Q8IV31 7 143279957-143288048 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.1;kidney: 22.6;placenta: 28.0" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 48.8;Ductal cells: 42.9;Enterocytes: 54.0;Proximal tubular cells: 67.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 9.7;CAPAN-2: 18.3;EFO-21: 12.9;RPTEC TERT1: 32.2;SK-BR-3: 11.3;T-47d: 31.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036982, HPA036983" Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane" "Focal adhesion sites" "HPA036982: AB_2675413, HPA036983: AB_10672275" "unprognostic (2.58e-1)" "unprognostic (4.38e-1)" "unprognostic (6.62e-3)" "unprognostic (1.41e-1)" "unprognostic (2.10e-1)" "unprognostic (2.16e-3)" "unprognostic (2.83e-2)" "unprognostic (4.90e-2)" "unprognostic (1.60e-1)" "unprognostic (2.82e-2)" "prognostic unfavorable (1.66e-4)" "unprognostic (2.89e-1)" "prognostic favorable (3.05e-5)" "unprognostic (1.73e-1)" "unprognostic (1.42e-2)" "unprognostic (2.83e-2)" "unprognostic (9.08e-3)" 1.5 2.2 0.9 2.8 1.9 0.0 2.1 0.6 1.6 6.3 14.7 6.0 1.5 22.7 1.6 3.5 0.4 4.6 4.8 2.3 1.6 1.1 22.6 7.8 5.5 0.1 4.2 0.7 0.9 9.6 6.4 2.0 28.0 4.8 1.6 2.9 1.4 6.1 2.2 0.1 1.1 25.1 0.4 13.4 0.8 2.0 3.0 2.1 0.1 8.8 0.4 0.7 2.1 2.4 0.5 0.3 0.9 3.2 0.0 2.0 0.4 9.7 0.7 0.1 0.0 0.0 0.0 6.5 0.1 0.0 0.0 0.0 2.3 18.3 0.1 12.9 0.0 0.8 8.3 0.0 4.2 0.0 0.1 0.0 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.2 0.0 0.6 0.7 0.4 0.0 0.2 0.7 0.1 0.1 0.0 32.2 2.5 0.1 0.0 0.5 11.3 0.0 0.2 31.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 3.2 0.0 0.5 1.3 0.8 0.0 0.0 1.1 0.6 0.0 0.0 2.4 0.3 2.0 0.4 0.9 1.9 0.6 1.6 1.6 1.1 4.2 0.7 4.8 2.1 14.9 5.1 0.0 2.4 0.1 0.0 2.0 35.7 2.7 5.7 48.8 0.0 26.6 29.9 42.9 12.0 0.3 54.0 0.0 4.0 4.7 0.3 0.3 0.0 13.4 1.7 0.0 3.5 1.3 0.6 8.8 0.0 0.1 5.0 1.8 4.3 8.3 23.3 23.0 0.0 67.4 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 7.4 1.2 TMEM2 ENSG00000135048 "Transmembrane protein 2" Q9UHN6 9 71683366-71816690 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Developmental protein, Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 67.6" "Cell type enhanced" "Detected in many" 5 "Ito cells: 115.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 36.6;BEWO: 34.0;OE19: 36.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044889 Approved Supported "Vesicles,Plasma membrane" NA NA 130000 "Plasma membrane" Vesicles "HPA044889: AB_10962641" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (3.85e-2)" "unprognostic (1.01e-2)" "unprognostic (6.15e-3)" "unprognostic (1.21e-2)" "unprognostic (2.93e-2)" "unprognostic (3.53e-1)" "unprognostic (3.29e-2)" "unprognostic (1.92e-1)" "unprognostic (1.57e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (1.13e-2)" "unprognostic (2.33e-1)" "unprognostic (7.59e-2)" "unprognostic (1.16e-1)" 23.3 3.9 6.0 10.5 4.4 12.4 13.6 8.9 6.0 3.0 18.6 1.9 10.1 12.2 4.5 5.2 4.4 4.9 19.2 9.5 8.6 3.6 9.3 24.9 35.7 14.0 4.0 4.1 3.1 9.2 24.0 9.5 67.6 4.3 5.5 13.1 7.9 9.5 10.2 5.5 6.4 20.0 5.5 5.1 15.6 14.5 3.7 2.4 6.4 8.0 4.6 8.8 11.4 6.8 6.3 0.9 5.5 2.1 0.5 4.1 1.4 5.8 28.0 36.6 1.7 3.8 6.9 34.0 19.7 12.6 13.7 10.1 7.8 8.0 0.1 5.9 5.0 3.0 8.7 11.8 2.7 18.6 0.7 3.6 10.0 5.9 20.8 5.9 0.0 2.7 7.1 3.0 10.6 2.4 3.6 18.0 0.8 1.4 3.0 7.4 4.9 1.1 0.1 7.6 36.1 2.7 0.9 10.9 0.7 8.6 18.9 1.8 0.2 5.1 3.6 5.3 11.8 2.5 0.3 7.8 9.3 10.5 5.1 9.8 0.6 8.4 0.3 1.8 0.9 11.7 0.2 2.1 5.5 2.7 1.9 0.8 0.7 2.9 2.6 0.9 6.3 4.1 2.0 4.5 0.5 1.8 0.2 3.9 1.4 6.0 4.4 8.9 6.0 8.6 3.6 4.0 4.1 4.3 2.4 32.8 30.4 9.4 38.3 26.8 5.5 0.0 33.1 4.0 17.0 0.0 9.8 36.3 0.0 0.0 10.6 37.9 75.4 0.0 0.0 12.0 19.0 42.5 4.6 27.6 35.9 0.0 9.7 115.4 56.5 2.9 2.8 14.9 16.9 0.0 32.3 73.6 0.0 26.4 1.1 0.0 35.2 6.5 20.8 1.0 0.6 19.2 75.1 62.3 28.3 40.3 TMEM40 FLJ11036 ENSG00000088726 "Transmembrane protein 40" Q8WWA1 3 12733525-12769457 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 62.9;lymphoid tissue: 41.8;placenta: 53.6;tongue: 40.5" "Cell type enhanced" "Detected in many" 24 "Cytotrophoblasts: 120.6;Suprabasal keratinocytes: 176.4;Syncytiotrophoblasts: 549.0;Urothelial cells: 120.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 13.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 4.5" "Lineage enriched" "Detected in single" 7 "granulocytes: 4.5" "Cell line enhanced" "Detected in some" "HBEC3-KT: 73.7;hTCEpi: 16.6;hTERT-HME1: 21.0;RT4: 10.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA044165, HPA073122" Enhanced Approved Cytosol NA NA 7000000 Cytosol "HPA044165: AB_10961279, HPA073122: " "unprognostic (2.51e-3)" "unprognostic (1.96e-2)" "unprognostic (2.64e-3)" "unprognostic (8.25e-2)" "unprognostic (2.27e-1)" "unprognostic (1.92e-1)" "unprognostic (5.15e-4)" "unprognostic (5.96e-2)" "unprognostic (3.15e-1)" "unprognostic (2.60e-1)" "unprognostic (1.81e-3)" "unprognostic (2.47e-1)" "unprognostic (1.20e-3)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (1.46e-2)" "unprognostic (6.77e-2)" 0.0 0.0 0.0 0.0 0.2 1.4 1.8 0.0 0.0 11.7 0.0 0.0 0.4 0.0 0.9 0.6 62.9 1.6 0.1 1.6 0.0 0.0 0.3 0.0 1.8 0.0 0.1 0.0 0.4 0.0 0.0 0.0 53.6 0.1 2.3 0.0 0.0 6.6 1.4 0.4 24.0 0.0 0.7 0.0 1.1 0.0 0.4 0.0 0.4 0.0 40.5 41.8 10.6 18.6 0.0 0.5 4.5 0.6 0.0 0.3 21.1 7.4 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.3 0.3 0.4 0.2 1.1 0.0 0.0 0.0 0.2 2.1 0.0 73.7 1.4 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 16.6 0.0 21.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.4 10.3 0.0 0.0 0.0 9.2 0.0 1.4 0.8 0.2 0.0 0.0 0.4 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.7 0.6 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.0 4.5 0.0 0.0 0.5 0.0 21.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 71.9 57.1 0.0 3.3 0.0 22.7 6.8 1.8 0.0 120.6 0.0 0.5 0.6 0.4 0.0 0.0 0.0 12.6 4.3 9.6 0.0 0.6 9.6 0.0 0.0 0.0 0.3 1.6 0.3 0.2 10.1 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.3 0.2 1.9 176.4 549.0 0.0 0.0 120.1 TMPRSS13 "MSPL, TMPRSS11" ENSG00000137747 "Transmembrane serine protease 13" Q9BYE2 11 117900643-117929459 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 22.1;salivary gland: 16.6;skin 1: 26.0" "Cell type enhanced" "Detected in many" 9 "Cholangiocytes: 7.6;Cytotrophoblasts: 12.9;Extravillous trophoblasts: 12.2;Syncytiotrophoblasts: 16.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 7.5;BEWO: 17.9;MCF7: 15.1;SK-BR-3: 25.9;T-47d: 26.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "unprognostic (1.08e-3)" "unprognostic (5.18e-2)" "unprognostic (6.59e-2)" "unprognostic (1.06e-3)" "unprognostic (1.04e-1)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "unprognostic (5.61e-2)" "unprognostic (1.20e-1)" "unprognostic (1.49e-1)" "unprognostic (1.92e-2)" "unprognostic (2.03e-1)" "unprognostic (3.16e-6)" "unprognostic (2.05e-1)" "unprognostic (7.75e-2)" "unprognostic (1.08e-1)" "unprognostic (3.44e-1)" 0.2 0.3 0.2 0.6 0.2 0.3 6.2 0.2 0.2 5.8 0.2 0.2 0.2 0.2 0.9 0.7 14.8 0.1 0.2 0.2 0.4 0.0 0.7 0.2 4.0 0.7 0.2 0.2 0.3 5.7 0.0 0.5 22.1 0.2 0.9 0.2 0.6 16.6 0.2 0.2 26.0 0.5 0.2 0.2 1.0 0.1 0.3 0.2 0.4 9.5 13.7 10.6 0.3 5.6 1.0 2.6 1.0 0.7 1.9 1.2 0.8 7.5 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 5.7 0.1 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 15.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 2.1 0.2 0.0 0.0 25.9 0.3 0.9 26.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 1.0 0.6 0.0 0.9 0.7 0.0 1.0 0.1 1.2 1.8 0.5 0.4 0.1 0.0 1.9 0.5 2.6 0.7 0.8 0.2 0.2 0.2 0.2 0.4 0.0 0.2 0.2 0.2 0.2 0.0 2.9 0.0 3.7 1.4 0.0 1.4 7.6 0.0 2.3 0.0 0.0 12.9 0.0 6.2 0.3 0.0 0.4 0.0 1.0 12.2 0.5 5.3 0.0 0.0 2.5 0.0 0.0 0.0 1.2 0.6 0.0 0.7 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 6.9 16.2 0.0 0.4 6.9 TNFRSF12A "CD266, FN14, TweakR" ENSG00000006327 "TNF receptor superfamily member 12A" Q9NP84 16 3018445-3022383 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.3" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 1094.9;Ductal cells: 954.3;Exocrine glandular cells: 607.7;Pancreatic endocrine cells: 874.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 25.0" "Group enriched" "Detected in many" 8 "eosinophil: 38.1;neutrophil: 29.9" "Lineage enriched" "Detected in many" 9 "granulocytes: 38.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA007853 Approved Approved "Plasma membrane,Cytosol" NA Yes 170000 "Plasma membrane, Cytosol" "HPA007853: AB_1858463" "unprognostic (1.44e-1)" "unprognostic (2.46e-3)" "unprognostic (8.90e-2)" "unprognostic (2.60e-1)" "unprognostic (4.06e-3)" "prognostic unfavorable (5.50e-4)" "unprognostic (7.04e-3)" "unprognostic (1.98e-3)" "unprognostic (4.17e-3)" "unprognostic (2.85e-1)" "unprognostic (5.02e-3)" "unprognostic (3.88e-1)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.98e-2)" "unprognostic (6.00e-2)" "unprognostic (2.80e-3)" "unprognostic (2.17e-2)" 10.8 14.2 2.4 11.3 5.1 2.7 21.2 0.9 3.0 8.0 18.9 3.2 4.1 14.5 11.6 10.2 10.7 6.4 28.1 27.0 5.0 2.6 50.4 36.2 23.0 2.6 4.8 0.5 6.4 47.0 51.1 20.0 81.3 25.0 11.1 1.9 2.8 17.3 6.9 23.3 5.0 31.0 16.8 4.3 3.9 13.2 5.3 3.3 1.2 11.5 11.5 4.7 14.8 5.2 0.0 4.1 38.1 3.5 2.0 2.4 1.1 24.5 19.9 2.2 4.1 4.1 9.3 13.2 51.8 37.5 44.4 28.6 8.6 43.9 0.1 68.6 34.4 51.6 27.2 0.5 37.9 17.0 0.9 1.3 0.1 6.7 7.2 28.0 0.4 1.8 8.6 26.3 46.6 55.9 38.3 12.8 0.0 2.7 0.3 46.7 46.5 0.0 3.3 10.7 11.0 43.8 0.2 24.9 1.0 44.9 4.9 2.5 0.9 36.9 17.2 30.5 7.7 9.0 0.7 22.5 80.0 36.9 52.9 84.9 0.8 0.3 0.3 25.0 2.3 62.8 3.5 3.5 38.1 1.8 2.0 2.4 0.0 0.8 1.5 4.1 0.0 0.4 0.8 29.9 2.0 1.3 0.1 1.0 1.1 2.4 5.1 0.9 3.0 5.0 2.6 4.8 0.5 25.0 3.3 95.3 43.1 5.0 1094.9 544.0 0.9 57.7 163.1 50.9 130.8 172.7 2.0 112.5 54.7 954.3 0.6 22.7 41.3 0.0 607.7 131.7 179.4 600.3 58.8 15.3 38.1 0.0 26.1 28.8 4.6 0.4 5.8 29.4 106.3 16.2 4.6 20.6 874.5 25.8 6.3 93.5 5.1 6.5 212.1 7.7 4.1 314.4 158.1 8.6 12.4 560.0 TNS4 CTEN ENSG00000131746 "Tensin 4" Q8IZW8 17 40475828-40501597 "Predicted intracellular proteins" Apoptosis Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 76.9;salivary gland: 58.8;skin 1: 60.1" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 73.7;Basal keratinocytes: 118.5;Suprabasal keratinocytes: 57.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "MAIT T-cell: 1.4" "Lineage enriched" "Detected in single" 7 "T-cells: 1.4" "Cell line enhanced" "Detected in some" "HaCaT: 23.7;HBEC3-KT: 105.4;hTCEpi: 78.5;hTERT-HME1: 24.6;OE19: 21.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" NA NA "unprognostic (4.16e-2)" "unprognostic (9.83e-2)" "unprognostic (1.01e-1)" "unprognostic (3.40e-2)" "unprognostic (3.68e-4)" "unprognostic (7.88e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (5.16e-4)" "unprognostic (1.89e-1)" "unprognostic (8.02e-3)" "unprognostic (2.01e-3)" "unprognostic (1.79e-1)" "unprognostic (2.37e-2)" "unprognostic (3.72e-1)" "unprognostic (2.06e-1)" "unprognostic (3.10e-2)" "unprognostic (7.08e-2)" 0.4 0.2 0.2 0.5 0.2 0.0 10.4 0.2 0.2 12.5 1.7 0.0 18.2 0.3 1.2 10.8 35.3 0.6 2.4 0.2 0.2 0.2 2.6 0.2 1.3 0.0 0.2 0.0 0.2 0.2 0.0 1.0 76.9 0.0 17.5 3.5 0.0 58.8 38.2 0.2 60.1 0.4 2.1 0.2 0.2 0.9 1.2 0.0 0.0 8.1 28.4 27.6 7.4 23.1 0.0 0.0 0.0 0.0 0.2 1.4 0.1 1.2 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 3.2 0.0 0.6 0.0 0.0 23.7 0.0 105.4 0.0 0.0 0.0 0.0 9.4 1.5 0.0 0.0 0.0 0.0 78.5 0.0 24.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 12.2 0.0 0.0 0.0 0.0 5.5 0.0 0.0 13.6 2.5 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.0 73.7 118.5 0.0 0.6 0.0 6.7 15.9 0.0 0.0 3.5 1.7 0.2 0.0 0.6 4.9 0.0 0.2 0.4 1.9 13.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 5.0 1.0 1.7 0.0 14.6 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 57.2 3.7 0.7 0.9 25.7 TP53TG3 "P53TG3, TP53TG3A" ENSG00000183632 "TP53 target 3" Q9ULZ0 16 32673528-32676732 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.9;placenta: 1.4;testis: 4.3" "Cell type enhanced" "Detected in single" 34 "Early spermatids: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 3.4;HMC-1: 1.5;SK-MEL-30: 1.2;SuSa: 1.1;U-2 OS: 1.6" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 1.2 1.1 0.0 0.0 0.0 0.5 1.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 TP53TG3E ENSG00000275034 "TP53 target 3 family member E" Q9ULZ0 16 33303739-33306935 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 1.3;placenta: 1.6;salivary gland: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "A549: 1.5;AN3-CA: 3.2;SH-SY5Y: 1.3;U-266/70: 1.1" "HPA047832, HPA060916" Approved "Centriolar satellite" NA NA "Centriolar satellite" "HPA047832: , HPA060916: " 0.0 0.0 0.6 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 1.2 0.0 1.5 0.0 3.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRAPPC3L "bA259P20.2, BET3L, FLJ11180" ENSG00000173626 "Trafficking protein particle complex 3 like" Q5T215 6 116494989-116545610 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 10.9;placenta: 9.7" "Group enriched" "Detected in some" 6 "Ito cells: 6.2;Kupffer cells: 3.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 12.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA060912 Approved "Golgi apparatus,Vesicles" NA NA "Golgi apparatus, Vesicles" "HPA060912: " "unprognostic (1.34e-1)" "unprognostic (7.24e-2)" "unprognostic (1.93e-2)" "unprognostic (2.91e-1)" "unprognostic (5.25e-2)" "unprognostic (1.15e-2)" "unprognostic (8.98e-2)" "unprognostic (9.09e-4)" "unprognostic (8.41e-2)" "unprognostic (3.23e-2)" "unprognostic (1.96e-1)" "unprognostic (2.91e-3)" "unprognostic (2.59e-3)" "unprognostic (1.21e-1)" "unprognostic (1.52e-1)" "unprognostic (8.11e-2)" "unprognostic (7.47e-3)" 1.1 0.9 0.8 0.5 0.9 4.3 1.0 0.6 1.3 0.7 0.8 0.7 0.4 0.7 1.1 2.2 0.9 0.8 1.3 2.6 1.5 1.6 1.3 5.2 3.4 5.0 1.4 0.4 1.1 0.5 1.5 0.8 9.7 0.8 1.8 0.1 3.4 1.1 0.5 1.8 2.6 1.9 1.6 2.3 10.9 0.9 1.9 0.4 0.4 2.1 0.4 0.4 0.9 0.7 0.4 0.7 2.1 0.5 0.4 0.6 7.0 1.6 0.9 2.2 3.2 0.7 2.3 2.2 1.2 1.0 0.8 1.1 1.0 1.4 2.7 1.4 0.5 1.6 1.9 0.7 1.4 1.2 1.5 1.1 2.6 3.3 1.2 1.2 1.8 1.5 1.4 0.9 0.7 1.0 3.1 1.5 2.1 1.6 12.6 0.8 2.8 1.6 2.1 2.1 0.7 1.1 1.7 1.5 4.0 1.5 2.6 2.1 1.6 1.6 1.0 1.2 2.7 1.6 1.6 2.3 2.4 2.0 2.6 1.2 2.5 1.5 1.7 1.8 1.8 1.5 1.1 0.4 0.6 0.5 0.4 0.3 0.3 0.4 0.4 0.3 0.4 0.6 0.4 2.1 0.4 0.5 0.7 0.3 7.0 0.8 0.9 0.6 1.3 1.5 1.6 1.4 0.4 0.8 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.8 0.0 0.0 6.2 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 TREML2 "C6orf76, dJ238O23.1, FLJ13693, TLT2" ENSG00000112195 "Triggering receptor expressed on myeloid cells like 2" Q5T2D2 6 41190277-41201194 "Plasma proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 20.8;bone marrow: 13.6;placenta: 54.3" "Group enriched" "Detected in some" 12 "Early spermatids: 19.0;Late spermatids: 25.1;Syncytiotrophoblasts: 7.3" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "naive B-cell: 16.1;neutrophil: 20.8" "Group enriched" "Detected in many" 15 "B-cells: 16.1;dendritic cells: 5.5;granulocytes: 20.8" "Cell line enhanced" "Detected in some" "HEL: 24.6;HL-60: 5.7;JURKAT: 7.0;SuSa: 4.3;U-698: 7.0;U-937: 4.5" "Not detected" "Not detected" NA NA 2300000 "unprognostic (3.76e-3)" "unprognostic (2.39e-1)" "unprognostic (9.05e-3)" "unprognostic (1.30e-3)" "unprognostic (3.22e-3)" "unprognostic (2.02e-2)" "unprognostic (1.01e-1)" "unprognostic (1.83e-1)" "unprognostic (7.46e-2)" "unprognostic (2.51e-1)" "unprognostic (2.40e-3)" "unprognostic (2.46e-1)" "unprognostic (2.02e-2)" "unprognostic (7.45e-2)" "unprognostic (1.54e-2)" "unprognostic (6.23e-2)" "unprognostic (6.71e-2)" 1.7 0.2 0.2 6.3 0.2 13.6 0.2 0.2 0.2 0.2 0.4 0.1 0.1 0.1 0.2 0.1 0.4 0.9 0.3 0.5 0.2 0.2 0.3 0.4 1.5 9.2 0.2 0.1 0.2 0.2 0.0 0.2 54.3 0.3 0.2 0.0 0.1 1.5 0.1 0.2 0.2 1.9 0.1 0.3 12.3 0.4 5.9 0.2 4.9 0.3 0.1 7.5 0.8 0.2 16.1 5.5 20.8 0.8 0.4 0.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 24.6 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 0.3 0.0 0.0 1.3 1.8 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.1 4.5 0.0 1.4 0.3 7.7 0.2 0.7 0.3 3.6 0.6 0.1 1.3 16.1 0.9 0.2 20.8 0.4 0.8 5.5 0.4 1.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.3 0.2 0.0 1.4 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 25.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 7.3 0.0 0.0 0.0 TRIM10 "HERF1, RFB30, RNF9" ENSG00000204613 "Tripartite motif containing 10" Q9UDY6 6 30151945-30160934 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 3.0;kidney: 3.1;liver: 5.9;placenta: 5.8" "Cell type enriched" "Detected in some" 12 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "EFO-21: 1.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 18 "hippocampal formation: 4.0" HPA043325 Uncertain NA NA "HPA043325: AB_2678428" "unprognostic (2.98e-1)" "unprognostic (3.13e-2)" "unprognostic (2.99e-2)" "unprognostic (2.13e-1)" "unprognostic (2.98e-1)" "unprognostic (9.53e-3)" "unprognostic (6.32e-2)" "unprognostic (2.71e-1)" "unprognostic (2.64e-2)" "unprognostic (1.74e-3)" "unprognostic (1.46e-2)" "unprognostic (4.37e-2)" "unprognostic (1.22e-2)" 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.6 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 5.9 0.7 0.0 0.0 0.0 0.7 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.6 0.0 0.0 0.9 1.0 3.0 0.0 0.0 1.4 0.1 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 70.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 5.8 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 TRIM40 RNF35 ENSG00000204614 "Tripartite motif containing 40" Q6P9F5 6 30136108-30148735 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "intestine: 13.5;placenta: 39.4" "Group enriched" "Detected in some" 7 "Enterocytes: 3.6;Intestinal endocrine cells: 1.7;Paneth cells: 3.5;Spermatocytes: 1.8" "Cancer enhanced" "Detected in some" "colorectal cancer: 0.7;stomach cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 52 "HEL: 5.1" "Region enriched" "Detected in single" 19 "thalamus: 3.4" "Low region specificity" "Detected in all" HPA043818 Uncertain Approved Cytosol NA NA Cytosol "HPA043818: AB_10963090" "unprognostic (2.88e-1)" "unprognostic (5.20e-2)" "unprognostic (4.11e-1)" "unprognostic (1.13e-1)" "unprognostic (1.77e-1)" "unprognostic (4.84e-2)" 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 4.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 39.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 0.0 0.1 0.3 2.5 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.5 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.2 0.0 TRIM58 BIA2 ENSG00000162722 "Tripartite motif containing 58" Q8NG06 1 247857199-247878205 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.8;placenta: 22.4;thyroid gland: 15.2" "Cell type enriched" "Detected in many" 16 "Erythroid cells: 186.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 8.0;HEL: 21.4;K-562: 11.8;PC-3: 20.7;U-2 OS: 16.8;WM-115: 21.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA023637 Uncertain NA NA 310000 "HPA023637: AB_1858309" "unprognostic (3.85e-1)" "unprognostic (5.24e-3)" "unprognostic (7.00e-2)" "unprognostic (6.52e-4)" "unprognostic (1.46e-1)" "unprognostic (3.47e-2)" "unprognostic (1.10e-1)" "unprognostic (4.14e-5)" "unprognostic (3.59e-1)" "unprognostic (2.07e-1)" "unprognostic (1.27e-1)" "unprognostic (5.00e-2)" "unprognostic (3.31e-1)" "unprognostic (1.08e-2)" "unprognostic (3.34e-1)" "unprognostic (1.00e-2)" "unprognostic (2.57e-2)" 0.7 0.8 1.3 1.0 4.4 24.8 0.7 0.3 3.7 0.6 1.3 0.2 0.0 0.3 0.5 0.4 0.5 1.4 0.5 0.8 1.5 3.2 0.5 0.6 3.4 0.4 2.4 1.2 1.1 0.4 0.3 0.7 22.4 6.9 1.7 1.0 1.1 0.5 0.4 0.5 1.2 0.6 0.8 1.3 5.8 0.7 4.9 0.1 0.0 15.2 0.0 0.4 1.9 0.7 3.1 0.6 3.7 0.7 1.7 0.3 1.9 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.2 1.0 8.0 0.0 0.0 0.0 0.8 21.4 0.0 0.0 0.0 2.8 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.8 11.8 0.1 0.0 0.0 0.0 0.1 1.4 0.0 20.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.1 2.1 0.0 0.0 16.8 0.0 0.0 3.6 0.0 0.0 0.0 6.1 21.8 2.8 0.7 1.8 0.3 0.5 0.2 3.1 0.2 0.2 0.6 1.0 0.3 0.2 3.7 1.7 0.6 0.6 0.2 1.9 1.3 4.4 0.3 3.7 1.5 3.2 2.4 1.2 6.9 0.1 3.0 4.0 1.7 0.6 0.9 2.3 0.4 0.0 6.7 10.3 1.8 11.8 2.4 0.0 0.1 3.1 0.8 0.0 186.9 0.0 3.3 1.5 2.9 8.1 0.0 2.0 0.0 1.2 1.8 2.6 0.5 0.9 1.6 1.7 0.0 0.4 1.5 0.2 0.0 0.7 0.0 3.5 0.0 0.8 2.8 10.9 0.6 4.1 1.3 0.8 0.9 TRIM60 "FLJ35882, RNF129, RNF33" ENSG00000176979 "Tripartite motif containing 60" Q495X7 4 165031953-165041744 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "placenta: 5.0;testis: 6.6" "Cell type enhanced" "Detected in some" 11 "Cytotrophoblasts: 4.8;Extravillous trophoblasts: 8.2;Spermatocytes: 3.8;Spermatogonia: 6.4;Syncytiotrophoblasts: 4.7" "Cancer enriched" "Detected in single" 103 "testis cancer: 5.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "BEWO: 18.0" "Not detected" "Not detected" "HPA035809, HPA035810, HPA061496" Uncertain Uncertain Nucleoplasm,Nucleoli,Cytosol NA NA Nucleoli "Nucleoplasm, Cytosol" "HPA035809: AB_2674794, HPA035810: AB_10601827, HPA061496: AB_2684540" "unprognostic (1.10e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.7 1.1 0.2 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.4 0.1 0.2 1.1 0.2 0.3 0.0 0.5 0.3 0.2 1.1 0.1 0.1 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.5 0.0 1.4 0.0 0.0 0.0 4.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 8.2 0.2 0.2 0.0 0.8 0.4 0.0 0.0 0.0 2.2 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.3 0.0 0.0 3.8 6.4 0.3 4.7 0.5 0.0 0.0 TRIM64 "C11orf28, TRIM64A" ENSG00000204450 "Tripartite motif containing 64" A6NGJ6 11 89968502-89975228 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 65 "blood: 8.6;placenta: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 86 "basophil: 8.6" "Lineage enriched" "Detected in single" 86 "granulocytes: 8.6" "Not detected" "Not detected" HPA045370 Approved NA NA "HPA045370: AB_2679298" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM64B ENSG00000189253 "Tripartite motif containing 64B" A6NI03 11 89869282-89876017 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 24 "blood: 22.3;placenta: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 223 "basophil: 22.3" "Lineage enriched" "Detected in single" 223 "granulocytes: 22.3" "Cell line enhanced" "Detected in single" "WM-115: 1.4" HPA045370 Approved NA NA "HPA045370: AB_2679298" "unprognostic (2.08e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.4 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM75P TRIM75 ENSG00000250374 "Tripartite motif containing 75, pseudogene" A6NK02 4 165059148-165060554 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "placenta: 1.8;testis: 1.2" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 8 "testis cancer: 0.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 15 "BEWO: 7.0" NA NA "unprognostic (8.51e-2)" "unprognostic (2.81e-2)" "unprognostic (1.94e-3)" "unprognostic (3.29e-2)" "unprognostic (3.78e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIML2 "FLJ25801, SPRYD6" ENSG00000179046 "Tripartite motif family like 2" Q8N7C3 4 188091273-188109603 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 9.8;testis: 6.2" "Cell type enhanced" "Detected in some" 17 "Cytotrophoblasts: 13.9;Early spermatids: 18.8;Extravillous trophoblasts: 5.5;Syncytiotrophoblasts: 7.4" "Cancer enriched" "Detected in some" 33 "testis cancer: 24.4" "Region enhanced" "Detected in single" "basal ganglia: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SuSa: 58.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA043838 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043838: AB_10963835" "unprognostic (3.32e-1)" "unprognostic (1.99e-1)" "unprognostic (1.30e-1)" "unprognostic (9.82e-2)" "unprognostic (1.21e-5)" "unprognostic (3.06e-2)" "unprognostic (1.65e-3)" "unprognostic (2.65e-1)" "unprognostic (0.00e+0)" "unprognostic (2.26e-2)" "unprognostic (1.20e-1)" "unprognostic (1.28e-3)" 0.1 0.1 0.2 0.1 1.4 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 9.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 6.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 12.6 0.0 0.0 0.0 0.0 7.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.9 0.3 2.4 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 58.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 18.8 0.0 0.0 0.0 0.0 5.5 0.3 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.5 0.0 7.4 0.0 0.0 0.3 TRPC6 "FSGS2, TRP6" ENSG00000137672 "Transient receptor potential cation channel subfamily C member 6" Q9Y210 11 101451564-101872562 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 35.3;placenta: 20.6" "Cell type enhanced" "Detected in some" 16 "Club cells: 19.4;Leydig cells: 5.8;Smooth muscle cells: 9.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "eosinophil: 5.5" "Lineage enriched" "Detected in many" 5 "granulocytes: 5.5" "Cell line enhanced" "Detected in some" "A549: 4.7;ASC diff: 8.8;BJ hTERT+: 4.7;HEL: 4.4;RPTEC TERT1: 21.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebral cortex: 7.1;hippocampal formation: 12.5;midbrain: 9.6" HPA045098 Approved NA NA 140000 "HPA045098: AB_10959600" "unprognostic (1.45e-1)" "unprognostic (4.21e-1)" "unprognostic (2.43e-1)" "unprognostic (8.71e-5)" "unprognostic (1.86e-1)" "unprognostic (1.36e-2)" "unprognostic (4.33e-2)" "unprognostic (1.14e-1)" "unprognostic (4.30e-2)" "unprognostic (3.04e-1)" "unprognostic (1.98e-2)" "unprognostic (1.30e-1)" "unprognostic (5.47e-4)" "unprognostic (1.99e-3)" "unprognostic (4.88e-2)" "unprognostic (7.16e-2)" "unprognostic (1.32e-2)" 6.0 0.5 1.5 0.6 2.4 0.1 9.7 0.8 2.0 7.6 3.9 1.1 7.5 1.1 6.6 7.0 10.8 5.3 3.2 1.1 2.0 1.5 1.6 0.4 35.3 0.9 2.2 3.4 2.2 1.0 1.0 0.6 20.6 2.9 2.3 1.6 0.3 3.3 7.2 0.8 3.0 1.9 3.9 0.7 2.0 1.5 1.0 0.1 0.1 9.6 2.7 1.1 1.6 3.8 0.0 1.0 5.5 0.5 0.0 0.0 0.3 0.0 4.7 0.2 0.0 8.8 2.2 0.0 3.0 4.7 0.7 0.1 0.2 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 4.4 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 21.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.5 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.0 0.3 1.5 2.4 0.8 2.0 2.0 1.5 2.2 3.4 2.9 0.1 0.0 1.6 0.0 1.7 2.1 0.8 0.4 0.0 1.4 19.4 3.5 0.0 0.9 0.0 0.0 0.6 0.8 0.0 0.0 0.2 0.0 1.5 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.8 2.6 1.7 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 9.8 0.0 0.0 3.0 0.3 0.0 0.0 1.0 TRPV6 "CaT1, ECAC2" ENSG00000165125 "Transient receptor potential cation channel subfamily V member 6" Q9H1D0 7 142871203-142885762 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 26.1;placenta: 65.1;salivary gland: 34.2" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 25.5;Collecting duct cells: 26.2;Ductal cells: 63.7;Early spermatids: 26.4;Late spermatids: 28.8" "Cancer enriched" "Detected in many" 5 "prostate cancer: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.7;HaCaT: 10.5;RT4: 18.7;SK-BR-3: 13.8;T-47d: 30.8" "Low region specificity" "Detected in some" HPA062864 Approved NA NA "HPA062864: AB_2684885" "unprognostic (9.85e-2)" "unprognostic (1.60e-2)" "unprognostic (6.29e-2)" "unprognostic (8.72e-2)" "unprognostic (1.08e-1)" "unprognostic (1.14e-1)" "unprognostic (7.11e-2)" "unprognostic (5.43e-2)" "unprognostic (3.50e-1)" "unprognostic (4.56e-2)" "unprognostic (3.89e-2)" "unprognostic (3.27e-2)" "unprognostic (8.49e-2)" "unprognostic (9.39e-3)" "unprognostic (1.69e-1)" "unprognostic (7.17e-3)" "unprognostic (3.53e-2)" 0.3 0.0 0.3 0.3 0.3 0.0 2.1 0.3 0.3 0.4 1.2 0.3 0.3 4.1 0.3 0.4 1.7 0.1 4.1 0.3 0.3 0.2 2.5 0.6 0.8 0.3 0.8 0.3 0.3 26.1 0.0 0.4 65.1 0.4 12.6 0.0 0.4 34.2 0.7 0.3 3.7 1.0 0.5 2.0 0.3 2.4 0.7 0.3 0.3 0.7 0.6 1.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.7 1.1 0.0 0.0 13.8 0.3 0.6 30.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.2 0.8 0.3 0.4 0.3 3.0 0.0 0.0 0.9 0.5 0.4 1.6 25.5 1.4 2.3 26.2 0.0 13.3 0.0 63.7 26.4 0.0 0.0 0.0 2.8 0.6 0.4 14.3 0.0 0.0 1.4 3.2 0.0 0.0 0.0 28.8 0.9 0.0 0.0 3.6 0.0 0.8 13.2 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 1.6 5.0 0.0 0.0 3.1 TUSC3 "MGC13453, MRT7, N33, OST3A" ENSG00000104723 "Tumor suppressor candidate 3" Q13454 8 15417215-15766649 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 127.8" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 406.6;Extravillous trophoblasts: 249.7;Syncytiotrophoblasts: 655.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 18 "T-cells: 1.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049851, HPA049974" Approved NA NA "HPA049851: AB_2680913, HPA049974: AB_2680976" "unprognostic (3.31e-2)" "unprognostic (7.17e-2)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (4.46e-1)" "unprognostic (2.34e-1)" "unprognostic (7.15e-3)" "unprognostic (5.02e-2)" "unprognostic (7.39e-2)" "unprognostic (4.79e-2)" "unprognostic (1.59e-3)" "unprognostic (4.81e-1)" "unprognostic (1.60e-3)" "unprognostic (5.99e-3)" "unprognostic (1.17e-1)" "prognostic favorable (7.86e-4)" "unprognostic (1.55e-1)" 10.5 35.3 10.5 4.0 23.0 0.1 19.7 21.5 19.8 12.1 6.2 5.4 5.1 4.5 16.0 50.5 6.1 27.0 8.1 16.1 10.4 21.4 11.6 3.2 8.5 3.3 6.0 15.6 35.5 15.8 24.8 50.6 127.8 13.4 23.9 7.1 11.6 5.7 14.1 2.8 3.8 4.1 14.4 4.3 3.6 5.2 10.2 3.3 2.9 4.7 3.6 2.4 15.0 9.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 13.2 9.6 26.5 24.7 30.9 35.8 0.0 18.8 40.4 20.8 34.9 0.0 0.0 0.1 6.6 25.0 23.0 10.1 9.2 18.0 30.3 0.0 12.6 0.0 7.8 1.5 13.4 0.0 1.3 28.4 5.7 29.1 10.9 29.9 1.7 3.9 17.5 4.0 31.6 9.5 4.8 0.1 13.2 0.0 8.3 5.9 22.0 0.1 28.8 33.0 10.5 20.3 0.0 10.7 14.6 20.2 12.6 0.0 8.1 19.2 19.0 8.0 9.3 0.0 2.3 0.0 0.3 0.0 26.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.5 23.0 21.5 19.8 10.4 21.4 6.0 15.6 13.4 3.3 0.0 9.3 0.0 50.9 8.9 49.5 42.5 20.4 75.0 29.6 75.0 7.9 406.6 14.9 137.4 9.6 16.8 0.2 0.0 10.2 249.7 45.2 77.9 1.1 0.0 36.4 30.2 92.1 10.4 0.0 5.7 32.2 2.2 23.6 2.8 20.2 33.8 32.0 0.0 21.5 18.8 20.0 38.8 18.3 50.1 42.8 3.6 655.5 0.5 8.3 40.9 TWIST1 "ACS3, bHLHa38, BPES2, BPES3, CRS, CRS1, H-twist, SCS, TWIST" ENSG00000122691 "Twist family bHLH transcription factor 1" Q15672 7 19020991-19117672 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Repressor" "Cancer-related genes, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 50.0;placenta: 45.6" "Group enriched" "Detected in some" 6 "Basal keratinocytes: 11.1;Fibroblasts: 17.6;Melanocytes: 11.8;Smooth muscle cells: 9.8;Suprabasal keratinocytes: 7.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 6 "SH-SY5Y: 75.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" NA NA "unprognostic (4.58e-2)" "unprognostic (1.35e-1)" "unprognostic (1.67e-1)" "unprognostic (3.62e-1)" "unprognostic (1.29e-2)" "unprognostic (9.80e-3)" "unprognostic (1.78e-2)" "unprognostic (1.57e-2)" "unprognostic (8.51e-3)" "unprognostic (5.91e-2)" "unprognostic (8.99e-3)" "unprognostic (3.69e-1)" "unprognostic (1.29e-9)" "unprognostic (8.55e-3)" "unprognostic (1.54e-1)" "unprognostic (6.83e-3)" "unprognostic (1.97e-2)" 19.9 5.1 0.6 2.6 0.6 0.1 50.0 0.4 1.2 4.6 3.3 0.5 1.4 0.2 19.6 4.0 7.0 2.2 7.5 3.3 0.6 0.4 0.7 0.3 0.4 2.8 0.7 1.1 6.2 0.4 0.2 5.3 45.6 1.6 7.6 0.6 2.2 6.4 1.0 3.5 12.0 0.4 11.3 1.0 0.1 4.5 3.6 0.5 0.0 2.8 8.6 5.3 12.6 11.4 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.4 0.5 2.5 0.0 13.1 5.4 0.0 10.7 5.0 8.2 10.9 0.0 0.0 0.0 1.1 8.8 2.0 0.0 1.0 0.8 5.5 2.3 2.8 0.0 1.1 0.0 7.8 2.7 0.0 13.0 2.8 1.7 4.5 2.5 0.0 0.1 0.0 0.0 8.7 0.0 0.0 0.1 1.1 0.0 4.4 0.0 0.0 0.0 0.0 0.0 4.5 75.7 1.7 0.0 2.1 1.7 0.2 3.4 0.0 10.2 0.0 8.0 1.8 0.0 0.0 0.0 5.6 0.0 12.8 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.6 0.4 1.2 0.6 0.4 0.7 1.1 1.6 0.5 0.0 0.0 0.0 0.2 11.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.1 0.8 0.0 0.0 0.0 0.1 17.6 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 1.2 11.8 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.3 0.0 9.8 0.5 0.9 7.4 1.1 0.0 0.0 0.3 TXK "BTKL, PSCTK5, PTK4, RLK, TKL" ENSG00000074966 "TXK tyrosine kinase" P42681 4 48066393-48134256 "Enzymes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Transcription, Transcription regulation" "DNA-binding, Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.5;lymphoid tissue: 49.1;placenta: 28.4" "Cell type enriched" "Detected in some" 9 "T-cells: 43.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "NK-cell: 43.5" "Group enriched" "Detected in many" 26 "NK-cells: 43.5;T-cells: 17.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.8;HMC-1: 11.3;U-266/70: 5.5;U-266/84: 6.8;WM-115: 25.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA062482 Approved Vesicles NA NA Vesicles "HPA062482: AB_2684778" "unprognostic (1.04e-2)" "unprognostic (2.21e-2)" "unprognostic (4.13e-2)" "unprognostic (9.24e-3)" "unprognostic (1.09e-2)" "unprognostic (2.58e-4)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (1.50e-1)" "unprognostic (6.39e-3)" "unprognostic (8.13e-2)" "unprognostic (4.06e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (1.61e-1)" "unprognostic (2.59e-1)" "unprognostic (2.04e-2)" 1.8 1.5 0.3 15.3 0.4 3.9 1.5 0.2 0.6 0.8 2.1 0.3 0.2 1.3 1.3 11.6 2.4 2.6 1.7 0.7 0.2 0.4 2.1 2.8 4.0 49.1 0.5 0.5 0.5 1.0 0.4 1.3 28.4 0.6 0.9 1.0 1.0 6.1 0.2 0.5 1.7 7.9 0.4 0.4 17.8 1.0 1.7 0.2 14.0 1.9 0.2 19.3 2.4 1.4 0.0 0.1 1.1 0.0 43.5 17.5 10.6 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 4.8 0.0 1.4 0.0 0.2 0.2 0.0 0.0 0.4 0.2 0.1 2.4 0.0 0.0 0.0 0.3 11.3 0.0 0.0 0.1 0.0 0.8 0.1 0.4 0.2 0.0 0.7 0.0 0.0 2.1 0.0 0.6 0.8 0.3 0.0 0.0 1.4 1.3 0.0 0.2 0.0 0.0 1.1 0.1 0.0 0.2 0.4 0.0 0.0 0.3 0.1 5.5 6.8 0.4 0.0 0.4 25.4 1.1 0.0 0.3 13.2 0.0 17.4 0.0 6.8 6.4 0.0 0.0 17.5 11.9 0.8 43.5 0.0 0.1 5.1 10.6 0.3 0.4 0.2 0.6 0.2 0.4 0.5 0.5 0.6 0.2 0.0 2.6 0.8 0.5 0.3 0.0 0.2 2.5 0.0 0.0 0.0 3.9 0.2 1.7 1.3 4.3 0.1 0.0 0.0 0.0 0.1 0.5 0.4 1.1 1.0 1.2 0.0 0.0 4.3 5.1 1.3 0.3 0.5 1.7 0.0 0.0 2.3 0.2 0.0 0.0 0.6 0.4 0.0 0.0 0.4 0.2 1.0 0.5 43.1 0.2 0.6 UCK2 UMPK ENSG00000143179 "Uridine-cytidine kinase 2" Q9BZX2 1 165827531-165911618 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.8" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 94.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057128 Approved Nucleoplasm NA NA Nucleoplasm "HPA057128: AB_2683346" "unprognostic (5.37e-2)" "unprognostic (1.75e-2)" "unprognostic (2.51e-1)" "unprognostic (1.20e-2)" "unprognostic (4.54e-2)" "unprognostic (6.83e-3)" "prognostic unfavorable (9.22e-8)" "prognostic unfavorable (4.98e-4)" "prognostic unfavorable (6.70e-4)" "unprognostic (3.04e-2)" "unprognostic (1.49e-1)" "unprognostic (1.13e-2)" "prognostic unfavorable (5.12e-13)" "unprognostic (2.49e-3)" "unprognostic (1.14e-1)" "unprognostic (2.01e-3)" "unprognostic (1.83e-1)" 12.5 7.1 6.5 11.1 8.6 11.6 17.5 16.9 9.6 9.3 18.4 8.9 11.0 15.3 10.1 15.3 20.5 8.8 9.0 9.6 6.4 6.6 6.6 14.6 11.1 10.3 10.5 6.6 7.5 17.6 7.9 9.4 65.8 11.2 8.1 19.9 5.0 16.1 9.9 20.9 15.0 24.8 10.0 8.2 7.7 13.2 7.2 7.9 13.1 6.4 12.4 12.3 9.0 11.1 3.4 14.7 0.8 5.6 3.4 3.9 2.0 25.2 26.3 14.2 12.7 7.3 12.2 23.1 27.9 20.6 29.8 34.0 24.9 27.8 12.5 19.9 17.3 12.1 20.8 26.6 32.8 26.7 22.9 22.4 14.5 22.6 25.6 18.2 28.3 11.1 11.5 16.9 56.2 35.0 7.2 19.6 24.1 38.3 18.0 26.7 18.3 25.1 18.2 38.9 35.2 25.5 11.5 15.6 42.5 13.8 16.5 21.4 25.3 19.9 39.4 19.3 28.3 24.3 27.0 20.4 16.7 23.3 18.9 29.5 24.2 36.0 46.3 14.4 18.8 12.7 0.8 5.6 0.1 1.8 3.7 3.9 3.4 1.7 2.4 14.7 3.4 0.0 1.4 0.2 3.4 3.2 14.0 2.2 2.0 6.5 8.6 16.9 9.6 6.4 6.6 10.5 6.6 11.2 7.9 0.0 1.4 3.0 24.7 20.4 4.3 4.1 12.7 1.4 4.5 8.7 0.0 1.2 6.6 15.0 94.9 15.3 22.2 0.0 19.1 46.9 11.0 10.1 0.0 4.9 11.9 0.0 6.4 4.9 3.5 31.3 6.1 7.1 10.1 17.2 13.7 4.0 38.8 14.4 3.2 5.8 4.2 0.0 9.0 5.2 11.5 26.0 22.1 4.8 18.3 20.9 UNC13D Munc13-4 ENSG00000092929 "Unc-13 homolog D" Q70J99 17 75827225-75844717 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Exocytosis "Familial hemophagocytic lymphohistiocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 67.1" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 70.2;granulocytes: 43.9;Hofbauer cells: 46.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 56.1;HMC-1: 58.2;SK-BR-3: 39.8" "Region enriched" "Detected in single" 6 "cerebellum: 5.6" "Not detected" "Not detected" "HPA067117, HPA073525" Enhanced Supported Vesicles,Cytosol NA NA 14000000 Cytosol Vesicles "HPA067117: AB_2685784, HPA073525: AB_2686615" "unprognostic (6.79e-3)" "unprognostic (4.36e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.62e-4)" "unprognostic (2.98e-2)" "unprognostic (1.42e-3)" "unprognostic (3.93e-1)" "unprognostic (1.37e-2)" "unprognostic (2.74e-1)" "unprognostic (1.31e-2)" "prognostic unfavorable (6.01e-4)" "unprognostic (1.89e-1)" "prognostic unfavorable (5.28e-12)" "unprognostic (3.27e-2)" "unprognostic (5.58e-2)" "unprognostic (1.56e-1)" "unprognostic (8.59e-2)" 4.5 3.3 2.9 17.1 5.2 31.3 4.5 4.1 3.1 5.2 5.2 2.8 1.4 4.5 3.8 1.8 11.5 5.2 8.7 13.0 1.8 1.6 2.6 4.9 30.1 24.9 4.5 1.6 8.7 5.5 0.3 5.3 67.1 3.2 3.1 2.6 2.6 8.0 3.9 3.2 3.0 7.6 2.8 3.7 33.8 7.2 2.2 3.3 23.6 2.4 9.3 24.7 7.0 8.2 4.0 6.9 24.8 13.6 8.2 11.5 7.9 8.4 3.2 0.1 0.0 0.1 0.2 10.7 0.0 0.0 0.0 0.0 8.2 19.1 0.7 10.2 0.0 1.4 2.9 0.0 0.5 0.0 0.1 0.1 56.1 24.9 5.2 0.9 21.4 58.2 0.1 0.4 0.1 0.5 0.5 3.8 9.8 19.4 0.2 0.0 14.4 22.6 10.7 0.2 15.0 0.4 7.2 0.2 0.3 0.3 3.4 0.0 15.6 3.6 39.8 0.2 0.1 10.7 12.1 10.6 0.1 15.1 0.1 0.0 0.3 1.3 0.9 0.1 6.8 0.0 24.8 8.0 16.4 11.5 9.4 10.4 4.0 6.7 8.1 6.9 2.2 5.3 6.9 22.4 8.2 13.6 4.0 6.0 7.9 2.9 5.2 4.1 3.1 1.8 1.6 4.5 1.6 3.2 3.3 41.7 11.7 22.2 1.7 1.0 11.3 70.2 10.2 0.0 5.7 3.5 19.6 2.8 0.0 6.2 3.9 5.7 20.0 0.0 5.3 8.4 2.3 1.1 43.9 0.8 46.9 4.8 5.8 4.3 22.7 0.0 2.6 18.4 1.7 13.6 2.3 5.8 27.8 10.5 1.4 0.6 15.5 0.0 1.4 1.4 0.9 1.3 21.6 30.5 2.2 2.0 UPK1B "TSPAN20, UPK1" ENSG00000114638 "Uroplakin 1B" O75841 3 119173517-119205153 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 56.4;urinary bladder: 41.9" "Cell type enhanced" "Detected in some" 16 "Cholangiocytes: 35.7;Club cells: 9.1;Ductal cells: 10.8;Proximal tubular cells: 11.2;Urothelial cells: 19.0" "Cancer enhanced" "Detected in many" "urothelial cancer: 147.3" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "CACO-2: 15.4;RPTEC TERT1: 14.4;RT4: 55.5" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA031799, HPA031800" Enhanced NA NA "HPA031799: AB_10671579, HPA031800: AB_10671580" "unprognostic (1.20e-2)" "unprognostic (7.18e-2)" "prognostic favorable (3.87e-5)" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (8.77e-3)" "unprognostic (3.67e-1)" "unprognostic (2.71e-1)" "unprognostic (3.26e-2)" "unprognostic (2.03e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.76e-4)" "unprognostic (1.68e-1)" "unprognostic (6.76e-2)" "unprognostic (2.95e-2)" 6.1 0.2 0.2 0.2 1.2 0.0 0.2 0.2 0.3 3.6 0.7 0.0 0.0 0.0 1.5 0.3 2.4 5.1 12.9 1.8 0.2 0.2 6.6 0.6 1.4 0.0 0.2 0.1 0.8 11.6 0.0 0.4 56.4 1.1 15.4 0.0 0.0 0.4 0.0 0.2 0.6 0.2 4.3 1.8 0.2 22.9 0.7 0.0 1.4 0.2 1.4 12.9 41.9 1.1 0.7 1.1 2.5 0.5 0.6 1.9 0.5 0.0 6.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 15.4 0.0 0.0 2.1 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 14.4 55.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.5 0.5 0.3 0.3 0.2 0.4 0.2 0.3 0.5 0.7 1.9 0.3 1.8 0.6 0.4 1.1 0.2 0.5 0.2 1.2 0.2 0.3 0.2 0.2 0.2 0.1 1.1 0.0 0.0 1.0 0.0 0.3 0.2 0.4 0.1 35.7 0.0 9.1 0.0 0.0 1.0 0.0 10.8 3.0 0.1 0.0 0.0 0.6 7.7 0.2 0.8 2.3 0.0 0.5 1.6 0.0 0.0 0.0 1.0 0.0 1.4 1.7 1.8 0.0 0.2 0.6 0.0 0.0 11.2 0.6 0.0 0.2 0.2 0.2 0.0 1.3 0.0 0.0 19.0 USP43 FLJ30626 ENSG00000154914 "Ubiquitin specific peptidase 43" Q70EL4 17 9644698-9729691 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 61.6" "Cell type enhanced" "Detected in many" 11 "Syncytiotrophoblasts: 61.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "NK-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 12.4;SK-BR-3: 8.6;T-47d: 10.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA023389, HPA027762" Uncertain NA NA "HPA023389: AB_1858691, HPA027762: AB_10603001" "unprognostic (1.39e-1)" "unprognostic (1.75e-2)" "unprognostic (1.07e-1)" "unprognostic (2.30e-3)" "unprognostic (1.08e-1)" "unprognostic (5.24e-2)" "unprognostic (2.04e-1)" "unprognostic (6.40e-3)" "unprognostic (2.26e-1)" "unprognostic (3.05e-3)" "unprognostic (2.41e-2)" "unprognostic (7.49e-2)" "unprognostic (5.95e-2)" "prognostic favorable (5.39e-4)" "unprognostic (3.24e-1)" "unprognostic (2.06e-1)" "unprognostic (3.28e-1)" 0.2 0.2 4.2 1.2 3.4 0.9 3.0 0.7 6.0 4.9 10.0 0.6 15.7 6.2 2.9 1.7 6.7 6.3 5.1 0.2 4.1 3.8 3.7 8.7 3.4 0.2 1.7 3.1 1.0 7.7 1.7 3.7 61.6 0.7 10.8 5.0 0.3 11.3 12.4 0.2 2.4 12.5 0.3 1.0 0.2 2.6 2.9 0.2 0.4 1.7 4.2 2.7 1.3 2.1 0.0 0.5 0.0 0.0 1.1 0.1 0.1 5.7 1.5 0.0 0.6 0.0 0.0 12.4 0.1 0.2 0.7 1.7 2.8 4.7 0.0 1.9 0.2 2.7 7.0 0.6 5.5 0.7 3.6 1.9 0.3 3.0 1.0 0.1 0.5 0.0 0.0 7.2 0.3 3.0 0.3 0.0 0.8 0.0 0.0 0.0 2.7 0.9 4.7 0.7 4.9 0.3 3.7 0.0 0.8 4.4 3.1 0.8 0.0 2.5 8.6 1.0 4.1 10.4 1.4 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 4.2 3.4 0.7 6.0 4.1 3.8 1.7 3.1 0.7 0.2 3.0 1.9 0.0 7.2 4.1 0.0 0.5 7.6 21.4 7.9 10.4 5.9 16.6 1.7 3.9 1.1 0.0 9.0 0.0 4.0 19.6 0.6 9.5 0.0 12.4 2.4 0.0 2.4 0.0 1.6 0.8 0.0 0.0 5.0 0.0 7.8 8.1 8.5 2.9 0.0 1.3 1.3 0.0 0.3 1.1 0.2 2.9 61.2 0.0 9.0 10.0 VAV3 ENSG00000134215 "Vav guanine nucleotide exchange factor 3" Q9UKW4 1 107571160-107965144 "Predicted intracellular proteins" Angiogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 47.5;placenta: 54.4" "Cell type enhanced" "Detected in many" 11 "Distal tubular cells: 99.5;Syncytiotrophoblasts: 205.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "REH: 19.1;RH-30: 23.5;RPTEC TERT1: 33.0;T-47d: 40.3" "Low region specificity" "Detected in all" CAB002012 Uncertain NA NA "CAB002012: " "unprognostic (4.80e-3)" "unprognostic (7.99e-3)" "unprognostic (5.31e-3)" "unprognostic (3.78e-3)" "unprognostic (1.15e-1)" "unprognostic (1.67e-3)" "unprognostic (6.84e-2)" "unprognostic (2.34e-2)" "unprognostic (3.39e-2)" "unprognostic (1.88e-2)" "unprognostic (2.25e-1)" "unprognostic (2.34e-1)" "prognostic favorable (4.60e-8)" "unprognostic (1.89e-1)" "unprognostic (2.21e-1)" "unprognostic (7.47e-2)" "unprognostic (1.23e-2)" 2.3 1.2 1.8 12.2 2.4 7.1 15.2 2.7 3.0 11.4 17.5 0.8 6.4 3.8 3.3 4.8 32.6 1.6 1.7 2.0 1.2 1.9 47.5 1.1 7.1 8.6 3.8 0.8 1.0 7.3 0.5 2.0 54.4 3.1 6.2 22.2 6.9 6.3 5.3 0.8 27.1 7.6 2.1 1.0 13.1 3.7 2.5 0.4 8.9 4.2 17.6 17.6 7.3 11.5 4.4 4.8 6.8 1.1 3.8 4.6 1.1 0.0 4.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 6.3 0.2 0.0 0.0 0.0 1.7 6.4 2.3 3.7 0.0 5.9 2.5 0.0 13.9 0.0 0.4 0.0 0.0 3.2 0.0 5.0 0.0 2.0 12.2 1.5 1.9 0.0 0.4 19.1 23.5 0.1 33.0 10.9 1.1 1.0 6.1 2.7 0.1 0.6 40.3 10.9 0.4 0.2 0.0 0.0 0.2 3.0 1.1 0.2 5.0 9.6 0.4 6.8 1.1 1.4 4.1 1.0 2.3 2.9 1.2 2.0 4.8 4.4 0.3 2.9 3.3 3.8 0.4 3.1 4.6 1.1 1.8 2.4 2.7 3.0 1.2 1.9 3.8 0.8 3.1 0.4 0.0 1.7 22.9 10.8 10.4 14.6 1.7 2.5 13.4 19.4 48.8 2.0 73.5 99.5 3.9 44.5 6.3 29.0 0.0 0.0 24.7 2.6 1.9 7.0 0.0 20.4 0.0 20.3 12.9 16.3 31.8 0.3 12.8 3.3 0.0 25.9 1.8 0.1 43.2 0.4 39.3 28.4 6.5 1.0 0.6 0.5 18.3 205.7 14.1 47.7 1.3 VGLL1 "TDU, TONDU" ENSG00000102243 "Vestigial like family member 1" Q99990 X 136532152-136556807 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 124.6" "Group enriched" "Detected in some" 11 "Cytotrophoblasts: 1053.7;Extravillous trophoblasts: 494.4;Syncytiotrophoblasts: 1495.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 47.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 25.3;BEWO: 39.0;CAPAN-2: 14.2;RT4: 67.0;SK-BR-3: 65.8" "Low region specificity" "Detected in all" "HPA042403, HPA064616" Supported Supported Nucleoplasm NA NA Nucleoplasm "HPA042403: AB_2677980, HPA064616: AB_2685300" "unprognostic (1.38e-1)" "unprognostic (1.58e-1)" "unprognostic (3.09e-1)" "prognostic unfavorable (4.54e-4)" "unprognostic (5.16e-2)" "unprognostic (1.80e-1)" "unprognostic (4.28e-1)" "unprognostic (6.14e-3)" "unprognostic (1.92e-3)" "unprognostic (1.37e-2)" "unprognostic (5.53e-2)" "unprognostic (3.05e-1)" "unprognostic (1.46e-2)" "unprognostic (1.64e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 2.6 0.1 0.1 0.5 0.1 0.1 0.2 0.0 0.1 0.7 1.4 0.4 0.3 0.1 0.1 0.0 3.7 0.1 0.9 0.1 0.1 0.1 0.2 0.6 0.0 1.3 124.6 0.1 2.8 0.0 0.1 5.0 2.3 0.1 0.1 0.1 0.6 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.1 0.7 19.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 3.8 14.2 0.0 0.0 0.0 0.0 1.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 67.0 0.0 0.0 0.0 65.8 0.0 2.8 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 20.8 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.0 4.5 34.9 0.0 1053.7 0.0 1.3 0.0 0.0 0.0 0.0 0.2 494.4 0.0 2.2 1.1 0.0 93.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1495.8 0.0 0.0 9.8 VGLL3 VGL-3 ENSG00000206538 "Vestigial like family member 3" A8MV65 3 86876388-86991119 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "placenta: 195.7" "Group enriched" "Detected in many" 4 "Early spermatids: 105.6;Extravillous trophoblasts: 167.0;Late spermatids: 52.5;Leydig cells: 122.6;Peritubular cells: 140.4;Syncytiotrophoblasts: 67.5" "Cancer enhanced" "Detected in many" "prostate cancer: 7.9" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 4 "U-2197: 106.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054983 Approved Approved Nucleoli,Cytosol NA NA "Nucleoli, Cytosol" "HPA054983: AB_2682663" "unprognostic (9.08e-2)" "unprognostic (4.47e-3)" "unprognostic (5.97e-2)" "unprognostic (1.54e-1)" "unprognostic (2.98e-2)" "unprognostic (1.13e-1)" "unprognostic (2.77e-2)" "unprognostic (3.86e-2)" "unprognostic (1.38e-2)" "unprognostic (4.94e-2)" "unprognostic (3.70e-2)" "unprognostic (3.44e-2)" "unprognostic (2.73e-8)" "unprognostic (3.85e-3)" "unprognostic (1.27e-1)" "unprognostic (5.42e-3)" "unprognostic (1.05e-1)" 22.5 1.0 0.5 3.4 0.5 0.2 8.6 0.2 0.3 6.3 6.2 0.4 3.3 0.6 8.2 7.8 6.1 5.2 6.8 4.3 1.0 0.7 1.8 0.6 16.1 3.6 0.6 0.3 10.6 2.7 0.7 0.4 195.7 0.8 8.0 1.6 2.8 1.9 3.1 7.5 4.0 2.1 11.9 0.8 2.4 2.9 8.0 0.3 0.1 3.4 1.9 1.0 12.2 9.2 1.1 0.6 2.3 0.5 0.8 0.7 0.1 1.5 2.6 14.2 0.0 19.0 23.8 0.2 9.8 6.9 8.4 10.5 3.0 0.6 0.0 0.0 15.3 0.9 1.3 0.9 0.9 11.6 5.5 0.0 0.7 0.9 0.0 8.7 0.1 0.0 18.1 1.5 12.3 5.5 4.5 1.2 0.0 0.0 0.0 10.4 0.0 0.1 0.0 0.3 0.0 0.0 0.0 18.9 0.1 0.0 1.6 0.0 0.0 4.2 0.1 0.0 0.5 0.0 0.0 0.5 18.7 2.7 106.2 0.3 0.0 0.0 0.0 3.4 0.0 0.7 2.3 0.5 0.7 0.4 0.3 0.4 0.5 0.5 0.3 0.2 1.1 0.6 0.7 2.0 0.8 0.4 0.6 0.5 0.1 0.5 0.5 0.2 0.3 1.0 0.7 0.6 0.3 0.8 0.3 3.0 2.1 0.0 7.4 7.1 0.0 0.7 0.0 5.3 4.5 10.4 0.0 20.7 0.0 10.3 105.6 1.5 0.0 0.0 2.1 167.0 26.2 18.3 0.0 0.0 6.7 0.0 0.0 4.3 0.0 52.5 122.6 2.4 3.3 0.0 0.0 15.8 8.4 0.0 140.4 0.0 0.3 12.9 17.8 1.4 1.0 4.5 67.5 0.0 0.0 3.7 VSTM5 "C11orf90, LOC387804" ENSG00000214376 "V-set and transmembrane domain containing 5" A8MXK1 11 93818232-93850531 "Predicted membrane proteins" "Developmental protein" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 9.9;placenta: 10.7" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 16.9;Syncytiotrophoblasts: 4.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.3;OE19: 6.8;PC-3: 10.0;SH-SY5Y: 4.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029525, HPA063591" Uncertain Uncertain "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA029525: AB_10600789, HPA063591: AB_2732704" "unprognostic (1.26e-1)" "unprognostic (4.48e-3)" "unprognostic (2.78e-1)" "unprognostic (1.54e-4)" "unprognostic (2.45e-2)" "unprognostic (9.91e-2)" "unprognostic (8.56e-2)" "unprognostic (1.37e-2)" "unprognostic (1.68e-2)" "unprognostic (1.04e-1)" "unprognostic (2.52e-2)" "unprognostic (2.13e-1)" "unprognostic (1.31e-1)" "unprognostic (3.53e-2)" "unprognostic (2.37e-1)" "unprognostic (3.29e-1)" "unprognostic (1.26e-1)" 0.5 0.6 3.1 0.4 2.9 0.1 1.1 2.2 8.2 2.8 3.0 0.4 0.6 0.5 0.9 3.2 0.5 0.5 1.5 0.8 3.2 9.9 2.1 0.1 0.3 0.2 4.7 3.5 0.3 1.3 0.1 1.2 10.7 4.9 1.6 4.4 0.3 1.4 1.3 0.2 0.3 1.3 1.9 1.3 0.1 4.9 0.4 0.0 0.0 0.4 0.0 0.3 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.9 0.2 1.0 0.0 0.0 0.2 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 10.0 0.0 0.0 0.3 0.0 0.3 0.2 4.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 2.9 2.2 8.2 3.2 9.9 4.7 3.5 4.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.3 0.0 0.0 0.5 0.0 2.7 0.3 0.2 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 0.8 2.5 0.4 1.0 0.3 0.0 0.0 0.0 0.0 0.1 4.9 0.0 1.6 0.0 WNT1 INT1 ENSG00000125084 "Wnt family member 1" P04628 12 48978453-48981676 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes, Disease mutation, Osteogenesis imperfecta, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 7.7;brain: 6.5;placenta: 17.5" "Cell type enriched" "Detected in single" 36 "Cardiomyocytes: 3.6" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basal ganglia: 6.5;cerebral cortex: 1.8" "Group enriched" "Detected in some" 8 "gdT-cell: 5.3;MAIT T-cell: 7.7;memory CD4 T-cell: 3.0;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 24 "T-cells: 7.7" "Cell line enhanced" "Detected in some" "CACO-2: 1.7;JURKAT: 2.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "cerebral cortex: 1.3;hippocampal formation: 1.5;midbrain: 3.5;olfactory region: 2.1" "Secreted to extracellular matrix" NA NA "unprognostic (2.02e-2)" "unprognostic (5.80e-3)" "unprognostic (1.23e-1)" "unprognostic (1.64e-2)" "unprognostic (1.03e-1)" "unprognostic (7.65e-3)" "unprognostic (5.29e-3)" "unprognostic (5.68e-2)" "unprognostic (1.63e-1)" "unprognostic (1.20e-1)" "unprognostic (4.08e-2)" "unprognostic (4.97e-2)" "unprognostic (1.32e-2)" "unprognostic (1.67e-2)" "unprognostic (1.70e-1)" "unprognostic (7.35e-3)" "unprognostic (2.76e-2)" 0.3 0.1 0.4 1.5 6.5 2.3 0.3 0.3 2.9 0.3 0.3 0.3 0.3 1.5 0.3 0.3 0.5 0.1 0.7 0.3 0.6 0.5 0.3 0.3 0.7 2.9 0.3 0.3 0.3 0.3 0.0 0.3 17.5 0.3 0.3 0.0 0.3 1.2 0.3 0.3 0.0 1.8 0.3 0.3 1.9 1.2 1.4 0.3 0.3 0.3 0.3 0.3 0.6 0.3 0.3 0.0 0.0 0.0 0.0 7.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 7.7 0.3 3.0 4.8 0.0 0.0 0.5 3.2 0.0 0.0 0.0 0.0 0.4 0.8 0.4 6.5 0.3 1.8 0.6 0.5 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WNT2 "INT1L1, IRP" ENSG00000105989 "Wnt family member 2" P09544 7 117276631-117323289 "Cancer-related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 10.4;lung: 10.9;placenta: 40.9" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 24.8;Fibroblasts: 9.4;Hofbauer cells: 6.8;Ito cells: 11.1;Late spermatids: 7.0;Syncytiotrophoblasts: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2197: 21.6" "Region enhanced" "Detected in many" "basal ganglia: 12.6" "Low region specificity" "Detected in all" HPA020920 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA020920: AB_1858850" "unprognostic (1.90e-1)" "unprognostic (6.97e-2)" "unprognostic (2.88e-2)" "unprognostic (4.11e-3)" "unprognostic (9.14e-2)" "unprognostic (2.47e-1)" "unprognostic (2.54e-2)" "unprognostic (2.75e-1)" "unprognostic (2.74e-1)" "unprognostic (5.70e-2)" "unprognostic (1.36e-2)" "unprognostic (1.41e-1)" "unprognostic (3.43e-1)" "unprognostic (4.05e-2)" "unprognostic (2.50e-2)" "unprognostic (1.05e-1)" "unprognostic (2.10e-1)" 1.8 0.0 0.2 0.1 1.1 0.0 1.4 0.3 2.3 3.0 0.2 0.4 0.4 0.0 10.4 2.7 0.4 1.0 0.2 0.7 0.9 0.9 0.3 0.8 10.9 0.0 0.1 0.5 0.8 0.1 0.0 0.2 40.9 0.5 7.6 0.0 0.9 0.1 0.5 0.0 1.1 0.2 1.2 0.2 1.5 0.1 0.7 0.0 0.0 0.2 0.0 0.1 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.4 2.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.3 2.3 0.9 0.9 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 2.3 0.0 0.0 3.8 0.0 0.0 24.8 0.4 0.0 0.0 0.0 2.9 9.4 0.2 0.0 0.0 6.8 0.0 0.0 11.1 1.0 7.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.3 1.6 0.1 2.4 7.6 0.0 0.0 0.1 WNT3A ENSG00000154342 "Wnt family member 3A" P56704 1 228007051-228061260 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "lung: 7.4;placenta: 19.9" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 1: 11.9;Basal glandular cells: 2.4;Basal keratinocytes: 3.1;Syncytiotrophoblasts: 2.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HEK 293: 2.8;U-2 OS: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA066281 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA066281: AB_2685647" "unprognostic (9.84e-3)" "prognostic favorable (6.11e-5)" "unprognostic (2.40e-1)" "unprognostic (3.37e-1)" "unprognostic (7.82e-2)" "unprognostic (4.94e-2)" "unprognostic (2.19e-1)" "unprognostic (1.96e-1)" "unprognostic (4.22e-2)" "unprognostic (4.12e-2)" "unprognostic (2.16e-1)" "unprognostic (4.80e-3)" "unprognostic (1.99e-1)" "unprognostic (7.26e-2)" "unprognostic (5.43e-3)" "unprognostic (1.54e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.6 0.1 0.1 0.1 0.0 0.1 0.1 2.0 0.2 0.1 0.1 0.1 0.0 0.2 0.1 7.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 19.9 0.1 2.4 0.0 0.1 1.7 0.1 0.1 3.0 0.1 0.1 0.6 0.1 0.0 1.0 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 11.9 0.0 0.0 2.4 3.1 0.0 1.4 0.0 0.0 1.2 1.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.9 2.4 0.0 0.0 0.5 WNT7A ENSG00000154764 "Wnt family member 7A" O00755 3 13816258-13880121 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.5;gallbladder: 8.7;placenta: 19.4" "Group enriched" "Detected in some" 7 "Cytotrophoblasts: 48.0;Extravillous trophoblasts: 129.2;Pancreatic endocrine cells: 57.6;Syncytiotrophoblasts: 155.3" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory CD4 T-cell: 4.4;naive CD4 T-cell: 4.2" "Lineage enriched" "Detected in single" 45 "T-cells: 4.4" "Cell line enhanced" "Detected in some" "BEWO: 25.3;EFO-21: 23.8;PC-3: 8.3;RPTEC TERT1: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015719, CAB025894" Approved "Secreted to extracellular matrix" NA NA "CAB025894: , HPA015719: AB_1858856" "unprognostic (1.26e-2)" "unprognostic (4.60e-1)" "unprognostic (2.98e-1)" "prognostic unfavorable (2.96e-5)" "unprognostic (3.02e-1)" "unprognostic (1.14e-3)" "unprognostic (2.49e-1)" "unprognostic (3.32e-4)" "unprognostic (2.20e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.03e-6)" "unprognostic (7.89e-2)" "unprognostic (3.78e-2)" "unprognostic (6.49e-4)" "unprognostic (1.90e-1)" "unprognostic (3.74e-1)" "unprognostic (8.88e-3)" 0.4 0.4 7.8 0.6 6.1 0.7 0.4 1.2 11.5 1.1 0.4 2.1 0.0 0.4 3.4 1.0 1.6 0.7 8.7 0.4 3.3 2.8 0.7 0.5 5.7 1.4 3.1 3.2 0.4 0.8 0.4 0.2 19.4 3.9 0.5 0.4 0.0 0.5 1.4 0.4 2.8 0.4 0.5 4.4 3.1 0.4 2.3 2.3 0.0 0.4 0.0 0.7 0.9 0.5 0.0 0.0 0.0 0.0 0.0 4.4 0.5 3.4 0.0 0.3 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.0 3.1 0.0 23.8 0.0 0.0 4.6 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.6 42.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.6 0.0 0.0 4.2 0.4 0.0 0.0 0.0 0.0 0.0 0.5 7.8 6.1 1.2 7.2 3.3 2.8 3.1 3.2 3.9 2.3 11.9 0.0 0.0 2.3 5.3 0.0 0.6 0.0 0.0 1.2 0.0 0.0 48.0 0.0 13.3 14.3 0.0 0.0 0.0 8.2 129.2 0.5 0.2 0.0 0.0 6.6 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 57.6 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.4 1.1 155.3 0.5 0.0 4.7 XAGE2 "CT12.2, GAGED3, XAGE-2, XAGE2B" ENSG00000155622 "X antigen family member 2" Q96GT9 X 52369030-52375680 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "placenta: 106.9" "Group enriched" "Detected in some" 12 "Cytotrophoblasts: 760.4;Extravillous trophoblasts: 1534.6;Syncytiotrophoblasts: 1143.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 46.2;SK-BR-3: 10.8;SuSa: 14.0;T-47d: 9.5" "HPA052507, HPA060900" Supported NA NA "HPA052507: AB_2681855, HPA060900: AB_2684383" "unprognostic (1.21e-1)" "unprognostic (9.67e-2)" "unprognostic (1.49e-1)" "unprognostic (4.47e-2)" 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 4.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 106.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.8 0.5 14.0 9.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 35.7 10.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 2.3 0.0 0.0 760.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1534.6 0.0 0.0 0.0 0.0 93.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1143.7 0.0 0.0 0.0 XAGE3 "CT12.3a, CT12.3b, GAGED4, PLAC6, pp9012, XAGE-3" ENSG00000171402 "X antigen family member 3" Q8WTP9 X 52862525-52868068 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "placenta: 98.5" "Group enriched" "Detected in some" 10 "Cytotrophoblasts: 1947.3;Extravillous trophoblasts: 1021.2;Syncytiotrophoblasts: 2239.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "memory B-cell: 1.7" "Lineage enriched" "Detected in single" 10 "B-cells: 1.7" "Cell line enhanced" "Detected in some" "BEWO: 3.3;U-266/70: 5.8;U-266/84: 5.3" "HPA052507, HPA060900" Supported NA NA "HPA052507: AB_2681855, HPA060900: AB_2684383" "unprognostic (6.04e-2)" "unprognostic (2.30e-1)" "unprognostic (2.92e-1)" 1.0 0.0 0.1 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 98.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 1.2 0.5 0.7 0.0 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 5.8 5.3 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1947.3 0.0 0.1 0.1 0.0 0.0 0.0 0.3 1021.2 0.0 0.0 0.0 3.4 166.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 5.5 6.4 0.0 2239.5 0.0 0.0 0.0 XG PBDX ENSG00000124343 "Xg blood group" P55808 X 2752048-2816500 "Blood group antigen proteins, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 22.8;placenta: 18.4;skin 1: 25.8" "Group enriched" "Detected in some" 8 "Basal keratinocytes: 12.8;Melanocytes: 10.1;Suprabasal keratinocytes: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 16 "memory B-cell: 2.1;naive B-cell: 1.0" "Lineage enriched" "Detected in single" 21 "B-cells: 2.1" "Group enriched" "Detected in some" 6 "ASC diff: 34.4;ASC TERT1: 25.6;fHDF/TERT166: 16.1;hTCEpi: 23.9;T-47d: 12.9" "Low region specificity" "Detected in all" NA NA "prognostic unfavorable (4.25e-4)" "unprognostic (1.69e-2)" "unprognostic (1.40e-1)" "unprognostic (8.55e-3)" "unprognostic (1.89e-1)" "unprognostic (3.86e-2)" "unprognostic (4.50e-2)" "unprognostic (1.59e-1)" "unprognostic (2.16e-2)" "unprognostic (8.62e-2)" "unprognostic (7.21e-2)" "unprognostic (2.30e-1)" "unprognostic (8.10e-6)" "unprognostic (3.96e-3)" "unprognostic (7.98e-2)" "unprognostic (5.83e-3)" "unprognostic (6.77e-3)" 8.9 0.0 0.3 0.3 0.6 0.8 9.1 0.5 0.6 22.8 0.3 0.3 0.3 0.0 2.6 0.3 7.1 0.6 3.0 1.2 1.4 0.0 1.3 0.3 0.3 0.3 0.6 0.3 1.1 0.3 0.0 0.3 18.4 1.9 0.5 0.0 0.3 4.1 0.4 1.4 25.8 0.3 0.3 4.2 0.3 0.1 0.3 0.3 0.3 0.9 0.3 2.4 1.2 7.2 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.4 25.6 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 16.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 23.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.1 1.7 0.0 12.9 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.5 0.6 1.4 0.0 0.6 0.3 1.9 0.3 0.0 0.0 0.0 0.6 12.8 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.5 19.2 0.5 0.0 0.0 0.1 XKRX "XKR2, XPLAC" ENSG00000182489 "XK related, X-linked" Q6PP77 X 100913445-100929433 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pituitary gland: 12.0;placenta: 12.2;skin 1: 12.9;thyroid gland: 11.0" "Cell type enhanced" "Detected in some" 17 "Melanocytes: 1.7;Syncytiotrophoblasts: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "naive B-cell: 5.0;naive CD4 T-cell: 3.7;naive CD8 T-cell: 2.8" "Group enriched" "Detected in many" 44 "B-cells: 5.0;T-cells: 3.7" "Cell line enriched" "Detected in some" 5 "CACO-2: 13.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" NA NA "unprognostic (3.35e-1)" "unprognostic (2.38e-2)" "unprognostic (4.51e-3)" "unprognostic (1.87e-1)" "unprognostic (8.53e-2)" "unprognostic (2.67e-2)" "unprognostic (2.96e-2)" "unprognostic (5.18e-2)" "unprognostic (3.69e-2)" "unprognostic (7.37e-2)" "unprognostic (5.70e-2)" "unprognostic (1.58e-2)" "unprognostic (5.60e-6)" "unprognostic (1.25e-1)" "unprognostic (2.60e-1)" "prognostic favorable (3.52e-4)" "unprognostic (1.18e-1)" 0.1 1.0 0.2 2.1 0.3 0.1 1.1 0.1 0.1 1.2 7.2 0.2 8.3 0.4 0.2 1.9 3.5 1.1 0.5 0.1 0.2 0.4 0.3 0.1 3.3 2.4 0.2 0.0 0.3 0.2 0.0 12.0 12.2 0.2 0.5 1.3 0.0 1.0 1.8 0.2 12.9 6.8 0.0 0.2 0.6 0.5 0.4 0.0 0.8 11.0 1.9 5.4 0.5 2.4 5.0 0.0 0.0 0.0 0.0 3.7 0.6 0.3 1.0 0.1 0.0 0.1 0.0 0.1 0.1 0.6 0.0 0.0 13.2 1.6 1.0 0.1 0.0 1.1 0.2 0.0 0.9 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.3 2.5 1.0 0.0 0.1 0.1 0.6 0.1 0.0 0.4 2.5 0.0 0.0 0.0 2.5 0.1 2.1 0.3 1.1 0.2 1.1 0.0 0.3 0.4 0.0 2.3 0.0 0.3 0.0 0.0 2.0 0.5 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.1 0.0 0.0 5.0 3.7 2.8 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.1 0.1 0.2 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 2.2 0.0 0.1 0.3 ZFAT "KIAA1485, ZFAT1, ZNF406" ENSG00000066827 "Zinc finger and AT-hook domain containing" Q9P243 8 134477788-134713049 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 68.8" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 57.3;Early spermatids: 44.4;Late spermatids: 36.0;Syncytiotrophoblasts: 106.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "plasmacytoid DC: 22.1" "Lineage enriched" "Detected in single" 25 "dendritic cells: 22.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020989, HPA063592" Enhanced Approved "Nucleoplasm,Nuclear bodies" NA NA "Nuclear bodies" Nucleoplasm "HPA020989: AB_2670552, HPA063592: AB_2685051" "unprognostic (2.00e-1)" "unprognostic (1.45e-1)" "unprognostic (4.62e-3)" "unprognostic (5.91e-3)" "unprognostic (2.45e-1)" "unprognostic (5.12e-2)" "unprognostic (1.31e-4)" "unprognostic (6.27e-2)" "unprognostic (2.68e-2)" "unprognostic (1.28e-1)" "unprognostic (2.43e-2)" "unprognostic (1.13e-1)" "unprognostic (1.90e-2)" "unprognostic (1.80e-1)" "unprognostic (2.24e-1)" "unprognostic (7.08e-3)" "unprognostic (1.33e-1)" 4.5 2.9 4.2 3.5 4.2 1.7 5.0 6.8 4.5 3.0 7.8 2.6 2.8 3.2 5.0 3.1 4.2 3.3 2.4 3.8 3.0 1.7 12.4 2.8 4.1 4.5 2.5 2.8 3.3 3.3 3.7 4.6 68.8 2.9 3.9 2.6 4.3 3.7 4.2 8.5 3.4 3.8 3.9 2.0 4.4 3.6 3.5 3.0 4.8 3.3 2.8 4.0 6.0 5.3 0.6 22.1 0.8 0.5 0.0 0.5 0.5 5.7 9.0 3.3 4.1 6.4 6.4 2.8 6.2 5.5 5.8 5.8 6.2 7.2 6.4 5.5 6.4 3.4 4.4 6.6 7.8 7.4 5.4 8.8 12.0 9.2 4.6 5.0 6.7 5.9 5.4 4.0 6.4 8.2 5.2 7.0 2.4 4.5 12.0 4.8 7.4 6.9 0.8 4.6 5.8 5.9 4.3 4.3 2.7 5.4 8.6 3.7 3.1 6.4 4.9 5.2 3.9 4.1 6.4 7.6 3.4 5.0 4.8 7.0 4.4 5.8 6.4 4.3 5.0 6.4 0.7 0.3 0.8 0.3 0.5 0.3 0.6 0.2 0.5 0.3 0.6 0.4 0.2 0.7 0.0 0.3 22.1 0.1 0.5 4.2 4.2 6.8 4.5 3.0 1.7 2.5 2.8 2.9 3.0 3.0 3.5 6.0 1.2 1.3 3.6 1.6 0.0 0.0 3.4 1.8 3.9 57.3 0.0 2.0 44.4 1.1 1.1 0.0 1.3 13.9 2.4 1.2 2.3 1.0 7.1 1.6 0.0 0.6 2.4 36.0 3.1 2.0 8.5 3.6 1.3 2.6 2.9 0.0 2.5 9.2 5.9 0.0 1.6 2.9 5.5 1.5 106.0 1.3 1.1 1.1 ZFP42 "REX1, ZNF754" ENSG00000179059 "ZFP42 zinc finger protein" Q96MM3 4 187995771-188005050 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 4.7;placenta: 6.6;testis: 7.1" "Group enriched" "Detected in some" 5 "Early spermatids: 41.4;Extravillous trophoblasts: 49.9" "Cancer enriched" "Detected in some" 41 "testis cancer: 40.5" "Region enriched" "Detected in single" 5 "pons and medulla: 1.3" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 13 "BEWO: 47.2;SuSa: 33.1" "Not detected" "Not detected" "Not detected" "Not detected" CAB025557 Uncertain NA NA "CAB025557: " "unprognostic (2.30e-1)" "unprognostic (1.07e-4)" "unprognostic (4.88e-3)" "unprognostic (3.75e-1)" "unprognostic (1.77e-1)" "unprognostic (3.86e-1)" "unprognostic (2.27e-1)" "unprognostic (4.66e-3)" 0.5 0.2 0.2 0.3 0.2 1.3 0.2 0.2 0.3 0.3 0.9 0.2 0.2 0.6 0.2 0.5 0.2 0.5 0.2 0.2 0.2 0.3 0.4 0.2 1.1 0.8 0.3 0.2 0.2 0.2 0.0 0.2 6.6 1.3 0.2 0.3 0.2 0.4 0.2 1.9 1.8 0.2 0.2 0.2 1.1 0.5 7.1 0.2 0.2 0.2 0.2 0.4 0.2 0.2 1.9 1.2 4.7 1.0 2.3 2.0 0.4 0.1 0.0 0.1 0.1 0.0 0.0 47.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 3.0 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.0 33.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 4.3 1.0 1.2 2.0 0.8 1.5 1.7 1.6 1.3 0.4 1.9 1.7 1.7 4.7 2.3 0.9 1.2 1.5 0.4 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.2 1.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 41.4 0.0 0.0 0.0 0.0 49.9 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.3 0.0 7.9 0.0 0.0 0.1 ZNF217 ZABC1 ENSG00000171940 "Zinc finger protein 217" O75362 20 53567065-53609907 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.5" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 114.7;Suprabasal keratinocytes: 93.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 50.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA051857 Approved Enhanced "Nuclear speckles" NA NA "Nuclear speckles" "HPA051857: AB_2681641" "unprognostic (4.17e-2)" "unprognostic (4.05e-1)" "unprognostic (2.41e-1)" "unprognostic (1.18e-1)" "unprognostic (1.44e-1)" "unprognostic (3.72e-2)" "unprognostic (2.49e-3)" "unprognostic (1.19e-1)" "unprognostic (1.47e-2)" "unprognostic (7.17e-2)" "unprognostic (4.13e-3)" "unprognostic (2.87e-2)" "unprognostic (2.03e-1)" "unprognostic (2.33e-1)" "unprognostic (2.90e-1)" "unprognostic (2.67e-1)" "unprognostic (2.52e-2)" 9.9 3.0 3.6 9.3 2.9 10.9 15.0 2.2 3.1 7.6 6.7 3.1 6.1 4.5 6.2 2.9 10.0 5.7 5.7 5.4 3.4 1.6 6.3 10.3 8.8 20.9 3.0 2.3 6.1 7.1 8.3 3.9 65.5 4.8 7.1 6.8 5.7 11.0 8.6 5.2 11.9 8.9 6.6 3.4 16.8 6.7 9.9 2.4 16.7 6.9 4.9 9.5 10.6 8.6 4.3 4.1 19.4 11.5 5.8 3.6 2.2 9.2 11.0 9.3 13.5 8.7 10.0 20.4 10.4 10.7 11.8 5.9 7.1 10.4 9.0 11.2 12.6 15.3 9.1 7.4 10.9 13.7 6.4 2.1 2.9 4.8 12.3 6.8 4.6 12.5 5.4 10.6 6.3 17.6 9.3 6.7 9.4 6.3 42.8 8.8 36.9 16.0 10.3 9.8 5.3 11.0 12.6 7.8 10.4 6.8 20.7 0.9 2.6 9.6 50.0 10.1 12.3 14.9 19.8 4.7 23.9 8.9 12.2 12.7 17.8 19.7 7.6 8.7 5.3 7.6 5.9 4.9 8.4 2.8 6.3 3.6 4.3 3.0 3.5 3.9 3.9 3.4 3.3 19.4 5.8 11.5 4.1 2.9 2.2 3.6 2.9 2.2 3.1 3.4 1.6 3.0 2.3 4.8 2.4 0.0 10.1 12.3 36.1 114.7 0.6 7.5 15.3 22.7 14.8 17.4 0.0 11.9 8.3 23.0 36.2 14.6 32.6 23.3 14.3 14.2 18.3 61.3 11.5 24.3 13.3 0.0 5.8 16.0 38.2 20.0 6.4 34.4 20.3 6.4 27.1 2.0 19.8 28.1 4.9 9.6 0.5 0.0 8.6 5.4 24.0 93.3 37.8 20.8 21.0 72.7 ZNF28 "DKFZp781D0275, KOX24" ENSG00000198538 "Zinc finger protein 28" P17035 19 52797409-52857600 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 64.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "prognostic unfavorable (9.29e-4)" "unprognostic (2.11e-1)" "unprognostic (7.05e-2)" "unprognostic (3.40e-2)" "unprognostic (1.25e-1)" "unprognostic (2.03e-1)" "unprognostic (1.31e-2)" "unprognostic (6.91e-3)" "unprognostic (5.38e-3)" "unprognostic (4.43e-1)" "unprognostic (1.63e-1)" "unprognostic (6.57e-2)" "unprognostic (1.06e-2)" "unprognostic (7.09e-2)" "unprognostic (1.11e-2)" "unprognostic (2.22e-1)" "unprognostic (5.68e-2)" 7.3 7.8 7.5 4.8 6.4 1.0 7.6 10.2 5.7 6.8 7.5 4.5 11.6 6.8 5.7 5.9 7.3 8.1 8.1 4.6 5.7 3.9 8.9 3.9 5.2 9.0 5.0 3.1 5.9 8.3 7.2 7.0 64.1 5.9 7.3 9.3 3.2 6.5 5.8 2.2 4.7 11.0 6.0 4.7 6.1 6.8 6.1 5.7 12.7 11.7 2.8 6.9 8.8 6.5 5.4 6.1 15.4 4.7 19.4 8.0 5.5 7.5 0.8 4.5 8.4 7.2 5.8 15.9 6.7 5.2 6.7 9.3 6.3 7.3 12.9 7.9 5.1 6.8 5.8 7.3 4.3 9.3 0.1 7.7 10.2 4.4 1.8 7.4 0.1 10.4 4.8 6.8 8.8 8.7 5.1 6.6 7.2 11.8 0.1 7.8 2.3 10.2 4.2 5.6 8.2 6.5 6.7 11.4 7.4 7.1 26.0 7.4 5.6 14.4 6.8 5.2 12.5 10.0 9.5 5.6 3.4 6.9 3.0 6.8 2.7 11.3 14.0 0.2 1.6 13.3 15.4 4.7 7.3 8.0 3.5 6.9 5.0 5.6 6.6 6.1 5.4 6.5 7.6 2.5 19.4 3.8 3.2 4.4 5.5 7.5 6.4 10.2 5.7 5.7 3.9 5.0 3.1 5.9 5.7 3.0 6.6 1.5 3.2 2.9 1.4 4.7 12.7 9.4 13.6 10.4 2.0 5.9 6.6 6.7 0.8 4.0 10.9 0.0 4.4 7.3 2.8 6.1 8.1 4.2 8.3 4.8 13.9 8.0 10.2 0.9 2.3 3.7 3.3 3.6 11.6 1.5 6.5 12.9 1.8 4.4 1.6 0.0 2.3 1.8 4.7 1.9 5.8 6.4 10.0 8.7 ZNF468 ENSG00000204604 "Zinc finger protein 468" "A2RRD8, Q5VIY5" 19 52838008-52890375 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 65.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 46.9" "HPA043696, HPA062474" Uncertain Uncertain "Nucleoplasm,Cytoplasmic bodies" NA NA Nucleoplasm "Cytoplasmic bodies" "HPA043696: AB_10793951, HPA062474: AB_2732685" "prognostic unfavorable (6.87e-4)" "unprognostic (2.16e-1)" "unprognostic (1.00e-2)" "unprognostic (1.31e-1)" "unprognostic (1.46e-2)" "unprognostic (2.24e-1)" "unprognostic (1.42e-2)" "unprognostic (9.93e-2)" "unprognostic (1.38e-2)" "unprognostic (2.55e-1)" "unprognostic (2.09e-1)" "unprognostic (1.25e-2)" "prognostic favorable (3.94e-7)" "unprognostic (1.04e-1)" "unprognostic (2.95e-2)" "unprognostic (1.41e-1)" "unprognostic (5.59e-2)" 6.6 7.6 6.6 3.5 5.1 5.2 6.9 8.4 5.1 6.2 6.2 4.3 11.0 3.2 4.7 6.4 6.3 6.3 8.0 4.6 4.2 2.9 8.2 3.4 4.9 9.8 4.2 2.8 4.8 10.0 8.8 5.5 65.5 5.2 7.9 7.2 3.1 7.0 5.8 3.7 4.6 10.8 6.2 3.9 5.1 7.1 3.4 3.3 12.0 10.4 1.9 5.5 8.0 5.4 8.8 7.0 11.5 10.3 19.1 12.5 8.6 6.2 0.8 5.7 10.0 6.1 4.5 16.7 5.0 6.3 6.5 9.7 6.2 3.9 9.6 5.1 5.3 7.7 3.3 3.9 5.1 8.6 0.0 5.8 7.3 6.4 2.6 12.4 0.4 9.4 7.2 6.1 8.0 6.6 3.6 5.4 5.3 7.2 0.4 5.7 1.4 9.1 5.9 7.0 4.5 6.1 5.5 8.2 6.4 8.8 46.9 5.9 8.7 6.3 5.7 1.5 12.6 7.5 5.7 4.4 2.2 5.7 3.0 7.3 3.9 13.9 8.6 0.5 0.8 8.0 8.3 6.1 11.5 12.3 10.3 12.5 8.1 8.0 9.8 7.0 8.8 10.0 9.2 6.3 19.1 8.0 5.3 9.3 8.6 6.6 5.1 8.4 5.1 4.2 2.9 4.2 2.8 5.2 3.3 3.0 3.7 4.5 4.7 3.0 1.0 3.3 7.6 0.0 5.7 8.7 0.0 6.4 14.9 6.1 2.4 3.1 5.3 0.0 8.3 10.7 2.5 8.9 17.3 2.6 5.4 0.0 8.2 3.1 10.0 0.4 0.9 3.5 1.7 3.6 12.2 0.8 7.5 7.0 2.5 5.4 0.2 0.0 2.7 0.5 4.0 4.6 20.1 6.9 6.9 9.7 ZNF595 FLJ31740 ENSG00000272602 "Zinc finger protein 595" 4 53285-88211 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "placenta: 35.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 28.1;K-562: 64.4;SH-SY5Y: 44.1" NA NA "unprognostic (1.03e-1)" "unprognostic (1.02e-1)" "unprognostic (6.33e-2)" "unprognostic (2.95e-1)" "unprognostic (6.98e-2)" "unprognostic (1.03e-2)" "unprognostic (2.02e-1)" "unprognostic (1.02e-1)" "unprognostic (1.10e-1)" "unprognostic (6.63e-3)" "unprognostic (2.52e-2)" "unprognostic (1.11e-2)" "unprognostic (1.09e-2)" "unprognostic (4.56e-3)" "unprognostic (2.31e-1)" "unprognostic (2.68e-1)" "unprognostic (6.46e-2)" 5.4 5.0 3.5 3.8 5.3 4.5 5.8 15.9 5.7 6.7 3.6 3.7 3.0 2.3 6.0 3.5 2.5 4.4 2.8 2.5 3.9 3.1 3.5 4.0 5.3 4.5 4.2 10.1 4.2 3.5 10.3 35.9 7.0 4.6 3.5 3.1 2.9 2.5 5.1 3.9 1.8 6.4 5.5 5.1 2.7 4.7 4.7 9.5 7.4 1.9 5.7 4.2 3.2 12.5 11.6 11.0 2.4 16.7 6.7 3.4 1.0 3.6 2.4 2.2 14.1 17.5 18.8 1.3 1.2 1.4 1.9 1.7 1.5 28.1 2.2 1.0 2.4 0.8 13.6 1.2 2.1 2.2 1.9 0.1 0.0 0.0 0.9 0.0 7.4 1.9 1.6 1.4 1.5 1.6 1.1 12.9 64.4 0.3 1.1 8.0 0.0 7.8 4.2 0.0 1.6 0.0 0.5 0.0 2.0 1.1 2.0 44.1 1.6 1.9 0.7 10.1 13.7 4.5 7.9 1.5 10.9 0.8 1.6 0.1 13.6 3.3 0.0 0.0 4.8 3.4 2.1 11.0 6.7 2.4 3.1 12.5 3.6 4.3 3.1 12.4 5.0 5.0 3.7 16.7 2.2 11.6 2.7 3.4 6.0 9.4 10.5 8.7 4.0 8.2 4.9 7.6 2.7 19.4 3.5 2.0 8.7 13.3 6.6 3.9 8.2 1.6 0.0 3.8 7.3 4.8 4.8 7.0 3.4 3.3 3.2 0.0 9.2 3.5 4.9 10.3 2.6 5.0 1.0 2.7 9.8 3.3 2.9 8.5 4.2 6.2 0.0 4.7 12.2 12.7 4.0 7.1 8.6 3.3 5.2 ZNF777 KIAA1285 ENSG00000196453 "Zinc finger protein 777" Q9ULD5 7 149431363-149461123 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "placenta: 65.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003252 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA003252: AB_1080755" "unprognostic (7.19e-2)" "unprognostic (1.06e-1)" "unprognostic (1.17e-2)" "unprognostic (3.37e-2)" "unprognostic (4.78e-2)" "unprognostic (6.64e-2)" "unprognostic (5.87e-3)" "unprognostic (4.52e-2)" "unprognostic (1.10e-1)" "unprognostic (6.15e-2)" "unprognostic (5.17e-3)" "unprognostic (2.64e-1)" "unprognostic (4.00e-2)" "unprognostic (6.33e-2)" "unprognostic (1.68e-1)" "unprognostic (8.23e-2)" "unprognostic (5.72e-2)" 5.0 4.3 5.5 4.1 8.8 6.9 4.9 7.1 9.3 5.2 5.2 5.4 3.5 4.5 7.3 3.5 4.1 6.5 3.5 4.7 5.3 5.1 3.8 4.4 4.4 4.7 4.3 5.3 9.1 6.6 6.6 5.9 65.7 6.6 5.8 3.3 5.0 7.3 5.8 10.6 7.3 4.4 5.4 6.2 6.0 4.9 4.2 3.5 3.5 5.2 4.8 3.9 6.2 5.0 0.4 0.2 0.6 0.3 0.1 1.5 0.1 10.2 12.7 8.6 12.4 6.4 5.2 11.0 6.6 7.0 9.0 7.8 7.9 6.6 6.5 13.4 7.5 5.6 6.8 8.3 10.1 5.0 10.5 12.7 6.4 3.6 7.8 10.9 9.0 9.3 6.1 11.6 7.3 10.7 4.8 4.8 8.9 20.5 0.0 5.1 13.2 18.9 12.3 10.4 4.6 7.5 15.7 4.4 13.6 5.6 8.0 9.3 13.1 11.4 11.8 11.0 3.3 5.5 15.1 7.5 7.6 3.0 14.9 10.8 6.2 5.4 3.0 5.7 6.2 9.7 0.0 0.3 0.0 0.5 0.3 0.1 0.3 0.4 0.4 0.0 0.4 0.1 1.5 0.6 0.1 0.1 0.2 0.0 0.1 5.5 8.8 7.1 9.3 5.3 5.1 4.3 5.3 6.6 3.5 0.0 1.7 1.5 1.4 1.0 6.9 2.3 2.5 1.4 0.0 1.8 5.9 1.8 0.0 0.7 2.1 1.6 1.5 0.0 0.9 2.8 1.1 2.0 0.0 5.0 1.3 1.6 1.7 2.5 2.8 2.5 2.6 1.1 0.0 0.0 3.1 4.9 1.0 2.9 3.2 1.4 5.4 0.0 1.4 0.6 4.7 1.6 3.2 2.2 2.6 0.9 ZNF850 ZNF850P ENSG00000267041 "Zinc finger protein 850" A8MQ14 19 36714383-36772825 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 17.9" "Cell type enhanced" "Detected in many" 5 "Ito cells: 8.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 14.7" HPA029299 Uncertain Approved Nucleoplasm NA NA Nucleoplasm "HPA029299: AB_2672987" "unprognostic (1.35e-2)" "unprognostic (5.54e-2)" "unprognostic (3.85e-2)" "unprognostic (1.38e-3)" "unprognostic (7.78e-2)" "unprognostic (6.63e-2)" "unprognostic (1.65e-3)" "unprognostic (1.68e-1)" "unprognostic (1.21e-2)" "unprognostic (1.25e-1)" "unprognostic (3.00e-2)" "unprognostic (5.56e-2)" "unprognostic (4.11e-3)" "unprognostic (1.77e-1)" "unprognostic (7.49e-2)" "unprognostic (4.49e-2)" "unprognostic (7.37e-3)" 4.0 3.4 2.6 3.0 4.2 11.5 3.3 8.7 3.1 5.1 2.4 3.4 1.6 1.9 5.6 2.6 2.8 2.9 3.2 4.6 2.5 1.7 2.0 2.8 3.0 4.0 5.9 0.7 5.9 4.1 3.2 6.4 17.9 3.2 3.4 2.9 3.0 2.3 2.2 1.9 3.2 2.9 2.3 3.5 3.6 2.7 6.7 3.8 7.0 2.6 1.0 2.9 5.0 4.4 6.8 3.5 6.0 3.8 3.8 6.0 5.1 0.3 1.7 3.7 5.8 0.8 0.3 7.2 2.4 1.3 1.4 2.1 1.3 0.4 1.2 5.1 0.4 7.8 0.8 2.6 0.5 2.7 0.6 2.1 14.7 0.2 1.1 1.0 1.8 8.4 1.1 0.1 2.4 0.0 0.5 1.4 1.8 3.8 0.8 3.7 0.8 2.6 1.8 10.8 0.6 1.0 1.6 7.3 0.9 0.6 7.4 2.5 4.0 3.8 0.2 0.6 5.4 1.5 3.3 3.0 3.7 5.8 2.1 3.6 1.5 2.6 3.2 0.0 0.8 5.7 4.2 3.4 2.4 3.9 3.6 5.0 6.8 4.8 3.2 3.2 5.4 5.7 6.0 6.0 3.8 3.8 3.5 3.2 5.1 2.6 4.2 8.7 3.1 2.5 1.7 5.9 0.7 3.2 3.8 0.0 0.0 0.9 1.1 1.9 1.1 2.4 2.5 0.0 0.0 3.5 0.0 3.0 0.0 1.1 6.1 2.1 0.0 0.0 0.6 3.8 2.6 0.5 0.0 1.8 1.1 4.8 0.0 8.6 2.7 3.6 1.1 1.1 3.3 0.0 2.9 1.3 0.5 0.0 0.4 0.4 0.0 0.0 1.4 2.6 2.5 3.0 2.4 0.9 0.6 0.9 ZP4 ZPB ENSG00000116996 "Zona pellucida glycoprotein 4" Q12836 1 237877864-237890922 "Predicted membrane proteins, Predicted secreted proteins" Fertilization Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 2.1;ovary: 2.3;placenta: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "BJ hTERT+: 8.5" "Not detected" "Not detected" HPA008547 Supported "Secreted in female reproductive system" NA NA "HPA008547: AB_1080766" "unprognostic (7.12e-2)" "unprognostic (2.70e-1)" "unprognostic (4.59e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0